Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,negative regulation of immune system process (GO:0002683),0.9991981008328005,1.2950212130472272,0.0,1.0,0.9485,1/19,0.01%,COL3A1
prerank,heme catabolic process (GO:0042167),0.9889036837823049,1.2887631292646944,0.0385,1.0,1.0,2/16,0.69%,FABP1;GSTA1
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.9889036837823049,1.2887631292646944,0.0385,1.0,1.0,2/16,0.69%,FABP1;GSTA1
prerank,protein localization to cell-cell junction (GO:0150105),0.9881974767256632,1.286494955442292,0.0285,1.0,1.0,2/15,0.10%,ACTG1;ACTB
prerank,epithelial structure maintenance (GO:0010669),0.9892364172802046,1.2861635617724971,0.0335,1.0,1.0,4/17,0.66%,TFF3;MUC2;MUC13;TFF1
prerank,error-prone translesion synthesis (GO:0042276),0.984807255848398,1.2855316446989087,0.037,1.0,1.0,4/21,0.57%,RPS27A;UBC;UBA52;UBB
prerank,negative regulation of nervous system development (GO:0051961),0.9901449517747715,1.2852705683139973,0.028,1.0,1.0,1/18,0.07%,B2M
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.9899772635751494,1.284391812946453,0.0355,1.0,1.0,2/18,0.68%,FTH1;GSTP1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.9885020114958987,1.2842885682955243,0.0375,1.0,1.0,4/17,0.66%,TFF3;MUC2;MUC13;TFF1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.9880417415990237,1.2830227129007294,0.0345,1.0,1.0,1/16,0.18%,TMSB4X
prerank,regulation of lymphocyte proliferation (GO:0050670),0.9917202369195256,1.2823765578320112,0.023,1.0,1.0,1/19,0.21%,LGALS3
prerank,ribosomal large subunit assembly (GO:0000027),0.9904364406153838,1.2805367190316728,0.0275,1.0,1.0,8/25,0.43%,RPL10;RPL11;RPL3;RPL5;RPLP0;RPL6;RPL24;RPL23A
prerank,epithelial cell development (GO:0002064),0.985891925628003,1.279509725055739,0.035,1.0,1.0,2/21,0.48%,ACTA2;CLDN3
prerank,ribosomal small subunit assembly (GO:0000028),0.9911182203177966,1.2790838914150418,0.0325,1.0,1.0,7/16,0.41%,RPS27;RPS19;RPS28;RPS15;RPS14;RPSA;RPS5
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.9780041643848416,1.2772223410772383,0.0455,1.0,1.0,11/17,1.48%,COX4I1;COX7C;COX6A1;COX5B;COX6C;NDUFA4;COX6B1;COX8A;COX5A;COX7B;CYCS
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.9860731376465955,1.2762113562378727,0.0445,1.0,1.0,4/15,0.50%,RPL11;RPL5;RPS7;RPL23
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.9933168163815408,1.2761171787563013,0.019,1.0,1.0,5/29,0.42%,RPS8;RPS19;RPS14;RPS16;RPS21
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.9897655680666786,1.2760975842989157,0.027,1.0,1.0,1/27,0.01%,EEF1A1
prerank,error-free translesion synthesis (GO:0070987),0.9778275859152568,1.2755816358986685,0.045,1.0,1.0,4/22,0.57%,RPS27A;UBC;UBA52;UBB
prerank,positive regulation of T cell cytokine production (GO:0002726),0.989852867764314,1.2748764442141962,0.0295,1.0,1.0,3/21,0.62%,B2M;HLA-A;CD81
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.9803895366993784,1.2732652709527137,0.0495,1.0,1.0,4/24,0.57%,RPS27A;UBC;UBA52;UBB
prerank,intermediate filament organization (GO:0045109),0.9815083849900456,1.2729314550639421,0.052,1.0,1.0,3/18,0.61%,VIM;DES;KRT20
prerank,regulation of T cell cytokine production (GO:0002724),0.9897751835638406,1.272712311864062,0.036,1.0,1.0,2/19,0.37%,B2M;HLA-A
prerank,negative regulation of immune effector process (GO:0002698),0.9841467795406633,1.2721856002835061,0.046,1.0,1.0,2/16,0.21%,RPS19;LGALS3
prerank,negative regulation of actin filament polymerization (GO:0030837),0.985142448685987,1.2720809422844839,0.0445,1.0,1.0,4/24,0.61%,TMSB10;TMSB4X;PFN1;GSN
prerank,eosinophil migration (GO:0072677),0.9834379174726489,1.2716470251276266,0.0475,1.0,1.0,2/15,0.98%,LGALS3;CCL21
prerank,eosinophil chemotaxis (GO:0048245),0.9834379174726489,1.2716470251276266,0.0475,1.0,1.0,2/15,0.98%,LGALS3;CCL21
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.9794865977548459,1.271094447579235,0.055,1.0,1.0,4/18,0.57%,RPS27A;UBC;UBA52;UBB
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.9850536779263607,1.2706207833675398,0.0405,1.0,1.0,4/24,0.57%,RPS27A;UBC;UBA52;UBB
prerank,regulation of neuron migration (GO:2001222),0.9917059404718901,1.2704320655951031,0.025,1.0,1.0,2/28,0.48%,COL3A1;MDK
prerank,negative regulation of lymphocyte activation (GO:0051250),0.9847959109579819,1.2701150821627303,0.048,1.0,1.0,1/22,0.21%,LGALS3
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.9800148879931175,1.2699314435643425,0.062031015507753876,1.0,1.0,2/18,0.85%,APOA1;APOA4
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.983970945617844,1.2698809974104088,0.051,1.0,1.0,1/17,0.16%,APOA1
prerank,negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.9770405352957433,1.2698229514871449,0.058,1.0,1.0,4/16,1.53%,HLA-A;HLA-B;CEACAM1;HLA-E
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.994083626232507,1.269515180749062,0.011,1.0,1.0,2/31,0.16%,COL3A1;APOA1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.9855450197028386,1.2692785066349026,0.0425,1.0,1.0,3/21,0.85%,APOA1;APOC3;APOA4
prerank,receptor clustering (GO:0043113),0.9851936493912938,1.2688552990378337,0.04,1.0,1.0,2/28,0.41%,PIGR;FLNA
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.9796537446392852,1.2686993149604011,0.0635,1.0,1.0,3/17,1.07%,APOC3;CEACAM1;ACADVL
prerank,triglyceride catabolic process (GO:0019433),0.9848472427486081,1.2682009221311665,0.039,1.0,1.0,2/22,0.23%,FABP1;APOC3
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.9841572647121721,1.2681240896880355,0.0495,1.0,1.0,2/17,0.68%,APOA1;GSTP1
prerank,embryonic skeletal system development (GO:0048706),0.9904426847695026,1.2670980331242216,0.025,1.0,1.0,1/34,0.05%,COL1A1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.9825824898689904,1.2668717825595581,0.0475,1.0,1.0,6/24,1.06%,RPL11;RPL5;RPS7;RPL23;EFNA1;HSP90AB1
prerank,peptide cross-linking (GO:0018149),0.9894992090895256,1.2668596245127517,0.0325,1.0,1.0,2/30,0.55%,COL3A1;FN1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.9850175107498897,1.2667918647582666,0.0395,1.0,1.0,4/27,0.57%,RPS27A;UBC;UBA52;UBB
prerank,cellular response to zinc ion (GO:0071294),0.9779842659785721,1.2665846563924157,0.060030015007503754,1.0,1.0,5/18,1.34%,MT1G;MT1H;MT2A;MT1E;MT1F
prerank,detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),0.9996644374861793,1.2665511581361697,0.0,1.0,1.0,1/39,0.03%,PIGR
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.980402236950085,1.266494821114631,0.065,1.0,1.0,3/22,1.07%,APOC3;CEACAM1;ACADVL
prerank,sensory perception of bitter taste (GO:0050913),0.9996644294658575,1.2661175799436148,0.0,1.0,1.0,1/40,0.03%,PIGR
prerank,transition metal ion homeostasis (GO:0055076),0.9918058038637951,1.2659159766773975,0.0205,1.0,1.0,2/29,0.07%,FTL;B2M
prerank,positive regulation of embryonic development (GO:0040019),0.9785527526684121,1.265640880861592,0.057,1.0,1.0,2/19,0.47%,RACK1;CFL1
prerank,maturation of SSU-rRNA (GO:0030490),0.9913562392663559,1.2653628062785605,0.0195,1.0,1.0,5/34,0.39%,RPS8;RPS19;RPS28;RPS14;RPS16
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.9731848391924678,1.264046797165426,0.062031015507753876,1.0,1.0,2/15,0.72%,TMSB4X;HSPB1
prerank,mucosal immune response (GO:0002385),0.9844751071017638,1.2639704403735414,0.0445,1.0,1.0,3/23,0.85%,PIGR;RPL39;APOA4
prerank,regulation of response to cytokine stimulus (GO:0060759),0.9709418733205448,1.2638810119608834,0.074,1.0,1.0,3/21,1.66%,APOA1;CD24;KLF4
prerank,regulation of tissue remodeling (GO:0034103),0.9796478923191365,1.2638072497559953,0.0535,1.0,1.0,3/20,0.49%,CST3;MDK;CEACAM1
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.9784253347828176,1.2637951811707442,0.0635,1.0,1.0,4/18,1.15%,APOA1;APOC3;APOA4;APOE
prerank,membrane repolarization (GO:0086009),0.9740038969870126,1.2635207475553114,0.05552776388194097,1.0,1.0,3/16,1.35%,ATP1A1;ATP1B3;ATP1B1
prerank,negative regulation of neuron differentiation (GO:0045665),0.9848057434264091,1.2631671139167986,0.0405,1.0,1.0,2/24,0.92%,B2M;CALR
prerank,regulation of transmembrane transport (GO:0034762),0.9867379614881081,1.2631258089567248,0.035,1.0,1.0,1/34,0.10%,ACTB
prerank,cellular response to copper ion (GO:0071280),0.9761239425215816,1.262952509886064,0.068,1.0,1.0,6/19,1.40%,MT1G;MT1H;MT2A;MT1E;MT1F;AOC1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.9683664456998817,1.2629386234712698,0.064,1.0,1.0,3/15,2.08%,ATP1A1;ATP1B1;YWHAE
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.9996591085215412,1.2622140794919576,0.0,1.0,1.0,1/43,0.03%,PIGR
prerank,negative regulation of cell development (GO:0010721),0.9807935076607321,1.2612381972828082,0.0605,1.0,1.0,1/26,0.07%,B2M
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.9823791071689688,1.26116709376041,0.05,1.0,1.0,2/26,0.68%,APOA1;GSTP1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.976797663278865,1.2611658170437465,0.0605,1.0,1.0,4/22,0.57%,RPS27A;UBC;UBA52;UBB
prerank,acylglycerol homeostasis (GO:0055090),0.9803025283929857,1.2607596356015145,0.057,1.0,1.0,4/24,1.15%,APOA1;APOC3;APOA4;APOE
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.9768745978387361,1.2607470873372773,0.0655,1.0,1.0,4/23,0.57%,RPS27A;UBC;UBA52;UBB
prerank,regulation of protein localization to cell periphery (GO:1904375),0.9738206566009351,1.2607214202267052,0.0665,1.0,1.0,4/20,1.73%,ACTB;MISP;SPTBN1;VAMP8
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.9755154257481785,1.260572273369207,0.0675,1.0,1.0,5/21,1.29%,RPL11;RPL5;RPS7;RPL23;SKP1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.9814071896235902,1.260389825916657,0.068,1.0,1.0,7/22,0.98%,RPL37;RPS15;RPS7;RPL23;RPS20;UBB;DDX5
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.9811561622153471,1.259876232385451,0.053,1.0,1.0,4/28,0.57%,RPS27A;UBC;UBA52;UBB
prerank,negative regulation of lipid metabolic process (GO:0045833),0.9763225791127285,1.2598276261866141,0.072,1.0,1.0,2/24,0.49%,APOC3;CEACAM1
prerank,cardiac muscle cell contraction (GO:0086003),0.9746356047820122,1.2597924257747486,0.069,1.0,1.0,2/19,0.61%,ATP1A1;GSN
prerank,reverse cholesterol transport (GO:0043691),0.9738835192176403,1.2594933654137304,0.071,1.0,1.0,4/17,1.15%,APOA1;APOC3;APOA4;APOE
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.9727653613884735,1.259436047925476,0.071,1.0,1.0,2/15,0.98%,RPL26;DDX5
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.9716923155801264,1.259017852010936,0.068,1.0,1.0,5/27,1.29%,RPS27A;UBC;UBA52;UBB;SKP1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.9711336322404157,1.2589303910142666,0.065,1.0,1.0,4/23,0.57%,RPS27A;UBC;UBA52;UBB
prerank,vitamin transport (GO:0051180),0.981281844851265,1.258709586186868,0.05,1.0,1.0,2/30,0.79%,APOA1;AMN
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.973168619274704,1.2584601754609261,0.07,1.0,1.0,2/21,0.62%,RPS3;CD81
prerank,morphogenesis of an epithelium (GO:0002009),0.9833734902344227,1.258274359588467,0.0435,1.0,1.0,2/30,0.10%,ACTG1;ACTB
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.9737558711233185,1.2582649574756364,0.0705,1.0,1.0,1/16,0.30%,VIM
prerank,negative regulation of RNA metabolic process (GO:0051253),0.969485107144145,1.2582538557052905,0.058,1.0,1.0,4/19,1.84%,RPS13;RPS26;TMBIM6;PTBP1
prerank,cellular response to hydrogen peroxide (GO:0070301),0.9782704425595459,1.257863608338083,0.0585,1.0,1.0,2/35,0.28%,FABP1;RPS3
prerank,transition metal ion transport (GO:0000041),0.9877453070960072,1.2576236929021816,0.0295,1.0,1.0,1/36,0.02%,FTH1
prerank,retina homeostasis (GO:0001895),0.9874609334918418,1.257182308541387,0.035,1.0,1.0,5/36,0.72%,PIGR;B2M;ACTG1;ACTB;HSPB1
prerank,regulation of water loss via skin (GO:0033561),0.9738095555539107,1.2570919918990096,0.0605,1.0,1.0,4/19,2.05%,CLDN4;STMN1;SFN;LSR
prerank,establishment of skin barrier (GO:0061436),0.9738095555539107,1.2570919918990096,0.0605,1.0,1.0,4/19,2.05%,CLDN4;STMN1;SFN;LSR
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.9669748582965053,1.2565406113256272,0.073,1.0,1.0,2/15,0.72%,TMSB4X;HSPB1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.9655650366849554,1.2559774242268,0.0805,1.0,1.0,2/19,0.85%,APOA1;APOA4
prerank,negative regulation of lipid catabolic process (GO:0050995),0.9709148942777299,1.2558835814840001,0.081,1.0,1.0,1/18,0.23%,APOC3
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.9812299597891124,1.2558643109535397,0.0505,1.0,1.0,4/29,0.57%,RPS27A;UBC;UBA52;UBB
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.9668613343884771,1.2556942340283734,0.071,1.0,1.0,3/16,1.53%,HLA-A;CD81;HLA-E
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.9764012837813927,1.2556147152418524,0.06803401700850426,1.0,1.0,2/16,0.28%,TPT1;RPS3
prerank,global genome nucleotide-excision repair (GO:0070911),0.9750054737556636,1.2555309511180108,0.0675,1.0,1.0,4/26,0.57%,RPS27A;UBC;UBA52;UBB
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.9737733350172979,1.255069589148401,0.0715,1.0,1.0,4/19,1.03%,LGALS3;CEACAM1;EZR;PHPT1
prerank,hydrogen peroxide catabolic process (GO:0042744),0.9741314176442392,1.2550582560426407,0.069,1.0,1.0,9/20,2.17%,HBG2;HBA1;HBB;APOA4;PRDX5;PRDX2;PXDN;PRDX1;HBG1
prerank,positive regulation of response to wounding (GO:1903036),0.9790037626202966,1.2546727705957172,0.068,1.0,1.0,8/28,1.44%,ACTG1;CLDN4;CLDN3;MDK;MYLK;ITGB1;GRN;PTN
prerank,negative regulation of interleukin-8 production (GO:0032717),0.9672719718620607,1.2543523765342866,0.0665,1.0,1.0,3/18,2.45%,TMSB4X;KLF4;ANXA4
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.971206325261204,1.2542463037006375,0.07953976988494248,1.0,1.0,1/28,0.10%,FXYD3
prerank,regulation of cellular senescence (GO:2000772),0.9804805258414926,1.2537410512899476,0.0515,1.0,1.0,1/31,0.07%,B2M
prerank,response to copper ion (GO:0046688),0.9727944657470311,1.2536234098185672,0.078,1.0,1.0,7/23,1.52%,MT1G;MT1H;MT2A;MT1E;MT1F;AOC1;ATP5F1D
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.977424150595795,1.2534119469229277,0.0625,1.0,1.0,4/30,0.57%,RPS27A;UBC;UBA52;UBB
prerank,positive regulation of collagen metabolic process (GO:0010714),0.9715584961492177,1.2529527671019902,0.073,1.0,1.0,1/17,0.30%,VIM
prerank,defense response to fungus (GO:0050832),0.9687125311745528,1.2527477363678443,0.0795,1.0,1.0,2/24,1.68%,GAPDH;RARRES2
prerank,negative regulation of interleukin-1 production (GO:0032692),0.9804179948067712,1.2526653125094513,0.062,1.0,1.0,3/30,0.68%,APOA1;CEACAM1;GSTP1
prerank,negative regulation of biosynthetic process (GO:0009890),0.967259982745393,1.2524326565440453,0.067,1.0,1.0,4/17,1.85%,CEACAM1;GSTP1;EMILIN1;PARK7
prerank,positive regulation of JUN kinase activity (GO:0043507),0.9700371018046311,1.2522914063976276,0.086,1.0,1.0,1/23,0.28%,RPS3
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.9774218909374944,1.2521125751085598,0.0625,1.0,1.0,4/31,0.57%,RPS27A;UBC;UBA52;UBB
prerank,DNA methylation or demethylation (GO:0044728),0.9640761504631087,1.2514579171399236,0.072,1.0,1.0,1/19,0.28%,FOS
prerank,DNA alkylation (GO:0006305),0.9640761504631087,1.2514579171399236,0.072,1.0,1.0,1/19,0.28%,FOS
prerank,regulation of collagen biosynthetic process (GO:0032965),0.9693547014551258,1.2514571940982526,0.071,1.0,1.0,2/19,0.88%,VIM;EMILIN1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.9752607901158946,1.2513944441107057,0.0745,1.0,1.0,5/29,1.07%,APOA1;APOC3;CEACAM1;APOA4;ACADVL
prerank,positive regulation of lipid catabolic process (GO:0050996),0.9703595374110813,1.251022724899395,0.081,1.0,1.0,2/21,0.85%,APOA1;APOA4
prerank,ribosomal small subunit biogenesis (GO:0042274),0.9847603210853927,1.2509110720559873,0.0395,1.0,1.0,14/39,1.07%,RPS27;RPS19;RPS24;RPS28;RPS6;RPS15;RPS14;RPS7;RPSA;RPS16;RPS25;RPS5;RPS17;NPM1
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.9666782670137404,1.250613609650985,0.0775,1.0,1.0,4/20,1.85%,RPS3;CD24;HMGB1;IGFBP2
prerank,maturation of LSU-rRNA (GO:0000470),0.9747440744655135,1.2504894229398433,0.0795,1.0,1.0,4/26,0.40%,RPL7A;RPL35;RPL10A;RPL7
prerank,lymphocyte activation involved in immune response (GO:0002285),0.9747530486764011,1.2502273677737885,0.0765,1.0,1.0,2/24,0.98%,MDK;CD74
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.9736631213959293,1.2498912573708405,0.0685,1.0,1.0,4/29,0.57%,RPS27A;UBC;UBA52;UBB
prerank,positive chemotaxis (GO:0050918),0.96436611670711,1.2497439493039144,0.076,1.0,1.0,1/18,0.21%,LGALS3
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.9645692963275467,1.2496281525714108,0.0825,1.0,1.0,1/21,0.10%,ACTG1
prerank,actin-myosin filament sliding (GO:0033275),0.9797756014006213,1.2495325252846874,0.0565,1.0,1.0,5/38,0.47%,MYL6;VIM;TPM2;DES;TPM1
prerank,muscle filament sliding (GO:0030049),0.9797756014006213,1.2495325252846874,0.0565,1.0,1.0,5/38,0.47%,MYL6;VIM;TPM2;DES;TPM1
prerank,killing by host of symbiont cells (GO:0051873),0.9692321459223555,1.2493611460075429,0.0830415207603802,1.0,1.0,2/16,1.90%,GAPDH;ROMO1
prerank,acylglycerol catabolic process (GO:0046464),0.9776993100382239,1.2492145282763791,0.0515,1.0,1.0,2/34,0.23%,FABP1;APOC3
prerank,cellular response to cadmium ion (GO:0071276),0.9730634807364312,1.249164829550226,0.082,1.0,1.0,7/27,1.34%,MT1G;MT1H;FOS;MT2A;MT1E;JUN;MT1F
prerank,response to zinc ion (GO:0010043),0.9715658303434566,1.2482281431753803,0.083,1.0,1.0,5/29,1.34%,MT1G;MT1H;MT2A;MT1E;MT1F
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.9726412441470379,1.248159131248249,0.0795,1.0,1.0,4/25,1.03%,LGALS3;CEACAM1;EZR;PHPT1
prerank,regulation of transport (GO:0051049),0.9808937607812994,1.2478154497290872,0.053,1.0,1.0,3/37,0.48%,ACTG1;ACTB;CLDN3
prerank,JNK cascade (GO:0007254),0.9759556639318214,1.247734756911351,0.0605,1.0,1.0,4/41,0.57%,RPS27A;UBC;UBA52;UBB
prerank,mononuclear cell differentiation (GO:1903131),0.9723474813496256,1.2472517649930979,0.075,1.0,1.0,2/26,1.25%,MT1G;MYH9
prerank,response to cadmium ion (GO:0046686),0.9729143973942774,1.2471097060802787,0.081,1.0,1.0,7/29,1.34%,MT1G;MT1H;FOS;MT2A;MT1E;JUN;MT1F
prerank,cholesterol efflux (GO:0033344),0.9704569744693274,1.2468459456785244,0.087,1.0,1.0,4/24,1.15%,APOA1;APOC3;APOA4;APOE
prerank,cellular zinc ion homeostasis (GO:0006882),0.9678386448205044,1.246840259780533,0.0905,1.0,1.0,7/28,2.25%,MT1G;MT1H;MT2A;MT1E;MT1F;SLC39A5;MT1X
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.9613105145202535,1.2468364481700314,0.0935,1.0,1.0,15/16,3.19%,ATP5F1E;ATP5ME;ATP5F1B;ATP5MG;ATP5MC2;ATP5F1A;ATP5PF;ATP5MC3;ATP5F1D;ATP5PO;ATP5MF;ATP5MC1;ATP5PB;ATP5PD;ATP5F1C
prerank,triglyceride homeostasis (GO:0070328),0.9746697093767055,1.246236782779379,0.075,1.0,1.0,4/30,1.15%,APOA1;APOC3;APOA4;APOE
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.9788343119987385,1.2460117480260204,0.068,1.0,1.0,3/34,0.39%,B2M;HLA-A;HLA-B
prerank,negative regulation of response to wounding (GO:1903035),0.9643899175628534,1.245717812645425,0.082,1.0,1.0,2/21,0.48%,CLDN3;MDK
prerank,hydrogen peroxide metabolic process (GO:0042743),0.9729523415239107,1.2454788776430672,0.0795,1.0,1.0,12/28,2.17%,HBG2;HBA1;HBB;APOA4;PRDX5;CYBA;PRDX2;PXDN;PARK7;SOD1;PRDX1;HBG1
prerank,ribosome assembly (GO:0042255),0.9870198747435751,1.2450793561566165,0.0335,1.0,1.0,15/49,0.43%,RPL10;RPS27;RPL11;RPS19;RPS28;RPS15;RPS14;RPL3;RPL5;RPLP0;RPL6;RPSA;RPL24;RPS5;RPL23A
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.9531768755336707,1.2447625051320501,0.0795,1.0,1.0,2/15,1.27%,DCN;VCAN
prerank,regulation of protein localization to membrane (GO:1905475),0.9670155196721858,1.244718685610291,0.082,1.0,1.0,5/30,1.89%,ACTB;GSN;SPTBN1;VAMP8;GPC3
prerank,monocyte chemotaxis (GO:0002548),0.9817372900168791,1.2443690760709478,0.0515,1.0,1.0,3/41,0.98%,RPS19;LGALS3;CCL21
prerank,sarcomere organization (GO:0045214),0.9745080940566033,1.2442389221653478,0.0765,1.0,1.0,4/28,2.05%,KRT19;TPM1;CSRP1;WDR1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.964687753917861,1.24377627478712,0.0815,1.0,1.0,3/25,1.66%,APOA1;CEACAM6;KLF4
prerank,endocrine system development (GO:0035270),0.9617271188397511,1.2437307436851104,0.0985,1.0,1.0,1/24,0.48%,MDK
prerank,membrane raft organization (GO:0031579),0.9570674369646058,1.24348595772872,0.079,1.0,1.0,2/15,0.91%,S100A10;ANXA2
prerank,DNA methylation (GO:0006306),0.9612774063361681,1.2431960896173788,0.0845,1.0,1.0,1/23,0.28%,FOS
prerank,zinc ion homeostasis (GO:0055069),0.9677105551690741,1.243164720085792,0.0915,1.0,1.0,7/30,2.25%,MT1G;MT1H;MT2A;MT1E;MT1F;SLC39A5;MT1X
prerank,sterol transport (GO:0015918),0.9645229704424154,1.242397182177989,0.0915,1.0,1.0,6/21,2.77%,APOA1;APOB;NPC2;APOA2;LDLR;CAV1
prerank,substantia nigra development (GO:0021762),0.9744391128105272,1.2423240941463376,0.068,1.0,1.0,13/42,2.08%,CKB;ACTB;CALM2;DYNLL1;COX6B1;CALM1;ATP5PF;RHOA;YWHAQ;HSPA5;CDC42;CALM3;YWHAE
prerank,negative regulation of endocytosis (GO:0045806),0.9688748768168327,1.242251144501392,0.0855,1.0,1.0,3/25,1.43%,LGALS3;APOC3;RAC1
prerank,platelet aggregation (GO:0070527),0.9739970211895743,1.2418279357244677,0.0685,1.0,1.0,13/36,1.56%,ACTG1;ACTB;MYL9;FLNA;GNAS;PPIA;FN1;HSPB1;HBB;CSRP1;MYH9;CLIC1;MYL12A
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.9700930809605424,1.2416039176496763,0.086,1.0,1.0,5/25,1.36%,TPT1;MUC1;CD74;MIF;CXCL12
prerank,cellular response to cAMP (GO:0071320),0.9684214785257542,1.2413171723519172,0.0855,1.0,1.0,5/31,1.24%,SLC26A3;EZR;IGFBP5;AQP8;ZFP36L1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.9762583727663534,1.2412774195788117,0.065,1.0,1.0,2/42,0.48%,COL1A1;MDK
prerank,regulation of actin filament bundle assembly (GO:0032231),0.9656279820882487,1.2406992162404495,0.0815,1.0,1.0,6/26,2.50%,ACTG1;PFN1;RAC1;CDC42;VIL1;SYNPO2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.9777418532729456,1.2405123567480796,0.0705,1.0,1.0,2/33,0.37%,B2M;HLA-A
prerank,aggrephagy (GO:0035973),0.9686645114930481,1.2404655738555608,0.0885,1.0,1.0,6/29,0.75%,RPS27A;VIM;UBC;UBA52;UBB;DYNLL1
prerank,maintenance of blood-brain barrier (GO:0035633),0.9691133402181813,1.2403807337837895,0.0805,1.0,1.0,3/30,0.48%,ACTG1;ACTB;CLDN3
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.9641095789039209,1.2401430652337289,0.085,1.0,1.0,2/20,0.52%,CLDN4;CLDN7
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.9618025806275786,1.2397830058393904,0.09,1.0,1.0,1/23,0.18%,TMSB4X
prerank,innate immune response in mucosa (GO:0002227),0.9609936342302432,1.2396678773225815,0.087,1.0,1.0,3/16,1.58%,RPL39;APOA4;DEFA3
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.9842388350171011,1.23948448235186,0.039,1.0,1.0,1/47,0.03%,PIGR
prerank,ATP synthesis coupled proton transport (GO:0015986),0.9596635866749339,1.239015117490785,0.101,1.0,1.0,15/18,3.19%,ATP5F1E;ATP5ME;ATP5F1B;ATP5MG;ATP5MC2;ATP5F1A;ATP5PF;ATP5MC3;ATP5F1D;ATP5PO;ATP5MF;ATP5MC1;ATP5PB;ATP5PD;ATP5F1C
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.9587048694119541,1.238782553761972,0.0805,1.0,1.0,1/22,0.41%,FLNA
prerank,regulation of mononuclear cell migration (GO:0071675),0.960731021806916,1.2387463232815779,0.0905,1.0,1.0,3/23,1.68%,LGALS3;MDK;RARRES2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.9733108471844734,1.238696441805798,0.083,1.0,1.0,6/35,1.03%,LGALS3;RPS3;CEACAM1;CD81;EZR;PHPT1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.9693669746536504,1.2381928098768462,0.084,1.0,1.0,9/33,2.03%,B2M;HLA-A;HLA-B;HLA-C;CALR;HLA-E;CANX;PDIA3;TAPBP
prerank,regulation of cellular amide metabolic process (GO:0034248),0.9715726523662562,1.2381616639753406,0.0785,1.0,1.0,1/32,0.05%,RPL10
prerank,regulation of lipid catabolic process (GO:0050994),0.963544903914514,1.2378865168923987,0.099,1.0,1.0,3/21,2.53%,APOC3;RARRES2;APOA2
prerank,odontogenesis (GO:0042476),0.977909908221087,1.2376641964416708,0.058,1.0,1.0,2/39,1.13%,COL1A2;LAMB1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.9538547123991088,1.2376047592826542,0.087,1.0,1.0,2/17,1.35%,ATP1A1;ATP1B1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.9724962926834422,1.23760331955213,0.089,1.0,1.0,6/30,1.36%,TPT1;RPS3;CD74;PTTG1IP;MIF;CXCL12
prerank,stress granule assembly (GO:0034063),0.958408505331136,1.2370603832504385,0.1015,1.0,1.0,2/20,0.73%,RPS23;CIRBP
prerank,ERK1 and ERK2 cascade (GO:0070371),0.9599179467483752,1.2369810926131568,0.099,1.0,1.0,3/22,1.24%,APOA1;ZFP36L2;ZFP36L1
prerank,cellular sodium ion homeostasis (GO:0006883),0.9551854746894048,1.2367934902187585,0.09104552276138068,1.0,1.0,3/15,1.35%,ATP1A1;ATP1B3;ATP1B1
prerank,regulation of stem cell proliferation (GO:0072091),0.951283817835194,1.2367866905539393,0.0905,1.0,1.0,5/17,2.44%,EPCAM;FBLN1;ZFP36L1;HNRNPU;HMGB2
prerank,T cell activation involved in immune response (GO:0002286),0.9690867226619826,1.2365682332353494,0.0975,1.0,1.0,2/28,0.98%,MDK;CD74
prerank,TOR signaling (GO:0031929),0.9652382239087164,1.236279871998447,0.101,1.0,1.0,1/25,0.17%,RPS6
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.9624650494469678,1.2360482193132825,0.106,1.0,1.0,4/28,1.53%,HLA-A;HLA-B;CEACAM1;HLA-E
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.9554026843590797,1.2358713586107768,0.0955,1.0,1.0,1/23,0.21%,LGALS3
prerank,positive regulation of cellular component movement (GO:0051272),0.9598449001368308,1.235666859948757,0.1125,1.0,1.0,5/27,1.65%,RPS19;CCL21;PHPT1;ACTN4;TUBB2B
prerank,positive regulation of innate immune response (GO:0045089),0.968830171786497,1.2355355469773932,0.0935,1.0,1.0,2/35,1.53%,RPS19;HLA-E
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.9624867862622211,1.2352257635446373,0.109,1.0,1.0,1/24,0.16%,APOA1
prerank,"wound healing, spreading of cells (GO:0044319)",0.9583719231963185,1.235134112707235,0.092,1.0,1.0,6/22,1.50%,FLNA;CEACAM1;COL5A1;RHOC;RHOA;CD151
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.9661525593110535,1.2351032294583424,0.1005,1.0,1.0,4/37,0.57%,RPS27A;UBC;UBA52;UBB
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.9627161413845378,1.2349212518918546,0.0965,1.0,1.0,1/29,0.14%,RPS2
prerank,positive regulation of response to stimulus (GO:0048584),0.9785874756130958,1.2348164075713821,0.0575,1.0,1.0,1/46,0.07%,B2M
prerank,negative regulation of RNA splicing (GO:0033119),0.9483649783753163,1.2347616703898159,0.088,1.0,1.0,9/19,2.89%,RPS13;RPS26;TMBIM6;PTBP1;SRSF6;RBMX;SRSF7;SAP18;RNPS1
prerank,translesion synthesis (GO:0019985),0.9655930738980154,1.2347252004225777,0.089,1.0,1.0,4/42,0.57%,RPS27A;UBC;UBA52;UBB
prerank,regulation of cell morphogenesis (GO:0022604),0.9618898799216586,1.2343771188188315,0.104,1.0,1.0,4/32,0.48%,SPARC;CLDN4;CFL1;CLDN3
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.9674852135018888,1.2339146063435498,0.0915,1.0,1.0,4/42,0.57%,RPS27A;UBC;UBA52;UBB
prerank,ribosomal large subunit biogenesis (GO:0042273),0.9846596496368407,1.2338611893896259,0.035,1.0,1.0,14/56,0.43%,RPL10;RPL11;RPL3;RPL7A;RPL5;RPLP0;RPL35A;RPL6;RPL26;RPL10A;RPL7;RPL24;RPL23A;RPL14
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.9582063973332826,1.2336916570159822,0.1025,1.0,1.0,5/31,1.69%,LGALS3;CALR;HMGB1;CXCL12;S100A14
prerank,positive regulation of wound healing (GO:0090303),0.9664187996525265,1.233509778248669,0.092,1.0,1.0,5/40,1.34%,ACTG1;CLDN4;CLDN3;MYLK;ITGB1
prerank,homotypic cell-cell adhesion (GO:0034109),0.9731580002754513,1.2329011939152956,0.0715,1.0,1.0,15/44,1.56%,ACTG1;ACTB;MYL9;CEACAM5;FLNA;GNAS;PPIA;FN1;HSPB1;HBB;CSRP1;CD99;MYH9;CLIC1;MYL12A
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.9910631937616117,1.2328352775254967,0.016,1.0,1.0,2/63,0.16%,COL3A1;APOA1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.9622742642993704,1.2328226925897414,0.1045,0.998224673429693,1.0,4/28,1.32%,S100A6;FN1;CD74;MIF
prerank,bone development (GO:0060348),0.9748598880679193,1.23269513590555,0.0745,0.995513473792303,1.0,2/40,0.44%,RPL13;GNAS
prerank,regulation of fibroblast proliferation (GO:0048145),0.9764864637769448,1.2325733064386661,0.0715,0.9927494391455198,1.0,5/46,0.98%,FTH1;S100A6;FN1;GSTP1;CD74
prerank,negative regulation of response to stimulus (GO:0048585),0.9867874473865725,1.2325378006559693,0.027,0.9884119784842128,1.0,2/60,0.16%,COL3A1;APOA1
prerank,negative regulation of phagocytosis (GO:0050765),0.954683175398417,1.232382584992772,0.0925,0.9863857613779835,1.0,3/17,2.25%,RACK1;HMGB1;SNX3
prerank,dendritic cell chemotaxis (GO:0002407),0.9504054782755906,1.2322083905139205,0.0935,0.9846970305161493,1.0,3/16,2.72%,CCL21;HMGB1;TRPM4
prerank,positive regulation of cholesterol efflux (GO:0010875),0.959479074666358,1.2321764414602623,0.1075,0.9804236389236493,1.0,3/23,1.86%,APOA1;APOE;LRP1
prerank,chordate embryonic development (GO:0043009),0.983570423101021,1.2319387267800888,0.0435,0.9797213067720164,1.0,1/58,0.05%,COL1A1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.9477693701331198,1.2318758723883474,0.09154577288644322,0.9760447596992877,1.0,2/15,1.53%,CEACAM1;HLA-E
prerank,regulation of establishment of cell polarity (GO:2000114),0.9460164573778373,1.2311094397837419,0.097,0.9845261340645409,1.0,2/15,0.61%,RACK1;GSN
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.9650734429944395,1.230609658997264,0.1025,0.988335249781419,1.0,4/39,0.57%,RPS27A;UBC;UBA52;UBB
prerank,amyloid fibril formation (GO:1990000),0.9803843344581381,1.2304832405743757,0.05,0.9857437121974121,1.0,11/58,0.85%,B2M;TTR;RPS27A;APOA1;CST3;UBC;UBA52;UBB;GSN;ITM2B;APOA4
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.9454941489311759,1.2298128206193553,0.0985,0.9924088315896994,1.0,1/16,0.39%,RACK1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.954023507370336,1.229734188360037,0.1115,0.9890694969412258,1.0,4/25,2.66%,HLA-A;HLA-B;HLA-E;HLA-DRA
prerank,positive regulation of lipid metabolic process (GO:0045834),0.9655425560617579,1.2296542241184634,0.097,0.9858088040145345,1.0,3/25,1.15%,APOA1;APOA4;APOE
prerank,regulation of cholesterol transport (GO:0032374),0.9602147943790413,1.2296140559991924,0.0935,0.9819171946004663,1.0,5/25,2.53%,APOA1;APOA4;TSPO;LRP1;APOA2
prerank,negative chemotaxis (GO:0050919),0.9572864265409156,1.2294935829840754,0.1085,0.9792177312981756,1.0,2/33,1.42%,APOA1;RHOA
prerank,T cell mediated immunity (GO:0002456),0.9496115451558418,1.2293170857678795,0.093,0.9776868073881572,1.0,1/16,0.37%,HLA-A
prerank,regulation of intracellular pH (GO:0051453),0.9637675124542568,1.2291101304261727,0.0995,0.9766604743599053,1.0,3/36,1.02%,SLC26A3;ATP5F1B;CA2
prerank,response to hydrogen peroxide (GO:0042542),0.9659815622376275,1.2289789956346922,0.0905,0.9743679485140851,1.0,4/48,0.75%,FABP1;RPS3;HBA1;HBB
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.9454840041551884,1.2287443630338133,0.10155077538769385,0.9738475878252825,1.0,1/18,0.35%,CEACAM5
prerank,protein homotetramerization (GO:0051289),0.9790197743755102,1.2285810075564956,0.061,0.9720862297127225,1.0,1/52,0.07%,B2M
prerank,myoblast fusion (GO:0007520),0.9478508371153958,1.2283770759316925,0.09054527263631816,0.9710177080295558,1.0,2/15,1.01%,CD81;CD9
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.9549476865271797,1.227881193265394,0.102,0.974675186939401,1.0,4/19,1.43%,MDK;CD74;CCL21;RAC1
prerank,positive regulation of interleukin-2 production (GO:0032743),0.9569830878311589,1.2278444591284932,0.112,0.9708699558467535,1.0,2/26,1.60%,RPS3;SPTBN1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.9718363565436877,1.2277753215411327,0.09,0.9677553678774083,1.0,6/39,1.43%,B2M;APOC3;CCL21;HNRNPK;ARF1;RAC1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.9483617976114258,1.2276955654449615,0.111,0.9648046592468462,1.0,1/22,0.42%,RPS21
prerank,response to estrogen (GO:0043627),0.9593693897975064,1.2276778395233088,0.108,0.9608275435615101,1.0,2/34,0.77%,KRT19;CD24
prerank,positive regulation of neutrophil migration (GO:1902624),0.9576210185479053,1.2275674085205184,0.1025,0.958420004729651,1.0,5/22,1.43%,MDK;CD74;CCL21;CD99;RAC1
prerank,regulation of calcium ion import (GO:0090279),0.9553428322660095,1.2275283711493936,0.1105,0.9548780560519338,1.0,3/25,1.89%,LGALS3;CXCL12;CTNNB1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.9584991359709619,1.2274482406896108,0.106,0.9520268275582291,1.0,10/36,1.96%,APOA1;S100A10;FLNA;MDK;OLFM4;P4HB;CALR;RAC1;CIB1;CDC42
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.9742396777349397,1.227426009436379,0.068,0.9481967991318035,1.0,1/46,0.05%,RPL10
prerank,positive regulation of protein processing (GO:0010954),0.9484974647006282,1.226862484026492,0.1025,0.9529248592849102,1.0,5/20,2.68%,GSN;ENO1;MYH9;MELTF;HPN
prerank,negative regulation of neurogenesis (GO:0050768),0.9585607533306723,1.2268226290521886,0.0975,0.9494810099702746,1.0,4/35,1.63%,B2M;RHOA;PTN;RTN4
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.959902937821218,1.2265809150917402,0.113,0.9492565450123699,1.0,5/39,2.20%,FXYD3;FHL1;FXYD6;YWHAE;PHB2
prerank,anion transport (GO:0006820),0.968663543020417,1.2264609875261505,0.089,0.9470310426456668,1.0,3/43,1.96%,SLC26A3;TSPO;VDAC2
prerank,basement membrane organization (GO:0071711),0.9405322557643563,1.2262873492507673,0.10205102551275638,0.9456744256703281,1.0,10/16,4.39%,COL4A1;LAMB1;NID1;PXDN;FLRT2;LAMB2;HPN;CTSS;LAMB3;RAMP2
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.9859109681662275,1.2261906613341715,0.035,0.9432407142928437,1.0,17/58,1.07%,RPL11;RPS19;RPS24;RPS28;RPS6;RPS15;RPL5;RPL35A;RPS7;RPL26;RPS16;RPL7;RPS25;RPL14;RPL38;RPS17;NPM1
prerank,regulation of muscle contraction (GO:0006937),0.9585986042395932,1.2260396729230445,0.1,0.9415559583609288,1.0,5/28,1.18%,MYL9;TPM1;CNN1;ENO1;SRI
prerank,postreplication repair (GO:0006301),0.9619504309099765,1.2258562834381121,0.1045,0.9405516448267096,1.0,4/45,0.57%,RPS27A;UBC;UBA52;UBB
prerank,response to cAMP (GO:0051591),0.9635579070026885,1.2257602658053852,0.1025,0.9380546650952069,1.0,5/38,1.24%,SLC26A3;EZR;IGFBP5;AQP8;ZFP36L1
prerank,cellular iron ion homeostasis (GO:0006879),0.98236191178737,1.2252167320937004,0.0425,0.9422394372959281,1.0,2/58,0.04%,FTH1;FTL
prerank,negative regulation of T cell activation (GO:0050868),0.97125707763751,1.2251182428644871,0.089,0.9398436752977904,1.0,2/44,0.49%,LGALS3;CEACAM1
prerank,negative regulation of innate immune response (GO:0045824),0.9602999011831573,1.2250240694498162,0.104,0.9373744959910398,1.0,3/38,1.61%,RPS19;GRN;A2M
prerank,iron ion homeostasis (GO:0055072),0.9849328201205948,1.2247952678281115,0.034,0.9369367867513188,1.0,3/61,0.07%,FTH1;FTL;B2M
prerank,glycolytic process (GO:0006096),0.9508187718488026,1.22477976760663,0.11,0.9333175485770133,1.0,8/29,2.07%,GAPDH;TPI1;LDHA;ENO1;PKM;PFKL;PGAM1;PGK1
prerank,positive regulation of leukocyte migration (GO:0002687),0.9589899593788184,1.2241688009630556,0.116,0.9386073363561455,1.0,3/29,1.44%,LGALS3;MDK;PTN
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.9611357688943647,1.2240370610053568,0.1025,0.9367117377504324,1.0,8/38,1.85%,RPL11;RPL5;RPS7;RPL23;HSP90AB1;NOP53;GIPC1;PARK7
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.9434096449858635,1.2237018162427225,0.1025,0.9380854911465696,1.0,4/16,1.32%,MUC1;CD74;PTTG1IP;MIF
prerank,positive regulation of immune effector process (GO:0002699),0.9556601155155993,1.2235101253063307,0.111,0.9371520721582813,1.0,2/32,0.62%,RPS19;CD81
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.9539575557359817,1.2234899783549529,0.113,0.9336613486270157,1.0,5/22,1.69%,MDK;CD74;CCL21;RAC1;S100A14
prerank,neuron apoptotic process (GO:0051402),0.9447576115978885,1.2230084789271702,0.106,0.9370555636056999,1.0,3/20,2.70%,GAPDH;APP;ERBB3
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.9469344494930486,1.222877806198297,0.0985,0.9351940906873821,1.0,3/16,1.98%,MDK;RHOA;ST3GAL4
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.9688718133654676,1.2217166704478253,0.1,0.9484748729522944,1.0,4/42,0.50%,RPL11;RPL5;RPS7;RPL23
prerank,iron ion transport (GO:0006826),0.9731482942038838,1.2215189756874951,0.072,0.9475940933568848,1.0,1/50,0.02%,FTH1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.9492915206175115,1.2212484588141772,0.104,0.9478519373725205,1.0,5/18,1.88%,PPIA;HSPB1;P4HB;SFPQ;SOD1
prerank,myeloid cell differentiation (GO:0030099),0.9700466676904036,1.2209488079644206,0.083,0.9483595527132841,1.0,4/51,1.24%,RPS19;RPS14;SLC25A5;ATP5IF1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.9935193431543655,1.2209376724649408,0.006,0.9448344847019318,1.0,76/90,0.57%,RPL41;RPL13;RPL10;RPS8;RPLP1;RPS12;RPL13A;RPL34;RPS27;RPS23;RPS2;RPS18;RPS15A;RPL37A;RPL32;RPS27A;RPL11;RPS19;RPS24;RPS28;RPS6;RPL37;RPL28;RPS3A;RPS15;RPS14;RPL9;RPL3;RPL12;RPS4X;RPL29;RPL30;RPL19;RPL18A;RPL8;RPL18;RPL7A;RPL5;RPLP0;RPL35A;RPL36;RPS3;RPL15;RPL4;RPL6;RPL21;RPL35;RPS11;RPLP2;RPS13;RPL39;RPS29;RPS7;RPL22;RPL26;RPS26;RPSA;RPS9;RPL31;RPL10A;RPS16;RPL7;RPL24;RPS25;RPS5;RPS21;RPL23A;RPL14;RPL27A;RPS10;RPL23;RPS20;RPL36A;RPL27;UBA52;RPL38
prerank,regulation of exit from mitosis (GO:0007096),0.9578370550074029,1.2206787351942117,0.1115,0.9449029518785734,1.0,4/38,0.57%,RPS27A;UBC;UBA52;UBB
prerank,glucose catabolic process to pyruvate (GO:0061718),0.9474261045532111,1.2206553151672082,0.112056028014007,0.9379480326319742,1.0,7/24,2.07%,GAPDH;TPI1;ENO1;PKM;PFKL;PGAM1;PGK1
prerank,canonical glycolysis (GO:0061621),0.9474261045532111,1.2206553151672082,0.112056028014007,0.9379480326319742,1.0,7/24,2.07%,GAPDH;TPI1;ENO1;PKM;PFKL;PGAM1;PGK1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.9723043362805766,1.2201057741278507,0.0905,0.9422017004003245,1.0,5/44,0.99%,B2M;CD63;ANXA2;CCL21;HNRNPK
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.9502490457029574,1.2200027221113843,0.113,0.9400211217769371,1.0,3/34,1.25%,MT1G;HSPB1;NR4A1
prerank,skeletal muscle organ development (GO:0060538),0.9535053333867408,1.2198922474069727,0.1235,0.9381271885791402,1.0,4/32,2.77%,MYL6;TCF21;MYH14;CAV1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.9376526203017559,1.2193327368270848,0.109,0.9426194434751263,1.0,3/17,2.83%,EPCAM;HNRNPU;LTBP3
prerank,negative regulation of anoikis (GO:2000811),0.9384234155095411,1.2193226316562211,0.102,0.9391588314128365,1.0,5/16,2.77%,CEACAM5;CEACAM6;ITGB1;MCL1;CAV1
prerank,negative regulation of platelet activation (GO:0010544),0.9416072490741423,1.2191271570219193,0.117,0.9383571606593074,1.0,4/16,3.03%,CEACAM1;CD9;APOE;PDGFRA
prerank,positive regulation of biosynthetic process (GO:0009891),0.9675019687536127,1.218927182411774,0.0965,0.9375973655602761,1.0,5/44,1.49%,APOA1;VIM;APOA4;APOE;CYBA
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.957918387348321,1.2184459757939934,0.113,0.9409176501121063,1.0,6/41,1.66%,APOA1;EPCAM;SPINT2;ASS1;CDH1;KLF4
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.9575306405398759,1.2181779821616618,0.124,0.9410073234294857,1.0,3/40,1.90%,FXYD3;SLC9A3R1;FXYD6
prerank,erythrocyte differentiation (GO:0030218),0.9658885808823215,1.2181654609432244,0.11,0.9376657657283686,1.0,5/45,1.59%,RPS19;RPS14;SLC25A5;ATP5IF1;ID2
prerank,antibacterial humoral response (GO:0019731),0.959860837050287,1.218102638267826,0.1095,0.9350586191487061,1.0,10/39,3.21%,RPL39;HLA-A;JCHAIN;HLA-E;PI3;DEFA3;SLPI;WFDC2;DEFA5;DMBT1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.9366863579580375,1.2178698193651931,0.1015,0.934787767433071,1.0,3/17,2.60%,RACK1;LLGL2;RAP1B
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.9364678067959123,1.2178546817474998,0.1185,0.9315596216282456,1.0,1/19,0.35%,EPCAM
prerank,negative regulation of DNA metabolic process (GO:0051053),0.9463004295440167,1.2172136165847787,0.12,0.9367944710245203,1.0,3/26,2.06%,RPS3;SUB1;CDKN1A
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.9422307017597787,1.2170133295198333,0.1055,0.9361486886850902,1.0,4/19,3.61%,HLA-A;HLA-E;HLA-DRA;HLA-DRB1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.9424785217467653,1.216971163499182,0.1035,0.933262757765579,1.0,2/19,0.56%,DCN;CD63
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.9532906039688714,1.2169527767364015,0.1205,0.9301089160273694,1.0,12/39,2.94%,RPS3;RPS7;RACK1;UBB;SLC9A3R1;SFPQ;SOD1;NUPR1;EIF5A;FIS1;CAV1;BCAP31
prerank,positive regulation of cation channel activity (GO:2001259),0.9531197713996465,1.2169021940345885,0.123,0.9273744045341604,1.0,6/38,2.82%,TMSB4X;CALM2;CALM1;CALM3;CTSS;GAL
prerank,striated muscle tissue development (GO:0014706),0.9513213155550265,1.2165773619348934,0.1205,0.9284062507723645,1.0,1/34,0.19%,MYL6
prerank,cytoplasmic translation (GO:0002181),0.9930231800157225,1.2162932160847066,0.008,0.9288393390138594,1.0,75/93,0.57%,RPL41;RPL13;RPL10;RPS8;RPLP1;RPS12;RPL13A;RPL34;RPS27;RPS23;RPS2;RPS18;RPS15A;RPL37A;RPL32;RPS27A;RPL11;RPS19;RPS24;RPS28;RPS6;RPL37;RPL28;RPS3A;RPS15;RPS14;RPL9;RPL3;RPL12;RPS4X;RPL29;RPL30;RPL19;RPL18A;RPL8;RPL18;RPL7A;RPL5;RPLP0;RPL35A;RPL36;RPS3;RPL15;RPL4;RPL6;RPL21;RPL35;RPS11;RPS13;RPL39;RPS29;RPS7;RPL22;RPL26;RPS26;RPSA;RPS9;RPL31;RPL10A;RPS16;RPL7;RPL24;RPS25;RPS5;RPS21;RPL23A;RPL14;RPL27A;RPS10;RPL23;RPS20;RPL36A;RPL27;UBA52;RPL38
prerank,cotranslational protein targeting to membrane (GO:0006613),0.9932494566303353,1.2162698949832784,0.0065,0.925784177670673,1.0,76/94,0.57%,RPL41;RPL13;RPL10;RPS8;RPLP1;RPS12;RPL13A;RPL34;RPS27;RPS23;RPS2;RPS18;RPS15A;RPL37A;RPL32;RPS27A;RPL11;RPS19;RPS24;RPS28;RPS6;RPL37;RPL28;RPS3A;RPS15;RPS14;RPL9;RPL3;RPL12;RPS4X;RPL29;RPL30;RPL19;RPL18A;RPL8;RPL18;RPL7A;RPL5;RPLP0;RPL35A;RPL36;RPS3;RPL15;RPL4;RPL6;RPL21;RPL35;RPS11;RPLP2;RPS13;RPL39;RPS29;RPS7;RPL22;RPL26;RPS26;RPSA;RPS9;RPL31;RPL10A;RPS16;RPL7;RPL24;RPS25;RPS5;RPS21;RPL23A;RPL14;RPL27A;RPS10;RPL23;RPS20;RPL36A;RPL27;UBA52;RPL38
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.9460027488459922,1.2160626409388067,0.11605802901450725,0.9252152767425372,1.0,7/25,2.07%,GAPDH;TPI1;ENO1;PKM;PFKL;PGAM1;PGK1
prerank,regulation of superoxide anion generation (GO:0032928),0.9352956564080166,1.2160421970846713,0.1115,0.9222552154836328,1.0,3/15,1.88%,GSTP1;CD177;SOD1
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.9440445935714722,1.216002682192024,0.113,0.9195145975813056,1.0,4/25,2.46%,TPM1;ID2;DSG2;FKBP1A
prerank,regulation of lipid biosynthetic process (GO:0046890),0.9553856128524623,1.2156323364978556,0.121,0.9210626028608191,1.0,7/35,2.85%,APOA1;CEACAM1;APOA4;APOE;EIF6;ASAH1;PCK1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.9491907097305127,1.2152708288882625,0.1285,0.9224659925125211,1.0,2/31,1.29%,RPS2;SKP1
prerank,sodium ion homeostasis (GO:0055078),0.9498402180957733,1.214920388410687,0.118,0.9240646610016402,1.0,5/25,1.77%,ATP1A1;SCNN1B;ATP1B3;ATP1B1;SCNN1A
prerank,skin development (GO:0043588),0.9839498235346686,1.2143193814721227,0.0345,0.9286519098007614,1.0,9/79,0.91%,COL3A1;COL1A1;COL1A2;CLDN4;COL5A1;STMN1;COL5A2;SFN;TXNIP
prerank,cristae formation (GO:0042407),0.9441272615444906,1.2140215294642225,0.129,0.9290688199168631,1.0,16/26,3.19%,ATP5F1E;ATP5ME;ATP5F1B;ATP5MG;ATP5MC2;ATP5F1A;ATP5PF;ATP5MC3;ATP5F1D;ATP5PO;ATP5MF;ATP5MC1;ATP5PB;ATP5PD;SPG7;ATP5F1C
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.9406463183136726,1.2139753242333675,0.116,0.9264345082367393,1.0,6/16,4.29%,MDK;IGFBP5;S100A11;PDGFRB;ADAMTS1;NRP1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.9409879869424687,1.2138312975754506,0.1145,0.9250701924889917,1.0,3/23,0.53%,TUBA1A;TUBB;TUBA1B
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.9746265038600103,1.2137695977492893,0.074,0.9227193942349048,1.0,5/59,0.58%,RPS19;RPL30;GAPDH;RPL39;HMGN2
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.9412794801474687,1.2137395782134637,0.122,0.9199211424559934,1.0,3/21,1.59%,MDK;NAP1L1;ID2
prerank,regulation of activated T cell proliferation (GO:0046006),0.9474698065425925,1.213364335218479,0.1255,0.9215928736087954,1.0,4/34,1.85%,RPS3;CD24;HMGB1;IGFBP2
prerank,regulation of interleukin-1 production (GO:0032652),0.9319714958439139,1.2132816844449588,0.111,0.9195150571803148,1.0,5/16,4.41%,CEACAM1;HMGB1;TMED10;GAS6;ANXA1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.936057829129751,1.2128620534462067,0.1125,0.9216849638092987,1.0,4/18,2.40%,FLNA;ATF4;POLR2L;ERBB2
prerank,potassium ion homeostasis (GO:0055075),0.9455113794074321,1.2125831343821056,0.119,0.922163304636783,1.0,3/24,1.35%,ATP1A1;ATP1B3;ATP1B1
prerank,skeletal muscle tissue development (GO:0007519),0.9514458132948684,1.212349511087107,0.128,0.9220239558704321,1.0,4/37,2.77%,MYL6;TCF21;MYH14;CAV1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.9512343370523912,1.21216792125605,0.1335,0.9211150124694825,1.0,5/32,2.67%,TMSB4X;ENO1;APP;NUPR1;VCP
prerank,regulation of platelet aggregation (GO:0090330),0.9367814114656074,1.2120589720649024,0.1135,0.9193721221725378,1.0,2/18,1.01%,CEACAM1;CD9
prerank,negative regulation of cellular component movement (GO:0051271),0.9316054167544433,1.2118470689695438,0.109,0.9188023274839378,1.0,4/15,2.12%,SPINT2;FBLN1;CD9;ACTN1
prerank,wound healing (GO:0042060),0.9815893942619923,1.2116821299139844,0.0445,0.9177150103264884,1.0,2/69,0.47%,COL3A1;TPM1
prerank,triglyceride metabolic process (GO:0006641),0.9660203266371811,1.2116410245642837,0.101,0.9151624719766573,1.0,6/53,1.59%,FABP1;APOC3;APOB;DGAT1;APOE;FABP5
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.9481967595110509,1.2110971842987868,0.1345,0.9189421880408414,1.0,5/35,2.55%,APOA1;APOA4;APOE;CHP1;LDLR
prerank,regulation of wound healing (GO:0061041),0.9621877442580488,1.2109406454901603,0.121,0.9178668238857071,1.0,7/47,2.20%,ACTG1;CLDN4;CLDN3;MYLK;ITGB1;VIL1;SRSF6
prerank,regulation of anoikis (GO:2000209),0.9333744351508672,1.2105619582102964,0.1145,0.9196584808359284,1.0,5/20,2.77%,CEACAM5;CEACAM6;ITGB1;MCL1;CAV1
prerank,extracellular matrix assembly (GO:0085029),0.9381333892781349,1.2105495873878278,0.1245,0.9168037564431298,1.0,12/24,4.39%,MYH11;MFAP4;EMILIN1;LAMB1;PXDN;QSOX1;LAMB2;LAMB3;LTBP3;EFEMP2;GAS6;RAMP2
prerank,cardiac muscle cell action potential (GO:0086001),0.9401588986112075,1.210470857421474,0.1195,0.9147302567949996,1.0,3/30,2.08%,ATP1A1;ATP1B1;YWHAE
prerank,response to muscle stretch (GO:0035994),0.9350225491607467,1.2103579205715034,0.106,0.9131650513170776,1.0,2/15,1.89%,GSN;CTNNB1
prerank,modulation by host of viral genome replication (GO:0044827),0.9274086383607307,1.210287129766116,0.112,0.9110503155786697,1.0,5/15,3.46%,IFI27;NUCKS1;PPIB;VAPA;PHB
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.9421809495437489,1.210206152704832,0.125,0.9090818656393961,1.0,4/26,2.51%,RPS3;RAC1;STMN2;NUMA1
prerank,muscle organ development (GO:0007517),0.9619843960307443,1.2101858110917507,0.106,0.9063669411893207,1.0,6/58,1.82%,TAGLN;COL6A3;SRI;TCF21;FHL1;SMTN
prerank,protein targeting to ER (GO:0045047),0.9930579619908321,1.210058423474027,0.007,0.9050511968193053,1.0,76/102,0.57%,RPL41;RPL13;RPL10;RPS8;RPLP1;RPS12;RPL13A;RPL34;RPS27;RPS23;RPS2;RPS18;RPS15A;RPL37A;RPL32;RPS27A;RPL11;RPS19;RPS24;RPS28;RPS6;RPL37;RPL28;RPS3A;RPS15;RPS14;RPL9;RPL3;RPL12;RPS4X;RPL29;RPL30;RPL19;RPL18A;RPL8;RPL18;RPL7A;RPL5;RPLP0;RPL35A;RPL36;RPS3;RPL15;RPL4;RPL6;RPL21;RPL35;RPS11;RPLP2;RPS13;RPL39;RPS29;RPS7;RPL22;RPL26;RPS26;RPSA;RPS9;RPL31;RPL10A;RPS16;RPL7;RPL24;RPS25;RPS5;RPS21;RPL23A;RPL14;RPL27A;RPS10;RPL23;RPS20;RPL36A;RPL27;UBA52;RPL38
prerank,natural killer cell mediated immunity (GO:0002228),0.9353586327982681,1.2100201193836024,0.118,0.9026292409545876,1.0,2/20,1.06%,TUBB;TUBB4B
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.9530086821326004,1.2099521459805243,0.1265,0.9005899296027126,1.0,3/37,1.28%,RPS3;PPIA;TMBIM6
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.9464416597387898,1.2097491110100602,0.133,0.9001214920223075,1.0,5/34,2.28%,FOS;EGR1;JUN;KLF4;KLF5
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.9461172328767896,1.2095844509077958,0.135,0.8992642248704984,1.0,7/31,2.89%,RPL11;HSP90AB1;NOP53;GIPC1;PARK7;OGT;EIF3H
prerank,regulation of JUN kinase activity (GO:0043506),0.9498532509677172,1.2094090633214978,0.132,0.898538881887003,1.0,3/35,1.44%,RPS3;GSTP1;PDCD4
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.964003269600798,1.2086636707758076,0.102,0.9044131126788336,1.0,4/62,0.57%,RPS27A;UBC;UBA52;UBB
prerank,female gamete generation (GO:0007292),0.9464281899148153,1.2084470602041084,0.1305,0.9041490970625023,1.0,2/31,1.44%,MDK;PTN
prerank,negative regulation of viral life cycle (GO:1903901),0.9331563199854576,1.2083130638240003,0.12,0.9029986106923945,1.0,6/20,4.48%,PPIA;GSN;IFITM3;SNX3;IFITM2;LY6E
prerank,protein depolymerization (GO:0051261),0.9348723167121451,1.2082242884005154,0.1225,0.9012369747393697,1.0,7/28,2.15%,CFL1;STMN1;GSN;DSTN;WDR1;VIL1;STMN2
prerank,epithelial cell morphogenesis (GO:0003382),0.9274694069404833,1.207994683274109,0.107,0.9010413586902848,1.0,2/17,2.30%,CLDN3;COL18A1
prerank,regulation of ion transport (GO:0043269),0.9736608375658314,1.2078485518323077,0.0665,0.9000105555493366,1.0,3/79,1.02%,B2M;ATP1A1;CA2
prerank,regulation of Rho protein signal transduction (GO:0035023),0.9798450340520174,1.2078462167705495,0.0445,0.8972550844043569,1.0,4/73,0.59%,COL3A1;APOA1;APOC3;STMN1
prerank,positive regulation of peptidase activity (GO:0010952),0.9380640967678642,1.207031152473694,0.13,0.9039949073992569,1.0,8/22,2.91%,CLDN4;CLDN3;GRN;NDUFA13;PRELID1;PSME1;VCP;PSME2
prerank,tight junction assembly (GO:0120192),0.9615940359013695,1.2070049543149703,0.1075,0.9015147233213047,1.0,4/56,0.52%,ACTG1;CLDN4;CLDN3;CLDN7
prerank,positive regulation of heart rate (GO:0010460),0.9307571267937521,1.2067499147973568,0.114,0.9017228298292973,1.0,4/17,5.09%,TPM1;TRPM4;ATP2A2;ADM
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.9359201048431365,1.2067176559391013,0.126,0.8993060203781005,1.0,3/20,1.35%,ATP1A1;ATP1B3;ATP1B1
prerank,positive regulation of calcium ion transport (GO:0051928),0.9498185093045598,1.206631853235684,0.1375,0.8975148231284475,1.0,5/37,2.97%,LGALS3;MYLK;CXCL12;CAV1;PDGFRB
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.9331556539248166,1.2065650200776308,0.1295,0.8955477083523988,1.0,3/19,1.63%,MDK;PTN;MST1
prerank,negative regulation of insulin secretion (GO:0046676),0.9263846690702064,1.2064933395277426,0.11711711711711711,0.8936470248061977,1.0,5/16,5.14%,CHGA;FAM3D;MIDN;SFRP1;PIM3
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.9451941779164956,1.2060719327408627,0.1375,0.8957959345221179,1.0,9/36,3.48%,RPL11;HSP90AB1;NOP53;GIPC1;PARK7;OGT;EIF3H;GABARAPL2;BAG6
prerank,embryonic organ development (GO:0048568),0.9662751831431939,1.205922572411753,0.0995,0.8948661600916372,1.0,4/66,1.68%,RPL10;PKDCC;ATF4;RARRES2
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.9511212157078301,1.2056959075644236,0.1345,0.8947567451196652,1.0,10/50,1.96%,APOA1;S100A10;FLNA;MDK;OLFM4;P4HB;CALR;RAC1;CIB1;CDC42
prerank,positive regulation of endocytosis (GO:0045807),0.9632230061884215,1.205473436317075,0.125,0.8946644414847901,1.0,10/48,2.26%,B2M;CCL21;HNRNPK;APOE;CD151;LRP1;GPC3;VPS28;CDC42;CLU
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.9269028475812475,1.2053492859640957,0.1195,0.8934346373231019,1.0,4/17,4.79%,CHGA;FAM3D;MIDN;SFRP1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.9929261583801574,1.2052384736212622,0.0075,0.892078313570876,1.0,76/113,0.57%,RPL41;RPL13;RPL10;RPS8;RPLP1;RPS12;RPL13A;RPL34;RPS27;RPS23;RPS2;RPS18;RPS15A;RPL37A;RPL32;RPS27A;RPL11;RPS19;RPS24;RPS28;RPS6;RPL37;RPL28;RPS3A;RPS15;RPS14;RPL9;RPL3;RPL12;RPS4X;RPL29;RPL30;RPL19;RPL18A;RPL8;RPL18;RPL7A;RPL5;RPLP0;RPL35A;RPL36;RPS3;RPL15;RPL4;RPL6;RPL21;RPL35;RPS11;RPLP2;RPS13;RPL39;RPS29;RPS7;RPL22;RPL26;RPS26;RPSA;RPS9;RPL31;RPL10A;RPS16;RPL7;RPL24;RPS25;RPS5;RPS21;RPL23A;RPL14;RPL27A;RPS10;RPL23;RPS20;RPL36A;RPL27;UBA52;RPL38
prerank,diterpenoid metabolic process (GO:0016101),0.9634761311385261,1.2050168118438112,0.116,0.8918969215163406,1.0,13/64,2.13%,TTR;APOA1;APOC3;RBP2;APOA4;APOB;APOE;RBP1;RARRES2;HSPG2;LRP1;GPC3;ALDH1A1
prerank,regulation of cardiac conduction (GO:1903779),0.9597481159923245,1.2049618047885848,0.1135,0.8898879332954492,1.0,6/55,1.90%,FXYD3;ATP1A1;ATP1B3;ATP1B1;ATP2A3;FXYD6
prerank,positive regulation of cholesterol transport (GO:0032376),0.9506493810696273,1.2048053327768022,0.1375,0.8889962594284676,1.0,5/33,2.93%,APOA1;APOE;LRP1;CAV1;SCP2
prerank,integrin-mediated signaling pathway (GO:0007229),0.9733697690902763,1.2045301524290422,0.0675,0.8893060965602341,1.0,10/75,1.44%,COL3A1;APOA1;CEACAM1;FN1;FBLN1;COL16A1;CDH17;MYH9;ITGB1;PTN
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.9543080823569613,1.2044996177461011,0.129,0.8870512991434496,1.0,13/51,1.96%,APOA1;S100A10;FLNA;MDK;OLFM4;FBLN1;P4HB;CALR;ACTN4;RAC1;CIB1;MELTF;CDC42
prerank,positive regulation of stress fiber assembly (GO:0051496),0.9486688234295098,1.204471481487944,0.138,0.8848038435971022,1.0,7/43,1.96%,APOA1;S100A10;TPM1;RHOC;RHOA;RAC1;CDC42
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.9796923982190372,1.2043610550882438,0.045,0.883445005693628,1.0,9/89,0.88%,COL3A1;COL1A2;RPS27A;APOA1;FOS;UBC;UBA52;UBB;JUN
prerank,cellular response to gamma radiation (GO:0071480),0.9256663597843203,1.2042682913905935,0.1195,0.8819357427265729,1.0,1/17,0.34%,RPL26
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.9760731327094194,1.204206102162403,0.064,0.8800702536489404,1.0,2/75,0.10%,S100A6;ACTB
prerank,protein destabilization (GO:0031648),0.9448818244183979,1.203944572495381,0.1335,0.880373077127684,1.0,2/34,0.61%,SERF2;GSN
prerank,inorganic anion transport (GO:0015698),0.9605309999389599,1.2037265902944958,0.1185,0.8802450448565751,1.0,2/53,1.28%,FXYD3;CLIC1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.9605859335719952,1.2027565284756376,0.102,0.8885044305275054,1.0,8/61,1.33%,RPS27A;UBC;UBA52;UBB;APOB;HSP90B1;HMGB1;CTSB
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.9571516715769032,1.202747909995664,0.1285,0.8860373169249407,1.0,14/54,2.80%,RPL11;RPL5;RPS3;PARK7;COPS9;CTNNB1;VPS28;SQSTM1;CHP1;OGT;SOX4;HSPA1A;CAV1;IVNS1ABP
prerank,visual perception (GO:0007601),0.9821618491643427,1.2026942739033537,0.036,0.8841182329029073,1.0,1/93,0.05%,COL1A1
prerank,interstrand cross-link repair (GO:0036297),0.9623915973989832,1.2026620950875757,0.1175,0.8819310665047463,1.0,4/54,0.57%,RPS27A;UBC;UBA52;UBB
prerank,sensory perception of light stimulus (GO:0050953),0.9824284290448507,1.2025241586197466,0.0335,0.8809898845039412,1.0,1/95,0.05%,COL1A1
prerank,establishment of spindle localization (GO:0051293),0.924857349133327,1.202314604198078,0.123,0.8807320557963855,1.0,5/15,4.72%,CFL1;LLGL2;DYNC1H1;MAP4;KPNB1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.9390869951571172,1.2022045873459384,0.129,0.879347900245229,1.0,3/26,2.06%,APOC3;RAC1;APP
prerank,regulation of myotube differentiation (GO:0010830),0.9322049037472808,1.201846427400788,0.139,0.8807007195877151,1.0,1/24,0.35%,CEACAM5
prerank,DNA duplex unwinding (GO:0032508),0.9566865067804994,1.2016144126149515,0.1335,0.8806872888639755,1.0,4/51,0.57%,RPS27A;UBC;UBA52;UBB
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.9468803928766806,1.2014660615013326,0.1465,0.8797753693469776,1.0,6/42,3.68%,HLA-A;HLA-B;HLA-E;HLA-DRA;HLA-DRB1;LAMP1
prerank,eye morphogenesis (GO:0048592),0.9267669330225939,1.2013206365322129,0.1305,0.8789020417012063,1.0,6/19,3.39%,COL5A1;COL5A2;MFAP2;FBN1;FBN2;VEGFA
prerank,regulation of epithelial cell differentiation (GO:0030856),0.926229421963047,1.2013063169203075,0.1295,0.8766292178163607,1.0,3/19,2.77%,CEACAM1;CD24;CAV1
prerank,lipid droplet organization (GO:0034389),0.9311100340230725,1.2012922105413923,0.132,0.8742996222883692,1.0,3/22,3.13%,PPIA;SMIM22;AUP1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.9297762637471405,1.2010953056242692,0.125,0.8739663828863004,1.0,5/16,3.30%,TPM1;CNN1;PDCD4;CDKN1A;EFEMP2
prerank,cellular response to reactive oxygen species (GO:0034614),0.9615651536164843,1.2009528463338681,0.1175,0.8730828643803261,1.0,6/63,1.01%,FABP1;FOS;RPS3;TPM1;JUN;PRDX5
prerank,negative regulation of viral entry into host cell (GO:0046597),0.9237659673852681,1.2003880659270172,0.123,0.8766379139097848,1.0,5/17,4.48%,GSN;IFITM3;SNX3;IFITM2;LY6E
prerank,regulation of T cell migration (GO:2000404),0.9285412130808743,1.2001167358224094,0.127,0.8771205088259949,1.0,5/20,2.06%,CCL21;CXCL12;RHOA;TNFRSF14;APP
prerank,cardiac muscle contraction (GO:0060048),0.9407938537719566,1.200004452151059,0.132,0.8758700995356489,1.0,3/34,1.35%,TPM1;GSN;ATP1B1
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.9385653768913615,1.1995444984909185,0.134,0.878335812950943,1.0,4/25,1.43%,MDK;CD74;CCL21;RAC1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.9423478762873795,1.1994134017876616,0.145,0.8773530365187671,1.0,3/33,1.27%,APOA1;STARD10;SLC44A4
prerank,ERBB signaling pathway (GO:0038127),0.9654501532691139,1.1993521102192626,0.108,0.8756451072223854,1.0,1/66,0.03%,PIGR
prerank,collagen fibril organization (GO:0030199),0.9765115771667964,1.1989874771632634,0.058,0.8770026746975369,1.0,14/89,1.14%,COL3A1;COL1A1;COL1A2;COL5A1;COL6A1;COL6A2;LUM;COL5A2;COL6A3;P4HB;COL4A1;COL4A2;SERPINH1;COL16A1
prerank,DNA biosynthetic process (GO:0071897),0.9217718918626987,1.1988346993598407,0.1195,0.8762191832080911,1.0,1/16,0.46%,PPIA
prerank,cholesterol transport (GO:0030301),0.9563502555052799,1.19866720237301,0.1435,0.8755799842704715,1.0,10/50,2.77%,APOA1;APOC3;APOA4;APOB;APOE;NPC2;CLU;APOA2;LDLR;CAV1
prerank,microtubule depolymerization (GO:0007019),0.9196697703779959,1.1986660055396794,0.125,0.8732397065919499,1.0,2/18,2.15%,STMN1;STMN2
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.9239008254691562,1.198649330582334,0.1295,0.8710593327252835,1.0,3/23,2.67%,RACK1;GPC3;VCP
prerank,positive regulation of protein binding (GO:0032092),0.9559207216433614,1.1986313982933396,0.137,0.8689133308294622,1.0,8/57,2.50%,B2M;RPL11;APOE;LRP1;RAN;APP;FKBP1A;ADD1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.9576197554815422,1.1984647297900461,0.1335,0.8683683872417559,1.0,5/49,2.22%,RPL10;APOE;KLF4;APP;RBM3
prerank,stress-activated MAPK cascade (GO:0051403),0.9498425904854063,1.1983559658155,0.1395,0.867144613334726,1.0,7/62,1.73%,RPS27A;UBC;UBA52;UBB;ZFP36L1;SKP1;ZFP36
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.9268890251641827,1.198308779071424,0.1315,0.8653362114946409,1.0,2/21,1.27%,DCN;VCAN
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.9676186608301028,1.1982080819749474,0.1035,0.8640938873334049,1.0,5/66,0.64%,B2M;HLA-A;HLA-B;HLA-C;MT2A
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.9507347032492601,1.1980086114124977,0.1415,0.863815268151037,1.0,8/54,2.29%,FABP1;SFN;BEX3;KLF4;PARK7;YWHAE;PLAUR;DDX3X
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.9255114354663342,1.1975920235495179,0.1185,0.8657563818118853,1.0,1/21,0.43%,ATP1A1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.9328841692505204,1.1969382336130796,0.139,0.8701397484978834,1.0,4/28,2.65%,RPS3;RAC1;NUMA1;HSPA1A
prerank,regulation of cholesterol efflux (GO:0010874),0.9446938634241836,1.1964358180232038,0.146,0.8730351681322007,1.0,3/33,1.86%,APOA1;APOE;LRP1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.9200038421819503,1.1960673363915746,0.133,0.8745677974394868,1.0,7/19,4.79%,S100A10;COL16A1;RAC1;THY1;VEGFA;NRP1;SFRP1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.9496369575198825,1.195941862623447,0.146,0.8735108222412329,1.0,6/52,2.29%,FABP1;SFN;BEX3;KLF4;YWHAE;DDX3X
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.925614030698705,1.1956550483901176,0.1295,0.8740232362314995,1.0,4/22,3.39%,MDK;NAP1L1;CTNNB1;VEGFA
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.9473326452721298,1.195510752301575,0.1495,0.8731569643472945,1.0,3/42,1.32%,CEACAM5;CEACAM6;CD164
prerank,Rho protein signal transduction (GO:0007266),0.9538217460047768,1.1953172096975586,0.1425,0.8727328636833417,1.0,6/55,1.96%,COL1A2;CFL1;RHOA;EPS8L2;CDC42EP5;CDC42
prerank,sensory perception of chemical stimulus (GO:0007606),0.9736821897090054,1.1951454535074122,0.069,0.8723070856868366,1.0,1/93,0.44%,GNAS
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.9238155612664012,1.1949837817309785,0.1360680340170085,0.8716625635381293,1.0,5/15,3.72%,CST3;LRP1;MELTF;FSCN1;DDR1
prerank,regulation of cell development (GO:0060284),0.9484033391867391,1.1949586765784446,0.1495,0.8697042709592766,1.0,5/41,2.44%,RPS19;GRN;CTNNB1;ADGRA2;HMGB2
prerank,prostanoid metabolic process (GO:0006692),0.9219495447279642,1.1948784105938566,0.1215,0.8682863342151206,1.0,3/18,1.24%,GSTP1;GSTA1;CES2
prerank,defense response to Gram-negative bacterium (GO:0050829),0.9596646406228454,1.1948576773400792,0.105,0.8662688911733395,1.0,9/71,2.44%,RPS19;RPL30;CHGA;LYPD8;DEFA3;RARRES2;ROMO1;TNFRSF14;HMGB2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.9755750815377782,1.1946684821124416,0.0575,0.8659895773079411,1.0,2/88,0.04%,FTH1;FTL
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.9538722404428192,1.1945713088740282,0.142,0.8647491213590982,1.0,2/54,0.68%,APOA1;GSTP1
prerank,myofibril assembly (GO:0030239),0.9479260681423881,1.1945271074987875,0.1505,0.863005157539677,1.0,6/43,3.03%,KRT19;TPM1;CSRP1;WDR1;PDGFRB;PDGFRA
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.9203614990861647,1.1944835083697702,0.1315,0.8612763105676526,1.0,5/19,5.13%,MDK;PTN;HES1;TMEM98;NOTCH1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.9391290986780685,1.1941447221891464,0.142,0.8623704285818751,1.0,11/34,3.81%,APOA1;APOA4;ACAA2;HMGCS1;FDPS;MSMO1;FDFT1;INSIG1;DHCR24;MVD;IDI1
prerank,protein tetramerization (GO:0051262),0.9637789450222073,1.193523657023568,0.11,0.8662348467215163,1.0,1/71,0.07%,B2M
prerank,cell-cell junction assembly (GO:0007043),0.9582515808513976,1.1933144815288705,0.125,0.8661376453755728,1.0,11/66,2.25%,ACTG1;ACTB;RHOC;CD9;RHOA;CTNNA1;JUP;CTNNB1;WDR1;VCL;CTNND1
prerank,dendritic cell migration (GO:0036336),0.9218226481547944,1.193261414909293,0.13,0.8644794650799694,1.0,4/18,5.53%,CCL21;HMGB1;TRPM4;EPS8
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.9235569992148158,1.192989031081694,0.1355,0.86498398725734,1.0,3/20,1.47%,HNRNPA1;HNRNPC;HNRNPU
prerank,response to interferon-gamma (GO:0034341),0.9681909048853512,1.1928573223518304,0.08,0.8641025880336594,1.0,5/77,0.98%,RPL13A;GAPDH;IFITM3;CD74;CCL21
prerank,O-glycan processing (GO:0016266),0.9510504841292622,1.1926954269544556,0.156,0.8635392508479856,1.0,5/60,1.10%,MUC12;MUC2;MUC13;MUC1;MUC5B
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.9503875517481113,1.1925798017314915,0.1475,0.8624827440859932,1.0,9/53,2.95%,ACTB;HSP90AB1;CCND2;CAMK2N1;CDKN1C;CDKN1A;CDC37;CCNI;CDK5RAP3
prerank,linoleic acid metabolic process (GO:0043651),0.9288939021981605,1.1925760825522587,0.138,0.8603963383166737,1.0,2/21,0.69%,GSTP1;GSTA1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.9406296403685609,1.1925566461986004,0.156,0.8584678957637678,1.0,2/42,1.38%,ACTB;HNRNPC
prerank,potassium ion import across plasma membrane (GO:1990573),0.9438359682775879,1.1921120684280389,0.1525,0.8606432671827665,1.0,3/42,1.35%,ATP1A1;ATP1B3;ATP1B1
prerank,bicarbonate transport (GO:0015701),0.932170815186881,1.1920189985893175,0.144,0.8593519325795683,1.0,5/35,2.28%,HBA1;CA4;HBB;CA2;CA1
prerank,positive regulation of chemotaxis (GO:0050921),0.9442114013177654,1.1919389716999207,0.1525,0.8580400355213907,1.0,6/45,1.68%,TMSB4X;MDK;HSPB1;CCL21;PTN;RARRES2
prerank,regulation of kinase activity (GO:0043549),0.9797134577795775,1.1918782862647996,0.0555,0.8564944532028851,1.0,1/94,0.01%,EEF1A1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.9449534313260269,1.1915914555295475,0.1495,0.8572675120690707,1.0,10/50,2.50%,APOA1;S100A10;TPM1;PFN1;RHOC;RHOA;RAC1;CDC42;VIL1;SYNPO2
prerank,positive regulation of catalytic activity (GO:0043085),0.9363847772863632,1.191469881615828,0.147,0.856308594872523,1.0,7/40,3.56%,APOA1;CIB1;SOD1;CAV1;YWHAB;MAPK3;XRCC5
prerank,translational elongation (GO:0006414),0.974663130619999,1.19142184336306,0.0545,0.8547082604910969,1.0,5/103,0.90%,EEF1A1;RACK1;EEF2;EEF1B2;EEF1D
prerank,regulation of phagocytosis (GO:0050764),0.9512559291959832,1.1911378810307693,0.1475,0.8554064092610615,1.0,7/58,2.53%,APOA1;RACK1;OLFM4;CALR;CYBA;SNX3;APOA2
prerank,cholesterol biosynthetic process (GO:0006695),0.9383975739723396,1.1911040390174616,0.1455,0.853677498841031,1.0,11/35,3.81%,APOA1;APOA4;ACAA2;HMGCS1;FDPS;MSMO1;FDFT1;INSIG1;DHCR24;MVD;IDI1
prerank,positive regulation of viral life cycle (GO:1903902),0.9214409329284474,1.1905293103399892,0.1435,0.8571373607648731,1.0,4/24,1.18%,LGALS1;P4HB;CD74;TMPRSS2
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.9603721718042416,1.190453045045272,0.119,0.855739712809894,1.0,3/76,1.01%,COL1A1;MDK;EFNA1
prerank,regulation of stress fiber assembly (GO:0051492),0.9580867964046309,1.1902503893747796,0.1145,0.8556039010301706,1.0,9/73,1.43%,ACTG1;APOA1;S100A10;TPM1;PFN1;STMN1;RHOC;RHOA;RAC1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.935761797522272,1.189773298504923,0.151,0.8580410181169343,1.0,3/44,1.96%,ACTB;POLR2L;SF3B1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.9489112054688562,1.189348622438459,0.15,0.8598514614023678,1.0,8/51,2.29%,RPL13A;HMGB1;NOP53;HSPA5;PARK7;CDC42;CLU;DDX3X
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.9426509790606097,1.189260636420352,0.161,0.858684962833956,1.0,6/48,1.57%,TMSB4X;HSPB1;ATP5F1B;HMGB1;ATP5F1A;CIB1
prerank,axon development (GO:0061564),0.9657788963571156,1.1891638969600618,0.098,0.8575867473053481,1.0,3/79,0.82%,S100A6;ACTB;NREP
prerank,negative regulation of catabolic process (GO:0009895),0.9437574876100209,1.1891242282606898,0.1605,0.8558889242415209,1.0,6/49,2.53%,APOC3;FLNA;CST3;NUPR1;SNX3;APOA2
prerank,exogenous drug catabolic process (GO:0042738),0.9183059429090685,1.1889711326057786,0.132,0.8553410415074229,1.0,1/21,0.72%,CYP2W1
prerank,regulation of macrophage chemotaxis (GO:0010758),0.9203953104270604,1.1884502947725986,0.1295,0.8580900239591258,1.0,6/22,3.10%,MDK;MIF;MST1;RARRES2;DDT;MAPK3
prerank,regulation of neurogenesis (GO:0050767),0.9565639611781385,1.1877788849899156,0.1405,0.8623145503652596,1.0,1/62,0.07%,B2M
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.9369602451262385,1.187651319301933,0.1615,0.8614652628609961,1.0,4/37,1.24%,SPARC;APOE;ATP5F1A;ATP5IF1
prerank,acylglycerol metabolic process (GO:0006639),0.9332036674464909,1.187111379039029,0.1585,0.8644433441635202,1.0,7/39,3.98%,APOC3;DGAT1;APOE;APOA2;CAV1;MGLL;PNPLA2
prerank,cellular transition metal ion homeostasis (GO:0046916),0.970083118639929,1.186836404373883,0.0785,0.8649406453927396,1.0,10/96,1.37%,FTH1;FTL;MT1G;MT1H;MT2A;MT1E;SKP1;ARF1;MT1F;LCN2
prerank,sterol biosynthetic process (GO:0016126),0.9375019274875432,1.186570658442835,0.1545,0.8653333757949112,1.0,11/38,3.81%,APOA1;APOA4;ACAA2;HMGCS1;FDPS;MSMO1;FDFT1;INSIG1;DHCR24;MVD;IDI1
prerank,regulation of focal adhesion assembly (GO:0051893),0.9425848748092296,1.1862623521119353,0.169,0.8662042440546659,1.0,5/54,1.43%,ACTG1;S100A10;COL16A1;RHOA;RAC1
prerank,regulation of blood circulation (GO:1903522),0.9327085224423695,1.185990734329978,0.1525,0.8666350269698408,1.0,3/35,1.18%,DES;TPM1;SRI
prerank,selective autophagy (GO:0061912),0.9471187414684764,1.1859575354078171,0.166,0.8649670575753767,1.0,9/58,2.20%,RPS27A;VIM;UBC;UBA52;UBB;DYNLL1;PARK7;SQSTM1;PHB2
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.9263164271633355,1.1858305835047978,0.144,0.8641115407620978,1.0,5/28,1.85%,PPIA;HSPB1;TXN;ATF4;PARK7
prerank,adherens junction organization (GO:0034332),0.9476471458683492,1.1857654928668329,0.1535,0.862679882102092,1.0,8/49,2.25%,ACTB;CDH17;CTNNA1;JUP;CDH1;CTNNB1;VCL;CTNND1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.9211980160507302,1.1856734465391068,0.144,0.8615115012526231,1.0,4/19,2.43%,PPIA;HSPB1;PARK7;NONO
prerank,neutrophil chemotaxis (GO:0030593),0.9541550151317276,1.1856470133403871,0.144,0.8597950587767315,1.0,4/68,0.98%,LGALS3;PPIA;BSG;CCL21
prerank,negative regulation of protein binding (GO:0032091),0.9571786608345656,1.1855165546282416,0.1365,0.8589101088772693,1.0,10/72,2.51%,B2M;ACTB;RACK1;TMBIM6;ATP2A3;PARK7;CDKN1A;PTPRF;PPP1CA;SLPI
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.9246143758463236,1.1854877494573488,0.1445,0.857234728652385,1.0,1/31,0.43%,ATP1A1
prerank,defense response to Gram-positive bacterium (GO:0050830),0.9505279134171214,1.1851279113508522,0.151,0.8585093315754365,1.0,12/65,3.21%,RPL39;HLA-A;CHGA;PLA2G2A;HLA-E;DEFA3;RARRES2;ROMO1;TNFRSF14;HMGB2;DEFA5;DMBT1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.9196368230059717,1.1850753284573114,0.1445,0.8570611341475096,1.0,7/19,2.42%,CD81;EZR;PTTG1IP;APOE;HSP90AA1;ATP5IF1;CTSC
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.9130206029563913,1.1849857622092954,0.1365,0.8559348914394069,1.0,5/20,5.24%,MDK;XRCC6;GAS6;XBP1;ZMIZ1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.9472736736299829,1.1848842633839036,0.1615,0.8548949436252355,1.0,3/57,0.68%,APOA1;RACK1;GSTP1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.9637395035847282,1.184854405813087,0.099,0.8532418465590138,1.0,9/88,2.39%,COL1A1;EPS8L2;SOD1;WDR1;MYO1A;TIMM13;MYH14;NDUFB9;SERPINB6
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.9119839464947487,1.1848127001053703,0.147,0.8516871300901002,1.0,1/21,0.39%,RACK1
prerank,peptide biosynthetic process (GO:0043043),0.9931017479136959,1.1848017627818168,0.0055,0.8498660240452739,1.0,76/157,0.57%,EEF1A1;RPL41;RPL13;RPL10;RPS8;RPLP1;RPS12;RPL13A;RPL34;RPS27;RPS23;RPS2;RPS18;RPS15A;RPL37A;RPL32;RPS27A;RPL11;RPS19;RPS24;RPS28;RPS6;RPL37;RPL28;RPS3A;RPS15;RPS14;RPL9;RPL3;RPL12;RPS4X;RPL29;RPL30;RPL19;RPL18A;RPL8;RPL18;RPL7A;RPL5;RPLP0;RPL35A;RPL36;RPS3;RPL15;RPL4;RPL6;RPL21;RPL35;RPS11;RPLP2;RPS13;RPL39;RPS29;RPS7;RPL22;RPL26;RPS26;RPSA;RPS9;RPL31;RPL10A;RPS16;RPL7;RPL24;RPS25;RPS5;RPS21;RPL23A;RPL14;RPL27A;RPS10;RPL23;RPS20;RPL36A;RPL27;RPL38
prerank,regulation of protein catabolic process (GO:0042176),0.9760377387360922,1.1847633009323255,0.057,0.8482766315782967,1.0,4/101,0.84%,EEF1A1;FLNA;CTSA;OAZ1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.935091443686047,1.1846625192971998,0.1635,0.847233040023359,1.0,19/46,4.17%,RPLP0;PPIA;CFL1;HNRNPA2B1;P4HB;ANXA2;HNRNPDL;MIF;ARF1;PDCD4;SOD1;CDC42;CA1;RAP1B;PSME2;GSTO1;HNRNPF;CNN2;CAPZA1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.9759819147623383,1.1842193785003428,0.0575,0.849266670520491,1.0,13/114,1.42%,COL3A1;COL1A2;RPS27A;APOA1;FOS;UBC;UBA52;UBB;JUN;ZFP36L2;ZFP36L1;ITGB1;RHOA
prerank,carbohydrate catabolic process (GO:0016052),0.9299418710703381,1.1841951362618537,0.1655,0.8475859410175661,1.0,12/41,4.53%,GAPDH;TPI1;LDHA;ENO1;PKM;PFKL;PGAM1;PGK1;NEU1;ALDOB;MAN2C1;GPI
prerank,positive regulation of glial cell differentiation (GO:0045687),0.91029253547112,1.1840936605061765,0.1415,0.846559686082393,1.0,6/18,5.95%,MDK;PTN;ID2;HES1;NOTCH1;BIN1
prerank,positive regulation of heart contraction (GO:0045823),0.9116494524415003,1.1839508940452348,0.144,0.8459016690686336,1.0,5/20,5.09%,CHGA;TRPM4;ATP2A2;RGS2;ADM
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.9080131733857831,1.1838228909079058,0.14,0.8451164006581289,1.0,4/19,3.47%,HMGB1;CXCL12;S100A14;LGMN
prerank,positive regulation of phagocytosis (GO:0050766),0.9470629132336159,1.1838205398803845,0.168,0.8432802244057519,1.0,3/53,1.49%,APOA1;CALR;CYBA
prerank,proton transmembrane transport (GO:1902600),0.9324820711990611,1.183730446428716,0.167,0.842253785661765,1.0,7/36,3.86%,ATP1A1;ATP5F1B;ATP5PO;ATP5MF;ATP6V0D1;ATP6V0E1;ATP6V1F
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.94204592121731,1.1836942185063943,0.1625,0.8407179351125872,1.0,9/52,1.93%,LGALS3;RACK1;AGR2;ITGB1;CIB1;SPTBN1;PLS1;LRP1;SQSTM1
prerank,cell junction organization (GO:0034330),0.9553121153365249,1.183674436373734,0.134,0.8390401080780622,1.0,8/72,2.06%,ACTG1;ACTB;FLNA;CLDN3;RHOA;VMP1;CDC42;APP
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.917236076088373,1.183593687228293,0.1455,0.8378878232431884,1.0,4/20,3.10%,MDK;RARRES2;S100A14;MAPK3
prerank,regulation of viral entry into host cell (GO:0046596),0.9302395186286234,1.1832841907241376,0.157,0.8387065763108562,1.0,9/39,3.68%,LGALS1;GSN;P4HB;IFITM3;CD74;TMPRSS2;SNX3;HLA-DRB1;IFITM2
prerank,negative regulation of transport (GO:0051051),0.9412278701742853,1.1831789708789442,0.1685,0.8378055159261631,1.0,2/51,0.39%,LGALS3;RACK1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.9364680501799405,1.1830331755285008,0.1645,0.8372465353289218,1.0,3/41,2.39%,LGALS3;DDX3X;TMBIM1
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.9133754722256591,1.1827841560601688,0.128,0.8375714249087823,1.0,6/16,4.75%,ZFP36L2;ZFP36L1;HNRNPU;ZFP36;ANXA1;UBE2L3
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.9186708591915771,1.1825801088795391,0.1445,0.8374686277723415,1.0,1/23,0.62%,CD81
prerank,regulation of establishment of protein localization (GO:0070201),0.9097770503612462,1.182125646113874,0.149,0.8394241768522899,1.0,1/15,0.55%,CTSD
prerank,response to gamma radiation (GO:0010332),0.9159078323280313,1.1820737348598431,0.1505,0.8380767246501454,1.0,1/24,0.34%,RPL26
prerank,response to reactive oxygen species (GO:0000302),0.9450323970294022,1.1813200034199107,0.168,0.8426399396350239,1.0,11/57,1.90%,FOS;RPS3;HBA1;TPM1;GSTP1;HBB;JUN;PRDX5;APOE;SOD1;ROMO1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.9109755239112947,1.180949918130976,0.1295,0.8439876576308544,1.0,6/22,3.96%,CALM2;CALM1;ATP1B1;VMP1;CALM3;GSTO1
prerank,negative regulation of peptidase activity (GO:0010466),0.9459700270856412,1.1808916272262397,0.169,0.8426828663177177,1.0,12/62,3.31%,GAPDH;CST3;SERPINA1;SERPINH1;TIMP2;PARK7;LRP1;TIMP1;SERPINB6;CSTB;TIMP3;SERPINB1
prerank,protein localization to cell surface (GO:0034394),0.9151460718660536,1.1808755934918618,0.143,0.8410267328708951,1.0,4/28,2.13%,FLNA;CD177;CTNNB1;VCL
prerank,ruffle organization (GO:0031529),0.9110871150313108,1.1807085286217283,0.1445,0.8406342606410905,1.0,3/17,1.43%,TPM1;CCL21;RAC1
prerank,fibrinolysis (GO:0042730),0.9077589190907827,1.1806260938910684,0.1435,0.8395199430447832,1.0,2/15,2.33%,PLAUR;PLAT
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.9066443610387216,1.180609833146194,0.1340670335167584,0.8378873887003541,1.0,8/18,5.27%,PRDX6;CIRBP;RBM3;RBMX;NCL;TRA2B;TRA2A;DAZAP1
prerank,positive regulation of cartilage development (GO:0061036),0.9156117672322283,1.1805503950982161,0.1485,0.836608230699501,1.0,4/18,4.25%,MDK;PKDCC;BMP1;LOXL2
prerank,rRNA metabolic process (GO:0016072),0.9914500578991067,1.1805066013388927,0.0055,0.8352016466416016,1.0,58/162,0.57%,RPL41;RPL13;RPL10;RPLP1;RPL13A;RPL34;RPS27;RPS2;RPL37A;RPL32;RPL11;RPS19;RPS24;RPS28;RPS6;RPL37;RPL28;RPS15;RPS14;RPL9;RPL3;RPL12;RPL29;RPL30;RPL19;RPL18A;RPL8;RPL18;RPL7A;RPL5;RPLP0;RPL35A;RPL36;RPL15;RPL4;RPL6;RPL21;RPL35;RPLP2;RPL39;RPS7;RPL22;RPL26;RPS9;RPL31;RPL10A;RPS16;RPL7;RPL24;RPS25;RPL23A;RPL14;RPL27A;RPL23;RPL36A;RPL27;UBA52;RPL38
prerank,sensory perception of sound (GO:0007605),0.9625129328428762,1.1800618736293114,0.1055,0.8369536320992642,1.0,9/91,2.39%,COL1A1;EPS8L2;SOD1;WDR1;MYO1A;TIMM13;MYH14;NDUFB9;SERPINB6
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.9312484066130158,1.1800283720775997,0.168,0.8354598566832642,1.0,6/45,2.28%,FOS;EGR1;JUN;DDX5;KLF4;KLF5
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.9219015280103441,1.1798737424280148,0.1585,0.8349842523325708,1.0,1/26,0.48%,MDK
prerank,stem cell differentiation (GO:0048863),0.9278086336937184,1.1796024427373655,0.165,0.835541335495981,1.0,1/40,0.35%,EPCAM
prerank,granulocyte chemotaxis (GO:0071621),0.9500343899775828,1.1795805503876793,0.153,0.8339513765081704,1.0,4/71,0.98%,LGALS3;PPIA;BSG;CCL21
prerank,cellular response to interleukin-12 (GO:0071349),0.932776072256412,1.1795161319943384,0.168,0.8327074007333308,1.0,19/48,4.17%,RPLP0;PPIA;CFL1;HNRNPA2B1;P4HB;ANXA2;HNRNPDL;MIF;ARF1;PDCD4;SOD1;CDC42;CA1;RAP1B;PSME2;GSTO1;HNRNPF;CNN2;CAPZA1
prerank,chloride transport (GO:0006821),0.9549298004456818,1.1792669447944313,0.1365,0.8330777178922397,1.0,2/75,1.28%,FXYD3;CLIC1
prerank,positive regulation of interleukin-12 production (GO:0032735),0.918544114277414,1.1788266040525812,0.161,0.8348998919053332,1.0,3/34,2.75%,MDK;HMGB1;HSPD1
prerank,regulation of B cell differentiation (GO:0045577),0.9086662806222172,1.1787814190246988,0.1415,0.8335809870344605,1.0,5/18,4.79%,ZFP36L2;ZFP36L1;ID2;XBP1;SFRP1
prerank,phospholipid transport (GO:0015914),0.9467694092794321,1.1785993512921928,0.1695,0.8333391359025466,1.0,10/58,3.12%,APOA1;APOC3;APOA4;APOE;PRELID1;NPC2;APOA2;LDLR;SCP2;SCARB2
prerank,myoblast differentiation (GO:0045445),0.9070040645131762,1.1785930275032601,0.14607303651825912,0.8316775743506496,1.0,7/15,6.48%,DDX17;DDX5;SDC1;JAG1;MBNL1;TCF7L2;EPAS1
prerank,neutrophil migration (GO:1990266),0.952459181857735,1.1785634092623791,0.149,0.8301914630127755,1.0,5/75,0.98%,LGALS3;PPIA;CD177;BSG;CCL21
prerank,regulation of myeloid cell differentiation (GO:0045637),0.9461902843035277,1.1783970692863184,0.161,0.8298564863523175,1.0,2/64,0.26%,LGALS3;MYL9
prerank,cell-matrix adhesion (GO:0007160),0.9686111443098805,1.178316090610719,0.077,0.8288040967113626,1.0,7/100,1.43%,COL3A1;FN1;CD63;EMILIN1;CCL21;ITGB1;RAC1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.955479362202818,1.177778582284337,0.1545,0.8315336708358255,1.0,9/72,2.09%,B2M;SPARC;CEACAM1;APOE;ATP5F1A;ATP5IF1;MAGED1;CDKN1C;NUPR1
prerank,positive regulation of neuron death (GO:1901216),0.9329851296028596,1.1773528688161383,0.17,0.8331895428719059,1.0,7/47,2.26%,FOS;EGR1;ATF4;GRN;CTNNB1;NUPR1;CLU
prerank,cellular response to decreased oxygen levels (GO:0036294),0.9515302241746981,1.1773473031489423,0.1625,0.8315231488203977,1.0,8/68,2.07%,FABP1;NDRG1;P4HB;ZFP36L1;NOP53;ACAA2;LMNA;PGK1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.9907099893547228,1.1772675486587154,0.007,0.8304962394067124,1.0,76/171,0.57%,RPL41;RPL13;RPL10;RPS8;RPLP1;RPS12;RPL13A;RPL34;RPS27;RPS23;RPS2;RPS18;RPS15A;RPL37A;RPL32;RPS27A;RPL11;RPS19;RPS24;RPS28;RPS6;RPL37;RPL28;RPS3A;RPS15;RPS14;RPL9;RPL3;RPL12;RPS4X;RPL29;RPL30;RPL19;RPL18A;RPL8;RPL18;RPL7A;RPL5;RPLP0;RPL35A;RPL36;RPS3;RPL15;RPL4;RPL6;RPL21;RPL35;RPS11;RPLP2;RPS13;RPL39;RPS29;RPS7;RPL22;RPL26;RPS26;RPSA;RPS9;RPL31;RPL10A;RPS16;RPL7;RPL24;RPS25;RPS5;RPS21;RPL23A;RPL14;RPL27A;RPS10;RPL23;RPS20;RPL36A;RPL27;UBA52;RPL38
prerank,rRNA processing (GO:0006364),0.9913034188224761,1.1770670028264976,0.0055,0.8304576306219862,1.0,58/173,0.57%,RPL41;RPL13;RPL10;RPLP1;RPL13A;RPL34;RPS27;RPS2;RPL37A;RPL32;RPL11;RPS19;RPS24;RPS28;RPS6;RPL37;RPL28;RPS15;RPS14;RPL9;RPL3;RPL12;RPL29;RPL30;RPL19;RPL18A;RPL8;RPL18;RPL7A;RPL5;RPLP0;RPL35A;RPL36;RPL15;RPL4;RPL6;RPL21;RPL35;RPLP2;RPL39;RPS7;RPL22;RPL26;RPS9;RPL31;RPL10A;RPS16;RPL7;RPL24;RPS25;RPL23A;RPL14;RPL27A;RPL23;RPL36A;RPL27;UBA52;RPL38
prerank,positive regulation of macrophage migration (GO:1905523),0.9094204000075138,1.1770403035186052,0.1525,0.8290071586636788,1.0,3/19,3.10%,MDK;RARRES2;MAPK3
prerank,cellular response to hexose stimulus (GO:0071331),0.9181310644261307,1.176874687518971,0.1545,0.8287042146668528,1.0,8/25,5.28%,RACK1;SOX4;PCK1;TRA2B;GAS6;XBP1;SLC26A6;SLC39A14
prerank,positive regulation of mitochondrial fission (GO:0090141),0.9068168902736509,1.1767396922861288,0.1495,0.8281778427440303,1.0,2/18,2.67%,DCN;FIS1
prerank,regulation of cartilage development (GO:0061035),0.9126298953322262,1.1765921583914107,0.15407703851925963,0.827661631976407,1.0,1/18,0.48%,MDK
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.9161851559034029,1.1765115652233222,0.153,0.8266568557171358,1.0,2/27,1.27%,DCN;VCAN
prerank,metal ion export (GO:0070839),0.9250867504851854,1.1763873621903105,0.161,0.825977536838303,1.0,5/32,3.93%,ATP1A1;ATP1B3;ATP1B1;ATP2B4;SLC40A1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.9477081399753795,1.1763868204849075,0.1645,0.8243315777900591,1.0,14/70,1.96%,APOA1;S100A10;FLNA;MDK;FN1;OLFM4;AGR2;P4HB;CALR;CCL21;RAC1;CIB1;JUP;CDC42
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.9460816273060081,1.1763022587113285,0.1655,0.8233514330844738,1.0,7/71,1.97%,ACTG1;ACTB;HSP90AB1;HSP90AA1;RAC1;CDC42;ARPC3
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.9014021244272341,1.176187358433285,0.147,0.8210074710915692,1.0,5/15,4.84%,PABPC1;ZFP36L2;ZFP36L1;ZFP36;CNOT1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.9014021244272341,1.176187358433285,0.147,0.8210074710915692,1.0,5/15,4.84%,PABPC1;ZFP36L2;ZFP36L1;ZFP36;CNOT1
prerank,"phototransduction, visible light (GO:0007603)",0.9003014764564499,1.1759401712796191,0.1515,0.8212879365892489,1.0,3/15,8.13%,GNB1;GNA11;GNAQ
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.9093544360826928,1.1757743430622507,0.161,0.8209380054950084,1.0,10/24,6.11%,S100A10;COL16A1;RAC1;THY1;VEGFA;NRP1;SFRP1;ARF6;ABL1;FERMT2
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.9178900441918518,1.1755125271484343,0.159,0.8214456093803908,1.0,9/32,3.30%,TPM1;CNN1;IGFBP5;OGN;VIP;PDCD4;IGFBP3;CDKN1A;EFEMP2
prerank,muscle tissue morphogenesis (GO:0060415),0.9030380782991322,1.1753022961681003,0.1485742871435718,0.8214407011574065,1.0,4/17,5.80%,MYLK;EFEMP2;NOTCH1;ACTC1
prerank,positive regulation of DNA repair (GO:0045739),0.9244742292537186,1.1752027582192888,0.1695,0.8206381126804136,1.0,3/47,2.08%,RPS3;HMGB1;TRIM28
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.9547446235323586,1.1751681827063143,0.143,0.8193085773124382,1.0,19/80,2.47%,RPS4X;RPL5;VIM;RPL26;RACK1;EEF2;CIRBP;EFNA1;NPM1;RPS27L;PLXNB2;HNRNPD;EIF3E;RBM3;CLU;DDX3X;EIF6;ERBB2;SOX4
prerank,cardiac muscle cell development (GO:0055013),0.9157585521111231,1.1751621580546623,0.1635,0.8177559757554188,1.0,8/24,7.31%,MYH11;PDGFRB;PDGFRA;VEGFA;OBSL1;ACTC1;CXADR;PDLIM5
prerank,retinoid metabolic process (GO:0001523),0.9573111488398821,1.1750273809731322,0.134,0.8171882541552384,1.0,13/92,2.13%,TTR;APOA1;APOC3;RBP2;APOA4;APOB;APOE;RBP1;RARRES2;HSPG2;LRP1;GPC3;ALDH1A1
prerank,digestive tract morphogenesis (GO:0048546),0.9042452478715446,1.1750179838598334,0.143,0.8156575696913902,1.0,5/15,4.35%,AGR2;TCF21;ID2;PDGFRA;FOXF1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.9097993026007863,1.1747673017290339,0.1555,0.8160380226825737,1.0,4/22,4.76%,TUBB;TUBB4B;CORO1A;KIF5B
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.945848748383091,1.1745714455091365,0.1695,0.815982458449352,1.0,7/72,1.97%,ACTG1;ACTB;HSP90AB1;HSP90AA1;RAC1;CDC42;ARPC3
prerank,regulation of catecholamine secretion (GO:0050433),0.9172806928387961,1.1741826188911573,0.169,0.8174164140511692,1.0,2/30,4.12%,CHGA;GRK2
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.9741253578339153,1.1740497702214536,0.0505,0.8168868072565018,1.0,10/133,0.98%,COL3A1;COL1A2;RPS27A;APOA1;FOS;UBC;UBA52;UBB;JUN;DDX5
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.9103621714291711,1.1739894495852874,0.1665,0.8157735639613434,1.0,9/25,5.38%,RACK1;TMBIM6;PARK7;CLU;HSPA1A;XBP1;UBXN1;SELENOS;HERPUD1
prerank,gluconeogenesis (GO:0006094),0.924138856120557,1.1737945028389727,0.175,0.8156928948216174,1.0,13/40,4.53%,GAPDH;TPI1;ENO1;ATF4;PGAM1;PGK1;PCK1;SLC25A1;MDH1;MDH2;ALDOB;SLC37A4;GPI
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.9032550813268186,1.1737549507822316,0.14307153576788395,0.8144177601227353,1.0,9/18,5.19%,DDX17;DDX5;SFPQ;SRSF6;HNRNPM;SRSF9;SRSF1;PUF60;DHX9
prerank,secondary alcohol metabolic process (GO:1902652),0.9393819955268359,1.1737383701337174,0.1765,0.8129745675159872,1.0,4/49,1.15%,APOA1;APOA4;APOB;APOE
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.9424412371524292,1.1735163654173708,0.1765,0.8131059325276321,1.0,14/64,2.65%,TPT1;PPIA;HSPB1;PTTG1IP;ENO1;TMBIM6;CXCL12;NDUFA13;PARK7;PLAUR;CLU;DDX3X;MCL1;HSPA1A
prerank,regulation of T cell activation (GO:0050863),0.9304355322917548,1.1734174489968239,0.183,0.8123657241191159,1.0,4/46,3.26%,LGALS3;PRELID1;HSPD1;THY1
prerank,regulation of interleukin-2 production (GO:0032663),0.9358826076466014,1.172925124304954,0.1855,0.8145776341796958,1.0,4/48,1.73%,RPS3;EZR;SPTBN1;ZFP36
prerank,translation (GO:0006412),0.9900216738618538,1.1729196568618123,0.006,0.8130641000644673,1.0,80/196,0.74%,EEF1A1;RPL41;RPL13;RPL10;RPS8;RPLP1;RPS12;RPL13A;RPL34;RPS27;RPS23;RPS2;RPS18;RPS15A;RPL37A;RPL32;RPS27A;RPL11;RPS19;RPS24;RPS28;RPS6;RPL37;RPL28;RPS3A;RPS15;RPS14;RPL9;RPL3;RPL12;RPS4X;RPL29;RPL30;RPL19;RPL18A;RPL8;RPL18;RPL7A;RPL5;RPLP0;RPL35A;RPL36;RPS3;RPL15;RPL4;RPL6;RPL21;RPL35;RPS11;RPLP2;RPS13;RPL39;RPS29;RPS7;RPL22;RPL26;RPS26;RPSA;RPS9;RPL31;RPL10A;RPS16;RPL7;RPL24;RPS25;RPS5;RPS21;RPL23A;RPL14;RPL27A;RPS10;RPL23;RPS20;EEF2;RPL36A;RPL27;UBA52;RPL38;TMA7;EEF1B2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.9457618910125479,1.172807438255741,0.17,0.8123824508530813,1.0,7/74,1.97%,ACTG1;ACTB;HSP90AB1;HSP90AA1;RAC1;CDC42;ARPC3
prerank,regulation of leukocyte activation (GO:0002694),0.9033064394306728,1.1714500925615023,0.1535,0.8213680897170604,1.0,3/16,1.32%,PLA2G2A;CD74;MIF
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.9313271063682821,1.1712391397558373,0.1865,0.8214478991526738,1.0,4/52,1.63%,APOC3;CEACAM1;ACADVL;MST1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.9069644730569295,1.1711741316080604,0.1635,0.8203425855977584,1.0,2/18,1.10%,MDK;HMGB1
prerank,regulation of cellular component movement (GO:0051270),0.9351775464610123,1.1711459607825805,0.1965,0.8189883105918976,1.0,7/50,2.70%,RPS19;CD9;ACTN4;RHOA;ACTN1;ERBB2;ERBB3
prerank,positive regulation of binding (GO:0051099),0.9523580662707383,1.170833434669415,0.1455,0.8198084628062264,1.0,14/89,2.50%,B2M;RPL11;STMN1;EDF1;TXN;HMGB1;APOE;LRP1;RAN;APP;PLAUR;HMGB2;FKBP1A;ADD1
prerank,metal ion transport (GO:0030001),0.9504066499380447,1.1701500842491563,0.1525,0.8234823892766823,1.0,1/88,0.09%,TPT1
prerank,regulation of heart contraction (GO:0008016),0.9567626103738361,1.1700292998589525,0.1285,0.8228558717763688,1.0,12/93,2.05%,FXYD3;ATP1A1;DES;TPM1;CALM2;CALM1;ATP1B3;SRI;ATP1B1;ATP2A3;FXYD6;CALM3
prerank,regulation of monocyte chemotaxis (GO:0090025),0.9048410789733113,1.1698543704689621,0.1565,0.8226104410013136,1.0,6/25,3.47%,HMGB1;DUSP1;CXCL12;NBL1;S100A14;LGMN
prerank,endoderm formation (GO:0001706),0.9157557169795714,1.1697042949931264,0.179,0.8221797232845491,1.0,8/36,2.82%,FN1;COL6A1;COL4A2;LAMB1;MMP2;DUSP1;COL12A1;LAMB3
prerank,positive regulation of potassium ion transport (GO:0043268),0.9165448825556937,1.1696844550053178,0.169,0.8207858346882506,1.0,3/38,1.94%,FLNA;FHL1;GNB1
prerank,negative regulation of cellular component organization (GO:0051129),0.94842974364838,1.1696570598669034,0.1685,0.8194586735491752,1.0,13/78,2.65%,APOA1;LGALS3;APOC3;APOA4;HSPA8;NOP53;DNM2;HSPA5;CDC42;CLU;DDX3X;APOA2;HSPA1A
prerank,regulation of leukocyte migration (GO:0002685),0.9003773991840341,1.1694829473415762,0.1585,0.819276295622731,1.0,4/17,4.41%,CD81;RAC1;VEGFA;ANXA1
prerank,nucleus organization (GO:0006997),0.9302479882869028,1.169071104099525,0.187,0.8207737800030187,1.0,1/47,0.16%,RPS19
prerank,regulation of interleukin-12 production (GO:0032655),0.9281678183913156,1.1690702270021762,0.1955,0.8192565707872733,1.0,3/51,1.10%,HLA-B;MDK;HMGB1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.9478575288958493,1.1690383894395033,0.1725,0.817957802755272,1.0,14/80,2.39%,ACTB;LGALS3;AGR2;ITGB1;TMEM59;CIB1;SPTBN1;VAMP8;PLS1;LRP1;AP2M1;SQSTM1;CLTC;TMBIM1
prerank,sensory perception (GO:0007600),0.923838779936222,1.169029348144039,0.1845,0.8165160597330616,1.0,2/50,1.36%,GNAS;PENK
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.9446669775597873,1.168712493139846,0.1775,0.817441539802901,1.0,4/74,0.57%,RPS27A;UBC;UBA52;UBB
prerank,ncRNA processing (GO:0034470),0.990683041133607,1.168687081907727,0.005,0.8161266040734507,1.0,59/198,0.62%,RPL41;RPL13;RPL10;RPLP1;RPL13A;RPL34;RPS27;RPS2;RPL37A;RPL32;RPL11;RPS19;RPS24;RPS28;RPS6;RPL37;RPL28;RPS15;RPS14;RPL9;RPL3;RPL12;RPL29;RPL30;RPL19;RPL18A;RPL8;RPL18;RPL7A;RPL5;RPLP0;RPL35A;RPL36;RPL15;RPL4;RPL6;RPL21;RPL35;RPLP2;RPL39;RPS7;RPL22;RPL26;RPS9;RPL31;RPL10A;RPS16;RPL7;RPL24;RPS25;RPL23A;RPL14;RPL27A;RPL23;RPL36A;RPL27;UBA52;RPL38;HNRNPA2B1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.9394110645346393,1.1685816193064256,0.187,0.8154429256666864,1.0,6/65,2.13%,ACTG1;CCL21;RHOA;CIB1;JUP;VCL
prerank,endoderm development (GO:0007492),0.9013273751375683,1.1685788553332905,0.16708354177088544,0.8139760384657447,1.0,2/15,2.64%,DUSP1;LAMC1
prerank,aerobic respiration (GO:0009060),0.9021866427362764,1.1684430687671776,0.1615,0.8135156923386764,1.0,13/21,7.08%,UQCRB;UQCR10;UQCRH;UQCRC1;ATP5F1D;BLOC1S1;NDUFS8;NDUFS7;MDH2;UQCRC2;OXA1L;SDHB;MTFR1L
prerank,regulation of acute inflammatory response (GO:0002673),0.9106746949670153,1.1684108063967928,0.1545,0.8122869730957366,1.0,3/20,6.57%,GSTP1;DNASE1;IL6ST
prerank,cellular response to type I interferon (GO:0071357),0.9398022999555299,1.168031489114556,0.1895,0.8122084262134783,1.0,7/65,1.53%,HLA-A;HLA-B;HLA-C;IFI27;EGR1;IFITM3;HLA-E
prerank,type I interferon signaling pathway (GO:0060337),0.9398022999555299,1.168031489114556,0.1895,0.8122084262134783,1.0,7/65,1.53%,HLA-A;HLA-B;HLA-C;IFI27;EGR1;IFITM3;HLA-E
prerank,circulatory system development (GO:0072359),0.967014558281348,1.1677957364409453,0.0895,0.812495968679452,1.0,2/125,0.55%,COL3A1;FN1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.9412549716397098,1.1677773152226292,0.1785,0.8111837086867524,1.0,12/68,2.79%,RPS27A;UBC;UBA52;UBB;EMILIN1;FBN1;FKBP1A;FBN2;HSPA1A;TGFB1I1;CAV1;HTRA3
prerank,negative regulation of endopeptidase activity (GO:0010951),0.9343629760667183,1.1676727740421868,0.2005,0.8105261347599324,1.0,8/62,3.31%,GAPDH;SERPINA1;SERPINH1;TIMP2;TIMP1;SERPINB6;TIMP3;SERPINB1
prerank,regulation of immune response (GO:0050776),0.9842150901327331,1.1673288175852143,0.02,0.8115651143985512,1.0,8/174,0.62%,COL3A1;COL1A1;COL1A2;B2M;HLA-A;HLA-B;HLA-C;CD81
prerank,protein localization to nucleus (GO:0034504),0.959565166474603,1.1671936514948789,0.111,0.8110914156286316,1.0,12/106,2.20%,COL1A1;RPL11;CALR;PTTG1IP;SKP1;NOP53;HNRNPU;CHCHD10;LMNA;RAN;YWHAE;PHB2
prerank,prostaglandin metabolic process (GO:0006693),0.9086835752240187,1.1670929764804343,0.163,0.8103565350785588,1.0,7/30,4.37%,GSTP1;GSTA1;CD74;CES2;MIF;PTGES3;HPGD
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.9002529251442593,1.16690891664433,0.1565,0.810238998432721,1.0,1/18,0.62%,HNRNPA2B1
prerank,response to ethanol (GO:0045471),0.8955107462056191,1.1668545349632813,0.15057528764382191,0.8091691939637451,1.0,2/15,2.49%,SOD1;SDF4
prerank,barbed-end actin filament capping (GO:0051016),0.8998987768110152,1.1668010269850138,0.1595,0.8066245280893303,1.0,13/19,8.05%,GSN;VIL1;ADD1;CAPZB;ADD3;CAPZA1;TRIOBP;VILL;EPS8;SVIL;CAPG;FLII;CAPZA2
prerank,actin filament capping (GO:0051693),0.8998987768110152,1.1668010269850138,0.1595,0.8066245280893303,1.0,13/19,8.05%,GSN;VIL1;ADD1;CAPZB;ADD3;CAPZA1;TRIOBP;VILL;EPS8;SVIL;CAPG;FLII;CAPZA2
prerank,cellular response to interferon-gamma (GO:0071346),0.9688215707684614,1.166660832051312,0.0815,0.8061941719066754,1.0,8/117,0.98%,B2M;RPL13A;GAPDH;HLA-A;HLA-B;HLA-C;MT2A;CCL21
prerank,ribosome biogenesis (GO:0042254),0.9902030805397948,1.16645731278628,0.0065,0.8062534399791327,1.0,58/190,0.57%,RPL41;RPL13;RPL10;RPLP1;RPL13A;RPL34;RPS27;RPS2;RPL37A;RPL32;RPL11;RPS19;RPS24;RPS28;RPS6;RPL37;RPL28;RPS15;RPS14;RPL9;RPL3;RPL12;RPL29;RPL30;RPL19;RPL18A;RPL8;RPL18;RPL7A;RPL5;RPLP0;RPL35A;RPL36;RPL15;RPL4;RPL6;RPL21;RPL35;RPLP2;RPL39;RPS7;RPL22;RPL26;RPS9;RPL31;RPL10A;RPS16;RPL7;RPL24;RPS25;RPL23A;RPL14;RPL27A;RPL23;RPL36A;RPL27;UBA52;RPL38
prerank,regulation of aerobic respiration (GO:1903715),0.8992811451627314,1.166326546499524,0.16008004002001,0.8058377228774035,1.0,7/15,6.53%,COX7A2;NOP53;VCP;COX7A2L;UQCC2;PINK1;COX7A1
prerank,regulation of microtubule polymerization (GO:0031113),0.9191746519043948,1.1663111194202975,0.18,0.8045288713136323,1.0,5/40,2.51%,RPS3;STMN1;RAC1;STMN2;NUMA1
prerank,hexose biosynthetic process (GO:0019319),0.9194354912330077,1.166048381936949,0.1785,0.8049752736937474,1.0,13/43,4.53%,GAPDH;TPI1;ENO1;ATF4;PGAM1;PGK1;PCK1;SLC25A1;MDH1;MDH2;ALDOB;SLC37A4;GPI
prerank,regulation of viral life cycle (GO:1903900),0.9073889391285342,1.1660007318182581,0.165,0.8039343550733044,1.0,1/26,0.46%,PPIA
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.9567325790197647,1.1655418867328344,0.1345,0.8058350964479105,1.0,11/111,1.83%,TPT1;MT1G;MT1H;MT2A;MT1E;CALR;MT1F;ATP1B1;CXCL12;ATP2A3;SLC39A5
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.8985397554371226,1.1655380933964858,0.1595,0.8044455955305378,1.0,4/18,6.47%,CHGA;PHB;SLC39A14;C3
prerank,leukocyte cell-cell adhesion (GO:0007159),0.9092965828229895,1.1651410967016982,0.174,0.8058452331865216,1.0,8/27,5.83%,EZR;CD177;APOA4;ITGB1;TNIP1;PECAM1;MSN;F11R
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.9047332762762408,1.1651313136229826,0.1685,0.8045080187006824,1.0,11/27,6.10%,HBB;HSP90AB1;HSP90AA1;ASS1;KLF4;CLU;KLF2;DDAH2;AKT1;P2RX4;DDAH1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.9120599206181981,1.165098925670659,0.167,0.803349065352753,1.0,2/29,1.65%,CEACAM1;FBN1
prerank,response to cytokine (GO:0034097),0.9684054128882303,1.1648342755836452,0.0755,0.8038891949212238,1.0,1/148,0.01%,COL3A1
prerank,endodermal cell differentiation (GO:0035987),0.9080614596689387,1.1645722318168337,0.17,0.8043409547887236,1.0,7/32,2.82%,FN1;COL6A1;COL4A2;LAMB1;MMP2;COL12A1;LAMB3
prerank,regulation of DNA repair (GO:0006282),0.9171623287995891,1.164493513676644,0.188,0.8034988007632858,1.0,2/43,2.08%,RPS3;TRIM28
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.9040529702617685,1.1643342320296781,0.167,0.803237595138518,1.0,11/28,6.10%,HBB;HSP90AB1;HSP90AA1;ASS1;KLF4;CLU;KLF2;DDAH2;AKT1;P2RX4;DDAH1
prerank,cholesterol homeostasis (GO:0042632),0.9429895620928194,1.1641882513472939,0.1785,0.8028434737193129,1.0,14/71,2.99%,APOA1;APOC3;CD24;APOA4;APOB;APOE;MALL;NPC2;CNBP;RALY;APOA2;LDLR;CAV1;INSIG1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.9067269141284598,1.1640183344733837,0.167,0.8026606510658394,1.0,7/28,3.96%,CALM2;CALM1;SRI;CALM3;YWHAE;FKBP1A;GSTO1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.8957253625883274,1.1637696794606174,0.1630815407703852,0.8030638626319032,1.0,6/15,4.80%,HNRNPA1;DDX3X;VCP;GSTO1;MKNK2;ATF3
prerank,negative regulation of mRNA processing (GO:0050686),0.8911250238541215,1.1636704375701485,0.1645822911455728,0.8023479078251505,1.0,11/15,6.77%,PTBP1;SRSF6;RBMX;SRSF7;SAP18;RNPS1;SRSF10;SRSF9;PCBP4;C1QBP;SRSF4
prerank,drug catabolic process (GO:0042737),0.8996551504538957,1.1635273127334214,0.1565,0.8019787574316023,1.0,2/22,3.23%,CYP2W1;CYP3A5
prerank,sterol homeostasis (GO:0055092),0.9428533045233398,1.1634826476319755,0.178,0.8009078976783551,1.0,14/72,2.99%,APOA1;APOC3;CD24;APOA4;APOB;APOE;MALL;NPC2;CNBP;RALY;APOA2;LDLR;CAV1;INSIG1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.931133000929989,1.1633299069226881,0.201,0.8006190378749822,1.0,7/55,1.58%,TMSB4X;HSPB1;ATP5F1B;HMGB1;APOE;ATP5F1A;JUP
prerank,organic substance transport (GO:0071702),0.9663290164639494,1.163190157800493,0.079,0.8002590535726042,1.0,7/134,1.25%,ZG16;APOA1;AMN;APOA4;TXNIP;HSP90B1;MYH9
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.9394483530891771,1.162920421339759,0.1865,0.8007573690209113,1.0,18/73,3.27%,B2M;HLA-A;HLA-B;HLA-C;CALR;CYBA;HLA-E;VAMP8;PDIA3;TAPBP;PSMB1;PSME1;PSMB4;PSME2;PSMD8;PSMB3;PSMA7;PSMB5
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.9109320485412857,1.1628863686910669,0.1785,0.7996368991327096,1.0,3/41,2.71%,FLNA;GNB1;CTSS
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.8993507249274219,1.1627000325942243,0.165,0.799597323738489,1.0,8/18,7.20%,DDX17;DDX5;DEFA3;RBFOX2;PADI2;SAFB;NCOA4;ARID1A
prerank,copper ion homeostasis (GO:0055070),0.8954497889171558,1.1626517022319165,0.1645,0.7985849788321714,1.0,5/17,4.60%,MT2A;ARF1;APP;ATOX1;ANKRD9
prerank,negative regulation of reproductive process (GO:2000242),0.9004504660614333,1.1622717258685007,0.167,0.7998062913521742,1.0,6/21,8.30%,CALR;DUSP1;TIMP1;SULF1;ARHGDIB;GJA1
prerank,dendrite self-avoidance (GO:0070593),0.8956585214134675,1.1620108320641827,0.164,0.8001617760250861,1.0,3/16,3.88%,BSG;NPTN;PALLD
prerank,negative regulation of immune response (GO:0050777),0.9784335624440976,1.1618186661523624,0.041,0.8001631466329038,1.0,2/177,0.21%,COL3A1;LGALS3
prerank,aerobic electron transport chain (GO:0019646),0.9293093333878378,1.1617888154568834,0.2005,0.7990161212829381,1.0,48/70,4.09%,COX4I1;COX7C;UQCRQ;COX6A1;COX5B;COX6C;UQCR11;NDUFA4;COX6B1;UQCRB;COX8A;UQCR10;UQCRH;COX5A;NDUFB2;NDUFA1;COX7B;NDUFS5;NDUFA11;NDUFB7;NDUFA13;CYCS;NDUFB1;UQCRC1;NDUFB11;NDUFB10;NDUFB4;NDUFA3;NDUFS6;NDUFV1;NDUFC2;NDUFB9;CYC1;NDUFB8;NDUFA6;UQCRFS1;NDUFA2;NDUFS8;NDUFS7;NDUFAB1;NDUFC1;NDUFV2;UQCRC2;NDUFA10;NDUFA12;NDUFB3;SDHA;NDUFB6
prerank,lipid homeostasis (GO:0055088),0.9352416283104035,1.1616464038651193,0.2045,0.7986550310899795,1.0,4/61,1.39%,APOA1;APOA4;APOE;RBP1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.8935564257084302,1.161633832640857,0.1745,0.7973878230513923,1.0,4/19,2.02%,IGFBP5;IGFBP4;IGFBP2;IGFBP3
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.9202169219395293,1.1616312804160889,0.1905,0.7960591651827302,1.0,5/50,2.95%,MYL9;CIB1;EIF6;HMGB2;PRMT1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.9711767070472662,1.161535702077781,0.0675,0.7953465283968829,1.0,4/143,1.04%,CKB;BSG;LDHA;SLC6A8
prerank,ephrin receptor signaling pathway (GO:0048013),0.9428647796967008,1.1612079237974389,0.179,0.796258740969372,1.0,9/82,1.97%,ACTG1;ACTB;EFNA1;MMP2;RHOA;RAC1;AP2M1;CDC42;ARPC3
prerank,regulation of interleukin-1 beta production (GO:0032651),0.9464430983218834,1.1611133445346302,0.1705,0.795586725763966,1.0,4/83,0.72%,APOA1;GSTP1;EGR1;HSPB1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.9651152743458113,1.1609433446832547,0.0925,0.7954015652612918,1.0,20/134,1.30%,RPL10;RPS27;RPL11;RPS19;RPS28;RPS15;RPS14;RPL3;RPL5;RPLP0;RPL6;RPSA;RPL24;RPS5;RPL23A;RPL38;HSP90AB1;HSP90AA1;SNRPD2;NOP53
prerank,negative regulation of protein catabolic process (GO:0042177),0.919663766224982,1.1609292531957596,0.1995,0.7941650457609166,1.0,10/42,3.46%,FLNA;CST3;CTSA;TIMP2;SNRNP70;TIMP1;SNX3;CDK5RAP3;TIMP3;PHB
prerank,cellular response to growth factor stimulus (GO:0071363),0.9676392266118029,1.1608860690668963,0.0715,0.793143700287036,1.0,7/156,1.25%,EEF1A1;MT1G;RACK1;HSPB1;ZFP36L2;ZFP36L1;NR4A1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.9320563441326801,1.1605037254603454,0.204,0.7945175072206024,1.0,4/60,2.98%,FLNA;PSAP;AKAP12;GNAI2
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.9081429235960772,1.160455902177306,0.1825,0.7935430380780834,1.0,33/39,6.71%,NDUFA4;NDUFB2;NDUFA1;NDUFS5;NDUFA11;NDUFB7;NDUFA13;NDUFB1;NDUFB11;NDUFB10;NDUFB4;NDUFA3;NDUFS6;NDUFV1;NDUFC2;NDUFB9;NDUFB8;NDUFA6;NDUFA2;NDUFS8;NDUFS7;NDUFAB1;NDUFC1;NDUFV2;NDUFA10;NDUFA12;NDUFB3;NDUFB6;NDUFS3;NDUFA5;NDUFS4;NDUFA8;NDUFS2
prerank,T cell migration (GO:0072678),0.8948160035633912,1.1602815255601089,0.162,0.7933951808525768,1.0,3/18,5.71%,CD99;SLC12A2;MSN
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.9029434895351666,1.1602171542108137,0.1715,0.7925094974680074,1.0,3/26,1.47%,HNRNPA1;HNRNPC;HNRNPU
prerank,establishment of apical/basal cell polarity (GO:0035089),0.8913579572358654,1.1601591669784972,0.1630815407703852,0.7915704927081368,1.0,5/15,2.93%,EZR;RHOA;SLC9A3R1;CDC42;FSCN1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.8971754120766671,1.1601143766278963,0.1655,0.7905701719882798,1.0,8/18,6.30%,CALM2;CALM1;HSP90AB1;CALM3;PDGFRB;ITGA1;PPP1R14D;PTPA
prerank,positive regulation of transport (GO:0051050),0.9470818940530012,1.1600599839303658,0.167,0.7895904679118992,1.0,13/91,2.53%,ACTB;APOA1;ANXA2;CALR;APOE;CYBA;CHCHD10;CD151;LRP1;GPC3;CHP1;NUMA1;APOA2
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.9285299169071887,1.1598765640684996,0.203,0.7895779327920446,1.0,48/71,4.09%,COX4I1;COX7C;UQCRQ;COX6A1;COX5B;COX6C;UQCR11;NDUFA4;COX6B1;UQCRB;COX8A;UQCR10;UQCRH;COX5A;NDUFB2;NDUFA1;COX7B;NDUFS5;NDUFA11;NDUFB7;NDUFA13;CYCS;NDUFB1;UQCRC1;NDUFB11;NDUFB10;NDUFB4;NDUFA3;NDUFS6;NDUFV1;NDUFC2;NDUFB9;CYC1;NDUFB8;NDUFA6;UQCRFS1;NDUFA2;NDUFS8;NDUFS7;NDUFAB1;NDUFC1;NDUFV2;UQCRC2;NDUFA10;NDUFA12;NDUFB3;SDHA;NDUFB6
prerank,cellular response to organonitrogen compound (GO:0071417),0.9532526151737821,1.1596618450526281,0.143,0.78966570139281,1.0,15/102,1.89%,ACTB;SLC26A3;EGR1;EZR;HSP90B1;IGFBP5;AQP8;ZFP36L1;AOC1;LAMTOR4;CTNNA1;CAPN2;JUP;CDH1;CTNNB1
prerank,cardiac muscle cell differentiation (GO:0055007),0.8997322467652623,1.1591443568358322,0.1725,0.7918511342771798,1.0,2/24,3.39%,MYH11;VEGFA
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.8901404189312951,1.1589358023312444,0.16566566566566568,0.7919447181021187,1.0,3/15,5.21%,CEACAM6;THY1;FLOT1
prerank,regulation of peptidase activity (GO:0052547),0.9019871818602336,1.1588896301624865,0.1775,0.7909740527318139,1.0,10/23,7.29%,CST3;NDUFA13;CSTB;CAV1;HDAC1;CTSH;PINK1;RCN3;NRDC;FURIN
prerank,positive regulation of inflammatory response (GO:0050729),0.9381436947853817,1.1587074449255463,0.2025,0.7910442702990964,1.0,10/87,2.35%,RPS19;MDK;CD81;PLA2G2A;GRN;PDCD4;VAMP8;APP;NUPR1;DDT
prerank,regulation of T cell proliferation (GO:0042129),0.937773720819573,1.158500700572827,0.196,0.7911574601510866,1.0,1/75,0.21%,LGALS3
prerank,regulation of ERBB signaling pathway (GO:1901184),0.8917487934921343,1.1583116052783402,0.1765,0.791102639987394,1.0,3/16,3.47%,CEACAM1;ERBB2;LGMN
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.9386597260046992,1.1581681282658023,0.192,0.7907993824119904,1.0,18/78,3.27%,B2M;HLA-A;HLA-B;HLA-C;CALR;CYBA;HLA-E;VAMP8;PDIA3;TAPBP;PSMB1;PSME1;PSMB4;PSME2;PSMD8;PSMB3;PSMA7;PSMB5
prerank,positive regulation of B cell proliferation (GO:0030890),0.9050610021397869,1.1579442036653202,0.1785,0.7909781217607352,1.0,4/30,3.76%,CD81;CD74;MIF;TFRC
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.9127931260379315,1.1578053113607336,0.19,0.7906201703233223,1.0,4/44,1.94%,FLNA;ATP1B3;ATP1B1;GNB1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.9358680173236388,1.15765509132542,0.1955,0.7903337190271083,1.0,10/78,2.41%,TMSB4X;RPS3;EZR;ACTN4;RHOA;PDCD4;APP;PHB2;DDX3X;ILK
prerank,regulation of cardiac muscle contraction (GO:0055117),0.9032094182732893,1.1576511923993373,0.182,0.7890827589013026,1.0,9/36,5.72%,CHGA;CALM2;CALM1;SRI;ATP1B1;CALM3;ATP2A2;RGS2;P2RX4
prerank,glial cell development (GO:0021782),0.9000697292359217,1.1575371812463147,0.1725,0.7885796958880308,1.0,4/26,2.47%,MDK;MXRA8;APP;SOX4
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.9155820554179356,1.1570161730949438,0.193,0.7906643005146533,1.0,4/36,1.20%,PPIA;GSTP1;EZR;DUSP1
prerank,muscle contraction (GO:0006936),0.9657935232359364,1.1569516699483549,0.099,0.7898365720088366,1.0,17/129,1.82%,ACTG2;MYL6;MYL9;ACTA2;VIM;TPM2;DES;TPM1;MYH11;MYLK;MYL12B;CALD1;CALM1;SLC6A8;MYL12A;TPM4;SMTN
prerank,positive regulation of lipid kinase activity (GO:0090218),0.9070995257229119,1.1568426543939319,0.189,0.7892954216848361,1.0,5/30,3.03%,CD81;CCL21;FGFR3;PDGFRB;PDGFRA
prerank,regulation of interleukin-8 production (GO:0032677),0.937097319334061,1.156828328404212,0.189,0.7881186078142913,1.0,10/81,2.84%,TMSB4X;CD74;HMGB1;KLF4;PARK7;ANXA4;APOA2;HSPA1A;RAB1A;LAMTOR5
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.917560428687512,1.1565936129724568,0.2035,0.7883726138010763,1.0,8/52,2.41%,RPS3;ACTN4;RHOA;PDCD4;APP;PHB2;DDX3X;ILK
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.9023111135027062,1.1565422065731987,0.1825,0.7874588501757669,1.0,4/23,4.78%,STMN1;YWHAB;GRK2;RGS2
prerank,positive regulation of protein import into nucleus (GO:0042307),0.8974870049839868,1.1565198874625486,0.1775,0.7863511620482206,1.0,5/28,2.08%,FLNA;JUP;CDH1;RAN;TRIM28
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.9020757489209273,1.1564165660060561,0.1765,0.7857490573287149,1.0,4/23,5.40%,MDK;VEGFA;AGT;SMO
prerank,negative regulation of cation channel activity (GO:2001258),0.8986511509286409,1.1563707787628794,0.176,0.784784243923429,1.0,6/27,3.96%,CALM2;CALM1;SRI;CALM3;FKBP1A;GSTO1
prerank,pyruvate metabolic process (GO:0006090),0.9207914467645786,1.1562401611208895,0.205,0.7843689565822632,1.0,13/55,3.82%,GAPDH;BSG;TPI1;LDHA;ENO1;PKM;LDHB;PFKL;PGAM1;PGK1;PCK1;VDAC1;ALDOB
prerank,protein kinase A signaling (GO:0010737),0.887054457261351,1.1559578056214372,0.17658829414707353,0.7850240074912441,1.0,6/15,8.92%,EZR;GAL;GCG;RAB13;PRKACB;PRKACA
prerank,cell junction assembly (GO:0034329),0.946699637156771,1.1558949140617876,0.1625,0.784202488166378,1.0,10/102,2.41%,ACTG1;ACTB;FLNA;FN1;RHOA;VMP1;CDH1;CDC42;CTNND1;ILK
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.922304319904088,1.15587484328502,0.2075,0.7830978139254006,1.0,9/52,2.51%,LGALS3;AGR2;ITGB1;CIB1;SPTBN1;PLS1;LRP1;SQSTM1;NUMA1
prerank,skeletal system development (GO:0001501),0.9699853204504,1.1557220583643095,0.069,0.7828919300462981,1.0,4/156,0.44%,COL1A1;RPL13;COL1A2;GNAS
prerank,myeloid leukocyte differentiation (GO:0002573),0.9307877950465689,1.1556086526860985,0.1985,0.7823813851888852,1.0,4/71,2.06%,MT1G;MYH9;CDC42;CDKN1A
prerank,negative regulation of metabolic process (GO:0009892),0.9236630716792895,1.155604874612529,0.212,0.7811771519888074,1.0,7/56,2.67%,APOC3;GSTP1;ATF4;ID1;ALDH1A1;LAMA4;FIS1
prerank,positive regulation of phosphatase activity (GO:0010922),0.8944877424730455,1.1554216728049378,0.174,0.7811901810782297,1.0,8/21,6.30%,CALM2;CALM1;HSP90AB1;CALM3;PDGFRB;ITGA1;CHP2;PTPA
prerank,cellular response to osmotic stress (GO:0071470),0.8922662328674368,1.155100504904182,0.17,0.7820818971892244,1.0,4/22,2.39%,MYLK;ZFP36L1;DDX3X;SERPINB6
prerank,cellular metal ion homeostasis (GO:0006875),0.946061476293223,1.1545397813377911,0.168,0.784551933884195,1.0,7/104,1.48%,TPT1;ATP1A1;CALR;ATP1B3;ATP1B1;CXCL12;ATP2A3
prerank,positive regulation of translation (GO:0045727),0.9476200734185004,1.1545126064179685,0.17,0.7835126665497897,1.0,20/99,2.50%,RPS4X;RPL5;VIM;RPL26;RPS9;EEF2;CIRBP;NPM1;PKM;RPS27L;PLXNB2;HNRNPD;EIF3E;CNBP;RBM3;DDX3X;EIF6;ERBB2;SOX4;EIF5A
prerank,regulation of epithelial cell proliferation (GO:0050678),0.9464519193973034,1.154502392257747,0.18,0.782363612258586,1.0,13/92,2.68%,B2M;LAMB1;ZFP36L1;NR4A1;GRN;ZFP36;MAGED1;CDKN1C;NUPR1;SRSF6;ERBB2;LAMC1;HPN
prerank,regulation of lipid metabolic process (GO:0019216),0.9430083055689237,1.1544501084842722,0.184,0.7814827596742944,1.0,9/91,2.16%,FABP1;APOC3;EDF1;PSAP;ID2;RARRES2;HMGCS1;NPC2;FDPS
prerank,glycerophospholipid metabolic process (GO:0006650),0.9388763549844028,1.1542569506748892,0.195,0.7814633312171382,1.0,4/79,0.92%,APOA1;PRDX6;APOA4;PLA2G2A
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.9444720821729633,1.1539677013191278,0.177,0.7821391544513026,1.0,12/85,2.29%,RPL13A;GAPDH;RPS3;RACK1;CALR;IGFBP5;APOE;YBX1;RTN4;ILF3;CLU;DDX3X
prerank,cellular response to peptide (GO:1901653),0.9180396411926582,1.153838801565159,0.199,0.781742273950921,1.0,7/57,3.47%,VIM;RPL23;ZFP36L1;LRP1;APP;CAV1;LGMN
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.8903842910788573,1.1538156723800597,0.1635,0.7806845223671746,1.0,8/18,6.72%,ZFP36L2;ZFP36L1;HNRNPU;ZFP36;PCK1;ANXA1;UBE2L3;PCK2
prerank,aorta morphogenesis (GO:0035909),0.8946156853776138,1.1535537940029423,0.1775,0.7811970079859821,1.0,9/17,8.13%,MYLK;LRP1;PDGFRB;EFEMP2;JAG1;RBPJ;ENG;ACVRL1;TBX2
prerank,positive regulation of mRNA processing (GO:0050685),0.888664753437552,1.1532580242647763,0.1705,0.7818706126520394,1.0,8/23,5.27%,PRDX6;CIRBP;RBM3;RBMX;NCL;TRA2B;TRA2A;DAZAP1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.9149189515117825,1.1529389613293342,0.2045,0.7826630166864741,1.0,10/49,2.80%,RPS3;PARK7;VPS28;SQSTM1;CHP1;OGT;SOX4;HSPA1A;CAV1;IVNS1ABP
prerank,negative regulation of defense response (GO:0031348),0.9352792933734176,1.1529191108748087,0.2035,0.7815880649008878,1.0,4/82,1.66%,APOA1;PCBP2;APOE;KLF4
prerank,positive regulation of T cell proliferation (GO:0042102),0.9234932063122541,1.1528676317873792,0.22,0.7807052305115203,1.0,8/65,4.41%,RPS3;CD24;HMGB1;IGFBP2;HHLA2;TFRC;CD46;ANXA1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.9382886302183688,1.1526569222389977,0.1945,0.780814479053997,1.0,16/88,3.43%,FABP1;CTSD;SFN;BEX3;HMGB1;NDUFA13;CYCS;KLF4;YWHAE;DDX3X;FIS1;LAMTOR5;BCAP31;DHCR24;VEGFA;PDCD6
prerank,regulation of potassium ion transport (GO:0043266),0.8966200602261991,1.152523467552017,0.1845,0.7804673400106119,1.0,3/31,1.74%,CD63;VIP;FHL1
prerank,androgen receptor signaling pathway (GO:0030521),0.886168397925474,1.1522517942236024,0.18109054527263632,0.7810220416045873,1.0,5/15,7.20%,DDX17;DDX5;PLPP1;ZMIZ1;ARID1A
prerank,plasma membrane invagination (GO:0099024),0.9000306914932912,1.1521433089820838,0.1865,0.7804971380109759,1.0,4/30,1.96%,GSN;MYH9;RHOA;CDC42
prerank,regulation of protein binding (GO:0043393),0.9528778352410028,1.152086181245991,0.142,0.7796531631494719,1.0,14/115,2.51%,B2M;ACTB;RPL11;RACK1;TMBIM6;PARK7;LRP1;RAN;APP;CDKN1A;FKBP1A;PPP1CA;ADD1;SLPI
prerank,neuropeptide signaling pathway (GO:0007218),0.9233954716716191,1.151848194128493,0.216,0.7799616801513204,1.0,5/63,2.82%,PYY;PENK;NTS;CPE;GAL
prerank,positive regulation of DNA binding (GO:0043388),0.8976011238870667,1.1515856325990899,0.181,0.7804515094246691,1.0,11/32,7.79%,EDF1;TXN;HMGB1;PARK7;PLAUR;HMGB2;HES1;NME1;HAND2;CEBPG;SIRT2
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.9163756816721575,1.1515589929450782,0.2195,0.7794431204245746,1.0,8/58,2.94%,RPS3;RACK1;SLC9A3R1;G0S2;NUPR1;FIS1;CAV1;BCAP31
prerank,negative regulation of cell migration (GO:0030336),0.9631355839123974,1.1514406440915732,0.092,0.7790601019095239,1.0,14/142,2.13%,COL3A1;TPM1;CLDN3;CALR;CD74;IGFBP5;MIF;RAC1;CDH1;LRP1;DPYSL3;TIMP1;IGFBP3;VCL
prerank,regulation of chondrocyte differentiation (GO:0032330),0.8959636020484523,1.1513519627333415,0.1865,0.7784544874434308,1.0,2/26,1.11%,MDK;PKDCC
prerank,Fc receptor signaling pathway (GO:0038093),0.9480196435198708,1.1513004814927212,0.1495,0.7775880368616104,1.0,6/112,1.43%,PIGR;FOS;JUN;CALM1;SKP1;RAC1
prerank,negative regulation of proteolysis (GO:0045861),0.9115348191811017,1.1512575619978307,0.1995,0.7766857639465705,1.0,10/43,3.48%,CST3;EFNA1;TMEM59;TIMP2;CAMK2N1;TIMP1;PLAT;CSTB;TIMP3;BAG6
prerank,inner mitochondrial membrane organization (GO:0007007),0.9161809244393712,1.1512212458881752,0.2185,0.7757237501227779,1.0,20/46,3.19%,ATP5F1E;ATP5ME;ATP5F1B;ATP5MG;ATP5MC2;ATP5F1A;ATP5PF;ATP5MC3;NDUFA13;ATP5F1D;ATP5PO;ATP5MF;ROMO1;ATP5MC1;TIMM13;GHITM;ATP5PB;ATP5PD;SPG7;ATP5F1C
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.8900933754244231,1.1510450321423689,0.1815,0.7757309063538743,1.0,2/18,0.92%,APOB;PLA2G2A
prerank,calcium ion homeostasis (GO:0055074),0.9406690257504086,1.1510436455297826,0.187,0.774575148274413,1.0,6/97,1.69%,TPT1;CALR;ATP1B1;CXCL12;ATP2A3;S100A14
prerank,cellular response to metal ion (GO:0071248),0.9606087585569562,1.1508610165258182,0.1145,0.7745532908160915,1.0,10/131,1.62%,B2M;MT1G;MT1H;FOS;MT2A;MT1E;JUN;MT1F;AOC1;CDH1
prerank,actomyosin structure organization (GO:0031032),0.9310915471066248,1.1507756585293232,0.215,0.7739465571964373,1.0,10/76,2.32%,KRT19;TPM1;CSRP1;MYH9;ITGB1;RHOA;PDLIM1;WDR1;ZYX;MYH14
prerank,negative regulation of stress fiber assembly (GO:0051497),0.8932176882866525,1.150737257637237,0.1795,0.7730122593504656,1.0,2/24,0.59%,PFN1;STMN1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.9239367181082959,1.1500609085278704,0.22,0.7760855584847212,1.0,6/73,1.51%,RPS27A;UBC;UBA52;UBB;HMGN1;POLR2L
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.8969266986716358,1.1499674265133681,0.1785,0.7755216997592472,1.0,2/32,2.46%,TPM1;FKBP1A
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.8900743164169251,1.1499228050885142,0.1875,0.7746606101788043,1.0,5/26,5.30%,PPIA;PPIB;FKBP1A;NKTR;PIN1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.8931261126453791,1.1498568718830644,0.182,0.7739119621429313,1.0,8/24,3.79%,UBB;EFNA1;APOE;ATP5IF1;CTSC;PSME1;PSME2;PKD1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.8960642558727452,1.149838236013059,0.1875,0.7728786338041983,1.0,6/30,4.01%,PPIA;HSP90AB1;HSP90AA1;PTGES3;NOP10;NHP2
prerank,regulation of hydrolase activity (GO:0051336),0.9247227260492242,1.1497414814313238,0.211,0.7723524774654268,1.0,8/73,3.12%,APOA1;ATP5IF1;PLXNB2;SOD1;CAV1;CDK5RAP3;PLXNB1;SCARB2
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.8888250368769234,1.149637267931043,0.18409204602301152,0.7718589223125892,1.0,6/18,8.13%,GNB1;GNA11;AGRN;GRK2;RGS10;GNAQ
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.9234208037088113,1.1496305828089557,0.2245,0.7707564469592298,1.0,12/60,3.88%,CEACAM5;CEACAM1;CEACAM6;BSG;CDH17;ITGB1;CDH1;PLXNB2;DSG2;NPTN;PKD1;PALLD
prerank,regulation of ruffle assembly (GO:1900027),0.8937571354509188,1.1495339723233966,0.1805,0.7702224832719518,1.0,8/24,5.72%,PFN1;EPS8L2;CAV1;EVL;EPS8L3;PFN2;EPS8;P2RX4
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.9268096425298488,1.14940171144163,0.216,0.7699160103721407,1.0,10/74,2.38%,SPARC;DCN;EMILIN1;COL4A2;GTF2I;KLF4;HSPG2;CTNNB1;PGK1;THBS2
prerank,negative regulation of translation (GO:0017148),0.9427694523516954,1.1493717157185752,0.1985,0.7689344163879748,1.0,10/88,2.29%,RPL13A;GAPDH;RPS3;RACK1;CALR;IGFBP5;YBX1;ILF3;EIF3E;DDX3X
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.8910185616938734,1.1493268976024311,0.184,0.7681017170827972,1.0,5/23,3.96%,CALM2;CALM1;SRI;CALM3;GSTO1
prerank,toll-like receptor signaling pathway (GO:0002224),0.9380753753727706,1.149280966845629,0.201,0.7672612025805606,1.0,12/91,2.75%,RPS27A;UBC;UBA52;UBB;APOB;HSP90B1;HMGB1;CTSB;S100A14;UBE2D3;CTSS;HSPD1
prerank,cellular response to glucose stimulus (GO:0071333),0.9010205624464238,1.149170844045164,0.187,0.7668028390724114,1.0,10/32,6.72%,RACK1;SOX4;PCK1;TRA2B;GAS6;XBP1;SLC39A14;MLXIPL;RAB11B;PCK2
prerank,pre-replicative complex assembly (GO:0036388),0.9213640895103007,1.1486696262840226,0.219,0.7687119374429396,1.0,18/64,4.20%,RPS27A;UBC;UBA52;UBB;PSMB1;PSME1;PSMB4;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;MCM7;PSMA1;PSMA4;PSMC5
prerank,"phagocytosis, engulfment (GO:0006911)",0.9072310124181352,1.1484678566915025,0.21,0.7688640680002787,1.0,4/37,1.96%,GSN;MYH9;RAC1;CDC42
prerank,heart contraction (GO:0060047),0.9043410272000215,1.1484150144006526,0.192,0.7680790581495007,1.0,3/40,1.88%,TPM1;ATP1B1;SOD1
prerank,protein trimerization (GO:0070206),0.8841941143938081,1.1483852544975341,0.1805902951475738,0.7660249308312856,1.0,2/15,1.40%,MIF;ITLN1
prerank,protein homotrimerization (GO:0070207),0.8841941143938081,1.1483852544975341,0.1805902951475738,0.7660249308312856,1.0,2/15,1.40%,MIF;ITLN1
prerank,mesoderm development (GO:0007498),0.8893651142979433,1.1482396449473498,0.177,0.7658029695390441,1.0,2/20,3.39%,MEST;VEGFA
prerank,regulation of defense response (GO:0031347),0.9333874442027988,1.148122822252267,0.218,0.7654049571435992,1.0,4/82,1.85%,TMSB4X;APOE;GRN;PARK7
prerank,regulation of striated muscle contraction (GO:0006942),0.8909141649364772,1.148118443454394,0.1745,0.7643247580939988,1.0,7/29,6.91%,CALM2;CALM1;SRI;CALM3;GRK2;P2RX4;ANK2
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.923441083151054,1.147835661263661,0.218,0.7649004871504037,1.0,3/71,1.96%,ACTB;POLR2L;SF3B1
prerank,bicellular tight junction assembly (GO:0070830),0.9121429347212697,1.1477332095155865,0.196,0.764359853434315,1.0,14/53,6.00%,CLDN4;CLDN3;CLDN7;CLDN23;PDCD6IP;RAMP2;CLDN5;PECAM1;MICALL2;TBCD;CDH5;F11R;ARL2;AFDN
prerank,platelet degranulation (GO:0002576),0.9551130930698228,1.1477289627145115,0.1345,0.7632887096815477,1.0,27/124,2.26%,APOA1;TMSB4X;SPARC;SELENOP;FLNA;FN1;SERPINA1;CD63;PSAP;CALM1;MAGED2;CD9;APLP2;ACTN4;LGALS3BP;A2M;RARRES2;QSOX1;TAGLN2;SOD1;TIMP1;WDR1;APP;ACTN1;VCL;ANXA5;CLU
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.9287933128910046,1.1475835294498962,0.2135,0.7630941700475573,1.0,13/73,3.63%,RPS27A;UBC;UBA52;UBB;CTSB;CAPN2;NEDD8;CTSC;VCP;CTSS;LGMN;BAG6;PDCD6IP
prerank,positive regulation of cell cycle (GO:0045787),0.9202806428372915,1.1475066206610958,0.2175,0.7624428776298853,1.0,6/65,2.45%,RPS15A;CALR;CCND2;APP;NUPR1;USP22
prerank,phosphatidylcholine metabolic process (GO:0046470),0.9317462883428005,1.1472540926772774,0.218,0.762862329465912,1.0,6/72,1.36%,APOA1;APOA4;PLA2G2A;STARD10;SLC44A4;DBI
prerank,synaptonemal complex assembly (GO:0007130),0.8837138259631351,1.147158066955603,0.1755,0.7612550457947164,1.0,4/15,8.24%,BAG6;RAD21;REC8;P3H4
prerank,synaptonemal complex organization (GO:0070193),0.8837138259631351,1.147158066955603,0.1755,0.7612550457947164,1.0,4/15,8.24%,BAG6;RAD21;REC8;P3H4
prerank,bile acid and bile salt transport (GO:0015721),0.8940498409477797,1.146901099083908,0.18,0.7616751106951903,1.0,3/28,4.89%,CEACAM1;ABCC3;ATP8B1
prerank,sulfur compound catabolic process (GO:0044273),0.9027478684962525,1.1467659388222513,0.1995,0.7614075562365173,1.0,7/40,2.56%,DCN;LUM;OGN;VCAN;TST;MPST;GNS
prerank,regulation of mitochondrial fission (GO:0090140),0.8903461025503526,1.1466878301454375,0.188,0.7608218870951795,1.0,3/23,2.97%,DCN;FIS1;INF2
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.886041915246539,1.146608391841492,0.1795,0.7602186934603274,1.0,6/21,4.30%,CALM2;CALM1;ATP1B1;CALM3;GSTO1;ATP2A2
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.9428351984874995,1.1465217349046701,0.192,0.7596803817988101,1.0,16/93,2.95%,RPL13A;GAPDH;RPS3;RACK1;CST3;CALR;IGFBP5;APOE;YBX1;CAMK2N1;ILF3;DDX3X;PLAT;CSTB;NCL;CDK5RAP3
prerank,heart development (GO:0007507),0.9634535414422005,1.146445404201114,0.1025,0.7590401197551091,1.0,2/163,0.55%,COL3A1;FN1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.882383507478565,1.1463449842952858,0.1865,0.7585623298622858,1.0,7/17,9.03%,CALM2;CALM1;CALM3;GSTO1;ANK2;PRKACA;CAMK2D
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.9118945687956446,1.1462012564676738,0.2125,0.7583212376859242,1.0,6/54,2.77%,FLNA;CD63;FHL1;GNB1;YWHAE;CAV1
prerank,positive regulation of protein import (GO:1904591),0.8908704349408642,1.1461332461990315,0.19,0.7576291485622239,1.0,12/30,7.30%,FLNA;JUP;CDH1;RAN;TRIM28;PDCD5;CHP2;IPO5;PSEN1;HYAL2;TPR;DMAP1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.8884789295654961,1.1459634125170257,0.1755,0.7565295074613243,1.0,10/21,7.71%,GSTP1;GSTA1;MGST3;GSTK1;AKR1A1;GSTO1;ESD;GSTA2;MGST2;GSTM3
prerank,glutathione derivative metabolic process (GO:1901685),0.8884789295654961,1.1459634125170257,0.1755,0.7565295074613243,1.0,10/21,7.71%,GSTP1;GSTA1;MGST3;GSTK1;AKR1A1;GSTO1;ESD;GSTA2;MGST2;GSTM3
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.9016547669968797,1.1456637900396422,0.199,0.757272290782646,1.0,9/36,4.17%,TPM1;JUN;CNN1;IGFBP5;MMP2;PDCD4;CDKN1A;EFEMP2;ADAMTS1
prerank,nitrogen compound transport (GO:0071705),0.9536272957842148,1.1453867498189723,0.135,0.7579133345895562,1.0,8/140,1.27%,ZG16;HBB;AMN;TXNIP;SLC6A8;HSP90B1;MYH9;SLC44A4
prerank,positive regulation of cell death (GO:0010942),0.9203885208343527,1.1450700885745737,0.2285,0.7587228740870626,1.0,6/66,2.26%,FOS;HBA1;EGR1;HBB;LRP1;CLU
prerank,regulation of oxidative phosphorylation (GO:0002082),0.8838966430637635,1.1450305150000475,0.1915,0.7578890769147231,1.0,8/16,6.53%,COX7A2;NUPR1;VCP;COX7A2L;UQCC2;MLXIPL;PINK1;COX7A1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.8837208781881152,1.144921134494396,0.18859429714857429,0.757504169181023,1.0,11/15,8.21%,NOP10;CCT7;CCT3;NHP2;CCT4;TCP1;CCT5;CCT6A;CCT8;CCT2;RUVBL2
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.8796413585121057,1.1448902467532083,0.1805,0.7566485822798666,1.0,9/19,9.46%,CLDN3;MYO1C;CLDN5;EPHA2;F11R;SNAI2;ROCK2;PRKACA;OCLN
prerank,negative regulation of chemokine production (GO:0032682),0.8819464948150572,1.1448379090020455,0.181,0.7559075809412702,1.0,5/17,5.85%,GSTP1;KLF4;C1QTNF3;SIGIRR;LGALS9
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.9296586904580756,1.1446931711070445,0.217,0.7557420797174064,1.0,19/90,3.83%,LGALS3;RPS3;RACK1;CLDN3;PFN1;CHGA;RHOC;EMILIN1;PARK7;VIL1;CLU;SYNPO2;VCP;SDC1;VEGFA;BRK1;PDCD6IP;TFRC;RAB7A
prerank,apical junction assembly (GO:0043297),0.9132187158672614,1.1445089931556076,0.2105,0.7557945580936534,1.0,19/60,6.00%,CLDN4;CLDN3;CLDN7;RHOC;RHOA;CTNNA1;WDR1;VCL;CLDN23;PDCD6IP;RAMP2;CLDN5;PECAM1;MICALL2;TBCD;CDH5;F11R;ARL2;AFDN
prerank,regulation of keratinocyte proliferation (GO:0010837),0.8926015442487499,1.1444682521385812,0.1905,0.7549516507883031,1.0,9/24,7.65%,MDK;ZFP36L1;ZFP36;SRSF6;AREG;NOTCH2;VDR;EPB41L4B;SNAI2
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.8853592164643649,1.1444318795914605,0.1835,0.7541062304914246,1.0,1/18,0.59%,STMN1
prerank,chondroitin sulfate metabolic process (GO:0030204),0.8899184743821751,1.1436701295694316,0.1895,0.7575920000800086,1.0,2/30,1.27%,DCN;VCAN
prerank,negative regulation of binding (GO:0051100),0.9294294293453841,1.1436415471183068,0.224,0.7566982713652202,1.0,9/85,2.77%,ACTB;RACK1;JUN;TMBIM6;PARK7;CDKN1A;PPP1CA;SLPI;CAV1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.8893759560720396,1.143434650348476,0.1875,0.7569029701223497,1.0,7/25,5.39%,CALM2;CALM1;SRI;CALM3;FKBP1A;GSTO1;SELENON
prerank,muscle cell development (GO:0055001),0.8944726727173088,1.1433365805390603,0.196,0.7564247978509295,1.0,11/33,8.07%,MYH11;SDC1;EFEMP2;VEGFA;HES1;RAMP2;BIN1;ANK2;CXADR;ENG;KDM1A
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.9386267194740371,1.143221678695436,0.2055,0.7560463624678666,1.0,23/101,2.85%,RPS4X;RPL5;VIM;RPL26;EEF2;CIRBP;EZR;NPM1;PTTG1IP;HSP90AA1;KLF4;RPS27L;PLXNB2;HNRNPD;EIF3E;RBM3;DDX3X;EIF6;ERBB2;OGT;SOX4;AURKAIP1;PERP
prerank,positive regulation of ATPase activity (GO:0032781),0.9014527238552144,1.1426229874943767,0.204,0.7586023744707803,1.0,15/42,6.12%,TPM1;PFN1;DYNLL1;ATP1B3;ATP1B1;HNRNPU;VMP1;GABARAPL2;ALDOB;PFN2;DHX9;DNAJB1;CHTOP;SSBP1;DYNLL2
prerank,carbohydrate homeostasis (GO:0033500),0.9198919404528223,1.1425203438611569,0.225,0.7581835515082225,1.0,7/69,3.74%,RPS6;PARK7;SOX4;PCK1;GCG;CEBPA;HNF4A
prerank,membrane assembly (GO:0071709),0.895579397597594,1.1420207813863794,0.197,0.7600969798313483,1.0,9/36,5.94%,S100A10;ANXA2;SPTBN1;CHMP2A;GAK;FLOT1;CEL;PTEN;PICALM
prerank,establishment of endothelial barrier (GO:0061028),0.8877252467406834,1.141809897070639,0.1935,0.7602590630450953,1.0,11/29,6.00%,CLDN3;EZR;RAP1B;RAB1A;RAB1B;TJP3;PECAM1;MSN;F11R;RAP1A;AFDN
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.8867453056591976,1.1417257627136814,0.1925,0.7597330601231534,1.0,2/23,1.44%,GSN;PDCD4
prerank,external encapsulating structure organization (GO:0045229),0.969900818531988,1.1416627596962836,0.0515,0.7590787989177353,1.0,29/216,1.74%,COL3A1;COL1A1;COL1A2;TTR;SPARC;DCN;POSTN;FN1;COL5A1;COL6A1;COL6A2;LUM;COL5A2;BSG;COL6A3;COL4A1;COL4A2;LAMB1;COL16A1;MMP2;VCAN;ITGB1;ELN;MFAP2;NID1;CDH1;FBN1;HSPG2;PXDN
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.8794159232360782,1.1415886024930721,0.188,0.7584767669245659,1.0,5/17,4.39%,CALM2;CALM1;CALM3;EIF4G1;DDIT4
prerank,extracellular structure organization (GO:0043062),0.9698258660940408,1.141540223793796,0.051,0.7577320568405855,1.0,29/215,1.74%,COL3A1;COL1A1;COL1A2;TTR;SPARC;DCN;POSTN;FN1;COL5A1;COL6A1;COL6A2;LUM;COL5A2;BSG;COL6A3;COL4A1;COL4A2;LAMB1;COL16A1;MMP2;VCAN;ITGB1;ELN;MFAP2;NID1;CDH1;FBN1;HSPG2;PXDN
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.888099521408457,1.1414388017382473,0.192,0.7572599421266919,1.0,2/27,0.59%,PFN1;STMN1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.8776415420818959,1.1411433338577235,0.19109554777388693,0.7579798970869157,1.0,6/16,7.66%,ZFP36L2;ZFP36L1;ZFP36;TARDBP;MOV10;UPF1
prerank,sterol metabolic process (GO:0016125),0.9258173443680204,1.1410275277923123,0.2355,0.7576151696031312,1.0,7/70,2.99%,APOA1;APOA4;APOB;APOE;APOA2;MSMO1;INSIG1
prerank,peptide hormone secretion (GO:0030072),0.8867963007596427,1.1409123372647563,0.192,0.7572554928885661,1.0,6/27,4.41%,LTBP4;VIP;PARK7;GAL;RAB1A;ANXA1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.8886670014099198,1.1404377434199608,0.187,0.7589427946584402,1.0,2/32,1.01%,CFL1;EFNA1
prerank,negative regulation of ossification (GO:0030279),0.8857386301661118,1.1403877936490048,0.189,0.758225100295978,1.0,4/24,5.13%,MDK;TRPM4;SFRP1;NOTCH1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.9228917217010425,1.140358699701862,0.229,0.7573697594423062,1.0,6/79,2.95%,TMSB4X;COMMD6;KLF4;CHP1;ANXA4;CDK5RAP3
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.886036827066124,1.1403310524114494,0.1975,0.756523458170262,1.0,11/35,6.29%,FLNA;RAC1;PLXNB2;ARHGDIA;PLXNB1;SEMA3B;NRP1;PLXND1;NRP2;SEMA4G;SEMA5A
prerank,Wnt signaling pathway (GO:0016055),0.9301428800606004,1.1402374100090498,0.217,0.7560311533688042,1.0,11/92,2.29%,RPS27A;UBC;UBA52;UBB;CD24;SKP1;CTNNB1;CPE;RBX1;SNX3;DDX3X
prerank,RNA stabilization (GO:0043489),0.891504802029537,1.1401360489946804,0.199,0.75559725778296,1.0,6/33,1.47%,CIRBP;PABPC1;FUS;YBX1;VIP;HNRNPU
prerank,regulation of T cell differentiation (GO:0045580),0.8952239528029954,1.1400168757489266,0.205,0.7552939714144024,1.0,6/39,5.65%,MDK;PRELID1;SOD1;XBP1;ZMIZ1;ABL1
prerank,regulation of amyloid fibril formation (GO:1905906),0.8860924585858276,1.139358136374196,0.2031015507753877,0.7580075953894058,1.0,7/15,6.11%,PFDN5;APOE;APP;CLU;LDLR;PFDN2;PSEN1
prerank,embryonic digestive tract development (GO:0048566),0.8818371542157263,1.1384486600823325,0.1875,0.7622122914297242,1.0,6/20,4.35%,PKDCC;TCF21;ID2;RARRES2;PDGFRA;FOXF1
prerank,regulation of sodium ion transport (GO:0002028),0.8893243078284941,1.138426445287,0.198,0.7613228842814127,1.0,4/36,3.43%,ATP1A1;PRSS8;ATP2B4;YWHAH
prerank,activation of protein kinase B activity (GO:0032148),0.886880437344892,1.1383180760646796,0.193,0.7609441933270433,1.0,3/31,1.85%,PPIA;TXN;PARK7
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.9159340123875003,1.138149165270665,0.2335,0.7608956273889605,1.0,22/75,4.20%,RPS27A;UBC;UBA52;UBB;ELOB;HIGD1A;PSMB1;RBX1;PSME1;PSMB4;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;HIF3A;VEGFA;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5
prerank,cellular response to ionizing radiation (GO:0071479),0.8973591471499669,1.1379792491442025,0.2195,0.7608884417393077,1.0,9/48,4.14%,RPL26;EEF1D;CDKN1A;PRAP1;NUCKS1;XRCC6;RHOB;XRCC5;NET1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.924662556091666,1.1378896175169047,0.2475,0.7603816064143804,1.0,11/81,4.21%,ACTB;CCND2;CDKN1C;CDKN1A;CDC37;CCNI;CDK5RAP3;CEBPA;PKD1;CCND1;NR2F2
prerank,positive regulation of cell junction assembly (GO:1901890),0.9048119204081115,1.1378548402745734,0.227,0.75958480969978,1.0,16/57,6.11%,S100A10;CLDN3;COL16A1;RAC1;CLSTN1;CAV1;THY1;VEGFA;NRP1;CLDN5;SFRP1;AGT;FLOT1;ABL1;EPHA2;FERMT2
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.8999405769562763,1.1374629415273751,0.2175,0.7608418169043095,1.0,10/43,3.39%,S100A10;CEACAM6;CCL21;COL16A1;RAC1;CIB1;JUP;THY1;EFEMP2;VEGFA
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.9876445489282221,1.1373911056993262,0.007,0.7602569778809695,1.0,78/310,0.57%,EEF1A1;RPL41;RPL13;RPL10;RPS8;RPLP1;RPS12;RPL13A;RPL34;RPS27;RPS23;RPS2;RPS18;RPS15A;RPL37A;RPL32;RPS27A;RPL11;RPS19;RPS24;RPS28;RPS6;RPL37;RPL28;RPS3A;RPS15;RPS14;RPL9;RPL3;RPL12;RPS4X;RPL29;RPL30;RPL19;RPL18A;RPL8;RPL18;RPL7A;RPL5;RPLP0;RPL35A;RPL36;RPS3;RPL15;RPL4;RPL6;RPL21;RPL35;RPS11;RPLP2;RPS13;RPL39;RPS29;RPS7;RPL22;RPL26;RPS26;RPSA;RPS9;RPL31;RPL10A;RPS16;RPL7;RPL24;PTMA;RPS25;RPS5;RPS21;RPL23A;RPL14;RPL27A;RPS10;RPL23;RPS20;EEF2;RPL36A;RPL27;RPL38
prerank,positive regulation of dephosphorylation (GO:0035306),0.8847497962581079,1.1372142789594115,0.1965,0.760232178278601,1.0,18/29,9.86%,PPIA;CALM2;CALM1;PTBP1;CALM3;PIN1;CHP2;CDH5;CAMTA1;PTPA;GBA;SPPL3;SYMPK;SMPD1;NSMF;ANKLE2;SRC;DLC1
prerank,regulation of cell motility (GO:2000145),0.9459606124170793,1.1368124397157877,0.174,0.7615236127034162,1.0,12/131,1.91%,TMSB10;TMSB4X;FLNA;CEACAM1;SPINT2;FBLN1;CCL21;PHPT1;RHOA;RAC1;PLXNB2;LMNA
prerank,negative regulation of endothelial cell migration (GO:0010596),0.8940023642550127,1.1367454053892536,0.213,0.7609065700035361,1.0,8/38,5.13%,DCN;HMGB1;APOE;JUP;CSNK2B;ATP2B4;NR2F2;NOTCH1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.874536263196682,1.136729459419278,0.1845,0.7599916152980558,1.0,2/22,1.18%,AHNAK;SRI
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.9196190126476895,1.1365596944810477,0.24,0.7599548036615524,1.0,15/76,2.77%,LGALS3;GSTP1;SLC25A5;TMBIM6;NDUFA13;ACAA2;PRELID1;PARK7;GHITM;PLAUR;CLU;DDX3X;MCL1;HSPA1A;MAZ
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.9061334765532015,1.1364921066400935,0.2425,0.7593396285858477,1.0,3/54,2.08%,RPS3;DDX5;TRIM28
prerank,regulation of postsynapse organization (GO:0099175),0.884616513760247,1.1362830610442598,0.1965,0.7595549150530718,1.0,1/28,0.47%,CFL1
prerank,epithelial cell differentiation (GO:0030855),0.9297703130440292,1.135989520237178,0.2285,0.7601815528879077,1.0,23/101,3.45%,TAGLN;LGALS3;FSTL1;GSTA1;EDF1;ACADVL;CTSB;TST;TCF21;TAGLN2;MAF;PGK1;VIL1;ANXA4;GSTK1;PCK1;HNRNPH3;DMBT1;CNN3;DHRS9;CDHR2;VEGFA;VDAC1
prerank,regulation of transforming growth factor beta production (GO:0071634),0.8810084923286143,1.1356865306282427,0.204,0.7609033447864413,1.0,9/18,9.82%,FN1;CD46;CD34;LGALS9;SMAD4;HIF1A;ITGAV;LRRC32;LTBP1
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.8835177322561046,1.135639472142185,0.1985,0.760151022923482,1.0,10/29,7.14%,CIRBP;PABPC1;FUS;YBX1;VIP;HNRNPU;PKP3;LARP1;ELAVL1;THRAP3
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.8771427889997192,1.1355376314416337,0.207,0.7597144260341695,1.0,9/17,7.97%,APOE;RTN4;CLU;RTN3;PIN1;SORL1;BIN1;PRNP;RTN1
prerank,regulation of developmental growth (GO:0048638),0.8881490617481267,1.1353980416006004,0.2115,0.7595284762619805,1.0,7/31,2.62%,AGR2;APOE;FGFR3;DNM2;SOD1;APP;CTTN
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.8811817832267672,1.135374608855579,0.21,0.7586579179843742,1.0,7/24,8.21%,SLC26A2;SULT1B1;SULT1A1;PAPSS2;SULT1E1;SULT2A1;ABHD14B
prerank,negative regulation of cellular catabolic process (GO:0031330),0.918339911057109,1.1351792423103446,0.251,0.7587532243703041,1.0,10/69,3.16%,APOC3;CST3;EIF4G2;TIMP2;TIMP1;NUPR1;MCL1;CDK5RAP3;WDR6;TIMP3
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.8937514822050848,1.1348434036600548,0.214,0.7596548913903662,1.0,13/36,5.22%,HNRNPA1;HNRNPA2B1;CTNNB1;MAPK3;XRCC5;CCT7;CCT3;CCT4;TCP1;PKIB;CCT5;CCT6A;CCT8
prerank,striated muscle contraction (GO:0006941),0.9033892470826425,1.134819420360309,0.219,0.7588102392959193,1.0,4/54,4.12%,TPM1;ATP1B1;MYH14;GRK2
prerank,positive regulation of exosomal secretion (GO:1903543),0.8738371730170876,1.134732122277311,0.1991991991991992,0.758322462588702,1.0,12/15,10.00%,SDC1;PDCD6IP;RAB7A;CHMP2A;SDC4;SDCBP;HGS;VPS4B;SNF8;SMPD3;VPS4A;TSG101
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.8871417776442038,1.1347042094779953,0.2105,0.7575082220766849,1.0,4/31,2.06%,HNRNPA1;HNRNPC;HNRNPU;CDKN1A
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.8773826972943934,1.1347016200311013,0.188,0.7565430861883521,1.0,4/25,2.06%,CALM2;CALM1;CALM3;APP
prerank,regulation of endopeptidase activity (GO:0052548),0.9145133277529939,1.134495792448677,0.2505,0.7567158174019565,1.0,11/70,3.31%,GAPDH;SERPINA1;SERPINH1;TIMP2;PRELID1;TIMP1;SERPINB6;PSME1;PSME2;TIMP3;SERPINB1
prerank,digestive tract development (GO:0048565),0.8924097950296003,1.1341989405482602,0.218,0.7574006502795613,1.0,7/39,4.35%,PYY;AGR2;PKDCC;RARRES2;PKD1;CDX2;FOXF1
prerank,positive regulation of viral genome replication (GO:0045070),0.8833937086623529,1.13384777981187,0.202,0.7583750330855099,1.0,9/29,6.23%,PPIA;PABPC1;DDX3X;TOP2A;DDB1;TOP2B;ADAR;LARP1;RAD23A
prerank,positive regulation of T cell differentiation (GO:0045582),0.8970347998369017,1.133800001957936,0.215,0.7576700020534449,1.0,8/43,5.24%,MDK;SOX4;HLA-DRA;PCK1;HLA-DRB1;CD46;XBP1;ZMIZ1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.9497276120558764,1.1337408362245163,0.1575,0.7570168121348272,1.0,6/156,0.50%,RPL11;RPL37;RPS15;RPL5;RPL23;RPS20
prerank,regulation of RNA splicing (GO:0043484),0.9102909657960255,1.1335778034348276,0.2445,0.7569943672517648,1.0,23/74,4.38%,RPS13;RPS26;HNRNPH1;HNRNPK;AHNAK;FUS;TMBIM6;RBM39;SRSF3;SNRNP70;PTBP1;HSPA1A;TIA1;CLK1;SF1;HNRNPH3;SON;KHDRBS1;SLC38A2;TRA2B;HNRNPF;FASTK;SRSF10
prerank,autonomic nervous system development (GO:0048483),0.878787313075763,1.1334966663820965,0.2005,0.7564652734714153,1.0,3/21,4.29%,FN1;SOX4;NRP1
prerank,regulation of endocytosis (GO:0030100),0.9090853010163114,1.133461183941555,0.2345,0.7556979218813393,1.0,19/61,6.16%,LGALS3;CD177;APOE;CD151;LRP1;GPC3;AP2S1;PACSIN2;LRPAP1;RAB5C;NEDD4L;ARFGAP1;TSC2;FLOT1;RAB17;RAB5B;ABL1;PICALM;SNX17
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.8770090302396132,1.133411701854606,0.1965,0.7550059171796099,1.0,5/23,3.39%,CALM2;CALM1;CALM3;DDX3X;VEGFA
prerank,positive regulation of endothelial cell migration (GO:0010595),0.9248571687711858,1.1333553097530797,0.2385,0.754352005756207,1.0,9/85,1.43%,TMSB4X;SPARC;HSPB1;ATP5F1B;CALR;HMGB1;ATP5F1A;GRN;RAC1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.8793263408011069,1.1332663930369264,0.193,0.7538760765959649,1.0,5/20,5.65%,ZFP36L2;ZFP36L1;PRELID1;XRCC6;ABL1
prerank,long-term memory (GO:0007616),0.8768112273159808,1.1329072791659316,0.199,0.7548552293339477,1.0,7/19,7.50%,APOE;LDLR;SGK1;PJA2;NFATC4;KAT2A;PRNP
prerank,DNA geometric change (GO:0032392),0.8805805436192902,1.1325021483770938,0.198,0.7561049021132561,1.0,5/26,5.19%,HNRNPA2B1;HMGB1;HMGB2;ANXA1;DHX9
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.8849144797270999,1.1321877664931586,0.205,0.7568707572715233,1.0,9/37,6.36%,MDK;NUPR1;CAST;GAS6;RAMP2;CDH5;YAP1;SEMA5A;TCF7L2
prerank,regulation of steroid biosynthetic process (GO:0050810),0.8728717818213897,1.132146449578534,0.2065,0.7561280652151935,1.0,2/17,2.74%,EGR1;ASAH1
prerank,gene expression (GO:0010467),0.9851232030530678,1.1319714328031352,0.0085,0.7561532013664749,1.0,78/351,0.62%,EEF1A1;RPL41;RPL13;RPL10;RPS8;RPLP1;RPS12;RPL13A;RPL34;RPS27;RPS23;RPS2;RPS18;RPS15A;RPL37A;RPL32;RPS27A;RPL11;RPS19;RPS24;RPS28;RPS6;RPL37;RPL28;RPS3A;RPS15;RPS14;RPL9;RPL3;RPL12;RPS4X;RPL29;RPL30;RPL19;RPL18A;RPL8;RPL18;RPL7A;RPL5;RPLP0;RPL35A;RPL36;RPS3;RPL15;RPL4;RPL6;RPL21;RPL35;RPS11;RPLP2;RPS13;RPL39;RPS29;RPS7;RPL22;RPL26;RPS26;RPSA;RPS9;RPL31;RPL10A;RPS16;RPL7;RPL24;PTMA;RPS25;RPS5;RPS21;RPL23A;RPL14;RPL27A;RPS10;RPL23;RPS20;RPL36A;RPL27;RPL38;HNRNPA2B1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.9131667809976881,1.1318759293483494,0.256,0.7557379842735391,1.0,6/69,3.93%,RPS3;CD24;ERBB2;PDGFRB;VEGFA;FGFR1
prerank,protein O-linked glycosylation (GO:0006493),0.9259891543224757,1.131854715236837,0.2495,0.7549137340028974,1.0,10/98,3.27%,MUC12;MUC2;MUC13;MUC1;MUC5B;ST3GAL4;OGT;MUC4;OGA;GCNT3
prerank,protein homooligomerization (GO:0051260),0.9386551317134532,1.1317602333426042,0.211,0.7544740328541603,1.0,4/121,1.40%,B2M;FUS;MIF;ITLN1
prerank,regulation of cellular protein catabolic process (GO:1903362),0.8769964197824691,1.131590842781718,0.208,0.7545036427622428,1.0,8/18,7.20%,EZR;PTTG1IP;HSP90AA1;CDK5RAP3;ATRAID;MSN;VGLL4;VPS35
prerank,gliogenesis (GO:0042063),0.8731012645735571,1.131500228298141,0.2005,0.754036023450731,1.0,8/17,10.11%,CD9;NFIB;ANXA1;METRN;NDUFS2;PHOX2B;CDK6;METTL3
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.8856740031058734,1.131489357717963,0.2075,0.7531477481271599,1.0,18/34,8.89%,PPIA;CALM2;CALM1;HSP90AB1;PTBP1;CALM3;PDGFRB;PIN1;ITGA1;CDH5;CAMTA1;PTPA;GBA;SPPL3;SYMPK;SMPD1;NSMF;PPP1R15A
prerank,response to glucocorticoid (GO:0051384),0.8792555353592494,1.1309692508053821,0.203,0.7550816644601466,1.0,7/27,5.78%,ZFP36L2;ZFP36L1;HNRNPU;ZFP36;ANXA1;UBE2L3;SLIT3
prerank,regulation of cell size (GO:0008361),0.8770193791306737,1.1308763906994748,0.191,0.7546463863460517,1.0,8/23,5.71%,EZR;RHOA;LAMTOR4;RAC1;SLC9A3R1;LAMTOR5;PTEN;MSN
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.8752188525114158,1.1307332641106478,0.197,0.7545104981783546,1.0,4/21,2.06%,TXN;TXNIP;HSP90AB1;APP
prerank,peptidyl-proline modification (GO:0018208),0.879883313350318,1.130443609060562,0.2135,0.7551794164766084,1.0,6/31,5.30%,PPIA;PPIB;FKBP1A;NKTR;FKBP10;PIN1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.8913335423317423,1.1304391633914523,0.214,0.7542659395932969,1.0,9/40,5.71%,RACK1;NOP53;SLC9A3R1;CIB1;PDCD6;TSC2;AKT1;PTEN;EPHA2
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.8739240245562483,1.1301628875301586,0.2045,0.7548394174118699,1.0,1/17,0.60%,FSTL1
prerank,regulation of protein import into nucleus (GO:0042306),0.8840541022257483,1.1300409645471452,0.2165,0.754562714433678,1.0,6/36,2.24%,FLNA;JUP;CDH1;RAN;TRIM28;CHP1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.9171156879501747,1.129847079046048,0.249,0.7547279495699736,1.0,30/87,4.93%,RPS27A;UBC;UBA52;UBB;MUC1;ELOB;HIGD1A;ATF4;PSMB1;RBX1;PSME1;PSMB4;HSPA1A;PSME2;KLF2;PSMD8;PSMB3;PSMA7;PSMB5;HIF3A;VEGFA;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5;PSMC3;ATF3;PSMD2;PSMA2
prerank,regulation of steroid metabolic process (GO:0019218),0.8773647366694529,1.1294797173634503,0.212,0.7557822466940078,1.0,6/23,5.07%,ACADVL;APOE;ASAH1;LAMTOR1;EPHX2;STUB1
prerank,negative regulation of lyase activity (GO:0051350),0.8650651150939386,1.1291319968853495,0.192,0.7567056008491102,1.0,4/16,9.04%,PHPT1;GNAI2;GNAI3;PALM
prerank,positive regulation of interferon-gamma production (GO:0032729),0.9058718550992579,1.128921596589363,0.2495,0.7569140039744134,1.0,1/56,0.37%,HLA-A
prerank,positive regulation of T cell migration (GO:2000406),0.8764680119059302,1.128535745171252,0.2125,0.7581020583616355,1.0,5/25,2.06%,CCL21;CXCL12;RHOA;TNFRSF14;APP
prerank,glucose metabolic process (GO:0006006),0.9053709051737258,1.128471541029302,0.2425,0.7575417319106166,1.0,14/61,4.53%,GAPDH;TPI1;ENO1;ATF4;PGAM1;PGK1;PCK1;SLC25A1;MDH1;MDH2;AKR1A1;ALDOB;SLC37A4;GPI
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.875188987795207,1.1283904584853988,0.212,0.7570420089859708,1.0,11/19,8.45%,APOE;RTN4;CLU;RTN3;PIN1;SORL1;PICALM;BIN1;PRNP;RTN1;FLOT2
prerank,defense response to bacterium (GO:0042742),0.9488045621419088,1.1282218400428585,0.159,0.7570228554341883,1.0,19/170,2.52%,RPS19;RPL30;RPL39;HLA-A;CHGA;LYPD8;PLA2G2A;LCN2;JCHAIN;HLA-E;PI3;DEFA3;RARRES2;S100A14;ROMO1;TNFRSF14;HMGB2;SLPI;WFDC2
prerank,body fluid secretion (GO:0007589),0.8730790411193384,1.1281912414485442,0.208104052026013,0.7562640915699401,1.0,4/16,9.23%,VIP;VEGFA;GPAT4;ZBTB7B
prerank,regulation of amyloid-beta clearance (GO:1900221),0.8756225241377628,1.1281390619666676,0.209,0.7556190512564775,1.0,7/16,6.74%,APOE;LRP1;CLU;LRPAP1;HDAC1;HMGCR;IFNGR1
prerank,protein-DNA complex disassembly (GO:0032986),0.8714597130137723,1.1279829520694304,0.222,0.755518847498637,1.0,7/18,8.03%,RPL23;SET;HMGA1;SMARCA4;ARID1A;SMARCD3;SUPT16H
prerank,neuron projection morphogenesis (GO:0048812),0.9426309580473293,1.1277065776265482,0.189,0.7561411102898474,1.0,8/139,2.06%,S100A6;ACTB;UBB;DNM2;NBL1;CTNNB1;CDC42;APP
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.9367089492585515,1.127568932416146,0.2265,0.7559327406522748,1.0,18/128,2.47%,RPS4X;RPL5;VIM;RPL26;EEF2;CIRBP;CCL21;NPM1;KLF4;RPS27L;PLXNB2;HNRNPD;EIF3E;RBM3;DDX3X;EIF6;ERBB2;SOX4
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.9040369209656395,1.126943489326926,0.2515,0.7583908006079018,1.0,5/64,2.77%,LGALS3;GSTP1;PARK7;G0S2;CAV1
prerank,positive regulation of DNA metabolic process (GO:0051054),0.900498237148184,1.126921995862115,0.2515,0.7575809541608514,1.0,4/62,2.97%,RPS3;HMGB1;TRIM28;PDGFRB
prerank,negative regulation of secretion by cell (GO:1903531),0.8906633400827911,1.1268780107128766,0.2305,0.7568981550813628,1.0,9/39,5.13%,CHGA;APOE;VAMP8;PNKD;ERP29;TNFRSF1A;ANXA1;HMGCR;NOTCH1
prerank,regulation of translation (GO:0006417),0.9536814815129484,1.126803635490782,0.137,0.7563925147927767,1.0,32/174,2.47%,RPL10;RPL13A;RPS4X;RPL5;GAPDH;RPS3;VIM;RPL26;RACK1;EEF2;EIF1;HSPB1;CIRBP;CALR;EIF4G2;NPM1;IGFBP5;EIF4A2;YBX1;RPS27L;PLXNB2;ILF3;EIF4B;HNRNPD;APP;EIF3E;RBM3;DDX3X;EIF6;CSDE1;ERBB2;SOX4
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.916488452716181,1.1266728541191178,0.251,0.7561802390570268,1.0,22/94,4.20%,RPS27A;UBC;UBA52;UBB;EGR1;SKP1;SQSTM1;PSMB1;RBX1;PSME1;PSMB4;PSME2;MAPK3;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5
prerank,protein localization to organelle (GO:0033365),0.9395336520043546,1.1265468095790658,0.204,0.7559745585029459,1.0,10/140,2.08%,COL1A1;RPL11;CALR;YBX1;SEC61G;SEC61B;LMNA;WDR83OS;APP;YWHAE
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.8736523649339578,1.1263756696925142,0.2105,0.7550735158008866,1.0,8/26,5.94%,SFN;YWHAZ;YWHAQ;YWHAE;YWHAB;YWHAH;YWHAG;BAD
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.8736523649339578,1.1263756696925142,0.2105,0.7550735158008866,1.0,8/26,5.94%,SFN;YWHAZ;YWHAQ;YWHAE;YWHAB;YWHAH;YWHAG;BAD
prerank,cellular response to hypoxia (GO:0071456),0.9353888611450522,1.1262315924504658,0.2255,0.7549177717304613,1.0,27/130,3.49%,FABP1;RPS27A;UBC;UBA52;UBB;ELOB;NDRG1;HIGD1A;P4HB;ZFP36L1;NOP53;ACAA2;LMNA;PGK1;PSMB1;RBX1;PSME1;PSMB4;HP1BP3;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;HIF3A;VEGFA;PSMB7
prerank,negative regulation of neuron projection development (GO:0010977),0.8965660881876995,1.126101080909797,0.2365,0.7546982826198669,1.0,15/57,5.70%,ITM2C;EFNA1;APOE;RHOA;CIB1;RTN4;DPYSL3;STMN2;ARHGDIA;GDI1;THY1;GAK;HDAC2;PTEN;CRMP1
prerank,cellular response to organic cyclic compound (GO:0071407),0.9447409550408401,1.1257346733892268,0.1765,0.7557348403238094,1.0,15/148,1.94%,ACTB;SLC26A3;ATP1A1;EGR1;EZR;HSP90B1;IGFBP5;AQP8;ZFP36L1;AOC1;CTNNA1;JUP;CDH1;CTNNB1;GNB1
prerank,positive regulation of receptor internalization (GO:0002092),0.8781564403100297,1.1252024935672447,0.219,0.7577380586013993,1.0,2/23,3.39%,CD63;VEGFA
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.8829462456338224,1.124861666075424,0.2235,0.7586225864650377,1.0,4/30,4.37%,GSTP1;GPX4;EPHX2;HPGD
prerank,positive regulation of cellular component organization (GO:0051130),0.9243241972691061,1.1248110428513418,0.2435,0.7579849062076034,1.0,17/111,3.51%,LGALS3;RPS3;RACK1;CLDN3;RHOC;APOE;CD151;PARK7;LRP1;GPC3;CLU;ADD1;VCP;SURF4;VEGFA;TMED9;BRK1
prerank,ion transport (GO:0006811),0.9307167473183741,1.124804377900901,0.239,0.7571076449361027,1.0,4/116,1.96%,SLC26A3;SLC26A2;TSPO;VDAC2
prerank,negative regulation of protein polymerization (GO:0032272),0.8753128471583113,1.1247719901829014,0.2035,0.7563610130429154,1.0,6/26,5.63%,PFN1;STMN1;STMN2;PFN2;TBCD;CDH5
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.8757698938680135,1.1247194190745922,0.214,0.755710948895204,1.0,5/28,2.46%,CALM2;CALM1;AHNAK;YWHAE;FKBP1A
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.9244316222310964,1.1247124741558578,0.249,0.754838970684064,1.0,15/99,2.79%,RPS27A;UBC;UBA52;UBB;LTBP4;NREP;EMILIN1;HSP90AB1;GIPC1;CDKN1C;FKBP1A;HSPA1A;TGFB1I1;CAV1;HTRA3
prerank,cellular respiration (GO:0045333),0.8853682557238416,1.1244432134302935,0.2235,0.7553561855297792,1.0,20/41,7.08%,UQCRB;UQCR10;UQCRH;CYCS;UQCRC1;ATP5F1D;BLOC1S1;UQCRFS1;NDUFS8;NDUFS7;ETFB;MDH2;UQCRC2;SDHA;ETFA;NDUFA5;OXA1L;NDUFS4;SDHB;MTFR1L
prerank,regulation of lipid storage (GO:0010883),0.8763757617464373,1.124371769496081,0.2145,0.7548345732914452,1.0,5/22,6.47%,MEST;APOB;ALKBH7;NFKBIA;C3
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.874842552522338,1.1243450358239102,0.211,0.7540742231468829,1.0,4/30,3.26%,MDK;RHOA;HSPD1;THY1
prerank,chromosome organization (GO:0051276),0.9182527598672775,1.1242216863109364,0.262,0.7537855432931226,1.0,10/100,2.63%,RPS27A;UBC;UBA52;UBB;HMGN2;HMGN1;NUCKS1;RBX1;HMGB2;HMGN3
prerank,regulation of smooth muscle cell migration (GO:0014910),0.8672437546454748,1.1241592745890627,0.2115,0.7532486105277304,1.0,7/19,5.66%,IGFBP5;S100A11;LRP1;IGFBP3;PDGFRB;NRP1;SORL1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.925700872379537,1.1241253707405734,0.2475,0.7525398566299477,1.0,12/107,2.79%,RPS27A;UBC;UBA52;UBB;EMILIN1;NBL1;UBE2D3;FKBP1A;HSPA1A;TGFB1I1;CAV1;HTRA3
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.8776682314697405,1.1240711258196503,0.212,0.7519409210756318,1.0,7/34,7.84%,TPM1;FKBP1A;DSP;NOTCH1;RBPJ;ENG;SMAD4
prerank,negative regulation of angiogenesis (GO:0016525),0.9109444433576556,1.1240355456064068,0.263,0.7512365906158772,1.0,12/83,3.42%,SPARC;DCN;EMILIN1;COL4A2;GTF2I;KLF4;HSPG2;CTNNB1;PGK1;THBS2;KLF2;ATP2B4
prerank,negative regulation of response to external stimulus (GO:0032102),0.926140103097746,1.1235468762717395,0.2515,0.752936846063056,1.0,5/115,1.66%,APOA1;CLDN3;PCBP2;APOE;KLF4
prerank,regulation of protein sumoylation (GO:0033233),0.8679604136614014,1.1234458343342268,0.2085,0.7525663144924902,1.0,7/18,8.72%,EGR1;PARK7;CTNNB1;ZMIZ1;SAE1;PIAS3;UBA2
prerank,regulation of cell junction assembly (GO:1901888),0.8696031723835251,1.1234261823957055,0.2135,0.7517821417907098,1.0,15/27,10.05%,CLDN3;RAP1B;MYO1C;CLDN5;FLOT1;RAB17;F11R;RAP1A;APLNR;PDLIM5;SNAI2;ROCK2;PRKACA;OCLN;RAPGEF1
prerank,endothelial cell migration (GO:0043542),0.8790255768250022,1.1231973649587266,0.2305,0.7520859823784565,1.0,16/38,5.65%,FSTL1;MYH9;NR4A1;RHOA;ID1;GIPC1;ADGRA2;PRSS3;S100P;VEGFA;PXN;LOXL2;NRP1;PLXND1;CDH5;ABL1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.9120033034869736,1.1231930352391342,0.2695,0.7512216385402786,1.0,11/80,4.17%,RPS2;UBB;PTTG1IP;RBX1;FKBP1A;CAV1;CDK5RAP3;PDCD6;CENPX;NDFIP1;INAVA
prerank,regulation of cation transmembrane transport (GO:1904062),0.8777446060356042,1.1231381661779394,0.2185,0.7506315584601537,1.0,2/30,3.42%,CD63;ATP2B4
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.912296927467272,1.1227497393365926,0.264,0.7517796441606865,1.0,7/79,2.65%,LGALS3;GSTP1;PARK7;DDX3X;MCL1;TMBIM1;HSPA1A
prerank,regulation of proteolysis (GO:0030162),0.8950321643549131,1.1226048175876961,0.246,0.751667038833529,1.0,17/54,5.94%,CST3;LTBP4;CAMK2N1;NEDD8;PLAUR;PLAT;OGT;CSTB;AURKAIP1;CAV1;PERP;BAG6;IST1;STUB1;AKT1;HDAC2;BAD
prerank,cell projection assembly (GO:0030031),0.8699847572397502,1.122585353089716,0.2095,0.7508964975504352,1.0,7/22,7.23%,GSN;RAC1;CDC42;NCKAP1;CYFIP1;CAPG;PARVA
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.872147462832233,1.1225627914354486,0.218,0.7501342161725204,1.0,10/28,6.92%,PFN1;CXCL12;WDR1;CTTN;BRK1;PFN2;GBA2;COTL1;DBN1;DBNL
prerank,positive regulation of T cell activation (GO:0050870),0.9058979226990228,1.122503928535909,0.26,0.7495828448993815,1.0,11/73,5.24%,HLA-A;MDK;CD81;HSPD1;THY1;TFRC;CD46;ANXA1;XBP1;CCL2;ZMIZ1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.8678964545861737,1.1222150286202848,0.226,0.750190662467143,1.0,2/17,2.51%,SFN;NUMA1
prerank,negative regulation of wound healing (GO:0061045),0.8767144641454241,1.1217522784027139,0.2245,0.7517256824511496,1.0,2/29,1.15%,CLDN3;APOE
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.872609953911772,1.1215269953291116,0.215,0.752037713960839,1.0,9/26,7.19%,ATP1B3;ITGB1;ATP1B1;FHL1;YWHAE;NEDD4L;CAB39;ANK2;AKAP9
prerank,cell projection organization (GO:0030030),0.8752408583927566,1.1211548130154132,0.2115,0.7531635298708611,1.0,9/30,7.23%,GSN;ITGB1;RAC1;CDC42;PACSIN2;NCKAP1;CYFIP1;CAPG;PARVA
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.8683941130242374,1.1211176193316517,0.206,0.7524848855759386,1.0,9/25,7.19%,NDUFA4;ATP1B3;ATP1B1;CTSS;COX17;GLRX;WNK2;ANK2;AKAP9
prerank,inorganic cation import across plasma membrane (GO:0098659),0.9078124754216975,1.1210207566171784,0.2675,0.7521044815248724,1.0,11/77,5.43%,ATP1A1;ATP1B3;ATP1B1;SLC39A5;TRPM4;ATP2B4;SLC9A3;SLC12A7;SLC39A14;SLC39A4;SLC12A2
prerank,cholesterol metabolic process (GO:0008203),0.9137071490503548,1.1207956472346936,0.2675,0.7524221743939874,1.0,14/77,3.81%,APOA1;APOA4;APOB;APOE;ACAA2;HMGCS1;FDPS;APOA2;MSMO1;FDFT1;INSIG1;DHCR24;MVD;IDI1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.9099464448733403,1.1207172338213747,0.258,0.751945810798223,1.0,24/83,4.93%,RPS27A;UBC;UBA52;UBB;PSMB1;PSME1;PSMB4;ANAPC11;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;UBE2S;PSMA1;PSMA4;ANAPC16;PSMC5;PSMC3;ANAPC5;PSMD2;PSMA2
prerank,calcium ion transport (GO:0006816),0.9231536740314072,1.1203623553747641,0.2645,0.7529266638123607,1.0,1/115,0.09%,TPT1
prerank,regulation of autophagy (GO:0010506),0.9607702629909458,1.1196847380456239,0.099,0.7554968885377487,1.0,8/230,1.10%,EEF1A1;GAPDH;DCN;CTSA;HSPB1;PSAP;EIF4G2;HMGB1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.8654642481298299,1.1196815491033925,0.2195,0.7546461819772049,1.0,3/17,1.32%,CD74;PTTG1IP;MIF
prerank,response to steroid hormone (GO:0048545),0.8760608734839888,1.1196663512883465,0.2165,0.7538696488402178,1.0,6/34,7.00%,ATP1A1;CAV1;UBE2L3;YAP1;TFPI;WBP2
prerank,epithelium development (GO:0060429),0.9262439229039722,1.1190309870830875,0.26,0.7562965974122796,1.0,22/122,3.45%,TAGLN;LGALS3;GSTA1;ACADVL;CTSB;TST;SLC9A3R1;TCF21;TAGLN2;PGK1;VIL1;VCL;ANXA4;GSTK1;HNRNPH3;KANK2;DMBT1;CNN3;DHRS9;CDHR2;VEGFA;VDAC1
prerank,regulation of protein-containing complex assembly (GO:0043254),0.920493619640889,1.1189318238988917,0.2655,0.7559377834456747,1.0,15/112,2.67%,LGALS3;RPS3;RACK1;GSN;RHOC;APOE;HSPA8;HSP90AA1;NOP53;HSPA5;PARK7;CDC42;CLU;DDX3X;VCP
prerank,filopodium assembly (GO:0046847),0.8645233690110086,1.1185640705303486,0.2235,0.7570390823829372,1.0,2/16,5.23%,EZR;RAB17
prerank,negative regulation of kinase activity (GO:0033673),0.8887723273263588,1.1181930650491732,0.2415,0.7581637213633495,1.0,15/59,5.16%,PPIA;CEACAM1;GSTP1;HSPB1;SFN;HNRNPU;CAMK2N1;PARK7;CDKN1C;CHP1;THY1;RTRAF;TSC2;PRDX3;AKT1
prerank,response to axon injury (GO:0048678),0.865644245205628,1.1181665219353656,0.2215,0.7574312571390501,1.0,6/18,7.99%,NREP;SOD1;DPYSL3;GAP43;P2RX4;MAPK8IP3
prerank,modified amino acid transport (GO:0072337),0.8596148403906427,1.117939931491402,0.217,0.7577583269789472,1.0,2/17,1.55%,SLC6A8;SLC9A3R1
prerank,cellular protein metabolic process (GO:0044267),0.9806531496349934,1.1178939634068752,0.018,0.7571294312156144,1.0,94/411,1.15%,EEF1A1;RPL41;RPL13;RPL10;RPS8;RPLP1;RPS12;RPL13A;RPL34;RPS27;RPS23;RPS2;RPS18;RPS15A;RPL37A;RPL32;RPS27A;RPL11;APOA1;RPS19;RPS24;RPS28;RPS6;RPL37;RPL28;RPS3A;RPS15;RPS14;RPL9;RPL3;RPL12;RPS4X;RPL29;RPL30;RPL19;RPL18A;RPL8;RPL18;RPL7A;RPL5;RPLP0;RPL35A;RPL36;RPS3;RPL15;RPL4;RPL6;RPL21;RPL35;RPS11;RPLP2;RPS13;RPL39;RPS29;RPS7;RPL22;RPL26;LGALS1;RPS26;RPSA;RPS9;RPL31;RPL10A;RPS16;RPL7;RPL24;RPS25;RPS5;RPS21;RPL23A;RPL14;CST3;RPL27A;RPS10;RPL23;RPS20;RPL36A;RPL27;UBA52;FN1;SERPINA1;RPL38;FSTL1;P4HB;IGFBP7;APOB;RPL17;RPS17;UBL5;HSP90B1;IGFBP5;LAMB1;MMP2;APOE
prerank,mRNA stabilization (GO:0048255),0.8812749580989458,1.1178538333481975,0.23,0.7564825160396826,1.0,16/44,7.14%,CIRBP;PABPC1;FUS;YBX1;HNRNPC;VIP;HNRNPU;ZFP36;HNRNPA0;DHX9;TARDBP;LARP1;SYNCRIP;YBX3;ELAVL1;THRAP3
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.9198870075620602,1.1175754130956714,0.2645,0.7570399452072177,1.0,15/109,3.26%,ACTB;CALM2;CALM1;CCND2;RHOA;CIB1;MST1;CALM3;CDKN1A;DDX3X;CDC37;MAP2K2;CCNI;CDK5RAP3;THY1
prerank,response to growth factor (GO:0070848),0.8770280505161165,1.1174038149726562,0.226,0.7570987156650615,1.0,14/41,8.08%,RACK1;CIB1;KLF4;CTNNB1;ERBB2;SFRP1;SHC1;AKT1;EPHA2;TGFBR2;GATA6;BMPR2;ACVRL1;HDAC6
prerank,regulation of protein export from nucleus (GO:0046825),0.866525826828099,1.117103343434177,0.224,0.7577830787226488,1.0,5/23,4.21%,IFI27;PARK7;YWHAE;ANP32B;GAS6
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.8879404278200665,1.117017796507548,0.2505,0.7573674074066791,1.0,14/54,5.90%,MDK;CALR;HMGB1;CXCL12;PTN;RARRES2;S100A14;MAPK3;VEGFA;LGMN;GAS6;VEGFB;LGALS9;C1QBP
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.8669279610244627,1.1170131961062477,0.219,0.7565338262001662,1.0,12/25,7.19%,CALM1;JUP;DSG2;CALM3;TRPM4;CAV1;DSC2;ATP2A2;DSP;ANK2;CXADR;AKAP9
prerank,chromatin remodeling (GO:0006338),0.9162454493519069,1.1170073424962663,0.2655,0.7557072577143442,1.0,3/103,1.38%,ACTB;NPM1;HNRNPC
prerank,receptor internalization (GO:0031623),0.8903874518260971,1.116922190422069,0.2515,0.7552874130710467,1.0,15/49,5.94%,CEACAM1;CD81;CD9;ITGB1;DNM2;LRP1;AP2M1;CLTC;CAV1;TFRC;GRK2;RAMP2;ADM;RAMP1;PICALM
prerank,extracellular matrix organization (GO:0030198),0.9630287616376382,1.1166003963678675,0.074,0.7561548425435677,1.0,39/299,1.74%,COL3A1;COL1A1;COL1A2;TTR;SPARC;DCN;POSTN;FN1;COL5A1;COL6A1;GSN;COL6A2;LUM;COL5A2;BSG;COL6A3;P4HB;COL4A1;COL4A2;SERPINH1;LAMB1;COL16A1;MMP2;VCAN;COL12A1;ITGB1;ELN;CAPN2;CD151;MFAP2;NID1;TIMP2;A2M;CDH1;FBN1;HSPG2;CAPNS1;PXDN;QSOX1
prerank,nucleotide-excision repair (GO:0006289),0.9111980282977709,1.1164595948260314,0.278,0.7560560915934208,1.0,6/105,1.51%,RPS27A;UBC;UBA52;UBB;HMGN1;POLR2L
prerank,glucose homeostasis (GO:0042593),0.9086765726307637,1.116337893763151,0.2755,0.7558302421438856,1.0,8/85,3.74%,RPS6;PARK7;NUCKS1;SOX4;PCK1;GCG;CEBPA;HNF4A
prerank,cytoplasmic translational initiation (GO:0002183),0.8630817067496416,1.1160193308524433,0.2245,0.7566042412380453,1.0,13/19,9.83%,EIF4A2;EIF4A1;EIF4B;EIF4H;EIF4G1;EIF3I;EIF5;EIF3M;EIF3D;EIF3A;EIF2S3;EIF2S2;DENR
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.8716581168844799,1.1159118092004126,0.2195,0.756272138474926,1.0,10/26,9.14%,HMGB1;CYBA;RTN4;DDX3X;CAV1;FLOT1;PJA2;NR1H3;NINJ1;F2RL1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.8650673391916865,1.1155125900444824,0.222,0.7574567105452317,1.0,10/20,8.49%,EGR1;HSP90AB1;HSP90AA1;HSPA1A;WASHC1;ZMIZ1;PINK1;EPAS1;HIF1A;HSPA1B
prerank,regulation of cellular pH (GO:0030641),0.8710756820414587,1.115424396096128,0.226,0.7570618665205205,1.0,8/31,6.93%,ATP5F1B;CA2;CHP1;SLC9A3;ATP6AP1;SLC26A6;SLC4A4;CA7
prerank,positive regulation of protein transport (GO:0051222),0.8998005461464191,1.1153843218390682,0.27,0.7563871294370403,1.0,7/69,2.60%,RACK1;PPIA;EZR;OAZ1;VPS28;CHP1;TMED10
prerank,negative regulation of protein secretion (GO:0050709),0.8744926071083081,1.1153301323408564,0.23,0.7558150806051407,1.0,8/38,5.60%,CHGA;FAM3D;APOE;MIDN;ERP29;HMGCR;SFRP1;RAB11FIP1
prerank,regulated exocytosis (GO:0045055),0.9440968624410001,1.1149044349402253,0.18,0.7571436200888064,1.0,30/179,2.60%,APOA1;TMSB4X;SPARC;SELENOP;FLNA;FN1;SERPINA1;CD63;PSAP;CALM1;MAGED2;CD9;MYH9;APLP2;ACTN4;LGALS3BP;A2M;RARRES2;QSOX1;TAGLN2;SOD1;TIMP1;WDR1;APP;ACTN1;VCL;ANXA5;CLU;SDF4;TMED10
prerank,negative regulation of epithelial cell migration (GO:0010633),0.8757450266131575,1.1148689809599837,0.238,0.7564805966159266,1.0,5/35,4.26%,DCN;APOE;EVL;NR2F2;PFN2
prerank,regulation of protein dephosphorylation (GO:0035304),0.876598645129872,1.1147066795447176,0.23,0.7564089153836869,1.0,25/41,9.98%,PPIA;CALM2;CALM1;HSP90B1;PTBP1;CALM3;YWHAB;PPP1R16A;ENSA;PIN1;CDH5;ARPP19;PPP6R3;CAMTA1;PTPA;GBA;SPPL3;SYMPK;SMPD1;PPP6R1;NSMF;PPP1R15A;ANKLE2;DLC1;PPP6R2
prerank,protein stabilization (GO:0050821),0.9392478463234207,1.11460133532004,0.2,0.7561174956627,1.0,31/173,2.75%,RPL11;APOA1;RPL5;GAPDH;TSPAN1;RPS7;FLNA;RPL23;PFN1;CALR;EFNA1;HSP90AB1;ATP1B3;HSP90AA1;NOP53;ATP1B1;GRN;RTN4;PARK7;CDKN1A;PHB2;CHP1;CTNND1;CLU;PPIB;CDC37;SOX4;APOA2;PTGES3;HSPA1A;HSPD1
prerank,lipid transport (GO:0006869),0.921793328727267,1.1145608303188999,0.2705,0.7554746122999164,1.0,10/108,2.93%,APOA1;CEACAM1;APOA4;APOE;FABP5;PRELID1;NPC2;NME4;LDLR;SCP2
prerank,retinoic acid metabolic process (GO:0042573),0.8671501118928158,1.1145475874289756,0.2235,0.754708667068348,1.0,2/26,3.23%,CYP2W1;CYP3A5
prerank,positive regulation of vasoconstriction (GO:0045907),0.8622623361369499,1.1144591622672133,0.226,0.7543281057823846,1.0,3/16,8.32%,TRPM4;CAV1;F2R
prerank,electron transport chain (GO:0022900),0.8518782860396752,1.1143755261236343,0.2306153076538269,0.7539261112423856,1.0,7/15,7.95%,UQCRFS1;ETFB;SDHA;ETFA;NDUFA5;SDHB;POR
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.8596852178347735,1.1141511010778804,0.2381190595297649,0.7542366783576552,1.0,10/15,8.85%,ARPC3;ARPC2;ARPC5;ARPC4;ACTR2;ARPC1A;WASHC1;ARPC1B;ACTR3;TRIM27
prerank,regulation of immune effector process (GO:0002697),0.8905195462756131,1.1139904623491688,0.2675,0.754242529165698,1.0,14/53,6.47%,CD81;PHB2;CLU;HLA-DRA;C7;C1S;CD59;HLA-DRB1;CD46;C1R;C1QA;C1QBP;SERPING1;C3
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.8733572204921959,1.1133487237769137,0.2335,0.7566184625804174,1.0,4/31,2.46%,FSTL1;LTBP4;NREP;FKBP1A
prerank,diol metabolic process (GO:0034311),0.8565483667003215,1.1132620837470875,0.226,0.7562134923980407,1.0,7/19,7.83%,CALM1;HSP90AA1;GCHFR;PLPP1;AKT1;PLPP3;PLPP2
prerank,protein localization to membrane (GO:0072657),0.9409248261618374,1.1130142176516788,0.192,0.7566386930727304,1.0,13/195,1.62%,PIGR;S100A10;FLNA;CD81;EZR;BSG;ATP1B3;ATP1B1;PTN;SLC9A3R1;JUP;SPTBN1;CDH1
prerank,positive regulation of RNA splicing (GO:0033120),0.8651603367430383,1.1128651165412502,0.2235,0.7565909503633164,1.0,12/31,7.14%,PRDX6;CIRBP;RBM3;RBMX;HSPA1A;NCL;SLC38A2;TRA2B;TRA2A;DAZAP1;POLR2A;THRAP3
prerank,regulation of neuroblast proliferation (GO:1902692),0.8538686340490788,1.11284298189981,0.23723723723723725,0.7558761670130427,1.0,5/15,8.07%,PTN;CTNNB1;VEGFA;SMARCD3;KDM1A
prerank,response to glucose (GO:0009749),0.8830446916537086,1.112681809901778,0.2495,0.7558956268072794,1.0,11/49,5.28%,RACK1;PFKL;SOX4;APOA2;PCK1;HNF4A;TRA2B;GAS6;XBP1;SELENOS;SLC39A14
prerank,regulation of complement activation (GO:0030449),0.8879197337990175,1.1122348584058592,0.2655,0.7572640390640736,1.0,13/50,6.47%,CD81;PHB2;CLU;C7;C1S;CD59;PHB;CD46;C1R;C1QA;C1QBP;SERPING1;C3
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.9237881003021261,1.1122154483341953,0.271,0.7565156200567361,1.0,21/130,3.64%,COL1A1;JUP;GPC3;ADGRA2;PSMB1;DDX3X;ILK;SOX4;PSME1;PSMB4;VCP;TRPM4;CAV1;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;ZEB2;PSMB6
prerank,negative regulation of cell projection organization (GO:0031345),0.8824180935141177,1.1121369720793612,0.2465,0.7560797668006431,1.0,10/48,5.70%,ITM2C;APOE;CIB1;DPYSL3;STMN2;YWHAH;GAK;HDAC2;PTEN;CRMP1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.8795712952604878,1.11201183357942,0.247,0.7558707953680667,1.0,11/51,2.94%,RACK1;P4HB;NDUFA13;SLC9A3R1;NUPR1;PLAUR;DDX3X;MCL1;FIS1;CAV1;BCAP31
prerank,positive regulation of protein polymerization (GO:0032273),0.8965164733161581,1.1119813001017378,0.282,0.7551928141891133,1.0,17/67,5.97%,RPS3;PFN1;CCL21;HSP90AA1;RAC1;CDC42EP5;NUMA1;CTTN;EVL;PFN2;VASP;BAIAP2L2;ARF6;NCKAP1;LMOD1;BIN1;ARL2
prerank,actin cytoskeleton reorganization (GO:0031532),0.8917173541795866,1.1118324414298122,0.268,0.75512294457956,1.0,6/63,1.42%,FLNA;CLDN3;GSN;EZR;MYH9;RHOA
prerank,cellular glucose homeostasis (GO:0001678),0.8815264286097796,1.1116523573634824,0.243,0.7551825284488723,1.0,8/43,5.28%,RACK1;NUCKS1;SOX4;PCK1;TRA2B;GAS6;XBP1;SLC39A14
prerank,cellular response to light stimulus (GO:0071482),0.8956523882505618,1.1111341976200404,0.271,0.7569801505402435,1.0,5/70,1.94%,RPL26;NPM1;ATF4;COPS9;GNB1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.8583831402267043,1.1108854528386884,0.2345,0.7574022100185194,1.0,8/21,10.32%,JUN;IGFBP5;MMP2;ADAMTS1;GJA1;DNMT1;MFN2;MEF2D
prerank,actin filament bundle assembly (GO:0051017),0.8720048366252002,1.11082722398704,0.234,0.7568851710340831,1.0,16/33,8.20%,EZR;CALD1;HSP90B1;PLS1;DPYSL3;ADD1;FSCN1;MICAL1;BAIAP2L2;EPS8;LIMA1;USH1C;PLS3;MYO1B;BAIAP2L1;CORO1B
prerank,glycosaminoglycan catabolic process (GO:0006027),0.8804355477017998,1.1107614518033369,0.243,0.7563987174125459,1.0,19/56,6.49%,DCN;LUM;OGN;VCAN;HSPG2;GPC3;CHP1;GNS;AGRN;SDC1;SDC2;HEXB;HEXA;SDC4;GUSB;FUCA1;GPC6;GPC1;HYAL2
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.8606765651115553,1.1107330360499075,0.228,0.7557345991731463,1.0,6/25,8.51%,RBP2;RBP1;LGMN;VDR;VKORC1;CYP4F12
prerank,spindle assembly (GO:0051225),0.9031127715739028,1.1107177304652263,0.2825,0.7549897382864549,1.0,10/83,4.73%,RPS3;FLNA;MISP;RHOA;NUMA1;RAB11A;ZNF207;CSNK1D;KPNB1;GOLGA8A
prerank,supramolecular fiber organization (GO:0097435),0.964196543475668,1.1107126277924366,0.058,0.7541964771750163,1.0,46/345,1.74%,COL3A1;COL1A1;COL1A2;B2M;TTR;RPS27A;APOA1;VIM;TPM2;CST3;DES;UBC;TPM1;MYH11;UBA52;UBB;COL5A1;COL6A1;STMN1;GSN;KRT20;MARCKS;MFAP4;COL6A2;LUM;ITM2B;COL5A2;COL6A3;P4HB;APOA4;COL4A1;RHOC;EMILIN1;COL4A2;SERPINH1;HSP90AB1;COL16A1;COL12A1;MARCKSL1;RHOA;RAC1;CD151;CIB1;TPM4;HSPG2;PXDN
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.8738285274149886,1.1106293835608696,0.2335,0.7538149948197588,1.0,4/34,1.57%,MUC1;CCL21;EFNA1;CIB1
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.859899817711015,1.1103318228341335,0.2345,0.7544537520016226,1.0,7/21,8.39%,GNB1;GNA11;AGRN;GRK2;RGS10;GNAQ;CHRNA3
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.8491963412689408,1.1102053965545524,0.2365,0.7542679165583607,1.0,14/15,13.94%,HSP90B1;SEC61B;VCP;OS9;AUP1;SELENOS;HERPUD1;NPLOC4;SEL1L;SYVN1;UFD1;DERL2;DERL1;TMEM129
prerank,negative regulation of interleukin-2 production (GO:0032703),0.8638398935331414,1.1094050420177857,0.238,0.7574215488758905,1.0,7/22,8.92%,EZR;ZFP36;CD34;LAPTM5;PRNP;TRIM27;HDAC7
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.8727263622278696,1.1092772864346294,0.245,0.7572815728100706,1.0,14/33,7.51%,HNRNPA1;CTNNB1;MAPK3;XRCC5;CCT7;CCT3;CCT4;TCP1;PKIB;CCT5;CCT6A;CCT8;CCT2;MAPK1
prerank,regulation of exosomal secretion (GO:1903541),0.8571644281327504,1.1091689277154255,0.233,0.7570095546897108,1.0,14/19,10.00%,SDC1;PDCD6IP;RAB7A;CHMP2A;SDC4;SDCBP;CHMP3;HGS;VPS4B;SNF8;SMPD3;ATP9A;VPS4A;TSG101
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.8767051935967864,1.1089635246128116,0.2565,0.7572108129114847,1.0,18/46,7.30%,FLNA;JUP;CDH1;RAN;YWHAE;TRIM28;KHDRBS1;ANP32B;GAS6;DHX9;CHP2;IPO5;PSEN1;TCF7L2;CPSF6;HYAL2;TPR;DMAP1
prerank,regulation of synapse organization (GO:0050807),0.86359968878268,1.108947868622954,0.2295,0.7564613498967536,1.0,6/26,7.31%,YWHAZ;ABHD17C;RAB17;ABL1;ABHD17A;PDLIM5
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.863010996645028,1.1089103143622523,0.243,0.7558432652262748,1.0,13/24,8.99%,MUC1;ATF4;HSPA5;KLF2;VEGFA;ATF3;NOTCH1;RBPJ;HIF1A;HSF1;CEBPB;CREB3L1;GCN1
prerank,negative regulation of growth (GO:0045926),0.9227271305096686,1.108884635497801,0.2745,0.7551657334045772,1.0,17/124,2.69%,MT1G;MT1H;RACK1;MT2A;MT1E;ENO1;FGFR3;MT1F;NDUFA13;RTN4;FHL1;PPP2R1A;CDKN1A;MT1X;DDX3X;HSPA1A;IP6K2
prerank,regulation of monooxygenase activity (GO:0032768),0.8637886318518319,1.108706765766014,0.2375,0.7552402363761571,1.0,11/24,7.95%,CALM1;HSP90AA1;DNM2;CAV1;DDAH2;AKT1;WASL;NOSIP;DDAH1;VDR;POR
prerank,sodium ion transmembrane transport (GO:0035725),0.9063615859573257,1.1086407281688964,0.2905,0.7547773414306865,1.0,11/87,5.75%,ATP1A1;SCNN1B;SLC6A8;ATP1B3;ATP1B1;SCNN1A;TRPM4;SLC9A3;SLC6A19;SLC12A2;SLC4A4
prerank,regulation of supramolecular fiber organization (GO:1902903),0.8596748505140785,1.108593652753109,0.2315,0.754200709006329,1.0,9/21,5.97%,APOE;HSPA8;PARK7;MAP1B;AEBP1;EFEMP2;GBA2;ABL1;ARL2
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.9304265098313211,1.1081904001961878,0.255,0.7553487147581137,1.0,13/155,2.84%,RPS27A;RPS3;PPIA;UBC;UBA52;UBB;NPM1;CIB1;APP;CLU;HSPA1A;CAV1;LAMTOR5
prerank,organic hydroxy compound transport (GO:0015850),0.8747863807034605,1.108004490021441,0.247,0.7555104390227038,1.0,4/40,4.89%,CEACAM1;NPC2;ABCC3;ATP8B1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.8599680219144306,1.1074821859753854,0.2345,0.7573343516775142,1.0,12/20,9.59%,HSP90AA1;NUPR1;CDC37;OGT;ASAH1;PDCD6IP;STUB1;FLOT1;SDCBP;CFLAR;FLOT2;BIRC2
prerank,regulation of sprouting angiogenesis (GO:1903670),0.8638329004275248,1.1073277148532645,0.237,0.7572827444720869,1.0,7/33,4.28%,CEACAM1;PKM;KLF4;KLF2;GLUL;VEGFA;EPN1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.877382211277217,1.1070897753965216,0.252,0.7576925211667018,1.0,14/47,5.95%,PFN1;GSN;CCL21;CDC42EP5;CTTN;EVL;ARPC4;PFN2;VASP;BAIAP2L2;ARF6;NCKAP1;LMOD1;BIN1
prerank,regulation of phosphate metabolic process (GO:0019220),0.8505504272347553,1.106992933065236,0.231,0.757372163403444,1.0,6/16,8.03%,CD24;PGAM1;MCM7;PSEN1;SIRT2;IGBP1
prerank,regulation of cellular component size (GO:0032535),0.8629621406064794,1.1068672400111885,0.2415,0.7572020161241108,1.0,12/30,5.94%,EZR;LAMTOR4;RAC1;SLC9A3R1;AP2M1;PPP1CA;HP1BP3;LAMTOR5;EPS8;PTEN;MSN;PICALM
prerank,cardiac ventricle morphogenesis (GO:0003208),0.871936676789782,1.1066776706884986,0.239,0.7573277796315855,1.0,11/44,7.64%,TPM1;CPE;FKBP1A;SOX4;FOXF1;SFRP2;JAG1;NOTCH1;TGFBR2;RBPJ;ENG
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.9107164153302618,1.1063347996539694,0.2915,0.7582210984393853,1.0,16/116,3.89%,LGALS3;RPS3;RACK1;RHOC;HSP90AA1;PARK7;RBX1;CLU;DDX3X;RAP1B;VCP;FSCN1;VEGFA;BRK1;TFRC;EIF4G1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.855928992650028,1.1062309086086553,0.222,0.7579460963362211,1.0,4/27,5.30%,STMN1;STMN2;ZNF207;PIN1
prerank,positive regulation of hydrolase activity (GO:0051345),0.9243380479231582,1.106005504962933,0.268,0.7582502971159489,1.0,15/145,2.44%,APOA1;RPS3;S100A10;RACK1;CALM2;PSAP;RHOC;CALM1;CCL21;ITGB1;RHOA;NDUFA13;CALM3;ERBB2;HMGB2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.9374124277162413,1.1059626348366098,0.234,0.7576455571770198,1.0,30/179,2.55%,APOA1;RPS4X;RPL5;VIM;RPL26;EEF2;EGR1;CIRBP;HBB;APOA4;CCL21;HSP90AB1;NPM1;HSP90AA1;ASS1;KLF4;RPS27L;GIPC1;PLXNB2;PARK7;HNRNPD;EIF3E;RBM3;CHP1;CLU;DDX3X;EIF6;ERBB2;SOX4;LDLR
prerank,glycerolipid catabolic process (GO:0046503),0.857039266517538,1.1058628166962283,0.2495,0.7573339671320319,1.0,8/19,11.66%,PRDX6;MGLL;SMPD4;LYPLA2;ABHD12;GDE1;ABHD2;GPCPD1
prerank,Ras protein signal transduction (GO:0007265),0.923696302326607,1.1056266831314867,0.2745,0.7576996486462547,1.0,17/140,3.20%,COL1A2;CFL1;JUN;RHOA;RAC1;EPS8L2;CDC42EP5;PARK7;GNB1;CDKN1A;TRIM28;ARHGDIA;RAP1B;RHOB;GDI1;TAX1BP3;EPS8L3
prerank,cellular response to oxidative stress (GO:0034599),0.9203827561568526,1.1055330211707302,0.297,0.7573691371055299,1.0,21/124,3.10%,FOS;RPS3;PPIA;TPM1;PRDX6;GSTP1;CHCHD2;JUN;PRDX5;ATF4;CYCS;CYBA;GPX2;PRDX2;PARK7;SOD1;ROMO1;PRDX1;HSPA1A;PDGFRA;MAPK3
prerank,extracellular matrix disassembly (GO:0022617),0.8898725064089948,1.1054845745657291,0.275,0.75682322136734,1.0,22/66,7.39%,GSN;BSG;MMP2;CAPN2;TIMP2;A2M;CAPNS1;TIMP1;LAMC1;HPN;CTSS;BMP1;MMP15;WASHC1;CTSL;CAPN1;FLOT1;ADAM15;CAPG;ADAM10;FURIN;HTRA1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.9066702663551228,1.1050088487905703,0.3005,0.7583613747008776,1.0,19/101,3.87%,RPL11;RACK1;ELOB;HSP90AB1;NOP53;SUMO2;GIPC1;PARK7;RBX1;CLU;OGT;HSPA1A;VCP;EIF3H;CSNK1A1;CEBPA;BAG6;XPO1;FOXF2
prerank,central nervous system neuron development (GO:0021954),0.8550164960860511,1.104995705915416,0.247,0.7576272675610844,1.0,7/15,11.09%,HSP90AB1;HSP90AA1;GBA2;PTEN;NPY;ARHGAP35;B4GALT5
prerank,regulation of endothelial cell migration (GO:0010594),0.9012180686059804,1.1048681972732959,0.2925,0.7574605752444774,1.0,25/88,5.97%,SPARC;DCN;CEACAM1;CALR;APOE;GRN;RAC1;PTN;RHOB;GLUL;VEGFA;PDCD6;EMC10;NR2F2;NRP1;BCAR1;GPI;AGT;AKT1;AAMP;NRP2;ABL1;EPHA2;PRCP;SCARB1
prerank,positive regulation of cell motility (GO:2000147),0.9445269264836001,1.1048659941136356,0.1905,0.7566759454852994,1.0,19/219,1.57%,COL1A1;ACTG1;CLDN4;RACK1;CLDN3;MDK;MYLK;CEACAM6;RHOC;CCL21;SMIM22;PHPT1;LAMB1;ITGB1;CXCL12;GRN;ACTN4;CD151;CIB1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.8464961826578731,1.1046628834109034,0.237,0.7568708031820413,1.0,15/17,13.94%,HSP90B1;SEC61B;VCP;OS9;AUP1;SELENOS;HERPUD1;HM13;NPLOC4;SEL1L;SYVN1;UFD1;DERL2;DERL1;TMEM129
prerank,positive regulation of establishment of protein localization (GO:1904951),0.8571906992428422,1.1046340167602013,0.2475,0.7562099493033066,1.0,10/19,8.47%,CHP1;CCT7;CCT3;CCT4;TCP1;CCT5;CCT6A;CCT8;CCT2;PTP4A3
prerank,detection of mechanical stimulus (GO:0050982),0.8544003325648668,1.1043438281491793,0.242,0.7568663610839023,1.0,7/18,13.29%,JUP;CTNNB1;PKD1;PIEZO1;PTK2;PIEZO2;PKD2
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.8518602940761599,1.1043211832424167,0.232,0.7561959184032312,1.0,6/22,2.75%,HSP90AB1;HSP90AA1;CLU;PTGES3;HSPA1A;HSPD1
prerank,vasculature development (GO:0001944),0.8552834708998194,1.104123847302007,0.25,0.7563716669254668,1.0,10/17,8.01%,TCF21;PDGFRB;PDGFRA;FOXF1;CDH5;ERRFI1;APLNR;STK11;BMPR2;ACVRL1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.8845055516102591,1.104096686165299,0.2765,0.7557130502223058,1.0,13/56,5.75%,RPL26;MUC1;SFN;ARID3A;CDKN1A;PRAP1;SOX4;PRMT1;BTG2;CNOT1;PLAGL1;PCNA;PCBP4
prerank,response to acidic pH (GO:0010447),0.8488881636335833,1.1039218609894688,0.2445,0.7557784771475603,1.0,4/15,6.40%,CHP1;CTSS;LGMN;RAB11B
prerank,cellular component disassembly (GO:0022411),0.8887620019970751,1.1039190299830137,0.2785,0.7550036996201828,1.0,21/66,7.39%,GSN;BSG;MMP2;CAPN2;TIMP2;A2M;CAPNS1;TIMP1;LAMC1;CTSS;BMP1;MMP15;WASHC1;CTSL;CAPN1;FLOT1;ADAM15;CAPG;ADAM10;FURIN;HTRA1
prerank,prostaglandin biosynthetic process (GO:0001516),0.8522516129568746,1.1038815329444507,0.2465,0.7544041967333813,1.0,3/18,2.65%,CD74;MIF;PTGES3
prerank,fluid transport (GO:0042044),0.8502981762569194,1.1038491675152013,0.2345,0.7537846445592055,1.0,4/18,7.81%,AQP8;UPK3A;SLC26A6;PDZD3
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.8679512454964851,1.1036012470849956,0.2505,0.7542295372936006,1.0,15/40,6.10%,HBB;HSP90AB1;HSP90AA1;RAC1;ASS1;KLF4;CLU;CAV1;KLF2;ATP2B4;DDAH2;AKT1;CD34;P2RX4;DDAH1
prerank,cell-substrate junction assembly (GO:0007044),0.8666299276641574,1.1035061166967643,0.243,0.7539001607186105,1.0,17/34,8.04%,FN1;CD151;ACTN1;CTTN;LAMC1;PLEC;LAMB3;DST;THY1;ITGB4;RCC2;SORBS1;FERMT2;TRIP6;ARHGEF7;LAMA3;ITGA6
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.8505023247156487,1.10331170493267,0.249,0.754064922077559,1.0,7/18,8.32%,HNRNPC;ZFP36;HNRNPA0;TARDBP;YBX3;ELAVL1;MAPKAPK2
prerank,regulation of catabolic process (GO:0009894),0.8521666211879271,1.1030359993629555,0.249,0.7546684922114909,1.0,10/17,9.12%,ITGB1;RARRES2;HPGD;ODC1;NEDD4L;TMEM9;HGS;FURIN;SNF8;ZDHHC7
prerank,receptor-mediated endocytosis (GO:0006898),0.9249556107681852,1.102718590778703,0.2715,0.755391209901659,1.0,28/143,3.12%,APOA1;SPARC;HBA1;CD81;HBB;AMN;APOB;CALR;CD9;HSP90B1;APOE;HSP90AA1;ITGB1;JCHAIN;DNM2;HSPG2;CANX;LRP1;AP2M1;PDLIM7;CLTB;CLTC;CLTA;LDLR;CTTN;CAV1;AP2S1;SCARB2
prerank,cellular calcium ion homeostasis (GO:0006874),0.9173345798125823,1.102673811068421,0.2875,0.7548229998408769,1.0,11/135,3.46%,TPT1;CALR;ATP1B1;CXCL12;ATP2A3;YWHAE;CAV1;NPTN;ANXA6;ATP2B4;SMDT1
prerank,nucleic acid-templated transcription (GO:0097659),0.8749715884972451,1.1023312496072406,0.2565,0.7557343427519334,1.0,9/42,5.47%,PTMA;POLR2L;RNPS1;POLR2J;POLR2H;POLR2E;POLR2F;POLR2I;POLR2G
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.8731105321410383,1.1022511312771794,0.2535,0.7553668180274982,1.0,18/48,8.51%,FN1;EFNA1;LAMB1;RHOA;RAC1;ILK;LAMB2;LAMC1;LAMB3;LAMA5;PXN;NRP1;MICALL2;FERMT2;PARVA;EPHB3;ANTXR1;VAMP3
prerank,cellular response to lectin (GO:1990858),0.9066864967157282,1.1019736225365138,0.2995,0.755121882597458,1.0,20/114,4.20%,MUC12;MUC2;MUC13;MUC1;MUC5B;SKP1;PSMB1;PSME1;PSMB4;PSME2;MUC4;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.9066864967157282,1.1019736225365138,0.2995,0.755121882597458,1.0,20/114,4.20%,MUC12;MUC2;MUC13;MUC1;MUC5B;SKP1;PSMB1;PSME1;PSMB4;PSME2;MUC4;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.8669941456743395,1.1019106435240618,0.2445,0.7546431429720958,1.0,10/37,6.27%,MDK;PHPT1;CDC42;ARHGDIA;PDGFRA;NRP1;BAIAP2L2;ABL1;F11R;NOTCH2
prerank,positive regulation of protein localization to membrane (GO:1905477),0.9036733308166118,1.1018683108568046,0.3035,0.7540884353398997,1.0,21/101,3.71%,LGALS3;CD81;AGR2;SFN;YWHAZ;ITGB1;CIB1;SPTBN1;YWHAQ;PLS1;LRP1;SQSTM1;YWHAE;CHP1;ERBB2;FIS1;YWHAB;MYO1C;ATP2B4;YWHAH;PDCD5
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.8555556027392562,1.1018660812635597,0.257,0.7533262858813903,1.0,4/17,9.46%,PLA2G2A;MBOAT7;LPGAT1;PLA2G10
prerank,regulation of B cell proliferation (GO:0030888),0.8728881130527866,1.1016550527027504,0.259,0.7536070161459667,1.0,4/46,3.76%,CD81;CD74;MIF;TFRC
prerank,negative regulation of inflammatory response (GO:0050728),0.9340794652539308,1.1011559422107546,0.226,0.755261388751969,1.0,10/210,1.94%,APOA1;RPS19;MDK;GSTP1;APOE;MYH9;GRN;VIP;KLF4;GNB1
prerank,regulation of mRNA catabolic process (GO:0061013),0.9108163202856918,1.1009890779205596,0.2985,0.7553111900689362,1.0,38/122,4.93%,RPS27A;VIM;UBC;UBA52;UBB;HSPB1;YWHAZ;PABPC1;ZFP36L2;HSPA8;ZFP36L1;ZFP36;HNRNPD;PSMB1;SET;SERBP1;PSME1;PSMB4;HSPA1A;PSME2;YWHAB;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;APEX1;XPO1;EIF4G1;PSMA1;PSMA4;PSMC5;PKP3;PSMC3;PSMD2;CNOT1;PSMA2
prerank,nucleocytoplasmic transport (GO:0006913),0.8684854082661067,1.1008016136660645,0.244,0.7554328542012237,1.0,10/40,4.25%,HNRNPA1;NPM1;SNRPD2;SNRPG;SNRPB;SNRPE;XPO1;SNRPF;SNRPD3;SNRPD1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.9078747678761693,1.1006949597718414,0.32,0.755184107244804,1.0,15/105,2.97%,APOA1;CD63;APOA4;CHCHD2;ANXA2;APOE;KLF4;PRELID1;ROMO1;CDKN1A;GHITM;APOA2;HPN;RAB1A;PDGFRB
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.8542066942987726,1.1006612834336282,0.2465,0.7545762688826402,1.0,4/18,5.58%,CCL21;CIB1;SFRP2;PIEZO1
prerank,neuron projection organization (GO:0106027),0.8494610360671451,1.100174717658888,0.25362681340670334,0.7562125809131546,1.0,7/16,7.50%,ARF1;PLS1;APP;LGMN;PSEN1;DCTN1;PRNP
prerank,peptidyl-arginine modification (GO:0018195),0.8462377165918604,1.1001069418096392,0.24324324324324326,0.7557559010784691,1.0,5/15,10.79%,PARK7;PRMT1;PADI2;KRTCAP2;PRMT5
prerank,detection of visible light (GO:0009584),0.8471258139719522,1.0994999893296753,0.2595,0.7580528979194119,1.0,3/17,8.13%,GNA11;REEP6;GNAQ
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.9066385399963758,1.0993608128983512,0.305,0.7579635608068908,1.0,20/117,4.20%,MUC12;MUC2;MUC13;MUC1;MUC5B;SKP1;PSMB1;PSME1;PSMB4;PSME2;MUC4;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.8520201360075829,1.0990740573772246,0.2531265632816408,0.7585641099946049,1.0,4/18,2.65%,SLC25A5;CHCHD10;ACAA2;HSPA1A
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.8594835174668211,1.098949193333179,0.2485,0.7583949547085688,1.0,5/34,3.96%,CALM2;CALM1;CALM3;THY1;GSTO1
prerank,signal transduction by p53 class mediator (GO:0072331),0.8628809058905598,1.0988293703117977,0.2585,0.7582296820056038,1.0,3/33,0.98%,HINT1;NDRG1;DDX5
prerank,cardiac myofibril assembly (GO:0055003),0.8471487913977735,1.0987902585808556,0.254,0.7576590468256037,1.0,4/15,5.80%,PDGFRB;PDGFRA;OBSL1;ACTC1
prerank,regulation of extracellular matrix organization (GO:1903053),0.8452404113314544,1.098529037453076,0.25062531265632815,0.7581459349178777,1.0,8/15,8.66%,LRP1;AEBP1;EFEMP2;DDR1;AGT;NOTCH1;DDR2;FGFR4
prerank,regulation of primary metabolic process (GO:0080090),0.9128801789867297,1.0980865756709854,0.301,0.7596014297703735,1.0,33/129,4.93%,FABP1;EDF1;OAZ1;PSAP;APOE;ID2;HMGCS1;PSMB1;FDPS;PSME1;PSMB4;LDLR;PSME2;FDFT1;PSMD8;PSMB3;PSMA7;PSMB5;MVD;PSMB7;PSMB6;HNF4A;IDI1;SREBF2;PSMA1;PSMA4;PSMC5;PLPP1;PSMC3;ODC1;HMGCR;PSMD2;PSMA2
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.8464167203208142,1.098012249491653,0.2475,0.7591993727479479,1.0,1/19,1.15%,APOE
prerank,actin polymerization or depolymerization (GO:0008154),0.8692891994846882,1.0979525381890298,0.268,0.758713589399228,1.0,17/50,7.51%,CFL1;GSN;DSTN;RAC1;WDR1;VIL1;EVL;MICAL1;VILL;MICALL2;WASL;SVIL;ENAH;MSRB2;CAPG;FLII;TTC17
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.9045836314761955,1.0974508239930487,0.3095,0.7603963607508321,1.0,11/120,2.97%,SPARC;CLDN4;CFL1;CLDN3;CEACAM1;CTNNB1;ADGRA2;ERBB2;CAPZB;CDX1;INF2
prerank,microvillus assembly (GO:0030033),0.8398045617157058,1.0974493573366677,0.265,0.7596386716387393,1.0,3/15,2.60%,EZR;SLC9A3R1;RAP1B
prerank,protein-DNA complex assembly (GO:0065004),0.9036775617112129,1.0973578516604383,0.317,0.7593039114006445,1.0,29/115,4.93%,RPS27A;UBC;UBA52;UBB;NPM1;NAP1L1;PSMB1;RBX1;HMGB2;PSME1;PSMB4;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;ANP32B;PSMB6;MCM7;PSMA1;BRD2;PSMA4;NAP1L4;PSMC5;PSMC3;PSMD2;DDB1;PSMA2
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.920313662665785,1.0972024172961232,0.296,0.7592760389747356,1.0,39/153,5.32%,COL1A1;JUP;GPC3;ADGRA2;PSMB1;DDX3X;ILK;SOX4;PSME1;PSMB4;VCP;TRPM4;CAV1;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;ZEB2;PSMB6;PSMA1;PSMA4;SULF2;MACF1;PSMC5;CSNK1D;SFRP2;PSMC3;UBE2B;SFRP1;PSMD2;CSNK1E;PSMA2;TMEM9;PTK7;SPIN1;PIN1;PSMB2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.842468058082061,1.0971570561503239,0.2541270635317659,0.7587440475882101,1.0,9/15,14.58%,PKM;KLF4;VEGFA;ITGA5;JAK1;JMJD8;DLL1;TJP1;PDPK1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.8545255706595889,1.0971176774093685,0.2365,0.7581596031713207,1.0,5/27,8.64%,BAG6;RAD21;REC8;P3H4;SIRT7
prerank,atrioventricular valve morphogenesis (GO:0003181),0.846722262031316,1.0960506220495996,0.2505,0.7624765794280061,1.0,9/19,8.41%,EFNA1;SOX4;NOTCH1;SLIT3;OLFM1;TGFBR2;SMAD4;BMPR2;MDM4
prerank,regulation of mRNA stability (GO:0043488),0.9115416917838334,1.095980617532059,0.2925,0.7620443165102853,1.0,39/146,4.20%,RPS27A;VIM;UBC;UBA52;UBB;HSPB1;CIRBP;YWHAZ;PABPC1;NPM1;ZFP36L2;FUS;HSPA8;ZFP36L1;YBX1;VIP;HNRNPU;ZFP36;HNRNPD;PSMB1;SET;SERBP1;PSME1;PSMB4;HSPA1A;PSME2;YWHAB;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;APEX1;XPO1;EIF4G1;PSMA1;PSMA4;PSMC5
prerank,regulation of protein polymerization (GO:0032271),0.8540105829727922,1.0959766985491457,0.247,0.7612992520550529,1.0,10/34,6.92%,PFN1;HSP90AA1;CTTN;PFN2;GBA2;ABL1;COTL1;DBN1;ARL2;DBNL
prerank,myeloid cell development (GO:0061515),0.8494649671798923,1.0959355752919124,0.262,0.7607290379153281,1.0,2/20,2.06%,ANXA2;APP
prerank,actin filament bundle organization (GO:0061572),0.8590471737102634,1.0957158274775571,0.2545,0.7609811284820307,1.0,17/33,9.27%,EZR;CALD1;PLS1;DPYSL3;ADD1;FSCN1;MICAL1;BAIAP2L2;EPS8;LIMA1;USH1C;PLS3;MYO1B;BAIAP2L1;CORO1B;RFLNA;ESPN
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.8456535656942392,1.0956486225411965,0.258,0.760531689526886,1.0,4/17,9.57%,SAT1;SAT2;SRM;DDC
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.8381963048917137,1.0953435459476113,0.2545,0.7612319849455306,1.0,9/15,11.55%,TMBIM6;PARK7;HSPA1A;XBP1;SELENOS;HERPUD1;CREB3L1;SYVN1;TXNDC12
prerank,stress fiber assembly (GO:0043149),0.8428351857564929,1.0951254468290095,0.2676338169084542,0.760784887302847,1.0,9/15,11.60%,ITGB1;RHOA;PDLIM1;ZYX;SORBS1;FAM171A1;SRC;ITGB5;CUL3
prerank,contractile actin filament bundle assembly (GO:0030038),0.8428351857564929,1.0951254468290095,0.2676338169084542,0.760784887302847,1.0,9/15,11.60%,ITGB1;RHOA;PDLIM1;ZYX;SORBS1;FAM171A1;SRC;ITGB5;CUL3
prerank,regulation of intracellular protein transport (GO:0033157),0.8586658508239209,1.0950958266673703,0.2545,0.7601824232406338,1.0,2/32,0.84%,IFI27;OAZ1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.8560922238982431,1.095068259813101,0.259,0.7595697735804456,1.0,4/28,3.03%,CCL21;FGFR3;PDGFRB;PDGFRA
prerank,cellular response to catecholamine stimulus (GO:0071870),0.8501466999757362,1.0949370395248261,0.252,0.7594481200293484,1.0,11/24,8.92%,ATF4;GNB1;MAPK3;ATP2B4;TGM2;ABL1;MAPK1;SIRT2;GNG2;ADCY6;PRKACA
prerank,regulation of protein localization (GO:0032880),0.8779558804879395,1.094870059866461,0.29,0.7590181169879587,1.0,6/66,2.46%,RACK1;CTSD;HSP90AB1;HSP90AA1;VIP;FKBP1A
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.8406121317457483,1.0948599377946353,0.262,0.7583043539431485,1.0,9/18,11.06%,EMILIN1;MELTF;FSCN1;EFEMP2;COLGALT1;CLASP2;DDR2;IER3IP1;SMAD3
prerank,mitotic spindle assembly (GO:0090307),0.869100571435802,1.0948182198570588,0.275,0.7577344092467175,1.0,6/44,4.72%,FLNA;MISP;RHOA;RAB11A;ZNF207;KPNB1
prerank,regulation of neuron death (GO:1901214),0.8937123532130938,1.0947994255003106,0.306,0.7570715612510336,1.0,8/86,2.26%,FOS;UBB;CHGA;EGR1;PARK7;NENF;CHP1;CLU
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.8722195756002374,1.0946164381083743,0.2725,0.7564636586068608,1.0,36/58,6.71%,NDUFB2;NDUFA1;NDUFS5;NDUFA11;NDUFB7;NDUFA13;NDUFB1;NDUFB11;NDUFB10;NDUFB4;NDUFA3;NDUFS6;NDUFV1;NDUFC2;NDUFB9;NDUFB8;NDUFA6;NDUFA2;NDUFS8;NDUFS7;NDUFAB1;NDUFC1;NDUFV2;NDUFA10;NDUFA12;NDUFB3;NDUFB6;DMAC1;NDUFAF3;NDUFS3;NDUFA5;OXA1L;NDUFAF8;NDUFS4;NDUFA8;NDUFS2
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.8722195756002374,1.0946164381083743,0.2725,0.7564636586068608,1.0,36/58,6.71%,NDUFB2;NDUFA1;NDUFS5;NDUFA11;NDUFB7;NDUFA13;NDUFB1;NDUFB11;NDUFB10;NDUFB4;NDUFA3;NDUFS6;NDUFV1;NDUFC2;NDUFB9;NDUFB8;NDUFA6;NDUFA2;NDUFS8;NDUFS7;NDUFAB1;NDUFC1;NDUFV2;NDUFA10;NDUFA12;NDUFB3;NDUFB6;DMAC1;NDUFAF3;NDUFS3;NDUFA5;OXA1L;NDUFAF8;NDUFS4;NDUFA8;NDUFS2
prerank,regulation of protein modification process (GO:0031399),0.8687828386444261,1.0945938409687295,0.2865,0.7558339531363003,1.0,11/50,6.03%,FN1;HSPB1;NOP53;PLXNB2;PPIB;PPP1R16A;PIN1;PPP2CA;CDH5;STAT2;NDUFS4
prerank,regulation of cell division (GO:0051302),0.8849174836116908,1.0945891358612463,0.2965,0.7551182009209166,1.0,8/76,2.97%,RACK1;CALM2;SFN;TXNIP;CALM1;CIB1;CALM3;RAB11A
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.8470385390136529,1.0945765894676245,0.271,0.7544303051946285,1.0,9/15,9.98%,TCF21;PHB;HDAC1;SFRP1;NCOR2;DAB2;SMARCA4;NCOR1;FOXP1
prerank,maintenance of protein localization in organelle (GO:0072595),0.8445787172810383,1.0939340635752113,0.262,0.75669527748018,1.0,8/19,6.50%,SKP1;HNRNPU;CHCHD10;HSPA5;AKT1;ARL2;PINK1;HK2
prerank,negative regulation of cytokine production (GO:0001818),0.9262378684288252,1.0939311997335788,0.2715,0.7559710052614512,1.0,11/179,1.73%,APOA1;TMSB4X;CEACAM1;FN1;EZR;PCBP2;HMGB1;RAC1;PDCD4;KLF4;ZFP36
prerank,regulation of necroptotic process (GO:0060544),0.8523072960788297,1.0938870310212596,0.255,0.7554508494558662,1.0,13/23,9.59%,HSP90AA1;CDC37;OGT;PDCD6IP;STUB1;FLOT1;SDCBP;YBX3;CFLAR;ARHGEF2;SLC25A4;FLOT2;BIRC2
prerank,superoxide metabolic process (GO:0006801),0.8597682630651607,1.0937422952790252,0.2665,0.7553664799783839,1.0,7/31,4.74%,APOA4;CYBA;PRDX2;SOD1;PRDX1;SH3PXD2A;CCS
prerank,keratinocyte differentiation (GO:0030216),0.8625416157306357,1.0936258883843373,0.268,0.7551433428276647,1.0,9/40,5.71%,TXNIP;ST14;KRT10;ASAH1;CLIC4;ANXA1;JAG1;DSP;EPHA2
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.8376204258640625,1.0934713087965038,0.2595,0.7551383325986448,1.0,9/15,14.90%,CD74;AGPAT2;GAS6;DHX9;AGPAT1;TRIM44;AXL;MAVS;TAF9
prerank,negative regulation of protein metabolic process (GO:0051248),0.875862804244816,1.093155556323612,0.2805,0.7558660499375328,1.0,11/52,5.30%,FLNA;PFDN5;HSP90AB1;APOE;SNX3;CLU;LDLR;PHB;PFDN2;HMGCR;PIN1
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.8617921273543874,1.0929711010292158,0.262,0.7559779727431148,1.0,15/39,7.02%,UBB;ATP5IF1;PRELID1;PARK7;SOD1;VCP;HEBP2;ARL6IP5;PRDX3;STOML2;AKT1;ABL1;BAD;PINK1;AKT2
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.9055056770749419,1.0928421317811947,0.324,0.7558371728914041,1.0,21/118,3.88%,RPS3;RACK1;CTSD;GSN;BEX3;HMGB1;NDUFA13;CYCS;ATP2A3;RPS27L;HSPE1;MTCH1;DDX3X;FIS1;VCP;HSPD1;BCAP31;PDCD6;ANP32B;PDCD5;FAM162A
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.8453772737288594,1.0927225886213952,0.2665,0.7556845185543072,1.0,8/17,7.72%,APOE;SOD1;RAN;SREBF2;KPNB1;MBTPS1;SREBF1;SCAP
prerank,cellular response to UV (GO:0034644),0.8838751266971767,1.0926658462739878,0.3055,0.7552084176212805,1.0,8/76,2.06%,RPL26;MFAP4;NPM1;MMP2;ATF4;COPS9;TIMP1;CDKN1A
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.8444526574208779,1.0926626912440998,0.25962981490745374,0.754490183423982,1.0,3/20,5.94%,SFN;BTG1;BAD
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.8949685559747559,1.0926204814083291,0.324,0.7539469904295729,1.0,27/88,6.29%,RPS3;PFN1;CCL21;APOE;RAC1;CDC42EP5;WDR1;APP;VIL1;STMN2;CLU;SYNPO2;NUMA1;CTTN;EVL;EFEMP2;COLGALT1;PFN2;VASP;BAIAP2L2;ARF6;NCKAP1;LMOD1;BIN1;ARL2;PSEN1;SEMA5A
prerank,regulation of programmed cell death (GO:0043067),0.9222767634874706,1.0918550639718978,0.276,0.7568208622654725,1.0,28/193,3.78%,TPT1;RPS3;LGALS1;OLFM4;NDRG1;CALR;HSP90AA1;NOP53;CTSB;ACTN4;RTN4;PRDX2;PRELID1;MAGED1;IGFBP3;TP53I3;ACTN1;CLU;VCP;ASAH1;PERP;KANK2;PHB;TMEM219;TGM2;ANP32B;APEX1;SGK1
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.8716128570401912,1.0917509631406164,0.277,0.7565762683273736,1.0,24/54,9.00%,HNRNPA1;DDX17;DDX5;HNRNPU;PTBP1;SRSF6;RBM5;RBMX;SAP18;RNPS1;KHDRBS1;RBFOX2;RBM8A;TRA2B;PUF60;RBM25;MBNL1;MAGOH;THRAP3;WTAP;YTHDC1;HNRNPL;CELF1;FXR1
prerank,glutathione metabolic process (GO:0006749),0.8558913434052605,1.0917223069584001,0.2535,0.7559790987488224,1.0,11/40,7.71%,GSTP1;GSTA1;ETHE1;PARK7;SOD1;GSTK1;CNDP2;GSTA2;MGST2;DPEP1;GSTM3
prerank,epithelial cell migration (GO:0010631),0.8614621708563096,1.0914247790439813,0.2725,0.7566532129303205,1.0,13/41,5.65%,FSTL1;RHOA;GIPC1;ADGRA2;PRSS3;S100P;KANK2;ZEB2;PXN;LOXL2;NRP1;PLXND1;ABL1
prerank,mammary gland epithelium development (GO:0061180),0.8438518420269971,1.091325522314726,0.2726363181590795,0.7563984157639657,1.0,7/15,9.04%,ID2;AKT1;EPHA2;AKT2;IRF6;SCRIB;ZNF703
prerank,establishment of epithelial cell polarity (GO:0090162),0.8457115005850973,1.0912632818379682,0.265,0.7559781940193119,1.0,7/20,7.52%,EZR;RHOA;SLC9A3R1;CDC42;MSN;GOLPH3;CYTH1
prerank,positive regulation of interleukin-10 production (GO:0032733),0.8555770344348249,1.0912120395104374,0.26,0.7554852714277586,1.0,10/32,10.31%,HMGB1;HSPD1;CD46;INAVA;CD34;PRKCZ;LGALS9;F2RL1;PYCARD;ISG15
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.8481635194969153,1.0907173690190881,0.2615,0.7571282879385204,1.0,16/22,12.37%,PSMB1;PSMB4;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;PSMA1;PSMA4;ENC1;PSMA2;PSMB2;PSMA3;PSMA5;PSMB8;NFE2L2
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.8498714353865742,1.0904985766917745,0.2685,0.7574599968856052,1.0,4/27,1.32%,CD74;DDX5;PTTG1IP;MIF
prerank,apoptotic DNA fragmentation (GO:0006309),0.8379961311377055,1.0904159777378568,0.2702702702702703,0.7571270803721413,1.0,3/15,4.72%,HMGB1;HMGB2;KPNB1
prerank,regulation of smoothened signaling pathway (GO:0008589),0.861152097472925,1.0900706159958118,0.271,0.7579937195503142,1.0,8/51,6.27%,RACK1;GPC3;VCP;RAB34;SFRP1;SMO;GAS1;PTCH1
prerank,positive regulation of cell migration (GO:0030335),0.9386608827799872,1.0899113519146162,0.219,0.7580142837480938,1.0,22/266,1.78%,COL1A1;ACTG1;CLDN4;RACK1;CLDN3;MDK;FN1;PFN1;MYLK;CEACAM6;RHOC;SMIM22;LAMB1;S100A11;ITGB1;CXCL12;GRN;ACTN4;CD151;CIB1;RTN4;HSPA5
prerank,positive regulation of histone acetylation (GO:0035066),0.8443478582522426,1.0898880141868266,0.262,0.7573956529514914,1.0,9/23,11.24%,MUC1;MAPK3;WBP2;SMAD4;RUVBL2;SMARCB1;GLYR1;PIH1D1;BRD7
prerank,regulation of protein metabolic process (GO:0051246),0.8663493009310506,1.0896309300593097,0.2775,0.75787919326377,1.0,20/47,8.18%,LTBP4;HSP90AB1;APOE;KLF4;NEDD8;APP;PLAUR;FKBP1A;LDLR;KLF2;ODC1;NEDD4L;TMEM9;HGS;VPS35;FURIN;MTPN;ROCK2;GBA;SNF8
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.8405898873961741,1.089446871993307,0.2595,0.7580294929038179,1.0,20/24,13.94%,HSP90B1;SEC61B;VCP;OS9;AUP1;SURF4;TMED9;SEC13;SELENOS;HERPUD1;NPLOC4;SEC16A;SEL1L;LMAN1;SYVN1;UFD1;DERL2;PREB;DERL1;TMEM129
prerank,regulation of DNA binding (GO:0051101),0.858950850237742,1.0891747226675856,0.265,0.7585934356094451,1.0,17/46,8.07%,EDF1;JUN;TXN;HMGB1;PLAUR;HMGB2;CSNK2B;CPNE1;HES1;SMO;SUMO1;NME1;NFKBIA;SUMO3;CEBPG;SIRT2;KDM1A
prerank,skeletal muscle contraction (GO:0003009),0.8442835476605066,1.08913851073187,0.27,0.758039901307956,1.0,1/20,2.32%,MYH14
prerank,phospholipid catabolic process (GO:0009395),0.8468480187379281,1.0891146522179054,0.2715,0.757439878129206,1.0,6/23,8.58%,PRDX6;APOA2;SMPDL3A;SMPD4;ABHD12;SMPD1
prerank,regulation of cell death (GO:0010941),0.8897734748386689,1.089064647616757,0.3295,0.7569815868962985,1.0,18/95,4.15%,HBA1;UBB;OLFM4;AGR2;HBB;PARK7;LRP1;SRSF6;CHP1;CLU;SOX4;HSPA1A;DHCR24;PHB;AGR3;LRPAP1;EIF4G1;CHMP2A
prerank,positive regulation of filopodium assembly (GO:0051491),0.8453167593664712,1.0890103080867264,0.26,0.7565156247653066,1.0,16/26,13.38%,CCL21;DPYSL3;CDC42;FSCN1;AGRN;NRP1;WASL;ARAP1;MIEN1;PALM;FNBP1L;FMR1;RHOQ;PIK3R1;RALA;NEURL1
prerank,regulation of ossification (GO:0030278),0.8531763904886994,1.0888817602563838,0.2685,0.7563804988765814,1.0,8/36,8.30%,MDK;PTN;SFRP1;NOTCH1;NBR1;RBPJ;BMPR2;DDR2
prerank,negative regulation of catalytic activity (GO:0043086),0.8503830048109297,1.088305901474145,0.268,0.7584077030921899,1.0,11/27,9.70%,PHPT1;ATP5IF1;TIMP1;TMBIM1;NOTCH1;OXA1L;NOSIP;CAND1;HDAC6;PPP1R12A;NES
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.8379244848596668,1.0881588638503616,0.2675,0.7583836561282081,1.0,1/19,1.55%,SLC9A3R1
prerank,neutrophil degranulation (GO:0043312),0.9575071063224312,1.0876684038879951,0.0955,0.7600014235330642,1.0,58/476,1.92%,EEF1A1;FTH1;PIGR;FTL;B2M;TTR;LGALS3;HLA-B;CST3;PPIA;CEACAM1;HLA-C;EEF2;TUBB;CTSD;SERPINA1;CD63;OLFM4;GSN;PRDX6;ANPEP;CTSA;GSTP1;HBB;DYNLL1;CEACAM6;CD177;PSAP;SRP14;ANXA2;DGAT1;TUBB4B;HSP90AB1;HMGB1;S100A11;HSPA8;HSP90AA1;PLAC8;MIF;CTSB;LCN2;GRN;AOC1;RHOA;RAC1;CYBA;PKM;TIMP2;JUP;FABP5;PFKL;VAMP8;QSOX1;MVP;AGPAT2;CYSTM1;NPC2;PGAM1
prerank,negative regulation of protein processing (GO:0010955),0.8347085359952916,1.0876169068699921,0.2705,0.7595305587129835,1.0,6/15,11.42%,TMEM59;GAS1;PRNP;SERPINE2;CTSZ;THBS1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.8739546612032422,1.0871952975136172,0.2995,0.7607912584225082,1.0,19/72,6.11%,CLDN3;FN1;EFNA1;LAMB1;ATF4;RHOA;RAC1;ACTN1;ILK;LAMB2;LAMC1;LAMB3;LAMA5;PXN;NRP1;MICALL2;TBCD;EPHA2;FERMT2
prerank,neutrophil mediated immunity (GO:0002446),0.9574002998223856,1.0870475939871123,0.0965,0.7607801379053934,1.0,58/483,1.92%,EEF1A1;FTH1;PIGR;FTL;B2M;TTR;LGALS3;HLA-B;CST3;PPIA;CEACAM1;HLA-C;EEF2;TUBB;CTSD;SERPINA1;CD63;OLFM4;GSN;PRDX6;ANPEP;CTSA;GSTP1;HBB;DYNLL1;CEACAM6;CD177;PSAP;SRP14;ANXA2;DGAT1;TUBB4B;HSP90AB1;HMGB1;S100A11;HSPA8;HSP90AA1;PLAC8;MIF;CTSB;LCN2;GRN;AOC1;RHOA;RAC1;CYBA;PKM;TIMP2;JUP;FABP5;PFKL;VAMP8;QSOX1;MVP;AGPAT2;CYSTM1;NPC2;PGAM1
prerank,regulation of cell-cell adhesion (GO:0022407),0.8592275996828697,1.0870418623148508,0.2695,0.760086644315758,1.0,14/43,10.12%,CEACAM1;SPINT2;CDH1;JAG1;AFDN;FUT3;PTK2;EPHB3;FLOT2;CD47;SRC;DPP4;CITED2;FSTL3
prerank,protein deacetylation (GO:0006476),0.8555400215528842,1.086849905710343,0.267,0.7602987537336156,1.0,15/44,8.92%,FLNA;MORF4L1;MORF4L2;PHB;HDAC1;HDAC2;HDAC5;MTA1;RBM14;TBL1XR1;SIRT2;HDAC6;SIRT7;SIRT6;HDAC7
prerank,neutrophil activation involved in immune response (GO:0002283),0.9573128593916237,1.0867454042146651,0.097,0.7600704923117987,1.0,58/480,1.92%,EEF1A1;FTH1;PIGR;FTL;B2M;TTR;LGALS3;HLA-B;CST3;PPIA;CEACAM1;HLA-C;EEF2;TUBB;CTSD;SERPINA1;CD63;OLFM4;GSN;PRDX6;ANPEP;CTSA;GSTP1;HBB;DYNLL1;CEACAM6;CD177;PSAP;SRP14;ANXA2;DGAT1;TUBB4B;HSP90AB1;HMGB1;S100A11;HSPA8;HSP90AA1;PLAC8;MIF;CTSB;LCN2;GRN;AOC1;RHOA;RAC1;CYBA;PKM;TIMP2;JUP;FABP5;PFKL;VAMP8;QSOX1;MVP;AGPAT2;CYSTM1;NPC2;PGAM1
prerank,organelle transport along microtubule (GO:0072384),0.8483251905039245,1.086702858535381,0.267,0.7595524387970006,1.0,14/31,11.22%,UBB;CDC42;RAB1A;RHOT2;UXT;PAFAH1B1;KIF5B;RAB6A;TRAK1;ARHGAP21;LRPPRC;BICDL2;COPG1;HTT
prerank,actin nucleation (GO:0045010),0.8436557352164461,1.0864950037485344,0.2675,0.7597771199843307,1.0,12/21,9.40%,ARPC3;ARPC2;ARPC5;ARPC4;ACTR2;ARPC1A;WASHC1;ARPC1B;LMOD1;ACTR3;TRIM27;SPIRE2
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.8766099342075542,1.086487333879007,0.308,0.759094382350487,1.0,15/65,5.75%,RPL26;MUC1;SFN;ARID3A;RPS27L;CDKN1A;PRAP1;SOX4;PRMT1;BTG2;CCND1;CNOT1;PLAGL1;PCNA;PCBP4
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.8362638060133284,1.0861571207136727,0.2695,0.759893199082112,1.0,8/17,7.51%,EZR;SNX3;MAP2K2;MAPK3;MSN;CHMP3;DAB2;MAPK1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.833170549740513,1.0859322650587069,0.28,0.7602395080017421,1.0,5/15,5.47%,PABPC1;ZFP36;BTG2;CNOT1;POLR2G
prerank,positive regulation of cell adhesion (GO:0045785),0.8847356136059846,1.0859305122451908,0.3175,0.7595372200680968,1.0,12/80,3.58%,TPM1;MDK;AGR2;P4HB;CCL21;CXCL12;RAC1;CIB1;ERBB2;VEGFA;FBLN2;TGM2
prerank,regulation of amyloid-beta formation (GO:1902003),0.8494276921468892,1.0859301001179171,0.2705,0.7588297070997436,1.0,15/34,8.83%,EFNA1;APOE;RTN4;CLU;TMED10;RTN3;PIN1;SORL1;PICALM;BIN1;IFNGR1;PRNP;ROCK2;RTN1;RELA
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.8396215116180634,1.0851530688145035,0.279,0.7616893122991559,1.0,5/18,11.43%,PLA2G2A;LPGAT1;LPCAT4;PLA2G10;CRLS1
prerank,regulation of humoral immune response (GO:0002920),0.8688530551518214,1.0851375739827982,0.3045,0.7610431042582745,1.0,12/54,6.47%,CD81;PHB2;CLU;C7;C1S;CD59;CD46;C1R;C1QA;C1QBP;SERPING1;C3
prerank,regulation of cholesterol metabolic process (GO:0090181),0.8425232107899507,1.0846900534334247,0.27,0.7624708181025439,1.0,8/21,6.86%,ACADVL;APOE;RAN;SREBF2;EPHX2;KPNB1;MBTPS1;SREBF1
prerank,positive regulation of type I interferon production (GO:0032481),0.879823174199504,1.0846894951426798,0.317,0.7617655349272718,1.0,14/76,5.21%,GAPDH;HSP90AA1;POLR2L;CTNNB1;DDX3X;XRCC6;HSPD1;XRCC5;POLR2H;POLR2E;POLR2F;RIOK3;DHX9;FLOT1
prerank,nitric oxide mediated signal transduction (GO:0007263),0.8332138233192868,1.084426869885172,0.266,0.7622431062826754,1.0,6/18,12.05%,APOE;DDAH2;AGT;DDAH1;GUCY1B1;GUCY1A1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.8417675494009962,1.084348761345362,0.2715,0.7618699815217479,1.0,9/21,9.26%,PKDCC;TMEM59;AP2M1;CLTC;TMBIM1;PICALM;DAB2;CSK;NUMB
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.9003891540457953,1.0841765186309011,0.331,0.7620027857835912,1.0,3/128,0.75%,RPS27;STMN1;DYNLL1
prerank,positive regulation of stem cell differentiation (GO:2000738),0.833485817504519,1.0841287956662113,0.276,0.7615109894301042,1.0,2/17,2.83%,PTN;LTBP3
prerank,regulation of endothelial cell proliferation (GO:0001936),0.8863040885537052,1.0840871068420679,0.3385,0.7609909302955111,1.0,15/92,4.29%,SPARC;APOE;ATP5F1A;ATP5IF1;NR4A1;VIP;HMGB2;CAV1;EGFL7;MYDGF;VEGFA;PDCD6;EMC10;NR2F2;NRP1
prerank,negative regulation of leukocyte activation (GO:0002695),0.8338271823331026,1.0840799417378517,0.2775,0.7603177696910254,1.0,2/15,9.09%,GRN;NR1H3
prerank,maintenance of protein location in nucleus (GO:0051457),0.8345007235421333,1.0840796524143748,0.262,0.7596144230030595,1.0,7/20,5.97%,SKP1;HNRNPU;CHCHD10;PARK7;SUN1;SUN2;ARL2
prerank,nucleic acid metabolic process (GO:0090304),0.8743682180484936,1.083660234867665,0.319,0.760887499689668,1.0,24/71,4.63%,HNRNPA1;HNRNPA2B1;HNRNPH1;HNRNPK;PCBP2;HNRNPC;HNRNPA3;HNRNPU;POLR2L;PCBP1;PTBP1;RAN;HNRNPD;HNRNPM;RBMX;HNRNPA0;POLR2J;RBFOX2;POLR2H;HNRNPR;POLR2E;HNRNPF;POLR2F;POLR2I
prerank,regulation of response to external stimulus (GO:0032101),0.8994257201973996,1.0834733300069055,0.351,0.7610924498304441,1.0,7/128,3.03%,TMSB4X;CALM1;GRN;PARK7;ADGRA2;CAV1;PDGFRA
prerank,negative regulation of cell adhesion (GO:0007162),0.876387425564119,1.0834065924921668,0.31,0.7606954833051037,1.0,18/73,5.55%,MDK;MUC1;SPINT2;FBLN1;DUSP1;CD164;RHOA;CDH1;PLXNB2;ADAMDEC1;ARHGDIA;ERBB3;PLXNB1;TGFBI;PLXND1;JAG1;NOTCH1;TBCD
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.8422395353225469,1.083278089833897,0.276,0.7606183918044452,1.0,2/24,0.82%,LTBP4;NREP
prerank,vesicle transport along actin filament (GO:0030050),0.8388818968772458,1.083024694479566,0.288144072036018,0.7610645761718663,1.0,10/19,9.71%,ACTN4;MYO1A;MYO1D;MYO1C;MYO7B;WASL;MYO1B;MYO6;FNBP1L;MYO5B
prerank,positive regulation of lipid storage (GO:0010884),0.8431688720700652,1.0824512222117884,0.2705,0.7630002120899976,1.0,7/21,9.46%,APOB;SREBF2;PLIN3;SCARB1;C3;EHD1;PLA2G10
prerank,protein catabolic process (GO:0030163),0.873161665609827,1.0822512763044607,0.309,0.7632587668241368,1.0,10/63,4.87%,CEACAM1;CTSD;APOE;HSPA8;HSP90AA1;VCP;OGA;BAG6;TPP1;DDB1
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.8908116138732806,1.0820689206136394,0.33,0.7633975502140705,1.0,14/113,5.00%,VIM;GSTP1;HMGB1;RHOA;PDCD4;DEFA3;ZFP36;HMGB2;DEFA5;PABPN1;XBP1;SELENOS;DEFA6;CCL2
prerank,regulation of inflammatory response (GO:0050727),0.9182388041568804,1.0819959167847446,0.3145,0.7630382438164589,1.0,11/202,2.35%,APOA1;TMSB4X;MDK;PLA2G2A;APOE;GRN;PDCD4;KLF4;PARK7;APP;DDT
prerank,protein targeting (GO:0006605),0.901278514832478,1.0818205610739255,0.3575,0.7631407935878134,1.0,17/125,4.02%,RPL11;NACA;SLC25A6;SRP14;TOMM7;SEC61G;GIPC1;TSPO;TIMM13;SEC61A1;CDC37;FIS1;BCAP31;MYO1C;SPCS1;TOMM20;TIMM8B
prerank,cellular response to dsRNA (GO:0071359),0.836329041779177,1.0815860799571697,0.2855,0.7635478985899036,1.0,10/17,13.51%,NPM1;CAV1;RIOK3;DHX9;FLOT1;COLEC12;PQBP1;ZCCHC3;RALB;MAVS
prerank,protein localization to lysosome (GO:0061462),0.8413072668597571,1.0815319182741414,0.2805,0.7631044102861736,1.0,10/28,6.27%,CD81;LAMTOR4;RTN4;LAMTOR5;SCARB2;RAB7A;SORL1;NCOA4;LAPTM5;HGS
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.8773324165204258,1.081462753761319,0.3275,0.7627275026787853,1.0,10/74,2.95%,RPL26;MUC1;NDRG1;SFN;ARID3A;RPS27L;CDKN1A;PRAP1;SOX4;PRMT1
prerank,negative regulation of hydrolase activity (GO:0051346),0.8641879838723375,1.0812817317225778,0.304,0.7628833508885139,1.0,11/58,5.97%,CST3;ATP5IF1;CHP1;CSTB;APOA2;GCHFR;TMED2;SLC39A14;RCC2;F11R;ARL2
prerank,positive regulation of immune response (GO:0050778),0.8772256935159339,1.0810270743901162,0.3215,0.7633475604775607,1.0,14/72,6.57%,CD81;CD177;CD74;GRN;CYBA;HLA-DRA;PCK1;HLA-DRB1;CD46;XBP1;RIOK3;DHX9;LGALS9;IL6ST
prerank,ethanol metabolic process (GO:0006067),0.839566512188887,1.0809111820004311,0.2795,0.7631691431397934,1.0,10/19,9.80%,ACSS2;ALDH1A1;ALDH2;ADH5;SULT1B1;SULT1A1;SULT1E1;ADH1C;SULT2A1;ACSS1
prerank,cellular response to ATP (GO:0071318),0.8387560005971579,1.0805989234246267,0.292,0.7638893624307401,1.0,2/15,5.72%,HSP90B1;P2RX4
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.8450167694430785,1.0805604048748332,0.281,0.7633675102424347,1.0,7/27,8.75%,SCNN1B;SCNN1A;SLC12A7;SLC12A2;CLCN3;CYP4F12;PDK2
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.8372828657133587,1.0803838598979862,0.2815,0.7634816404789175,1.0,5/24,2.33%,ATF4;GRN;CTNNB1;NUPR1;MCL1
prerank,microglial cell activation (GO:0001774),0.8373203235427235,1.0803266752099072,0.2835,0.7630468807764349,1.0,5/22,6.74%,GRN;APP;CLU;C1QA;IFNGR1
prerank,glutamine family amino acid catabolic process (GO:0009065),0.82871376011683,1.0801245572694673,0.27913956978489246,0.7632885058385727,1.0,4/16,11.36%,GLS;GLUL;DDAH1;GLUD1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.8507601626020799,1.079655163767977,0.286,0.764712045933759,1.0,13/39,6.91%,CALM1;APOE;HSP90AA1;DNM2;CAV1;ATP2B4;DDAH2;AKT1;WASL;SCARB1;NOSIP;DDAH1;NPR3
prerank,cellular response to lipopolysaccharide (GO:0071222),0.8913069330783593,1.079531685665844,0.3415,0.7645842149546377,1.0,14/119,5.00%,VIM;GSTP1;HMGB1;RHOA;PDCD4;DEFA3;ZFP36;HMGB2;DEFA5;PABPN1;XBP1;SELENOS;DEFA6;CCL2
prerank,regulation of cellular respiration (GO:0043457),0.8346034971704477,1.0794066820729982,0.2895,0.7644466671869782,1.0,3/17,2.67%,NOP53;PRELID1;VCP
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.8584115252305511,1.0793455192889254,0.303,0.7640306198303002,1.0,13/48,6.34%,GSTP1;EZR;FBLN1;EMILIN1;SLC9A3R1;CAMK2N1;TIMP3;PHB;TNIP1;PIN1;PTEN;DUSP6;WNK2
prerank,monocarboxylic acid transport (GO:0015718),0.8639646635629025,1.0792716060734553,0.293,0.7636789675897432,1.0,6/57,5.03%,CEACAM1;SLC6A8;SLC9A3R1;ABCC3;ATP8B1;SLC26A6
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.8550037508458312,1.0790624055638716,0.282,0.7639615553752456,1.0,11/47,8.47%,MDK;CEACAM6;PLAUR;THY1;FLOT1;PIEZO1;AFDN;FUT3;PLPP3;JAK1;CD47
prerank,positive regulation of cell differentiation (GO:0045597),0.926146417205908,1.0787102229638408,0.274,0.7648654035297028,1.0,19/253,2.02%,COL1A1;MDK;CEACAM1;APOB;PLA2G2A;HSP90AB1;PKDCC;ZFP36L1;RHOA;CTNNA1;PTN;NBL1;ID2;RARRES2;ZFP36;CTNNB1;CDC42;ADIRF;IGFBP3
prerank,aminoglycan catabolic process (GO:0006026),0.8388870982416154,1.0786139550869378,0.276,0.7645949770139298,1.0,16/31,10.34%,HSPG2;GPC3;GNS;AGRN;SDC1;SDC2;SDC4;GUSB;FUCA1;GPC6;GPC1;HYAL2;GLB1;GPC4;IDS;HGSNAT
prerank,endothelial cell development (GO:0001885),0.8358109912557805,1.0785600127930808,0.283,0.7641653771714112,1.0,11/26,10.05%,EZR;COL18A1;RAP1B;PECAM1;MSN;RAP1A;COL15A1;MYADM;GSTM3;F2RL1;RAPGEF1
prerank,cellular response to interleukin-1 (GO:0071347),0.8997677183987807,1.0781805034442766,0.347,0.7652207280483087,1.0,29/154,5.00%,RPS27A;UBC;UBA52;UBB;EGR1;CCL21;SKP1;SQSTM1;PSMB1;RBX1;PSME1;RBMX;PSMB4;PSME2;MAPK3;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5;PSMC3;SFRP1;PSMD2;PSMA2;CCL2
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.8330755472382294,1.0781713904606762,0.2865,0.7645736026778647,1.0,5/18,8.39%,APOE;AKT1;SCARB1;NPR3;HIF1A
prerank,retrograde axonal transport (GO:0008090),0.8265475277079701,1.0779101501120734,0.2845,0.7651113248631773,1.0,8/16,11.33%,SOD1;DST;DYNC1H1;PAFAH1B1;KIF5B;KIF1C;ACTR10;NEFL
prerank,actin filament polymerization (GO:0030041),0.8397708682323384,1.0778776272366652,0.2805,0.7645707697336718,1.0,7/29,7.51%,GSN;RAC1;VIL1;MICALL2;WASL;MSRB2;TTC17
prerank,negative regulation of programmed cell death (GO:0043069),0.9422362647273854,1.077649670655322,0.182,0.7649508246371366,1.0,49/378,2.75%,RPL10;FABP1;TPT1;RPS27A;RPS3A;CEACAM5;PTMA;FLNA;UBC;CFL1;UBA52;UBB;FSTL1;KRT18;GSTP1;HSPB1;HIGD1A;YWHAZ;CD74;HNRNPK;PRDX5;HSP90B1;NPM1;TMBIM6;MIF;CCND2;VIP;GPX4;CIB1;PRDX2;PRELID1;HSPA5;PARK7;CTNNB1;SQSTM1;NUPR1;PRAP1;NAA38;PLAUR;ANXA5;PHB2;DDX3X;MCL1;ANXA4;ARHGDIA;HIGD2A;HSPA1A;HPN;HSPD1
prerank,regulation of embryonic development (GO:0045995),0.8467124648026979,1.0770217271535336,0.2815,0.7671365218398333,1.0,7/34,8.20%,CFL1;BAG6;PHLDB1;RAB14;TRIP12;CLASP2;DAG1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.8769286636659595,1.0766448636026649,0.3365,0.7682036632761604,1.0,9/77,3.93%,DCN;FN1;ERBB3;MAZ;PDGFRB;PLXNB1;PDGFRA;MYDGF;FGFR1
prerank,innate immune response (GO:0045087),0.9277731584666055,1.0766076091728716,0.2625,0.767677012482709,1.0,22/288,2.52%,B2M;RPL39;IFI27;CHGA;MFAP4;APOA4;IFITM3;CD74;HMGB1;LCN2;JCHAIN;CYBA;HLA-E;PI3;DEFA3;RARRES2;APP;TRIM28;PHB2;DDX3X;SLPI;WFDC2
prerank,negative regulation of multicellular organismal process (GO:0051241),0.9179563909654593,1.0764094047196249,0.3185,0.7678950055891891,1.0,16/213,2.68%,APOA1;RPS19;APOC3;MDK;APOA4;CALR;EFNA1;ATF4;GRN;ID1;TIMP1;ALDH1A1;LAMA4;SRSF6;APOA2;HPN
prerank,negative regulation of transferase activity (GO:0051348),0.8388671836409108,1.0759638233681363,0.28,0.7692109004821114,1.0,8/29,5.65%,PHPT1;EIF4A2;HNRNPU;ZFP36;PARK7;CDKN1C;PRDX3;ABL1
prerank,negative regulation of cell aging (GO:0090344),0.8275452803299367,1.07565815985119,0.29,0.7699040944759727,1.0,2/16,1.38%,MIF;YBX1
prerank,negative regulation of protein transport (GO:0051224),0.8386221332051914,1.0755550301786427,0.2905,0.7696639024549173,1.0,11/26,11.82%,PKDCC;APOE;SNX3;ERP29;NDFIP1;HMGCR;NDFIP2;CSK;ADTRP;RHBDF1;PPM1F
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.9085209137193478,1.0755395300603028,0.3475,0.7690533871389161,1.0,21/170,4.60%,CEACAM5;CLDN4;CEACAM1;CLDN7;CEACAM6;CD177;BSG;CDH17;CD164;ITGB1;CDH1;PLXNB2;DSG2;PTPRF;CLDN23;NPTN;PKD1;PALLD;DCHS1;OBSL1;CLDN5
prerank,DNA-dependent DNA replication (GO:0006261),0.8951700049728362,1.0755112994695266,0.3625,0.7684985876374176,1.0,19/129,4.20%,RPS27A;UBC;UBA52;UBB;PSMB1;PSME1;PSMB4;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;MCM7;PSMA1;PSMA4;HMGA1;PSMC5
prerank,positive regulation of epithelial cell migration (GO:0010634),0.879622165518323,1.0754017564356662,0.336,0.7682948967248996,1.0,24/93,5.97%,SPARC;PFN1;CALR;GRN;RAC1;RTN4;VIL1;RHOB;RAB11A;VEGFA;PDCD6;EMC10;NRP1;BCAR1;GPI;AGT;AKT1;ARF6;AAMP;NRP2;ABL1;GLIPR2;CTSH;SCARB1
prerank,regulation of cell migration (GO:0030334),0.9401379120219846,1.0753870487312887,0.192,0.7676783540583723,1.0,32/403,1.91%,COL1A1;TMSB10;ACTG1;TMSB4X;CLDN4;RACK1;FLNA;TPM1;CLDN3;MDK;CEACAM1;MYLK;CEACAM6;RHOC;CD74;SMIM22;IGFBP5;LAMB1;MIF;ITGB1;CXCL12;GRN;ACTN4;RHOA;RAC1;CD151;CIB1;CDH1;HSPA5;PLXNB2;LMNA;DPYSL3
prerank,cellular response to oxygen-containing compound (GO:1901701),0.9314435814512142,1.0753725599016601,0.2475,0.7670668912716389,1.0,35/319,3.10%,ACTB;SLC26A3;FOS;RPS3;VIM;TPM1;GSTP1;EGR1;EZR;JUN;PRDX5;HSP90B1;IGFBP5;HMGB1;AQP8;ZFP36L1;AOC1;RHOA;LAMTOR4;PDCD4;NDUFA13;CAPN2;DEFA3;ZFP36;ROMO1;GNB1;HMGB2;RAP1B;VCP;IP6K2;LAMTOR5;INSIG1;PDGFRA;MAPK3;DEFA5
prerank,positive regulation of multicellular organismal process (GO:0051240),0.9343779238164729,1.0752475418800134,0.2365,0.7669592784995379,1.0,23/341,1.93%,COL1A1;RPS19;GAPDH;GNAS;CFL1;MDK;ENO1;APOE;PLAC8;MIF;LCN2;VIP;PTN;MFAP2;FABP5;RTN4;MST1;VAMP8;AGPAT2;LRP1;SOD1;CTNNB1;G0S2
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.837717621849262,1.0747326747354005,0.291,0.768701515070419,1.0,11/27,9.03%,SRI;JUP;DSG2;TRPM4;CAV1;DSC2;ATP2A2;DSP;ANK2;AKAP9;CAMK2D
prerank,negative regulation of protein kinase activity (GO:0006469),0.8730485224657475,1.0745033221565972,0.326,0.769098059409707,1.0,22/86,5.69%,PPIA;CEACAM1;GSTP1;HSPB1;SFN;NPM1;CAMK2N1;MVP;PARK7;CDKN1C;CDKN1A;CHP1;CAV1;CDK5RAP3;THY1;RTRAF;TSC2;AKT1;ADAR;ABL1;SORL1;YWHAG
prerank,positive regulation of cellular catabolic process (GO:0031331),0.9053999842813756,1.07448087610309,0.373,0.7685245810079764,1.0,10/139,2.06%,APOA1;DCN;EZR;APOA4;PTTG1IP;HMGB1;APOE;HSP90AA1;TMEM59;APP
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.8361066901817163,1.0744286293348932,0.2866433216608304,0.7680901522857122,1.0,7/25,7.57%,AGR2;RTN4;PLAUR;AGT;AKT1;ARAP1;RBPJ
prerank,membrane organization (GO:0061024),0.9203909446837253,1.0744237302896293,0.31,0.7674423459862231,1.0,35/240,3.76%,ACTG1;ACTB;RPS27A;UBC;UBA52;UBB;APOB;HSPA8;DNM2;SLC9A3R1;SPTBN1;VAMP8;AP2M1;ARPC3;CLTB;CHP1;MTCH1;SNX3;CLTC;CLTA;LDLR;ARPC2;CTTN;ARPC5;VAPA;AP2S1;SCARB2;ARPC4;SYNGR2;SERP1;ACTR2;PDCD6IP;PACSIN2;SUN1;TFRC
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.8427685863208941,1.0743084532856335,0.295,0.7672773002722247,1.0,12/38,6.30%,CALM2;CALM1;HSP90B1;HSP90AB1;CALM3;FKBP1A;PDGFRB;CSNK2B;PPP1R1B;ITGA1;PPP6R3;PTPA
prerank,keratan sulfate biosynthetic process (GO:0018146),0.8380342536641423,1.0740596045713067,0.2805,0.7677063416643779,1.0,8/28,8.47%,LUM;OGN;ST3GAL4;B4GALT1;B3GNT7;FMOD;B3GNT3;B4GALT2
prerank,regulation of mRNA processing (GO:0050684),0.8410637031299351,1.0739731781128878,0.2845,0.7674372014855222,1.0,19/35,10.18%,HNRNPK;ZFP36L1;RBM39;SRSF3;TIA1;SF1;SON;KHDRBS1;PAPOLA;PABPN1;SRSF10;SAFB;DHX9;QKI;YTHDC1;RBM23;AHCYL1;SLTM;SUPT6H
prerank,negative regulation of macrophage activation (GO:0043031),0.828653753527287,1.0738323839420658,0.288144072036018,0.7674100262562995,1.0,2/15,2.55%,GRN;LDLR
prerank,leukotriene biosynthetic process (GO:0019370),0.8289739478909168,1.073763663798744,0.286,0.767048177687925,1.0,5/18,12.00%,MGST3;GGT6;MGST2;LTA4H;GGT1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.8307161662935961,1.0730069929942434,0.293,0.7698708183818014,1.0,7/19,9.63%,SLC25A5;ALKBH7;SPG7;HEBP2;BAD;SLC25A4;BNIP3
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.8235624272302648,1.0726854076431154,0.291,0.7706482336983155,1.0,11/19,11.65%,NOP53;C1QBP;PUM2;NPLOC4;PUM1;TRIM15;BIRC2;DDX60;ZCCHC3;UFD1;ANKRD17
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.8741546415651616,1.0724840740125035,0.338,0.7709088673505619,1.0,45/89,9.19%,HNRNPA1;PRDX6;DDX17;CIRBP;DDX5;HNRNPK;HNRNPU;RBM39;SRSF3;PTBP1;SRSF6;RBM3;RBM5;RBMX;SRSF7;SAP18;NCL;TIA1;SF1;RNPS1;SON;KHDRBS1;RBFOX2;RBM8A;TRA2B;SRSF10;SRSF9;TRA2A;PUF60;DAZAP1;PCBP4;C1QBP;RBM25;MBNL1;MAGOH;SRSF4;THRAP3;QKI;WTAP;YTHDC1;RBM23;HNRNPL;CELF1;FXR1;SFSWAP
prerank,response to metal ion (GO:0010038),0.8623378038124478,1.0723116078055788,0.3185,0.7710038001555385,1.0,19/71,6.06%,MT2A;NDRG1;CALM2;CALM1;ATP5F1D;CALM3;MT1X;PPP1CA;CAV1;ANXA11;PDCD6;SEC31A;D2HGDH;LOXL2;PPP2CB;ITPR3;NEDD4L;PPP2CA;PAM
prerank,response to interferon-alpha (GO:0035455),0.8256124347925363,1.0719447034783136,0.299,0.7720245266325473,1.0,5/17,7.20%,IFITM3;IFITM2;GAS6;ADAR;TPR
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.8927637981368883,1.0718657455614957,0.3675,0.7716862912077629,1.0,11/143,2.45%,TMSB4X;FLNA;COMMD6;ID2;ID3;KLF4;ID1;NUPR1;PHB2;CHP1;ANXA4
prerank,blood vessel endothelial cell migration (GO:0043534),0.8289294634582967,1.0714317857373719,0.2945,0.7729928441451289,1.0,14/23,12.59%,MYH9;NR4A1;ID1;VEGFA;NRP1;AKT1;CDH5;EPHB4;GREM1;ADTRP;SRF;EMP2;ROBO1;EFNB2
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.826307922369269,1.07125554089013,0.2995,0.7731361621908786,1.0,6/18,8.83%,EFNA1;CLU;PICALM;IFNGR1;ROCK2;RELA
prerank,regulation of monocyte differentiation (GO:0045655),0.828527027978649,1.0712133241984958,0.311,0.77264593953995,1.0,6/16,10.24%,CD74;ZFP36L1;HLA-DRB1;CDK6;FOXP1;ACIN1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.8276972661604521,1.0711370366644943,0.3055,0.7723366075093211,1.0,10/17,11.43%,SRP14;SEC61G;SEC61A1;SPCS1;SPCS2;SPCS3;RAB10;ZFAND2B;ZFAND2A;MAN1A1
prerank,regulation of B cell activation (GO:0050864),0.8386653224805529,1.0707642675780265,0.295,0.7734008163725729,1.0,2/28,1.24%,ZFP36L2;ZFP36L1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.8302864683666896,1.0701877645979818,0.3075,0.7753396584776125,1.0,11/18,8.21%,NOP10;CCT7;CCT3;NHP2;CCT4;TCP1;CCT5;CCT6A;CCT8;CCT2;RUVBL2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.8336804061046683,1.0701157491101132,0.296,0.7750114440908312,1.0,11/28,9.17%,CIB1;PTBP1;CHP1;ATP2B4;RCAN1;FHL2;CHP2;CAMTA1;PRNP;SPPL3;DYRK2
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.8377351738627773,1.0699694775102875,0.303,0.7750144558207245,1.0,9/34,5.94%,SFN;YWHAZ;CHCHD10;YWHAQ;YWHAE;YWHAB;YWHAH;YWHAG;BAD
prerank,negative regulation of mitochondrion organization (GO:0010823),0.8440430371940042,1.0698954390084037,0.2935,0.7746792982738753,1.0,11/33,6.97%,SLC25A5;ACAA2;PRELID1;GHITM;CLU;HSPA1A;TFRC;AKT1;VAT1;PINK1;HUWE1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.8868090837396478,1.0697440428465645,0.3555,0.7746657204277525,1.0,23/116,4.93%,TMSB4X;ACTN4;TNFRSF14;PSMB1;ILK;PSME1;EIF5A;PSMB4;TXNDC17;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5;TNFRSF1A;PSMC3;PSMD2;PSMA2
prerank,glucan catabolic process (GO:0009251),0.820474249772805,1.0696747674075582,0.296,0.7743042133281056,1.0,2/15,2.23%,CALM1;PYGB
prerank,regulation of smooth muscle contraction (GO:0006940),0.8293125265857829,1.0694395983677523,0.3085,0.7747038468908822,1.0,9/20,12.98%,CNN1;CTTN;CAV1;F2R;CHRNA3;SRF;DAPK3;ATP2B1;PLCE1
prerank,lipid catabolic process (GO:0016042),0.8315751862540937,1.0694074815623922,0.2895,0.7741638616751106,1.0,6/27,11.30%,APOA4;CEL;SIRT2;CYP4F12;LIPH;CES1
prerank,regulation of epithelial cell migration (GO:0010632),0.8516173965266131,1.069341545953813,0.298,0.7738019988419932,1.0,20/51,9.58%,CEACAM1;PFN1;PTN;RTN4;VIL1;EVL;RAB11A;GLUL;MACF1;PFN2;GLIPR2;CTSH;BMPR2;HDAC6;PTK2;CLASP2;HIF1A;DAB2IP;RAB25;SRC
prerank,positive regulation of interleukin-1 production (GO:0032732),0.8583678123692731,1.0692310491993504,0.3195,0.7736561343870553,1.0,11/62,6.62%,EGR1;HSPB1;HMGB1;APP;TMED10;S100A13;GSDMD;INAVA;LGALS9;NLRP1;STMP1
prerank,positive regulation of macroautophagy (GO:0016239),0.8508841342172795,1.0691018972010746,0.314,0.7735828246995295,1.0,19/50,9.63%,DCN;SLC25A5;VDAC1;TSC2;LARP1;SUPT5H;PINK1;BNIP3L;SH3GLB1;WAC;OPTN;GNAI3;PIP4K2B;CALCOCO2;GPSM1;SLC25A4;SESN3;PAFAH1B2;BNIP3
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.8473741702695263,1.0690595599228987,0.309,0.773117474294708,1.0,18/48,10.05%,PPIA;GSTP1;MAP2K2;MAPK3;STK25;INAVA;ARL6IP5;LGALS9;NBR1;MAPK1;MAPK8IP3;IGBP1;DAB2IP;F2RL1;IGF1R;GREM1;MAP4K4;COPS5
prerank,organic anion transport (GO:0015711),0.8748518052440902,1.0690191283390709,0.3555,0.7726357386356886,1.0,7/99,2.28%,HBA1;CA4;HBB;CA2;SLC44A4;SLC9A3R1;CA1
prerank,gland development (GO:0048732),0.8598266134266055,1.068940550325383,0.3315,0.7723385577118453,1.0,15/71,6.13%,MDK;EZR;SLC9A3R1;TCF21;SOD1;LSR;CAV1;CDK5RAP3;CEBPA;HES1;PRKCSH;ANXA1;XBP1;MSN;HAND2
prerank,regulation of nervous system process (GO:0031644),0.8228654179575697,1.068905038512389,0.2965,0.7718265790465885,1.0,4/19,7.95%,APP;AKAP9;DLGAP4;ROCK2
prerank,positive regulation of gene expression (GO:0010628),0.940111193879324,1.068836639529771,0.184,0.7714804635373848,1.0,47/475,2.47%,ACTG1;ACTG2;ACTB;RPL11;RPS4X;RPL5;GAPDH;ACTA2;RPS3;VIM;RPS7;RPL26;CLDN3;RPL23;EEF2;FN1;GSN;AGR2;EGR1;CIRBP;EZR;EMILIN1;CD74;DDX5;NPM1;ATF4;MIF;POLR2L;ID2;KLF4;RPS27L;CAMK2N1;AGPAT2;PLXNB2;PARK7;SOD1;SF3B1;HNRNPD;APP;EIF3E;RBM3;CLU;DDX3X;EIF6;ERBB2;SOX4;MAP2K2
prerank,axonogenesis (GO:0007409),0.912633085036627,1.0687184101056009,0.3265,0.7713455984769835,1.0,20/238,3.49%,S100A6;ACTB;EZR;BSG;EFNA1;HSP90AB1;HSP90AA1;CXCL12;SPTBN1;PDLIM7;APP;SPTAN1;MAP1B;EVL;SEMA3B;NPTN;MAPK3;LAMA5;NCAM1;NOTCH3
prerank,glycerophospholipid catabolic process (GO:0046475),0.8370928359160178,1.0686601148088566,0.301,0.7709649801444459,1.0,1/27,0.63%,PRDX6
prerank,positive regulation of monooxygenase activity (GO:0032770),0.8375702989413373,1.068529620934565,0.2975,0.7709132812852597,1.0,8/28,8.39%,APOE;PARK7;AKT1;SCARB1;VDR;NPR3;POR;HIF1A
prerank,response to amino acid (GO:0043200),0.8282822386109109,1.0684545027206542,0.284,0.7706011597237069,1.0,10/30,9.13%,TMBIM6;LAMTOR4;CAPN2;LAMTOR5;LAMTOR1;XBP1;IPO5;LAMTOR2;NSMF;RRAGA
prerank,regulation of platelet activation (GO:0010543),0.8315080159170674,1.068447351258352,0.3075,0.7699750914053717,1.0,2/22,3.03%,APOE;PDGFRA
prerank,mitotic spindle organization (GO:0007052),0.8984348088182439,1.068419726704438,0.3705,0.7694421805908099,1.0,15/157,3.74%,RPS27;FLNA;STMN1;DYNLL1;MISP;RHOA;RAN;VCP;RAB11A;DYNC1H1;MAP4;DCTN2;PPP1CC;XPO1;ZNF207
prerank,lysosome localization (GO:0032418),0.8341470374265322,1.0684029541404836,0.293,0.7688505418918348,1.0,10/37,8.08%,CHGA;MYH9;BLOC1S1;LAMTOR1;S100A13;RAB34;KIF5B;SPAG9;KXD1;HDAC6
prerank,regulation of protein ubiquitination (GO:0031396),0.8807505524363135,1.0683231344333382,0.374,0.7685655006935221,1.0,26/107,5.16%,RPS3;UBB;HSP90AB1;PTTG1IP;HSP90AA1;PARK7;VPS28;SQSTM1;CHP1;OGT;FKBP1A;SOX4;HSPA1A;CAV1;IVNS1ABP;CDK5RAP3;CENPX;FOXF2;NDFIP1;DNAJA1;INAVA;WASHC1;UBE2L3;UBXN1;STUB1;AKT1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.8387424898079698,1.068291367725565,0.292,0.7680589641557043,1.0,4/36,3.61%,CD74;ZFP36L1;ID2;HLA-DRB1
prerank,response to unfolded protein (GO:0006986),0.8472401208954756,1.0680520912944733,0.308,0.768468923627242,1.0,20/49,9.13%,HSPB1;SERPINH1;HSP90AB1;HSPA8;HSP90AA1;TMBIM6;HSPA5;HSPE1;HSPA1A;HSPD1;DNAJA1;HERPUD1;DNAJB1;HSPA9;STT3B;OPTN;DNAJC4;HSPA1B;HSF1;DAB2IP
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.8236836841709894,1.0679638217223681,0.2865,0.7682061595582087,1.0,1/25,0.97%,CALM1
prerank,miRNA metabolic process (GO:0010586),0.829208079590532,1.0679176816748996,0.308,0.7677644189455771,1.0,3/20,5.39%,DDX17;RAN;SND1
prerank,negative regulation of cell population proliferation (GO:0008285),0.9321835766288296,1.0675078249621637,0.2485,0.7689453381509426,1.0,31/372,2.69%,FTH1;B2M;CLDN3;GSTP1;FBLN1;IGFBP7;NPM1;IGFBP5;S100A11;OGN;CD164;VIP;SLC9A3R1;CIB1;KLF4;CAMK2N1;MAGED1;CTNNB1;LMNA;CDKN1C;IGFBP3;APP;CDKN1A;NUPR1;RBM5;SST;COL18A1;SOX4;HSPA1A;HPN;TGFB1I1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.9330837395798218,1.0674097081040652,0.24,0.7687319583673878,1.0,27/380,2.29%,ACTG1;ACTG2;RPL11;RPL5;ACTA2;RPS3;RPS7;CLDN3;RPL23;FN1;CD63;GSN;AGR2;EGR1;EZR;EMILIN1;ANXA2;CD74;ATF4;ID2;KLF4;CAMK2N1;PARK7;APP;TRIM28;CLU;DDX3X
prerank,icosanoid biosynthetic process (GO:0046456),0.8261995605724191,1.06720377686248,0.3095,0.7690579560546106,1.0,3/15,10.34%,MGST3;MGST2;LTA4H
prerank,regulation of macrophage activation (GO:0043030),0.8345352191607963,1.0671716019127273,0.299,0.7685404752691194,1.0,7/29,9.46%,CD74;MIF;HSPD1;CEBPA;PJA2;NR1H3;PLA2G10
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.8333553738312106,1.0669608045735355,0.295,0.7688559466984036,1.0,14/30,10.93%,KRT18;AMN;SPTBN1;RAB34;MACF1;GOLPH3;RAB10;OPTN;SEC16A;ARFRP1;GGA2;GGA1;VAMP2;PREPL
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.8255238936062803,1.0666066525794218,0.3106553276638319,0.7698136179742143,1.0,9/15,16.79%,MAPK3;DDR1;ABL1;IGF1R;DYRK1A;PTK2B;AATK;EGFR;KDR
prerank,cytoskeleton organization (GO:0007010),0.8834307839813275,1.0664619493817897,0.382,0.7697863584891746,1.0,19/119,4.58%,DES;CFL1;TPM1;MDK;RHOC;APOE;RHOA;RAC1;CAPZB;RHOB;DST;THY1;DPYSL2;MICAL1;PACSIN2;PALLD;CNN2;MAST2;OBSL1
prerank,positive regulation of chemokine production (GO:0032722),0.8498763724983555,1.0663731900611682,0.306,0.7695379593804388,1.0,5/53,2.29%,EGR1;CD74;HMGB1;APP;DDX3X
prerank,regulation of interleukin-13 production (GO:0032656),0.823252841205758,1.066331263621285,0.31,0.7690849756882269,1.0,3/16,5.85%,HLA-E;PRKCZ;LGALS9
prerank,regulation of epidermal cell differentiation (GO:0045604),0.8237620038284065,1.0659254540386138,0.3035,0.77025036920015,1.0,5/25,5.66%,SFN;ZFP36L1;ZFP36;CTSL;ERRFI1
prerank,transferrin transport (GO:0033572),0.8385185910018839,1.065353179347528,0.307,0.7721891505364874,1.0,14/36,7.03%,DNM2;ATP6V0B;CLTC;ATP6V1G1;ATP6V0D1;ATP6V0E1;TFRC;ATP6V1F;ATP6AP1;ARHGAP1;TCIRG1;ATP6V1E1;RAB11B;ATP6V0A1
prerank,regulation of multicellular organism growth (GO:0040014),0.8204185828921806,1.0653309277105973,0.30815407703851927,0.7716397659581314,1.0,4/18,6.27%,SOD1;APP;PPIB;PTCH1
prerank,artery morphogenesis (GO:0048844),0.8324614110159572,1.0653269876832427,0.2995,0.7710111723378122,1.0,18/30,13.68%,LRP1;PDGFRB;VEGFA;HES1;NRP1;FOXF1;HPGD;JAG1;NOTCH1;ENG;BMPR2;TBX2;BMP4;TGFBR1;BMPR1A;ADAMTS9;PKD2;NF1
prerank,regulation of receptor recycling (GO:0001919),0.8197059777799114,1.0652726272253585,0.311,0.7706091550548527,1.0,6/17,8.65%,ANXA2;LAMTOR1;ECE1;OPTN;VAMP3;SCRIB
prerank,cellular polysaccharide catabolic process (GO:0044247),0.8170386353792418,1.0651288782447463,0.3045,0.7705663335098818,1.0,2/16,2.23%,CALM1;PYGB
prerank,positive regulation of transferase activity (GO:0051347),0.8944582391913066,1.0649635245602098,0.4015,0.7706767484965543,1.0,28/147,4.84%,RPS2;HNRNPA2B1;CD74;HSP90AB1;HSP90AA1;FGFR3;DBI;KLF4;PARM1;CTNNB1;HNRNPD;ERBB2;PTGES3;ERBB3;PDGFRB;PDGFRA;MAPK3;XRCC5;HLA-DRB1;DDR1;FGFR1;PABPN1;UBE2I;SERINC1;CCT4;TCP1;UBE2L3;PKIB
prerank,positive regulation of telomerase activity (GO:0051973),0.8367111123642215,1.0649152560817008,0.3025,0.7702601312653273,1.0,13/34,7.51%,HSP90AB1;HSP90AA1;KLF4;PARM1;CTNNB1;PTGES3;MAPK3;XRCC5;CCT4;TCP1;PKIB;CCT2;MAPK1
prerank,regulation of cell differentiation (GO:0045595),0.8930084999881456,1.0648991766391576,0.391,0.7696975687920944,1.0,20/155,3.93%,LGALS3;MDK;LTBP4;DDX17;CD24;NREP;DDX5;HSP90AB1;ZFP36L1;ATF4;ID2;KLF4;PTBP1;PPP2R1A;CDK5RAP3;CEBPD;YWHAH;ANP32B;OCIAD1;FGFR1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.8734332606093214,1.0646220712882548,0.3575,0.7702897345139944,1.0,40/101,8.09%,HLA-A;CTSD;DYNLL1;CD74;ARF1;DNM2;HLA-E;CANX;AP2M1;CLTC;CLTA;HLA-DRA;CTSS;CAPZB;AP2S1;DYNC1H1;LGMN;DCTN2;SEC31A;HLA-DRB1;KLC1;RAB7A;CAPZA1;KIF22;DYNC1LI2;SEC13;CTSL;AP2A2;DCTN3;DYNLL2;DYNC1I2;DCTN1;ACTR1A;AP2B1;SEC24C;AP1B1;ACTR1B;ACTR10;CAPZA2;HLA-DPB1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.8200761684776905,1.064523938690847,0.3065,0.7701009612030503,1.0,5/20,5.16%,HSP90AB1;CCND2;PKD1;CCND1;AKT1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.8298800304031558,1.0644666428511884,0.305,0.7696882977667763,1.0,16/24,14.28%,RAC1;CDC42;ARPC2;FSCN1;ACTR2;BRK1;WASF2;NCKAP1;CYFIP1;ACTR3;OCLN;ABI2;AUTS2;PIK3R1;PLCE1;TWF2
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.8224777704379039,1.0644340599406517,0.338,0.7692001226130245,1.0,4/15,5.16%,PRELID1;GHITM;CLU;AKT1
prerank,negative regulation of apoptotic process (GO:0043066),0.9381299413096666,1.0644173168692357,0.206,0.7686299676606752,1.0,63/478,2.77%,RPL10;FABP1;TPT1;RPS27A;RPS3A;CEACAM5;PTMA;FLNA;UBC;CFL1;MDK;UBA52;UBB;FSTL1;KRT18;GSTP1;HSPB1;CEACAM6;HIGD1A;SFN;YWHAZ;BEX3;CD74;HNRNPK;PRDX5;HSP90B1;NPM1;APOE;TMBIM6;MIF;ITGB1;GRN;CCND2;VIP;CIB1;SFPQ;KLF4;PRDX2;PRELID1;HSPA5;PARK7;SOD1;CTNNB1;SQSTM1;YWHAE;NUPR1;PRAP1;NAA38;PLAUR;SET;ANXA5;PHB2;DDX3X;MCL1;ANXA4;ARHGDIA;HIGD2A;HSPA1A;HPN;ERBB3;HSPD1;CAV1;MAZ
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.8205293602668096,1.0643052659009486,0.3306653326663332,0.768484357469461,1.0,12/16,15.32%,HSPA5;VAPA;BCAP31;GABARAPL2;ANK2;GBF1;SEC16A;PPP1R15A;DDRGK1;UBAC2;BCAP29;MIA3
prerank,actin filament-based transport (GO:0099515),0.8257498200222523,1.0642783027404448,0.3181590795397699,0.7679639262529632,1.0,12/21,11.52%,ACTN4;MYO1A;MYO1D;MYO1C;MYO7B;SUN2;WASL;MYO1B;MYO6;FNBP1L;MYO5B;SYNE2
prerank,inorganic anion transmembrane transport (GO:0098661),0.8550255705228667,1.0640409244794973,0.335,0.7684013663679043,1.0,7/65,6.12%,SLC26A2;SLC25A3;ANO9;SLC37A4;SLC12A7;SLC12A2;SLC20A1
prerank,cellular component assembly (GO:0022607),0.9146161728810346,1.0636461605579683,0.3405,0.7695081756762215,1.0,36/258,3.71%,ACTG1;ACTB;FLNA;GSN;ELOB;EZR;YWHAZ;CALD1;CD74;RHOA;JCHAIN;RAC1;CHCHD10;SLC9A3R1;VMP1;SPTBN1;RTN4;QSOX1;PLS1;DPYSL3;PPP2R1A;CDC42;TAPBP;VIL1;ILK;ST13;ADD1;LAMC1;FLNC;FSCN1;SPG7;MYO7B;BAG6;MICAL1;STK25;HES1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.8190049173764653,1.0631880373872487,0.3075,0.770902758502639,1.0,6/20,8.05%,KLF4;APP;HPN;KLF2;MTPN;GBA
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.8468824112085525,1.0630625757134433,0.318,0.770815481008446,1.0,13/52,9.03%,CALM2;CALM1;SRI;CALM3;FKBP1A;THY1;GSTO1;SELENON;APLNR;ANK2;F2R;PRKACA;CAMK2D
prerank,regulation of receptor internalization (GO:0002090),0.8377583602436706,1.0627608017460741,0.31,0.7715188008694847,1.0,6/36,5.36%,CD63;ARF1;VEGFA;LRPAP1;FLOT1;SDCBP
prerank,receptor metabolic process (GO:0043112),0.8520735265693457,1.062545907605982,0.331,0.7718576744917678,1.0,20/58,7.35%,CD81;CD9;ITGB1;DNM2;LRP1;AP2M1;CLTC;PLEKHJ1;CAV1;LGMN;TFRC;GRK2;RAMP2;ADM;RAMP1;PICALM;RAB11B;GRB2;SH3GLB1;SNX1
prerank,cellular response to cytokine stimulus (GO:0071345),0.9361364156087592,1.0623151071744512,0.2305,0.7722463678203755,1.0,38/478,2.33%,COL1A2;RPL13A;RPS27A;GAPDH;FOS;RPS3;VIM;UBC;UBA52;FN1;UBB;MUC1;MT2A;EGR1;YWHAZ;CCL21;HSP90B1;ZFP36L2;MMP2;DUSP1;HSPA8;JUNB;HSP90AA1;ZFP36L1;ITGB1;CXCL12;LCN2;RHOA;NDUFA13;HNRNPU;CIB1;ZFP36;DPYSL3;TIMP1;CDKN1A;MT1X;MAOA;MCL1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.8579872650121225,1.062169198325831,0.343,0.7722585329485343,1.0,26/68,7.30%,FLNA;JUP;CDH1;PARK7;RAN;TRIM28;LAMTOR5;CDK5RAP3;TFRC;CCT7;CCT3;CCT4;TCP1;CCT5;CCT6A;AKT1;CCT8;CHP2;IPO5;PSEN1;FERMT2;YAP1;HYAL2;CCT2;TPR;DMAP1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.8315036323660681,1.062121562240119,0.32,0.7718316126085462,1.0,9/24,12.35%,HINT1;NUDT4;PDE9A;XDH;NUDT3;PNP;NT5C2;ACAT1;NUDT16
prerank,positive regulation of acute inflammatory response (GO:0002675),0.8217503491888366,1.0619785801224941,0.32,0.7718321536890214,1.0,2/15,6.57%,PARK7;IL6ST
prerank,negative regulation of T cell proliferation (GO:0042130),0.8280461924310458,1.0619140605652044,0.303,0.7714968374288269,1.0,9/34,9.84%,TNFRSF14;HLA-DRB1;PRKAR1A;SDC4;LGALS9;PRNP;SCRIB;CEBPB;DLG5
prerank,response to alcohol (GO:0097305),0.8263842154732702,1.0616710139899899,0.306,0.7719697681878191,1.0,10/30,13.60%,CCL21;SOD1;SDF4;SLIT3;TGFBR2;PMVK;SMAD2;TGFBR1;GOT2;TGFBR3
prerank,regulation of blood coagulation (GO:0030193),0.8266569851514308,1.0616170488177632,0.305,0.7715683225482514,1.0,11/27,11.85%,APOE;ST3GAL4;CAV1;CD34;TFPI;F2R;SERPINE2;F2RL1;ADTRP;THBS1;EPHB2
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.8263637297161622,1.061395750173276,0.306,0.7719078018984271,1.0,10/28,10.20%,STMN1;STMN2;MAP1B;GBA2;ABL1;ARL2;CLASP2;STMN3;MAPRE1;CAMSAP3
prerank,regulation of immunoglobulin production (GO:0002637),0.8232716961731127,1.0613151791984856,0.3015,0.771603472040706,1.0,9/28,11.85%,HLA-E;PHB2;PHB;GPI;XBP1;VAMP3;STX4;SUPT6H;EPHB2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.8564225194635746,1.0612959509711044,0.3365,0.7710647684711813,1.0,27/74,10.47%,RACK1;CD24;CD74;HSP90AB1;AGPAT2;CDC37;IFNGR2;GAS6;TNFRSF1A;SPPL2B;RBCK1;SIGIRR;SUMO1;SPPL2A;IFNGR1;SOCS3;TAX1BP1;CFLAR;JAK1;AGPAT1;SHARPIN;MADD;BIRC2;PYCARD;TRIM44;LIFR;IRAK1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.8268935340528679,1.061184505663651,0.3185,0.770956990829924,1.0,17/26,14.41%,HSPA8;HSPA5;HSPE1;ST13;PTGES3;HSPA1A;GAK;DNAJB1;HSPA9;ERO1A;BAG1;HSPA1B;SDF2L1;HSPA2;DNAJC7;SDF2;DNAJB12
prerank,cobalamin metabolic process (GO:0009235),0.8164685960320296,1.0608012649877854,0.3071535767883942,0.7719739514190792,1.0,6/19,11.67%,AMN;PRSS3;ABCD4;CD320;MMADHC;LMBRD1
prerank,keratan sulfate metabolic process (GO:0042339),0.8304132500452441,1.060769390882355,0.3025,0.771478792190863,1.0,12/33,9.54%,LUM;OGN;ST3GAL4;GNS;B4GALT1;HEXB;HEXA;B3GNT7;FMOD;B3GNT3;B4GALT2;GLB1
prerank,regulation of chemokine production (GO:0032642),0.8374124877762728,1.0607107151209523,0.313,0.7710935282073978,1.0,10/42,9.98%,EGR1;CD74;APP;SIGIRR;LGALS9;SNAI2;HIF1A;F2RL1;PYCARD;FOXP1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.8209722582053544,1.060664866593168,0.324,0.7706607230566234,1.0,13/22,15.56%,DYNLL1;CDKN1C;CDKN1A;CDA;ANKLE2;BMP4;CDKN1B;TESK1;CDKN2B;TP53;PRKRIP1;ROCK1;CDKN2D
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.8211458195304914,1.0606512015911456,0.3165,0.770088717266411,1.0,13/21,15.50%,CTNNB1;PPP1CA;CAV1;CSNK1A1;FZD1;DVL3;FZD5;DVL1;DVL2;GSK3B;AXIN1;LRP6;FZD2
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.8287710918043922,1.0605959267522194,0.309,0.7697034920455433,1.0,10/34,8.01%,HMGB1;APOE;RHOA;JUP;KLF4;CSNK2B;ATP2B4;NOTCH1;HDAC5;ACVRL1
prerank,tetrapyrrole metabolic process (GO:0033013),0.8160118437180199,1.0602408895899524,0.3085,0.7706745568321612,1.0,6/20,11.67%,AMN;PRSS3;ABCD4;CD320;MMADHC;LMBRD1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.8211039610061184,1.0600739273133801,0.304,0.7707838610786554,1.0,11/23,13.36%,NPM1;RAB11A;CCND1;CDK4;RCC2;VPS4B;PHOX2B;CDC25B;CDK1;BRD4;CCNB1
prerank,protein targeting to lysosome (GO:0006622),0.8212465154533458,1.059761667318308,0.3265,0.771543085406836,1.0,16/20,15.55%,HSPA8;CLU;SCARB2;RAB7A;SORL1;NCOA4;LAPTM5;HGS;VPS4A;LAMP2;M6PR;ZFYVE16;GCC2;GGA3;GNPTAB;AP3M1
prerank,cellular response to unfolded protein (GO:0034620),0.830143313847724,1.0594338683260205,0.331,0.7723888219375608,1.0,11/27,10.02%,HSPA8;TMBIM6;HSPA5;HSPA1A;HSPD1;HSPA9;OPTN;HSPA1B;HSF1;DAB2IP;BAX
prerank,positive regulation of locomotion (GO:0040017),0.8284774861511333,1.0592650961460266,0.316,0.7724915963682325,1.0,13/31,11.82%,CCL21;PHPT1;RARRES2;PDGFRB;CAVIN1;AKT2;DUOX2;STX3;F2RL1;STX4;CFAP20;THBS1;PPM1F
prerank,regulation of type I interferon production (GO:0032479),0.8627258628703326,1.05923412317421,0.3595,0.7720069309035682,1.0,26/87,9.56%,GAPDH;PCBP2;POLR2L;CTNNB1;XRCC6;XRCC5;POLR2H;POLR2E;POLR2F;DHX9;PIN1;STAT6;LRRFIP1;G3BP1;NPLOC4;TAX1BP1;CREBBP;PQBP1;POLR2K;RELA;IRF3;DTX4;PRKDC;DDX41;TRIM15;UBA7
prerank,regulation of protein kinase A signaling (GO:0010738),0.8193444157743494,1.0591622301556085,0.317,0.7717033862342966,1.0,9/20,15.96%,MIF;AKAP12;PRKAR1A;PJA2;TCIM;PRKAR2B;AKAP7;PRKAR1B;PRKAR2A
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.8954793510060166,1.0590804825809337,0.398,0.7714355613978647,1.0,43/186,4.96%,RPS27A;TUBA1A;UBC;TUBB;UBA52;UBB;DYNLL1;TUBB4B;ZFP36L2;HSP90AA1;ZFP36L1;SKP1;ID2;PPP2R1A;YWHAE;PSMB1;PSME1;PSMB4;ANAPC11;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;DYNC1H1;PSMB7;DCTN2;PSMB6;PKD1;UBE2S;PSMA1;PSMA4;ANAPC16;PSMC5;CSNK1D;PSMC3;ANAPC5;PAFAH1B1;PSMD2;CSNK1E;DDB1;PSMA2;SSNA1
prerank,DNA conformation change (GO:0071103),0.8168236756365619,1.0588811347470257,0.3245,0.7716654115312483,1.0,6/18,5.89%,HMGB1;HMGB2;TOP2A;TOP2B;ABL1;NAA10
prerank,positive regulation of defense response (GO:0031349),0.862550674227073,1.0587534358182515,0.3635,0.7716143313751643,1.0,24/95,9.12%,MDK;PLA2G2A;GRN;PDCD4;CYBA;APP;DDT;CEBPA;TNFRSF1A;TNIP1;AGT;RIOK3;DHX9;NFKBIA;HYAL2;S100A8;MGST2;OPTN;MAPK13;CD47;PLSCR1;NFKBIZ;S100A9;NINJ1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.8616192070101739,1.0587063211274919,0.362,0.7712046386712262,1.0,22/83,7.99%,TUBA1A;TUBB;DYNLL1;TUBB4B;NPM1;HSP90AA1;PPP2R1A;YWHAE;DYNC1H1;DCTN2;CSNK1D;PAFAH1B1;CSNK1E;SSNA1;DCTN3;YWHAG;DYNC1I2;DCTN1;AKAP9;ACTR1A;PCM1;SFI1
prerank,cellular response to acid chemical (GO:0071229),0.8200246218658818,1.058693602475884,0.3065,0.7706373928342335,1.0,11/27,9.13%,LAMTOR4;CAPN2;LAMTOR5;KLF2;VEGFA;LAMTOR1;XBP1;IPO5;LAMTOR2;NSMF;RRAGA
prerank,aortic valve morphogenesis (GO:0003180),0.8308893240384067,1.0583211288510321,0.3175,0.7716515323597778,1.0,8/32,7.95%,EMILIN1;EFNA1;ELN;JAG1;NOTCH1;SLIT3;SNAI2;ROCK2
prerank,regulation of mitotic spindle assembly (GO:1901673),0.8176993054815761,1.0580588525338954,0.317,0.7721885449122705,1.0,13/19,12.41%,HNRNPU;HSPA1A;PDCD6IP;CHMP2A;CHMP1A;CHMP5;CHMP3;TPR;VPS4B;CHMP1B;HSPA1B;CHMP4B;CHMP2B
prerank,eye development (GO:0001654),0.8440381142676642,1.058033523618864,0.318,0.7716597251003849,1.0,7/58,4.03%,COL5A1;COL5A2;FBN1;SLC39A5;FBN2;MEIS1;PBX1
prerank,response to tumor necrosis factor (GO:0034612),0.8706847856100672,1.0580019746849685,0.3835,0.771176815549096,1.0,7/109,2.74%,RPS3;CCL21;ZFP36L2;ZFP36L1;CIB1;ZFP36;ASAH1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.8210834684701911,1.0578270832622274,0.324,0.7713302231095039,1.0,4/20,8.63%,HLA-E;LAMP1;NECTIN2;HLA-F
prerank,regulation of T cell chemotaxis (GO:0010819),0.8120548104436038,1.057798151879897,0.3325,0.7708346982707293,1.0,1/15,0.98%,CCL21
prerank,acidic amino acid transport (GO:0015800),0.8163626841664653,1.057732271912426,0.33,0.7705025123139031,1.0,4/18,8.30%,SLC9A3R1;GIPC1;ARL6IP5;GJA1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.8236134089060643,1.0574929245396831,0.3045,0.7709560533675015,1.0,17/32,14.09%,STMN1;CIB1;STMN2;TBCD;CDH5;ARHGEF2;CLASP2;MAPRE1;HDGFL3;CAMSAP3;DYRK1A;TAOK1;FKBP4;TPX2;CLIP3;CLASP1;FGF13
prerank,response to ketone (GO:1901654),0.8234602690836252,1.0574862196821433,0.311,0.7703646514070344,1.0,10/28,13.60%,CCL21;CAV1;SLIT3;YAP1;WBP2;NR1H3;THBS1;ABHD2;UBE3A;TGFBR3
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.8205175906380203,1.0573572772743816,0.3135,0.7703155050576678,1.0,6/22,7.29%,APOE;TIMP2;TIMP1;TIMP3;NRDC;FURIN
prerank,regulation of interferon-gamma production (GO:0032649),0.8640557149234939,1.0572852745500194,0.3675,0.7700008008370162,1.0,19/85,9.87%,HLA-A;HMGB1;HSPD1;HLA-DRB1;GAS6;LGALS9;C1QBP;LAPTM5;CEBPG;PRNP;HLA-DPB1;CD47;SCRIB;CD276;TRIM27;F2RL1;FZD5;PYCARD;HLA-DPA1
prerank,nucleosome assembly (GO:0006334),0.8211005099703128,1.0570891396776976,0.311,0.7702142503811809,1.0,12/30,9.49%,NPM1;NAP1L1;HMGB2;NASP;ANP32B;BRD2;NAP1L4;RBBP4;SMARCA5;CABIN1;NAA60;ATRX
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.8179838785487084,1.0564064233344594,0.319,0.7726548989027102,1.0,11/21,13.25%,ZFP36L1;CIB1;ZFP36;PRMT1;MEIS1;HSPA9;CDK6;PTK2B;WDR61;MEIS2;HOXA9
prerank,nuclear transport (GO:0051169),0.8130346128904177,1.0563891707732553,0.327,0.7721151871180377,1.0,10/16,14.73%,NPM1;BANF1;XPO1;HMGA1;ANP32A;PSIP1;NUTF2;RBM15B;AAAS;NUP98
prerank,regulation of vacuole organization (GO:0044088),0.8143988421849875,1.056281961581034,0.313,0.771967936763106,1.0,5/20,6.66%,ANXA2;ENO1;SCARB2;RAB1B;LAPTM4B
prerank,regulation of centrosome cycle (GO:0046605),0.820792557778386,1.0560810093097865,0.3245,0.772200255136264,1.0,9/22,7.93%,NPM1;FBXW5;PDCD6IP;CHMP2A;CHMP1A;CHMP5;CHMP3;VPS4B;CHMP1B
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.8204596381953101,1.0559313117180174,0.3195,0.772251048462094,1.0,4/23,8.63%,HLA-E;LAMP1;NECTIN2;HLA-F
prerank,axon extension (GO:0048675),0.816690660440724,1.0558736061722391,0.3175,0.77188006591224,1.0,14/23,12.47%,HSP90AB1;HSP90AA1;MAP1B;NRP1;NRP2;SLIT3;CYFIP1;SEMA5A;USP9X;PPP3CB;ULK1;SEMA3A;AUTS2;ALCAM
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.8279835422723161,1.0554090434133587,0.3215,0.7732837562002678,1.0,16/32,11.53%,DDX5;TCF21;PARK7;PHB;HDAC1;SFRP1;NCOR2;PRMT2;DAB2;SMARCA4;NCOR1;KDM1A;HDAC6;FOXP1;PKN1;SAFB2
prerank,regulation of cytoplasmic translation (GO:2000765),0.8153312762105712,1.0552948052471933,0.3375,0.7731850169291008,1.0,6/15,13.58%,PKM;CNBP;DHX9;YBX3;FMR1;UNK
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.8451337217893862,1.055063488272165,0.331,0.7735896751950642,1.0,14/62,6.29%,CTSD;HMGB1;NDUFA13;CYCS;DDX3X;FIS1;PERP;BCAP31;PDCD6;LGMN;PDCD5;ARL6IP5;BAD;TNFSF10
prerank,neural crest cell migration (GO:0001755),0.8248637497982647,1.054950018368454,0.3115,0.7734583317327001,1.0,7/37,7.17%,FN1;SEMA3B;ANXA6;NRP1;SEMA4G;SEMA5A;SEMA3C
prerank,regulation of protein autophosphorylation (GO:0031952),0.8271320129519096,1.0548398416232179,0.3225,0.7733327440593364,1.0,7/37,3.39%,CALM2;CALM1;MVP;CALM3;CHP1;DDX3X;VEGFA
prerank,regulation of cellular localization (GO:0060341),0.8400886770535048,1.0548370512476561,0.33,0.7727274833326134,1.0,16/48,9.66%,GSN;HSP90AB1;HSP90AA1;NUMA1;DYNC1H1;CSNK1E;REEP6;PINK1;REEP5;DVL3;CDK16;STXBP2;KDM1A;CAMK2D;DVL1;PARP1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.8465155568147287,1.0547812301499773,0.3475,0.7723637183646938,1.0,19/61,5.41%,HNRNPA1;HSP90AB1;HSP90AA1;KLF4;PARM1;CTNNB1;PTGES3;PDGFRB;MAPK3;XRCC5;CCT7;CCT3;CCT4;TCP1;PKIB;CCT5;CCT6A;CCT8;PCNA
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.813299382082394,1.0546981244590912,0.3365,0.7721246555555983,1.0,14/16,16.70%,VPS28;CHMP5;TMEM50A;VPS25;SNF8;LEPROT;TMEM50B;CHMP4A;CHMP4B;VPS36;VTA1;CHMP7;LEPROTL1;CHMP6
prerank,actin filament organization (GO:0007015),0.880386975511683,1.0543285637712503,0.4,0.773151929967761,1.0,41/151,6.54%,TPM2;FLNA;TPM1;GSN;MARCKS;RHOC;DSTN;MARCKSL1;RHOA;RAC1;TPM4;PLS1;DPYSL3;CDC42;VIL1;MYO1A;ACTN1;TPM3;RHOB;EVL;ARPC4;MYO1D;MYO1C;MYO7B;MPRIP;TRIOBP;BCAR1;CORO1A;VILL;FAT1;BAIAP2L2;INPPL1;EPS8;LMOD1;ACTC1;DBN1;WASL;SVIL;ENAH;PLS3;EFS
prerank,regulation of multicellular organismal development (GO:2000026),0.8202247550040135,1.0543085598277362,0.3165,0.7726252929388985,1.0,11/28,13.07%,CD24;PTN;BAG6;DUSP6;RAB14;KAT2A;TRIP12;INSR;CDK1;KIAA1109;EHMT1
prerank,apoptotic nuclear changes (GO:0030262),0.8154229121463533,1.0543075138225018,0.3265,0.7720178523073099,1.0,7/23,5.76%,HMGB1;HMGB2;CDK5RAP3;TOP2A;KPNB1;BLCAP;ERN2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.9060180354184164,1.0542690660605607,0.39,0.7715831801867455,1.0,32/252,3.64%,COL1A1;MDK;PFDN5;APOE;IGFBP4;SLC9A3R1;JUP;IGFBP2;CTNNB1;GPC3;ADGRA2;PSMB1;RBX1;CTNND1;DDX3X;ILK;PPP1CA;SOX4;PSME1;PSMB4;VCP;TRPM4;CAV1;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;CSNK1A1;PSMB7;ZEB2;PSMB6
prerank,regulation of presynapse organization (GO:0099174),0.8149164799914755,1.054158251836116,0.3405,0.7708421837511633,1.0,6/18,10.75%,APP;EIF4G1;GPC6;VPS35;GPC4;PTPRD
prerank,regulation of presynapse assembly (GO:1905606),0.8149164799914755,1.054158251836116,0.3405,0.7708421837511633,1.0,6/18,10.75%,APP;EIF4G1;GPC6;VPS35;GPC4;PTPRD
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.8838811624594984,1.054068786389881,0.416,0.7706217530384527,1.0,22/156,4.66%,APOA1;GSTP1;GSTA1;APOE;MGST3;STARD10;SLC44A4;ASS1;ST3GAL4;CPS1;APOA2;GSTK1;VAPA;CSNK2B;AKR1A1;ASL;GSTO1;ELOVL1;SLC44A1;PLPP1;TNIP1;ESD
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.9019366229107789,1.0539943184828517,0.3965,0.7703305682464584,1.0,17/245,2.84%,RPS27A;RPS3;PPIA;UBC;UBA52;UBB;NPM1;CIB1;JUP;PARK7;CTNNB1;APP;PHB2;CLU;HSPA1A;CAV1;LAMTOR5
prerank,glycogen catabolic process (GO:0005980),0.8091129705070133,1.0537336897983653,0.3253253253253253,0.7708864910279777,1.0,2/15,2.23%,CALM1;PYGB
prerank,positive regulation of ion transport (GO:0043270),0.8370720644923882,1.0536756051828604,0.3185,0.7705445689435256,1.0,4/50,1.74%,MYLK;PRSS8;VAMP8;FHL1
prerank,sulfur compound biosynthetic process (GO:0044272),0.8674010936516284,1.0536200325086866,0.3785,0.7701941695744381,1.0,27/111,7.71%,DCN;SLC26A2;GSTP1;LUM;GSTA1;MGST3;OGN;VCAN;ST3GAL4;MPST;MAT2A;GSTK1;AKR1A1;GSTO1;ESD;B4GALT1;CHPF;GGT6;CNDP2;B3GNT7;UGDH;PAPSS2;GSTA2;FMOD;MGST2;BGN;GSTM3
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.8712088633174071,1.053419637975502,0.3985,0.7704563745245717,1.0,13/105,3.13%,DCN;CEACAM1;FN1;NOP53;SLC9A3R1;IER3;ERBB3;MAZ;PDGFRB;PLXNB1;PDGFRA;MAPK3;MYDGF
prerank,cellular response to chemical stress (GO:0062197),0.8634503075428978,1.053350215047014,0.3895,0.770165285500875,1.0,17/100,2.77%,PPIA;PRDX6;GSTP1;CHCHD2;PRDX5;ATF4;CYCS;CYBA;GPX2;PRDX2;PARK7;SOD1;PRDX1;DDX3X;SERPINB6;HSPA1A;CAV1
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.8189345854960083,1.0531944284067243,0.3265,0.7702562457050554,1.0,7/30,5.67%,APOE;PTN;SQSTM1;APP;LGMN;ABL1;SCGN
prerank,cortical cytoskeleton organization (GO:0030865),0.8280502204097058,1.0531686522892643,0.3155,0.7697688699250648,1.0,11/41,7.95%,EZR;RHOC;RHOA;RAC1;LLGL2;RHOB;ARF6;NCKAP1;RHOF;RAB13;ROCK2
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.8205779113407745,1.053124597993663,0.327,0.7693654036786584,1.0,4/24,6.03%,ACADVL;CYCS;GFPT1;NDUFS4
prerank,dorsal/ventral pattern formation (GO:0009953),0.8189052785042179,1.0529542840682726,0.3275,0.7695012422925332,1.0,9/24,11.95%,NBL1;SFRP1;PTCH1;ACVRL1;GREM1;FBXL15;MDFI;BMPR1A;AIDA
prerank,regulation of filopodium assembly (GO:0051489),0.8280676607952723,1.0528673159151947,0.324,0.7692720562098672,1.0,25/40,14.44%,CCL21;DPYSL3;CDC42;CAPZB;FSCN1;AGRN;NRP1;GAP43;RAB17;ARF6;WASL;ARAP1;MIEN1;FXR1;PALM;RAB5A;FNBP1L;FMR1;RHOQ;MYO10;PIK3R1;RALA;NEURL1;FXR2;PRKCD
prerank,regulation of viral genome replication (GO:0045069),0.8465340843319955,1.052861602670971,0.3495,0.76869310873477,1.0,12/66,5.48%,PPIA;PABPC1;IFITM3;ILF3;DDX3X;SLPI;BANF1;IFITM2;TNIP1;DDB1;ADAR;LARP1
prerank,regulation of cytokine production (GO:0001817),0.8816516269957939,1.052828858186378,0.4135,0.7682310297901962,1.0,16/146,5.21%,GAPDH;HLA-B;MIF;AGPAT2;SOD1;PLD3;NPTN;HHLA2;S100A13;HLA-DRB1;C1QTNF3;MAST2;ANXA1;BTNL3;AGT;FLOT1
prerank,positive regulation of cell killing (GO:0031343),0.8078621152875088,1.0523997345531946,0.3405,0.7694728212275405,1.0,5/15,11.37%,RAC1;CYBA;FZD7;NOXA1;DVL2
prerank,negative regulation of MAPK cascade (GO:0043409),0.8603130056215711,1.052259291971195,0.372,0.769486433604518,1.0,24/91,6.49%,PPIA;GSTP1;EZR;FBLN1;EMILIN1;APOE;DUSP1;SLC9A3R1;UCHL1;CAMK2N1;PEBP1;CAV1;CDK5RAP3;TIMP3;PHB;TNIP1;RGS2;AGT;PIN1;PTEN;SORL1;DUSP6;WNK2;HYAL2
prerank,dendritic spine organization (GO:0097061),0.8237946378551018,1.0522237372643501,0.342,0.7690570395249056,1.0,15/27,15.08%,ARF1;CDC42;LGMN;PTEN;WASL;ITGA3;PRNP;EPHB3;IGF1R;INSR;EPHB2;SHANK3;FYN;PICK1;DIP2A
prerank,regulation of cell killing (GO:0031341),0.8133043287774343,1.0521952626261184,0.3325,0.7685805953889856,1.0,7/17,11.37%,RAC1;CYBA;CD59;FZD7;NOXA1;CD55;DVL2
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.8410826573235655,1.052060800901326,0.342,0.7685611435334739,1.0,11/56,9.71%,EGR1;HSPB1;APP;GSDMD;INAVA;LGALS9;NLRP1;STMP1;F2RL1;FZD5;PYCARD
prerank,regulation of translational initiation (GO:0006446),0.8489096126597939,1.0520008936105678,0.3545,0.768231075040213,1.0,29/67,9.29%,EIF1;HSPB1;EIF4G2;NPM1;EIF4A2;ATF4;EIF4B;EIF3E;DDX3X;CSDE1;EIF3H;EIF4H;KHDRBS1;EIF3B;EIF4G1;EIF5;EIF4EBP2;ATF3;POLR2G;LARP1;EIF1B;EIF4EBP1;TPR;PAIP2;DDX1;CEBPB;RPS6KB2;EIF2B5;YTHDF3
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.8313062544761753,1.0517385079324186,0.328,0.7687951935058704,1.0,12/49,7.11%,GSTP1;CD177;CYBA;SOD1;ROMO1;CDKN1A;PDGFRB;AGT;DCXR;TGFBR2;ACE2;GRB2
prerank,acetyl-CoA metabolic process (GO:0006084),0.8117319211308167,1.0516469784071694,0.3405,0.7685776095597976,1.0,8/15,11.14%,HMGCS1;HMGCS2;MVD;ACLY;PPCS;ACSS1;PMVK;ACAT1
prerank,cellular response to heat (GO:0034605),0.822257482782517,1.051631520639503,0.3185,0.7680403886555244,1.0,16/36,8.92%,HSP90AB1;HSP90AA1;HSBP1;YWHAE;HSPA1A;VCP;PDCD6;RBBP7;STUB1;SUMO1;HSBP1L1;TPR;HSPA1B;HSF1;TCIM;PRKACA
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.8545658001751829,1.0515960251860283,0.37,0.7675920386361252,1.0,18/80,6.85%,RACK1;BEX3;CYCS;ATP2A3;RPS27L;HSPE1;MTCH1;VCP;HSPD1;ANP32B;FAM162A;DAP;NLRP1;BAD;LAPTM5;TNFSF10;S100A8;EGLN3
prerank,phosphate ion transport (GO:0006817),0.8119301801698434,1.0515212869355925,0.3315,0.767315310216924,1.0,4/17,7.71%,SLC25A3;SLC37A4;SLC20A1;SLC25A11
prerank,peptide catabolic process (GO:0043171),0.8199554303108098,1.0514745947042867,0.3215,0.766918718214075,1.0,8/25,10.34%,ANPEP;TPP1;ECE1;NPEPPS;CTSH;DPEP1;XPNPEP1;LTA4H
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.8130256755999801,1.0513829282107345,0.325,0.7667172888333991,1.0,8/23,14.55%,BEX3;DELE1;BIRC2;PYCARD;NGFR;FYN;PCID2;IFI16
prerank,epidermal cell differentiation (GO:0009913),0.8366682903456311,1.0512854343915512,0.335,0.7665415767089945,1.0,12/52,5.71%,TXNIP;ST14;CTNNB1;KRT10;ASAH1;CLIC4;ANXA1;HDAC1;JAG1;DSP;HDAC2;EPHA2
prerank,clathrin-dependent endocytosis (GO:0072583),0.82250695841144,1.0512436481027683,0.335,0.7661134158023092,1.0,18/26,14.91%,CANX;AP2M1;CLTB;CLTC;CLTA;AP2S1;GAK;AP2A2;PICALM;AP2B1;FNBP1L;DLL1;LMBRD1;INPP5F;AP2A1;GPR107;PIP5K1C;ITSN1
prerank,outflow tract septum morphogenesis (GO:0003148),0.8144169076074638,1.0507483675382314,0.324,0.767678054618611,1.0,14/25,11.94%,NRP1;NRP2;TGFBR2;SEMA3C;PARVA;ENG;SMAD4;GATA6;BMPR2;TBX2;BMP4;ROBO1;FGFR2;BMPR1A
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.8119922558979475,1.0507170117164923,0.348,0.7672128081165712,1.0,2/18,2.20%,NPM1;PHB2
prerank,spliceosomal complex assembly (GO:0000245),0.832650132396078,1.0506244808926228,0.3335,0.7670061698458875,1.0,25/46,9.94%,SNRPD2;SRSF5;SF3B1;LUC7L3;SRSF6;RBM5;SNRPG;SF1;SNRNP200;SNRPE;TXNL4A;LUC7L;SNRPD1;SRSF10;SRSF9;SRSF1;PUF60;YTHDC1;DDX1;LUC7L2;CELF1;SCAF11;DDX23;PRPF6;SF3A1
prerank,heterotypic cell-cell adhesion (GO:0034113),0.8194293097607239,1.050465650104025,0.3225,0.7670893728722149,1.0,10/30,9.25%,ITGB1;JUP;DSG2;DSC2;DSP;ITGA5;CXADR;PARVA;NINJ1;ITGAV
prerank,regulation of protein kinase activity (GO:0045859),0.8580357020754562,1.0499954979443435,0.3725,0.768523163371514,1.0,23/106,6.24%,PPIA;CEACAM1;GSTP1;HSPB1;SFN;CCL21;SLC9A3R1;CAMK2N1;PARK7;SOD1;CDKN1A;CHP1;JTB;XRCC6;THY1;XRCC5;GAS6;RTRAF;TSC2;AKT1;YWHAG;RAP1A;IQGAP1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.8141549160661272,1.0499307043799537,0.3305,0.7676301372708265,1.0,10/23,7.84%,HSP90AB1;GIPC1;CDKN1C;TGFB1I1;ZEB2;SDCBP;STK11;DAB2;CREBBP;SMAD4
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.8141549160661272,1.0499307043799537,0.3305,0.7676301372708265,1.0,10/23,7.84%,HSP90AB1;GIPC1;CDKN1C;TGFB1I1;ZEB2;SDCBP;STK11;DAB2;CREBBP;SMAD4
prerank,T cell activation (GO:0042110),0.8588965254140349,1.0498697416764355,0.382,0.7673031627536312,1.0,6/92,2.75%,MDK;CD74;CCL21;FKBP1A;SOX4;HSPD1
prerank,cellular response to glucose starvation (GO:0042149),0.8300897729732596,1.0497014219051444,0.3355,0.7674431221330681,1.0,3/43,1.78%,HNRNPA1;ATF4;HSPA5
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.8112235232368464,1.0496969072510614,0.35,0.7668766894781722,1.0,7/15,15.86%,CANX;IL6ST;JAK1;TYK2;OAS1;STAT1;STAT3
prerank,regulation of cellular component organization (GO:0051128),0.8731162930906008,1.0496490709862198,0.4145,0.7664942063519871,1.0,30/139,6.39%,MUC12;CEACAM1;LTBP4;CD177;APOE;HSPA8;HSP90AA1;HNRNPU;PARK7;MELTF;RAP1B;AP2S1;LAMTOR1;PACSIN2;TFRC;SGK1;RAB5C;NET1;BCAR1;ARFGAP1;TSC2;AGT;RAB17;RAB5B;ABL1;SSRP1;RAP1A;PICALM;SNX17;PINK1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.8388731347918558,1.0495829520894002,0.34,0.7661862470326253,1.0,14/52,5.22%,HNRNPA1;HNRNPC;HNRNPU;CTNNB1;MAPK3;XRCC5;CCT7;CCT3;CCT4;TCP1;PKIB;CCT5;CCT6A;CCT8
prerank,aortic valve development (GO:0003176),0.8271829424386041,1.049368064072868,0.3325,0.7665041048362239,1.0,10/36,7.96%,EMILIN1;EFNA1;ELN;TNFRSF1A;JAG1;NOTCH1;SLIT3;SNAI2;ROCK2;BMPR2
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.846292739846063,1.0493054890042262,0.3635,0.7661813848685091,1.0,9/71,3.47%,MDK;APOE;GRN;PARK7;SOD1;SET;NONO;ERBB3;LGMN
prerank,release of cytochrome c from mitochondria (GO:0001836),0.8129028737005143,1.0487135798449694,0.3435,0.7681605225363182,1.0,8/18,10.02%,SFN;CLU;FIS1;BAD;MFF;SOD2;DNM1L;BAX
prerank,epithelial to mesenchymal transition (GO:0001837),0.8311927576876896,1.04866018709317,0.3395,0.7678016959717465,1.0,20/46,10.51%,DDX17;DDX5;CTNNB1;TRIM28;HNRNPAB;FOXF2;FGFR1;LOXL2;NOTCH1;OLFM1;S100A4;RBPJ;ENG;SNAI2;ROCK2;HIF1A;LIMS1;DLG5;TBX3;CUL7
prerank,positive regulation by host of viral transcription (GO:0043923),0.810242483888948,1.0485468512141363,0.35267633816908456,0.7676989444422335,1.0,3/16,2.68%,JUN;NUCKS1;HPN
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.8081890708804524,1.0482619710626266,0.328,0.7683247954732861,1.0,14/22,16.81%,TMBIM6;PARK7;HSPA1A;XBP1;SELENOS;HERPUD1;CREB3L1;SYVN1;TXNDC12;BOK;CREB3;DDIT3;OPA1;BCL2L1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.8105040814628048,1.048100980673099,0.3365,0.7684458577951464,1.0,13/24,12.89%,CIB1;CHP1;ERBB2;FIS1;MYO1C;AKT2;PRNP;MFF;MTCL1;ITGB1BP1;HRAS;FYN;SLC51B
prerank,protein localization to plasma membrane (GO:0072659),0.8712109534445754,1.0480065127224822,0.408,0.7682723903433899,1.0,40/136,8.46%,S100A10;FLNA;CD81;EZR;BSG;ATP1B3;ATP1B1;SLC9A3R1;JUP;SPTBN1;CDH1;RAB11A;EHD2;RAB34;GAS6;TMED2;TNFRSF1A;RAMP2;GAK;PKP3;FLOT1;PACS2;RAMP1;EPHA2;F11R;RAP1A;AFDN;PTCH1;ANK2;RAB10;MYADM;ZDHHC3;RAB13;PDZD3;ROCK2;SEC16A;CLASP2;SLMAP;FLOT2;EHD1
prerank,cellular response to hormone stimulus (GO:0032870),0.843095703447616,1.0479118172247466,0.3545,0.7680889652232095,1.0,16/75,7.00%,ATP1A1;ZFP36L1;CTSB;CTSS;CAV1;RAMP2;XBP1;UBE2L3;SFRP1;CTSL;RAMP1;SLIT3;CTSH;NCOA4;TFPI;WBP2
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.8052237514613206,1.047761282469242,0.3525,0.7681524370740671,1.0,13/17,17.30%,VCL;ADD1;VEGFA;TNFRSF1A;CLDN5;CDH5;F11R;ROCK2;PPP1R12A;S1PR3;ROCK1;S1PR2;IKBKB
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.8074369686183718,1.0476029549311925,0.3476738369184592,0.7682486957938237,1.0,10/18,12.59%,NR4A1;VEGFA;NRP1;AKT1;EPHB4;GREM1;ADTRP;SRF;ROBO1;EFNB2
prerank,'de novo' posttranslational protein folding (GO:0051084),0.8191401763465082,1.0474191850090693,0.341,0.7684645331135324,1.0,20/31,14.41%,HSPA8;HSPA5;HSPE1;ST13;PTGES3;HSPA1A;GAK;SELENOF;DNAJB1;HSPA9;CCT2;ERO1A;BAG1;HSPA1B;ENTPD5;SDF2L1;HSPA2;DNAJC7;SDF2;DNAJB12
prerank,negative regulation of developmental process (GO:0051093),0.84628289640341,1.0473409107416567,0.356,0.7682211340899858,1.0,21/75,9.95%,CST3;FGFR3;MIF;THY1;ANP32B;TFRC;NFIB;GAS6;LOXL2;ZNF706;SFRP1;NOTCH1;VAT1;PINK1;HUWE1;ROCK2;TBX2;GREM1;CDK6;BNIP3;BMP4
prerank,embryonic digit morphogenesis (GO:0042733),0.8116038530959625,1.0472860273197877,0.3575,0.7678826940061962,1.0,9/18,13.11%,HDAC1;ECE1;HDAC2;OSR1;CREBBP;TBX2;TBX3;MAP3K20;GLI3
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.8255620844874815,1.047062280614565,0.3365,0.7682652521117618,1.0,12/38,11.85%,HLA-E;TNFRSF14;PHB2;PHB;INAVA;GPI;XBP1;LAPTM5;VAMP3;F2RL1;STX4;EPHB2
prerank,regulation of DNA recombination at telomere (GO:0072695),0.8124103254698143,1.0469281868975417,0.342,0.7677008302998619,1.0,12/20,9.49%,POLR2L;POLR2J;POLR2H;POLR2E;POLR2F;POLR2I;POLR2G;POLR2A;POLR2K;TERF2IP;POLR2B;ATRX
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.8124103254698143,1.0469281868975417,0.342,0.7677008302998619,1.0,12/20,9.49%,POLR2L;POLR2J;POLR2H;POLR2E;POLR2F;POLR2I;POLR2G;POLR2A;POLR2K;TERF2IP;POLR2B;ATRX
prerank,regulation of cell communication (GO:0010646),0.820458710801718,1.0467944726446639,0.3305,0.7676491642361877,1.0,14/38,10.59%,IGFBP7;SRI;MTCH1;MGLL;GRK2;ANXA1;YWHAG;ANK2;CXADR;NCLN;CDC42SE2;CAMK2D;CRK;NUP62
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.8481899591272165,1.0466207984744416,0.3675,0.7678128467037395,1.0,30/92,7.51%,HNRNPA1;HNRNPH1;ZFP36L2;ZFP36L1;NR4A1;FGFR3;POLR2L;ZFP36;PTBP1;FLRT2;HNRNPM;TIA1;MAPK3;POLR2J;RBFOX2;POLR2H;FGFR1;POLR2E;HNRNPF;POLR2F;POLR2I;SFRP1;TIAL1;CCL2;POLR2G;POLR2A;HYAL2;RAB14;GRB2;MAPK1
prerank,protein insertion into membrane (GO:0051205),0.8205038334481806,1.0465207821002422,0.347,0.7676752055564582,1.0,17/33,13.70%,SEC61G;SEC61B;WDR83OS;APP;VAPA;SERP1;OXA1L;TRAM1;PRNP;CYB5A;SGTA;UBE2J2;ALDH3A2;VAMP2;STX5;CCDC47;EMD
prerank,organophosphate ester transport (GO:0015748),0.8176530930250864,1.0460794581440622,0.3475,0.7689943881167643,1.0,12/25,11.72%,SLC44A4;PRELID1;NPC2;LDLR;SCP2;MTTP;SCARB1;PRELID3B;PITPNA;PITPNM1;OSBPL2;PITPNB
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.8110211102882914,1.0460756561877973,0.3365,0.7684366152135171,1.0,14/23,13.79%,MYH9;RBMX;SPPL2B;HM13;SPPL2A;PSEN1;APH1A;NCSTN;ADAM10;SPPL3;DAG1;PSENEN;BACE2;ADAM9
prerank,regulation of macroautophagy (GO:0016241),0.8652211971699219,1.0460646746084385,0.4055,0.7679085200031724,1.0,33/110,8.20%,GAPDH;DCN;LAMTOR4;UCHL1;CAPNS1;QSOX1;ATP6V0B;LAMTOR5;ATP6V1G1;ATP6V0D1;LAMTOR1;ATP6V0E1;SNX5;RHEB;EXOC7;TSC2;CAPN1;AKT1;LARP1;ATP6V1E1;SUPT5H;PINK1;BNIP3L;LAMTOR2;ATP6V0A1;VPS35;SH3GLB1;WAC;GNAI3;SNX6;GBA;HDAC6;GPSM1
prerank,glycosphingolipid metabolic process (GO:0006687),0.8291785982213039,1.0460625620776365,0.338,0.7673411675870705,1.0,21/46,12.37%,CTSA;PSAP;ASAH1;NEU1;GBA2;HEXB;HEXA;SMPD4;ENPP7;CERK;ESYT2;GBA;SMPD3;SMPD1;GLTP;SUMF2;GLB1;GLA;ESYT1;UGCG;ARSA
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.8098872554575518,1.0458057429254195,0.362,0.7678267365781362,1.0,5/18,9.95%,DDX5;MAP2K2;NCOR2;NCOR1;BMP4
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.8041643470925952,1.0457606733758487,0.3626813406703352,0.767449398293669,1.0,2/16,6.14%,CD74;LAPTM5
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.9168713266726535,1.0457571831786205,0.3425,0.7668900096655495,1.0,61/403,4.43%,COL1A1;ACTG1;ACTB;HNRNPA1;STMN1;COL4A2;HNRNPH1;EFNA1;MMP2;HSP90AA1;FGFR3;RHOA;RAC1;CYBA;POLR2L;MST1;RARRES2;MVP;PTBP1;AP2M1;CDC42;ARPC3;ATP6V0B;FLRT2;HNRNPM;PLAT;ERBB2;ARPC2;HPN;ERBB3;TIA1;ARPC5;PDGFRB;AP2S1;ATP6V1G1;PDGFRA;MAPK3;ARPC4;ATP6V0D1;ACTR2;VEGFA;POLR2J;BRK1;RBFOX2;ATP6V0E1;DDR1;PILRB;WASF2;ATP6V1F;POLR2H;FGFR1;POLR2E;HNRNPF;SULF2;ATP6AP1;PXN;NRP1;BCAR1;ARPC1A;DDIT4;POLR2F
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.8218247267857511,1.0456142409473255,0.34,0.766900160997989,1.0,19/31,13.92%,ATP5IF1;NUPR1;CLU;CTSC;CDK5RAP3;PSMC5;PSMC3;PTEN;LAPTM5;PSMC6;GBA;PTK2;DAB2IP;MAGEF1;FMR1;PSMC2;DDRGK1;AXIN1;ECSCR
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.8282054602540729,1.0453088451716974,0.3455,0.7676269862887217,1.0,13/44,7.20%,DDX17;DDX5;DEFA3;PHB;RBFOX2;PADI2;PLPP1;SAFB;ZMIZ1;NCOA4;YAP1;WBP2;ARID1A
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.8384455387505566,1.0451960470187838,0.3605,0.7675154749554245,1.0,7/52,4.11%,GSTP1;GSTA1;GPX4;SCP2;MGLL;ELOVL1;ACAA1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.8037236060628824,1.0451601850546048,0.329,0.7671058923293145,1.0,10/22,13.24%,JUN;SUB1;BCLAF1;MED16;SRF;SETX;MED14;MED13;MED4;MED12
prerank,regulation of cellular amine metabolic process (GO:0033238),0.83125292535364,1.0450843332396156,0.3455,0.7668531824175684,1.0,30/51,9.00%,OAZ1;PSMB1;PSME1;PSMB4;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5;PSMC3;ODC1;PSMD2;PSMA2;PSMB2;OAZ2;PSMD13;PSMD4;PSMD3;PSMC1;PSMC6;AZIN1;PSMC4;PSMF1;PSMA3;PSMA5
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.8135315125998596,1.0450760317353602,0.341,0.7663301946364642,1.0,5/25,8.32%,CCL21;ANXA6;ITPR3;ERO1A;F2R
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.8214572478392737,1.0450531845337845,0.3435,0.7658607376681338,1.0,17/31,10.76%,UBL5;TOMM7;UBE2D3;PDCD5;SREBF2;UBE2L3;NPEPPS;MICALL2;PINK1;HUWE1;SAE1;SH3GLB1;LEPROT;BAP1;FZD5;UBE2J2;ARIH2
prerank,protein deubiquitination (GO:0016579),0.8969035518372849,1.0448162744991933,0.4175,0.7662955397927973,1.0,21/267,3.27%,ACTB;RPS27A;UBC;UBA52;UBB;RHOA;UCHL1;NEDD8;EIF3F;PSMB1;SNX3;OGT;USP22;PSME1;PSMB4;VCP;PSME2;PSMD8;PSMB3;PSMA7;PSMB5
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.8113050867153334,1.04477785388572,0.348,0.7659084144515717,1.0,7/23,9.96%,EMILIN1;PDCD6;ITGA5;HGS;HIF1A;DAB2IP;PRKD2
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.8598353120371641,1.0446606075629825,0.399,0.7658146960774512,1.0,26/111,5.98%,FOS;JUN;CALM1;SKP1;RAC1;PSMB1;PSME1;PSMB4;PSME2;MAPK3;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5;PSMC3;PSMD2;PSMA2;SHC1;PSMB2;PSMD13;PSMD4
prerank,regulation of interleukin-6 production (GO:0032675),0.8597873397580736,1.0446202970918697,0.401,0.7654114627527119,1.0,20/108,8.47%,HLA-B;CD74;HMGB1;CYBA;APP;HSPD1;INAVA;C1QTNF3;GAS6;XBP1;SELENOS;DHX9;LGALS9;HYAL2;ARHGEF2;GBA;MAPK13;MAPKAPK2;F2R;CD47
prerank,positive regulation of viral process (GO:0048524),0.8353912720962436,1.044592343232497,0.347,0.7649596001821245,1.0,25/63,8.32%,PPIA;PABPC1;POLR2L;DDX3X;POLR2J;RAB7A;POLR2H;POLR2E;POLR2F;POLR2I;DDB1;DHX9;ADAR;POLR2G;LARP1;SUPT5H;RAD23A;NELFB;POLR2A;SUPT4H1;NELFE;NELFCD;KPNA2;POLR2K;STAU1
prerank,negative regulation of cell motility (GO:2000146),0.8602351118969371,1.0444845740639355,0.409,0.7648468202646626,1.0,22/113,6.23%,TPM1;CLDN3;SPINT2;FBLN1;CD74;IGFBP5;MIF;CDH1;DPYSL3;VCL;RHOB;CLIC4;THY1;SFRP2;CLDN5;SFRP1;STK24;JAG1;PIN1;PTEN;AFDN;ADAM15
prerank,triglyceride biosynthetic process (GO:0019432),0.8086280609204127,1.0444298783455657,0.354,0.7645076561711571,1.0,7/18,10.94%,DGAT1;PCK1;PCK2;LPGAT1;GPAT4;MOGAT2;LPIN3
prerank,cellular response to tumor necrosis factor (GO:0071356),0.8888740109585178,1.0442789777214503,0.436,0.7645800291708187,1.0,35/193,5.32%,TMSB4X;RPS3;CCL21;ZFP36L2;ZFP36L1;ACTN4;CIB1;ZFP36;TNFRSF14;PSMB1;ILK;PSME1;EIF5A;PSMB4;ASAH1;TXNDC17;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5;TNFRSF1A;PSMC3;SFRP1;PSMD2;PSMA2;CCL2;AKT1;DHX9;PSMB2
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.880400623755115,1.0442693831201821,0.4355,0.764048559570799,1.0,22/170,4.29%,GAPDH;LGALS1;FLNA;RHOC;EEF1D;CD74;CCL21;RHOA;FKBP1A;LITAF;LAMTOR5;VAPA;S100A13;HLA-DRB1;TFRC;NDFIP1;SHISA5;INAVA;CANT1;TNFRSF1A;RBCK1;TFG
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.8195854273020194,1.043953531120833,0.3535,0.7648254947342586,1.0,7/31,9.46%,APOB;PLA2G2A;AGT;NFKBIA;NR1H3;ITGAV;PLA2G10
prerank,potassium ion transmembrane transport (GO:0071805),0.8727448532777284,1.0438939107570366,0.4345,0.7645212476836889,1.0,7/139,5.43%,ATP1A1;ATP1B3;ATP1B1;HPN;SLC9A3;SLC12A7;SLC12A2
prerank,positive regulation of apoptotic process (GO:0043065),0.9050884909534264,1.0437700522483027,0.3955,0.764476304723532,1.0,29/307,2.89%,RPS27A;RPS6;RPS3;RACK1;UBC;UBA52;CTSD;UBB;JUN;HMGB1;ATF4;ITGB1;GRN;DNM2;SOD1;CTNNB1;SQSTM1;IGFBP3;NUPR1;MTCH1;RBM5;CLU;DDX3X;SOX4;IP6K2;SAP18;HSPD1;RHOB;RNPS1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.8126165258423312,1.043577301130632,0.348,0.7647217362538832,1.0,12/30,13.08%,EFNA1;PRELID1;PSME1;PSME2;PICALM;APH1A;NCSTN;ROCK2;PYCARD;PSENEN;FYN;VSIR
prerank,positive regulation of lamellipodium organization (GO:1902745),0.8208392947068516,1.043477927392281,0.346,0.764603912482625,1.0,22/32,14.50%,RAC1;CDC42;VIL1;ARPC2;FSCN1;ACTR2;BRK1;WASF2;NCKAP1;CYFIP1;ACTR3;ARHGEF7;CORO1B;OCLN;ABI2;SRC;AUTS2;PIK3R1;PLCE1;RREB1;TWF2;CORO1C
prerank,protein localization to cell periphery (GO:1990778),0.869270255360498,1.0434563566223432,0.4175,0.7641217976906215,1.0,40/140,8.46%,S100A10;FLNA;CD81;EZR;BSG;ATP1B3;ATP1B1;SLC9A3R1;JUP;SPTBN1;CDH1;CAV1;RAB11A;EHD2;RAB34;GAS6;TMED2;TNFRSF1A;RAMP2;GAK;PKP3;FLOT1;PACS2;RAMP1;EPHA2;F11R;RAP1A;PTCH1;ANK2;RAB10;MYADM;ZDHHC3;RAB13;PDZD3;ROCK2;SEC16A;CLASP2;SLMAP;FLOT2;EHD1
prerank,sulfur amino acid metabolic process (GO:0000096),0.8088844123105307,1.043427333575996,0.365,0.763684080264616,1.0,7/23,7.57%,TST;MPST;CPS1;AHCY;TXN2;ADI1;DPEP1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.8437052769152251,1.043332483897467,0.378,0.7635096802289629,1.0,16/71,5.91%,PFN1;STMN1;PFDN5;EMILIN1;APOE;HSPA8;CIB1;STMN2;CLU;LDLR;PFN2;CORO1A;PFDN2;TBCD;CDH5;LIMA1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.8099542901529785,1.0432607252696275,0.35,0.7632409546271116,1.0,6/25,8.39%,ATF4;SULF2;C3;IL6ST;SULF1;HIF1A
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.8037340048929814,1.0432239252494702,0.358,0.7628381813762319,1.0,6/16,5.65%,PLAT;PDGFRB;PDGFRA;NRP1;BCAR1;ABL1
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.8139668685127711,1.043154781755558,0.331,0.7625805910682014,1.0,15/29,14.44%,PFN1;PFN2;CORO1A;LIMA1;MYADM;SMAD4;PLEKHH2;SHANK3;FKBP4;HIP1R;TJP1;TWF1;CLASP1;TWF2;PRKCD
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.8312109767280196,1.0429683059860078,0.3465,0.7627853703483048,1.0,18/48,9.98%,IGFBP5;OGN;ELN;VIP;ID2;CTNNB1;IGFBP3;XRCC6;PDGFRB;PHB;XRCC5;AKT1;TCF7L2;TRIB1;PRKDC;MFN2;BMP4;FOXP1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.8038570080143319,1.0428998430114427,0.368,0.7625285610647297,1.0,7/15,12.98%,GPC3;CSNK1D;SFRP1;CSNK1E;RNF213;DAAM2;DACT1
prerank,neuron projection extension (GO:1990138),0.8111315548904896,1.0428357462075772,0.3425,0.7622272008731745,1.0,16/32,12.47%,HSP90AB1;HSP90AA1;CTNNB1;MAP1B;CPNE1;NRP1;NRP2;CYFIP1;IQGAP1;SEMA5A;USP9X;PPP3CB;ULK1;SEMA3A;AUTS2;ALCAM
prerank,cellular response to interferon-beta (GO:0035458),0.8100897044668333,1.0428324698468334,0.3705,0.761684293797204,1.0,9/19,15.82%,NDUFA13;IFITM2;CDC34;UBE2G2;UBE2K;OAS1;IFI16;IRF1;STAT1
prerank,regulation of cellular component biogenesis (GO:0044087),0.8212959136036004,1.0428129007263278,0.3445,0.7612111116954778,1.0,12/39,7.95%,EZR;APOE;HSPA8;HSP90AA1;RAP1B;AGT;NOTCH1;MSN;RAP1A;PINK1;NCLN;ROCK2
prerank,regulation of spindle assembly (GO:0090169),0.8085900338171464,1.0426552866462504,0.336,0.7613228423787503,1.0,14/25,8.49%,HNRNPU;NUMA1;HSPA1A;DYNC1H1;PDCD6IP;CHMP2A;CHMP1A;CHMP5;CHMP3;SENP6;TPR;VPS4B;CHMP1B;HSPA1B
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.8096798784576914,1.0425603399761028,0.3435,0.761158354110719,1.0,6/26,8.39%,ATF4;SULF2;C3;IL6ST;SULF1;HIF1A
prerank,natural killer cell activation involved in immune response (GO:0002323),0.8103280397835118,1.0424456091427912,0.353,0.7610854505781818,1.0,2/21,10.89%,CORO1A;VAMP2
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.8028841385836559,1.0424411975643688,0.345,0.7605464410946663,1.0,17/19,18.82%,PARK7;VDAC1;SREBF2;PINK1;SREBF1;HDAC6;FZD5;DNM1L;FBXO7;HTT;HAX1;CAMKK2;GSK3A;CSNK2A2;USP36;ATP13A2;HTRA2
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.8037255215036718,1.0421951911699858,0.357,0.7610497070728026,1.0,8/16,15.69%,ADM;PRCP;DDAH1;KLK1;PLCB3;BMPR2;GSK3A;ACE
prerank,integrated stress response signaling (GO:0140467),0.8051862259733672,1.042081863298025,0.36868434217108553,0.7609592480076487,1.0,7/15,12.37%,ATF4;HSPA5;CCL2;HERPUD1;QRICH1;EIF2AK1;NFE2L2
prerank,regulation of calcium ion transport (GO:0051924),0.834434690746754,1.0418257951689722,0.3625,0.7614730950041468,1.0,4/58,2.42%,MYLK;SRI;CTNNB1;SARAF
prerank,positive regulation of B cell activation (GO:0050871),0.8293842822885681,1.0416661674190466,0.354,0.7615851558095285,1.0,5/53,4.68%,CD81;CD74;MIF;TFRC;XBP1
prerank,dendritic spine morphogenesis (GO:0060997),0.8088662924577488,1.0415757631727052,0.3725,0.7614307331636022,1.0,7/16,15.08%,CDC42;PTEN;WASL;EPHB3;EPHB2;SHANK3;DIP2A
prerank,negative regulation of blood coagulation (GO:0030195),0.820574422622802,1.0415754164507613,0.3475,0.7608800579992505,1.0,11/40,10.83%,APOE;A2M;PLAUR;PLAT;PDGFRA;CD34;SERPING1;TFPI;SERPINE2;ADTRP;F10
prerank,response to UV (GO:0009411),0.8526701016952261,1.041393099084986,0.392,0.7611088097558958,1.0,7/98,2.49%,RPL26;MFAP4;CIRBP;NPM1;ATF4;COPS9;SDF4
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.7980674705476888,1.04128055581745,0.362,0.7610161697719325,1.0,2/15,3.38%,FUS;ACTR2
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.8171087544955307,1.041221454015363,0.353,0.7607003844301907,1.0,11/32,10.20%,EZR;RHOA;SLC9A3R1;CDC42;WDR1;PDCD6IP;MSN;ERBIN;SCRIB;MTCL1;CAMSAP3
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.8126434082733602,1.0411021679197183,0.34,0.7606460818218259,1.0,13/35,12.13%,STMN1;ITGA3;LZTR1;STMN3;DAB2IP;MFN2;DLC1;ARHGAP35;CUL3;SPRY2;EPHB2;FBP1;KCTD10
prerank,positive regulation of phospholipase activity (GO:0010518),0.8097023666888145,1.0409938315275336,0.3585,0.7605561412317994,1.0,10/24,12.33%,FGFR3;PDGFRB;PDGFRA;ARF4;FGFR1;ARL1;PLCG1;HRAS;FGFR2;GNA13
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.8440025275693253,1.040858313218582,0.3755,0.7605600633874811,1.0,25/78,8.49%,RACK1;ELOB;NOP53;SUMO2;RBX1;CLU;HSPA1A;VCP;CDK5RAP3;CSNK1A1;CEBPA;CSNK1D;CSNK1E;STUB1;PTEN;SUMO1;LAPTM5;RAD23A;GABARAP;DAB2;SIRT2;HECTD1;PTK2;TRIB1;HSPA1B
prerank,positive regulation of programmed cell death (GO:0043068),0.8984518783851654,1.0408480101645552,0.4295,0.7600614290897786,1.0,26/284,2.89%,RPS27A;RPS6;RACK1;UBC;UBA52;CTSD;UBB;JUN;HMGB1;ATF4;ITGB1;DNM2;SOD1;CTNNB1;SQSTM1;IGFBP3;MTCH1;RBM5;CLU;DDX3X;SOX4;IP6K2;SAP18;HSPD1;RHOB;RNPS1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.8159138506599807,1.0408139818204256,0.337,0.7596574711766245,1.0,9/39,7.79%,CALM2;CALM1;CALM3;APP;EIF4G1;DDIT4;CAB39;MAPK1;SIRT2
prerank,regulation of cholesterol storage (GO:0010885),0.8083998685429928,1.0407165989139064,0.3625,0.7595113038306758,1.0,9/16,15.56%,APOB;SREBF2;SCARB1;EHD1;NR1H3;CES1;NR1H2;PPARG;PPARD
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.8529137898029328,1.0403514759427954,0.4065,0.7605034413130073,1.0,22/94,7.99%,TUBA1A;TUBB;DYNLL1;TUBB4B;HSP90AA1;PPP2R1A;YWHAE;RAB11A;DYNC1H1;DCTN2;CSNK1D;PAFAH1B1;CSNK1E;SSNA1;DCTN3;YWHAG;DYNC1I2;DCTN1;AKAP9;ACTR1A;PCM1;SFI1
prerank,stabilization of membrane potential (GO:0030322),0.8019025389603148,1.0402887043401343,0.3675,0.7602293544454984,1.0,1/17,1.50%,CHCHD10
prerank,eye photoreceptor cell development (GO:0042462),0.800946590468905,1.0402726213720523,0.3685,0.7597532093728211,1.0,3/15,6.28%,THY1;VEGFA;USH1C
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.831518453536276,1.0402540052299594,0.35,0.759292095916502,1.0,24/51,11.66%,UBB;HSP90AB1;APOE;NUPR1;PSME1;PSME2;GABARAPL2;XPO1;PKD1;FOXF2;PSMC5;PSMC3;RAD23A;PINK1;PSMC6;RAD23B;PSMF1;PRKACA;DAB2IP;RHBDF1;ARAF;FMR1;PSMC2;DDRGK1
prerank,protein modification by small protein removal (GO:0070646),0.8937693013714059,1.0401452163523959,0.4345,0.7592166112285654,1.0,21/276,3.27%,ACTB;RPS27A;UBC;UBA52;UBB;RHOA;UCHL1;NEDD8;EIF3F;PSMB1;SNX3;OGT;USP22;PSME1;PSMB4;VCP;PSME2;PSMD8;PSMB3;PSMA7;PSMB5
prerank,negative regulation of ATP metabolic process (GO:1903579),0.7997179735955996,1.0401140061155398,0.364,0.7587905711483978,1.0,8/17,12.08%,NUPR1;FIS1;MLXIPL;NCOR1;PARP1;GIT1;PPIF;FBP1
prerank,positive regulation of interleukin-4 production (GO:0032753),0.8053797543232039,1.0400809121106966,0.3645,0.7583758793087327,1.0,4/18,8.78%,HLA-E;PRKCZ;LGALS9;CEBPB
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.8097116771337249,1.0400543225299943,0.3635,0.7579456858858947,1.0,7/18,12.32%,ASS1;AKT1;LAPTM5;PAG1;ADTRP;WNK1;DUSP3
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.8014356088126046,1.0399959403955112,0.3675,0.7576547856503466,1.0,13/19,17.46%,UGP2;NANS;GFPT1;UGDH;NAGK;PMM1;SLC35D1;UAP1;AMDHD2;PGM3;MPI;GNPDA1;GMPPB
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.836561747787951,1.0398675929621646,0.3585,0.7576507447192151,1.0,25/75,8.66%,HNRNPA1;HNRNPH1;FGFR3;POLR2L;PTBP1;FLRT2;HNRNPM;TIA1;MAPK3;POLR2J;RBFOX2;POLR2H;FGFR1;POLR2E;HNRNPF;POLR2F;POLR2I;TIAL1;POLR2G;POLR2A;RAB14;GRB2;MAPK1;POLR2K;FGFR4
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.8028389147150253,1.0398568330243247,0.3805,0.7571527512752094,1.0,6/15,13.79%,APOE;NRDC;FURIN;SH3D19;SNX9;ADAM9
prerank,androgen metabolic process (GO:0008209),0.8014614180455073,1.0397737853127078,0.357,0.7569365101440457,1.0,5/21,10.53%,DHRS9;HSD17B11;SPP1;HSD17B10;HSD17B4
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.8463028787614653,1.0397055937828494,0.3845,0.7566799482144889,1.0,45/89,7.36%,NDUFB2;NDUFA1;NDUFS5;NDUFA11;NDUFB7;NDUFA13;NDUFB1;NDUFB11;NDUFB10;NDUFB4;NDUFA3;NDUFS6;NDUFV1;NDUFC2;NDUFB9;NDUFB8;NDUFA6;UQCRFS1;NDUFA2;NDUFS8;NDUFS7;PET100;NDUFAB1;NDUFC1;NDUFV2;NDUFA10;NDUFA12;COX17;COA3;NDUFB3;NDUFB6;DMAC1;COX14;NDUFAF3;NDUFS3;NDUFA5;OXA1L;NDUFAF8;UQCC2;NDUFS4;NDUFA8;NDUFS2;UQCC3;COX20;NDUFA9
prerank,regulation of cell-substrate adhesion (GO:0010810),0.8191435975545609,1.0396359867545166,0.3345,0.7564379977427377,1.0,15/43,10.73%,AGR2;RHOA;RAC1;THY1;FBLN2;NOTCH1;TBCD;ARL2;MYADM;NPNT;PTK2;RSU1;LIMS1;FZD7;EMP2
prerank,regulation of muscle cell differentiation (GO:0051147),0.8182994313505098,1.0396218475198344,0.346,0.7559540312151793,1.0,15/35,12.85%,CTNNA1;ID2;PTBP1;CTNNB1;CDC42;BOC;ABL1;TCF3;SPAG9;SUPT6H;SRF;FGFR2;MEF2A;MAPK14;BNIP2
prerank,negative regulation of viral process (GO:0048525),0.8384960051493451,1.0392295687645712,0.378,0.7570319962917432,1.0,9/69,4.55%,PPIA;IFITM3;ZFP36;ILF3;TRIM28;SLPI;BANF1;IFITM2;TNIP1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.8075015650247066,1.039220951813944,0.3415,0.7565294604105901,1.0,8/31,7.95%,ZFP36L1;ZFP36;SRSF6;NUMA1;CTSL;ERRFI1;VDR;ROCK2
prerank,negative regulation of protein phosphorylation (GO:0001933),0.867524523192827,1.039056376575824,0.4395,0.75667433172997,1.0,32/146,5.77%,RACK1;PPIA;CEACAM1;GSTP1;HSPB1;CALM2;FBLN1;SFN;EMILIN1;CALM1;CIB1;CAMK2N1;MVP;PARK7;IGFBP3;CALM3;CHP1;CAV1;CDK5RAP3;THY1;EIF4G1;DDIT4;SFRP2;RTRAF;SFRP1;TSC2;AKT1;TARDBP;PTEN;ERRFI1;YWHAG;PRKCZ
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.8176674990492105,1.0387822425556827,0.3535,0.7572725318603771,1.0,14/32,11.13%,CALR;TCF21;KANK2;PHB;HDAC1;SFRP1;CNOT1;NCOR2;DAB2;SMARCA4;NCOR1;CNOT2;FOXP1;PER1
prerank,water transport (GO:0006833),0.8005089765417664,1.0387062544639942,0.3535,0.7570489224521367,1.0,3/18,7.81%,AQP8;UPK3A;PDZD3
prerank,ncRNA metabolic process (GO:0034660),0.8190999913521637,1.0383613694868126,0.356,0.757934824050376,1.0,2/37,2.00%,DDX17;RAN
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.8307443063201444,1.0382212475333605,0.3705,0.7579986108015224,1.0,24/56,9.99%,SFN;YWHAZ;UBL5;TOMM7;YWHAQ;YWHAE;UBE2D3;YWHAB;YWHAH;SREBF2;UBE2L3;NPEPPS;MICALL2;YWHAG;BAD;PINK1;HUWE1;SAE1;SH3GLB1;LEPROT;BAP1;FZD5;UBE2J2;TFDP1
prerank,RNA transport (GO:0050658),0.8426894477826238,1.0380115952220197,0.3845,0.7583592067155508,1.0,25/76,7.20%,HNRNPA1;HNRNPA2B1;ZFP36L1;YBX1;SRSF5;TST;SRSF3;ZFP36;SRSF2;SRSF6;SRSF7;SRSF11;RNPS1;RBM8A;SRSF9;RTRAF;SRSF1;FLOT1;CHTOP;DDX39A;MAGOH;TGFBR2;SRSF4;CASC3;TPR
prerank,protein-containing complex disassembly (GO:0032984),0.8301124526613098,1.0378195617411157,0.365,0.7586086083465925,1.0,24/56,11.37%,RPL23;HSPA8;VAMP8;CTNNB1;PPP1CA;VCP;CAV1;CSNK1A1;GABARAPL2;MAP1LC3B;FZD1;CHMP3;GABARAP;MAP1LC3A;DVL3;VPS4A;LIX1L;FZD5;DVL1;LAMP2;TSG101;WIPI2;UBQLN1;DVL2
prerank,glycogen metabolic process (GO:0005977),0.8096857339423243,1.0375896980814556,0.3475,0.7590541323551299,1.0,3/27,2.23%,CALM1;UGP2;PYGB
prerank,regulation of angiogenesis (GO:0045765),0.8772495533655392,1.0370745300416817,0.4425,0.7607134160153922,1.0,42/198,6.29%,SPARC;DCN;CEACAM1;HSPB1;EMILIN1;COL4A2;GTF2I;ITGB1;GRN;JUP;KLF4;HSPG2;CTNNB1;ADGRA2;PGK1;THBS2;ERBB2;RHOB;MYDGF;GLUL;VEGFA;ATP2B4;PDCD6;BTG1;RNH1;EMC10;ADAMTS1;RAMP2;SFRP2;CLDN5;XBP1;SFRP1;PLXND1;VEGFB;STAB1;CD34;CDH5;EPHA2;CTSH;APLNR;HGS;SEMA5A
prerank,apoptotic cell clearance (GO:0043277),0.8140995511383105,1.0369973410219735,0.3595,0.7604962452335611,1.0,13/33,14.38%,HMGB1;RAC1;LRP1;TGM2;GAS6;ANXA1;SCARB1;NR1H3;ITGAV;THBS1;RHOG;TYRO3;RARA
prerank,positive regulation of mitochondrion organization (GO:0010822),0.8264063953050818,1.0368737095565201,0.3685,0.7604895451207818,1.0,18/57,10.02%,DCN;CHCHD10;PARK7;PLAUR;FIS1;PDCD5;FAM162A;MLLT11;BAD;TNFSF10;PINK1;VPS35;MFF;BNIP3;DNM1L;PYCARD;FBXO7;BAX
prerank,positive regulation of natural killer cell activation (GO:0032816),0.7970628089072368,1.0366889921081825,0.3725,0.7607059082955849,1.0,6/15,12.93%,HLA-E;LAMP1;GAS6;HLA-F;AXL;AP1G1
prerank,positive regulation of viral transcription (GO:0050434),0.8048760185467204,1.0363896683773643,0.367,0.7614318469995235,1.0,18/26,12.82%,POLR2L;POLR2J;POLR2H;POLR2E;POLR2F;POLR2I;DHX9;POLR2G;SUPT5H;NELFB;POLR2A;SUPT4H1;NELFE;NELFCD;POLR2K;POLR2B;GTF2F1;POLR2C
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.8053752046392876,1.0363471690952968,0.366,0.7610768452937584,1.0,1/21,0.92%,PLA2G2A
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.840058580633457,1.036325970001472,0.388,0.7606312706026491,1.0,29/78,9.64%,RACK1;ELOB;NOP53;SUMO2;RBX1;CLU;HSPA1A;VCP;CAV1;BCAP31;CSNK1A1;CEBPA;CSNK1D;CSNK1E;STUB1;HERPUD1;SUMO1;RAD23A;GABARAP;DAB2;SIRT2;HECTD1;TRIB1;HSPA1B;SGTA;SIRT6;ZER1;DVL1;TRIB2
prerank,negative regulation of protein modification process (GO:0031400),0.8407698196591171,1.0360916474488733,0.401,0.7610577562060358,1.0,30/78,9.46%,PPIA;FBLN1;DBI;CIB1;PARK7;IGFBP3;CHP1;YWHAB;CDK5RAP3;ATP2B4;CRTAP;ENSA;TARDBP;PTEN;ARPP19;PTPA;BEX4;MYADM;PLPP3;PRNP;DNAJC10;FKBP8;P3H1;XDH;TERF2IP;WWTR1;PPP1R15A;DAB2IP;PRKDC;OCLN
prerank,establishment of spindle orientation (GO:0051294),0.8055637776115482,1.0360382474705756,0.3505,0.7607360704695095,1.0,11/30,11.22%,MISP;ITGB1;LLGL2;NUMA1;MAP4;DYNLT1;PAFAH1B1;DCTN1;GJA1;NSFL1C;HTT
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.8054337641379796,1.0359586968535706,0.3655,0.7605183493842166,1.0,10/24,10.00%,GPRC5A;MVP;CAV1;THY1;ERRFI1;HYAL2;VPS25;SNX6;PTK6;TSG101
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.8042598018124203,1.0358584423654038,0.3645,0.7603963092476779,1.0,21/24,16.70%,VCP;CHMP2A;CHMP1A;CHMP5;UBXN6;CHMP3;TMEM50A;LAPTM4B;VPS4B;CHMP1B;SORT1;LEPROT;TMEM50B;CHMP4A;CHMP4B;MVB12A;CHMP2B;VTA1;CHMP7;LEPROTL1;CHMP6
prerank,positive regulation of cell population proliferation (GO:0008284),0.9148511782669964,1.0357422813531916,0.382,0.7603403152626464,1.0,49/469,3.54%,S100A6;RPS15A;RPS6;RPS4X;EPCAM;RPS9;MDK;RPL23;FN1;CD81;CEACAM6;SLC25A5;CALR;CD74;NPM1;LAMB1;FGFR3;MIF;NAP1L1;GRN;CCND2;VIP;PTN;HNRNPU;CIB1;ID2;CAPNS1;COPS9;ROMO1;TIMP1;CDKN1A;CNBP;ERBB2;SOX4;LAMC1;ERBB3;TRPM4;MAZ;PRMT1;PDGFRB;GNAI2;PDGFRA;MEIS1;VEGFA;MVD;PHB;LGMN;S100A13;COX17
prerank,epidermis development (GO:0008544),0.8427828832628237,1.035721918999874,0.3965,0.7598985307981119,1.0,24/82,12.95%,RBP2;EMP1;YBX1;FABP5;LAMB3;HLA-DRB1;PLOD1;ATP2A2;HDAC1;DSP;HDAC2;SVEP1;HOXB13;GATA6;LAMA3;FLOT2;COL7A1;ALDH3A2;CRABP2;DLL1;FGFR2;ATP2C1;UGCG;COL17A1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.7982738294945341,1.0356763329478187,0.375,0.7595563890754397,1.0,8/16,9.48%,ARF1;BRK1;WASF2;NCKAP1;CYFIP1;CORO1B;ARFIP2;ABI2
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.8493020448891345,1.0354908969690904,0.4015,0.75977628538904,1.0,22/98,7.23%,RACK1;TXN;HSP90AB1;HSP90AA1;MIF;PARK7;APP;CAV1;VEGFA;ATP2B4;TFRC;EIF4G1;GAS6;PFN2;DDIT4;SFRP2;AKT1;PTEN;MLXIPL;PINK1;AKAP9;RAF1
prerank,response to ATP (GO:0033198),0.8066260988886114,1.0354129043660212,0.3795,0.7595702821403816,1.0,2/19,5.72%,HSP90B1;P2RX4
prerank,establishment of mitotic spindle orientation (GO:0000132),0.8009081309170213,1.0352992115794184,0.355,0.7595349639889191,1.0,9/24,11.22%,MISP;ITGB1;NUMA1;DYNLT1;PAFAH1B1;DCTN1;GJA1;NSFL1C;HTT
prerank,macrophage differentiation (GO:0030225),0.7972282646140139,1.0351363270759542,0.38319159579789897,0.7596773008991883,1.0,5/15,9.95%,CDC42;VEGFA;HLA-DRB1;PARP1;BMP4
prerank,regulation of lamellipodium assembly (GO:0010591),0.8126998112230995,1.0349615979000386,0.35,0.759840360386807,1.0,19/34,14.28%,RAC1;CDC42;ARPC2;CAPZB;FSCN1;ACTR2;BRK1;WASF2;NCKAP1;EPHA2;CYFIP1;ACTR3;OCLN;ABI2;AUTS2;PIK3R1;PLCE1;TWF1;TWF2
prerank,chromatin disassembly (GO:0031498),0.7987310775646792,1.034956190618218,0.3725,0.7588018933049973,1.0,9/16,11.11%,SET;HMGA1;SMARCA4;ARID1A;SMARCD3;SUPT16H;SMARCB1;SMARCD2;SMARCC1
prerank,nucleosome disassembly (GO:0006337),0.7987310775646792,1.034956190618218,0.3725,0.7588018933049973,1.0,9/16,11.11%,SET;HMGA1;SMARCA4;ARID1A;SMARCD3;SUPT16H;SMARCB1;SMARCD2;SMARCC1
prerank,mRNA metabolic process (GO:0016071),0.8416477923988719,1.0348064680206983,0.395,0.758887278991124,1.0,54/93,11.84%,HNRNPA2B1;DDX5;PCBP2;ZFP36L2;SRSF5;SFPQ;ZFP36;SRSF2;PTBP1;NONO;SRSF7;SNRPG;HNRNPA0;AURKAIP1;HSPA1A;SRSF11;PRPF8;SNRPB;SON;SNRPE;SF3B2;HNRNPR;AKAP8L;RNH1;SNRPF;SNRPD3;SRSF9;LSM3;DHX15;SRSF1;LSM2;LSM5;CPSF6;SRSF4;SUPT4H1;SSB;HSPA1B;HSF1;CELF1;PRKACA;NUDT21;TBRG4;SCAF11;NUDT16L1;SF3B4;SF3A1;ALKBH5;METTL3;LSM6;TCERG1;HIPK3;PCF11;YTHDF2;NCBP2
prerank,regulation of viral transcription (GO:0046782),0.8154560169757188,1.0347523407997214,0.351,0.7585952733033949,1.0,21/41,9.41%,IFITM3;POLR2L;ZFP36;POLR2J;POLR2H;POLR2E;POLR2F;POLR2I;DHX9;POLR2G;SUPT5H;NELFB;POLR2A;SUPT4H1;NELFE;NELFCD;POLR2K;TRIM31;TRIM27;UBP1;POLR2B
prerank,regulation of defense response to virus (GO:0050688),0.7969325776787822,1.0347205402600022,0.384192096048024,0.7581990838234377,1.0,3/15,5.90%,PCBP2;DHX9;C1QBP
prerank,response to interferon-beta (GO:0035456),0.8076916205512845,1.0346281793947658,0.3675,0.7580520640653484,1.0,12/26,15.82%,IFITM3;NDUFA13;IFITM2;CDC34;PLSCR1;UBE2G2;UBE2K;OAS1;BST2;IFI16;IRF1;STAT1
prerank,mRNA splice site selection (GO:0006376),0.8092234069025417,1.0346029449361267,0.3575,0.7576286957079803,1.0,19/30,13.56%,SRSF5;LUC7L3;SRSF6;SF1;LUC7L;SNRPC;SRSF10;SRSF9;SRSF1;PUF60;PSIP1;YTHDC1;LUC7L2;CELF1;SFSWAP;SF3A1;SETX;KHDC4;SF3A3
prerank,lamellipodium assembly (GO:0030032),0.8038997706022474,1.034425338112884,0.362,0.7578338817629937,1.0,10/26,12.37%,ITGB1;RAC1;VCL;CYFIP1;GOLPH3;ARHGEF7;ARFIP2;ABLIM1;CDH13;CCDC88A
prerank,peptide metabolic process (GO:0006518),0.8368898175765032,1.034400931061471,0.3815,0.7574223402573389,1.0,25/79,8.54%,ANPEP;GSTP1;GSTA1;ETHE1;SOD1;CPE;AEBP1;GSTK1;SPCS1;SEC11A;TPP1;NPEPPS;SPCS2;HM13;PSEN1;GSTA2;SPCS3;FURIN;DPEP1;APEH;GSTM3;CPXM1;SPPL3;DNPEP;THOP1
prerank,leukotriene metabolic process (GO:0006691),0.8008288011146932,1.0343840190354503,0.361,0.7569673927552765,1.0,7/24,12.87%,MGST3;MGST2;DPEP1;MAPKAPK2;LTA4H;GGT1;PTGR1
prerank,negative regulation of gene expression (GO:0010629),0.8983163906051947,1.0342979072703595,0.443,0.7568047795202775,1.0,32/313,3.47%,RPL13A;GAPDH;RPS3;RPS13;RPS26;RACK1;CLDN3;EMILIN1;CALR;IGFBP5;ZFP36L2;APOE;TMBIM6;MIF;YBX1;ID2;KLF4;ZFP36;PTBP1;PARK7;ILF3;APP;DDX3X;MAP2K2;HSPA1A;NCL;NPTN;ERP29;VEGFA;ATP2B4;CPNE1;LGMN
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.8408626968976306,1.0342855650109146,0.3965,0.7563256462980487,1.0,31/85,9.64%,RACK1;ELOB;NOP53;SUMO2;TMEM259;NUPR1;RBX1;CLU;HSPA1A;VCP;CSNK1A1;CEBPA;BAG6;PSMC5;CSNK1D;PSMC3;CSNK1E;STUB1;SUMO1;RAD23A;GABARAP;DAB2;PSMC6;SIRT2;HECTD1;TRIB1;HSPA1B;ZER1;DAB2IP;DVL1;TRIB2
prerank,hepaticobiliary system development (GO:0061008),0.7995129493490706,1.034229008513516,0.3605,0.75602340750689,1.0,13/20,15.16%,LSR;CDK5RAP3;CEBPA;PRKCSH;XBP1;CEBPG;CITED2;PKD2;GFER;TGFBR3;NF1;PHF2;NIPBL
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.801644124509336,1.0342285770599606,0.363,0.7555012763813055,1.0,11/20,13.60%,PDCD4;NOTCH1;OLFM1;RBPJ;ENG;SNAI2;ACVRL1;TBX3;BMP4;TGFBR1;TGFBR3
prerank,response to progesterone (GO:0032570),0.7996777259846289,1.03409836678806,0.368,0.755520599157643,1.0,8/21,12.59%,CAV1;YAP1;WBP2;NR1H3;SRC;THBS1;ABHD2;UBE3A
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.8158522975558702,1.0340387252479157,0.3705,0.7552450596443872,1.0,4/36,5.63%,CDH17;DCHS1;CDH11;CDH5
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.8225327703323687,1.033907217523424,0.3695,0.7552776272380034,1.0,12/46,11.32%,SLC26A2;IMPDH2;PPCS;PAPSS2;PANK3;COASY;ACOT7;ADCY6;GUCY1B1;SLC35B2;ACAT1;AMPD2
prerank,autophagosome maturation (GO:0097352),0.8108995825910001,1.033787987265311,0.3575,0.7552371452672995,1.0,15/34,11.00%,CALM1;VMP1;VAMP8;VCP;GABARAPL2;MAP1LC3B;ATP2A2;CHMP3;GABARAP;MAP1LC3A;LIX1L;LAMP2;TSG101;WIPI2;UBQLN1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.8043579367839536,1.0337154902215733,0.3605,0.755000223962649,1.0,8/23,9.09%,HSP90AB1;CDC37;IFNGR2;SUMO1;IFNGR1;SOCS3;JAK1;NR1H3
prerank,positive regulation of protein secretion (GO:0050714),0.835101268657821,1.0336704801003676,0.384,0.7546649330096945,1.0,11/72,6.43%,PPIA;EZR;SOX4;TMED10;NNAT;C1QTNF3;MYH10;ARF6;BAD;TCF7L2;GOLPH3
prerank,lamellipodium organization (GO:0097581),0.8045768232652242,1.0335977491735377,0.3645,0.7544479756024893,1.0,12/29,12.37%,ITGB1;RAC1;VCL;CTTN;CYFIP1;GOLPH3;SNX1;ARHGEF7;ARFIP2;ABLIM1;CDH13;CCDC88A
prerank,retinol metabolic process (GO:0042572),0.8016119514184115,1.033451217202312,0.3775,0.7545383294045889,1.0,7/21,14.80%,DHRS9;RETSAT;DHRS3;RDH10;ADH1C;RDH11;ADH1B
prerank,protein kinase B signaling (GO:0043491),0.7998848055821709,1.0334206689385055,0.362,0.7541584037118495,1.0,11/24,13.75%,ZFP36L1;GAS6;TSC2;CCL2;AKT1;PTEN;EPHA2;SIRT2;ADTRP;SETX;TYRO3
prerank,mitotic cytokinetic process (GO:1902410),0.8016950049409987,1.0332140988401226,0.368,0.754493350999698,1.0,17/20,17.61%,RHOA;PDCD6IP;CHMP2A;CHMP1A;CHMP5;CHMP3;VPS4B;CHMP1B;VPS4A;CHMP4A;CHMP4B;CHMP2B;KLHDC8B;CHMP7;CNTROB;CHMP6;KIF20A
prerank,response to nutrient levels (GO:0031667),0.7973016949775655,1.0329890296975108,0.3765,0.7549272242500827,1.0,4/22,6.64%,ATF4;EIF4G1;SCT;CD68
prerank,protein insertion into ER membrane (GO:0045048),0.8086931173966994,1.0328043608360922,0.368,0.755178649336046,1.0,24/35,14.51%,SEC61G;SEC61B;WDR83OS;APP;VAPA;SERP1;BAG6;EMC10;EMC4;TRAM1;PRNP;CYB5A;SGTA;EMC6;UBE2J2;ALDH3A2;VAMP2;STX5;EMC3;EMC7;CCDC47;CAMLG;EMD;EMC9
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.7990452330262449,1.0326341841497186,0.384,0.755378736408795,1.0,10/22,14.69%,MST1;C1QTNF3;CDA;CLK2;NCOR1;SOGA1;BCKDK;C1QTNF12;GSK3A;PGP
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.8209644000840792,1.0326246118386992,0.379,0.7548993283527075,1.0,17/45,12.12%,JUN;IGFBP5;MMP2;ID2;PDGFRB;PHB;ADAMTS1;AKT1;GJA1;DNMT1;MFN2;BMP4;FOXP1;MEF2D;THBS1;BMPR1A;CDH13
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.7964864148837177,1.032582216593766,0.3685,0.7545607021149445,1.0,10/22,12.46%,DUSP1;PPP1CA;PPP2CB;PPP2CA;DUSP6;PPM1A;PPP5C;PPM1G;PPM1F;PPM1B
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.8005437724288498,1.0322800669443017,0.382,0.7552782299921097,1.0,5/17,6.99%,DPYSL3;DPYSL2;NT5C;CRMP1;UPP1
prerank,Notch signaling pathway (GO:0007219),0.8270330466038688,1.032159044368724,0.3815,0.7552660939936193,1.0,20/60,9.51%,MDK;YBX1;NOTCH3;HES1;PBX1;PLXND1;JAG1;NOTCH1;PSEN1;NOTCH2;APH1A;NCSTN;ADAM10;RBPJ;SNAI2;CREBBP;GMDS;TRAF7;DTX4;POFUT1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.8156921895793973,1.0320028928024079,0.3585,0.7553423119115675,1.0,9/40,6.23%,FBLN1;ACTN4;RHOA;MELTF;JAG1;NOTCH1;TBCD;RCC2;ADAM15
prerank,regulation of chemotaxis (GO:0050920),0.8070386659648414,1.031965730790209,0.3565,0.7549814712895803,1.0,15/31,12.59%,CCL21;RARRES2;ADGRA2;PDGFRB;PDGFRA;P2RX4;ZSWIM8;STX3;F2RL1;STX4;THBS1;PPM1F;DUSP3;YTHDF1;EFNB2
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.8167761967860725,1.0319496221194326,0.36,0.7545322244836027,1.0,18/39,9.60%,UBL5;TOMM7;ATP5IF1;UBE2D3;SREBF2;UBE2L3;NPEPPS;MICALL2;PINK1;SREBF1;HUWE1;SAE1;SH3GLB1;LMAN1;LEPROT;BAP1;FZD5;UBE2J2
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.8039288203872517,1.03176543444495,0.373,0.7547765908533739,1.0,1/23,0.92%,PLA2G2A
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.8228073824279852,1.031671157286482,0.373,0.7546464681847593,1.0,30/54,9.00%,OAZ1;PSMB1;PSME1;PSMB4;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5;PSMC3;ODC1;PSMD2;PSMA2;PSMB2;OAZ2;PSMD13;PSMD4;PSMD3;PSMC1;PSMC6;AZIN1;PSMC4;PSMF1;PSMA3;PSMA5
prerank,negative regulation of MAP kinase activity (GO:0043407),0.8190511659544647,1.0316680857640659,0.368,0.7541450001162741,1.0,18/48,11.95%,GSTP1;APOE;DUSP1;PDCD4;UCHL1;CDK5RAP3;DNAJA1;RGS2;AGT;SORL1;HYAL2;GBA;SMPD1;DAB2IP;BMP4;HIPK3;SPRY2;AIDA
prerank,clathrin coat assembly (GO:0048268),0.794859765757174,1.0315096697450794,0.3783783783783784,0.754278056106862,1.0,5/15,5.94%,CLTB;CLTC;CLTA;AP2S1;PICALM
prerank,regulation of vasculature development (GO:1901342),0.794940344339169,1.0312301897312641,0.3495,0.7549214624658128,1.0,13/26,14.21%,CTNNB1;ADGRA2;ERBB2;RNH1;SFRP1;PLXND1;EPHA2;HTATIP2;EGLN1;EMP2;ETS1;NF1;VASH1
prerank,mesonephric tubule development (GO:0072164),0.7957834612027153,1.0309303273265513,0.378,0.7556487998388799,1.0,7/17,13.29%,TCF21;PKD1;OSR1;NPNT;BMP4;FGFR2;PKD2
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.8030202158682291,1.0308472156667159,0.3755,0.755492424733245,1.0,6/27,6.21%,CCL21;CAPZB;EVL;CDK10;PFN2;YAP1
prerank,protein heterooligomerization (GO:0051291),0.7919810049166999,1.0306806451876627,0.3765,0.7556536783752271,1.0,9/17,13.29%,KRT10;MAT2A;PKD1;CPSF6;CPSF7;TMEM120A;NUDT21;FARSA;PKD2
prerank,negative regulation of JNK cascade (GO:0046329),0.8107948070336674,1.0306324741348223,0.3715,0.7553302785347473,1.0,14/33,13.52%,GSTP1;PDCD4;DNAJA1;PINK1;NCOR1;F2RL1;PER1;HIPK3;HDAC3;AIDA;DUSP3;ZMYND11;DACT1;SIRPA
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.8075412778587154,1.0304953289756593,0.3625,0.7553753867774751,1.0,14/30,14.37%,MIF;APP;ILK;PTGES3;NRP1;SDCBP;PSEN1;ITGA6;SRC;FZD7;PTH1R;THBS1;BCL10;KCTD20
prerank,embryonic organ morphogenesis (GO:0048562),0.8103047065297417,1.0304457595518566,0.368,0.7550712067438362,1.0,9/43,6.05%,MFAP2;TCF21;ID2;FBN1;FBN2;PDGFRA;HES1;FOXF1;HOXB3
prerank,regulation of protein targeting to membrane (GO:0090313),0.7997535759156605,1.0304118898436987,0.3655,0.7546958154711345,1.0,14/29,12.89%,CIB1;CHP1;ERBB2;FIS1;GDI1;MYO1C;AKT2;PRNP;MFF;MTCL1;ITGB1BP1;HRAS;FYN;SLC51B
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.8016842806756952,1.0303792181763571,0.3755,0.7543216067120256,1.0,16/21,17.01%,PHB2;SPG7;PHB;SMDT1;STOML2;YME1L1;LETM1;PMPCA;AFG3L2;PMPCB;MCUR1;SLC25A23;MICU2;MICU1;PARL;MCU
prerank,mitotic cytokinesis (GO:0000281),0.8191319223455574,1.0301489017102399,0.3645,0.7547468335389209,1.0,8/48,4.59%,STMN1;RHOC;SPTBN1;JTB;RHOB;SON;PDCD6IP;MYH10
prerank,hyaluronan catabolic process (GO:0030214),0.7927225008736216,1.0298117749722873,0.378,0.755606758037294,1.0,7/18,11.51%,CHP1;HEXB;HEXA;GUSB;HYAL2;LYVE1;CD44
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.792832123534544,1.0296066195124143,0.3973973973973974,0.7559186836895798,1.0,4/15,10.06%,CENPX;TOP2A;TOP2B;MUS81
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.8132784949373478,1.0294821615559528,0.3805,0.7559210946539318,1.0,11/39,9.03%,JUP;DSG2;YWHAE;TRPM4;CAV1;DSC2;DSP;BIN1;ANK2;AKAP9;CAMK2D
prerank,negative regulation of phosphorylation (GO:0042326),0.8377833788752204,1.029403405259459,0.4165,0.7557576190637729,1.0,28/83,9.49%,PPIA;DYNLL1;FBLN1;HNRNPU;CIB1;PARK7;CDKN1C;IGFBP3;CDKN1A;NUPR1;CHP1;CDK5RAP3;PRDX3;TARDBP;PTEN;MYADM;PLPP3;PRNP;NCOR1;DNAJC10;FKBP8;XDH;TERF2IP;WWTR1;DAB2IP;PRKDC;OCLN;ANKLE2
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.7962298893123638,1.0292738062576259,0.3815,0.7557762752128002,1.0,7/21,9.26%,TMEM59;AP2M1;CLTC;TMBIM1;PICALM;DAB2;NUMB
prerank,regulation of osteoblast proliferation (GO:0033688),0.7944589875771004,1.029138222298913,0.389,0.7558046509869096,1.0,9/16,15.28%,RHOA;PLXNB1;SFRP1;ATRAID;NPR3;GREM1;FGFR2;TMEM119;EIF2AK2
prerank,COPII vesicle coating (GO:0048208),0.8260483343960192,1.0289310486085375,0.387,0.7551464182158387,1.0,41/63,13.58%,SERPINA1;CTSC;TMED10;RAB1A;CD59;PDCD6;SEC31A;TMED2;TFG;AREG;CSNK1D;RAB1B;SEC13;TRAPPC2L;PPP6R3;NAPA;SEC24C;SEC16A;TRAPPC1;LMAN1;CNIH1;PPP6R1;SEC22B;SEC23A;GOLGA2;COL7A1;PEF1;CTSZ;TRAPPC4;TRAPPC3;USO1;MCFD2;STX5;SAR1B;CUL3;PPP6C;TRAPPC6A;PREB;TBC1D20;SCFD1;SEC24D
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.8260483343960192,1.0289310486085375,0.387,0.7551464182158387,1.0,41/63,13.58%,SERPINA1;CTSC;TMED10;RAB1A;CD59;PDCD6;SEC31A;TMED2;TFG;AREG;CSNK1D;RAB1B;SEC13;TRAPPC2L;PPP6R3;NAPA;SEC24C;SEC16A;TRAPPC1;LMAN1;CNIH1;PPP6R1;SEC22B;SEC23A;GOLGA2;COL7A1;PEF1;CTSZ;TRAPPC4;TRAPPC3;USO1;MCFD2;STX5;SAR1B;CUL3;PPP6C;TRAPPC6A;PREB;TBC1D20;SCFD1;SEC24D
prerank,vesicle coating (GO:0006901),0.8260483343960192,1.0289310486085375,0.387,0.7551464182158387,1.0,41/63,13.58%,SERPINA1;CTSC;TMED10;RAB1A;CD59;PDCD6;SEC31A;TMED2;TFG;AREG;CSNK1D;RAB1B;SEC13;TRAPPC2L;PPP6R3;NAPA;SEC24C;SEC16A;TRAPPC1;LMAN1;CNIH1;PPP6R1;SEC22B;SEC23A;GOLGA2;COL7A1;PEF1;CTSZ;TRAPPC4;TRAPPC3;USO1;MCFD2;STX5;SAR1B;CUL3;PPP6C;TRAPPC6A;PREB;TBC1D20;SCFD1;SEC24D
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.8404458571642158,1.0289272032611552,0.4095,0.7546597207243302,1.0,18/97,6.37%,DCN;LUM;OGN;VCAN;HSPG2;GPC3;ST3GAL4;AGRN;SDC1;B4GALT1;CHPF;SDC2;HEXA;SDC4;B3GNT7;GPC6;UGDH;GPC1
prerank,phagosome acidification (GO:0090383),0.8042048804837775,1.028877076938706,0.3775,0.7543578698999179,1.0,10/28,9.76%,ATP6V0B;ATP6V1G1;ATP6V0D1;ATP6V0E1;RAB7A;ATP6V1F;TCIRG1;ATP6V1E1;ATP6V0A1;ATP6V1B2
prerank,MAPK cascade (GO:0000165),0.8900612738889433,1.028536606523719,0.4785,0.7552458560261099,1.0,41/302,4.05%,RPS27A;APOA1;UBC;UBA52;UBB;CALM1;ZFP36L2;ZFP36L1;SKP1;FGFR3;SPTBN1;ZFP36;PPP1CB;PEBP1;YWHAE;PSMB1;RBX1;SPTAN1;ERBB2;MAP2K2;PSME1;PSMB4;ERBB3;PSME2;YWHAB;PDGFRB;PDGFRA;MAPK3;PSMD8;PSMB3;PSMA7;PSMB5;NCAM1;PSMB7;ABHD17C;PSMB6;PPP1CC;FGFR1;PABPN1;PSMA1;PSMA4
prerank,Rac protein signal transduction (GO:0016601),0.7949519310185401,1.0285235023072083,0.3915,0.7547878286576977,1.0,12/18,16.27%,RAC1;BRK1;NCKAP1;EPS8;CYFIP1;DBNL;ABI2;HACD3;CDH13;RHOG;AIF1;FARP2
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.8181329062439819,1.0285136490453592,0.377,0.7543200530099341,1.0,30/48,14.32%,SLC25A6;TOMM7;TSPO;ROMO1;TIMM13;FIS1;HSPD1;BCAP31;TOMM20;TIMM8B;AKT1;PINK1;HK2;TIMM17B;MFF;DNAJC15;TOMM22;MFN2;FBXO7;AIP;DNAJC19;TIMM44;TOMM40;HK1;TIMM10;TIMM17A;RALA;PITRM1;TIMM50;TOMM70
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.8692316665076016,1.028332168430841,0.485,0.7545559794650578,1.0,33/195,6.49%,TMSB4X;RACK1;GSTP1;DUSP1;NOP53;NDUFA13;SLC9A3R1;CIB1;PEBP1;PLAUR;DDX3X;MCL1;CAV1;ATP2B4;PDCD6;CPNE1;C1QTNF3;DDIT4;TNIP1;UBE2B;TSC2;CDC34;RIOK3;AKT1;NDUFS3;HERPUD1;PTEN;EPHA2;VGLL4;APLNR;PINK1;HYAL2;TLE1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.7888462984467832,1.0282996841837606,0.38,0.7541817745073467,1.0,12/16,16.47%,SNRNP200;SNRPC;SRSF1;CWC15;PSIP1;SFSWAP;DDX23;WBP11;NCBP2;RBM22;PRPF39;SART1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.7927015338497861,1.0281047042531113,0.3745,0.7544908608813771,1.0,13/20,12.94%,FIS1;BCAP31;TGM2;ATP2A2;TMCO1;SELENOK;PACS2;HERPUD1;PSEN1;CAMK2D;BAX;WFS1;CCDC47
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.8097545214621129,1.027913334781328,0.3725,0.7547688680685735,1.0,6/34,6.98%,AGR2;PLAUR;AREG;AGT;AKT1;ARAP1
prerank,negative regulation of axonogenesis (GO:0050771),0.799629982962932,1.0277667164876059,0.3685,0.7548786158674096,1.0,6/28,5.56%,RHOA;RTN4;ARHGDIA;GDI1;THY1;PTEN
prerank,response to lipopolysaccharide (GO:0032496),0.8619659351569049,1.0275941332273189,0.462,0.7550997357833188,1.0,22/158,5.97%,VIM;GSTP1;HMGB1;RHOA;PDCD4;DEFA3;S100A14;ZFP36;CPS1;HMGB2;SLPI;HNRNPA0;DEFA5;PABPN1;XBP1;SELENOS;DEFA6;PRDX3;CCL2;CHMP5;LGALS9;SCARB1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.790617231122936,1.0273569821648838,0.382,0.7555484395065577,1.0,4/18,11.27%,CCL21;ADAM10;WNK1;PTK2B
prerank,ureteric bud development (GO:0001657),0.7934011673186774,1.0270707682699463,0.378,0.7561893657770083,1.0,7/19,13.29%,TCF21;GPC3;OSR1;NPNT;BMP4;FGFR2;PKD2
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.7984292747499087,1.0269613003660825,0.378,0.7561556842345337,1.0,7/24,9.98%,DGAT1;TECR;ACSL5;ELOVL1;FAR1;ACOT7;HSD17B12
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.8405281071688462,1.0267135706196173,0.424,0.7561631070500592,1.0,38/96,8.09%,CTSD;DYNLL1;CD74;ARF1;DNM2;CANX;AP2M1;CLTC;CLTA;HLA-DRA;CTSS;CAPZB;AP2S1;DYNC1H1;LGMN;DCTN2;SEC31A;HLA-DRB1;KLC1;RAB7A;CAPZA1;KIF22;DYNC1LI2;SEC13;CTSL;AP2A2;DCTN3;DYNLL2;DYNC1I2;DCTN1;ACTR1A;AP2B1;SEC24C;AP1B1;ACTR1B;ACTR10;CAPZA2;HLA-DPB1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.8405281071688462,1.0267135706196173,0.424,0.7561631070500592,1.0,38/96,8.09%,CTSD;DYNLL1;CD74;ARF1;DNM2;CANX;AP2M1;CLTC;CLTA;HLA-DRA;CTSS;CAPZB;AP2S1;DYNC1H1;LGMN;DCTN2;SEC31A;HLA-DRB1;KLC1;RAB7A;CAPZA1;KIF22;DYNC1LI2;SEC13;CTSL;AP2A2;DCTN3;DYNLL2;DYNC1I2;DCTN1;ACTR1A;AP2B1;SEC24C;AP1B1;ACTR1B;ACTR10;CAPZA2;HLA-DPB1
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.7981498234956377,1.0265432178593268,0.377,0.7563765260709276,1.0,13/25,11.94%,NUMA1;NOTCH1;CDH5;SULF1;RBPJ;ENG;SMAD4;BMPR2;ACVRL1;FBXL15;BMP4;SMAD2;BMPR1A
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.7932678161958916,1.0264327882116384,0.39,0.7563090125322325,1.0,6/18,13.52%,PDCD4;CUEDC2;CHID1;APPL2;PYCARD;SIRPA
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.8212138866686848,1.0263973356411877,0.384,0.755952515678004,1.0,11/52,7.35%,UBB;DNM2;NBL1;CTTN;PLXNB1;SGK1;TRIO;NCKAP1;DBN1;DBNL;SNX1
prerank,negative regulation of cell communication (GO:0010648),0.7964784416566772,1.0262818710029502,0.394,0.755919455730324,1.0,4/21,9.18%,IGFBP3;ERBB3;HHIP;PTK6
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.8315860350909942,1.026221020192245,0.396,0.7556638868659579,1.0,17/77,6.29%,MDK;HMGB1;NR4A1;VIP;HMGB2;EGFL7;MYDGF;VEGFA;PDCD6;FGFR1;EMC10;NRP1;AKT1;VEGFB;NRP2;APLNR;SEMA5A
prerank,protein targeting to mitochondrion (GO:0006626),0.8185182556453859,1.0260873263049437,0.3805,0.7556779881063239,1.0,32/55,14.41%,SLC25A6;TOMM7;HSP90AA1;NDUFA13;TSPO;ROMO1;TIMM13;FIS1;HSPD1;BCAP31;TOMM20;TIMM8B;TIMM17B;MFF;DNAJC15;TOMM22;MFN2;PMPCA;FBXO7;PMPCB;AIP;DNAJC19;TIMM44;TOMM40;TIMM10;TIMM17A;PITRM1;TIMM50;SAMM50;IMMP1L;TOMM70;HSPA4
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.7980204925804042,1.0260248502932603,0.367,0.7554374476834242,1.0,13/29,11.43%,ATF4;ATP2A3;BAG6;SELENOK;ERN2;ERO1A;DNAJC10;CEBPB;PPP1R15A;DAB2IP;BAX;QRICH1;RNF186
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.8007240753935186,1.0259572405096513,0.3755,0.755235508753277,1.0,23/30,17.48%,OST4;RPN2;DAD1;OSTC;DPM3;MGAT1;RPN1;TUSC3;STT3B;DDOST;LMAN1;UBE2J1;ST6GAL1;MCFD2;MAGT1;DPM2;STT3A;NUDT14;MGAT5;DPM1;MGAT2;UGGT1;ALG5
prerank,regulation of fibroblast migration (GO:0010762),0.7909207727574217,1.0259394106160096,0.399,0.7548032961573969,1.0,9/20,11.42%,ITGB1;RAC1;HYAL2;ARHGEF7;PTK2;DDR2;APPL2;ITGB1BP1;THBS1
prerank,regulation of fatty acid oxidation (GO:0046320),0.792871083185717,1.0258930494765797,0.4065,0.7545041516863069,1.0,1/16,1.07%,ACADVL
prerank,ERBB2 signaling pathway (GO:0038128),0.8001877592786242,1.0256723837322619,0.378,0.7549000630878013,1.0,14/32,10.68%,HSP90AA1;CDC37;ERBB2;ERBB3;SHC1;STUB1;GRB2;ERBIN;PTPN18;PTK6;PTPN12;SRC;GAB1;CPNE3
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.7952686381031774,1.0255802956954192,0.3865,0.754765171961548,1.0,9/22,10.47%,CAMK2N1;CDKN1C;CDKN1A;CEBPA;NR2F2;PTEN;IPO5;IPO7;CDKN1B
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.8078319017280633,1.0255063568135583,0.393,0.7545617087523252,1.0,16/39,12.18%,EFNA1;MVP;APP;ERBB3;CAV1;THY1;GAS6;SHC1;AGT;HYAL2;PRNP;PTK6;NCK2;UNC119;RAP2B;DLG3
prerank,pharyngeal system development (GO:0060037),0.79080179935599,1.0253579796297272,0.397,0.7546366183848208,1.0,6/17,11.94%,HES1;PTCH1;BMPR2;BMP4;TGFBR1;BMPR1A
prerank,mitotic nuclear division (GO:0140014),0.8297162195510009,1.0252586422184633,0.4015,0.7545596563549776,1.0,13/74,6.23%,FLNA;MISP;RHOA;RAN;RAB11A;ZNF207;UBE2S;CHMP2A;KPNB1;EPS8;SMC4;LSM14A;UBE2C
prerank,histone H3 deacetylation (GO:0070932),0.7910570974281489,1.025256489828362,0.4027013506753377,0.7540724235902484,1.0,8/15,11.88%,SFPQ;HDAC1;HDAC2;SIRT2;SIRT7;SIRT6;PER1;HDAC3
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.8288463177044371,1.0250200891169607,0.397,0.7545392367597119,1.0,14/74,10.14%,CD81;CD74;MIF;HLA-E;TFRC;CD46;ANXA1;IL6ST;HLA-DPB1;CD320;CD276;PNP;HLA-DPA1;NCK2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.7933061052814825,1.0248252108528935,0.3895,0.7548218319852621,1.0,6/22,8.83%,EFNA1;CLU;PICALM;IFNGR1;ROCK2;RELA
prerank,cellular response to topologically incorrect protein (GO:0035967),0.8030155249449823,1.024438532324881,0.384,0.7559205645382696,1.0,12/32,10.02%,HSPA8;TMBIM6;HSPA5;HSPA1A;STUB1;HSPA9;OPTN;HDAC6;HSPA1B;HSF1;DAB2IP;BAX
prerank,osteoclast differentiation (GO:0030316),0.7949994906567344,1.0243948569452266,0.395,0.7555892496609892,1.0,12/22,18.57%,ANXA2;EPHA2;GLO1;SRC;FOXP1;MAPK14;SBNO2;CSF1R;TYROBP;FARP2;CSF1;TNFRSF11A
prerank,fatty acid transport (GO:0015908),0.7943425588128086,1.0242750010394397,0.3955,0.7555656306709717,1.0,2/20,1.59%,APOE;FABP5
prerank,mesenchymal cell differentiation (GO:0048762),0.8136015097581254,1.0239847575703889,0.3765,0.7562712712561246,1.0,20/51,11.79%,DDX17;DDX5;CTNNB1;TRIM28;HNRNPAB;FOXF2;FGFR1;LOXL2;NOTCH1;S100A4;RBPJ;ENG;SNAI2;ROCK2;HIF1A;LIMS1;DLG5;CUL7;TGFBR1;FGFR2
prerank,regulation of RNA metabolic process (GO:0051252),0.8200970131885917,1.02386000623891,0.3805,0.7563112888249363,1.0,34/64,13.40%,HNRNPH1;PCBP2;AHNAK;FUS;PCBP1;SNRNP70;PTBP1;CLK1;HNRNPH3;SON;TRA2B;HNRNPF;FASTK;IGF2BP2;PCBP4;FAM50A;MBNL1;CLK2;GRSF1;PQBP1;HNRNPL;CELF1;AKAP17A;CLK3;PTBP2;HNRNPH2;ESRP1;MBNL2;YTHDF2;PTBP3;OAS1;RBM38;ZNF326;RBM12
prerank,cell chemotaxis (GO:0060326),0.8235954501528635,1.0236823601907667,0.399,0.7565207495733686,1.0,16/67,8.48%,CCL21;NR4A1;CXCL12;HMGB2;PDGFRB;PDGFRA;VEGFA;NRP1;BCAR1;EPHA2;SEMA5A;ARHGEF16;PARVA;RAB13;CORO1B;CCL28
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.791571903330848,1.0235080799236203,0.4049049049049049,0.7567531087948984,1.0,4/15,9.95%,VEGFA;AGT;SMO;BMP4
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.8022271967851011,1.0233036430222662,0.3845,0.7571257372908032,1.0,17/37,15.47%,STMN1;STMN2;PHLDB1;CDK2AP2;CLASP2;STMN3;MAPRE1;CAMSAP3;TAOK1;SKA2;GSK3B;CLASP1;PRKAA1;MAPRE2;MAP6;ROCK1;STMN4
prerank,sphingolipid catabolic process (GO:0030149),0.7875556975228291,1.0232633116750118,0.409,0.7567883043358199,1.0,8/16,14.18%,ASAH1;SMPDL3A;SMPD4;PDXDC1;SMPD1;GLA;SGPL1;PPT1
prerank,regulation of phospholipase C activity (GO:1900274),0.7903194160144486,1.0230923295906005,0.417,0.756989741895336,1.0,6/15,11.40%,PDGFRB;PDGFRA;FGFR1;ABL1;PLCG1;HRAS
prerank,regulation of p38MAPK cascade (GO:1900744),0.8044939306461535,1.0229679460634167,0.384,0.7569962577550646,1.0,8/37,6.13%,EZR;DUSP1;PRMT1;VEGFA;EMC10;PJA2;LGALS9;HAND2
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.7991921718390611,1.0229059795204496,0.3745,0.7567607380623604,1.0,13/33,13.69%,CALR;DDX5;PARK7;PRMT2;KDM1A;HDAC6;UFM1;CARM1;PKN1;SAFB2;DDRGK1;AXIN1;CBFB
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.8310022100151853,1.0227902742164305,0.417,0.7567261075566276,1.0,23/80,6.29%,PFN1;CCL21;CDC42EP5;CDC42;WDR1;VIL1;SYNPO2;NUMA1;CTTN;EVL;DYNC1H1;PFN2;NRP1;SORBS3;VASP;PFDN2;BAIAP2L2;ARF6;NCKAP1;ABL1;LMOD1;BIN1;SEMA5A
prerank,N-glycan processing (GO:0006491),0.7901944252133238,1.0224379479435937,0.4065,0.7576905347739761,1.0,10/19,16.45%,MGAT4B;GANAB;PRKCSH;MAN1B1;MAN1A1;MAN2A1;MAN2A2;MGAT4A;GNPTAB;MAN1A2
prerank,T cell differentiation (GO:0030217),0.8039646295130266,1.022435961147788,0.378,0.7572085977150934,1.0,4/41,4.41%,ZFP36L2;ZFP36L1;SOX4;ANXA1
prerank,multivesicular body assembly (GO:0036258),0.7987922820721018,1.0224136326155806,0.386,0.7568093749919165,1.0,21/30,12.41%,VPS28;RAB11A;IST1;PDCD6IP;CHMP2A;CHMP1A;CHMP5;CHMP3;HGS;VPS25;VPS4B;CHMP1B;SNF8;VPS4A;TSG101;CHMP4A;VPS37B;CHMP4B;MVB12A;VPS36;CHMP2B
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.7982703920762153,1.0224069128452336,0.386,0.7563477659617662,1.0,6/29,11.85%,APOE;APP;DBN1;NSMF;RAB5A;EPHB2
prerank,positive regulation of telomere maintenance (GO:0032206),0.800971588186994,1.0222390351831188,0.385,0.7565393710387197,1.0,8/32,9.49%,HNRNPA2B1;HNRNPD;MAPK3;PKIB;MAPK1;ERCC1;SIRT6;ATRX
prerank,nucleotide catabolic process (GO:0009166),0.7915047558462939,1.022190091332018,0.4185,0.7562498410816938,1.0,8/15,10.87%,VCP;NT5C;DNPH1;ITPA;XDH;NUDT3;PNP;NT5C2
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.8353396819282628,1.022059725734991,0.426,0.756303723024358,1.0,20/90,6.27%,MDK;EZR;RHOC;SMIM22;PHPT1;RHOA;RAC1;LRP1;ARHGDIA;RHOB;FSCN1;PDGFRB;PDGFRA;CDK10;CORO1A;EPS8;ABL1;F11R;IQGAP1;NOTCH2
prerank,negative regulation of neuron death (GO:1901215),0.838330590626649,1.022058688815836,0.43,0.7558193806150066,1.0,32/98,11.44%,MDK;CHGA;APOE;ATF4;GRN;PARK7;SOD1;SET;NENF;ERBB3;LGMN;EIF4G1;CCL2;AKT1;CD34;SORL1;PINK1;NFATC4;VPS35;SNX6;GBA;F2R;HLA-F;SOD2;INPP5A;FBXO7;RETREG1;CHMP4A;NRBP2;PTK2B;CHMP4B;WFS1
prerank,regulation of Wnt signaling pathway (GO:0030111),0.8438099567666727,1.0220438845930806,0.436,0.7553896393518962,1.0,30/111,7.61%,RACK1;LRP1;CTNNB1;GPC3;PPP2R1A;APP;SNX3;PPP1CA;TAX1BP3;SULF2;MACF1;SFRP2;HIC1;SFRP1;TSC2;PTK7;SPIN1;PPP2CA;ATP6AP2;VGLL4;PSEN1;DACT3;TLE1;WIF1;SMARCA4;ITGA3;WLS;SULF1;GSKIP;NXN
prerank,insulin secretion (GO:0030073),0.7861215549515191,1.0219437009702041,0.4025,0.7553312486052082,1.0,6/20,10.65%,PARK7;GAL;ANXA1;RAB11B;SELENOT;CAMK2G
prerank,positive regulation of leukocyte activation (GO:0002696),0.7862670349647841,1.0219182197233942,0.403,0.7549495042783372,1.0,5/18,15.57%,HSPD1;CEBPA;NECTIN2;THBS1;TNIP2
prerank,focal adhesion assembly (GO:0048041),0.7908672934699075,1.021873848496655,0.399,0.7546395419336286,1.0,15/21,17.73%,ACTN1;CTTN;THY1;RCC2;SORBS1;FERMT2;TRIP6;ARHGEF7;SRC;DLC1;PEAK1;PTPRK;BCR;TAOK2;PIP5K1A
prerank,negative regulation of protein localization to membrane (GO:1905476),0.7957862290269696,1.0218600373756654,0.388,0.7542116708664752,1.0,10/26,11.64%,TMEM59;AP2M1;CLTC;TMBIM1;GDI1;PICALM;DAB2;NUMB;ITGB1BP1;RHOQ
prerank,telomere maintenance via telomerase (GO:0007004),0.7955582055701939,1.02160737758049,0.388,0.75472602262572,1.0,11/29,11.78%,HSP90AB1;HSP90AA1;PTGES3;NOP10;NHP2;PPP6R3;TERF2IP;RPA1;TELO2;TNKS1BP1;PPP6C
prerank,cellular response to virus (GO:0098586),0.8027548519745622,1.0213638939780865,0.393,0.7552107359221667,1.0,13/34,12.79%,HSP90AA1;ARF1;DDX3X;EIF5A;RIOK3;LGALS9;GBF1;HIF1A;IRF3;BAX;FMR1;OAS1;MAPK14
prerank,negative regulation of intracellular protein transport (GO:0090317),0.7914843119836038,1.0213114903535694,0.403,0.754939047798773,1.0,8/23,10.54%,PARK7;CHP1;INSIG1;GDI1;LMAN1;UFM1;RANGAP1;ITGB1BP1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.8020091800033647,1.0211226700770446,0.389,0.7551956733967,1.0,10/36,9.88%,HINT1;DDX5;RPS27L;BAG6;DDIT4;STK11;PDK2;DYRK2;PYCARD;TMEM109
prerank,gastrulation (GO:0007369),0.788676488209094,1.0210074647591134,0.397,0.7551650208742838,1.0,8/18,19.99%,GPC3;UGDH;SMAD2;LMBRD1;LRP5;NPHP3;MEGF8;MKKS
prerank,mRNA polyadenylation (GO:0006378),0.7926536590116195,1.0208861942860035,0.393,0.7546991567902297,1.0,9/26,8.86%,PABPC1;APP;CPSF1;PAPOLA;SSU72;GRSF1;SYMPK;WDR33;AHCYL1
prerank,RNA polyadenylation (GO:0043631),0.7926536590116195,1.0208861942860035,0.393,0.7546991567902297,1.0,9/26,8.86%,PABPC1;APP;CPSF1;PAPOLA;SSU72;GRSF1;SYMPK;WDR33;AHCYL1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.8138139652068064,1.0206438121207337,0.3955,0.755192924852262,1.0,33/56,11.55%,SKP1;FHL1;PSMB1;RBX1;PSME1;PSMB4;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5;PSMC3;PSMD2;PSMA2;PSMB2;PSMD13;PSMD4;PSMD3;PSMC1;PSMC6;PSMC4;PSMF1;PSMA3;PSMA5;USP47;PSMB8;PSMD7;PSMC2
prerank,mitochondrial transport (GO:0006839),0.8183162147661485,1.0202881568543067,0.406,0.756169061948576,1.0,31/55,12.44%,SLC25A6;SLC25A5;TOMM7;HSP90AA1;TSPO;TIMM13;FIS1;BCAP31;SPG7;TOMM20;TIMM8B;TMEM14C;OXA1L;BAD;TIMM17B;MFF;SLC25A4;TOMM22;MFN2;BNIP3;FBXO7;TMEM14B;AIP;DNAJC19;TIMM44;TOMM40;MTX2;PPIF;TIMM10;TMEM14A;TIMM17A
prerank,sympathetic nervous system development (GO:0048485),0.7823307746705518,1.0202345989400392,0.4085,0.7559063064401019,1.0,9/16,17.53%,CTNNB1;SOX4;NRP1;NRP2;PHOX2B;SEMA3A;NF1;SEMA3F;SOX11
prerank,positive regulation of secretion by cell (GO:1903532),0.8248990503726,1.0198225274722295,0.417,0.7570747136379937,1.0,10/72,6.43%,PPIA;EZR;TMED10;GRK2;ATP6AP1;MYH10;ARF6;SLC12A2;P2RX4;GOLPH3
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.7848213255319905,1.0198087079718945,0.4119119119119119,0.7566437723079154,1.0,9/15,14.75%,CTNNB1;SMAD4;DNMT1;KMT2E;WDR61;AUTS2;KMT2A;SNW1;WDR5
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.8225868111061637,1.019653622137793,0.403,0.7567961694804728,1.0,28/67,12.37%,CEACAM1;AGR2;MVP;CDC42;PLAUR;EPN1;AREG;AGT;AKT1;ITGA1;ERRFI1;HGS;ARAP1;GRB2;ARHGEF7;RNF126;DAB2IP;PTK6;PTPN12;TSG101;NUP62;RHBDF1;MVB12A;DGKD;SPRY2;CDH13;DUSP3;CCDC88A
prerank,negative regulation of cell death (GO:0060548),0.8318109243479355,1.0194910357623925,0.4275,0.7569822367917614,1.0,37/87,11.55%,CHGA;AGR2;PARK7;NENF;SRSF6;CLU;SOX4;HSPA1A;KANK2;AGR3;LRPAP1;EIF4G1;CHMP2A;PSMC5;AKT1;CD34;SORL1;FERMT2;PINK1;BNIP3L;VPS35;VPS4B;GBA;HSPA1B;HLA-F;ALB;PDE8A;BNIP3;INPP5A;TMEM109;BMP4;CHMP4A;NUP62;BECN1;CHMP4B;WFS1;TXNDC12
prerank,positive regulation of protein export from nucleus (GO:0046827),0.785720023488154,1.0194013634590788,0.416,0.7568673072141829,1.0,9/15,14.23%,YWHAE;ANP32B;GAS6;TCF7L2;TPR;GSK3B;TP53;EMD;RBM22
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.7923620263132889,1.0192825683854525,0.3965,0.7568737722712485,1.0,12/24,14.41%,HSP90AA1;NDUFA13;ROMO1;TIMM13;TIMM8B;BAD;TOMM22;BAX;TIMM10;SAMM50;TOMM70;HSPA4
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.8342355284774505,1.019177882420446,0.429,0.7568132664443423,1.0,27/97,9.61%,GNAS;PLAC8;LCN2;MFAP2;FABP5;G0S2;OGT;CAV1;HADH;DYNC1H1;VEGFA;STAT6;EPAS1;KDM1A;GJA1;APPL2;HSF1;SIRT6;CEBPB;PHOX2B;DECR1;IGF1R;ZBTB7B;PRKAB1;THRA;ADIPOR2;MFN2
prerank,epithelial tube morphogenesis (GO:0060562),0.7978934887767648,1.019089781807776,0.3935,0.7566820938707217,1.0,14/34,13.29%,COL4A1;CTNNB1;RHOB;CSNK2B;HES1;PKD1;ACVRL1;SCRIB;BMP4;PRKD2;CCM2;PODXL;PAK1;PKD2
prerank,glycolipid metabolic process (GO:0006664),0.8091851106544131,1.0190504466782389,0.402,0.7563692460060343,1.0,24/51,12.37%,CTSA;PSAP;ST3GAL4;ASAH1;NEU1;GBA2;HEXB;HEXA;FUCA1;SMPD4;ENPP7;CERK;ESYT2;GBA;SMPD3;SMPD1;GLTP;SUMF2;GLB1;GLA;B3GNT5;ESYT1;UGCG;ARSA
prerank,neural tube development (GO:0021915),0.7804795411542931,1.0190427480551698,0.408,0.7559145342868034,1.0,7/16,13.29%,SOX4;PKD1;PTCH1;ZNF358;DVL1;DACT1;PKD2
prerank,vacuolar acidification (GO:0007035),0.788062560613965,1.0187939179748409,0.402,0.756432704109506,1.0,7/21,7.03%,GRN;ATP6V0D1;ATP6V0E1;TMEM9;ATP6AP2;TCIRG1;ATP6V0A1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.8458262361231026,1.0183371601816005,0.467,0.757801113754471,1.0,32/123,6.36%,MDK;LAMB1;NR4A1;GRN;VIP;PTN;RTN4;MST1;SRSF6;ERBB2;HMGB2;LAMC1;HPN;EGFL7;MYDGF;VEGFA;PDCD6;EMC10;NRP1;AREG;XBP1;SFRP1;AKT1;VEGFB;NRP2;OSR1;BAD;NME1;YAP1;NOTCH2;SEMA5A;TCF7L2
prerank,midbody abscission (GO:0061952),0.7873111016795566,1.0182965782979514,0.4192096048024012,0.7574775498267506,1.0,14/17,17.61%,PDCD6IP;CHMP2A;CHMP1A;CHMP5;CHMP3;VPS4B;CHMP1B;VPS4A;CHMP4A;CHMP4B;CHMP2B;CHMP7;CHMP6;KIF20A
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.795527800164115,1.0182843444542713,0.404,0.7570458285947279,1.0,20/27,19.21%,GUK1;NME4;NME3;DUT;CMPK1;AK2;TYMS;GLRX;NME1;DTYMK;RRM2;DCTD;GSR;AK1;TXNRD1;AK6;RRM1;CTPS1;AK4;CTPS2
prerank,adenine nucleotide transport (GO:0051503),0.7847658209692867,1.0182748028276634,0.4085,0.7566054553294789,1.0,1/18,0.90%,SLC25A5
prerank,sodium ion transport (GO:0006814),0.8326520400100116,1.0180534087344488,0.435,0.7570410124352962,1.0,10/90,5.75%,SCNN1B;SLC6A8;ATP1B3;ATP1B1;SCNN1A;SGK1;NEDD4L;SLC6A19;SLC12A2;SLC4A4
prerank,RNA metabolic process (GO:0016070),0.8475566282964128,1.0179525558656786,0.468,0.756973813586711,1.0,42/133,5.82%,HNRNPA1;HNRNPA2B1;DDX17;HNRNPH1;HNRNPK;PCBP2;HNRNPC;HNRNPA3;HNRNPU;RBM39;POLR2L;PCBP1;PTBP1;HNRNPD;RBM3;RBM5;DDX3X;HNRNPM;RNASE1;RBMX;HNRNPA0;RBPMS;HNRNPH3;POLR2J;RBFOX2;RBM6;PAPOLA;POLR2H;HNRNPR;POLR2E;HNRNPF;PABPN1;POLR2F;POLR2I;DHX9;RNASEH2C;SND1;ADAR;POLR2G;SYNCRIP;HNRNPUL1;PABPC4
prerank,monocarboxylic acid catabolic process (GO:0072329),0.7932164878105908,1.0179263913115675,0.3925,0.7566046187785632,1.0,10/27,15.56%,CYP2W1;ACAA1;CEL;ACOX1;CYP4F12;LPIN3;FAAH;ACOT8;LPIN2;PPARD
prerank,positive regulation of growth (GO:0045927),0.8213839277092742,1.0177482952978467,0.412,0.7568339752023603,1.0,29/71,12.22%,AGR2;EIF4G2;SLC44A4;CIB1;CDC42;DDX3X;ERBB2;HPN;EIF4G1;DNPH1;SFRP2;SFRP1;AKT1;SDCBP;RPS6KA1;S100A8;ADAM10;MTPN;S100A9;HDGFL2;BRAT1;USP47;INSR;MMP14;WFS1;TGFBR1;CSNK2A1;PPM1F;DERL2
prerank,liver development (GO:0001889),0.7953722764378157,1.0175228436281054,0.396,0.757254053926109,1.0,16/32,14.44%,LSR;PCK1;CDK5RAP3;CEBPA;PRKCSH;ANXA1;XBP1;PCK2;CEBPG;CEBPB;CITED2;PKD2;GFER;TGFBR3;NF1;PHF2
prerank,establishment of mitotic spindle localization (GO:0040001),0.7908092001009235,1.0174036027308093,0.39,0.7572693783583972,1.0,12/29,11.22%,MISP;ITGB1;NUMA1;DYNLT1;PAFAH1B1;KPNB1;DCTN1;CLASP2;GJA1;NSFL1C;NUSAP1;HTT
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.7874084431143862,1.017178476419322,0.4195,0.7576974944812646,1.0,12/17,18.33%,PDE9A;AGT;HAND2;IL6ST;MTPN;ROCK2;CAMK2D;PARP1;MEF2A;ROCK1;SLC9A1;PRKCA
prerank,multivesicular body organization (GO:0036257),0.7947357010812979,1.0171560930906591,0.396,0.7572993378457373,1.0,25/31,16.88%,VPS28;RAB11A;IST1;PDCD6IP;CHMP2A;CHMP1A;CHMP5;CHMP3;HGS;VPS25;VPS4B;CHMP1B;SNF8;VPS4A;TSG101;CHMP4A;VPS37B;CHMP4B;MVB12A;VPS36;CHMP2B;VTA1;CHMP7;CHMP6;RAB27A
prerank,ion homeostasis (GO:0050801),0.7901927442885266,1.0171340737861063,0.3965,0.756904838407894,1.0,8/30,10.66%,FHL1;NEDD4L;AP3D1;SLC4A4;WNK2;CAMK2D;SLC4A2;WNK1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.8591676896155744,1.0168654634583003,0.5035,0.757515848805247,1.0,17/177,5.56%,APOA1;PLA2G2A;STARD10;SLC44A4;ARF1;AGPAT2;APOA2;CSNK2B;CPNE1;PI4KA;SLC44A1;MBOAT7;STARD7;SLC44A2;INPPL1;CHKA;PTEN
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.7887680339529805,1.0168012807237636,0.404,0.7573116852853742,1.0,14/26,14.52%,CCND2;DDX3X;EIF4G1;CDK10;CCND1;ADAMTS1;ANXA1;AKT1;CCND3;TFDP1;KMT2E;ANKRD17;RDX;AIF1
prerank,dopaminergic neuron differentiation (GO:0071542),0.7836669088521769,1.01664375783055,0.413,0.7574361688170982,1.0,7/20,17.27%,CTNNB1;VEGFA;MANF;PHOX2B;LRP6;RYK;PHOX2A
prerank,response to hexose (GO:0009746),0.7870102758850587,1.0160009864433333,0.403,0.7595764766215712,1.0,11/25,13.31%,PFKL;APOA2;HNF4A;SELENOS;TCF7L2;KHK;EIF2B5;SELENOT;VAMP2;THBS1;EIF2B1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.7833122132562473,1.0159662072054532,0.4295,0.7592327271533645,1.0,10/15,15.31%,RTN4;ARL6IP1;RTN3;RAB10;RAB18;REEP3;ZFYVE27;TMEM33;REEP4;TMEM170A
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.8065286085403074,1.0156967027018113,0.4015,0.7598302958262614,1.0,5/45,5.85%,GSTP1;GAS6;SELENOS;CD34;LGALS9
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.7928937228303936,1.015549041084242,0.3995,0.7599575942461833,1.0,11/27,14.30%,CTNNA1;CTNNB1;CDC42;BOC;ABL1;TCF3;SPAG9;MEF2A;MAPK14;BNIP2;CDON
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.8669483593422878,1.0155119439242726,0.5095,0.759620530397638,1.0,26/223,4.29%,GAPDH;LGALS1;FLNA;GSTP1;HSPB1;RHOC;EEF1D;CD74;CCL21;RHOA;SQSTM1;FKBP1A;LITAF;LAMTOR5;VAPA;CPNE1;S100A13;HLA-DRB1;TFRC;NDFIP1;SHISA5;INAVA;CANT1;TNFRSF1A;RBCK1;TFG
prerank,protein transport (GO:0015031),0.888029157488989,1.0154415533714878,0.517,0.7594178248035423,1.0,61/366,5.49%,ZG16;CTSA;AMN;APOB;TXNIP;CD74;HSP90B1;NPM1;APOE;MYH9;ARF1;DNM2;VMP1;SPTBN1;CANX;LRP1;ATP6V0B;CLU;CLTC;TMED10;CTTN;RAB1A;ATP6V1G1;ARF4;ERP29;ATP6V0D1;TMED9;PDCD6;YWHAH;SEC31A;ATP6V0E1;TFRC;COPZ1;RAB7A;ATP6V1F;MTTP;RAB5C;RAB34;CHMP2A;MACF1;ATP6AP1;TMED2;VPS29;PDIA4;RAMP2;RAB1B;SAR1A;CHMP1A;SEC13;AP3D1;ARL6IP5;COPA;ARF5;RAB17;TMED4;RAMP1;SCAMP2;ARL14;ARF6;RAB5B;TBC1D9B
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.7799896278339841,1.015297963621386,0.4005,0.7595059588429796,1.0,15/21,20.08%,ATF4;VEGFA;XBP1;NOTCH1;RBPJ;SMAD4;HIF1A;RELA;NFE2L2;SMAD5;CREB3;CHD6;EP300;SMAD9;BMP2
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.7845158834116738,1.0152889843208048,0.419,0.7590695650981423,1.0,5/22,8.33%,PARK7;PINK1;SIRT2;HDAC6;TRAP1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.815259349684653,1.0152496923651102,0.4055,0.7587476777603289,1.0,37/67,13.19%,HSPB1;HSP90AA1;RHOA;RAC1;CYBA;CDC42;VEGFA;PDCD6;BRK1;WASF2;PXN;NRP1;BCAR1;NCKAP1;VEGFB;AAMP;NRP2;CYFIP1;SHC2;SULF1;ROCK2;PTK2;MAPKAPK2;DAB2IP;ITGAV;CRK;SRC;ABI1;PRKD2;NCK2;PTK2B;AXL;VAV3;FYN;MAPK14;PIK3R1;PAK2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.77824413801071,1.015237620175639,0.4305,0.7583232561357698,1.0,7/15,16.48%,PDGFRA;TGFBR2;EIF4A3;TGFBR1;FGFR2;NIPBL;MTHFD1
prerank,peptidyl-asparagine modification (GO:0018196),0.7926254982161625,1.0151855379228698,0.4,0.7580685276629624,1.0,23/31,17.48%,OST4;RPN2;DAD1;OSTC;DPM3;MGAT1;RPN1;TUSC3;STT3B;DDOST;LMAN1;UBE2J1;ST6GAL1;MCFD2;MAGT1;DPM2;STT3A;NUDT14;MGAT5;DPM1;MGAT2;UGGT1;ALG5
prerank,regulation of cell adhesion (GO:0030155),0.8474867997299209,1.0148373921221439,0.477,0.7589912612126541,1.0,35/133,8.38%,TPM1;MDK;FBLN1;P4HB;EFNA1;DUSP1;CD164;CXCL12;PPP1CB;PLXNB2;PPP2R1A;ADAMDEC1;ERBB2;ARHGDIA;ERBB3;PLXNB1;VEGFA;TGM2;TGFBI;PLXND1;PPP2CA;ABL1;EPHA2;C1QBP;SEMA5A;EPB41L4B;MYADM;ADAM10;CYTH1;ROCK2;ACVRL1;PTK2;ARHGDIB;EPHB3;RSU1
prerank,apoptotic mitochondrial changes (GO:0008637),0.795869089824416,1.0148316014315644,0.397,0.7585396890627595,1.0,20/33,16.81%,SFN;CLU;FIS1;HSPD1;BAD;HK2;VPS35;MFF;SOD2;NDUFS1;BNIP3;DNM1L;BAX;BOK;CCAR2;TIMM50;ATG3;BAK1;GGCT;BCL2L1
prerank,negative regulation of interferon-gamma production (GO:0032689),0.7938469021133484,1.0147502406599935,0.396,0.7583882950383506,1.0,7/29,7.50%,HMGB1;HLA-DRB1;GAS6;LGALS9;C1QBP;LAPTM5;PRNP
prerank,positive regulation of dendritic spine development (GO:0060999),0.7860456832193617,1.0144723833546876,0.414,0.7590414881470618,1.0,9/22,13.38%,APOE;DBN1;PSEN1;CAPRIN1;DBNL;DLG5;FMR1;SHANK3;NEURL1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.79484713623547,1.0144712697083993,0.411,0.7585748326418502,1.0,11/29,16.12%,PLA2G2A;DBI;MBOAT7;NR1H3;LPCAT4;PLA2G10;MBOAT2;NR1H2;LPCAT3;LPCAT1;PLBD1
prerank,COPII-coated vesicle budding (GO:0090114),0.8168390945307678,1.014470988884147,0.4185,0.7581034632598606,1.0,44/70,13.58%,SERPINA1;CTSC;TMED10;RAB1A;VAPA;CD59;PDCD6;SEC31A;TMED2;TFG;AREG;CSNK1D;RAB1B;SAR1A;SEC13;TRAPPC2L;PPP6R3;NAPA;SCAP;SEC24C;SEC16A;TRAPPC1;LMAN1;CNIH1;PPP6R1;SEC22B;SEC23A;GOLGA2;COL7A1;PEF1;CTSZ;TRAPPC4;TRAPPC3;USO1;MCFD2;STX5;SAR1B;CUL3;PPP6C;TRAPPC6A;PREB;TBC1D20;SCFD1;SEC24D
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.781664877373824,1.014226455095063,0.42542542542542544,0.7586061792565162,1.0,6/16,13.92%,PDCD4;CCL2;ANO6;PLCG1;THBS1;ECSCR
prerank,inflammatory response (GO:0006954),0.8658244446065111,1.0139148187796834,0.5195,0.7593904607307242,1.0,18/229,5.85%,FOS;ELF3;CCL21;PRDX5;HMGB1;RAC1;CYBA;HSPG2;HNRNPA0;MGLL;TNFRSF1A;ANXA1;CCL2;ADM;ADGRE5;F11R;PJA2;LGALS9
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.8050037236476443,1.0139073458847758,0.4115,0.7589480695742312,1.0,12/52,9.22%,FSTL1;NBL1;FBN1;UBE2D3;HTRA3;NOTCH1;SORL1;SMAD4;BMPR2;GREM2;LEMD2;GREM1
prerank,blood circulation (GO:0008015),0.8047540723879874,1.0137425429534,0.4175,0.759125842809334,1.0,21/50,15.82%,CXCL12;ELN;SOD1;CYB5R3;ACTC1;SERPING1;ACE2;HOXB2;ROCK2;ACVRL1;ADCY6;MYOF;GUCY1B1;ITGB1BP1;SCPEP1;GUCY1A1;EDN3;SGCD;ROCK1;ACE;STAT1
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.7853277305804283,1.013629028281265,0.4155,0.759100297876293,1.0,12/22,13.38%,YWHAE;FKBP1A;YWHAB;ENSA;PPP1R1B;ARPP19;PTPA;PPP1R15A;BOD1;PPP1R11;TIPRL;GSK3B
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.8150506137792457,1.0135829031991321,0.417,0.7588125361517353,1.0,38/64,11.55%,OAZ1;PSMB1;PSME1;PSMB4;CAV1;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5;PSMC3;ODC1;PSMD2;PSMA2;PSMB2;OAZ2;PSMD13;PSMD4;NCOR2;PSMD3;PSMC1;PSMC6;AZIN1;PSMC4;FGFR4;PDK2;PSMF1;PSMA3;PSMA5;PSMB8;CES1;PSMD7;PSMC2
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.7840484233044086,1.0134811377928483,0.413,0.7587382120308165,1.0,10/20,13.36%,RAB11A;CCND1;CDK4;RCC2;VPS4B;PHOX2B;CDC25B;CDK1;BRD4;CCNB1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.783935497994246,1.0134281358240818,0.413,0.7584876082008294,1.0,15/21,20.01%,FIS1;BCAP31;ANXA6;SMDT1;TGM2;LETM1;AFG3L2;MCUR1;SLC25A23;MICU2;MICU1;MCU;PDZD8;SLC8B1;RAP1GDS1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.7867916615305967,1.0134005833228668,0.418,0.7581357085530106,1.0,11/25,14.69%,MST1;NUPR1;C1QTNF3;CLK2;NCOR1;GIT1;FBP1;SOGA1;C1QTNF12;GSK3A;PGP
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.7843267526725758,1.0133265783915435,0.4125,0.7579498724738595,1.0,7/22,12.26%,HMGB1;HMGB2;DNASE1;KPNB1;FBH1;MUS81;DICER1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.8055003714344727,1.0133030011687718,0.406,0.7575687305119702,1.0,5/47,5.85%,GSTP1;GAS6;SELENOS;CD34;LGALS9
prerank,cellular senescence (GO:0090398),0.7869681577076107,1.0132857808673994,0.404,0.7571698174025234,1.0,19/26,18.82%,CALR;ID2;CDKN1A;HMGA1;TBX2;ULK3;TBX3;SRF;HRAS;MAPK14;MAPKAPK5;CDKN2B;PRKCD;OPA1;PML;KAT6A;SMC5;HMGA2;MAP2K1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.7879377906314466,1.0131776405121313,0.415,0.7571310850557081,1.0,12/27,11.35%,DDX5;ZFP36;MAP2K2;EIF4G1;DHX9;PUM2;EIF4E2;DDX6;PUM1;FXR1;BMP4;FMR1
prerank,mesoderm formation (GO:0001707),0.7882556306972635,1.012925921951947,0.418,0.7576742151672379,1.0,5/20,10.67%,ITGB1;ITGB4;ITGA3;BMPR2;SMAD2
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.8235427861252009,1.0128845443532435,0.43,0.7573725766623033,1.0,39/85,9.40%,PFN1;RHOA;RAC1;AP2M1;CDC42;PSMB1;CLTC;PSME1;PSMB4;PSME2;AP2S1;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5;PSMC3;PSMD2;PSMA2;PSMB2;FZD1;AP2A2;PSMD13;PSMD4;PSMD3;DVL3;PSMC1;PSMC6;AP2B1;PSMC4;PSMF1;PSMA3;PSMA5;FZD5;DVL1
prerank,neuron maturation (GO:0042551),0.7805049791912521,1.0128352952701765,0.42471235617808906,0.7571104821159104,1.0,9/18,16.27%,APP;MTCH1;C1QA;C3;B4GALT5;ANKS1A;LGI4;PICK1;FARP2
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.7906740955071356,1.0124388395124717,0.4075,0.7582099307825134,1.0,5/30,8.63%,HLA-E;LAMP1;NECTIN2;LGALS9;HLA-F
prerank,protein export from nucleus (GO:0006611),0.7872328074538075,1.0123419994392175,0.406,0.7581244679982427,1.0,10/26,12.41%,CALR;RAN;CHP1;XPO1;PKD1;TPR;CSE1L;RANBP3;NUTF2;XPO6
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.7870400183949947,1.0122288901465817,0.417,0.7581083806929791,1.0,17/24,18.33%,PDE9A;RGS2;AGT;NOTCH1;P2RX4;HAND2;IL6ST;MTPN;SMAD4;ROCK2;CAMK2D;PARP1;GLRX3;MEF2A;ROCK1;SLC9A1;PRKCA
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.7799753736616354,1.0119478978967782,0.4455,0.7587568972993334,1.0,3/15,18.04%,ATP6AP1;TYROBP;CSF1
prerank,regulation of cellular protein localization (GO:1903827),0.798374777509929,1.0117221574047088,0.4035,0.7591964460279246,1.0,17/46,9.69%,HSP90AB1;HSP90AA1;CTNNB1;GPC3;VCP;CSNK1E;PIN1;GPC6;GPC1;RAB11B;SUMO3;DVL3;GBF1;KDM1A;DVL1;PARP1;GPC4
prerank,negative regulation of autophagy (GO:0010507),0.8104215255342108,1.0116705983840155,0.3995,0.7589406502161071,1.0,16/59,9.13%,CTSA;EIF4G2;SNRNP70;QSOX1;NUPR1;MCL1;WDR6;EIF4G1;WASHC1;AKT1;DAP;PINK1;SIRT2;SMG1;GOLGA2;RRAGA
prerank,regulation of protein processing (GO:0070613),0.7853590658314484,1.0115579745370673,0.409,0.7589268648076337,1.0,4/25,8.81%,TMEM59;GAS1;PRNP;SERPINE2
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.7863142926221374,1.0115451606723047,0.427,0.7585134840744594,1.0,8/22,12.58%,CIB1;STMN2;AKT1;RAP1A;KIDINS220;EHD1;RAPGEF1;ACAP2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.7767800723355853,1.0113658600909536,0.4255,0.7587653022490967,1.0,6/15,9.09%,LDLR;CTDNEP1;SCARB1;C3;SREBF1;NR1H3
prerank,metal ion homeostasis (GO:0055065),0.7997806801935893,1.0111564678016394,0.4155,0.7591363640987083,1.0,8/44,5.58%,SCNN1B;S100A14;SCNN1A;CAV1;SLC12A7;SELENON;SLC12A2;CNNM4
prerank,regulation of cell growth (GO:0001558),0.8608669901272642,1.0110669160389985,0.5295,0.7590048512922645,1.0,50/210,7.05%,MUC12;RACK1;CEACAM1;LTBP4;EIF4G2;ENO1;SLC44A4;NDUFA13;CIB1;RTN4;FHL1;MELTF;PPP2R1A;CDC42;CDKN1A;DDX3X;ERBB2;HSPA1A;HPN;IP6K2;PHB;LAMTOR1;HNF4A;TFRC;SGK1;EIF4G1;BTG1;NET1;DNPH1;BCAR1;SFRP2;RBBP7;SFRP1;AGT;CDA;AKT1;NDUFS3;SDCBP;RPS6KA1;PPP2CA;SLIT3;VGLL4;DACT3;ADAM15;HYAL2;STK11;S100A8;LAMTOR2;SMARCA4;CCDC85B
prerank,positive regulation of response to external stimulus (GO:0032103),0.8390811360643956,1.0108931232739573,0.4775,0.7592387599854312,1.0,33/136,9.48%,MDK;PLA2G2A;CCL21;GRN;PTN;PDCD4;CYBA;RARRES2;APP;DDT;PDGFRB;CEBPA;TNFRSF1A;TNIP1;AGT;RIOK3;DHX9;PUM2;NFKBIA;HYAL2;S100A8;MGST2;PUM1;OPTN;MAPK13;CD47;PLSCR1;NFKBIZ;S100A9;STX3;NINJ1;F2RL1;TRIM15
prerank,ceramide catabolic process (GO:0046514),0.7795104389498407,1.010739367552123,0.4305,0.7593989464948642,1.0,5/15,10.30%,ASAH1;NEU1;HEXB;HEXA;GLA
prerank,post-translational protein modification (GO:0043687),0.8800909227934668,1.010641077123737,0.545,0.759327144440747,1.0,79/344,5.06%,APOA1;LGALS1;CST3;FN1;SERPINA1;FSTL1;ELOB;P4HB;IGFBP7;APOB;HSP90B1;IGFBP5;LAMB1;APOE;VCAN;SKP1;PENK;IGFBP4;APLP2;SPARCL1;WSB1;FBN1;QSOX1;AFP;MXRA8;MELTF;GPC3;TIMP1;NEDD8;IGFBP3;APP;PSMB1;RBX1;PDIA6;LAMB2;PSME1;APOA2;PSMB4;FBXW5;LAMC1;GOLM1;RAB1A;PSME2;RNF7;RAB11A;PSMD8;PSMB3;PSMA7;PSMB5;CALU;HIF3A;PSMB7;PSMB6;PRKCSH;RCN1;MSLN;PNPLA2;PSMA1;SHISA5;PSMA4;PTP4A2;PSMC5;GAS6;RAB2A;RAB1B;PSMC3;OBSL1;ANKRD9;TGOLN2;SPSB3;RBBP7;PSMD2;SDC2;DDB1;PSMA2;UBE2M;FAM20C;CKAP4;COPS6
prerank,regulation of neuron differentiation (GO:0045664),0.8212108445472471,1.0105414393444052,0.4305,0.7592511517084058,1.0,15/79,6.75%,NREP;CALR;RHOA;NBL1;ID2;CDK5RAP3;YWHAH;CPNE1;HES1;FGFR1;PCP4;YWHAG;BIN1;TCF4;TCF3
prerank,regulation of mitotic spindle organization (GO:0060236),0.7925608458579037,1.0102291203284317,0.4035,0.7600136325721266,1.0,23/35,16.47%,HNRNPU;CLTC;NUMA1;HSPA1A;DYNC1H1;PDCD6IP;CHMP2A;CHMP1A;CHMP5;CHMP3;DCTN1;TPR;VPS4B;CHMP1B;HSPA1B;NUP62;CHMP4B;CHMP2B;TPX2;TACC3;DRG1;RAE1;EML3
prerank,positive regulation of signaling receptor activity (GO:2000273),0.7950981607913883,1.010166866506747,0.4075,0.7597926321994362,1.0,13/37,11.88%,ITGB1;PARK7;NRP1;AREG;HDAC1;CCL2;HDAC2;BUD31;HDAC6;HIF1A;GREM1;EPHB2;SHANK3
prerank,regulation of gluconeogenesis (GO:0006111),0.7853595205323638,1.010052656770739,0.422,0.7597985524059744,1.0,16/29,14.69%,MST1;OGT;C1QTNF3;SELENOS;DDB1;ARPP19;CLK2;USP7;SIRT7;PDK2;ZNF692;FBP1;SOGA1;C1QTNF12;DGKQ;PGP
prerank,plasma membrane organization (GO:0007009),0.8140412261187646,1.0100393474830913,0.4175,0.7593898530948591,1.0,22/64,12.31%,COL5A1;MYH9;SLC9A3R1;SPTBN1;ANXA6;SERP1;PACSIN2;EHD2;BIN1;ANK2;PLSCR1;SMPD1;FNBP1L;STX4;MYOF;DEGS1;ANO6;CHMP4A;OSBPL2;ARL8B;SNX9;UGCG
prerank,GTP metabolic process (GO:0046039),0.7771172849144021,1.0096917669468555,0.44022011005502754,0.7603243597219885,1.0,11/15,20.36%,RAN;IMPDH2;AK3;GNAI3;RHOQ;GTPBP1;OPA1;AK4;MFN1;IMPDH1;RAB23
prerank,positive regulation of cytokine production (GO:0001819),0.8782108203898649,1.00968243870616,0.556,0.7598993956191974,1.0,43/332,5.21%,GAPDH;RPS3;HLA-A;MDK;EGR1;CD74;HMGB1;ATF4;MIF;CYBA;POLR2L;HLA-E;SPTBN1;AGPAT2;PARK7;SOD1;CTNNB1;TNFRSF14;APP;APOA2;TMED10;HSPA1A;XRCC6;HSPD1;RAB1A;LAMTOR5;HHLA2;PHB;S100A13;XRCC5;POLR2H;CD46;POLR2E;INAVA;SULF2;C1QTNF3;ANXA1;POLR2F;XBP1;STOML2;AGT;DHX9;FLOT1
prerank,organic cation transport (GO:0015695),0.7814878772375836,1.0096115154710068,0.425,0.759727522271962,1.0,4/20,5.77%,SLC44A4;SLC44A1;SLC44A2;SLC22A18
prerank,regulation of interleukin-10 production (GO:0032653),0.8009307529579779,1.0095892958136747,0.406,0.7593548349740992,1.0,14/48,11.07%,HMGB1;HSPD1;HLA-DRB1;CD46;INAVA;CD34;PRKCZ;LGALS9;CD47;F2RL1;TRIB2;PYCARD;ISG15;DLL1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.7808269630817941,1.0094905989128153,0.439719859929965,0.7592774178082673,1.0,10/16,15.16%,RAD21;POGZ;REC8;PDS5A;MAU2;NAA50;BOD1;SMC1A;PDS5B;NIPBL
prerank,regulation of stem cell population maintenance (GO:2000036),0.779484527799944,1.0093641263753725,0.423,0.7593024585240337,1.0,11/19,15.91%,PTN;LOXL2;ZNF706;CNOT1;ELAVL1;KAT2A;CNOT2;MYC;CNOT3;ZC3H13;REST
prerank,diacylglycerol metabolic process (GO:0046339),0.7840514656120147,1.0092244615439532,0.419,0.7593969853094066,1.0,9/23,14.43%,DGAT1;APOA2;PNPLA2;MOGAT2;DGKD;DGKZ;PLCE1;DGKA;DGKQ
prerank,placenta development (GO:0001890),0.777452394860479,1.0092223667047298,0.4438877755511022,0.7589437942973408,1.0,8/15,20.79%,SOD1;PHLDA2;PTK2;CUL7;PPARG;ANG;ASCL2;ADAM19
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.831604943698208,1.0088809438949635,0.443,0.7598661520272273,1.0,7/118,5.29%,GNAS;VIP;GNB1;RAMP2;ADM;ADGRE5;RAMP1
prerank,cellular response to organic substance (GO:0071310),0.831137810218054,1.008834805602941,0.458,0.7595953370950397,1.0,17/122,5.78%,RACK1;IGFBP5;RHOA;CIB1;KLF4;PARK7;CTNNB1;DPYSL3;ERBB2;RAMP2;SIGIRR;SFRP1;ARL6IP5;SHC1;CCL2;RAMP1;SLIT3
prerank,anterior/posterior axis specification (GO:0009948),0.7841262646384153,1.0085882280450191,0.435,0.7601234119923458,1.0,5/20,9.88%,CDX1;CDX2;WLS;FZD5;TBX3
prerank,regulation of phosphatase activity (GO:0010921),0.7858329833024318,1.0084496139285462,0.422,0.7601999044299297,1.0,15/28,16.96%,HSP90B1;CHP1;CDK5RAP3;CHP2;PPP6R3;PTPA;PPP6R1;PPP6R2;PPP1R35;HTT;URI1;TIPRL;PPP1R2;SH3RF2;TSC1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.8077513211385366,1.0083847202068488,0.4155,0.7599753536308372,1.0,11/59,5.53%,STMN1;RHOC;RHOA;SPTBN1;JTB;RHOB;SON;IST1;PDCD6IP;MYH10;DCTN3
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.793830934033736,1.0083079450768824,0.41,0.7598106236741213,1.0,11/44,7.79%,COL4A1;TCF21;CTNNB1;VEGFA;PKD1;NRP1;SFRP2;EPHA2;TGFBR2;ENG;NPNT
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.8200502921025007,1.0081971528135254,0.4425,0.7597817345546773,1.0,43/82,13.50%,PFN1;CCL21;RAC1;EPS8L2;CDC42EP5;DPYSL3;CDC42;ARPC2;FSCN1;AGRN;EPS8L3;ACTR2;BRK1;WASF2;NRP1;WASHC1;NCKAP1;EPS8;WASL;CYFIP1;ACTR3;ARAP1;MIEN1;PALM;CDC42EP4;F2RL1;FNBP1L;OCLN;ABI2;EPS8L1;ARHGAP35;HTT;FMR1;HRAS;RHOQ;CDC42EP1;AUTS2;CCDC88A;PIK3R1;PLCE1;RALA;NEURL1;DEF8
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.7867380880721023,1.0081397359079216,0.4125,0.7595397285864668,1.0,10/28,13.37%,TPI1;ST3GAL4;TNIP1;GOLPH3;TKT;RRM2;B4GALT5;B3GNT5;GCNT1;SCCPDH
prerank,regulation of establishment of planar polarity (GO:0090175),0.8199483624421301,1.0080217209082545,0.441,0.7595578064568559,1.0,39/88,9.40%,PFN1;RHOA;RAC1;AP2M1;CDC42;PSMB1;CLTC;PSME1;PSMB4;PSME2;AP2S1;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5;PSMC3;PSMD2;PSMA2;PSMB2;FZD1;AP2A2;PSMD13;PSMD4;PSMD3;DVL3;PSMC1;PSMC6;AP2B1;PSMC4;PSMF1;PSMA3;PSMA5;FZD5;DVL1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.7738725852528038,1.007913603687916,0.436,0.7595321377190872,1.0,8/15,17.50%,BCAR1;DDIT4;GRB2;SORT1;ZFYVE27;NGFR;SOS1;CASP3
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.83711900337493,1.0076965330040715,0.479,0.7599308266340487,1.0,36/128,9.72%,TPM1;STMN1;CCL21;HMGB1;LAMB1;APOE;RAC1;SLC9A3R1;BLOC1S1;APP;STMN2;CTTN;VAPA;PRMT1;RAB11A;MAP4;BTG2;MICALL2;LIMA1;CYFIP1;ATXN10;NPY;CDK16;TTC17;RAB13;FRYL;GBA;PQBP1;CORO1B;EHD1;MANF;STMN3;STX3;ARFIP2;RAB25;HDGFL3
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.7842326905339969,1.0075147824477173,0.4135,0.7601802486664689,1.0,8/29,11.06%,HNRNPA2B1;ADAR;SRRT;PUM2;PUM1;METTL3;SMAD2;SMAD3
prerank,membrane depolarization (GO:0051899),0.7879524518624871,1.0074320236697611,0.417,0.7600552206114684,1.0,5/32,5.72%,ATP5IF1;CAV1;YWHAH;ABL1;P2RX4
prerank,modification-dependent protein catabolic process (GO:0019941),0.8574625720495167,1.0071648559110735,0.541,0.7606150186932215,1.0,26/200,5.10%,RPS27A;UBC;UBA52;UBB;SQSTM1;NEDD8;RBX1;ANAPC11;TTC3;OS9;UBA1;RNF7;BAG6;UBE2S;NDFIP1;UBE2I;ANAPC16;ANAPC5;NEDD4L;XBP1;UBE2B;UBE2D2;UBE2L3;DDB1;STUB1;CDC34
prerank,cellular response to lipid (GO:0071396),0.8560447980367247,1.0070560002007982,0.5375,0.7606056270814883,1.0,27/216,6.80%,VIM;ATP1A1;GSTP1;HMGB1;RHOA;PDCD4;NDUFA13;DEFA3;ZFP36;HMGB2;INSIG1;DEFA5;PABPN1;XBP1;UBE2L3;SFRP1;SELENOS;DEFA6;CCL2;PTK7;MSN;CHMP5;NCOA4;ADAM15;CD68;TFPI;SPP1
prerank,negative regulation of calcium ion transport (GO:0051926),0.7734273071145485,1.0070418341234333,0.4305,0.7602041434778339,1.0,1/19,1.28%,TMBIM6
prerank,positive regulation of interleukin-8 production (GO:0032757),0.8042550219424813,1.0068308488879318,0.421,0.7605682602552188,1.0,15/61,9.96%,CD74;HMGB1;PARK7;APOA2;HSPA1A;RAB1A;LAMTOR5;LGALS9;HYAL2;F2R;HSPA1B;RELA;F2RL1;PYCARD;PRKD2
prerank,protein polymerization (GO:0051258),0.8046766290365189,1.006777892037381,0.419,0.7603221336651578,1.0,26/59,14.52%,GSN;RAC1;GPX4;VIL1;ZNF207;UBE2S;CHMP2A;PIN1;MICALL2;WASL;CHMP3;UBE2C;MSRB2;TTC17;SPIRE2;HDGFL3;CHMP4A;UBE2K;CKAP5;CHMP4B;DIAPH1;FGF13;MSRB1;TPPP3;CORO7;AIF1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.8021592016292203,1.0065189738797244,0.422,0.7609076842228135,1.0,19/51,10.15%,ZFP36L1;HNRNPU;ID2;RARRES2;ZFP36;ADIRF;TRPM4;SFRP2;XBP1;SFRP1;AKT1;METRNL;SULT1E1;AAMDC;CEBPB;ZBTB7B;FRZB;SYAP1;CARM1
prerank,regulation of telomerase activity (GO:0051972),0.7982642510978306,1.0062611329661892,0.4115,0.7614541653709136,1.0,16/46,9.58%,HSP90AB1;HSP90AA1;KLF4;PARM1;CTNNB1;PTGES3;MAPK3;XRCC5;CCT4;TCP1;PKIB;CCT2;PARP4;MAPK1;GREM1;SRC
prerank,regulation of secretion (GO:0051046),0.7758361620249616,1.006124176783321,0.4375,0.7615461554080102,1.0,6/15,15.13%,ERBB3;SGK1;MYO6;POFUT2;CES1;ACSL3
prerank,regulation of neuron projection development (GO:0010975),0.8430695340403808,1.0060966942836485,0.502,0.7612102181381372,1.0,23/164,6.11%,ITM2C;CFL1;MDK;APOE;PTN;CIB1;PLXNB2;DPYSL3;STMN2;SNX3;NPTN;SCARB2;GAK;PTK7;AKT1;RAB17;HDAC2;FZD1;PTEN;CRMP1;DBN1;RAP1A;PSEN1
prerank,positive regulation of lymphocyte activation (GO:0051251),0.7890118891839967,1.0060382642277108,0.4145,0.7609746169455568,1.0,15/34,18.43%,XRCC6;HSPD1;THY1;CCL2;HLA-DPB1;CD47;PRKDC;PYCARD;HLA-DPA1;SIRPA;TNIP2;TYROBP;ZNF335;SH3KBP1;CCDC88B
prerank,positive regulation of metabolic process (GO:0009893),0.8308301943210561,1.0060101333658125,0.4665,0.7606385267173618,1.0,32/113,9.61%,GNAS;PLAC8;LCN2;JCHAIN;MFAP2;FABP5;G0S2;OGT;CAV1;HADH;DYNC1H1;VEGFA;FASN;ACLY;STAT6;EPAS1;PYURF;KDM1A;GJA1;APPL2;HSF1;SIRT6;AGPAT1;CEBPB;PHOX2B;DECR1;IGF1R;ZBTB7B;PRKAB1;THRA;ADIPOR2;MFN2
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.7840192121281157,1.0057328432209984,0.4195,0.7612779696406744,1.0,5/27,9.22%,CCL21;ITPR3;ERO1A;F2R;LETM1
prerank,positive regulation of neuron projection development (GO:0010976),0.8181282011226826,1.0056041232667219,0.445,0.7613246914523389,1.0,21/88,9.18%,MDK;APOE;PTN;PLXNB2;DPYSL3;STMN2;SNX3;NPTN;SCARB2;PTK7;FZD1;DBN1;RAP1A;CAPRIN1;DBNL;KIDINS220;ITGA6;P3H1;S100A9;DAB2IP;PTK6
prerank,defense response to symbiont (GO:0140546),0.8349247456677784,1.0055404492979996,0.4765,0.7611283882726868,1.0,23/121,10.31%,FLNA;IFI27;IFITM3;RNASE1;IFITM2;DDIT4;NLRP1;STAT2;MOV10;BNIP3L;G3BP1;ISG20;PQBP1;PLSCR1;RELA;SERINC3;IRF3;F2RL1;PLA2G10;BNIP3;PYCARD;NCBP3;ISG15
prerank,endothelial cell proliferation (GO:0001935),0.7793344426457484,1.005410501512087,0.4315,0.7611793199355448,1.0,8/18,12.71%,LOXL2;CD34;SEMA5A;BMPR2;ACVRL1;BMP4;ITGB1BP1;DLG1
prerank,energy reserve metabolic process (GO:0006112),0.7767030924750968,1.0052818621163955,0.434,0.7612355571919726,1.0,6/19,14.30%,UGP2;GFPT1;PHKG2;MYC;GSK3B;PHKB
prerank,engulfment of apoptotic cell (GO:0043652),0.7794841555782478,1.0052740560308526,0.4465,0.760811425600686,1.0,3/15,12.61%,RAC1;THBS1;RHOG
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.7709269751434359,1.0050889270833636,0.4467233616808404,0.7610786407595821,1.0,7/15,13.89%,PUM2;PUM1;TRIM15;DDX60;ZCCHC3;ANKRD17;ZDHHC5
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.7759692541442311,1.0049889921058848,0.4335,0.7610238330548497,1.0,12/18,18.33%,PDE9A;AGT;HAND2;IL6ST;MTPN;ROCK2;CAMK2D;PARP1;MEF2A;ROCK1;SLC9A1;PRKCA
prerank,positive regulation of proteolysis (GO:0045862),0.803980345625891,1.0049884107733609,0.422,0.7605729246313067,1.0,20/57,9.65%,APOE;ATP5IF1;NDUFA13;OGT;CTSC;AURKAIP1;PERP;IST1;TNIP1;STUB1;HDAC2;CTSH;BAD;PINK1;RCN3;NRDC;FURIN;GBA;FGFR4;ASPH
prerank,positive regulation of organelle organization (GO:0010638),0.7850734476004586,1.0049805835015606,0.423,0.7601507909558427,1.0,9/32,8.43%,ANXA2;SURF4;TMED9;ANXA1;SORBS3;PFDN2;AKT2;CALCOCO2;LMAN1
prerank,regulation of neuron apoptotic process (GO:0043523),0.8241280922431206,1.0049147954726616,0.4655,0.7599543369517063,1.0,22/98,9.16%,MDK;APOE;ATF4;GRN;PARK7;SOD1;CTNNB1;NUPR1;SET;ERBB3;LGMN;CCL2;PINK1;NFATC4;EGLN3;PRNP;TRIM2;SNX6;F2R;NSMF;FOXO3;SOD2
prerank,cellular response to alcohol (GO:0097306),0.7988591912700813,1.0048618889364316,0.427,0.7597109106190062,1.0,14/48,9.31%,CTNNA1;JUP;CDH1;CTNNB1;GNB1;SFRP1;SMO;LARP1;ADAM15;PTCH1;GOLPH3;GNG2;ADCY6;GRAMD1A
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.8397281746445173,1.0044416508737852,0.5025,0.760872127526814,1.0,59/148,9.38%,TUBA1A;TUBB;DYNLL1;TUBB4B;HSP90AA1;SKP1;FHL1;PPP2R1A;YWHAE;PSMB1;RBX1;PSME1;PSMB4;PSME2;RAB11A;PSMD8;PSMB3;PSMA7;PSMB5;DYNC1H1;PSMB7;DCTN2;PSMB6;CCND1;PSMA1;PSMA4;PSMC5;CSNK1D;PSMC3;PAFAH1B1;PSMD2;CSNK1E;PSMA2;SSNA1;CDK4;PSMB2;DCTN3;YWHAG;RCC2;PSMD13;PSMD4;PSMD3;DYNC1I2;DCTN1;PSMC1;AKAP9;PSMC6;ACTR1A;PCM1;VPS4B;SFI1;PSMC4;PSMF1;PRKACA;PSMA3;PHOX2B;PSMA5;CDC25B;MAPRE1
prerank,positive regulation of developmental growth (GO:0048639),0.7987537993478466,1.0043920481001793,0.4125,0.7606234042758512,1.0,7/52,6.92%,AGR2;PPIB;AGRN;MACF1;NEDD4L;DBN1;DBNL
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.7789161737912574,1.0039227920498324,0.4475,0.7620526895920897,1.0,6/17,18.59%,DDX3X;STMP1;CPTP;EIF2AK2;MYD88;CD36
prerank,cellular response to nitrogen compound (GO:1901699),0.7747657339363292,1.0038769247035955,0.4315,0.7617893443984516,1.0,9/20,11.35%,AOC1;CPS1;ATP2B4;RIOK3;ROCK2;RTF2;HSF1;ATRX;FMR1
prerank,cytoplasmic microtubule organization (GO:0031122),0.7955456285116645,1.0038722670265923,0.428,0.7613561041446306,1.0,25/54,14.57%,EZR;RHOA;CIB1;CHP1;NUMA1;RAB11A;DST;DYNC1H1;KPNB1;DCTN1;TUBGCP2;PCM1;VPS4B;HOOK2;STMN3;TUBGCP6;CAMSAP3;CCDC88A;DLG1;CLIP3;SLK;HOOK3;LIMK2;CLASP1;CLIP2
prerank,regulation of actin filament-based process (GO:0032970),0.8122971607976395,1.0036311518431118,0.4425,0.7618668012734056,1.0,33/73,13.06%,EZR;RHOC;SMIM22;RHOA;RAC1;LRP1;RHOB;FSCN1;PDGFRB;CDK10;CNN2;CORO1A;ABRACL;ABL1;F11R;IQGAP1;RHOF;ROCK2;ARHGAP17;CRK;DLC1;ARHGAP35;MLST8;TESK1;RHOQ;RHOBTB3;CCDC88A;TAOK1;RHOG;BST2;RND3;HIP1R;PAK1
prerank,leukocyte tethering or rolling (GO:0050901),0.7752526510031594,1.0036223548631795,0.4435,0.7614544285757207,1.0,7/18,18.29%,ITGB1;GOLPH3;GCNT1;ROCK1;MADCAM1;PODXL2;JAM2
prerank,protein autoprocessing (GO:0016540),0.7764628678105484,1.0035950408012537,0.4435,0.7611108011382199,1.0,4/17,10.03%,TMPRSS2;CTSL;FAM111A;AFG3L2
prerank,receptor catabolic process (GO:0032801),0.7831343716836145,1.0035100626357685,0.427,0.7609934939585203,1.0,11/25,12.85%,AP2M1;CLTC;CLTA;AP2S1;LGMN;AP2A2;SH3GLB1;AP2B1;BECN1;MVB12A;AP2A1
prerank,fatty acid oxidation (GO:0019395),0.8021998365668698,1.0034990260125018,0.4285,0.7605903365488631,1.0,26/58,11.14%,ACADVL;ACAA2;HADHA;SCP2;ACADS;HADH;ECHS1;ADH5;ACAA1;HADHB;ECI1;BDH2;ILVBL;ECHDC2;ACOX1;ABCD4;HSD17B10;DECR1;ADIPOR2;ECHDC1;ALDH3A2;HSD17B4;ECI2;ADIPOR1;ACAT2;ACAT1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.7756248769132323,1.0032063427714717,0.441,0.7612922947936082,1.0,8/19,18.36%,ITGB1;GOLPH3;GCNT1;ROCK1;MADCAM1;PODXL2;JAM2;SLC39A8
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.8092732242244034,1.002910295090719,0.437,0.7620066903120299,1.0,12/77,6.74%,HSPB1;HMGB1;MIF;CYBA;HLA-E;APP;CLU;DDT;DHX9;LGALS9;PSEN1;IFNGR1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.7759257178650895,1.0027924718776626,0.4325,0.7620302526417998,1.0,7/22,10.62%,ATF4;ERBB2;NCL;UBTF;SMARCA4;SMARCB1;PIH1D1
prerank,positive regulation of telomere capping (GO:1904355),0.7739534475526205,1.002655956103186,0.4455,0.7621176812072281,1.0,13/17,21.80%,HNRNPD;MAPK3;PKIB;MAPK1;MAPKAPK5;AURKB;TNKS;NEK7;PNKP;TNKS2;MAP2K7;MAP3K4;NABP2
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.7856610841155037,1.0025075056996209,0.4245,0.7622620949831168,1.0,19/35,15.56%,KLF4;FHL1;CDKN1A;KANK2;CCL2;CDK4;PTEN;PRMT2;CDK2AP2;CDK6;ZNF655;BRD7;WEE1;DLG1;DACT1;PKD2;CDKN2B;RBL2;CDKN2D
prerank,cellular defense response (GO:0006968),0.7959738164882735,1.0024579724646356,0.433,0.7620054861675217,1.0,7/48,12.28%,ITGB1;LGALS3BP;TCIRG1;RELA;BECN1;PTK2B;VEZF1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.7804507806677925,1.0023746933556963,0.44,0.7618767417465,1.0,7/22,11.01%,DGAT1;SLC25A1;FASN;ACLY;FAR1;HSD17B4;SCD
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.7900854573837114,1.002070212293511,0.4415,0.7626417362649202,1.0,5/35,4.65%,CCL21;FGFR3;PDGFRB;PDGFRA;WASHC1
prerank,regulation of protein secretion (GO:0050708),0.8308843754685171,1.0019448074284956,0.49,0.7626906772276162,1.0,19/125,6.43%,PPIA;EZR;APOE;LLGL2;TMED10;GCG;HADH;ERP29;HNF4A;ENSA;ITPR3;MYH10;HMGCR;ARF6;SLC12A2;SLC2A1;UQCC2;RAP1A;GOLPH3
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.8842917318676826,1.001939389188397,0.575,0.7622639511415139,1.0,22/466,2.67%,RPL10;RPL6;HINT1;PFDN5;EDF1;CALR;FUS;ATF4;YBX1;DNM2;SFPQ;MAGED1;PPP2R1A;HNRNPD;APP;NUCKS1;CNBP;RBM3;NONO;SOX4;HP1BP3;MLF2
prerank,regulation of protein transport (GO:0051223),0.7811856809076934,1.0019329370111276,0.439,0.7618415379347487,1.0,18/28,19.13%,HSPA8;LLGL2;CHP1;SNX3;NDFIP1;DNAJA1;NDFIP2;P3H1;RHBDF1;PPM1F;SCFD1;WWP2;NDEL1;SNX12;ARFIP1;STXBP5;ATP13A2;GAPVD1
prerank,positive regulation of intracellular protein transport (GO:0090316),0.8373449409913699,1.0018943127003095,0.506,0.7615564796543745,1.0,48/148,7.80%,FLNA;CD81;SFN;YWHAZ;OAZ1;UBL5;TOMM7;CIB1;JUP;CDH1;YWHAQ;RAN;YWHAE;TRIM28;UBE2D3;CHP1;ERBB2;FIS1;YWHAB;MYO1C;YWHAH;ANP32B;SREBF2;GAS6;SAR1A;UBE2L3;NPEPPS;MICALL2;CHP2;SORL1;YWHAG;OAZ2;BAD;IPO5;PSEN1;TCF7L2;PINK1;HYAL2;TMEM30A;HUWE1;AKT2;SAE1;TPR;SH3GLB1;DMAP1;PRNP;PCM1;MFF
prerank,regulation of interleukin-4 production (GO:0032673),0.7780419700817505,1.0018879073785645,0.4345,0.7611379052434835,1.0,5/23,8.78%,HLA-E;HLA-DRB1;PRKCZ;LGALS9;CEBPB
prerank,chemical homeostasis (GO:0048878),0.8021576146278299,1.0018862004190467,0.4325,0.7606969892880758,1.0,14/61,10.66%,APOA4;RBP1;DDX3X;CEBPA;HNF4A;PNPLA2;NEDD4L;USF2;SLC4A4;WNK2;ACOX1;NR1H3;SLC4A2;WNK1
prerank,vitamin D metabolic process (GO:0042359),0.7687027838670453,1.001471486025363,0.456,0.7618810982745989,1.0,4/15,17.74%,LGMN;VDR;CUBN;PIAS4
prerank,regulation of spindle organization (GO:0090224),0.7732451260090083,1.0014497778944806,0.443,0.7615174504282584,1.0,10/18,16.06%,CLTC;NUMA1;DYNC1H1;DCTN1;SENP6;NUP62;TPX2;TACC3;RNF4;RAE1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.7756197822901882,1.0014266809392263,0.452,0.7611659160597742,1.0,12/22,13.79%,SPPL2B;HM13;MBTPS1;SPPL2A;PSEN1;APH1A;NCSTN;ADAM10;RELA;PSENEN;NGFR;ADAM9
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.7705935344448829,1.0013989150031968,0.4525,0.7608404915229141,1.0,13/16,21.12%,PPP2R1A;CAV1;PPP2CA;HGS;SOCS3;LEPROT;ADIPOR1;INPP5F;BCL3;NF2;PTPN2;SH2B3;PARP14
prerank,lung development (GO:0030324),0.779266972843829,1.0011894271203536,0.418,0.7612235058435415,1.0,11/35,11.79%,TCF21;CEBPA;VEGFA;BAG6;PKD1;FOXF1;ERRFI1;RCN3;ITGA3;BMP4;FGFR2
prerank,cellular response to chemokine (GO:1990869),0.8057966083299474,1.0011120701216192,0.45,0.7610833605067061,1.0,6/59,5.43%,CCL21;DUSP1;CXCL12;RHOA;CCL2;SLC12A2
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.7852870113103485,1.0011027830735442,0.43,0.7606731377638092,1.0,12/36,11.89%,HSP90AB1;HSP90AA1;PTGES3;NOP10;NHP2;PPP6R3;TERF2IP;RPA1;TELO2;TNKS1BP1;PPP6C;ZBTB48
prerank,negative regulation of signaling (GO:0023057),0.7797782447460864,1.0007521848313576,0.4375,0.7616242988956066,1.0,5/25,9.18%,IGFBP3;ERBB3;OPTN;HHIP;PTK6
prerank,positive regulation of protein modification process (GO:0031401),0.8502218856199182,1.0007519320335452,0.557,0.7611813354384169,1.0,61/212,9.00%,RACK1;PPIA;CLDN3;CALM2;TXN;CALM1;CD74;EFNA1;HSP90AA1;CCND2;ITLN1;RAC1;CIB1;RARRES2;PTBP1;CALM3;APP;PLAUR;CHP1;DDX3X;ERBB2;ILK;NPTN;MAPK3;MYDGF;ERP29;VEGFA;HLA-DRB1;TFRC;CCND1;GAS6;CSNK1D;AKT1;FLOT1;PECAM1;RAMP1;PIN1;VEGFB;CDH5;ABL1;CAMTA1;PTPA;PINK1;C3;DVL3;DAB2;AKT2;UBE2N;FBH1;ENG;ROCK2;GBA;SPPL3;PTK2;SYMPK;SMPD1;NSMF;TERF2IP;GOLGA2;CCND3;FXR1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.7712385475794968,1.0006242164500327,0.4592296148074037,0.7612443769947823,1.0,10/16,21.74%,CAV1;OSR1;XDH;DLL1;SPRY2;SPRED1;ZEB1;SPRY1;NOTCH4;SPRED2
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.7729946233852252,1.0004976868061897,0.435,0.7612893128771969,1.0,6/21,11.37%,YWHAE;NEDD4L;OSR1;CAB39;CAMK2D;GOPC
prerank,positive regulation of bone mineralization (GO:0030501),0.7880891289323998,1.000443623513055,0.4355,0.7610691016946681,1.0,11/35,11.97%,PKDCC;PTN;FBN2;ATRAID;OSR1;BMPR2;BMP4;ISG15;ANO6;BMPR1A;ATP2B1
prerank,CENP-A containing chromatin organization (GO:0061641),0.7812872398251567,1.0004311760383882,0.4265,0.7602337186740128,1.0,7/29,7.94%,NPM1;NASP;CENPX;RBBP7;RBBP4;SMARCA5;CENPT
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.7812872398251567,1.0004311760383882,0.4265,0.7602337186740128,1.0,7/29,7.94%,NPM1;NASP;CENPX;RBBP7;RBBP4;SMARCA5;CENPT
prerank,response to amyloid-beta (GO:1904645),0.7862169075868205,1.0001954620024869,0.4305,0.7607094557901648,1.0,12/44,13.38%,MMP2;LRP1;APP;LGMN;PSEN1;PRNP;SNX6;GJA1;IGF1R;NGFR;FYN;GSK3B
prerank,defense response to virus (GO:0051607),0.8332781036752217,1.0000068455601612,0.496,0.7610094811123507,1.0,24/130,9.71%,FLNA;IFI27;IFITM3;PHB2;RNASE1;PHB;IFITM2;DDIT4;NLRP1;STAT2;MOV10;BNIP3L;G3BP1;ISG20;PQBP1;AKAP1;PLSCR1;RELA;SERINC3;IRF3;F2RL1;PLA2G10;BNIP3;PYCARD
prerank,detection of chemical stimulus involved in sensory perception (GO:0050907),-0.5507981500820528,-1.0,1.0,0.8333333333333334,0.174496644295302,23/23,44.96%,OR5AN1;OR1K1;OR4E2;GPR148;OR10T2;OR10K2;OR10K1;OR10R2;OR13G1;OR10J3;OR6N2;OR6K6;OR6K3;OR6K2;OR10Z1;OR12D2;OR12D3;OR2A4;OR2A25;OR10J1;OR4E1;OR2A7;PKD2L1
prerank,detection of chemical stimulus involved in sensory perception of smell (GO:0050911),-0.6323358295790196,-1.0,1.0,0.8333333333333334,0.174496644295302,21/21,36.81%,OR1K1;OR4E2;GPR148;OR10T2;OR10K2;OR10K1;OR10R2;OR13G1;OR10J3;OR6N2;OR6K6;OR6K3;OR6K2;OR10Z1;OR12D2;OR12D3;OR2A4;OR2A25;OR10J1;OR4E1;OR2A7
prerank,glutamate metabolic process (GO:0006536),0.7704391633766843,0.9995743881529398,0.4465,0.7623084959494077,1.0,8/22,12.74%,OAT;GLS;GLUL;ALDH18A1;GLUD1;GGT1;GOT2;GOT1
prerank,anterograde axonal transport (GO:0008089),0.7872429276782635,0.9995562911215828,0.4375,0.761936097116191,1.0,10/37,9.01%,HSPB1;BLOC1S1;SOD1;KIF5B;AP3D1;KIF1C;MAPK8IP3;TRAK1;AP3S1;KIF1B
prerank,protein modification process (GO:0036211),0.8155474009330581,0.9994408398133577,0.464,0.7619482899844506,1.0,33/77,11.29%,UBA52;UBL5;NEDD8;UBE2D3;CPE;PLAT;RPN2;SERP1;UBE2S;MMP15;UBE2I;LOXL2;UBE2D2;UBE2L3;UBE2M;CDC34;ABL1;RPN1;ERO1A;PLOD2;AKT2;PARP4;SEPHS1;GGCX;BAP1;PRKDC;UBA7;PARP1;MCRS1;LCMT1;ICMT;FBXO11;ARAF
prerank,artery development (GO:0060840),0.7774953480857769,0.9992660915807347,0.451,0.7621818043556561,1.0,13/23,13.68%,EFEMP2;VEGFA;HES1;NRP1;APLNR;ENG;BMPR2;ACVRL1;HECTD1;ROBO1;TGFBR1;PKD2;NF1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.7699234952435854,0.9992131692907161,0.4425,0.761952681332401,1.0,21/25,20.76%,SF3B1;PRPF8;TXNL4A;TRA2B;SRSF10;SRSF4;SF3B3;SCAF11;DDX23;PRPF6;SF3B4;SRRM1;LSM1;SF3A3;KHSRP;SLU7;PRPF3;SNRNP40;BCAS2;SMNDC1;MPHOSPH10
prerank,negative regulation of cell growth (GO:0030308),0.8298039181737737,0.9991310401822522,0.5,0.7618105212252014,1.0,35/124,8.59%,RACK1;ENO1;NDUFA13;RTN4;FHL1;PPP2R1A;CDKN1A;DDX3X;HSPA1A;IP6K2;CDHR2;PHB;HNF4A;BTG1;SFRP2;RBBP7;SFRP1;CDA;NDUFS3;PPP2CA;SLIT3;VGLL4;DACT3;ADAM15;HYAL2;STK11;SMARCA4;CCDC85B;EI24;SMAD4;BMPR2;ACVRL1;GJA1;HSPA1B;SMARCA2
prerank,glucuronate metabolic process (GO:0019585),0.7675701321490781,0.9989418155301815,0.465,0.7621156279393958,1.0,3/15,21.34%,UGT2B17;UGT2A3;ABHD10
prerank,regulation of actin filament polymerization (GO:0030833),0.8062888209026646,0.998869108085037,0.44,0.7619617029294692,1.0,30/69,12.96%,PFN1;CCL21;CDC42EP5;VIL1;CTTN;EVL;PFN2;GBA2;VASP;BAIAP2L2;ARF6;NCKAP1;COTL1;LMOD1;DBN1;BIN1;DBNL;MYADM;MTPN;BAIAP2L1;CDC42EP4;PYCARD;NCK2;PLEKHG2;PTK2B;ESAM;CDC42EP1;SNX9;HAX1;HIP1R
prerank,acylglycerol biosynthetic process (GO:0046463),0.7804544552243255,0.9986011272685903,0.4465,0.7625638056732706,1.0,9/23,14.63%,DGAT1;PNPLA2;LPGAT1;GPAT4;MOGAT2;LPIN3;PLCE1;MOGAT3;LPIN2
prerank,estrogen metabolic process (GO:0008210),0.7800582855642316,0.998316807756825,0.4425,0.7632675692442841,1.0,11/30,19.22%,CYP3A5;HSD17B11;UGT2B17;SULT1A1;SULT1E1;HSD17B10;HSD17B4;HSD17B2;CYP2C9;HSD17B14;HSD17B8
prerank,mitochondrial membrane organization (GO:0007006),0.7832918061172175,0.9982610744213802,0.4475,0.7630501392571838,1.0,20/30,17.22%,SLC25A5;GHITM;SPG7;HSPA9;BAD;IMMT;SLC25A4;MFN2;BNIP3;MTX2;PPIF;DNAJC11;MTX1;TIMM50;SAMM50;BAK1;CHCHD3;OPA1;BCL2L1;RCC1L
prerank,positive regulation of signaling (GO:0023056),0.7845883748904947,0.9980532737868594,0.439,0.7634302585047991,1.0,10/38,13.06%,ANXA2;CLSTN1;ILK;ECE1;WLS;VAMP3;SCRIB;INPP5F;EDN3;PTPN23
prerank,regulation of centrosome duplication (GO:0010824),0.7851765531918536,0.9980129028650936,0.44,0.7631568589079264,1.0,9/30,7.93%,NPM1;FBXW5;PDCD6IP;CHMP2A;CHMP1A;CHMP5;CHMP3;VPS4B;CHMP1B
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.8047968797046964,0.9978784061055437,0.4425,0.7632407625710856,1.0,10/72,4.40%,IFI27;FGFR3;CIB1;G0S2;DDX3X;MCL1;SIVA1;ERBB3;TNFRSF1A;MLLT11
prerank,B cell differentiation (GO:0030183),0.799063330915742,0.9977446671842124,0.4365,0.7633369320285334,1.0,8/61,7.45%,SLC25A5;ITGB1;KLF6;IRF2BP2;TPD52;TCF3;HDAC5;CEBPG
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.7749871562935801,0.9976934184363769,0.454,0.7631048587645447,1.0,10/22,11.94%,RBPMS;SH2B1;FAM89B;DAB2;PBLD;SMAD4;WWTR1;BMP4;TGFBR1;BMPR1A
prerank,spliceosomal snRNP assembly (GO:0000387),0.7868372755729376,0.9976056538386142,0.4415,0.7630140507422088,1.0,18/38,10.79%,SNRPD2;SNRPG;PRPF8;SNRPB;SNRPE;LSM4;SNRPF;SNRPD3;SNRPD1;SNRPC;SRSF10;LSM2;PRPF31;STRAP;CLNS1A;PRPF6;CD2BP2;PRMT5
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.7839050716373817,0.9974927373165935,0.4325,0.7630126043560043,1.0,14/36,14.18%,CD74;AGPAT2;HSPA1A;CPNE1;GAS6;LAPTM5;HIF1A;HSPA1B;AGPAT1;TRIM44;UBE2K;AXL;MAVS;C1QTNF4
prerank,protein K48-linked ubiquitination (GO:0070936),0.7987779684755686,0.9974795084337155,0.4505,0.7626250780081215,1.0,24/56,12.59%,IFI27;UBE2D3;RBX1;TTC3;UBE2E3;NEDD4L;UBE2B;UBE2D2;CDC34;UBE2C;UBE2R2;RNF187;UBE2H;RNF126;RNF5;UBE2G2;UBE2A;SYVN1;UBE2K;ARIH2;UBE2E1;CUL3;UBR5;UBE3A
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.7832931194934147,0.9971390576451911,0.44,0.7635136854242057,1.0,19/37,15.56%,KLF4;FHL1;CDKN1A;KANK2;CCL2;CDK4;PTEN;PRMT2;CDK2AP2;CDK6;ZNF655;BRD7;WEE1;DLG1;DACT1;PKD2;CDKN2B;RBL2;CDKN2D
prerank,nucleotide metabolic process (GO:0009117),0.77408865066973,0.9970624723847812,0.466,0.7633813076951343,1.0,8/23,13.33%,GUK1;PARK7;CMPK1;PNP;DCTD;REXO2;AK1;NUDT5
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.7774366757950898,0.9970553166429518,0.449,0.7629767693585727,1.0,11/29,12.71%,EFNA1;HPN;SFRP2;SFRP1;PPP2CA;PTEN;DAB2IP;ADIPOR1;SPRY2;SDHAF2;MAD2L2
prerank,histone H2A acetylation (GO:0043968),0.7651044590824109,0.9966036842597602,0.4695,0.764333268506788,1.0,10/16,16.50%,MORF4L1;MORF4L2;DMAP1;RUVBL2;BRD8;EP400;EPC1;MEAF6;TRRAP;ACTL6A
prerank,postsynaptic membrane organization (GO:0001941),0.7693234118554954,0.9964877304944663,0.4715,0.7643570993501672,1.0,4/19,12.35%,APOE;CEL;SHANK3;NLGN2
prerank,cellular glucuronidation (GO:0052695),0.7666635533917819,0.9963472211350133,0.4565,0.7644680876981556,1.0,3/19,21.34%,UGT2B17;UGT2A3;ABHD10
prerank,sensory perception of pain (GO:0019233),0.7698591607980707,0.9961332685926853,0.457,0.7648680656600841,1.0,4/21,13.02%,CCL2;P2RX4;RETREG1;NIPSNAP1
prerank,regulation of cation channel activity (GO:2001257),0.8122295509733164,0.9959467872678465,0.4645,0.7651508067709177,1.0,20/89,12.77%,CALM2;CALM1;AHNAK;ITGB1;APP;FKBP1A;CTSS;CAPN1;SELENON;ANK2;SLMAP;PRKACA;CAMK2D;VAMP2;PTK2B;NEFL;DLG3;NLGN2;DLG1;MINK1
prerank,fatty acid beta-oxidation (GO:0006635),0.7934319979545381,0.9957602059569036,0.45,0.7654352224672913,1.0,25/51,11.14%,ACADVL;ACAA2;HADHA;SCP2;ACADS;HADH;ETFB;ECHS1;ACAA1;HADHB;ECI1;ETFA;BDH2;ECHDC2;ACOX1;ABCD4;HSD17B10;DECR1;ECHDC1;DECR2;HSD17B4;ECI2;ACAT2;CRAT;ACAT1
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.7735090409156827,0.9954406606128794,0.4465,0.7662603361406821,1.0,5/25,11.43%,PLA2G2A;LPGAT1;LPCAT4;PLA2G10;CRLS1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.7665041679863138,0.9953822824014404,0.4645,0.7660461208837206,1.0,3/19,6.13%,PARK7;LAMTOR5;HAND2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.7711712715683824,0.9951563799594122,0.4685,0.7664893539277391,1.0,11/20,18.32%,NPTN;SULF2;GPC1;SULF1;CREB3L1;PRKD2;THBS1;SPRY2;SMOC2;SPRY1;SPRY4
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.8107658431839364,0.9950712428140756,0.4675,0.7663871439389498,1.0,54/92,13.73%,ZFP36L2;ZFP36L1;SKP1;KLF4;FHL1;CDKN1A;PSMB1;RBX1;PSME1;PSMB4;PSME2;KANK2;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5;PSMC3;PSMD2;PSMA2;CCL2;CDK4;PSMB2;PTEN;PSMD13;PSMD4;PSMD3;PRMT2;PSMC1;PSMC6;CDK2AP2;PSMC4;PSMF1;PSMA3;PSMA5;CDK6;ZNF655;USP47;PSMB8;BRD7;PSMD7;PSMC2;WEE1;DLG1;PSMD6;DACT1;CUL1;PKD2;CDKN2B;PSMD1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.7646970244449015,0.9950602568266551,0.472,0.765989688061814,1.0,12/21,17.51%,CIB1;STMN2;ARHGEF2;CLASP2;HDGFL3;CAMSAP3;TAOK1;TPX2;CLASP1;FGF13;MID1IP1;CAMSAP2
prerank,DNA metabolic process (GO:0006259),0.8568009357262761,0.9945580053896514,0.5815,0.7675029152510506,1.0,29/274,5.41%,RPS27A;UBC;UBA52;UBB;NPM1;HMGB1;NOP53;PARK7;RAN;TRIM28;CNBP;HMGB2;PTGES3;VCP;XRCC6;XRCC5;DNASE1;APEX1;BTG2;MCM7;TOP2A;RAD21;UBE2B;CSNK1E;DDB1;CDC34;TYMS;TOP2B;PCNA
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.8037763676217299,0.9943465150362849,0.4575,0.7679167412422877,1.0,12/81,6.74%,HSPB1;HMGB1;MIF;CYBA;HLA-E;APP;CLU;DDT;DHX9;LGALS9;PSEN1;IFNGR1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.8522515973519663,0.9941904633145573,0.576,0.7680988685161725,1.0,46/231,6.34%,CEACAM1;FN1;GSTP1;EZR;FBLN1;YWHAZ;EMILIN1;PLA2G2A;CD74;CCL21;HMGB1;APOE;FGFR3;MIF;SLC9A3R1;CIB1;CAMK2N1;APP;PHB2;DDT;ERBB2;PDGFRB;PDGFRA;MAPK3;TIMP3;PHB;HLA-DRB1;GAS6;ATP6AP1;NRP1;TNIP1;SHC1;CCL2;NOTCH1;PIN1;PTEN;EPHA2;PRKCZ;GLIPR2;LGALS9;RAP1A;FERMT2;HAND2;DUSP6;NOTCH2;WNK2
prerank,response to insulin (GO:0032868),0.8072808247555365,0.994068124406003,0.4685,0.7681490579654704,1.0,27/81,10.94%,CEACAM1;ZFP36L1;PKM;EIF6;OGT;PCK1;INSIG1;XBP1;SELENOS;AKT1;SLC39A14;SORBS1;PCK2;AKT2;HDAC5;RAB10;KHK;RAB13;SORT1;ZBTB7B;PRKDC;SYAP1;PARP1;RAB8A;INSR;VAMP2;LPIN3
prerank,positive regulation of developmental process (GO:0051094),0.8394540753926547,0.9939360352357339,0.545,0.7682340906185078,1.0,47/173,10.02%,DCN;CFL1;MDK;AGR2;HSP90AB1;APOE;PTN;RTN4;MST1;LMNA;VIL1;KRT10;NUMA1;FIS1;TRPM4;VEGFA;TFRC;BMP1;FGFR1;XBP1;RPS6KA1;PHLDB1;SORL1;C1QBP;PSEN1;BASP1;PINK1;DVL3;VPS35;ARHGEF7;PA2G4;MFF;BMPR2;CLASP2;CORO1B;DAG1;GJA1;CEBPB;ZNF703;DAB2IP;DVL1;SRC;BNIP3;DNM1L;DLG5;BMP4;TP53BP1
prerank,cellular response to drug (GO:0035690),0.7675737313852296,0.9938362716853142,0.4535,0.7681857439328691,1.0,12/26,17.91%,TFRC;GAS6;DPEP1;PPM1F;FBP1;KCNH2;MYC;TP53;RBM22;REST;RAP2A;MEF2C
prerank,positive regulation of biomineral tissue development (GO:0070169),0.7871932378422615,0.9937022588727832,0.4535,0.7682706593134883,1.0,12/40,11.97%,PKDCC;PTN;FBN2;ATRAID;OSR1;BMPR2;CEBPB;BMP4;ISG15;ANO6;BMPR1A;ATP2B1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.812394339462573,0.9936055448230728,0.4805,0.7682254625605722,1.0,10/81,4.37%,GSTP1;GSTA1;GPX4;SCP2;ACSL5;MGLL;ELOVL1;EPHX2;ACAA1;HPGD
prerank,granulocyte differentiation (GO:0030851),0.7657241399882727,0.9935102945087653,0.4575,0.7681806001205695,1.0,11/20,18.22%,CDKN1A;CEBPA;DEK;CDK4;LBR;RXRA;JAGN1;RARA;SRP54;PML;EP300
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.8251426258826778,0.9931247835460534,0.512,0.7692463207553717,1.0,32/129,8.00%,TUBA1A;TUBB;DYNLL1;TUBB4B;HSP90AA1;SKP1;DNM2;PPP1CB;PPP2R1A;CDKN1A;YWHAE;DYNC1H1;KHDRBS1;DCTN2;PPP1R12B;ENSA;CSNK1D;PAFAH1B1;CSNK1E;SSNA1;DCTN3;YWHAG;ARPP19;USH1C;DYNC1I2;DCTN1;AKAP9;OPTN;ACTR1A;PCM1;SFI1;PHLDA1
prerank,inner ear morphogenesis (GO:0042472),0.7707272736874085,0.9930875720641126,0.4745,0.768954914468638,1.0,5/24,11.85%,HPN;USH1C;MYO6;FGFR2;EPHB2
prerank,lymphocyte chemotaxis (GO:0048247),0.7862434458746478,0.9930139369706121,0.459,0.7688283215563676,1.0,4/43,5.43%,CCL21;GAS6;CCL2;SLC12A2
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.7654447120959391,0.9930050122099243,0.4755,0.7684315591458383,1.0,17/20,22.20%,CNDP2;PLOD2;MGST2;PLSCR1;GSS;HAGH;GGT1;GGCT;PTDSS1;MTHFS;GAMT;PTDSS2;FPGS;OPLAH;GCLC;SLC27A1;GATM
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.7980186606660353,0.9929693444842314,0.456,0.768135178811626,1.0,40/65,13.85%,SKP1;FHL1;PSMB1;RBX1;PSME1;PSMB4;PSME2;CDK5RAP3;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5;PSMC3;PSMD2;PSMA2;PSMB2;PSMD13;PSMD4;PSMD3;PSMC1;PSMC6;PSMC4;PSMF1;PSMA3;PSMA5;VPS4A;USP47;INTS3;PSMB8;PSMD7;PSMC2;PSMD6;CUL1;PSMD1;AURKB
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.7834032407482591,0.9926573240973456,0.439,0.7689143662381618,1.0,23/44,15.38%,PABPC1;ZFP36L2;ZFP36L1;ZFP36;BTG2;CNOT1;POLR2G;MOV10;PUM1;UPF1;ROCK2;CELF1;YTHDF3;TOB1;METTL3;YTHDF2;TNRC6A;YTHDF1;CNOT8;CNOT7;KHSRP;ROCK1;GTPBP1
prerank,sodium ion import across plasma membrane (GO:0098719),0.7656957420777615,0.9925997591735701,0.4745,0.7687122293171068,1.0,3/18,5.43%,TRPM4;SLC9A3;SLC12A2
prerank,cell cycle G2/M phase transition (GO:0044839),0.825237252699984,0.9925068300443065,0.5185,0.7686501036716977,1.0,33/130,8.00%,TUBA1A;TUBB;DYNLL1;TUBB4B;HSP90AA1;SKP1;DNM2;PPP1CB;PPP2R1A;CDKN1A;YWHAE;DYNC1H1;KHDRBS1;DCTN2;PPP1R12B;AKAP8L;ENSA;CSNK1D;PAFAH1B1;CSNK1E;SSNA1;DCTN3;YWHAG;ARPP19;USH1C;DYNC1I2;DCTN1;AKAP9;OPTN;ACTR1A;PCM1;SFI1;PHLDA1
prerank,regulation of axon extension (GO:0030516),0.7794671194652674,0.9923916454032681,0.453,0.7686736733826859,1.0,21/38,18.63%,APOE;DNM2;RTN4;CTTN;MACF1;ABL1;DBN1;OLFM1;DBNL;ZFYVE27;L1CAM;SEMA3A;GOLGA4;GSK3B;TWF2;NTN1;SIN3A;SHTN1;RUFY3;DIP2B;MAP3K13
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.763721711218768,0.9923750483678916,0.45,0.768317468258859,1.0,13/23,13.68%,SUB1;PSMC5;PSMC3;MED16;PSMC6;PSMC4;SRF;PSMC2;MED14;MED13;MED4;MED12;TP53
prerank,regulation of cell cycle (GO:0051726),0.8593960081297699,0.9920935394209298,0.5985,0.7689649406695387,1.0,53/294,6.70%,RPS15A;RACK1;RPL23;JUN;CALR;EIF4G2;SMIM22;HSP90AB1;JUND;DUSP1;JUNB;NR4A1;NOP53;MIF;PDCD4;HNRNPU;ID2;CAMK2N1;CDKN1A;NUPR1;RHOB;CDK5RAP3;WDR6;DHCR24;SON;GADD45GIP1;CTBP1;PKD1;CDK10;CCND1;HPGD;CHMP1A;SFRP1;RBBP4;TSC2;PLAGL1;NOTCH1;PIM3;CDK4;TARDBP;SDCBP;SND1;ABL1;BIN1;MLXIPL;RAD23A;IQGAP1;NOTCH2;TCF7L2;TP53I13;CKS2;MAEA;STK11
prerank,regulation of MAPK cascade (GO:0043408),0.8360289019023652,0.992059509035413,0.5435,0.7686629603908901,1.0,18/165,3.93%,CEACAM1;FN1;GSTP1;CD24;YWHAZ;CD74;HMGB1;DUSP1;FGFR3;PEBP1;ERBB2;MAP2K2;CAV1;MAPK3;MYDGF;LAMTOR1;HLA-DRB1;FGFR1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.7669297011143722,0.9919625639994308,0.471,0.7686221143045961,1.0,8/18,19.94%,IGFBP3;BTG1;BOC;MAPK14;AKIRIN1;LRRC8A;MEF2C;HIF1AN
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.7862450141028365,0.9919492564529115,0.458,0.7682397754967408,1.0,19/48,14.71%,ZFP36L2;ZFP36L1;SLC9A3R1;CTNNB1;CDKN1C;AURKAIP1;BTG2;BTG1;GAS1;SCRIB;BMP4;CDKN1B;SMAD3;PRCC;WEE1;TOM1L2;BTG3;PLK2;ZWINT
prerank,protein alkylation (GO:0008213),0.7701401099085016,0.9919242547626712,0.4615,0.7679044646080422,1.0,9/23,12.58%,PRMT1;SNRPB;SNRPD3;CSKMT;PRMT2;GSPT1;PCMT1;LCMT1;ETF1
prerank,regulation of integrin activation (GO:0033623),0.7629394880894522,0.9918577496514941,0.4785,0.767731410603861,1.0,8/15,17.25%,RAP1B;FBLIM1;PIEZO1;FERMT2;SRC;JAM3;FARP2;CXCL13
prerank,sprouting angiogenesis (GO:0002040),0.78883117780299,0.9918517591195247,0.453,0.7673246991027364,1.0,26/52,12.59%,NR4A1;ADGRA2;VEGFA;LOXL2;NRP1;RAMP2;AKT1;VEGFB;SEMA5A;EPHB4;PARVA;ENG;ACVRL1;GREM1;ADTRP;BMP4;NAXE;RNF213;SRF;ITGB1BP1;DLL1;PTK2B;THBS1;ROBO1;CDH13;EFNB2
prerank,alpha-amino acid metabolic process (GO:1901605),0.7816724487986653,0.9917960476158081,0.4575,0.7671174145567963,1.0,17/44,12.74%,ASS1;OAT;CPS1;GLS;GLUL;HNF4A;DDAH2;ALDH18A1;DDAH1;DPEP1;FOLH1;PYCR1;GLUD1;RIMKLB;GOT2;GPT;GOT1
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.7779006121772272,0.9917858181957823,0.444,0.7667215861808663,1.0,19/36,14.92%,AMN;SPTBN1;RAB7A;RAB34;MACF1;AFDN;GOLPH3;RAB10;OPTN;ARFRP1;GGA2;GGA1;VAMP2;PREPL;GORASP2;GOLGA4;GCC2;GOLGA7;GGA3
prerank,negative regulation of DNA binding (GO:0043392),0.7742385473384266,0.9916451710064458,0.4695,0.7668208314193299,1.0,8/30,9.89%,JUN;CPNE1;SMO;SUMO1;NFKBIA;SUMO3;KDM1A;MDFI
prerank,endocardial cushion development (GO:0003197),0.7699613604252362,0.9911227786823458,0.47,0.7684175730302576,1.0,10/21,11.94%,FOXF1;NOTCH1;ENG;BMPR2;ACVRL1;TBX2;MDM4;BMP4;CRELD1;BMPR1A
prerank,lymphocyte migration (GO:0072676),0.7815249190834153,0.991105368317307,0.457,0.7680532778941022,1.0,3/39,5.71%,CCL21;CCL2;MSN
prerank,regulation of viral release from host cell (GO:1902186),0.7666522897020288,0.9906798557353101,0.467,0.769315269999267,1.0,15/22,18.56%,TRIM28;CHMP2A;DDB1;CHMP3;TRIM31;VPS4A;TRIM15;TSG101;VPS37B;CHMP2B;TRIM8;TRIM26;PML;TRIM25;TRIM13
prerank,positive regulation of macrophage activation (GO:0043032),0.7638079735637218,0.9906658157649819,0.4804804804804805,0.768942780619684,1.0,4/15,15.57%,HSPD1;CEBPA;THBS1;TNIP2
prerank,phagosome maturation (GO:0090382),0.7818619255364032,0.9905588334810711,0.4465,0.7689299664950724,1.0,12/37,7.05%,ATP6V0B;ATP6V1G1;ATP6V0D1;ATP6V0E1;RAB7A;ATP6V1F;RAB34;CORO1A;TCIRG1;ATP6V1E1;ATP6V0A1;RAB14
prerank,positive regulation of translational initiation (GO:0045948),0.7702539501680349,0.9904981810402752,0.476,0.768735824016089,1.0,12/22,17.93%,DDX3X;KHDRBS1;POLR2G;LARP1;RPS6KB2;EIF2B5;YTHDF3;YTHDF2;YTHDF1;CDC123;UHMK1;MTOR
prerank,positive regulation of immunoglobulin production (GO:0002639),0.7724613259577415,0.9904447299185011,0.4475,0.7685226587350524,1.0,12/34,12.71%,HLA-E;PHB2;PHB;TFRC;GPI;XBP1;VAMP3;STX4;TP53BP1;KMT5B;EPHB2;MAD2L2
prerank,positive regulation of autophagy (GO:0010508),0.8108133805942007,0.9903440706785502,0.4845,0.7684710855107264,1.0,30/88,11.77%,DCN;HMGB1;TMEM59;PARK7;PHB2;TSC2;LARP1;BAD;SUPT5H;PINK1;BNIP3L;STK11;SH3GLB1;WAC;OPTN;GNAI3;TPCN1;GPSM1;FOXO3;SESN3;TRIM27;PAFAH1B2;BNIP3;FBXO7;ULK1;SCOC;MTDH;HTT;KAT5;TFEB
prerank,mitochondrial fission (GO:0000266),0.76614273014369,0.9902653090418615,0.4715,0.7683569022917452,1.0,8/18,16.73%,DNM2;FIS1;MTFR1L;MFF;DNM1L;DNM1;SLC25A46;OPA1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.7727800998733203,0.9902203362278509,0.458,0.7681033844235325,1.0,5/35,5.48%,FABP5;ABR;PSMC5;EIF4EBP2;CEL
prerank,pore complex assembly (GO:0046931),0.7663010433947669,0.9900424507808471,0.4705,0.7683851505816566,1.0,17/19,22.55%,RTN4;GSDMD;BAD;AFDN;TPR;ADAM10;ANO6;NUP98;TMEM170A;PDZD11;NUP93;PLEKHA7;AHCTF1;NUP205;NUP153;NUP107;NDC1
prerank,establishment of vesicle localization (GO:0051650),0.76154994080872,0.9897776024110486,0.485,0.7689966570384554,1.0,13/18,19.15%,DNM2;RAB11A;KIF5B;TMEM230;TESK1;LIMK2;SPG11;SYT11;IKBKG;RAB27A;TOR1A;KIF5C;SNAPIN
prerank,cell-cell junction organization (GO:0045216),0.8069368592752263,0.9897759906393033,0.464,0.7685753532147851,1.0,26/82,9.58%,CD177;CDH17;CTNNA1;JUP;CDH1;DSG2;CTNND1;FSCN1;DCHS1;PKP3;LIMS2;CLDN5;TLN1;DSP;TJP3;CDH11;NECTIN2;CDH5;AFDN;CXADR;MYADM;F2R;CSK;F2RL1;OCLN;LIMS1
prerank,regulation of protein localization to cell surface (GO:2000008),0.7720499097883811,0.9897429633854381,0.4685,0.768273116194499,1.0,16/33,16.12%,HSP90AB1;CTNNB1;TAX1BP3;NEDD4L;PICALM;RAB11B;GBF1;STX3;LEPROT;STX4;TM9SF4;GOPC;GPD1L;LEPROTL1;COMMD1;TYROBP
prerank,intracellular pH reduction (GO:0051452),0.7786800485857949,0.9895939290901018,0.4545,0.768447843496257,1.0,12/35,9.76%,ATP6V0B;ATP6V1G1;ATP6V0D1;ATP6V0E1;RAB7A;ATP6V1F;TMEM9;TCIRG1;ATP6V1E1;ATP6V0A1;CLCN3;ATP6V1B2
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.7773080274404207,0.989446149229889,0.462,0.7686035108690563,1.0,16/39,11.22%,ACTN4;MYO1A;RAB1A;MYO1D;MYO1C;MYO7B;PAFAH1B1;KIF5B;WASL;MYO1B;TRAK1;MYO6;FNBP1L;MYO5B;BICDL2;HTT
prerank,response to molecule of bacterial origin (GO:0002237),0.7975417060768009,0.989341229969595,0.4535,0.7685746104963145,1.0,21/72,12.00%,CD24;S100A14;CPS1;HMGB2;SLPI;HNRNPA0;INAVA;PRDX3;LGALS9;S100A8;ERBIN;SIRT2;TRIB1;MAPKAPK2;F2R;S100A9;FZD5;FOXP1;IRAK1;OTUD5;GGT1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.8067084712156672,0.9891906828111497,0.4825,0.7687031530915254,1.0,15/92,5.92%,CD81;CD74;EFNA1;MIF;TNFRSF14;APP;VEGFA;NRP1;SFRP2;SFRP1;AGT;PECAM1;ABL1;PRKCZ;ITGA5
prerank,positive regulation of angiogenesis (GO:0045766),0.8153722176502943,0.9891712006058297,0.4985,0.7683449023706215,1.0,39/116,11.87%,MDK;HSPB1;ITGB1;GRN;PKM;JUP;KLF4;RHOB;MYDGF;VEGFA;PDCD6;BTG1;EMC10;RAMP2;SFRP2;XBP1;VEGFB;CD34;CDH5;CTSH;ITGA5;APLNR;SEMA5A;HK2;RRAS;GATA6;JAK1;HIF1A;SIRT6;NINJ1;PRKD2;GAB1;JMJD8;MTDH;DLL1;PLCG1;THBS1;HSPB6;AQP1
prerank,phospholipid metabolic process (GO:0006644),0.8001813688126878,0.9887728074372314,0.463,0.7694891000344938,1.0,18/73,9.46%,CYP2W1;PLA2G2A;GPX4;AGPAT2;APOA2;FDFT1;PLPP1;ENPP7;PLPP3;GNPAT;ABHD12;PLPP2;PIP4K2B;SMPD3;SMPD1;AGPAT1;LPCAT4;PLA2G10
prerank,positive regulation of axon extension (GO:0045773),0.7665157408173028,0.9886733523532639,0.483,0.769458113282798,1.0,15/22,19.42%,VEGFA;MACF1;NRP1;DBN1;SEMA5A;DBNL;ZFYVE27;L1CAM;GOLGA4;TWF2;NTN1;SHTN1;RUFY3;MAP3K13;MEGF8
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.7650360784302421,0.9886158082186095,0.471,0.769248253409316,1.0,14/25,13.68%,PLAUR;PDCD5;FAM162A;MLLT11;BAD;TNFSF10;PINK1;MFF;BNIP3;DNM1L;PYCARD;BAX;PPIF;TP53
prerank,response to peptide hormone (GO:0043434),0.7846890730482887,0.9886074423262525,0.4575,0.7688548426381722,1.0,27/51,16.96%,IGFBP5;ZFP36L1;EIF6;OGT;CAV1;PCK1;ANXA1;XBP1;AKT1;STAT2;STAT6;KHK;ROCK2;SORT1;EIF2B5;ZBTB7B;SRC;STAT5B;EIF2B1;TGFBR3;ROCK1;EPM2AIP1;STAT1;STAT3;EIF2B4;CREB1;TSC1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.7845895093500037,0.9885828419625737,0.462,0.7685278816522173,1.0,25/54,13.76%,HSPG2;GPC3;GNS;AGRN;SDC1;SDC2;HEXA;SDC4;GUSB;FUCA1;GPC6;UGDH;GPC1;HYAL2;B3GAT3;GLB1;GPC4;IDS;HGSNAT;HS6ST1;EXT1;NAGLU;EXT2;SDC3;SLC35D2
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.7676462975569796,0.988371937235103,0.4595,0.7689190382163664,1.0,17/32,16.95%,RHOA;CIB1;KLF4;VEGFA;ANXA1;NOTCH1;HDAC5;HDAC7;ITGB1BP1;THBS1;JCAD;RHOJ;PDCD10;AKT3;CARD10;KDR;PIK3C2A
prerank,nuclear export (GO:0051168),0.8051171437718007,0.9883031715336906,0.4825,0.7687684319581257,1.0,31/83,10.84%,HNRNPA1;CALR;SRSF5;SRSF3;SRSF2;RAN;SRSF6;CHP1;SRSF7;SRSF11;RNPS1;XPO1;PKD1;RBM8A;SRSF9;SRSF1;CHTOP;DDX39A;MAGOH;SRSF4;CASC3;TPR;NXF1;POLDIP3;EIF4A3;SRRM1;CSE1L;DHX38;NUP62;THOC7;EIF4E
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.7705104654109705,0.9882289481806271,0.4745,0.7686538401340475,1.0,9/27,10.14%,GPRC5A;APP;AREG;SHC1;ERRFI1;VPS25;SNX6;TSG101;NCK2
prerank,female gonad development (GO:0008585),0.7672580744059028,0.9881027982047837,0.468,0.7687185168673754,1.0,5/22,9.02%,SOD1;VEGFA;NR2F2;CEBPB;EIF2B5
prerank,cellular response to radiation (GO:0071478),0.781412324284909,0.9880186154243381,0.4635,0.7686104142829983,1.0,5/45,4.14%,EEF1D;ADIRF;CDKN1A;RHOB;NET1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.7661176018292507,0.9878784489704467,0.4615,0.7687378119836001,1.0,17/27,15.96%,APP;USP22;LGMN;HES1;EIF4EBP1;HSF1;CDC25B;EIF4E;CUL3;PKN2;MEIS2;TTL;DUSP3;CCNB1;PPP1R10;CCDC57;SMOC2
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.8320259531915545,0.9878476468967913,0.546,0.7684418917390821,1.0,20/165,8.93%,GNAS;PSAP;VIP;AKAP12;GNA11;GNAI2;GCG;WASF2;VIPR1;RAMP2;ADM;ADGRE5;RAMP1;LGR4;GNAI3;GNAQ;PRKACB;ADGRL2;ADCY6;GABBR1
prerank,positive regulation of protein catabolic process (GO:0045732),0.8090980554546142,0.987738203696127,0.4935,0.7684457684942841,1.0,21/85,7.29%,EZR;OAZ1;PTTG1IP;APOE;HSP90AA1;VIP;NDUFA13;GPC3;VPS28;VCP;RAB7A;NEDD4L;DDB1;SORL1;MSN;OAZ2;VGLL4;HUWE1;NRDC;VPS35;FURIN
prerank,regulation of dendritic spine development (GO:0060998),0.7637976335262705,0.9874121507699803,0.481,0.7692722530179801,1.0,12/21,20.90%,APOE;ARF6;PSEN1;DLG5;FMR1;SHANK3;NEURL1;MEF2C;LLPH;CAMK1;TANC2;KIF1A
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.7608950265361983,0.9871815047582009,0.4765,0.7697508900178598,1.0,15/20,21.48%,LZTR1;DAB2IP;MFN2;CD2AP;SPRY2;EPHB2;FBP1;MAPKAP1;SH3BP1;SPRY1;ARHGAP12;SLIT2;SPRY4;CGNL1;STAMBP
prerank,histone methylation (GO:0016571),0.7639620197344001,0.9871352795932973,0.4745,0.7695036576733821,1.0,14/26,16.97%,TRMT112;PRMT1;FBL;PRMT2;CREBBP;SIRT7;NSD3;EHMT2;CARM1;PRMT5;EHMT1;EZH2;PRMT7;NSD1
prerank,positive regulation of reproductive process (GO:2000243),0.7716615681902257,0.9871327575355708,0.458,0.7690901406015898,1.0,11/35,17.44%,VIP;VEGFA;C1QBP;SIRT2;LHFPL2;PLA2G10;PDE3A;ACVR1B;SYDE1;AGO2;CACNA1H
prerank,regulation of vasoconstriction (GO:0019229),0.7725400760621051,0.9870613841471513,0.4685,0.7689359618218774,1.0,8/30,8.32%,TRPM4;CAV1;ECE1;AGT;ADM;ACE2;BMPR2;F2R
prerank,response to endoplasmic reticulum stress (GO:0034976),0.8115860605970362,0.9869849065218936,0.497,0.7688277254693888,1.0,49/108,11.73%,AGR2;P4HB;JUN;HSP90B1;ATF4;ATP2A3;TMEM259;HSPA5;PDIA3;VCP;OS9;BCAP31;CDK5RAP3;BAG6;ATP2A2;PDIA4;TMCO1;ATF3;SELENOS;SELENOK;FLOT1;HERPUD1;MBTPS1;ERN2;UFC1;UBXN6;ERO1A;RCN3;DNAJC10;SEC16A;SEL1L;RNF5;CEBPB;CREB3L1;PPP1R15A;EIF2B5;DAB2IP;UFM1;SYVN1;BAX;QRICH1;ERLEC1;UBQLN1;THBS1;RNF186;WFS1;GORASP2;DDRGK1;ERP44
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.7645633386690514,0.9868913331157547,0.481,0.7687667256870234,1.0,14/20,20.71%,CDKN1C;CEBPA;NR2F2;PTEN;IPO5;IPO7;CDKN1B;HEXIM1;MEN1;LATS1;PLK1;CDK5RAP1;MYOCD;APC
prerank,negative regulation of macroautophagy (GO:0016242),0.7683539115853851,0.9867489858402868,0.4835,0.7688755432454321,1.0,18/26,17.93%,QSOX1;NUPR1;TSC2;AKT1;PINK1;SMG1;SEC22B;CHMP4A;NRBP2;CHMP4B;SCFD1;FEZ2;PHF23;TSC1;UBQLN4;TMEM39A;USP36;MTOR
prerank,amyloid precursor protein metabolic process (GO:0042982),0.7612022047517087,0.9867198524591821,0.4755,0.7685598241541844,1.0,9/18,17.19%,APOE;PSEN1;APH1A;NCSTN;ADAM10;PSENEN;NSG1;BACE1;LDLRAP1
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.7849903775803752,0.9866952912015436,0.4615,0.7682365194271333,1.0,22/53,7.07%,ACADVL;HSPA5;LMNA;PDIA6;ADD1;CTDSP2;MYDGF;SERP1;ATP6V0D1;SEC31A;TPP1;HDGF;ARFGAP1;XBP1;TLN1;SHC1;SSR1;GFPT1;ERN2;YIF1A;DCTN1;KLHDC3
prerank,cortical actin cytoskeleton organization (GO:0030866),0.7571605070643559,0.9865039221387099,0.486,0.7685575616745766,1.0,14/20,21.28%,LLGL2;ARF6;NCKAP1;RAB13;ROCK2;FMNL2;RHOQ;DLG1;ROCK1;IKBKB;STRIP1;FHOD1;FMNL3;LCP1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.7592564890949584,0.9864764253772259,0.493,0.7682463589867456,1.0,12/18,20.67%,CIB1;VEGFA;ANXA1;HDAC7;JCAD;RHOJ;AKT3;KDR;PIK3C2A;FGFBP1;MAP3K3;HMOX1
prerank,negative regulation of protein depolymerization (GO:1901880),0.7614006255679926,0.9863613565859702,0.468,0.7682950941112626,1.0,14/24,17.51%,CIB1;STMN2;LIMA1;ARHGEF2;CLASP2;HDGFL3;CAMSAP3;PLEKHH2;TAOK1;TPX2;CLASP1;FGF13;MID1IP1;CAMSAP2
prerank,regulation of stem cell differentiation (GO:2000736),0.8051543328995864,0.9863244216280395,0.488,0.7680124827712753,1.0,51/90,13.73%,ZFP36L2;PTN;HNRNPU;PSMB1;PSME1;PSMB4;PSME2;PDGFRA;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;HES1;OCIAD1;PSMA1;PSMA4;PSMC5;PSMC3;PSMD2;PSMA2;JAG1;NOTCH1;PSMB2;ABL1;PSMD13;PSMD4;YAP1;NELFB;PSMD3;TCF3;PSMC1;PSMC6;PSMC4;PSMF1;TCF12;PSMA3;NUDT21;PSMA5;PRKDC;METTL3;PSMB8;PSMD7;PSMC2;YTHDF2;BMPR1A;PSMD6;KMT2A;CBFB;PSMD1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.764328056237872,0.9863237299717234,0.456,0.767595989433442,1.0,11/30,12.39%,TGM2;SHC1;NOTCH1;NOTCH2;GRB2;ERBIN;LRRC59;ITGAV;SRC;RAPGEF1;CRKL
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.774055416358443,0.9860527409614877,0.4785,0.7682109092628191,1.0,9/29,10.57%,CPS1;ASAH1;CYB5R3;GCHFR;DDAH2;AKT1;GBA;CYB5B;SPTLC1
prerank,regulation of protein phosphorylation (GO:0001932),0.8479349181990063,0.9859564576625779,0.6075,0.7681688323935918,1.0,66/262,8.11%,RACK1;PPIA;CLDN3;FN1;HSPB1;FBLN1;CD74;EFNA1;NPM1;HSP90AA1;ATF4;NOP53;CCND2;ITLN1;RAC1;SLC9A3R1;CIB1;RARRES2;PLXNB2;PARK7;SOD1;IGFBP3;APP;PLAUR;CHP1;ERBB2;ILK;CDK5RAP3;NPTN;MAPK3;MYDGF;ERP29;VEGFA;HLA-DRB1;TFRC;CCND1;AKAP8L;GAS6;CSNK1D;ATF3;AKT1;FLOT1;PECAM1;PIN1;TARDBP;VEGFB;PPP2CA;PTEN;CDH5;ABL1;STAT2;NDUFS4;PINK1;C3;DVL3;DAB2;AKT2;MYADM;PLPP3;FBH1;PRNP;ENG;ROCK2;DNAJC10;PPP2R5C;PTK2
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.7655313720762125,0.9858397729979171,0.4865,0.7682199276652721,1.0,2/26,1.85%,CYBA;PARK7
prerank,positive regulation of glycolytic process (GO:0045821),0.7628244548812714,0.9857719074597893,0.489,0.7676539129227561,1.0,10/20,18.24%,APP;SLC4A4;PSEN1;MLXIPL;HIF1A;ENTPD5;INSR;PRKAA1;PFKFB2;ARNT
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.7628244548812714,0.9857719074597893,0.489,0.7676539129227561,1.0,10/20,18.24%,APP;SLC4A4;PSEN1;MLXIPL;HIF1A;ENTPD5;INSR;PRKAA1;PFKFB2;ARNT
prerank,vasculogenesis (GO:0001570),0.7690690954109718,0.9855768169533308,0.4645,0.768023002995602,1.0,16/33,16.79%,CAV1;EGFL7;PDGFRB;VEGFA;RAMP2;ADM;NOTCH1;APLNR;TGFBR2;ENG;CUL7;CCM2;TGFBR3;SPRED1;SOX18;KDR
prerank,regulation of myoblast differentiation (GO:0045661),0.7732320162943399,0.9854990145805046,0.478,0.7678909360522292,1.0,11/34,12.79%,ZFP36L1;IGFBP3;BTG1;BOC;NOTCH1;FLOT2;TBX3;BMP4;DLL1;SRA1;MAPK14
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.7792185525513254,0.9854792383789203,0.4675,0.7675526277265156,1.0,5/42,8.32%,CCL21;ATP2B4;ITPR3;ERO1A;F2R
prerank,autophagy of nucleus (GO:0044804),0.7571492461034506,0.9853627376518348,0.502,0.7675905920164039,1.0,13/16,21.53%,WIPI2;ULK1;WDR45;ATG12;WDR45B;ATG3;ATG2A;ATG13;RB1CC1;ATG2B;ULK2;WIPI1;ATG5
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.7593295261950789,0.9853263034123301,0.5077538769384692,0.7673157473818137,1.0,14/15,23.82%,BAG6;EMC10;EMC4;SGTA;EMC6;EMC3;EMC7;CAMLG;EMC9;EMC8;EMC1;UBL4A;EMC2;MMGT1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.7719909399590622,0.9850336426396521,0.468,0.7680218314983864,1.0,12/36,11.59%,ZFP36L2;TRIO;FERMT2;YAP1;CCDC85B;ASXL1;SIRT2;WWTR1;TRIB2;LRP3;SMAD3;ZADH2
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.8373638273035104,0.985027366112677,0.5785,0.7676316178545405,1.0,57/193,8.80%,RACK1;CLDN3;EMILIN1;HSP90AB1;APOE;MIF;ID2;KLF4;SUB1;PARK7;APP;MAP2K2;LDLR;ERP29;VEGFA;ATP2B4;CPNE1;LGMN;LRPAP1;NDFIP1;CD46;HDAC1;SFRP2;CNPY2;CLDN5;SFRP1;NOTCH1;TARDBP;SDCBP;SMO;CD34;LGALS9;PICALM;MOV10;PSEN1;HAND2;APLNR;YAP1;NOTCH2;PINK1;OLFM1;YY1;VDR;NDFIP2;MYADM;ADAM10;OPTN;ENG;ROCK2;ACVRL1;HIF1A;FLOT2;DNMT1;ANKRD13D;XDH;CELF1;CREB3L1
prerank,positive regulation of cytokinesis (GO:0032467),0.77387853730145,0.9849475374237775,0.467,0.7675372953070968,1.0,9/36,13.85%,RHOA;GIPC1;CDC42;SVIL;CDC25B;CUL3;PKN2;CENPV;AURKB
prerank,negative regulation of B cell activation (GO:0050869),0.7640528880701326,0.9848691905186777,0.47573786893446723,0.7674233155677324,1.0,3/22,6.14%,ID2;SFRP1;LAPTM5
prerank,regulation of intracellular signal transduction (GO:1902531),0.8644015629592502,0.9847019519382496,0.647,0.7676551965040816,1.0,33/436,4.52%,RPL11;TMSB4X;RPL5;CEACAM1;HSPB1;EZR;CD24;RHOC;NOP53;RHOA;RAC1;A2M;SQSTM1;CDC42;AKAP12;IER3;ARHGDIA;RHOB;CSNK2B;MAPK3;CHD3;VEGFA;CPNE1;ABR;RHOT2;SGK1;NET1;PRKAR1A;DDIT4;HDAC1;TAF10;CHD4;VWF
prerank,regulation of vesicle-mediated transport (GO:0060627),0.8022691491101599,0.9843323200417146,0.476,0.7686758056632698,1.0,42/91,13.67%,OLFM4;CD177;MAP2K2;RAB11A;AP2S1;MAPK3;PACSIN2;RAB5C;NRP1;ARFGAP1;TSC2;RAB17;RAB5B;ABL1;MBTPS1;PICALM;SCARB1;GAS1;CHMP3;SNX17;RAB11B;RAB10;MAPK1;RAB13;USP7;ATP9A;ITGAV;RAB5A;RAB25;SRC;STX4;RAB8A;VAMP2;RAB3D;INPP5F;CDH13;RAB4A;RAB21;HIP1R;RALA;SCFD1;ZFYVE16
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.7567297674076431,0.9842618874458252,0.4935,0.7685362630422176,1.0,12/19,18.40%,PET100;COX17;COA3;COX14;OXA1L;COX20;COA5;SURF1;BCS1L;COX19;SMIM20;COA1
prerank,import into nucleus (GO:0051170),0.7975537291757872,0.983897844325539,0.4785,0.7695585336827981,1.0,25/77,10.59%,HNRNPA1;PTTG1IP;SNRPD2;RAN;PHB2;SNRPG;SNRPB;SNRPE;SNRPF;SNRPD3;SNRPD1;KPNB1;SEC13;TSC2;AKT1;IPO5;TPR;IPO7;APPL2;RPAIN;TNPO1;IPO9;HTATIP2;CSE1L;NUP62
prerank,respiratory system development (GO:0060541),0.7676929144055888,0.983811395311446,0.4715,0.7694845316025442,1.0,11/35,11.79%,TCF21;CEBPA;VEGFA;BAG6;FOXF1;BASP1;ITGA3;PHOX2B;BMP4;SMCHD1;FGFR2
prerank,regulation of GTPase activity (GO:0043087),0.83237344066068,0.9837848699207801,0.571,0.7691793912147955,1.0,46/186,10.05%,S100A10;RACK1;CCL21;ITGB1;PLXNB2;SOD1;ERBB2;PLXNB1;AGRN;THY1;TGM2;NET1;TMED2;SFRP1;ARHGAP27;PLXND1;CCL2;PIN1;RCC2;F11R;RAP1A;PICALM;ARL2;AFDN;FERMT2;DVL3;RGS10;ARAP1;ARHGEF7;SGSM2;ITGA6;PTK2;GPSM1;EPHB3;F2R;RSU1;STMN3;DAB2IP;F2RL1;SGSM3;CRK;LIMS1;ADAP1;CCL15;MAP4K4;RAPGEF1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.7789947213490361,0.9837199649358996,0.4745,0.7690158788489916,1.0,11/43,11.65%,GRN;CYBA;RIOK3;DHX9;PUM2;PUM1;PLSCR1;TRIM15;DDX60;ZCCHC3;ANKRD17
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.7579764023012895,0.9834851169136996,0.4835,0.76951634234336,1.0,17/24,21.82%,SEMA3B;VEGFA;NRP1;SEMA4G;SEMA5A;SEMA3C;SEMA6A;SEMA4B;SEMA3A;SEMA5B;SEMA6C;SEMA4C;SEMA3F;MEGF8;SEMA3D;SEMA6D;SEMA4D
prerank,membrane protein proteolysis (GO:0033619),0.7744400089800332,0.9834709772390573,0.4725,0.7691564588339312,1.0,23/39,16.79%,MYH9;RBMX;SPPL2B;HM13;MBTPS1;CTSH;SPPL2A;PSEN1;APH1A;NCSTN;ADAM10;SPPL3;DAG1;RELA;CLPP;AFG3L2;PSENEN;NGFR;BACE2;ADAM9;PARL;RET;BACE1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.7596748744534013,0.9832884933823652,0.499,0.7694484709221573,1.0,3/21,6.46%,PRDX5;CEBPA;MAF1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.7866865925518363,0.9832224022476713,0.4745,0.7692862421561916,1.0,17/58,12.62%,EMILIN1;CSNK2B;RBPMS;LEFTY1;PIN1;SDCBP;DAB2;ENG;SMAD4;BMPR2;ACVRL1;TWSG1;GREM1;BMP4;TGFBR1;BMPR1A;PMEPA1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.8159494550802603,0.9830672664779887,0.5275,0.7694595416107478,1.0,50/124,9.40%,PFN1;CALM1;RHOA;RAC1;AP2M1;CTNNB1;GNB1;CDC42;PSMB1;CLTC;PSME1;PSMB4;PSME2;AP2S1;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5;SFRP2;PSMC3;SFRP1;PSMD2;PSMA2;PSMB2;FZD1;AP2A2;PSMD13;PSMD4;MOV10;PSMD3;TCF7L2;DVL3;PSMC1;PSMC6;PLCB3;AP2B1;PSMC4;GNG2;PSMF1;PPP3CB;PSMA3;PSMA5;FRZB;FZD5;DVL1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.7962411924900796,0.9830587503860393,0.484,0.7690797666748774,1.0,16/71,7.79%,EZR;ZFP36L1;RHOA;ERBB2;OGT;ERBB3;PDGFRB;PDGFRA;PI4KA;FGFR1;AKT1;PTEN;C1QBP;PLCD3;PLCB3;SIRT2
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.7724538597975492,0.9829691145419042,0.4735,0.7690219611404949,1.0,11/40,12.95%,GSTP1;TNIP1;RIOK3;TLE1;PPM1A;CARD19;DAB2IP;PYCARD;PER1;PPM1B;ZMYND11
prerank,inositol lipid-mediated signaling (GO:0048017),0.7845548224912685,0.9828709115545711,0.472,0.7690004645245351,1.0,11/51,9.78%,EZR;RHOA;OGT;PDGFRB;PDGFRA;PI4KA;FGFR1;PLCD3;PLCB3;IGF1R;PI4KB
prerank,protein import into mitochondrial matrix (GO:0030150),0.763032203278762,0.9827145025351922,0.5005,0.7691976967237516,1.0,10/19,14.32%,ROMO1;TOMM20;TIMM17B;DNAJC15;DNAJC19;TIMM44;TOMM40;TIMM17A;TIMM50;TOMM70
prerank,protein hydroxylation (GO:0018126),0.7538400101651495,0.9824408688686787,0.4917458729364682,0.7698565688505961,1.0,8/15,9.76%,PLOD1;PLOD2;EGLN3;P3H4;P3H1;PLOD3;ASPH;P3H3
prerank,hyaluronan metabolic process (GO:0030212),0.7588375735729357,0.9822785519983409,0.4895,0.7700855657249128,1.0,9/23,17.26%,CHP1;HEXB;HEXA;GUSB;HYAL2;LYVE1;CD44;ABCC5;SLC9A1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.7665872509678335,0.9822542629484372,0.4785,0.7697658869966655,1.0,11/31,9.18%,MVP;PPP2R1A;CAV1;THY1;SFRP2;SFRP1;PPP2CA;PRKCZ;HYAL2;SOCS3;PTK6
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.7562412631347921,0.982226027556575,0.5045,0.7694620818734809,1.0,7/17,13.29%,CCND2;PKD1;CCND1;AKT1;CCND3;CCNY;PKD2
prerank,modulation by host of symbiont process (GO:0051851),0.7684699830800754,0.98181128604396,0.4865,0.7706292395727722,1.0,13/32,13.76%,JUN;NUCKS1;HPN;HDAC1;TARDBP;SMARCA4;SAP30BP;LRRC19;SMARCB1;AQP1;SP1;TAF11;SNW1
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.760256229113028,0.9817659877368412,0.502,0.7703943096125799,1.0,6/20,11.31%,PHB;HLA-DRB1;CD46;JAG1;GNL1;CD55
prerank,cellular response to amino acid stimulus (GO:0071230),0.7641682587182852,0.981719592306115,0.4775,0.7701470658091434,1.0,17/33,17.93%,LAMTOR4;CAPN2;LAMTOR5;LAMTOR1;XBP1;IPO5;LAMTOR2;NSMF;SESN3;RRAGA;FYN;LAMTOR3;NEURL1;UBR2;RRAGC;KLHL22;MTOR
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.7626736126704061,0.9816740680562165,0.5,0.7699179890090607,1.0,16/21,19.09%,ZFP36;CNOT1;CNOT2;TNKS1BP1;CNOT8;SAMD4B;CNOT3;PAN3;CNOT7;CNOT9;TUT4;PAN2;CNOT6;SAMD4A;CNOT11;CNOT6L
prerank,DNA repair (GO:0006281),0.8463847220750577,0.9816691654985054,0.618,0.7695275859332127,1.0,11/290,2.13%,RPS27A;UBC;UBA52;UBB;NPM1;NOP53;CIB1;PARK7;TDP2;TRIM28;NUCKS1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.7646596261862316,0.9816417937014166,0.4905,0.7692334231887439,1.0,9/27,9.54%,POLR2L;CAVIN1;POLR2H;POLR2E;POLR2F;UBTF;TAF1D;POLR2K;TAF1C
prerank,nucleosome organization (GO:0034728),0.7831731706021724,0.9815009614864865,0.471,0.769367214202694,1.0,24/56,11.11%,NPM1;NAP1L1;SET;HMGB2;NASP;ZNHIT1;ANP32B;BRD2;HMGA1;NAP1L4;SMARCA4;SMARCA5;ARID1A;DMAP1;MCM3AP;SMARCD3;SUPT16H;NAA60;SMARCB1;ATRX;BPTF;SUPT6H;SMARCD2;SMARCC1
prerank,regulation of microtubule depolymerization (GO:0031114),0.7591694792561811,0.9813074217530714,0.4985,0.7697091021962991,1.0,14/25,18.31%,CIB1;STMN2;MAP1B;ARHGEF2;CLASP2;HDGFL3;CAMSAP3;TAOK1;TPX2;CLASP1;FGF13;MID1IP1;CAMSAP2;MAP1S
prerank,heme biosynthetic process (GO:0006783),0.7632622367177516,0.9812359090883976,0.5,0.7695848009557741,1.0,6/22,9.19%,ATP5IF1;TSPO;PGRMC1;NFE2L1;UROD;ALB
prerank,dendrite morphogenesis (GO:0048813),0.7718794393837904,0.981174782067748,0.487,0.7694204136895499,1.0,16/35,15.08%,PTN;CDC42;SDC2;PTEN;WASL;FARP1;EPHB3;DVL1;EPHB2;SHANK3;MEF2A;TMEM106B;MINK1;BTBD3;MAP6;DIP2A
prerank,T cell receptor signaling pathway (GO:0050852),0.8207197672002191,0.9810669979697044,0.543,0.7694412147988364,1.0,46/155,9.02%,HLA-A;SKP1;PSMB1;PSME1;PSMB4;HLA-DRA;PSME2;PSMD8;PSMB3;PSMA7;THY1;PSMB5;HHLA2;PSMB7;KHDRBS1;HLA-DRB1;PSMB6;PSMA1;PSMA4;PSMC5;RBCK1;BCAR1;PSMC3;BTNL3;PSMD2;PSMA2;STOML2;PSMB2;PSMD13;PSMD4;PSMD3;PAG1;PSMC1;PSMC6;UBE2N;SPPL3;HLA-DPB1;PSMC4;CSK;NFKBIZ;CD276;PSMF1;RELA;PSMA3;PSMA5;EIF2B5
prerank,apoptotic process (GO:0006915),0.8379792965521322,0.9808394694502085,0.602,0.7698823753754991,1.0,37/226,6.85%,GAPDH;PPIA;IFI27;PDCD4;CIB1;RTN4;PPP2R1A;APP;OGT;IER3;ERBB3;HSPD1;RHOB;DHCR24;VDAC1;BAG6;FAM162A;DDIT4;TSC2;PLAGL1;IFI27L2;AKT1;PHLDA2;NCKAP1;DAP;PPP2CA;BCLAF1;NLRP1;BAD;ADAM15;NOTCH2;CASP7;NFKBIA;HK2;TGFBR2;STK11;EGLN3
prerank,phosphatidylserine metabolic process (GO:0006658),0.7684880284993162,0.9807650002649089,0.4795,0.7697555873036396,1.0,12/33,17.17%,PLA2G2A;SERINC1;ABHD12;PLSCR1;LPCAT4;PLA2G10;MBOAT2;LPCAT3;SERINC5;OSBPL5;PTDSS1;OSBPL8
prerank,positive regulation of signal transduction (GO:0009967),0.8407782829745064,0.9807575536850953,0.613,0.7693719236254175,1.0,43/247,7.57%,RPS3;FLNA;CD63;ELF3;CD74;AGPAT2;ILK;KLF2;NPTN;MYO1C;PHB;RAB34;SULF2;MACF1;GAS6;NRP1;SNX5;LIMS2;VWF;XBP1;SFRP1;JAG1;NOTCH1;SPIN1;ZMIZ1;SLC39A14;SMO;PTEN;ATP6AP2;SORL1;PRKCZ;ITGA5;SORBS1;YAP1;C3;IL6ST;CTBP2;SMARCA4;VPS35;ASXL1;WLS;SULF1;RBPJ
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.7556466085838704,0.9807400214344316,0.501,0.7690330297582675,1.0,7/19,12.63%,CDC42;NRP1;BAIAP2L2;ABL1;BAIAP2L1;HRAS;HAX1
prerank,establishment of protein localization to membrane (GO:0090150),0.7943416281098487,0.9805325414754555,0.4875,0.7694068293771388,1.0,9/70,7.37%,NACA;RAB11A;MYO1C;SDCBP;OXA1L;AFDN;RAB11B;RAB10;ZDHHC3
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.7574530983189937,0.9804698804349815,0.495,0.7692497816765509,1.0,13/18,20.55%,CTNNB1;SMAD4;KDM1A;DNMT1;PIH1D1;WDR61;AUTS2;KMT2A;SNW1;WDR5;ZNF335;BCOR;CTR9
prerank,cellular protein catabolic process (GO:0044257),0.7896525661811141,0.980342889007825,0.496,0.7693509568125995,1.0,25/60,10.07%,CTSB;CAPN2;AP2M1;CLTC;CTSC;CLTA;CTSS;AP2S1;LGMN;RAB7A;CTSL;AP2A2;CTSH;TCIRG1;BNIP3L;YME1L1;AP2B1;ADAMTS7;RNF5;UBE2G2;CLPP;DAB2IP;LONP1;BNIP3;CTSZ
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.7580365741214787,0.9798394136207883,0.5,0.7708844968131114,1.0,17/21,21.55%,RPS27L;BAG6;DDIT4;DYRK2;PYCARD;TMEM109;TP53;SNW1;HIPK1;IFI16;PHLDA3;BCL3;PML;EP300;MSH2;CDIP1;HIPK2
prerank,negative regulation of ATPase activity (GO:0032780),0.7564352381945443,0.9796676983881493,0.508,0.7711513424693156,1.0,2/17,5.46%,ATP5IF1;OXA1L
prerank,regulation of signal transduction (GO:0009966),0.8286376147136937,0.9795508670185825,0.593,0.7711983899723965,1.0,63/198,10.61%,PPIA;CD63;CD24;CD177;IGFBP7;IGFBP5;IGFBP4;LLGL2;IGFBP2;TIMP1;PPP2R1A;IGFBP3;APP;NUCKS1;MTCH1;SNX3;CLU;OGT;ILK;ERBB3;RGS5;NCAM1;DYNLT1;MGLL;CD46;SREBF2;GRK2;PXN;DHRS3;RGS2;TSC2;UBTF;PPP2CA;YWHAG;GAS1;PTCH1;SEMA5A;NCLN;ZDHHC3;ITGA3;SULF1;PRNP;GSKIP;CREBBP;HHIP;CDC42SE2;PLSCR1;CSK;WWTR1;SHARPIN;RFNG;ZDHHC7;PTK6;CRK;POFUT1;ZFAND2B;SRC;NCK2;LIFR;IRAK1;ITGB1BP1;NUP62;RGS3
prerank,positive regulation of catabolic process (GO:0009896),0.7913420312571395,0.9794742400318104,0.493,0.7710826247644481,1.0,28/67,14.54%,OAZ1;VIP;NDUFA13;GPC3;VPS28;APOA2;VCP;RAB7A;NEDD4L;DDB1;SORL1;OAZ2;SCT;HUWE1;SNF8;SEC22B;DAB2IP;CDKN1B;STX5;CSNK2A1;FZR1;DACT1;VSIR;GSK3B;AXIN1;GSK3A;PLK2;WWP2
prerank,termination of RNA polymerase II transcription (GO:0006369),0.7689682271773838,0.9793965603275541,0.4825,0.7709659240643194,1.0,19/34,13.91%,SNRPG;MAZ;SNRPB;SNRPE;CPSF1;PAPOLA;PABPN1;SNRPF;SNRPD3;SSU72;CPSF7;SYMPK;WDR33;NUDT21;PCF11;NCBP2;SETX;SLBP;CSTF3
prerank,RNA splicing (GO:0008380),0.7982738232130839,0.9792137150296374,0.5035,0.7712543693862123,1.0,43/98,10.02%,FUS;SNRPD2;HNRNPC;SFPQ;SRSF2;PTBP1;PPP2R1A;SF3B1;LUC7L3;NONO;SRSF7;SNRPG;SRSF11;IVNS1ABP;RNPS1;PRPF8;HNRNPH3;SNRPB;TXNL4A;LSM4;SF3B2;RBM8A;TRA2B;SNRPF;SNRPD3;SNRPD1;SRSF10;DHX15;TARDBP;SNRPN;PPP2CA;SYNCRIP;MBNL1;MAGOH;SRSF4;PRPF4B;SF3B3;SCAF11;DDX23;PRPF6;SNRPA1;SF3B4;SRRM1
prerank,protein K11-linked ubiquitination (GO:0070979),0.7656898123673181,0.9791785520710354,0.4915,0.7709870872205801,1.0,23/29,21.45%,UBE2D3;ANAPC11;UBE2E3;UBE2S;ANAPC5;UBE2B;UBE2L3;CDC16;UBE2C;UBE2H;UBE2A;ANAPC7;FZR1;UBE2T;ANAPC13;RNF4;CDC26;CDC27;ANAPC1;RNF26;CDC23;ANAPC4;UBE2E2
prerank,zymogen activation (GO:0031638),0.7719254135426514,0.9791352731623697,0.4725,0.7707338205629848,1.0,15/45,13.08%,PGK1;PLAT;PRSS3;PERP;LGMN;C1R;CTSL;CTSH;BAD;KLK1;FURIN;ASPH;MMP14;GGT1;VSIR
prerank,negative regulation of developmental growth (GO:0048640),0.7663290134613561,0.9790305644259758,0.479,0.770721021485218,1.0,7/32,10.81%,FGFR3;RTN4;CDKN1A;PTEN;PTCH1;CDKN1B;ULK1
prerank,regulation of telomere capping (GO:1904353),0.759220065832286,0.9790262223851266,0.4955,0.7703299228081735,1.0,18/23,23.14%,HNRNPD;MAPK3;PKIB;MAPK1;USP7;MAPKAPK5;AURKB;TNKS;NEK7;ATM;PNKP;TNKS2;MAP2K7;NBN;MAP3K4;NABP2;SMG6;TERF2
prerank,regulation of fat cell differentiation (GO:0045598),0.7938736513656388,0.9788381950056728,0.4935,0.7706567032679004,1.0,28/80,11.59%,ZFP36L2;ZFP36L1;ID2;RARRES2;ZFP36;ADIRF;TRPM4;SFRP2;XBP1;SFRP1;TRIO;AKT1;FERMT2;YAP1;SULT1E1;CCDC85B;ASXL1;SIRT2;AAMDC;CEBPB;WWTR1;FRZB;SYAP1;TRIB2;LRP3;CARM1;SMAD3;ZADH2
prerank,regulation of insulin secretion (GO:0050796),0.802946086267214,0.9788098997098784,0.5145,0.7703580259631664,1.0,17/103,7.21%,CHGA;FAM3D;SOX4;NNAT;MIDN;GCG;HADH;HNF4A;ENSA;ITPR3;SFRP1;SLC2A1;UQCC2;RAP1A;BAD;TCF7L2;CDK16
prerank,positive regulation of cell division (GO:0051781),0.7720737031147673,0.9786459375056826,0.479,0.7705738193094439,1.0,11/43,13.85%,RHOA;GIPC1;CDC42;SVIL;SIRT2;CDC25B;CUL3;PKN2;FGFR2;CENPV;AURKB
prerank,regulation of centriole replication (GO:0046599),0.7619281903480468,0.9786146752655016,0.5085,0.7702805023553436,1.0,6/18,15.18%,NPM1;RBM14;KAT2A;NUP62;PLK2;CDK5RAP2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.8295941586460355,0.9785424793978001,0.588,0.7701811521523951,1.0,62/190,9.42%,RACK1;MDK;PFDN5;APOE;IGFBP4;SLC9A3R1;IGFBP2;LRP1;PSMB1;RBX1;CTNND1;PSME1;PSMB4;CAV1;PSME2;TAX1BP3;PSMD8;PSMB3;PSMA7;PSMB5;CSNK1A1;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5;HDAC1;SFRP2;PSMC3;HIC1;SFRP1;PSMD2;TSC2;PSMA2;TLE2;PSMB2;PSMD13;PSMD4;VGLL4;DACT3;PSMD3;TCF7L2;TLE1;WIF1;STK11;DVL3;PSMC1;DAB2;PSMC6;NXN;SNAI2;RUVBL2;PSMC4;PSMF1;WWTR1;PSMA3;PSMA5;DAB2IP;GREM1;FRZB;DVL1;LZTS2
prerank,glutamine family amino acid metabolic process (GO:0009064),0.7643227374941249,0.9784972368375408,0.495,0.7699530445785223,1.0,20/37,19.18%,OAT;CPS1;GLS;GLUL;DDAH2;ALDH18A1;DDAH1;PYCR1;GLUD1;RIMKLB;CAD;GGT1;GOT2;GOT1;NIT2;PYCR2;MTHFS;SLC39A8;DGLUCY;FPGS
prerank,chemokine-mediated signaling pathway (GO:0070098),0.7831900619388107,0.9784028057167715,0.4955,0.7699209966894213,1.0,9/55,12.54%,CCL21;CXCL12;CIB1;CCL2;GPR35;CCL15;WNK1;PTK2B;ACKR3
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.7652058924607232,0.9783532864567845,0.4965,0.7697019350884983,1.0,10/29,9.54%,POLR2L;MAPK3;CAVIN1;POLR2H;POLR2E;POLR2F;UBTF;TAF1D;POLR2K;TAF1C
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.7737081348450959,0.9782479156543568,0.487,0.7697073376318128,1.0,16/40,10.02%,PRELID1;GHITM;PLAUR;CLU;PDCD5;FAM162A;MLLT11;AKT1;BAD;TNFSF10;PINK1;MFF;BNIP3;DNM1L;PYCARD;BAX
prerank,regulation of BMP signaling pathway (GO:0030510),0.7916902032381458,0.9781506454055112,0.5075,0.7696736322685056,1.0,23/74,11.12%,FSTL1;NBL1;UBE2D3;NUMA1;HTRA3;NOTCH1;CDH5;SORL1;ITGA3;SULF1;RBPJ;ENG;SMAD4;BMPR2;ACVRL1;TWSG1;LEMD2;GREM1;FBXL15;BMP4;FSTL3;SMAD2;CRIM1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.8024618415048811,0.9781297633819271,0.5235,0.7693443577129959,1.0,34/102,10.34%,HINT1;CD24;SFN;DDX5;ATF4;ATP2A3;CDKN1A;DDX3X;MCL1;BAG6;MLLT11;HIC1;STK24;ARL6IP5;SELENOK;ABL1;EPHA2;ERN2;C1QBP;BAD;ERO1A;STK11;GSKIP;DNAJC10;PDK2;CEBPB;PPP1R15A;DAB2IP;CUL4A;PRKDC;BNIP3;PYCARD;BAX;QRICH1
prerank,striated muscle cell differentiation (GO:0051146),0.7520884696625159,0.9779963527220887,0.506,0.7694340913423892,1.0,10/18,20.11%,PLD3;SDC1;AKAP13;SORT1;CBY1;MEF2C;KDM6B;MYOCD;BMP2;SKI
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.7867017505232347,0.9778976307619532,0.5,0.7694073947629396,1.0,52/72,17.89%,HSP90B1;HSPA5;SEC61B;VCP;OS9;AUP1;BAG6;SELENOS;STUB1;HERPUD1;MAN1B1;STT3B;PSMC6;NPLOC4;DNAJC10;TMUB2;TMUB1;SEL1L;RNF5;SGTA;RNF103;UBE2G2;UBE2J1;UBE2J2;UBE4A;SYVN1;RHBDD2;UBXN4;ANKZF1;UBQLN1;UFD1;MAN1A1;WFS1;ECPAS;FBXO17;DNAJB2;DERL2;DERL1;TMEM129;FAM8A1;ERLIN1;DNAJB12;USP19;FAF2;JKAMP;ERLIN2;AMFR;FBXO2;UBQLN2;TRIM25;DNAJB14;UBE4B
prerank,positive regulation of positive chemotaxis (GO:0050927),0.754767709356616,0.9777524462146491,0.5015,0.7695464967865957,1.0,7/17,16.79%,CXCL12;VEGFA;VEGFB;F2RL1;CDH13;F3;KDR
prerank,mRNA catabolic process (GO:0006402),0.76842468839086,0.9776494604349505,0.488,0.7695320712499222,1.0,20/44,14.72%,DDX5;ZFP36L2;ZFP36;HSPA1A;RNH1;LSM2;LSM5;THRAP3;UPF1;HSPA1B;NUDT16L1;METTL3;LSM6;NBDY;EXOSC10;YTHDF2;NUDT16;XRN2;NBAS;TUT4
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.7586546328680108,0.9776125302906545,0.509,0.7692623326849205,1.0,3/20,10.12%,FBN1;LRRC17;FSTL3
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.7529042949466052,0.9775188820397421,0.5245,0.7692232313138672,1.0,7/16,20.08%,HDAC1;HDAC2;ANKRD11;ROGDI;LRP6;GLI2;BMP2
prerank,mammary gland development (GO:0030879),0.7622233851312228,0.9775040174131867,0.492,0.7688797178439645,1.0,6/24,10.50%,CAV1;VEGFA;GPAT4;ZBTB7B;TBX3;ARHGAP35
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.8349229867939661,0.9774402058894115,0.6145,0.7687261921239879,1.0,124/251,10.14%,HNRNPA1;HNRNPA2B1;PABPC1;HNRNPH1;DDX5;HNRNPK;UBL5;PCBP2;FUS;HSPA8;SNRPD2;SRRM2;YBX1;HNRNPC;HNRNPA3;LSM7;HNRNPU;SRSF5;POLR2L;SFPQ;SRSF3;PCBP1;SNRNP70;SRSF2;PTBP1;SF3B1;HNRNPD;SRSF6;RBM5;HNRNPM;RALY;NONO;RBMX;SRSF7;SNRPG;HNRNPA0;SF3B6;SF1;SRSF11;RNPS1;PRPF8;SF3B5;SNRNP200;HNRNPH3;SNU13;SNRPB;SNRPE;POLR2J;RBM6;TXNL4A;LSM4;SF3B2;RBM8A;CPSF1;PAPOLA;POLR2H;TRA2B;HNRNPR;POLR2E;HNRNPF;PABPN1;SNRPF;SNRPD3;SNRPD1;SNRPC;PNN;SRSF10;SRSF9;POLR2F;TRA2A;LSM3;POLR2I;DHX15;SRSF1;PUF60;DHX9;SNRPN;RBM10;POLR2G;LSM2;SYNCRIP;LSM5;HNRNPUL1;SRRT;DNAJC8;DDX39A;MAGOH;POLR2A;PRPF31;SRSF4;CPSF7;SNRPA;CASC3;ELAVL1;BUD31;CWC15;RBM14;DDX42;U2SURP;YTHDC1;SYMPK;PQBP1;POLR2K;PRPF4B;WDR33;IK;HNRNPL;EIF4A3;NUDT21;SF3B3;SYF2;RBM17;DDX23;PRPF6;POLR2B;DDX41;SNRPB2;SNRPA1;SF3B4;SF3A1;SRRM1;CD2BP2;METTL3;CCAR1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.8038392696973541,0.9772127716078043,0.5125,0.7692045919597418,1.0,32/105,11.98%,CALM2;CD24;CALM1;CCND2;RHOA;CIB1;CALM3;DDX3X;ERBB2;MAP2K2;PDGFRB;VEGFA;ATP2B4;PKD1;FGFR1;CCND1;AKT1;PPP2CA;FERMT2;CAB39;TCIM;CCND3;DAB2IP;SYAP1;SRC;IRAK1;PIH1D1;TELO2;HRAS;ROBO1;CCNY;RALB
prerank,regulation of erythrocyte differentiation (GO:0045646),0.764890618135339,0.9771261917835816,0.492,0.7691340306529695,1.0,21/37,18.24%,ZFP36L1;ZFP36;HMGB2;HSPA1A;PRMT1;HSPA9;HIF1A;HSPA1B;FOXO3;CDK6;PRKDC;STAT5B;MAPK14;ETS1;ACVR1B;STAT1;STAT3;BRD1;FAM210B;HOXA5;ARNT
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.7542397491842036,0.9768788836293832,0.5045,0.7696886505584951,1.0,14/21,19.91%,MCL1;ERBB3;ITGAV;BAX;BOK;GSK3B;GSK3A;BAK1;MOAP1;BCL2L1;CASP3;APPL1;CASP2;BCL2L2
prerank,regulation of cellular metabolic process (GO:0031323),0.7773946024721339,0.9768496994515455,0.4915,0.7693994844636735,1.0,16/47,8.75%,ARF1;NPC2;EIF6;ARF4;LAMTOR1;MBOAT7;STUB1;FLOT1;FASN;ACLY;NCOR2;PINK1;VPS35;GBA;AGPAT1;PDK2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.7671716945588989,0.9768420222938596,0.4865,0.7690361124561201,1.0,12/34,13.89%,ZFP36L1;ERBB2;ERBB3;AKT1;PTEN;C1QBP;SIRT2;IGF1R;PIK3R1;NF1;TYRO3;PLEKHA1
prerank,positive regulation of intracellular transport (GO:0032388),0.7695544390633159,0.9767017532340014,0.5005,0.7691889314903437,1.0,24/38,19.08%,OAZ1;NUMA1;DYNC1H1;EHD2;SORL1;OAZ2;STK11;TPR;PCM1;EHD1;B3GAT3;VAMP2;TBC1D20;RIPOR1;STX18;PDCD10;CAPN10;PCNT;SPAG5;PRR5L;RUFY3;ICE1;PGAP1;RAB29
prerank,protein targeting to membrane (GO:0006612),0.7977633856871204,0.9766189610940608,0.5055,0.7691149186752373,1.0,21/86,10.68%,NACA;SRP14;SSR2;SEC61A1;FIS1;MYO1C;ARL6IP1;SSR1;SDCBP;TRAM1;PXMP2;ZDHHC3;SEC62;SGTA;ZDHHC7;SEC63;ALDH3A2;CHMP4A;ZDHHC12;VPS37B;ICMT
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.7685781237997287,0.9766132339127219,0.48,0.7687395169494617,1.0,28/40,19.88%,MVP;CDC42;ERBB2;LGMN;EPN1;AREG;ITGA1;ERRFI1;HGS;GRB2;PTPN18;ARHGEF7;RNF126;DAB2IP;PTPN12;TSG101;SPRY2;DUSP3;EPS15;PTPRJ;CBLC;SPRY1;EGFR;SH3KBP1;PTPN2;HBEGF;STAM2;PTPN3
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.7872827167090672,0.9764833557572953,0.4975,0.768838437284254,1.0,41/71,13.73%,PSMB1;PSME1;PSMB4;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5;PSMC3;PSMD2;PSMA2;PSMB2;ABL1;PSMD13;PSMD4;YAP1;N4BP2L2;PSMD3;TCF3;PSMC1;PSMC6;PSMC4;PSMF1;TCF12;PSMA3;PSMA5;PRKDC;METTL3;PSMB8;PSMD7;PSMC2;YTHDF2;PSMD6;KMT2A;CBFB;PSMD1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.7872825854592006,0.9761845827077631,0.4945,0.7695689213102604,1.0,15/75,9.71%,CD74;HMGB1;CYBA;APP;HSPD1;INAVA;XBP1;DHX9;LGALS9;HYAL2;ARHGEF2;MAPK13;F2R;F2RL1;PYCARD
prerank,regulation of protein kinase B signaling (GO:0051896),0.829985547402609,0.9761220098426148,0.598,0.7694029299666616,1.0,44/207,8.20%,RACK1;TXN;CCL21;HSP90AB1;HSP90AA1;NOP53;FGFR3;ITGB1;RAC1;SLC9A3R1;CIB1;RTN4;PARK7;ERBB2;ERBB3;MAZ;PDGFRB;PDGFRA;MYDGF;PDCD6;CPNE1;PHB;FGFR1;GAS6;AREG;TSC2;AKT1;PTEN;EPHA2;P2RX4;C1QBP;FERMT2;SEMA5A;TCF7L2;PINK1;HYAL2;RCN3;AKT2;GRB2;RRAS;ENG;PPP2R5C;PTK2;DAG1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.7526728688653971,0.9761018870497041,0.5025,0.7690811105930755,1.0,5/18,12.35%,PTEN;PRKCZ;PTK2B;SHANK3;NLGN2
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.7485470510820573,0.9760968456398628,0.516,0.7686981396807847,1.0,8/18,15.66%,CAV1;NEDD4L;BIN1;CAB39;CAMK2D;PPIF;KCNH2;COMMD1
prerank,response to exogenous dsRNA (GO:0043330),0.7667765532042975,0.9760965993816031,0.4985,0.7682994897218356,1.0,9/34,13.51%,CAV1;SLC3A2;DHX9;FLOT1;COLEC12;PQBP1;ZCCHC3;RALB;MAVS
prerank,action potential (GO:0001508),0.7710040677620766,0.9757374977362713,0.4905,0.7692968530993849,1.0,4/45,3.43%,SRI;MYH14;GNA11;YWHAH
prerank,7-methylguanosine mRNA capping (GO:0006370),0.7579520066407996,0.9756641671297472,0.506,0.7687764138382882,1.0,15/31,12.89%,POLR2L;POLR2J;POLR2H;POLR2E;POLR2F;POLR2I;POLR2G;SUPT5H;POLR2A;POLR2K;POLR2B;NCBP2;GTF2F1;POLR2C;GTF2H5
prerank,7-methylguanosine RNA capping (GO:0009452),0.7579520066407996,0.9756641671297472,0.506,0.7687764138382882,1.0,15/31,12.89%,POLR2L;POLR2J;POLR2H;POLR2E;POLR2F;POLR2I;POLR2G;SUPT5H;POLR2A;POLR2K;POLR2B;NCBP2;GTF2F1;POLR2C;GTF2H5
prerank,oligosaccharide biosynthetic process (GO:0009312),0.7553249532822893,0.975569955044004,0.5085,0.7687459907057825,1.0,8/23,14.97%,ST3GAL4;B4GALT1;FUT3;B3GALT5;MPDU1;ABO;ST3GAL2;FUT2
prerank,mRNA destabilization (GO:0061157),0.7653356387448761,0.9753957152013399,0.49,0.7690150899855462,1.0,17/38,15.02%,ZFP36L2;ZFP36L1;ZFP36;CNOT1;TARDBP;MOV10;PUM1;UPF1;ROCK2;CELF1;YTHDF3;METTL3;YTHDF2;YTHDF1;KHSRP;TUT4;ROCK1
prerank,ureteric bud morphogenesis (GO:0060675),0.7564000688857277,0.9753581487060122,0.5155,0.7687674399465946,1.0,5/19,13.29%,TCF21;NPNT;BMP4;MYC;PKD2
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.755914076379346,0.975223981728594,0.5095,0.768884075646844,1.0,11/20,19.62%,PABPN1;ENY2;MCM3AP;NXF1;POLDIP3;THOC2;PCID2;IWS1;NUP93;DDX19A;NUP133
prerank,positive regulation of neuron differentiation (GO:0045666),0.7668446428068717,0.9751909390087213,0.504,0.7686228050394015,1.0,8/43,7.98%,RHOA;NBL1;CPNE1;FGFR1;PCP4;TCF4;TCF3;ARHGEF2
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.7541368942357727,0.9750549489061273,0.5132566283141571,0.7687639138275544,1.0,6/15,19.05%,TSPO;AKR1B1;FDX1;STARD3;CACNA1H;STARD3NL
prerank,organelle assembly (GO:0070925),0.8537087925511695,0.9749337279579816,0.6715,0.7688311003181415,1.0,36/408,4.77%,RPS23;RPS3;FLNA;GSN;CIRBP;DYNLL1;SMIM22;NPM1;VMP1;VPS28;DDX3X;CSDE1;RAB1A;RAB11A;AUP1;ARF4;DYNC1H1;GABARAPL2;ATP6V0D1;ACTR2;IST1;PDCD6IP;EHD2;LSM4;PKD1;RAB7A;MAP1LC3B;CHMP2A;ATP2A2;CSNK1D;RAB1B;CORO1A;LSM3;GOLGA8A;CHMP1A;EXOC7
prerank,carbohydrate biosynthetic process (GO:0016051),0.755123070583401,0.9744033339519101,0.512,0.7704621962427667,1.0,8/24,14.97%,ST3GAL4;B4GALT1;FUT3;B3GALT5;MPDU1;ABO;ST3GAL2;FUT2
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.7489697085728504,0.9743169882910883,0.506,0.7703931481959272,1.0,14/20,21.82%,SEMA3B;SEMA4G;SEMA5A;SEMA3C;SEMA6A;SEMA4B;SEMA3A;SEMA5B;SEMA6C;SEMA4C;SEMA3F;SEMA3D;SEMA6D;SEMA4D
prerank,regulation of neuroinflammatory response (GO:0150077),0.752737117351608,0.9743022859532058,0.519,0.7700557925310646,1.0,1/19,2.09%,NUPR1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.7657605408899043,0.974255496180429,0.511,0.7694348691699943,1.0,9/31,14.31%,DBI;ACLY;ACOT7;GPAT4;ACAT1;ACBD6;ACSF2;ACOT13;ACOT8
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.7657605408899043,0.974255496180429,0.511,0.7694348691699943,1.0,9/31,14.31%,DBI;ACLY;ACOT7;GPAT4;ACAT1;ACBD6;ACSF2;ACOT13;ACOT8
prerank,rRNA transcription (GO:0009303),0.7498722378786528,0.9742438800302121,0.5222611305652827,0.7690818119482238,1.0,14/16,23.15%,CAVIN1;SPIN1;GTF3C6;GTF3C1;SIRT7;GTF3C5;GTF3A;BRF1;GTF3C2;ANG;NIFK;GTF3C3;TCOF1;GTF3C4
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.7981064976522163,0.9741610201807038,0.5085,0.7690002859423588,1.0,30/93,13.47%,TXN;HSP90AB1;HSP90AA1;MIF;PARK7;APP;CAV1;VEGFA;ATP2B4;TFRC;EIF4G1;GAS6;PFN2;SFRP2;AKT1;PINK1;AKAP9;RAF1;HDAC6;TERF2IP;PRKD2;ARAF;CD44;TNKS1BP1;SPRY2;TCL1A;HAX1;MAD2L2;PAK1;AXIN1
prerank,positive regulation of phosphorylation (GO:0042327),0.8381617815173676,0.9740573542615405,0.6455,0.768998225595568,1.0,60/250,8.39%,RACK1;PPIA;CLDN3;CD74;EFNA1;HSP90AA1;FGFR3;MIF;CCND2;ITLN1;RAC1;CIB1;RARRES2;APP;PLAUR;ERBB2;ILK;PTGES3;ERBB3;PDGFRB;PDGFRA;NPTN;MAPK3;MYDGF;ERP29;VEGFA;HLA-DRB1;DDR1;TFRC;FGFR1;CCND1;GAS6;NRP1;CSNK1D;AKT1;FLOT1;PECAM1;PIN1;SDCBP;VEGFB;ABL1;EPHA2;SLC4A4;PSEN1;MLXIPL;PINK1;C3;DVL3;DAB2;EPHB4;AKT2;FBH1;LMO4;ENG;ROCK2;ITGA6;PTK2;EPHB3;DDR2;HIF1A
prerank,blood vessel morphogenesis (GO:0048514),0.7725897021450536,0.9740104516033279,0.4955,0.768774063820599,1.0,22/56,14.74%,COL4A1;ID1;CAV1;EGFL7;VEGFA;HES1;NRP1;RAMP2;ADM;APLNR;TGFBR2;RBPJ;ENG;LAMA1;CUL7;CCM2;TGFBR1;EFNB2;TGFBR3;NF1;LOX;LRP5
prerank,negative regulation of blood pressure (GO:0045776),0.7472392188282715,0.9737678305548924,0.53,0.7693226043412358,1.0,3/15,11.38%,PRCP;BMPR2;SCPEP1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.7618813403786316,0.9736794931183628,0.5,0.7692752370931606,1.0,9/36,9.40%,CALM1;CTNNB1;GNB1;MOV10;TCF7L2;PLCB3;GNG2;PPP3CB;FZD5
prerank,oxoacid metabolic process (GO:0043436),0.7640557351009878,0.9736680335391309,0.5095,0.7689297579601833,1.0,8/32,8.21%,MIF;PPA1;SULT1B1;GRHPR;SULT1A1;SULT1E1;SULT2A1;ABHD14B
prerank,response to organophosphorus (GO:0046683),0.7519070456290843,0.9735027713694872,0.5345,0.7691773172171487,1.0,6/16,15.82%,TYMS;P2RX4;NDUFS4;DUOX2;DGKQ;STAT1
prerank,regulation of small molecule metabolic process (GO:0062012),0.7607955361929687,0.9734871535044995,0.5115,0.7688481211917452,1.0,12/28,17.99%,ACADVL;APOE;EPHX2;NCOR2;PDK2;ADIPOR1;BCKDK;DGKQ;FOXK2;NR1H4;TTC39B;FOXK1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.7571074477763284,0.9733948408519636,0.5195,0.7687980223487464,1.0,10/26,15.54%,PLA2G2A;CHKA;ETNK1;CHKB;PLA2G10;LPIN3;NAAA;LPIN2;PCYT2;PISD
prerank,regulation of Rac protein signal transduction (GO:0035020),0.752764033211358,0.9732340542523642,0.5285,0.769019172410455,1.0,7/16,15.15%,OGT;ARF6;GABARAP;ARHGAP17;STMN3;AUTS2;SH3BP1
prerank,neurotrophin signaling pathway (GO:0038179),0.7512603804260823,0.9731089650903348,0.518,0.7690938266452745,1.0,10/21,13.85%,BCAR1;DDIT4;RAP1A;GRB2;KIDINS220;SORT1;RAPGEF1;ZFYVE27;NGFR;SOS1
prerank,protein import into nucleus (GO:0006606),0.7849538712185341,0.973093030120687,0.5045,0.7687594684165948,1.0,26/76,13.42%,RPL23;PTTG1IP;RAN;PHB2;KPNB1;SEC13;TSC2;AKT1;IPO5;TPR;KPNA2;IPO7;APPL2;RPAIN;TNPO1;IPO9;CSE1L;RANBP2;NUP62;KPNA4;NUTF2;HIKESHI;NUP85;NUP50;PPP1R10;NUP188
prerank,purine ribonucleotide metabolic process (GO:0009150),0.7938509137183213,0.97274808700384,0.5145,0.7696960822013322,1.0,23/74,11.84%,HINT1;DBI;RAN;PDE9A;SULT1B1;EPHA2;ACLY;BAD;SULT1A1;SULT1E1;AK3;GNAI3;SULT2A1;ABHD14B;ACOT7;GPAT4;NT5C2;ACAT1;ACBD6;AMPD2;ACSF2;RHOQ;ACOT13
prerank,protein polyubiquitination (GO:0000209),0.8447590204739985,0.972723595028026,0.658,0.7693954606822383,1.0,40/308,5.10%,RPS27A;UBC;IFI27;UBA52;UBB;SKP1;WSB1;CTNNB1;PSMB1;UBE2D3;RBX1;PSME1;PSMB4;ANAPC11;FBXW5;TTC3;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;UBE2E3;UBE2S;PSMA1;PSMA4;PSMC5;RBCK1;PSMC3;ANAPC5;NEDD4L;UBE2B;UBE2D2;UBE2L3;PSMD2;PSMA2;NPEPPS;STUB1;CDC34
prerank,histone exchange (GO:0043486),0.7627422765032945,0.9721238549745392,0.4935,0.7713109910080189,1.0,9/37,7.94%,NPM1;NASP;ZNHIT1;CENPX;RBBP7;RBBP4;SMARCA5;DMAP1;CENPT
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.782026318450127,0.9720477877886269,0.505,0.7712243601899433,1.0,37/71,14.99%,CCND2;ID2;KLF4;FHL1;CDKN1A;DDX3X;PSME1;PSME2;KANK2;PKD1;EIF4G1;CCND1;ADAMTS1;ANXA1;CCL2;AKT1;CDK4;PTEN;PRMT2;CDK2AP2;APPL2;CCND3;CDK6;ZNF655;TFDP1;TMEM14B;KMT2E;BRD7;ANKRD17;WEE1;DLG1;DACT1;PKD2;CDKN2B;RDX;AIF1;RBL2
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.7541512295883513,0.9720459632050681,0.527,0.7708382714320889,1.0,5/19,13.29%,TCF21;NPNT;BMP4;MYC;PKD2
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.799491573191751,0.9716666602865477,0.5305,0.7718522096090941,1.0,31/104,10.94%,CEACAM1;ZFP36L1;NR4A1;PKM;CAV1;PCK1;INSIG1;GCG;PRKAR1A;XBP1;SELENOS;AKT1;SLC39A14;SORBS1;PCK2;AKT2;HDAC5;RAB10;RAB13;PRKACB;RELA;ADCY6;PRKACA;PRKDC;SYAP1;SRC;PARP1;RAB8A;INSR;VAMP2;LPIN3
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.7589568020563021,0.9715550003772424,0.514,0.7718815663752638,1.0,13/36,11.66%,ID2;CDKN1A;PHB2;PSME1;PSME2;ATP2B4;PKD1;PTEN;APPL2;TCIM;TMEM14B;CDKN1B;DDRGK1
prerank,regulation of adenylate cyclase activity (GO:0045761),0.7507482046738536,0.971426267009521,0.517,0.7719635837248157,1.0,10/22,22.64%,CAP1;GNAI2;GNAI3;PALM;EDNRB;NF1;STIM1;CACNA1D;ORAI1;CACNA1C
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.7496985055340175,0.971203819037274,0.5405,0.7724078028649117,1.0,3/15,11.35%,HPN;TMEM120A;PIEZO2
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.7544368346230167,0.971152418074304,0.5325,0.7722117903999346,1.0,8/15,14.31%,SCP2;ACAA1;ACOX1;DECR2;HSD17B4;ECI2;CRAT;ACOT8
prerank,membrane fusion (GO:0061025),0.7605634515297369,0.9711508939485071,0.507,0.7718233278256531,1.0,15/36,13.58%,DNM2;CHP1;VAPA;NAPA;HUWE1;VAMP3;DNM1L;MYOF;NSFL1C;VAMP2;USO1;SNAP23;DNM1;VTI1B;RABEP1
prerank,regulation of execution phase of apoptosis (GO:1900117),0.7448367092797649,0.9711072801852774,0.5175,0.7715996149360284,1.0,9/20,20.13%,SIRT2;DLC1;BOK;PTGIS;TP53;BCL2L1;TP53BP2;DFFA;ZC3H12A
prerank,inorganic cation transmembrane transport (GO:0098662),0.8376609729104117,0.9709791840892538,0.652,0.7716874068012155,1.0,29/273,5.75%,ATP1A1;ATP5F1B;SCNN1B;SLC6A8;ATP1B3;ATP1B1;ATP2A3;ATP5PO;ATP5MF;SCNN1A;FKBP1A;HPN;TRPM4;ATP6V0D1;ATP2B4;SLC9A3;ATP6V0E1;PKD1;ATP6V1F;SLC40A1;GAS6;ATP2A2;TMCO1;SLC6A19;SLC39A14;SLC39A4;SLC12A2;P2RX4;SLC4A4
prerank,protein localization to Golgi apparatus (GO:0034067),0.7590598544154247,0.970877419004428,0.51,0.771685275693325,1.0,22/28,22.86%,TMED10;GAK;CSNK1D;OBSL1;SORL1;GOLPH3;RAB6A;GBF1;OPTN;ARL1;ARFRP1;IFT20;VPS13C;RIPOR1;GCC2;ARL5B;VPS13A;VPS13D;COG7;SYS1;ARL5A;BICD2
prerank,regulation of Golgi organization (GO:1903358),0.7479697138528129,0.9706781324905995,0.534,0.772059800630862,1.0,13/17,21.86%,MAP2K2;MAPK3;AKAP9;MAPK1;CAMSAP3;PDE4DIP;STX5;STX18;PDCD10;CAMSAP2;MAP2K1;RBSN;ARMH3
prerank,neuron differentiation (GO:0030182),0.8166039842375832,0.9706696875040153,0.5865,0.7716997797265621,1.0,16/174,6.37%,ITM2C;IER2;ID2;CTNNB1;TDP2;ERBB2;SOX4;VEGFA;PBX1;DDIT4;XBP1;PIN1;FZD1;PBX3;HAND2;UGDH
prerank,regulation of phosphorylation (GO:0042325),0.8064825124869007,0.9706651721711017,0.5525,0.7713256811959964,1.0,25/124,6.11%,FN1;HSPB1;DYNLL1;CD24;NOP53;MIF;PLXNB2;PGAM1;CDKN1C;APP;CDKN1A;EIF6;OGT;ILK;PTGES3;MCM7;NRP1;SEC13;PIN1;SDCBP;PPP2CA;CDH5;STAT2;NDUFS4;PSEN1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.7512974925056777,0.9705770078338049,0.53,0.7712695415375855,1.0,8/17,12.58%,UPF1;GBA;HDAC6;GSPT1;IGF1R;BNIP3;INSR;ETF1
prerank,regulation of ion transmembrane transport (GO:0034765),0.7590156464124524,0.9703565534335813,0.5015,0.7717257837952187,1.0,8/35,14.54%,YWHAE;NEDD4L;AKAP9;AHCYL1;ANO6;WNK1;KCNH2;WWP2
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.7498862142733027,0.9700414115924658,0.5325,0.7725443615235726,1.0,10/18,15.86%,CEBPA;YAP1;IL6ST;SOCS3;SMAD4;JAK1;SRC;PTPN11;STAT1;STAT3
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.7680393811637947,0.9699241934106296,0.5195,0.772619687879819,1.0,19/41,15.86%,ELF3;JAG1;NOTCH1;ZMIZ1;YAP1;IL6ST;RBPJ;CREBBP;SRC;ITGB1BP1;DLL1;ROBO1;TSPAN14;SNW1;TM2D3;BMP2K;PDCD10;EPN2;STAT3
prerank,respiratory tube development (GO:0030323),0.7528536368032711,0.9698749926685692,0.5225,0.7724189449558058,1.0,8/30,11.79%,TCF21;CEBPA;VEGFA;BAG6;FOXF1;ITGA3;BMP4;FGFR2
prerank,RNA processing (GO:0006396),0.8168009363536647,0.9697288579685919,0.579,0.7726094501443534,1.0,75/177,10.11%,HNRNPA2B1;DDX17;HNRNPH1;HNRNPK;FUS;SNRPD2;HNRNPC;HNRNPU;SRSF5;RBM39;SFPQ;SRSF2;PTBP1;PPP2R1A;SF3B1;HNRNPD;LUC7L3;RBM3;RBM5;NONO;SRSF7;SNRPG;HNRNPA0;AURKAIP1;SRSF11;IVNS1ABP;RNPS1;PRPF8;RBPMS;HNRNPH3;SNRPB;SON;RBM6;LSM4;SF3B2;RBM8A;HNRNPR;HNRNPF;AKAP8L;PABPN1;SNRPF;SNRPD3;SNRPD1;SRSF9;LSM3;DHX15;SRSF1;TARDBP;SNRPN;ADAR;PPP2CA;SYNCRIP;LSM5;HNRNPUL1;PABPC4;MBNL1;MAGOH;CPSF6;SRSF4;SUPT4H1;PRPF4B;HNRNPL;CELF1;PRKACA;NUDT21;SF3B3;SCAF11;DDX23;PRPF6;SNRPA1;SF3B4;SF3A1;SRRM1;ALKBH5;METTL3
prerank,acyl-CoA metabolic process (GO:0006637),0.7659467631081777,0.9696878011994051,0.516,0.772379374464209,1.0,10/37,11.84%,DBI;HMGCS1;HMGCS2;SUCLG2;OGDH;ACOT7;GPAT4;ACBD6;ACSF2;ACOT13
prerank,neutrophil activation (GO:0042119),0.7524967250257082,0.9694985062655735,0.533,0.7727201125601288,1.0,8/16,21.35%,DNASE1;F2RL1;KMT2E;PRKCD;TYROBP;FCER1G;PREX1;SYK
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.7470568545709452,0.9693868641745462,0.546,0.772751271954442,1.0,8/18,16.86%,TECR;ACSL5;ELOVL1;HSD17B12;HACD2;ACSL3;ACSF3;ELOVL5
prerank,endoplasmic reticulum organization (GO:0007029),0.7831871238827973,0.9693820034086085,0.5205,0.7723828161395375,1.0,41/70,15.87%,SEC61G;RTN4;SEC61B;WDR83OS;APP;SEC61A1;VAPA;SERP1;LMAN2;SEC31A;GAK;RTN3;REEP6;SMPD4;TRAM1;REEP5;RAB10;PRNP;TOR1AIP2;CYB5A;SEC16A;LMAN1;SGTA;RAB18;UBE2J2;DNM1L;ALDH3A2;VAMP2;REEP3;STX5;ATL3;CCDC47;EMD;LPCAT3;TMEM33;STX18;REEP4;VAPB;TMEM170A;MIA3;LMAN2L
prerank,sphingosine metabolic process (GO:0006670),0.7510026672919708,0.9693574255741662,0.538,0.7720867971296955,1.0,8/19,15.11%,ASAH1;PLPP1;PLPP3;PLPP2;GBA;SPTLC1;NAAA;SPTLC2
prerank,positive regulation of cell projection organization (GO:0031346),0.8015108284316654,0.969138397517042,0.539,0.7725048171206954,1.0,41/117,12.84%,MDK;APOE;RHOA;PTN;PLXNB2;DPYSL3;STMN2;SNX3;ARHGDIA;PLXNB1;NPTN;SCARB2;OBSL1;PLXND1;PTK7;FZD1;RAP1A;METRN;CAPRIN1;CUX1;DVL3;KIDINS220;ITGA6;P3H1;S100A9;DAB2IP;PTK6;DVL1;RAPGEF1;ARHGAP35;CUL7;PTPRD;PTK2B;DVL2;ROBO1;PLXNA1;PLXNA3;NGFR;SETX;RETREG3;CBFA2T2
prerank,regulation of telomere maintenance (GO:0032204),0.7528880818206073,0.9691025105887063,0.525,0.7722518276980906,1.0,22/26,23.61%,HNRNPD;XRCC5;UPF1;ERCC1;USP7;SIRT6;SMG1;TERF2IP;ATRX;SMG5;GNL3;MYC;PPP1R10;YLPM1;PML;DHX36;NBN;PIF1;TINF2;SMG6;TERF2;MRE11
prerank,chromatin assembly (GO:0031497),0.7585962427318403,0.9690763190047624,0.5135,0.7719651276474543,1.0,10/36,9.49%,NPM1;NAP1L1;HMGB2;ANP32B;BRD2;NAP1L4;RBBP4;SMARCA5;NAA60;ATRX
prerank,positive regulation of glucose import (GO:0046326),0.7563787409390852,0.9690662162457646,0.5155,0.7716113224963855,1.0,15/26,19.14%,ITLN1;AKT1;ARPP19;SORBS1;AKT2;OCLN;INSR;RHOQ;PIK3R1;C1QTNF12;CAPN10;PTPN11;OSBPL8;APPL1;IRS1
prerank,medium-chain fatty acid metabolic process (GO:0051791),0.7474584388399294,0.9690476888658613,0.5525,0.7712890397496288,1.0,7/15,17.83%,ACOT7;ABHD3;CRAT;CES1;ABHD2;ACADM;ACAD9
prerank,negative regulation of DNA replication (GO:0008156),0.7433287938033782,0.9689606642370275,0.537,0.771240655380698,1.0,3/16,9.26%,S100A11;ENPP7;PDS5A
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.8324113488571262,0.9688196885262799,0.651,0.771401226388012,1.0,136/274,10.90%,HNRNPA1;HNRNPA2B1;DDX17;PABPC1;HNRNPH1;DDX5;HNRNPK;UBL5;PCBP2;FUS;HSPA8;SNRPD2;SRRM2;YBX1;HNRNPC;HNRNPA3;LSM7;HNRNPU;SRSF5;POLR2L;SFPQ;SRSF3;PCBP1;SNRNP70;SRSF2;PTBP1;SF3B1;HNRNPD;SRSF6;RBM5;HNRNPM;RALY;NONO;RBMX;SRSF7;SNRPG;HNRNPA0;SF3B6;SF1;SRSF11;RNPS1;PRPF8;SF3B5;SNRNP200;HNRNPH3;SNU13;SNRPB;SNRPE;POLR2J;RBM6;TXNL4A;LSM4;SF3B2;RBM8A;CPSF1;PAPOLA;POLR2H;TRA2B;HNRNPR;POLR2E;HNRNPF;PABPN1;SNRPF;SNRPD3;SNRPD1;SNRPC;PNN;SRSF10;SRSF9;POLR2F;TRA2A;LSM3;POLR2I;DHX15;SRSF1;PUF60;DHX9;SNRPN;RBM10;POLR2G;LSM2;SYNCRIP;LSM5;HNRNPUL1;SRRT;DNAJC8;DDX39A;MAGOH;POLR2A;PRPF31;SRSF4;CPSF7;SNRPA;CASC3;ELAVL1;BUD31;CWC15;RBM14;DDX42;U2SURP;YTHDC1;SYMPK;PQBP1;POLR2K;PRPF4B;WDR33;DDX1;STRAP;IK;HNRNPL;EIF4A3;NUDT21;SF3B3;SYF2;RBM17;CLNS1A;SCAF11;DDX23;PRPF6;POLR2B;DDX41;SNRPB2;SNRPA1;SF3B4;SF3A1;SRRM1;CD2BP2;METTL3;CCAR1;LSM8;DHX38;LSM6;PPIE;EFTUD2;PRMT5;HNRNPH2
prerank,regulation of tumor necrosis factor production (GO:0032680),0.8026720341122764,0.9687835207898289,0.5395,0.7711553258199263,1.0,24/123,9.98%,GSTP1;HSPB1;HMGB1;MIF;CYBA;HLA-E;ZFP36;APP;CLU;DDT;GAS6;SELENOS;DHX9;CD34;LGALS9;PSEN1;IFNGR1;ARHGEF2;MAPKAPK2;CD47;TRIM27;FZD5;PYCARD;FOXP1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.7517292693743661,0.9687555959663452,0.5225,0.7708808257994013,1.0,16/27,18.24%,HMGB2;HSPA1A;PRMT1;HIF1A;HSPA1B;FOXO3;PRKDC;STAT5B;MAPK14;ETS1;ACVR1B;STAT1;STAT3;BRD1;FAM210B;ARNT
prerank,negative regulation of chemotaxis (GO:0050922),0.7543671703951025,0.9687550954878035,0.511,0.7704960373019046,1.0,23/32,21.82%,SEMA3B;NOTCH1;SEMA4G;SEMA5A;SEMA3C;CORO1B;SEMA6A;SEMA4B;THBS1;ROBO1;SEMA3A;DUSP3;AIF1;SEMA5B;SEMA6C;SEMA4C;SEMA3F;SLIT2;PTPN2;SEMA3D;ROBO2;SEMA6D;SEMA4D
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.7749212860022004,0.9687534367585878,0.5125,0.7701143911984105,1.0,40/67,16.14%,ELOB;POLR2L;POLR2J;POLR2H;POLR2E;POLR2F;POLR2I;MLLT1;POLR2G;SSRP1;SUPT5H;NELFB;POLR2A;SUPT4H1;NELFE;NELFCD;ELOC;ADRM1;SUPT16H;POLR2K;POLR2B;ELP2;SUPT6H;AFF4;WDR61;NCBP2;GTF2F1;RTF1;TCEA1;POLR2C;GTF2H5;SETD2;ELOF1;PCID2;ERCC3;IWS1;CDK13;CCNT2;CCNK;NELFA
prerank,positive regulation of synapse assembly (GO:0051965),0.7523297182922949,0.9686959244723186,0.5145,0.7699520302133177,1.0,7/28,12.35%,CLSTN1;AGRN;EPHB3;DLG5;PTPRD;EPHB2;NLGN2
prerank,cellular protein-containing complex assembly (GO:0034622),0.8160079663817795,0.9686173372252722,0.585,0.7698691881296006,1.0,64/166,11.28%,RPL38;COX7A2;HIGD1A;HSP90AB1;HSP90AA1;GPX4;CYBA;RTN4;VAMP8;AP2M1;EIF4B;TBCA;CLTB;CLU;CLTC;FKBP1A;CLTA;HIGD2A;PTGES3;HSPA1A;HSPD1;POMP;AP2S1;CSNK2B;EIF4H;PILRB;CHMP2A;PXN;TCP1;DHX9;COX7A2L;TBCD;PICALM;BIN1;ARL2;PSMD13;PSMD4;TCF4;CHMP3;USH1C;POGZ;COX7A1;CCT2;FMOD;TPR;SMAD4;ADRM1;RAB5IF;CENPT;COG4;CHRNA3;VAMP3;HSF1;LONP1;PSMG3;SRC;NCK2;CHMP4A;SMAD2;VAMP2;PDE4DIP;PSMG2;SMAD3;CHMP4B
prerank,histone H4-K8 acetylation (GO:0043982),0.7453647457895254,0.9684943606399801,0.5415,0.7695512012059178,1.0,12/15,21.64%,OGT;MCRS1;KANSL3;ING4;KAT8;HCFC1;MEAF6;KANSL1;WDR5;PHF20;KAT7;KANSL2
prerank,histone H4-K5 acetylation (GO:0043981),0.7453647457895254,0.9684943606399801,0.5415,0.7695512012059178,1.0,12/15,21.64%,OGT;MCRS1;KANSL3;ING4;KAT8;HCFC1;MEAF6;KANSL1;WDR5;PHF20;KAT7;KANSL2
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.7597282909836831,0.9683867323506321,0.5155,0.7695911640548774,1.0,7/34,14.58%,CAV1;THY1;P2RX4;APLNR;F2R;PLCG1;PDPK1
prerank,mitochondrion disassembly (GO:0061726),0.7589431230219479,0.96826672985054,0.523,0.7696568198834693,1.0,27/36,21.53%,SQSTM1;FIS1;GABARAPL2;MAP1LC3B;PINK1;GABARAP;MAP1LC3A;FUNDC2;BNIP3;FBXO7;WIPI2;ULK1;BECN1;WDR45;ATG12;WDR45B;ATG3;ATG2A;GABARAPL1;CISD2;RB1CC1;CTSK;MARK2;ATG2B;ULK2;WIPI1;ATG5
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.7653406184450975,0.9682567554966728,0.503,0.7693103893509262,1.0,30/44,19.88%,GPRC5A;MVP;CDC42;RAB7A;EPN1;AREG;ITGA1;ERRFI1;HGS;VPS25;GRB2;ARHGEF7;SNX6;RNF126;DAB2IP;TSG101;SPRY2;DUSP3;EPS15;PTPRJ;CBLC;SPRY1;EGFR;CHMP6;SH3KBP1;CBLB;PTPN2;HBEGF;STAM2;PTPN3
prerank,regulation of MAP kinase activity (GO:0043405),0.7945300552597712,0.9681013805312141,0.534,0.7694981668076014,1.0,37/97,15.38%,GSTP1;CD24;APOE;DUSP1;UCHL1;ERBB2;CDK5RAP3;PDGFRB;VEGFA;FGFR1;RGS2;AGT;SORL1;HGS;HYAL2;GBA;TRIB1;SNF8;SMPD1;DAB2IP;TRIB2;BMP4;TSG101;IRAK1;HRAS;ROBO1;SPRY2;EDN3;STK38;MST1R;NF1;PRKCD;PDCD10;EZH2;PTPRJ;CBLC;KSR1
prerank,histone ubiquitination (GO:0016574),0.7466805307903716,0.9679921682808541,0.534,0.7695273495393381,1.0,17/21,22.68%,USP22;UBE2B;HUWE1;WAC;UBE2N;PHC1;UBE2A;RNF40;UBE2E1;ATXN7L3;UBR2;UHRF1;PAF1;CTR9;RNF20;DTX3L;LEO1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.7542890185046524,0.9679138203608473,0.5275,0.7694395646931712,1.0,23/27,22.89%,MORF4L1;MORF4L2;BAG6;KAT2A;CREBBP;RUVBL2;BRD8;NAA50;KAT5;KAT8;TRRAP;ATAT1;KAT6A;PHF20;PHF20L1;EP300;TAF6;KAT7;KAT6B;RUVBL1;MRGBP;TAF6L;MSL3
prerank,positive regulation of secretion (GO:0051047),0.7457512885147144,0.9678384000827743,0.5502751375687844,0.7693336749833193,1.0,4/15,15.13%,XBP1;SCT;AQP1;ACSL3
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.7560131589290248,0.9673769434464933,0.5295,0.770703233927088,1.0,14/27,19.12%,ID2;PPP1CB;PPP1CA;PPP1CC;MTA1;BHLHE40;PER1;FBXL3;TP53;FBXL12;CRTC1;PML;FBXL6;RBM4B
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.8400472100410062,0.9673432947254619,0.6795,0.770455160146945,1.0,91/319,9.00%,RPS27A;UBC;IFI27;UBA52;UBB;HSP90B1;PCBP2;SKP1;UCHL1;HSPA5;CTNNB1;SEC61B;PSMB1;UBE2D3;RBX1;PSME1;PSMB4;ANAPC11;FBXW5;VCP;OS9;PSME2;AUP1;PSMD8;PSMB3;PSMA7;PSMB5;BAG6;PSMB7;PSMB6;UBE2S;PSMA1;PSMA4;ANAPC16;PSMC5;RBCK1;PSMC3;ANKRD9;ANAPC5;NEDD4L;UBE2B;SPSB3;UBXN1;SELENOS;PSMD2;DDB1;PSMA2;STUB1;CDC34;PCNP;PSMB2;HERPUD1;PSMD13;PSMD4;CDC16;UBE2C;RAD23A;PSMD3;BUB3;AGAP3;MAEA;PTTG1;PSMC1;MAN1B1;HUWE1;STT3B;PSMC6;NPLOC4;ZSWIM8;MTA1;TRIM2;RAD23B;TBL1XR1;SIRT2;RNF187;DNAJC10;TMUB2;PPP2R5C;TMUB1;PSMC4;SEL1L;RNF126;RNF5;SGTA;RNF103;PSMF1;SHARPIN;UBE2G2;UBE2J1;PSMA3;PSMA5
prerank,positive regulation of chromosome organization (GO:2001252),0.7443069940384115,0.9670479971815381,0.5435,0.7711964686238183,1.0,11/15,23.61%,RAD21;SIRT6;ATRX;GNL3;PPP1R10;PML;DDX11;DHX36;NBN;FEN1;MRE11
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.766739676877778,0.9669349958141444,0.515,0.7712396417631986,1.0,20/47,15.95%,ATF4;ID1;ALDH1A1;LAMA4;RHEB;NOTCH1;LGR4;STK11;NPR3;NRDC;RBPJ;ARRDC3;NR1H3;TLE3;ACOT13;LNPEP;NR1H2;MAP2K6;IP6K1;DDIT3
prerank,cellular response to amyloid-beta (GO:1904646),0.754687111145573,0.9668651376626576,0.5195,0.7711274022968292,1.0,11/35,13.38%,LRP1;APP;LGMN;PSEN1;PRNP;SNX6;GJA1;IGF1R;NGFR;FYN;GSK3B
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.7551963549085565,0.9667872558800961,0.5255,0.7710520476933477,1.0,17/29,19.94%,DLK1;EGFL7;NOTCH3;AKT1;ARRDC1;TCIM;METTL3;MMP14;DLL1;YTHDF2;NEURL1;LFNG;WWP2;EGFR;ZBTB7A;ARRB1;HIF1AN
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.7438715062550043,0.9666785624957491,0.529,0.7710907580411592,1.0,8/18,15.95%,TMEM259;BAG6;XBP1;BAX;BOK;PIK3R1;BAK1;DDIT3
prerank,modulation by symbiont of entry into host (GO:0052372),0.7513224425442673,0.9665930996651427,0.5265,0.7710353541859869,1.0,5/20,8.85%,CAV1;EXOC7;NECTIN2;FUCA2;TRIM27
prerank,regulation of hormone secretion (GO:0046883),0.7453201722433643,0.9663965489921371,0.5555,0.771369022557343,1.0,7/16,18.62%,ANXA1;SNX6;VAMP3;VAMP2;EDN3;SOX11;SCG5
prerank,negative regulation of dephosphorylation (GO:0035305),0.7491023673272141,0.9663053362033038,0.544,0.7713430445725098,1.0,8/20,12.97%,CHP1;YWHAB;ENSA;ARPP19;PTPA;PPP1R15A;PPP1R35;URI1
prerank,DNA packaging (GO:0006323),0.7390018082776149,0.9662309201085104,0.5512756378189094,0.7712476939169807,1.0,10/15,25.04%,BANF1;RBBP4;NAA10;NOC2L;TP53;KAT6A;HAT1;AIFM1;CDAN1;CHAF1A
prerank,mesenchyme development (GO:0060485),0.7475463379924705,0.9661715973115792,0.542,0.7710905056336875,1.0,10/16,20.08%,FOXF1;SFRP2;BMPR2;BMP4;TGFBR1;CRELD1;FGFR2;PKD2;HMGA2;BMP2
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.7739026127998178,0.9661254502116341,0.5235,0.7708777618001993,1.0,41/69,16.14%,ELOB;POLR2L;POLR2J;POLR2H;POLR2E;POLR2F;POLR2I;MLLT1;POLR2G;SSRP1;SUPT5H;NELFB;POLR2A;SUPT4H1;NELFE;NELFCD;ELOC;ADRM1;SUPT16H;POLR2K;TCEA2;POLR2B;ELP2;SUPT6H;AFF4;WDR61;NCBP2;GTF2F1;RTF1;TCEA1;POLR2C;GTF2H5;SETD2;ELOF1;PCID2;ERCC3;IWS1;CDK13;CCNT2;CCNK;NELFA
prerank,acute-phase response (GO:0006953),0.7452543113173224,0.965921901434189,0.5427713856928464,0.7712673555814283,1.0,3/15,8.78%,SIGIRR;PLSCR1;CEBPB
prerank,ventricular septum morphogenesis (GO:0060412),0.7507513876386495,0.9658587326213045,0.5255,0.7711378480597375,1.0,19/28,21.11%,SOX4;HES1;NOTCH1;SLIT3;APLNR;TGFBR2;SMAD4;BMPR2;BMP4;CITED2;ROBO1;TGFBR1;BMPR1A;TGFBR3;SOX11;SLIT2;ZFPM1;ROBO2;SMAD7
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.7809629179001938,0.965757825063599,0.515,0.7711182425449971,1.0,25/68,12.70%,PKDCC;FGFR3;ERBB2;PDGFRB;PDGFRA;MAPK3;DDR1;FGFR1;ABL1;PTK2;DDR2;FGFR4;PTK6;IGF1R;ABI2;SRC;ABI1;INSR;DYRK1A;PTK2B;FGFR2;EPHB2;AATK;FYN;EFEMP1
prerank,cellular response to glucagon stimulus (GO:0071377),0.7460513336516906,0.9655863734992233,0.5395,0.7713890178584626,1.0,10/19,19.03%,GCG;PRKAR1A;PRKACB;ADCY6;PRKACA;PRKAR2B;PRKAR1B;PRKAR2A;ADCY5;ADCY3
prerank,sulfur compound transport (GO:0072348),0.7558191535775376,0.9654312071436009,0.537,0.7716007409120635,1.0,6/28,10.69%,SLC44A4;SLC9A3R1;SLC26A6;SLC25A11;MGST1;SLC35B2
prerank,positive regulation of axonogenesis (GO:0050772),0.7644916605953052,0.965395275470475,0.5205,0.7713582572741412,1.0,24/43,18.63%,RHOA;PLXNB2;ARHGDIA;PLXNB1;MACF1;PLXND1;DBN1;METRN;DBNL;ZFYVE27;L1CAM;ROBO1;PLXNA1;PLXNA3;NGFR;GOLGA4;TWF2;PLXNA2;MAP6;NTN1;SHTN1;RUFY3;SLIT2;MAP3K13
prerank,long-term synaptic potentiation (GO:0060291),0.7472231107803523,0.965222161462805,0.5435,0.7716378894138783,1.0,7/21,14.50%,NPTN;PRKCZ;NFATC4;STX4;VAMP2;PTK2B;PLK2
prerank,regulation of axonogenesis (GO:0050770),0.7702964527245747,0.9651093873944311,0.5215,0.7716829486952631,1.0,22/51,14.98%,RHOA;RTN4;PLXNB2;ARHGDIA;PLXNB1;GDI1;THY1;PLXND1;PTEN;METRN;EPHB3;ARHGAP35;ROBO1;PLXNA1;PLXNA3;NGFR;KIF13B;PAK1;PAK2;GSK3B;PLXNA2;MAP6
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.7425987012996235,0.9649458336731497,0.5395,0.7719441497658922,1.0,11/19,20.90%,FSCN1;CLIC4;ERBIN;SCRIB;MTCL1;DLG3;DLG1;PARD3;SYNJ2BP;MARK2;PRKCI
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.7562743095433292,0.9649128716302388,0.525,0.7716901485855475,1.0,21/32,22.09%,ITLN1;AKT1;ARPP19;SORBS1;C3;AKT2;OCLN;INSR;RHOQ;PIK3R1;CLIP3;C1QTNF12;CAPN10;PTPN11;OSBPL8;C2CD5;APPL1;IRS1;PRKCI;BRAF;IRS2
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.7494610030036679,0.9648372858537851,0.5325,0.7715868648180338,1.0,6/27,12.35%,APP;PTEN;PRKCZ;PTK2B;SHANK3;NLGN2
prerank,regulation of macrophage differentiation (GO:0045649),0.749506471036113,0.9646022682959792,0.5545545545545546,0.7720559635604164,1.0,7/15,19.24%,ID2;HSF1;CSF1;PRKCA;C1QC;RIPK1;PTPN2
prerank,heart morphogenesis (GO:0003007),0.7696301948052705,0.9645990872733141,0.5395,0.7716859145484358,1.0,19/53,11.94%,FLRT2;FKBP1A;VEGFA;HES1;NOTCH1;LEFTY1;ACTC1;OLFM1;EPHB4;ENG;ACVRL1;PTK2;TBX2;MDM4;DLC1;TBX3;INSR;TGFBR1;BMPR1A
prerank,C21-steroid hormone metabolic process (GO:0008207),0.7500616642219474,0.9645191032055153,0.532,0.7716024573499296,1.0,8/24,19.05%,TSPO;DHRS9;AKR1B1;HSD17B10;FDX1;STARD3;AKR1C3;STARD3NL
prerank,negative regulation of signaling receptor activity (GO:2000272),0.7496686189976999,0.9643990279710722,0.5455,0.7716783470711255,1.0,12/26,18.37%,GPRC5A;ERRFI1;ACE2;VPS25;SNX6;TSG101;EPHB2;CNRIP1;PPARG;CBLC;CHMP6;CBLB
prerank,positive regulation of GTPase activity (GO:0043547),0.8217495167182418,0.9641495756060963,0.633,0.7722226323653522,1.0,27/210,6.98%,S100A10;RACK1;CCL21;ITGB1;ERBB2;PLXNB1;AGRN;TAX1BP3;THY1;ABR;TGM2;NET1;SFRP1;ARHGAP27;CCL2;PIN1;TBC1D9B;EPHA2;F11R;RAP1A;PICALM;AFDN;FERMT2;DVL3;ARHGEF16;RGS10;ARAP1
prerank,regulation of organelle organization (GO:0033043),0.7822666449203859,0.9639084862927808,0.5215,0.7727904454091827,1.0,50/80,16.69%,EZR;CAPN2;SQSTM1;FIS1;PLXNB1;MAPK3;SCARB2;CLIC4;SURF4;TMED9;ZEB2;RHOT2;ARL6IP1;SAR1A;MSN;F11R;PINK1;GOLPH3;S100A8;AKAP9;VPS35;MAPK1;MFF;PTK2;LMAN1;SIRT7;STMN3;S100A9;DNM1L;CAMSAP3;PDE4DIP;STX5;SAR1B;DIAPH1;TAOK1;CENPV;PREB;TJP1;PAK2;MAVS;TMEM33;RDX;STX18;PDCD10;SYT11;PISD;SYDE1;PARL;NEXN;CAPN6
prerank,NIK/NF-kappaB signaling (GO:0038061),0.7770938292710097,0.9638219040520937,0.527,0.7727414588715565,1.0,40/74,13.73%,SKP1;PSMB1;PSME1;PSMB4;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5;PSMC3;PSMD2;PSMA2;AKT1;PSMB2;PSMD13;PSMD4;PSMD3;PSMC1;PSMC6;PSMC4;PSMF1;RELA;PSMA3;PSMA5;BIRC2;IRAK1;PSMB8;PSMD7;PSMC2;COPS8;DICER1;PSMD6;CUL1;ZFP91;PSMD1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.7437607825304328,0.9638134035489203,0.5495,0.7723957117752467,1.0,10/19,22.03%,KPNB1;IPO5;KPNA2;RANBP2;KPNA4;KPNA6;KPNA1;CBLB;NUP54;KPNA3
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.8018865880853159,0.9636720476227189,0.5735,0.7725487468851298,1.0,42/134,15.86%,CD81;CD74;EFNA1;FGFR3;MIF;TNFRSF14;ERBB3;STAP2;VEGFA;HES1;GAS6;TNFRSF1A;NRP1;AGT;PECAM1;ABL1;ITGA5;IL6ST;SOCS3;PRNP;ARHGEF2;PTK6;GREM1;SRC;UNC119;ARL2BP;CSPG4;PTK2B;CD44;DLG3;TNK2;HAX1;PAK2;TP53;NEDD9;DGKQ;FGF7;PTPRJ;PTPN11;CSF1R;ACE;STAT3
prerank,protein modification by small protein conjugation (GO:0032446),0.8451097818158925,0.9636246213812588,0.723,0.7723477713048372,1.0,39/393,5.17%,RPS27A;HLA-A;RACK1;UBC;UBA52;UBB;ELOB;SKP1;SUMO2;NEDD8;TRIM28;UBE2D3;RBX1;ANAPC11;FBXW5;VCP;TRPM4;OS9;UBA1;RNF7;CDK5RAP3;HIF3A;UBE2E3;UBE2S;UBE2I;ANAPC16;ENC1;RNF181;ANKRD9;NEDD4L;UBE2B;UBE2D2;UBE2L3;SELENOS;DDB1;UBE2M;STUB1;CDC34;PCNP
prerank,positive regulation of ossification (GO:0045778),0.760466934870388,0.9636105088824057,0.52,0.7720247698553897,1.0,11/39,11.97%,PKDCC;PTN;FBN2;ATRAID;OSR1;BMPR2;BMP4;ISG15;ANO6;BMPR1A;ATP2B1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.7552401016887696,0.9635854499863772,0.538,0.771737338375609,1.0,20/35,19.04%,CCND2;PHB2;DDX3X;EIF4G1;CCND1;ADAMTS1;ANXA1;AKT1;CCND3;TFDP1;KMT2E;ANKRD17;DDRGK1;RDX;AIF1;EZH2;EGFR;LSM10;GLI1;PAF1
prerank,excitatory postsynaptic potential (GO:0060079),0.7448758925946125,0.9634308543491621,0.5415,0.7719488784183152,1.0,7/19,17.91%,AKT1;CHRNA3;GSK3B;GSK3A;RAB3GAP1;ARRB2;MEF2C
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.745034446101474,0.9627714175270035,0.5365,0.7740392888492232,1.0,11/21,18.21%,NOTCH1;VGLL4;RBPJ;TBX2;TGFBR1;FGFR2;BMPR1A;TGFBR3;PIM1;MEF2C;GLI1
prerank,positive regulation of interferon-beta production (GO:0032728),0.7543802805431844,0.962715056998976,0.526,0.7738630102122349,1.0,12/35,15.34%,HSP90AA1;DDX3X;RIOK3;DHX9;FLOT1;IRF3;ISG15;OAS1;MAVS;TOMM70;IRF1;PTPN11
prerank,cardiac atrium morphogenesis (GO:0003209),0.7425177224577464,0.9624756430888459,0.546,0.7743730017505461,1.0,4/19,7.96%,NOTCH1;NOTCH2;ENG;BMPR2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.7429576426521948,0.9624126278970472,0.551,0.7742226193675624,1.0,7/20,15.82%,DDX3X;HSPD1;DHX9;IRF3;SETD2;MAVS;STAT1
prerank,autophagy of mitochondrion (GO:0000422),0.7588759945051565,0.9623427479406857,0.531,0.7741068017445194,1.0,28/40,20.56%,SQSTM1;PHB2;FIS1;GABARAPL2;MAP1LC3B;PINK1;GABARAP;MAP1LC3A;FUNDC2;BNIP3;FBXO7;WIPI2;ULK1;BECN1;WDR45;ATG12;WDR45B;ATG3;ATG2A;GABARAPL1;CISD2;ATG13;RB1CC1;CTSK;MARK2;ATG2B;ULK2;WIPI1
prerank,motor neuron axon guidance (GO:0008045),0.7424665431449445,0.9623092977302077,0.539,0.773854713019839,1.0,7/16,21.73%,RAC1;SEMA3A;RHOG;NTN1;SLIT2;LAMC2;RAC2
prerank,aminoglycan biosynthetic process (GO:0006023),0.7599573696479215,0.9621276201758509,0.5335,0.7741659426965382,1.0,25/49,18.23%,HSPG2;GPC3;AGRN;SDC1;SDC2;HEXA;SDC4;B3GNT7;GPC6;UGDH;GPC1;B3GALT5;B3GNT3;B3GAT3;GPC4;HS6ST1;EXT1;EXT2;SDC3;SLC35D2;B4GAT1;NDST1;B3GALT6;B4GALT7;B3GNT8
prerank,nuclear envelope organization (GO:0006998),0.7469501894851004,0.9619771312321538,0.5415,0.7743591418937187,1.0,14/21,18.34%,SUN1;CTDNEP1;SUN2;VPS4A;LEMD2;REEP3;TMEM43;DMPK;EMD;REEP4;TMEM170A;TOR1AIP1;NUP93;TOR1A
prerank,vesicle transport along microtubule (GO:0047496),0.7418052699102543,0.9619644422781635,0.5465,0.7740230056439547,1.0,15/23,21.84%,RAB1A;DYNC1H1;PAFAH1B1;KIF5B;KIF1C;TRAK1;BICDL2;HTT;NDEL1;TRAK2;KIFAP3;KIF3B;FBXW11;KIF1A;KIF13A
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.7530122432689996,0.9617524320565856,0.5435,0.7744269600591532,1.0,11/28,16.83%,AKT1;PTEN;PSEN1;VPS35;FBXO7;CAMK2G;CCDC88A;GSK3B;GSK3A;NDEL1;NCS1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.7758047300919674,0.9617281167149686,0.53,0.7741436893291747,1.0,41/75,13.73%,PSMB1;PSME1;PSMB4;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5;PSMC3;PSMD2;PSMA2;PSMB2;ABL1;PSMD13;PSMD4;YAP1;PSMD3;TCF3;PSMC1;PSMC6;PSMC4;PSMF1;TCF12;PSMA3;PSMA5;PRKDC;METTL3;PSMB8;PSMD7;PSMC2;YTHDF2;PDCD2;PSMD6;KMT2A;CBFB;PSMD1
prerank,intracellular protein transmembrane transport (GO:0065002),0.7626044825208977,0.9615831768224868,0.5255,0.7743104936366143,1.0,22/44,15.41%,SEC61G;HSPA5;SEC61B;ROMO1;SEC61A1;HSPD1;TOMM20;AKT2;TIMM17B;SEC62;DNAJC15;SEC63;ZFAND2B;DNAJC19;TIMM44;TOMM40;TIMM17A;TIMM50;TOMM70;PEX2;SRP54;PEX26
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.7443474664162519,0.9615068637819675,0.5445,0.7738467215242146,1.0,15/21,22.22%,RBX1;DDB1;ERCC1;CUL4A;PARP1;RPA1;RPA3;GTF2H5;ERCC3;CHD1L;RPA2;CUL4B;DDB2;GTF2H1;ERCC2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.7443474664162519,0.9615068637819675,0.5445,0.7738467215242146,1.0,15/21,22.22%,RBX1;DDB1;ERCC1;CUL4A;PARP1;RPA1;RPA3;GTF2H5;ERCC3;CHD1L;RPA2;CUL4B;DDB2;GTF2H1;ERCC2
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.7402302067298596,0.9614577487379975,0.5545,0.7736534322069406,1.0,2/18,2.24%,CTNNA1;CHP1
prerank,regulation of metal ion transport (GO:0010959),0.7394505256147649,0.9611466939237572,0.5682841420710355,0.7744385452791753,1.0,4/17,12.71%,SRI;ANK2;CAMK2G;DLG1
prerank,cellular response to sterol (GO:0036315),0.7378925221537914,0.961110039100728,0.5675,0.7741956504847409,1.0,6/16,14.57%,INSIG1;SMO;PTCH1;GRAMD1A;CES1;LRP6
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.7381532674014428,0.9610271274053297,0.5562781390695347,0.774128360700937,1.0,9/15,22.09%,AKT1;SORBS1;AKT2;DYRK2;INSR;PHKG2;EPM2AIP1;IRS1;IRS2
prerank,mRNA 3'-end processing (GO:0031124),0.7798434350728695,0.9610168642417859,0.5445,0.773785724405062,1.0,35/79,11.84%,PABPC1;SRSF5;SRSF3;SRSF2;APP;SRSF6;SRSF7;SRSF11;RNPS1;RBM8A;CPSF1;PAPOLA;PABPN1;SRSF9;SSU72;SRSF1;CHTOP;DDX39A;MAGOH;CPSF6;SRSF4;CPSF7;CASC3;GRSF1;SYMPK;WDR33;POLDIP3;EIF4A3;AHCYL1;NUDT21;SRRM1;DHX38;THOC7;PCF11;NCBP2
prerank,transcription by RNA polymerase I (GO:0006360),0.7533703747385423,0.9607580404952822,0.5395,0.774404471076231,1.0,10/31,9.54%,POLR2L;MAPK3;CAVIN1;POLR2H;POLR2E;POLR2F;UBTF;TAF1D;POLR2K;TAF1C
prerank,RNA export from nucleus (GO:0006405),0.7931167693203032,0.9606352617396857,0.5595,0.7744711172533785,1.0,38/105,10.84%,HNRNPA1;HNRNPA2B1;SRSF5;SRSF3;SRSF2;RAN;SRSF6;SRSF7;SRSF11;RNPS1;RBM8A;CPSF1;SRSF9;SEC13;SRSF1;CHTOP;DDX39A;MAGOH;SRSF4;CASC3;TPR;UPF1;MCM3AP;NXF1;YTHDC1;SYMPK;WDR33;POLDIP3;SMG1;EIF4A3;SRRM1;ALKBH5;RANBP2;DHX38;SMG5;NUP62;THOC7;EIF4E
prerank,cellular response to inorganic substance (GO:0071241),0.7416049144142597,0.9605198583947887,0.5515,0.7745294678728324,1.0,14/21,23.48%,AOC1;DPEP1;RTF2;ATRX;GUCY1B1;FMR1;AQP1;MTR;DDX11;SPIDR;TIMELESS;DDI2;CDK2;FOXO1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.7627277373492222,0.9603187745333505,0.5365,0.7745221707951032,1.0,33/51,15.32%,LMNA;PPP2R1A;RAN;BANF1;IST1;UBE2I;CHMP2A;KPNB1;SEC13;PPP2CA;SUMO1;LBR;CHMP3;SIRT2;VPS4A;LEMD2;ANKLE2;RANGAP1;CHMP4A;CDK1;REEP3;CHMP4B;CHMP2B;NUP85;PPP2R2A;CCNB1;NUP188;EMD;NUP160;NUP98;REEP4;POM121;CHMP7
prerank,mitotic nuclear membrane organization (GO:0101024),0.7627277373492222,0.9603187745333505,0.5365,0.7745221707951032,1.0,33/51,15.32%,LMNA;PPP2R1A;RAN;BANF1;IST1;UBE2I;CHMP2A;KPNB1;SEC13;PPP2CA;SUMO1;LBR;CHMP3;SIRT2;VPS4A;LEMD2;ANKLE2;RANGAP1;CHMP4A;CDK1;REEP3;CHMP4B;CHMP2B;NUP85;PPP2R2A;CCNB1;NUP188;EMD;NUP160;NUP98;REEP4;POM121;CHMP7
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.7443972247208961,0.9600644286083452,0.547,0.7751088474236978,1.0,16/24,21.49%,PRMT1;VEGFA;EMC10;PJA2;HAND2;XDH;MINK1;GADD45B;SASH1;GADD45A;GADD45G;BMP2;ZC3H12A;AGER;NCF1;MAP3K4
prerank,camera-type eye development (GO:0043010),0.7491974167587193,0.9599719059472934,0.5485,0.7750785857416264,1.0,12/26,20.11%,FBN1;FBN2;VEGFA;LAMA1;NES;EFEMP1;NF1;RAB3GAP1;TSKU;IFT122;TENM3;SKI
prerank,regulation of neuron projection arborization (GO:0150011),0.7376473952650391,0.9598299309863625,0.571,0.7752420383610397,1.0,10/15,23.09%,MACF1;MOV10;DVL3;DVL1;DVL2;MAP3K13;FZD4;MFSD2A;MYO9A;WNT5A
prerank,negative regulation of synaptic transmission (GO:0050805),0.7480597522037523,0.959750217258926,0.562,0.7751697404295261,1.0,10/24,19.04%,ARF1;PNKD;PTEN;SLC30A1;PLK2;PICK1;SYT11;STXBP1;ATAD1;ACHE
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.7451915853937333,0.9597451565559421,0.557,0.7748123319672343,1.0,3/24,10.30%,BAG6;BCAR1;SPG21
prerank,chromatin remodeling at centromere (GO:0031055),0.7506461677821221,0.9597338386442849,0.541,0.7744793837827074,1.0,7/31,7.94%,NPM1;NASP;CENPX;RBBP7;RBBP4;SMARCA5;CENPT
prerank,positive regulation of protein phosphorylation (GO:0001934),0.8365990902104099,0.9595500994825535,0.715,0.7748076790654761,1.0,83/369,8.30%,RACK1;PPIA;CLDN3;CD81;CALM2;TXN;CALM1;CD74;CCL21;EFNA1;HSP90AB1;HSP90AA1;MIF;CCND2;ITLN1;RAC1;CIB1;RARRES2;PARK7;TNFRSF14;CALM3;APP;CDKN1A;PLAUR;DDX3X;ERBB2;ILK;JTB;XRCC6;CAV1;CSNK2B;NPTN;MAPK3;RBPMS;MYDGF;ERP29;VEGFA;ATP2B4;XRCC5;HLA-DRB1;TFRC;EIF4G1;CCND1;GAS6;PFN2;NRP1;CSNK1D;SFRP2;AGT;AKT1;LEFTY1;FLOT1;PECAM1;PIN1;SDCBP;VEGFB;ABL1;ITGA5;RAP1A;APLNR;IQGAP1;PINK1;C3;CAB39;DVL3;DAB2;AKT2;AKAP9;RAF1;FBH1;PRNP;MAPK1;ENG;TRAF4;SMAD4;ROCK2;BMPR2;ARHGEF2;ACVRL1;HDAC6;PTK2;TWSG1;DDR2
prerank,regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.738948251906836,0.959437447788717,0.564,0.7748679952682732,1.0,8/16,23.73%,TOP2A;TOP2B;SETDB1;MPHOSPH8;HMGA2;MORC2;INPP5K;APOBEC3C
prerank,peptidyl-tyrosine modification (GO:0018212),0.7692734619489422,0.9593900910949773,0.541,0.7746795025610029,1.0,21/56,12.70%,PKDCC;FGFR3;ERBB2;PDGFRB;PDGFRA;FGFR1;ABL1;PTK2;DDR2;FGFR4;ABI2;SRC;ABI1;INSR;DYRK1A;PTK2B;FGFR2;EPHB2;TTL;FYN;EFEMP1
prerank,regulation of cytoskeleton organization (GO:0051493),0.7934133154493607,0.9591132329723802,0.5705,0.7753533367212794,1.0,56/112,15.15%,EZR;RHOC;SMIM22;RHOA;RAC1;CAPN2;LRP1;RHOB;FSCN1;PDGFRB;PLXNB1;MAPK3;CLIC4;CDK10;SORBS3;CORO1A;PFDN2;PHLDB1;ABL1;F11R;IQGAP1;S100A8;RHOF;MAPK1;CDK2AP2;ROCK2;PTK2;ARHGAP17;STMN3;S100A9;CRK;DLC1;CAMSAP3;ARHGAP35;MLST8;TESK1;RHOQ;RHOBTB3;CCDC88A;DIAPH1;TAOK1;RHOG;BST2;RND3;HIP1R;TJP1;PAK1;PAK2;GSK3B;CLASP1;PRKAA1;TWF2;PRKCD;MAP6;ROCK1;SH3BP1
prerank,cellular response to estradiol stimulus (GO:0071392),0.7439902825023365,0.9588457899956727,0.557,0.775988992740514,1.0,9/20,20.35%,SFRP1;RUVBL2;ZNF703;KAT5;NRIP1;LCOR;EGFR;FAM210B;NCOA3
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.7402315038257549,0.9587248678854128,0.5585,0.7760507884623622,1.0,8/15,16.56%,ENTPD6;ENTPD8;ENTPD5;NUDT16;NUDT5;NUDT1;ENTPD4;NUDT9
prerank,activation of protein kinase activity (GO:0032147),0.7885652185008987,0.9586612888759182,0.5525,0.7759248184731258,1.0,37/114,13.63%,PPIA;TXN;PARK7;PHB2;VEGFA;PHB;PILRB;PRKAR1A;GAS6;AKT1;ABL1;PINK1;TGFBR2;STK11;PRKACB;CHRNA3;ADCY6;PRKACA;MAP4K4;INSR;IRAK1;ITGB1BP1;EMP2;PRR5;MLST8;PTK2B;PRRC1;COPS8;PRKAR2B;CCDC88A;TAOK1;MINK1;PAK1;TPX2;PAK2;AXIN1;ZFP91
prerank,organelle disassembly (GO:1903008),0.7456496720269767,0.9585234102264089,0.5485,0.7760793126248955,1.0,25/33,20.39%,VCP;KLC1;KIF5B;UFC1;GBF1;GOLGA2;UFM1;DENR;TEX264;RETREG1;CDK1;ULK1;STX5;MCTS1;DDRGK1;MTIF3;PELO;ATG2A;MRRF;EIF2D;RB1CC1;ATG2B;UBA5;ZFAND1;ULK2
prerank,regulation of myelination (GO:0031641),0.7440617418796278,0.9583662237708956,0.5565,0.7762850418232343,1.0,12/26,18.29%,PTN;TMEM98;RNF10;SIRT2;NSUN5;DICER1;LGI4;PARD3;TNFRSF21;MYRF;TYMP;JAM2
prerank,photoperiodism (GO:0009648),0.7494340774201459,0.9582933438396004,0.5525,0.7761845802623976,1.0,14/28,19.12%,ID2;PPP1CB;PPP1CA;PPP1CC;MTA1;BHLHE40;PER1;FBXL3;TP53;FBXL12;CRTC1;PML;FBXL6;RBM4B
prerank,positive regulation of neurogenesis (GO:0050769),0.7747734677381273,0.9581852826205844,0.5375,0.7762132702762191,1.0,30/72,14.98%,NAP1L1;RHOA;PLXNB2;CTNNB1;ARHGDIA;PLXNB1;NPTN;VEGFA;TGM2;OBSL1;PLXND1;METRN;CAPRIN1;CUX1;SMARCD3;KDM1A;NUMB;CUL7;PTPRD;SERPINF1;ROBO1;PLXNA1;PLXNA3;SHANK3;NGFR;NEURL1;SPEN;SNW1;PLXNA2;MAP6
prerank,mRNA processing (GO:0006397),0.8257837063152559,0.957938486239212,0.678,0.7767408822496048,1.0,147/297,11.21%,HNRNPA1;HNRNPA2B1;PABPC1;HNRNPH1;DDX5;HNRNPK;UBL5;PCBP2;FUS;HSPA8;SNRPD2;SRRM2;YBX1;HNRNPC;HNRNPA3;LSM7;HNRNPU;SRSF5;POLR2L;SFPQ;SRSF3;PCBP1;SNRNP70;SRSF2;PTBP1;SF3B1;HNRNPD;SRSF6;RBM5;HNRNPM;RALY;NONO;RBMX;SRSF7;SNRPG;HNRNPA0;AURKAIP1;SF3B6;SF1;SRSF11;RNPS1;PRPF8;SF3B5;SNRNP200;HNRNPH3;SNU13;SNRPB;SON;SNRPE;POLR2J;RBM6;TXNL4A;LSM4;SF3B2;RBM8A;CPSF1;PAPOLA;POLR2H;TRA2B;HNRNPR;POLR2E;HNRNPF;AKAP8L;PABPN1;SNRPF;SNRPD3;SNRPD1;SNRPC;PNN;SRSF10;SRSF9;POLR2F;TRA2A;LSM3;POLR2I;DHX15;SRSF1;PUF60;DHX9;SNRPN;RBM10;POLR2G;LSM2;SYNCRIP;LSM5;CHTOP;HNRNPUL1;SRRT;DNAJC8;SUPT5H;DDX39A;MAGOH;POLR2A;CPSF6;PRPF31;SRSF4;CPSF7;SNRPA;CASC3;ELAVL1;SUPT4H1;BUD31;CWC15;RBM14;DDX42;U2SURP;YTHDC1;SYMPK;PQBP1;POLR2K;PRPF4B;WDR33;POLDIP3;IK;HNRNPL;EIF4A3;CELF1;PRKACA;NUDT21;SF3B3;TBRG4;SYF2;RBM17;SCAF11;DDX23;PRPF6;POLR2B;DDX41;SNRPB2;SNRPA1;SF3B4;SF3A1;SRRM1;ALKBH5;CD2BP2;METTL3;CCAR1;LSM8;DHX38;LSM6;PPIE;THOC7;EFTUD2;HNRNPH2;PRCC;TCERG1;WBP11
prerank,negative regulation of cell cycle (GO:0045786),0.779464729870682,0.9576538175827547,0.546,0.7774314289415208,1.0,26/80,11.64%,DUSP1;NR4A1;PDCD4;SLC9A3R1;CAMK2N1;CDKN1C;NUPR1;RHOB;CEBPA;BTG2;BTG1;NR2F2;HPGD;CHMP1A;PTEN;IPO5;GAS1;TP53I13;RNF167;IPO7;SCRIB;CDK6;BMP4;CDKN1B;SMAD3;SIPA1
prerank,fatty acid catabolic process (GO:0009062),0.7709418866729555,0.9575546674255412,0.5365,0.777442473028914,1.0,37/68,15.94%,ACADVL;ACAA2;HADHA;SCP2;ACADS;HADH;ECHS1;ACAA1;HADHB;ECI1;BDH2;ILVBL;CEL;ECHDC2;ACOX1;ABCD4;HSD17B10;ABHD3;AIG1;DECR1;ECHDC1;ADTRP;ALDH3A2;HSD17B4;ECI2;ACAT2;LPIN3;ACAT1;ABHD2;FAAH;ABCD3;ACOT8;LPIN2;PHYH;PEX2;PPARD;ACADM
prerank,Golgi to endosome transport (GO:0006895),0.737462376748129,0.9575506529729007,0.5767883941970986,0.7770819272532903,1.0,13/15,22.54%,RAB14;GBF1;SORT1;MON2;AP2A1;VPS13C;CORO7;EPS15;VPS13A;WIPI1;SYS1;AP1AR;AP4M1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.7410738818500469,0.9575002073122706,0.568784392196098,0.7768959408492143,1.0,12/17,20.21%,SLC25A1;FASN;ACLY;PPCS;ACSS1;SCD;ACAT1;PPT1;DIP2A;ACACA;HSD17B8;SCD5
prerank,cytosolic calcium ion transport (GO:0060401),0.7450052619092018,0.9574343418090442,0.545,0.7767608408766608,1.0,12/28,17.01%,ATP2A3;SMDT1;ATP2A2;ITPR3;AFG3L2;ATP2B1;MCUR1;SLC25A23;MICU2;CACNB3;MICU1;MCU
prerank,organonitrogen compound catabolic process (GO:1901565),0.7673630260498421,0.9570804020092979,0.54,0.7777363780864623,1.0,9/62,6.50%,ANPEP;TST;MPST;CYP3A5;TPP1;NPEPPS;PDXDC1;TXN2;NAGK
prerank,regulation of NMDA receptor activity (GO:2000310),0.7454978355812069,0.957066332360715,0.5405,0.7774189166350667,1.0,8/32,12.71%,APP;CCL2;CAPN1;PTK2B;NEFL;EPHB2;DLG3;DLG1
prerank,positive regulation of protein kinase activity (GO:0045860),0.7999471402744549,0.9567772448849349,0.594,0.7781307133352885,1.0,53/153,13.19%,EGR1;CALM2;CALM1;CCL21;EFNA1;HSP90AB1;HSP90AA1;RHOA;CIB1;CALM3;CDKN1A;CLU;DDX3X;JTB;MAP2K2;ERBB3;XRCC6;VEGFA;XRCC5;GAS6;AGT;PPP2CA;RAP1A;IQGAP1;TGFBR2;CAB39;STK11;PRNP;TRAF4;PTK2;DDR2;DAB2IP;SYAP1;SRC;NAB2;MAP4K4;INSR;UNC119;PIH1D1;EMP2;TELO2;PTK2B;MAP2K3;RALB;DLG3;SNX9;CCDC88A;TAOK1;TCL1A;MINK1;PAK1;TPX2;PAK2
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.7755147233296927,0.9566550548117921,0.551,0.7782256592327478,1.0,40/77,16.33%,GSTP1;APOE;DUSP1;UCHL1;CDKN1C;CDK5RAP3;CEBPA;PRKAR1A;NR2F2;RGS2;PKIB;AGT;AKT1;PTEN;ABL1;SORL1;IPO5;HYAL2;GBA;IPO7;SMPD1;DAB2IP;PYCARD;BMP4;PKIG;CDKN1B;TESK1;SPRY2;PRKAR2B;STK38;NF1;PRKCD;LRP6;LRP5;PTPRJ;CBLC;PRKAR1B;HEXIM1;PRKAR2A;SPRY1
prerank,respiratory chain complex IV assembly (GO:0008535),0.7380516722084882,0.956618314806138,0.567,0.777996230836019,1.0,13/22,18.40%,PET100;COX17;COA3;COX14;OXA1L;COX20;COA5;SURF1;BCS1L;COA6;COX19;SMIM20;COA1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.7934560619649412,0.9562859231701469,0.5775,0.7788653387717626,1.0,25/136,12.79%,CD81;MYH9;VIP;GNB1;GCG;HLA-DRB1;PRKAR1A;VIPR1;RAMP2;ADM;RAMP1;SCT;FURIN;DPEP1;PRKACB;GNG2;ADCY6;PRKACA;SRC;PTH1R;PLCG1;GGT1;PRKAR2B;FYN;MAPK14
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.7388258956246545,0.9562747391241513,0.5502751375687844,0.7785335541097863,1.0,11/18,21.09%,STK25;INAVA;ARL6IP5;TAOK1;KLHDC10;PDCD10;EIF2AK2;SEMA4C;TAOK2;RNF13;MID1
prerank,response to fatty acid (GO:0070542),0.7368117204653781,0.9560993755412268,0.5645,0.7788254209087624,1.0,10/19,23.68%,PPP5C;FOXO3;SCD;NR1H4;CD36;IRS1;PID1;SOX9;FOXO1;PDK4
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.7499493926569775,0.9559205243592679,0.551,0.7791286795270511,1.0,13/35,16.83%,APOE;CAP1;GAL;NUDT4;PDE9A;GUCY1B1;AQP1;DEFB1;PDE3A;DGKQ;KSR1;AHR;MAPK7
prerank,RNA catabolic process (GO:0006401),0.7544141276292798,0.9556352623952261,0.55,0.7798380020331636,1.0,23/49,16.15%,ZFP36L2;ZFP36;HNRNPD;HSPA1A;RNH1;RNASEH2C;SND1;LSM2;LSM5;PABPC4;RNASET2;ISG20;HSPA1B;NUDT16L1;METTL3;LSM6;YTHDF2;NUDT16;XRN2;MTREX;SIDT2;SKIV2L;DCP2
prerank,regulation of mitochondrion organization (GO:0010821),0.7584707676626996,0.9555805438181184,0.5445,0.7796934050574815,1.0,29/46,19.65%,SQSTM1;FIS1;INF2;VDAC1;RHOT2;SREBF2;STAT2;PINK1;GOLPH3;SREBF1;VPS35;MFF;HDAC6;SIRT7;FZD5;DNM1L;HAX1;GSK3B;GSK3A;MYO19;CSNK2A2;PISD;PARL;USP36;EP300;ATP13A2;HTRA2;RHOT1;MUL1
prerank,histone H2A monoubiquitination (GO:0035518),0.7402438990471297,0.9553897072815403,0.5675,0.7800388637187358,1.0,12/17,20.73%,SKP1;DDB1;PCGF3;RING1;PCGF2;RYBP;KDM2B;CUL4B;BCOR;PCGF5;BMI1;DDB2
prerank,response to peptide (GO:1901652),0.7511640920426037,0.955191923297625,0.5395,0.7804020597303314,1.0,15/39,15.92%,MMP2;INAVA;ANXA1;NLRP1;STAT2;STAT6;ERBIN;PRNP;EIF2B5;STAT5B;FYN;EIF2B1;STAT1;STAT3;EIF2B4
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.7395018641447368,0.9551279470748165,0.5645,0.7802638159598099,1.0,4/17,10.20%,USP22;FGFR1;CELF1;CAMSAP3
prerank,regulation of chromosome segregation (GO:0051983),0.7381690233986076,0.9550972460125152,0.5622811405702851,0.7800166979092251,1.0,9/17,17.28%,NUMA1;ZNF207;PUM2;PUM1;MKI67;CSNK2A1;AURKB;CSNK2A2;SMC5
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.8060041260508616,0.9550669797930254,0.6185,0.7797653045755838,1.0,46/182,9.02%,HLA-A;SKP1;PSMB1;PSME1;PSMB4;HLA-DRA;PSME2;PSMD8;PSMB3;PSMA7;THY1;PSMB5;HHLA2;PSMB7;KHDRBS1;HLA-DRB1;PSMB6;PSMA1;PSMA4;PSMC5;RBCK1;BCAR1;PSMC3;BTNL3;PSMD2;PSMA2;STOML2;PSMB2;PSMD13;PSMD4;PSMD3;PAG1;PSMC1;PSMC6;UBE2N;SPPL3;HLA-DPB1;PSMC4;CSK;NFKBIZ;CD276;PSMF1;RELA;PSMA3;PSMA5;EIF2B5
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.7570392242803112,0.9550557327435211,0.5455,0.7794394131978131,1.0,13/42,15.69%,EFNA1;ERBB3;GAS6;AREG;AGT;PRNP;SRC;UNC119;DLG3;FYN;NEDD9;CSF1R;ACE
prerank,lipid modification (GO:0030258),0.752657201617661,0.954828064851094,0.5525,0.779924162553156,1.0,13/43,14.43%,CYP3A5;EPHX2;PLPP1;MBOAT7;PLPP3;PLPP2;PLPP5;DGKD;DGKZ;MBOAT2;DGKA;LPCAT3;DGKQ
prerank,positive regulation of blood coagulation (GO:0030194),0.7343782955763025,0.9546698898305679,0.5765,0.780159565739591,1.0,5/17,15.81%,ST3GAL4;F2R;ANO6;THBS1;F3
prerank,presynapse assembly (GO:0099054),0.7353130844951309,0.9543896730738166,0.5715,0.7808375531625101,1.0,6/18,12.35%,CEL;FZD1;PTEN;DVL1;PTPRD;NLGN2
prerank,histone H2A ubiquitination (GO:0033522),0.7363390465101903,0.9543806967935382,0.582,0.7805044303082261,1.0,16/17,25.54%,SKP1;UBE2B;DDB1;RING1;UBE2A;RYBP;UBR2;KDM2B;CUL4B;BCOR;DDB2;DTX3L;RNF168;RNF2;RNF8;PCGF1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.741678812470866,0.9543724564089711,0.583,0.78016357533977,1.0,11/15,18.51%,WASL;DAB2;UNC119;DGKD;TNK2;HIP1R;SCYL2;BMP2K;SMAP1;UBQLN2;AAK1
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.7359905566562553,0.9542547689448566,0.5782891445722862,0.7802325728232932,1.0,8/16,21.56%,ENTPD6;CMPK1;ENTPD8;ENTPD5;AK1;ENTPD4;AK4;ENTPD1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.7432831201684561,0.9542044437231179,0.5745,0.7800357086359783,1.0,14/24,19.68%,ATP5IF1;TSPO;PGRMC1;NFE2L1;UROD;ALB;UROS;RSAD1;SUCLA2;ALAS1;HMBS;SLC25A38;ALAD;PPOX
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.8028422747985698,0.9540244300569725,0.612,0.780346499421233,1.0,75/164,13.98%,MDK;PFDN5;APOE;IGFBP4;SLC9A3R1;IGFBP2;PSMB1;RBX1;CTNND1;PSME1;PSMB4;CAV1;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;CSNK1A1;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5;HDAC1;SFRP2;PSMC3;SFRP1;PSMD2;PSMA2;TLE2;PSMB2;PSMD13;PSMD4;DACT3;PSMD3;TCF7L2;TLE1;STK11;DVL3;PSMC1;DAB2;PSMC6;SNAI2;RUVBL2;PSMC4;PSMF1;WWTR1;PSMA3;PSMA5;DAB2IP;GREM1;FRZB;DVL1;LZTS2;TLE3;DKK3;PSMB8;DVL2;PSMD7;PSMC2;CUL3;SDHAF2;UBAC2;MAD2L2;PSMD6;DACT1;IGFBP6;GLI3;GSK3B;AXIN1;EMD;PSMD1;GSK3A;CHD8;SCYL2
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.77372103712037,0.9539468410275671,0.551,0.7802733262868154,1.0,48/85,14.70%,KDELR2;TAPBP;TMED10;RAB1A;ERGIC3;ARF4;RER1;SURF4;COPE;TMED9;LMAN2;KLC1;COPZ1;KDELR1;TMED2;KIF22;RAB1B;ARFGAP1;COPA;ARF5;ARFGAP2;GOLPH3;NAPA;ARF3;PLPP3;RAB6A;COPB1;GBF1;TMED3;KIF1C;COG4;ERGIC1;COPB2;SCYL1;SEC22B;ARCN1;ATP9A;TMED7;COPG1;HTT;TMEM115;PITPNB;ARFGAP3;SCFD1;COPZ2;STX18;NBAS;PICK1
prerank,cardiac ventricle development (GO:0003231),0.7430675948713122,0.9539322177649049,0.574,0.779951332474599,1.0,5/20,8.41%,HES1;NOTCH1;ENG;HECTD1;MDM4
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.7432010264559579,0.9538400729441825,0.5805,0.7799244403635609,1.0,10/20,17.75%,APRT;CDA;TYMS;DGUOK;POLD2;PNP;AMPD2;GMPR2;POLL;POLD1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.7416893840532681,0.9538329840204348,0.5625,0.7795821547762622,1.0,10/28,14.34%,TRIR;RNASE1;NHP2;KHNYN;NYNRIN;PCF11;DICER1;NUDT16;CSTF3;POP7
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.7658334311261901,0.9536813633910399,0.5475,0.7797801835312085,1.0,5/64,7.01%,VIPR1;ANXA1;AGT;CCL2;NPY
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.732262455030596,0.9536104231228586,0.5685,0.7796881232935392,1.0,8/15,19.62%,TFRC;NECTIN2;TP53BP1;KMT5B;MAD2L2;RIF1;HMCES;SHLD2
prerank,mitochondrial gene expression (GO:0140053),0.7480827632055136,0.9535442778966752,0.5595,0.7795657598248824,1.0,26/41,18.10%,MRPS21;MRPL51;MRPL57;MRPS34;MRPL12;MRPL23;MRPS6;MRPS7;MRPS18A;MRPS16;FOXO3;PTCD3;IARS2;POLRMT;MRPS12;NDUFA7;MRPL16;MRPS15;MRPS11;MRPS2;MRPS18B;MRPL2;RARS2;MRPL47;GATC;MRPS14
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.7617859268503174,0.9532616677687781,0.546,0.7802509406513646,1.0,29/58,14.52%,CCND2;PHB2;DDX3X;ANAPC11;RAB11A;EIF4G1;CCND1;ADAMTS1;ANXA1;ANAPC5;AKT1;CDK4;RCC2;CDC16;UBE2C;VPS4B;CCND3;PHOX2B;CDC25B;TFDP1;CDK1;ANAPC7;KMT2E;CUL3;ANKRD17;BRD4;CCNB1;RDX;AIF1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.7710267802858132,0.9532584027755145,0.553,0.7798973040605617,1.0,29/76,13.81%,UBB;PTTG1IP;FKBP1A;CAV1;CDK5RAP3;CENPX;NDFIP1;INAVA;TNIP1;UBE2L3;STUB1;LAPTM5;PINK1;HUWE1;NDFIP2;SAE1;PIAS3;UBA2;BIRC2;UBQLN1;WFS1;CUL3;HDAC3;GNL3;UBE3A;BCL10;AXIN1;DERL1;GSK3A
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.7312482762600655,0.9532581573950769,0.5795,0.7795310617682282,1.0,8/16,20.67%,VEGFA;APLNR;THBS1;NGFR;JCAD;PDCD10;FGFBP1;HMOX1
prerank,negative regulation of signal transduction (GO:0009968),0.8224916071555328,0.9531161375060984,0.6835,0.7796949306568562,1.0,73/265,10.12%,RACK1;DCN;EMILIN1;CALR;IGFBP5;TMBIM6;SLC9A3R1;LRP1;GPC3;IGFBP3;DLK1;TMBIM1;ERBB2;VCP;ERBB3;MAZ;YWHAB;EGFL7;KANK2;TAX1BP3;PDCD6;LGMN;NOTCH3;LRPAP1;SULF2;DDIT4;SFRP2;SIGIRR;HIC1;RGS2;SFRP1;CNOT1;TSC2;TNS2;AGT;AKT1;PTEN;PRKCZ;VGLL4;DACT3;LGR4;PTCH1;HGS;GPC1;TLE1;ARRDC1;WIF1;PTPN18;ASXL1;SULF1;NXN;SNAI2;HHIP;PIP4K2B;GBA;TRIB1;CD47;ULK3;SMPD1;XDH;TCIM;CREB3L1;PALM;GPR108;DAB2IP;PTK6;LEPROT;FRZB;PTPN12;SEMA6A;MDFI;METTL3;FSTL3
prerank,negative regulation of viral genome replication (GO:0045071),0.7590617938530753,0.9529234764476939,0.5355,0.7800701702743945,1.0,21/51,18.48%,IFITM3;ILF3;SLPI;BANF1;IFITM2;TNIP1;ISG20;PLSCR1;FAM111A;ISG15;OAS1;BST2;MAVS;IFI16;EIF2AK2;N4BP1;SETDB1;MPHOSPH8;PARP10;HMGA2;SRPK1
prerank,embryonic limb morphogenesis (GO:0030326),0.7473452542755843,0.9528373851969263,0.5615,0.7800236156834706,1.0,17/36,16.76%,CTNNB1;HDAC1;ECE1;HDAC2;OSR1;MBNL1;PTCH1;CREBBP;ZNF358;TBX2;TBX3;MAP3K20;FBXW4;GLI3;LRP6;NIPBL;RARG
prerank,regulation of synapse assembly (GO:0051963),0.7533387641677715,0.9527171997559568,0.562,0.780103665690695,1.0,13/47,12.35%,CLSTN1;APP;EIF4G1;RAB17;GPC6;VPS35;PDLIM5;EPHB3;GPC4;DLG5;PTPRD;EPHB2;NLGN2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.7648189387648976,0.9526527316534256,0.5575,0.7799888424276369,1.0,9/59,10.82%,FGFR3;STAP2;VEGFA;HES1;TNFRSF1A;IL6ST;SOCS3;PTK6;ARL2BP
prerank,ERAD pathway (GO:0036503),0.7726260260753217,0.9522858531756437,0.5605,0.7809776208622694,1.0,59/86,18.56%,HSP90B1;HSPA5;SEC61B;VCP;OS9;AUP1;BAG6;SELENOS;STUB1;HERPUD1;UBXN6;MAN1B1;RCN3;STT3B;PSMC6;NPLOC4;DNAJC10;TMUB2;TMUB1;SEL1L;RNF5;SGTA;RNF103;UBE2G2;UBE2J1;UBE2J2;UBE4A;SYVN1;RHBDD2;UBXN4;ERLEC1;ANKZF1;UBQLN1;UFD1;MAN1A1;WFS1;ECPAS;FBXO17;DNAJB2;DERL2;CCDC47;DERL1;TMEM129;FAM8A1;ERLIN1;DNAJB12;USP19;FAF2;JKAMP;ERLIN2;AMFR;UGGT1;FBXO2;UBQLN2;TRIM25;DNAJB14;UBE4B;TOR1A;TRIM13
prerank,activation of protein kinase A activity (GO:0034199),0.7343441355499868,0.9522402030932511,0.5877938969484743,0.7807827733402245,1.0,10/17,19.03%,PRKAR1A;PRKACB;ADCY6;PRKACA;PRRC1;PRKAR2B;PRKAR1B;PRKAR2A;ADCY5;ADCY3
prerank,nuclear membrane reassembly (GO:0031468),0.7576762187964664,0.9521885452535299,0.554,0.780612717055318,1.0,34/54,15.32%,LMNA;PPP2R1A;RAN;BANF1;IST1;UBE2I;CHMP2A;KPNB1;SEC13;PPP2CA;SUMO1;LBR;CHMP3;SIRT2;VPS4A;LEMD2;ANKLE2;NSFL1C;RANGAP1;CHMP4A;CDK1;REEP3;CHMP4B;CHMP2B;NUP85;PPP2R2A;CCNB1;NUP188;EMD;NUP160;NUP98;REEP4;POM121;CHMP7
prerank,generation of neurons (GO:0048699),0.8073167548405554,0.9520895863993609,0.6355,0.7806213235587545,1.0,17/200,5.50%,ITM2C;IER2;RAC1;TUBB2B;PLXNB2;CTNNB1;TUBB2A;ERBB2;HMGB2;MAP1B;HES1;FGFR1;NRP1;DDIT4;PAFAH1B1;PIN1;FZD1
prerank,cellular response to ketone (GO:1901655),0.7490830895912601,0.9520198708909254,0.557,0.7805095706577703,1.0,21/39,19.03%,GNB1;PCK1;SFRP1;LARP1;MSN;NCOA4;ADAM15;GOLPH3;PCK2;SPP1;ROCK2;GNG2;ADCY6;SRC;AQP1;AHR;CFTR;ADCY5;NR3C1;AKR1C3;ADCY3
prerank,B cell activation (GO:0042113),0.77669325192485,0.9518378912306226,0.569,0.7808353374134229,1.0,11/85,8.78%,SLC25A5;ITGB1;KLF6;PHB2;HSPD1;PHB;TPD52;TCF3;HDAC5;CEBPG;AKAP17A
prerank,intracellular protein transport (GO:0006886),0.8260188952863143,0.9517522950232701,0.717,0.7807766904611183,1.0,85/333,8.72%,RPL11;CTSA;CALR;CD74;NPM1;PTTG1IP;ARF1;GIPC1;VPS28;RAN;PHB2;CHP1;CDC37;CLTC;TMED10;CTTN;RAB1A;ARF4;SURF4;ERP29;MYO1C;TMED9;PDCD6;YWHAH;SEC31A;XPO1;COPZ1;PKD1;RAB7A;RAB5C;TMED2;VPS29;RAB1B;SAR1A;KPNB1;SEC13;AP3D1;TSC2;COPA;ARF5;AKT1;RAB17;TMED4;ARL14;ARF6;RAB5B;OXA1L;TBC1D9B;SORL1;IPO5;LAPTM5;SNX17;GABARAP;NAPA;ARF3;VPS25;AKT2;RAB14;TPR;VPS35;RAB6A;SNX1;TMED3;STXBP2;WLS;TBC1D1;SNX6;SGSM2;STX16;ARHGEF2;HDAC6;SEC16A;TRAK1;SNF8;COPB2;IPO7;APPL2;STX10;RPAIN;LMAN1;EHD1;ARL1;ARFRP1;TNPO1;ARCN1
prerank,cellular response to misfolded protein (GO:0071218),0.7358056678781706,0.9516904608400477,0.578,0.7806432766779154,1.0,13/20,18.34%,VCP;AUP1;BAG6;STUB1;RNF126;RNF5;UFD1;CUL3;DERL1;DNAJB12;UGGT1;DNAJB14;TOR1A
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.7399647858616905,0.9511671512646996,0.5615,0.782241534018834,1.0,13/30,15.34%,HSP90AB1;CDC37;STAT2;YTHDF3;METTL3;ISG15;UBE2K;YTHDF2;OAS1;MAVS;TTLL12;CNOT7;PTPN11
prerank,primary alcohol metabolic process (GO:0034308),0.7477690705954452,0.9511287208368914,0.5655,0.7820269684136691,1.0,13/33,19.77%,DHRS9;RETSAT;DHRS3;RDH10;ADH1C;ALDH3A2;GDE1;NAAA;RDH11;ADH1B;GDPD3;GPD2;NAPEPLD
prerank,divalent inorganic cation homeostasis (GO:0072507),0.7389973774171722,0.9511227890598687,0.56,0.7816853512397265,1.0,14/25,23.92%,S100A14;CAV1;SELENON;CNNM4;WFS1;CIB2;TMTC2;ATP13A2;ANK3;JPH2;CNNM2;TRPM7;SLC8A1;SNCA
prerank,organic acid transport (GO:0015849),0.7781280492689516,0.9510052674207631,0.5655,0.7817611050863397,1.0,8/100,5.16%,CEACAM1;SLC7A7;SLC38A2;ABCC3;SLC3A2;ATP8B1;SLC26A6;SLC6A19
prerank,aspartate family amino acid metabolic process (GO:0009066),0.7297941411707661,0.950934537044217,0.584,0.7816674326741473,1.0,15/18,26.53%,ASS1;ADI1;FOLH1;SMS;GOT2;GOT1;NIT2;MTHFD1;SLC25A13;MTHFR;ASNS;SLC25A12;NAALAD2;ASPG;MSRA
prerank,positive regulation of protein metabolic process (GO:0051247),0.7892795859351324,0.9508922155267819,0.5945,0.7814519033182884,1.0,47/115,14.54%,OAZ1;APOE;VIP;NDUFA13;KLF4;GPC3;VPS28;APP;CLU;VCP;RAB1A;PRMT1;KLF2;RAB7A;EIF4G1;RAB1B;NEDD4L;DDB1;AGT;AKT1;SORL1;OAZ2;PSEN1;NFKBIA;HUWE1;MTPN;ROCK2;GBA;SNF8;SEC22B;NR1H3;DAB2IP;PLA2G10;SLC25A37;CDKN1B;WFS1;STX5;CSNK2A1;FZR1;DACT1;GSK3B;BCL10;AXIN1;GSK3A;NR1H2;PLK2;WWP2
prerank,regulation of ATP metabolic process (GO:1903578),0.7611836571635181,0.9505298399648198,0.5595,0.782446826884371,1.0,37/55,20.23%,COX7A2;ATP5IF1;PGAM1;EIF6;OGT;FIS1;SEC13;COX7A2L;UQCC2;PINK1;COX7A1;TPR;HIF1A;RANBP2;NUP62;JMJD8;SHMT2;NUP85;NUP50;NUP188;NUP160;AAAS;NUP98;POM121;RAE1;NUP214;NUP58;PRKAG1;ZBTB7A;POM121C;NUP93;EP300;AK4;NUP133;NUP205;NUP54;NUP153
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.7290383882274641,0.9505011950756881,0.581,0.7821957273695482,1.0,11/16,19.65%,STAT2;YTHDF3;METTL3;ISG15;YTHDF2;OAS1;TTLL12;CNOT7;SAMHD1;PTPN2;MUL1
prerank,positive regulation of DNA recombination (GO:0045911),0.7401093704039038,0.9503602053968216,0.57,0.7823525599345924,1.0,17/30,23.21%,FUS;ACTR2;TFRC;PARP1;TP53BP1;KMT5B;MAD2L2;MMS19;RIF1;WDR48;MRNIP;HMCES;SHLD2;TIMELESS;ARID2;ERCC2;KMT5C
prerank,carboxylic acid metabolic process (GO:0019752),0.7490428223020797,0.9501301451171333,0.569,0.7828355322168721,1.0,10/40,13.33%,MIF;CYB5R3;GSTO1;SLC2A1;GRHPR;CYB5A;ST6GAL1;GLUD1;CYP2S1;PTGIS
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.7359633612175437,0.9500473740246719,0.5755,0.7824027298117604,1.0,8/23,16.83%,MCL1;HSPA1A;AKT1;SNAI2;HSPA1B;UNC5B;BCL2L1;MAPK7
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.7359633612175437,0.9500473740246719,0.5755,0.7824027298117604,1.0,8/23,16.83%,MCL1;HSPA1A;AKT1;SNAI2;HSPA1B;UNC5B;BCL2L1;MAPK7
prerank,hexose metabolic process (GO:0019318),0.7532327073186625,0.9499817596768264,0.581,0.7822765709458589,1.0,23/41,17.06%,PCK1;AKR1A1;ALDOB;SLC37A4;FUCA1;DCXR;FUCA2;KHK;PMM1;GAA;ALDOA;PGM1;BRAT1;HK1;FBP1;OAS1;HECTD4;GALM;ADPGK;FUOM;PPARD;GALK1;GALT
prerank,histone mRNA metabolic process (GO:0008334),0.7367583068363944,0.9498787855431181,0.581,0.7823031478819861,1.0,20/28,20.78%,SNRPG;SNRPB;SNRPE;SNRPF;SNRPD3;UPF1;SSB;EXOSC10;NCBP2;LSM1;SLBP;TUT4;TENT2;DCP2;LSM10;XRN1;ATM;CPSF3;CPSF2;EXOSC4
prerank,histone monoubiquitination (GO:0010390),0.7379266878091798,0.9498389202643963,0.58,0.7820849738634834,1.0,20/24,23.49%,SKP1;DDB1;WAC;RING1;RNF40;UBE2E1;RYBP;ATXN7L3;UHRF1;KDM2B;CUL4B;BCOR;PAF1;CTR9;DDB2;RNF20;DTX3L;RNF168;LEO1;RNF2
prerank,gene silencing by miRNA (GO:0035195),0.7458356682361841,0.9496763325282989,0.5645,0.7823286101392118,1.0,26/32,22.75%,ZFP36;RAN;EIF6;CNOT1;ADAR;PUM2;MOV10;PUM1;TNRC6A;DICER1;CNOT8;CNOT7;PRKRA;CNOT6;AGO2;ZC3H7A;ZC3H7B;TNRC6B;SPOUT1;AGO3;AGO1;WTIP;TARBP2;NOTCH4;XPO5;AGO4
prerank,response to cholesterol (GO:0070723),0.7313406351492425,0.9496557115973406,0.578,0.7820447466827068,1.0,9/19,14.57%,SMO;PTCH1;TGFBR2;GRAMD1A;PMVK;SMAD2;CES1;TGFBR1;LRP6
prerank,regulation of dephosphorylation (GO:0035303),0.7296750500700092,0.9494554276013785,0.5875,0.7824391195404977,1.0,11/15,23.13%,CDK5RAP3;PPP1R16A;IGBP1;SRC;SMG5;SMG7;MTMR3;MTMR4;INPP5K;MTMR2;SMG6
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.7323374770152971,0.9492645173669934,0.5845,0.7827939595733548,1.0,16/20,22.75%,PUM2;PUM1;TSN;DICER1;PRKRA;AGO2;ZC3H7A;ZC3H7B;DROSHA;SPOUT1;TSNAX;AGO3;AGO1;TARBP2;MRPL44;AGO4
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.7466779036739388,0.9492522475991385,0.57,0.7824778441979297,1.0,12/42,15.86%,PDCD4;PLD3;CUEDC2;CHID1;APPL2;HIF1A;PYCARD;PER1;MAPK14;SIRPA;MYD88;STAT3
prerank,regulation of interferon-alpha production (GO:0032647),0.7386237146086075,0.9492152953502653,0.573,0.7822442193923825,1.0,7/25,15.82%,DDX3X;HSPD1;DHX9;IRF3;SETD2;MAVS;STAT1
prerank,autophagosome organization (GO:1905037),0.7547824326152051,0.9491182038397884,0.56,0.782233914623592,1.0,37/54,20.56%,VMP1;RAB1A;GABARAPL2;RAB7A;MAP1LC3B;ATP2A2;RAB1B;PACS2;GABARAP;MAP1LC3A;ULK3;EMC6;TP53INP2;NSFL1C;WIPI2;ULK1;UBQLN1;BECN1;TMEM41B;WDR45;STX12;ATG16L2;ATG12;WDR45B;ATG3;ATG2A;TP53INP1;ATG101;GABARAPL1;UBQLN2;ATG13;RB1CC1;ATP13A2;ATG2B;RAB23;ULK2;WIPI1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.7384702352502215,0.9490726502134293,0.5765,0.782040407508038,1.0,15/27,16.14%,HNRNPU;NELFB;SUPT4H1;NELFE;NELFCD;SUPT16H;SUPT6H;TCERG1;ZMYND11;BRD4;EAPP;CDK13;HEXIM1;LARP7;NELFA
prerank,protein secretion (GO:0009306),0.7597706831200265,0.9490478141866476,0.5465,0.7817682330894713,1.0,22/64,13.49%,VIP;CANX;PARK7;GAL;MTTP;PDIA4;ANXA1;GOLPH3;RCN3;RAB10;TMEM167A;WLS;RAB13;SEL1L;MIA2;RAB8A;COPG1;CAMK2G;RAB3D;ARFGAP3;PREB;SVBP
prerank,amide biosynthetic process (GO:0043604),0.7529896081101028,0.948935630543799,0.57,0.7818214880561044,1.0,18/51,16.24%,ASS1;CPS1;ASAH1;ASL;SMPD4;CERS2;SPTSSA;PAM;FURIN;GBA;SMPD1;DEGS1;SPTLC1;CERS6;CERS4;NMRAL1;SPTLC2;CERS5
prerank,positive regulation of cell development (GO:0010720),0.7484446949833158,0.9488580446647161,0.556,0.7817448676793762,1.0,13/37,17.53%,NAP1L1;TGM2;ATP6AP1;BAD;NUMB;BMP4;SERPINF1;PDE3A;SPEN;SNW1;TYROBP;ZNF335;SOX11
prerank,T cell proliferation (GO:0042098),0.7318905054522593,0.9487392380626636,0.5895,0.7818394154224321,1.0,6/15,20.85%,MSN;PPP3CB;CTPS1;CADM1;BTN3A1;LMBR1L
prerank,positive regulation of histone methylation (GO:0031062),0.7374745305257622,0.9487002497721687,0.5795,0.7816296894678008,1.0,16/25,20.55%,CTNNB1;OGT;CHTOP;SMAD4;DNMT1;PHF1;WDR61;AUTS2;KMT2A;SNW1;WDR5;RIF1;PHF19;MTF2;PAF1;CTR9
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.7605509659700214,0.9486239939167667,0.563,0.7815470352048747,1.0,29/61,14.40%,JUN;CTNNB1;CDKN1A;TRIM28;CCND1;CDK4;PTEN;BCLAF1;MOV10;TCF7L2;MED16;MED15;CEBPB;RELA;THRA;BAX;CDK1;TNRC6A;SETX;MED14;MED13;MED4;MED25;MED10;MED12;CCNB1;TP53;CBFB;CCNC
prerank,protein N-linked glycosylation (GO:0006487),0.7618165885309183,0.948341871923122,0.565,0.7822071582693025,1.0,40/67,18.36%,OST4;TMEM258;MGAT4B;RPN2;DAD1;OSTC;DPM3;B4GALT1;MGAT1;GFPT1;KRTCAP2;RPN1;TUSC3;STT3B;DDOST;PMM1;MPDU1;LMAN1;UBE2J1;ST6GAL1;ENTPD5;TMEM165;MCFD2;MAGT1;MOGS;DPM2;PGM3;STT3A;MGAT4A;NUDT14;ALG3;MGAT5;DPM1;MGAT2;UGGT1;ALG13;ALG12;ALG5;B4GALT7;SLC39A8
prerank,histone deubiquitination (GO:0016578),0.7325303459463415,0.94783544095083,0.5765,0.7837279556913506,1.0,13/19,24.29%,USP22;TAF10;ENY2;KAT2A;USP7;ATXN7L3;TRRAP;USP3;USP36;USP16;USP15;UIMC1;BRCC3
prerank,positive regulation of insulin secretion (GO:0032024),0.7450761607214144,0.9476173075920727,0.5795,0.7841478030393388,1.0,17/38,17.01%,SOX4;TRPM4;NNAT;GCG;HLA-DRB1;BAD;TCF7L2;PPP3CB;STX4;GLUD1;NLGN2;ANO1;PSMD9;CAPN10;CFTR;LRRC8A;MCU
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.7257657466291144,0.9476035257467074,0.586,0.783837102269703,1.0,10/15,23.50%,SNAI2;ADAMTS7;RFLNA;GREM1;TGFBR1;EFEMP1;PTPN11;RFLNB;SOX9;NKX3-2
prerank,microtubule polymerization (GO:0046785),0.7400488147173414,0.9471076290830868,0.583,0.7853182224268807,1.0,20/30,19.38%,ZNF207;CSNK1D;PIN1;AKAP9;TUBGCP2;CLASP2;GOLGA2;TUBGCP6;HDGFL3;CKAP5;TPX2;CLASP1;FGF13;TPPP3;NDEL1;CCDC57;TUBG1;RANBP9;SLAIN2;CENPJ
prerank,protein methylation (GO:0006479),0.7454345957628729,0.9463753826460986,0.5735,0.7876852819337178,1.0,21/40,17.38%,TRMT112;PRMT1;SNRPB;SNRPD3;CSKMT;PRMT2;RAB6A;GSPT1;NSD3;PCMT1;EHMT2;LCMT1;CARM1;ICMT;PRMT5;ETF1;EHMT1;EZH2;PRMT7;NSD1;SETD3
prerank,purine nucleotide metabolic process (GO:0006163),0.7394017273713296,0.9463735130118522,0.584,0.7873280831763065,1.0,14/23,21.03%,GUK1;NT5C;DNPH1;ITPA;XDH;PNP;NT5C2;PRPSAP1;PRPSAP2;MTHFD1;ADSL;GART;PRPS2;GDA
prerank,negative regulation of interleukin-10 production (GO:0032693),0.7285773010982897,0.9461420163757074,0.6075,0.787819316901885,1.0,7/17,25.46%,TRIB2;DLL1;VSIR;TYROBP;TNFRSF21;AGER;JAK3
prerank,regulation of protein localization to nucleus (GO:1900180),0.7501852561641851,0.9461139332975966,0.567,0.7875643863300142,1.0,21/46,15.40%,CTNNA1;PARK7;LAMTOR5;CDK5RAP3;GLUL;TFRC;AKT1;PIN1;FERMT2;YAP1;SUMO3;TPR;WWTR1;BMP4;CDK1;TESK1;NGFR;GSK3B;LIMK2;CARD10;ORMDL3
prerank,mitochondrial fusion (GO:0008053),0.7280148015043965,0.9460125951112188,0.5835,0.7875668725327363,1.0,11/18,18.75%,FIS1;SPG7;STOML2;MFF;MFN2;BAX;AFG3L2;MIGA2;CHCHD3;OPA1;MFN1
prerank,regulation of organelle assembly (GO:1902115),0.7710631514464185,0.9459946920261594,0.571,0.78727510960541,1.0,29/73,16.06%,GSN;EZR;NPM1;PDCD6IP;RAB1B;TBC1D9B;MSN;SENP6;TBC1D1;ATXN2L;SGSM3;RAB5A;TRAPPC12;TSG101;RABGAP1;IFT20;TBC1D2B;TBC1D14;TBC1D20;RDX;PLK2;RABEP2;STX18;TBC1D10B;RNF4;ATG3;MTMR3;TBC1D13;TBC1D5
prerank,regulation of cell cycle phase transition (GO:1901987),0.7752966168664456,0.945985105305976,0.576,0.7869517257251888,1.0,55/95,14.85%,SKP1;CDKN1A;PSMB1;PSME1;PSMB4;ANAPC11;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;ATP2B4;PSMB7;PSMB6;UBE2S;PSMA1;PSMA4;ANAPC16;PSMC5;PSMC3;ANAPC5;PSMD2;DDB1;PSMA2;PSMB2;PSMD13;PSMD4;CDC16;UBE2C;PSMD3;BUB3;PSMC1;PSMC6;PSMC4;TCIM;PSMF1;PSMA3;PSMA5;CDKN1B;CDK1;UBE2E1;ANAPC7;PSMB8;ANAPC15;PSMD7;PSMC2;FZR1;PSMD6;CUL1;CCNB1;TP53;PSMD1;ERCC3;PSMD9;CDC20
prerank,chondrocyte differentiation (GO:0002062),0.738616988500709,0.9456493899077196,0.572,0.7878316044513701,1.0,8/31,9.95%,FGFR3;NFIB;SULF2;SLC39A14;OSR1;SULF1;BMPR2;BMP4
prerank,arachidonic acid metabolic process (GO:0019369),0.7591678538470523,0.9455322676321086,0.5825,0.7878963075104554,1.0,12/55,13.33%,GPX4;PTGES3;MGLL;EPHX2;CYP4F12;PTGES2;PLA2G10;CBR1;CYP2S1;FAAH;PTGDS;PTGIS
prerank,rRNA catabolic process (GO:0016075),0.7256586778806041,0.9453724554920451,0.6147294589178357,0.7881208635757493,1.0,15/18,26.11%,TRIR;ERN2;EXOSC10;DEDD2;EXOSC8;PELO;EXOSC6;XRN1;EXOSC7;EXOSC4;EXOSC9;DIS3L;DIS3;EXOSC2;EXOSC5
prerank,epoxygenase P450 pathway (GO:0019373),0.7310454849154371,0.945030648710578,0.603,0.7890360940752166,1.0,4/19,17.40%,EPHX2;CYP4F12;CYP2S1;CYP2C9
prerank,regulation of fatty acid metabolic process (GO:0019217),0.7303147547864037,0.9446674134607966,0.596,0.7900356334740929,1.0,11/18,23.68%,EIF6;CAV1;NCOR1;ADIPOR2;ADIPOR1;PPARG;PPARD;PRKAB2;PANK2;PRKAG2;PDK4
prerank,blood vessel diameter maintenance (GO:0097746),0.7429751216201315,0.9446488090239352,0.5895,0.789742760155011,1.0,15/35,15.69%,CPS1;KLF2;ECE1;AGT;ACE2;ROCK2;EDNRA;ADCY6;F2RL1;ITGB1BP1;SCPEP1;EDNRB;EDN3;ROCK1;ACE
prerank,histone deacetylation (GO:0016575),0.7437195239898642,0.9445604817192781,0.5845,0.7897067354055312,1.0,30/46,20.17%,SFPQ;MORF4L1;MORF4L2;PHB;HDAC1;HDAC2;HDAC5;MTA1;RBM14;TBL1XR1;SIRT2;HDAC6;SIRT7;SIRT6;BAZ2A;SIN3B;PER1;HDAC3;RCOR3;RCOR1;MIER3;BRMS1;MTA3;REST;SIN3A;SUDS3;SMARCAD1;MIER1;ELK4;MIER2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.7307872646580793,0.9444975645924011,0.597,0.789576341415824,1.0,12/21,20.54%,SULF2;UGDH;GPC1;SULF1;B3GAT3;HS6ST1;EXT1;EXT2;GLCE;EXTL3;HS2ST1;SGSH
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.7355169617262509,0.9440658407378094,0.591,0.7908111882969885,1.0,19/29,21.46%,G0S2;CAV1;SFRP1;AGT;TNFSF10;LTBR;HYAL2;PYCARD;THBS1;DEDD2;PAK2;BCL10;RET;PML;TNFSF12;HTRA2;RIPK1;BID;TNFRSF12A
prerank,neuron projection development (GO:0031175),0.7982835070773344,0.9440474529437795,0.6485,0.7905166689944355,1.0,41/171,9.13%,UBB;STMN1;HMGB1;LAMB1;APOE;DNM2;NBL1;BLOC1S1;CDC42;APP;STMN2;CTTN;VAPA;PRMT1;RAB11A;PLXNB1;MAP4;SGK1;BTG2;TRIO;MICALL2;NCKAP1;PTEN;DBN1;WASL;USH1C;ATXN10;DBNL;NPY;CDK16;RAB13;FRYL;MAPK8IP3;GBA;PQBP1;EPHB3;EHD1;MANF;STMN3;STX3;DAB2IP
prerank,activation of phospholipase C activity (GO:0007202),0.7389861133483477,0.9439483595645489,0.5935,0.7905212156944124,1.0,9/32,19.70%,PHB2;PHB;GNAQ;EDNRA;PLCG1;EGFR;LPAR2;ANG;LPAR1
prerank,RNA interference (GO:0016246),0.7271147482826565,0.9436272616418857,0.5965,0.791343481040866,1.0,13/17,22.75%,DHX9;CELF1;TSN;DICER1;PRKRA;AGO2;DROSHA;TSNAX;AGO3;AGO1;TARBP2;MRPL44;AGO4
prerank,response to glucagon (GO:0033762),0.7299776355333564,0.9435044149576146,0.606,0.7914374999436065,1.0,11/21,19.03%,GCG;PRKAR1A;PRKACB;ADCY6;PRKACA;PRKAR2B;PRKAR1B;PRKAR2A;CREB1;ADCY5;ADCY3
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.7496363068521685,0.943501478401321,0.5785,0.7910880681954973,1.0,37/51,21.55%,SFN;RPS27L;MCL1;BAG6;DDIT4;HIC1;ABL1;EPHA2;DYRK2;PRKDC;PYCARD;TMEM109;BAX;BOK;CRIP1;TP53;SNW1;HIPK1;IFI16;MSH6;PHLDA3;BAK1;BCL3;MOAP1;BCL2L1;PML;EP300;CASP2;ATM;HTRA2;MSH2;BCL2L2;CDIP1;FNIP2;CIDEB;E2F1;HIPK2
prerank,rRNA modification (GO:0000154),0.7279557737676385,0.9431781440231941,0.6025,0.7919027983364045,1.0,15/21,24.49%,TRMT112;NOP10;FBL;NHP2;TSR3;BUD23;MTERF4;METTL5;FTSJ3;THUMPD1;GAR1;DKC1;MRM2;NAT10;DIMT1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.7492093982715443,0.9431521271129065,0.575,0.7912666116384974,1.0,43/50,22.55%,POLR2L;POLR2J;POLR2H;EIF4G1;POLR2E;POLR2F;POLR2I;SEC13;POLR2G;PUM2;POLR2A;TPR;PUM1;POLR2K;POLR2B;RANBP2;NUP62;FMR1;TNRC6A;NUP85;POLR2C;NUP50;NUP188;NUP160;AAAS;NUP98;POM121;RAE1;AGO2;NUP214;NUP58;IPO8;POM121C;NUP93;NUP133;NUP205;AGO1;NUP54;NUP153;NUP107;POLR2D;NUP43;NDC1
prerank,regulation of gene silencing by RNA (GO:0060966),0.7492093982715443,0.9431521271129065,0.575,0.7912666116384974,1.0,43/50,22.55%,POLR2L;POLR2J;POLR2H;EIF4G1;POLR2E;POLR2F;POLR2I;SEC13;POLR2G;PUM2;POLR2A;TPR;PUM1;POLR2K;POLR2B;RANBP2;NUP62;FMR1;TNRC6A;NUP85;POLR2C;NUP50;NUP188;NUP160;AAAS;NUP98;POM121;RAE1;AGO2;NUP214;NUP58;IPO8;POM121C;NUP93;NUP133;NUP205;AGO1;NUP54;NUP153;NUP107;POLR2D;NUP43;NDC1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.7453241416956602,0.943063018134721,0.593,0.791237582103362,1.0,20/39,20.21%,HMGCS2;SLC25A1;HPGD;GGT6;BDH2;FASN;ACLY;PAM;FAR1;SCD;ACAT1;BDH1;GGT1;HMGCL;PPT1;ACACA;GGT5;HSD17B8;AACS;SCD5
prerank,skeletal system morphogenesis (GO:0048705),0.7411498108851929,0.9428774892344148,0.58,0.7915622362374892,1.0,16/41,17.53%,FGFR3;FBN2;PDGFRA;FGFR1;HOXB3;ANKRD11;HHIP;RFLNA;TGFBR1;FGFR2;HOXA9;LRP6;LRP5;HOXA3;RFLNB;SOX11
prerank,negative regulation of cellular metabolic process (GO:0031324),0.7453630808056633,0.9426403844297346,0.594,0.7920841437232109,1.0,12/39,12.29%,APOE;LRPAP1;SDCBP;PINK1;OPTN;NCOR1;SIRT2;TRAP1;ANKRD13D;ITGAV;ANKRD13A;EDNRB
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.7365462487000978,0.942562037781883,0.5935,0.7919950217214048,1.0,7/32,15.41%,HES1;OCIAD1;NOTCH1;OCIAD2;F2R;IL10RB;MGAT5
prerank,glycoprotein metabolic process (GO:0009100),0.7531610136919776,0.9425247234140892,0.578,0.7917742498778247,1.0,22/55,14.80%,MGAT4B;PARK7;ST3GAL4;GANAB;OGA;PRKCSH;TNIP1;GOLPH3;MAN1B1;STT3B;ENGASE;HIF1A;B4GALT5;MAN1A1;ERP44;FBXO17;ADAMTS9;MAN2A1;GCNT1;MAN2A2;MGAT4A;ST3GAL2
prerank,negative regulation of histone modification (GO:0031057),0.7232282427117427,0.9424660030791767,0.619,0.791627459814868,1.0,5/15,16.19%,SET;CTBP1;TAF7;NOC2L;THAP7
prerank,synaptic vesicle membrane organization (GO:0048499),0.722652174459583,0.9424216787443885,0.6115,0.7914370083097764,1.0,11/17,23.06%,SYNGR2;AP3D1;STX3;STX4;SNAP23;SNAP29;TOR1A;SYNGR1;STX2;SNAP25;SNAP47
prerank,regulation of cellular response to stress (GO:0080135),0.7802175825325488,0.9424009165050712,0.6015,0.7911598603716187,1.0,57/117,14.89%,CHCHD2;HSP90AB1;NPM1;HSPA8;HSP90AA1;ATF4;HSBP1;YWHAE;NUPR1;MCL1;IER3;PTGES3;HSPA1A;MAPK3;SLC38A2;EIF4G1;SEC13;ATF3;DNAJB1;ABL1;PINK1;DNAJB6;BAG1;RSL1D1;TPR;MAPK1;CREBBP;ROCK2;MAPKAPK2;HSPA1B;HSF1;SMG1;MANF;CEBPB;CAMK2D;CRYAB;RPA1;RANBP2;NUP62;CAMK2G;MLST8;RPA3;HIKESHI;FKBP4;AKT1S1;NUP85;CCAR2;NUP50;GSK3B;NUP188;DNAJC7;VASH1;NUP160;AAAS;NUP98;USP19;POM121
prerank,positive regulation of histone modification (GO:0031058),0.7338026120974389,0.9423675832182322,0.5975,0.7909242251444121,1.0,19/33,19.04%,MAPK3;CTBP1;AKAP8L;CHTOP;APLNR;SAP30BP;UBE2N;KDM1A;RUVBL2;ZBTB7B;GLYR1;BRD7;FMR1;AKAP8;NIPBL;RPS6KA4;SART3;ARRB1;PAF1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.7284240388464855,0.9422903153446003,0.6025,0.7908540002643625,1.0,13/18,21.12%,IMPDH2;AK3;NT5C2;AMPD2;PAICS;ATIC;GMPR2;GMPS;AK4;IMPDH1;ADSL;GART;LHPP
prerank,negative regulation of DNA recombination (GO:0045910),0.7486676880547216,0.9422510937183222,0.593,0.7906359316546995,1.0,26/45,19.82%,POLR2L;POLR2J;POLR2H;POLR2E;POLR2F;POLR2I;POLR2G;POLR2A;FBH1;POLR2K;TERF2IP;POLR2B;ATRX;TP53BP1;MAGEF1;SMCHD1;MAD2L2;POLR2C;RIF1;MSH6;UBQLN4;DAXX;ACD;TERF1;SHLD2;MSH2
prerank,neuron migration (GO:0001764),0.7476829276184886,0.9422114441475725,0.5925,0.7904280223399188,1.0,12/50,9.00%,RAC1;TUBB2B;TUBB2A;MAP1B;VEGFA;FGFR1;NRP1;DDIT4;PAFAH1B1;TUBGCP2;USP9X;PHOX2B
prerank,Golgi to plasma membrane transport (GO:0006893),0.7482642537660019,0.9421797986057512,0.583,0.790183867166477,1.0,29/48,19.07%,AMN;SPTBN1;RAB34;MACF1;GOLPH3;RAB10;OPTN;ARFRP1;GGA2;GGA1;VAMP2;PREPL;GOPC;GOLGA4;ARL3;RABEP1;GCC2;GOLGA7;GGA3;OSBPL5;EXOC4;COMMD1;EXOC5;VAMP5;VPS35L;ARFGEF2;EXOC1;ANK3;NSF
prerank,protein deacylation (GO:0035601),0.73021621343255,0.9420989606203317,0.6125,0.7901168189649836,1.0,13/23,14.19%,ABHD17C;HDAC1;ABHD17A;LYPLA2;HDAC5;SIRT2;HDAC6;SIRT7;SIRT6;HDAC7;HDAC3;PPT1;LYPLA1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.730665736235042,0.942070494864573,0.608,0.789867599295097,1.0,21/25,24.37%,VCP;AUP1;BAG6;STUB1;YME1L1;HDAC6;RNF5;CLPP;ZER1;LONP1;UFD1;CUL3;DERL1;UGGT1;TOR1A;ZYG11B;RNF185;NGLY1;UGGT2;POMT2;UBE2W
prerank,cellular response to interleukin-6 (GO:0071354),0.7360058097936386,0.9419229739824106,0.5895,0.7900522841208049,1.0,14/28,15.86%,CEBPA;PHB;YAP1;IL6ST;SOCS3;SMAD4;JAK1;RELA;SRC;PTGIS;SBNO2;PTPN11;STAT1;STAT3
prerank,tRNA transport (GO:0051031),0.739548697265607,0.9418448184506228,0.5845,0.7899738659462382,1.0,29/36,22.63%,YBX1;RAN;TOMM20;SEC13;TPR;SSB;RANBP2;NUP62;NUP85;NUP50;NUP188;NUP160;AAAS;NUP98;POM121;RAE1;NUP214;NUP58;POM121C;NUP93;NUP133;NUP205;NUP54;XPOT;NUP153;NUP107;NUP43;NDC1;NOL6
prerank,positive regulation of hormone secretion (GO:0046887),0.7278612386206046,0.9416503946703546,0.609,0.7903213547607495,1.0,6/20,17.53%,VAMP8;C1QTNF3;SPP1;EDN3;SNX4;SOX11
prerank,regulation of mRNA polyadenylation (GO:1900363),0.7271619165909787,0.9416196129584515,0.6115,0.7900810690370026,1.0,15/18,25.25%,SUPT5H;CPSF6;CPSF7;NELFE;HSF1;NUDT21;RNF40;NCBP2;ZC3H14;VIRMA;CTR9;RNF20;CCNT1;NCBP1;ZC3H3
prerank,lytic vacuole organization (GO:0080171),0.7365855766781867,0.9415141251325176,0.5935,0.7901130547026088,1.0,18/32,19.85%,GRN;LAMTOR1;TPP1;MBTPS1;GAA;HOOK2;GBA;HPS1;TFEB;TMEM106B;HOOK3;ACP2;GNPTAB;HPS4;MTOR;MYO7A;SNAPIN;CLN5
prerank,mRNA transport (GO:0051028),0.7739386737538306,0.9414710238837157,0.6,0.7899195291961143,1.0,53/103,14.89%,HNRNPA2B1;ZFP36L1;SRSF5;SRSF3;ZFP36;SRSF2;SRSF6;SRSF7;SRSF11;RNPS1;RBM8A;CPSF1;SRSF9;SEC13;SRSF1;CHTOP;DDX39A;MAGOH;SRSF4;CASC3;TPR;UPF1;MCM3AP;NXF1;YTHDC1;SYMPK;WDR33;POLDIP3;SMG1;EIF4A3;SRRM1;ALKBH5;RANBP2;DHX38;SMG5;NUP62;THOC7;EIF4E;FMR1;NCBP2;SMG7;RBM15B;NUP85;AGFG1;NUP50;NUP188;THOC2;SLBP;FYTTD1;NUP160;AAAS;NUP98;POM121
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.769840556854755,0.9412754015065751,0.5955,0.7902700216561234,1.0,33/89,14.09%,HSP90AB1;GIPC1;CDKN1C;NUMA1;TGFB1I1;CSNK2B;RBPMS;ZEB2;NOTCH1;LEFTY1;SDCBP;CDH5;SH2B1;STK11;DAB2;SULF1;RBPJ;ENG;CREBBP;SMAD4;BMPR2;ACVRL1;TWSG1;FBXL15;BMP4;CITED2;SMAD2;THBS1;TGFBR1;BMPR1A;CDKN2B;SNW1;ACVR1B
prerank,heart trabecula morphogenesis (GO:0061384),0.7272387139755703,0.9412297591550308,0.602,0.7900943969242711,1.0,7/19,13.60%,FKBP1A;NOTCH1;RBPJ;ENG;TGFBR1;BMPR1A;TGFBR3
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.7270650884356147,0.941179452171488,0.6025,0.7899304145347136,1.0,9/17,18.21%,NOTCH1;RBPJ;TBX2;FGFR2;BMPR1A;TGFBR3;PIM1;MEF2C;GLI1
prerank,regulation of membrane depolarization (GO:0003254),0.7262315602355277,0.940913068521602,0.628,0.7905482689283599,1.0,7/18,21.11%,FHL1;NEDD4L;CAMK2D;GPD1L;RANGRF;PTPN3;SMAD7
prerank,positive regulation of lyase activity (GO:0051349),0.7213222805526105,0.9408635677797738,0.621,0.7903691565451555,1.0,7/15,22.64%,PARK7;ISCU;NF1;STIM1;CACNA1D;ORAI1;CACNA1C
prerank,determination of bilateral symmetry (GO:0009855),0.7272178312066997,0.9407716687767415,0.6105,0.7903469421676395,1.0,9/27,19.99%,NOTCH1;LEFTY1;CITED2;DLL1;PKD2;KIF3B;GALNT11;NPHP3;MKKS
prerank,steroid biosynthetic process (GO:0006694),0.7553013049158148,0.9407491653652498,0.582,0.790071654184936,1.0,22/65,16.57%,HSD11B2;MSMO1;SCP2;FDFT1;INSIG1;DHRS11;HMGCR;EBP;LBR;HSD17B10;CYP27A1;LSS;SQLE;HSD17B4;PMVK;OSBPL2;TM7SF2;ACOT8;DHCR7;OSBPL9;OSBP;SC5D
prerank,histone H4-K16 acetylation (GO:0043984),0.7269463099557055,0.940678517759736,0.612,0.7899662405320119,1.0,15/19,22.89%,OGT;MSL1;MCRS1;KANSL3;ING4;KAT8;HCFC1;KMT2A;MEAF6;KANSL1;WDR5;PHF20;KAT7;KANSL2;MSL3
prerank,mitochondrion organization (GO:0007005),0.7950496710951203,0.9403149365176149,0.6515,0.7909426764834399,1.0,74/175,12.78%,COX7A2;ATP5F1B;SLC25A6;HIGD1A;CHCHD2;TOMM7;CYCS;DNM2;CHCHD10;ATP5F1D;TSPO;PARK7;TIMM13;PHB2;MYH14;HIGD2A;FIS1;HSPD1;BCAP31;SPG7;PHB;RHOT2;TOMM20;SLIRP;ESRRA;TIMM8B;CLUH;PRDX3;STOML2;COX7A2L;OXA1L;SSBP1;PINK1;HK2;COX7A1;BNIP3L;CXADR;MTFR1L;TIMM17B;YME1L1;MFF;RAB5IF;GBA;TRAK1;HSD17B10;SLC25A4;TOMM22;SLC25A36;NDUFS1;LONP1;MFN2;BNIP3;PARP1;DNM1L;FBXO7;BAX;AFG3L2;AIP;POLRMT;DNAJC19;ATAD3B;TIMM44;TOMM40;NIPSNAP2;MTX2;TIMM10;HCFC1;MPV17;TIMM17A;MEF2A;HAX1;DNM1;RAB32;MIGA2
prerank,organophosphate biosynthetic process (GO:0090407),0.7369439846307363,0.9403123071762328,0.602,0.7905949882813923,1.0,16/39,19.71%,TPI1;CPS1;IP6K2;TKT;GNPAT;ITPKA;PPIP5K2;AGPAT3;LPCAT1;IP6K1;PCYT2;ITPKC;PIP5K1A;GK;GK5;ITPKB
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.7211051210806443,0.9402755979670613,0.614,0.7903757267759033,1.0,11/20,22.14%,OBSL1;DBN1;CAPRIN1;CUX1;DBNL;CUL7;PTPRD;SS18L2;CAPRIN2;DHX36;SS18L1
prerank,regulation of nervous system development (GO:0051960),0.7427040488973113,0.9401529400541053,0.5965,0.7904805048799561,1.0,12/41,13.77%,PTN;CTNNB1;HMGB2;HES1;YAP1;BHLHE40;SIRT2;NSUN5;DLL1;YTHDF2;HES6;LGI4
prerank,protein localization to chromatin (GO:0071168),0.7257193396999961,0.9399372187286043,0.6305,0.7909010406167273,1.0,11/17,19.82%,RAD21;RUVBL2;LEMD2;PIH1D1;NIPBL;CHMP7;PPHLN1;MRNIP;PLK1;WAPL;MSH2
prerank,"DNA-templated transcription, termination (GO:0006353)",0.7564373437131726,0.9396105307093321,0.592,0.7917605940297137,1.0,32/67,14.52%,POLR2L;SNRPG;MAZ;SNRPB;SNRPE;CAVIN1;CPSF1;PAPOLA;POLR2H;POLR2E;PABPN1;SNRPF;SNRPD3;POLR2F;SSU72;UBTF;POLR2A;CPSF7;TAF1D;SYMPK;POLR2K;WDR33;NUDT21;TAF1C;PRMT5;PCF11;NCBP2;SETX;GTF2H5;SLBP;CSTF3;ERCC3
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.7214661008737516,0.9395039070269092,0.624,0.7917893578291153,1.0,10/15,22.88%,CHKA;ETNK1;CHKB;LPIN3;LPIN2;PCYT2;PISD;LPIN1;SLC27A1;SELENOI
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.7935187061268976,0.9393623114953591,0.6505,0.7919712201599038,1.0,88/184,11.60%,SERPINA1;DYNLL1;KDELR2;SPTBN1;SPTAN1;CTSC;TMED10;RAB1A;CAPZB;VAPA;BCAP31;ERGIC3;ARF4;CD59;DYNC1H1;COPE;TMED9;PDCD6;LMAN2;DCTN2;SEC31A;COPZ1;KDELR1;CAPZA1;GAS6;TMED2;TFG;AREG;RAB2A;RAB1B;SAR1A;DYNC1LI2;ARFGAP1;SEC13;COPA;TRAPPC2L;TMED4;DCTN3;ARFGAP2;DYNLL2;NRBP1;YIF1A;NAPA;DYNC1I2;CNIH4;DCTN1;ANK2;COPB1;GBF1;TMED3;ACTR1A;GOLGB1;SEC24C;COG4;ACTR10;CAPZA2;SEC16A;ERGIC1;TRAPPC1;COPB2;LMAN1;CNIH1;SEC22B;SEC23A;ARCN1;GOLGA2;MIA2;COL7A1;TMED7;IER3IP1;PEF1;TRAPPC12;CTSZ;GOLT1A;TRAPPC4;COPG1;F10;NRBP2;TRAPPC3;USO1;DCTN5;CD55;GOPC;TMEM115;MCFD2;STX5;SAR1B;CUL3
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.7419123394610898,0.9392660099665775,0.5975,0.7919656277219593,1.0,22/41,19.00%,HNRNPD;ENTPD6;DNASE1;RNASEH2C;SND1;ENTPD8;PABPC4;RNASET2;ISG20;ENTPD5;NUDT16;NUDT5;XRN2;NUDT1;ENTPD4;MTREX;SIDT2;SKIV2L;NUDT9;RNASEH2B;EXOSC7;PPP1R8
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.725207439595855,0.9392251097898767,0.6155,0.7917663459447853,1.0,11/22,13.06%,VPS28;VPS25;VPS4B;SNF8;RNF126;VPS4A;TSG101;VPS37B;MVB12A;VPS36;PTPN23
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.788418104546667,0.9390371176810971,0.6425,0.7920937391361526,1.0,47/161,12.94%,TXN;CCL21;HSP90AB1;HSP90AA1;FGFR3;ITGB1;RAC1;RTN4;PARK7;ERBB2;ERBB3;MAZ;PDGFRB;PDGFRA;MYDGF;CPNE1;PHB;FGFR1;GAS6;AREG;P2RX4;C1QBP;FERMT2;SEMA5A;TCF7L2;PINK1;AKT2;GRB2;ENG;PTK2;FGFR4;IGF1R;SRC;INSR;ITGB1BP1;GAB1;F10;MTDH;THBS1;TGFBR1;SPRY2;FGFR2;AXL;FYN;RHOG;HAX1;PIK3R1
prerank,ear morphogenesis (GO:0042471),0.7276606681809548,0.9390203615703141,0.609,0.7918038513325947,1.0,6/23,15.16%,OSR1;USH1C;MYO6;FGFR2;EPHB2;NIPBL
prerank,positive regulation of RNA metabolic process (GO:0051254),0.7429628640763517,0.938941074481218,0.592,0.7917425023198035,1.0,20/45,16.58%,DDX5;TRMT112;MAP2K2;HSPA1A;SLC38A2;POLR2A;GRSF1;SIRT7;RELA;BMP4;DYRK1A;HRAS;BUD23;SETX;PIK3R1;TP53;RBM22;HNRNPLL;EGFR;U2AF2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.7342517454331269,0.9387744215088423,0.6105,0.7919906544846188,1.0,16/26,21.01%,DUSP1;ANAPC11;ANAPC5;CDC16;UBE2C;LCMT1;ANAPC7;ANAPC15;CUL3;CCNB1;CDK5RAP2;CDC27;PLK1;CDC23;RB1;ANAPC4
prerank,positive regulation of cellular protein localization (GO:1903829),0.7558514397540367,0.9387441674552193,0.5915,0.7917438258531007,1.0,34/70,16.21%,HSP90AB1;RTN4;PARK7;VPS28;NUMA1;LAMTOR5;CDK5RAP3;TFRC;AKT1;FERMT2;YAP1;WWTR1;STX3;TRAPPC12;STX4;TM9SF4;NUP62;CDK1;TESK1;DDRGK1;NGFR;GNL3;FYN;CCDC88A;GSK3B;LIMK2;PRKAA1;ENTR1;GPD1L;CARD10;SYT11;ORMDL3;TYROBP;CROCC
prerank,cellular response to insulin stimulus (GO:0032869),0.7822633284851324,0.9384784202306703,0.6315,0.7923774377068484,1.0,42/127,10.94%,CEACAM1;ZFP36L1;PKM;RARRES2;ATP6V0B;PCK1;INSIG1;ATP6V1G1;ATP6V0D1;ATP6V0E1;ATP6V1F;ATP6AP1;BCAR1;XBP1;SELENOS;SHC1;AKT1;SLC39A14;SORBS1;TCIRG1;ATP6V1E1;PCK2;AKT2;ATP6V0A1;HDAC5;GRB2;RAB10;RAB13;NAMPT;AP3S1;PDK2;ZDHHC7;IGF1R;PRKDC;SYAP1;PARP1;ATP6V1B2;RAB8A;INSR;GAB1;VAMP2;LPIN3
prerank,negative regulation of axon extension (GO:0030517),0.7285133525455613,0.9384451006793033,0.5935,0.7921487170832332,1.0,17/31,22.20%,RTN4;SEMA3B;SEMA4G;SEMA5A;SEMA3C;SEMA6A;SEMA4B;SEMA3A;SEMA5B;SEMA6C;SEMA4C;SEMA3F;DIP2B;SEMA3D;SEMA6D;SEMA4D;MAP2
prerank,calcium ion transmembrane transport (GO:0070588),0.7626698265024434,0.9383881930324142,0.596,0.7919999870335035,1.0,32/87,13.75%,ATP2A3;PHB2;FKBP1A;TRPM4;SPG7;ATP2B4;PHB;SMDT1;PKD1;GAS6;ATP2A2;TMCO1;STOML2;P2RX4;YME1L1;TRPC4AP;ATP2C2;LETM1;ITGAV;PMPCA;AFG3L2;PMPCB;ANO6;TMEM165;ATP2B1;ATP2C1;TRPM6;MCUR1;SLC25A23;MICU2;PKD2;CACNB3
prerank,branched-chain amino acid metabolic process (GO:0009081),0.727851021376519,0.9382752938593304,0.6225,0.791720070105534,1.0,19/20,26.87%,ECHS1;HSD17B10;DLD;BCAT2;ACAT1;BCKDK;IVD;HIBCH;BCAT1;MCCC2;HIBADH;MCCC1;BCKDHB;ACAD8;AUH;ALDH6A1;SLC25A44;DBT;ACADSB
prerank,branched-chain amino acid catabolic process (GO:0009083),0.727851021376519,0.9382752938593304,0.6225,0.791720070105534,1.0,19/20,26.87%,ECHS1;HSD17B10;DLD;BCAT2;ACAT1;BCKDK;IVD;HIBCH;BCAT1;MCCC2;HIBADH;MCCC1;BCKDHB;ACAD8;AUH;ALDH6A1;SLC25A44;DBT;ACADSB
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.7303424555095839,0.9382639831281134,0.6125,0.7914101441976565,1.0,20/23,24.31%,RBBP7;RBBP4;DNMT3A;DNMT1;TRIM27;CREBZF;PHF1;EPC1;EZH2;PPHLN1;AEBP2;SUZ12;MPHOSPH8;PHF19;MTF2;BMI1;MORC2;SMYD5;EED;JARID2
prerank,lysosome organization (GO:0007040),0.7372179474370266,0.9382138648502502,0.598,0.7912459899896406,1.0,21/36,19.85%,GRN;LAMTOR1;TPP1;CORO1A;MBTPS1;GAA;HOOK2;GBA;HPS1;TMEM165;TFEB;TMEM106B;HOOK3;ATP10B;ACP2;GNPTAB;HPS4;MTOR;MYO7A;SNAPIN;CLN5
prerank,sulfation (GO:0051923),0.7259981361649437,0.9382128202050193,0.6235,0.7908983030228989,1.0,4/17,7.54%,SULT1B1;SULT1A1;SULT1E1;SULT2A1
prerank,positive regulation of synaptic transmission (GO:0050806),0.7587698482451614,0.9381137260239897,0.5945,0.7909032274439749,1.0,18/73,12.35%,SQSTM1;CLSTN1;APP;NPTN;LGMN;CCL2;FLOT1;PRKCZ;NFATC4;ZDHHC3;STX4;ZDHHC12;VAMP2;PTK2B;FMR1;EPHB2;SHANK3;NLGN2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.7371902837925566,0.9379687538793722,0.604,0.7910787769334549,1.0,9/37,9.49%,NPM1;NASP;CENPX;RBBP7;RBBP4;SMARCA5;CABIN1;CENPT;ATRX
prerank,neuromuscular junction development (GO:0007528),0.7269009599389313,0.9378899512518882,0.62,0.7910245448123794,1.0,12/24,18.98%,AGRN;DCTN1;F2R;DVL1;PDZRN3;PPFIBP1;UNC13B;CACNB3;PPFIBP2;LRP4;DNAJA3;ANK3
prerank,regulation of Notch signaling pathway (GO:0008593),0.762448006935202,0.9377666507872723,0.5935,0.7911217487536429,1.0,42/78,18.51%,ELF3;LLGL2;DLK1;EGFL7;NOTCH3;CD46;SREBF2;JAG1;NOTCH1;AKT1;ZMIZ1;YAP1;IL6ST;ARRDC1;RBPJ;CREBBP;TCIM;RFNG;POFUT1;SRC;METTL3;ITGB1BP1;MMP14;DLL1;YTHDF2;TSPAN14;NEURL1;SNW1;LFNG;TM2D3;BMP2K;WWP2;PDCD10;EPN2;STAT3;EGFR;MAML1;SYNJ2BP;ZBTB7A;GALNT11;EP300;AAK1
prerank,response to estradiol (GO:0032355),0.7328298826702379,0.9377315152469622,0.602,0.7908907091147808,1.0,16/36,20.35%,CTNNB1;ANXA1;SFRP1;RUVBL2;ZNF703;KAT5;STAT5B;GGT1;NRIP1;LCOR;STAT3;EGFR;FAM210B;GGT5;STRN3;NCOA3
prerank,vesicle organization (GO:0016050),0.7451548477242049,0.9376351587029433,0.5945,0.7908996180054315,1.0,29/46,18.86%,SQSTM1;PLEKHJ1;CAV1;LAMTOR1;SAR1A;CORO1A;CD34;WASL;LAPTM4B;ALS2CL;HOOK2;SORT1;FNBP1L;SAR1B;CHMP2B;DNM1;SRGN;HOOK3;ZFYVE16;EPS15;RAB22A;DNAJC13;WASHC4;CAV2;ARFGEF2;PHETA1;USP8;VPS11;RNF26
prerank,ameboidal-type cell migration (GO:0001667),0.7422129911565242,0.9375835258730497,0.598,0.7907422583036618,1.0,29/51,21.08%,PDLIM1;GPC3;SEMA3B;ANXA6;AKT1;PDXDC1;SEMA4G;SEMA5A;SEMA3C;SEMA6A;AMOTL1;SEMA4B;PKN1;PKN2;SEMA3A;CENPV;SGPL1;CORO1C;SEMA5B;SEMA6C;SEMA4C;SEMA3F;AMOTL2;PHACTR4;MEGF8;SRGAP2;GDNF;SEMA3D;SEMA6D
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.7339265092547484,0.9375236857046649,0.6095,0.7905974467932105,1.0,12/28,17.39%,TRPM4;GCG;HLA-DRB1;PIM3;CDK16;PPP3CB;STX4;ANO1;LRP5;CFTR;NR1H4;ADCY5
prerank,negative regulation of biomineral tissue development (GO:0070168),0.7282475443560315,0.9371889700193909,0.615,0.791483109048584,1.0,12/22,20.32%,TRPM4;GAS6;NOTCH1;ROCK2;ASPN;GREM1;PTK2B;SRGN;ROCK1;BCOR;ECM1;AHSG
prerank,regulation of Ras protein signal transduction (GO:0046578),0.7605537481021756,0.9371008732085234,0.5875,0.7914671658033253,1.0,42/86,15.15%,EPS8L2;SQSTM1;OGT;ARHGDIA;KANK2;EPS8L3;ARFGAP1;SHC1;NOTCH1;ARF6;EPS8;NOTCH2;GABARAP;MYO9B;GRB2;ERBIN;RAF1;LRRC59;ARHGEF2;LZTR1;AKAP13;ARHGDIB;ARHGAP17;DAB2IP;MADD;SGSM3;MFN2;DLC1;RAPGEF1;EPS8L1;NUP62;SPRY2;EPHB2;FBP1;CRKL;PLCE1;DENND4B;MAPKAP1;RDX;PDCD10;BCR;SH3BP1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.7914304383681484,0.9370125545672995,0.664,0.7914366316575403,1.0,37/168,9.96%,PLA2G2A;CD74;CCL21;HMGB1;APOE;FGFR3;MIF;CIB1;APP;PHB2;DDT;PDGFRB;PDGFRA;MAPK3;PHB;HLA-DRB1;GAS6;ATP6AP1;NRP1;SHC1;CCL2;NOTCH1;PRKCZ;GLIPR2;LGALS9;RAP1A;FERMT2;HAND2;NOTCH2;NPNT;F2R;FGFR4;F2RL1;PDE8A;PYCARD;CCL15;PRKD2
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.7250612183506012,0.9367400196843548,0.62,0.7920586357973344,1.0,10/15,23.14%,XRCC5;TPP1;TERF2IP;ATRX;TNKS;ACD;TNKS2;NABP2;TINF2;TERF2
prerank,endocardial cushion morphogenesis (GO:0003203),0.7267613564653745,0.9365708897554191,0.6275,0.7922984840375744,1.0,8/19,11.94%,NOTCH1;TGFBR2;ENG;ACVRL1;TBX2;MDM4;BMP4;BMPR1A
prerank,regulation of mitotic nuclear division (GO:0007088),0.7499703986667403,0.9364653592165645,0.591,0.7923306061891029,1.0,24/57,15.34%,DUSP1;AURKAIP1;PDGFRB;OBSL1;PIN1;MKI67;LCMT1;BMP4;INSR;CUL7;NUSAP1;NUP62;PRMT5;DAPK3;ANAPC15;CCDC8;EDN3;PHIP;TOM1L2;CCNB1;LRP5;CDK5RAP2;CDK13;CUL9
prerank,protein-containing complex subunit organization (GO:0043933),0.770831575215449,0.9363489166944551,0.612,0.7924002524119509,1.0,33/110,11.27%,ELOB;CD74;JCHAIN;CHCHD10;SLC9A3R1;PPP2R1A;TAPBP;VIL1;ST13;LAMC1;SPG7;HES1;CAPZA1;GPAA1;TSPAN4;SLC2A1;WASL;PICALM;YAP1;CAPG;TPR;TUBGCP2;CREBBP;CAPZA2;MDM4;VAMP3;OCLN;DNM1L;AFG3L2;TEAD2;CD2AP;VAMP2;PTK2B
prerank,negative regulation of cellular protein localization (GO:1903828),0.7286087795545834,0.9362956175896204,0.6095,0.7922402058244001,1.0,15/34,17.09%,CTNNA1;TAX1BP3;DNAJA1;NEDD4L;PICALM;ROCK2;LEPROT;NSFL1C;GOPC;ANKRD13A;GSK3B;LEPROTL1;COMMD1;SIN3A;CDT1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.723241848422345,0.9362462643936267,0.6205,0.7920739002697026,1.0,11/18,20.43%,MCM7;PCNA;MCM3;POLD2;POLE;MCM4;LIG1;RFC4;POLE3;GINS2;LIG3
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.7234728396003874,0.9362192725445803,0.6385,0.7918221470868037,1.0,10/17,18.22%,NOTCH3;PBX1;PLXND1;NOTCH1;RBPJ;CREBBP;SNW1;STAT1;MAML1;EP300
prerank,autophagosome assembly (GO:0000045),0.7454296390766229,0.9362047278187058,0.5965,0.7915240891344919,1.0,38/56,21.53%,VMP1;RAB1A;GABARAPL2;RAB7A;MAP1LC3B;ATP2A2;RAB1B;PACS2;GABARAP;MAP1LC3A;EMC6;MFN2;TP53INP2;NSFL1C;WIPI2;ULK1;UBQLN1;BECN1;TMEM41B;WDR45;STX12;ATG16L2;ATG12;WDR45B;ATG3;ATG2A;TP53INP1;ATG101;GABARAPL1;UBQLN2;ATG13;RB1CC1;ATG2B;RAB23;ULK2;WIPI1;TRAPPC8;ATG5
prerank,endocytic recycling (GO:0032456),0.7503702560117165,0.9360671786544359,0.5925,0.7916840850791893,1.0,42/52,22.15%,SNX3;EHD2;RAB7A;VPS51;VPS29;WASHC1;RAB17;ARF6;MICALL2;SNX17;RAB11B;RAB14;VPS35;RAB13;SNF8;EHD1;VPS39;ANKRD50;VPS26A;RAB11FIP3;CMTM6;ACAP2;KIAA1109;PTPN23;EPS15;ENTR1;SNX12;VPS35L;SNX4;SNX27;VPS52;VPS26C;WASHC2C;DENND1A;EHD4;RAB35;CCDC93;VPS53;EIPR1;LMTK2;RAB11FIP4;STX6
prerank,metanephros development (GO:0001656),0.7271791704647735,0.93603164416025,0.6195,0.7914691883444548,1.0,9/26,15.16%,PKD1;OSR1;CTSH;BASP1;PTCH1;BMP4;PKD2;NF1;NIPBL
prerank,microtubule nucleation (GO:0007020),0.7276648349231496,0.9359480213910287,0.624,0.7914249277639152,1.0,14/20,19.38%,CSNK1D;AKAP9;TUBGCP2;CLASP2;GOLGA2;TUBGCP6;TPX2;CLASP1;NDEL1;CCDC57;TUBG1;RANBP9;SLAIN2;CENPJ
prerank,regulation of cellular response to heat (GO:1900034),0.7583841774735379,0.9357190936768496,0.6035,0.7919050282272168,1.0,51/78,18.58%,HSP90AB1;HSPA8;HSP90AA1;HSBP1;YWHAE;PTGES3;HSPA1A;MAPK3;SEC13;DNAJB1;CD34;DNAJB6;BAG1;TPR;MAPK1;CREBBP;MAPKAPK2;HSPA1B;HSF1;CAMK2D;CRYAB;RPA1;RANBP2;NUP62;CAMK2G;MLST8;RPA3;HIKESHI;FKBP4;AKT1S1;NUP85;CCAR2;NUP50;GSK3B;NUP188;DNAJC7;NUP160;AAAS;NUP98;POM121;RAE1;HSPH1;IER5;NUP214;RPA2;NUP58;MTOR;POM121C;NUP93;EP300;ATM
prerank,cilium assembly (GO:0060271),0.8099972953209081,0.9357138757622812,0.732,0.7915785471700452,1.0,30/300,6.12%,FLNA;TUBA1A;TUBB;GSN;DYNLL1;TUBB4B;HSP90AA1;PPP2R1A;YWHAE;RAB1A;RAB11A;DYNLRB1;ARF4;DYNC1H1;ATP6V0D1;ACTR2;DCTN2;EHD2;PKD1;CSNK1D;PAFAH1B1;EXOC7;CSNK1E;SSNA1;NOTCH1;RAB17;DCTN3;YWHAG;ACTR3;DYNLL2
prerank,regulation of glucose import (GO:0046324),0.7380286311721758,0.9356692585867444,0.6045,0.7913836485192921,1.0,24/37,23.20%,ITLN1;SELENOS;AKT1;ARPP19;SORBS1;PEA15;AKT2;APPL2;OCLN;INSR;RHOQ;PIK3R1;C1QTNF12;GSK3A;CAPN10;PTPN11;OSBPL8;APPL1;IRS1;PRKCI;PID1;IRS2;GRB10;PRKAG2
prerank,ncRNA export from nucleus (GO:0097064),0.7360541863925846,0.9355016941054735,0.6055,0.7916459435348341,1.0,30/37,22.63%,NPM1;RAN;SEC13;TPR;SSB;RANBP2;NUP62;NCBP2;NUP85;NUP50;NUP188;NUP160;AAAS;NUP98;POM121;RAE1;NUP214;NUP58;TSC1;POM121C;NUP93;NUP133;NUP205;NUP54;XPOT;NUP153;NUP107;NUP43;NDC1;NOL6
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.7260645613046798,0.9352334083128667,0.6203101550775387,0.7923118738356528,1.0,10/23,18.24%,APP;SLC4A4;PSEN1;MLXIPL;HIF1A;ENTPD5;INSR;PRKAA1;PFKFB2;ARNT
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.7430385495653614,0.9350885333217015,0.5985,0.7924648111085839,1.0,18/48,16.67%,PLA2G2A;AGPAT2;GNPAT;AGPAT1;GPAT4;LPCAT4;PLA2G10;LIPH;DGKD;DGKZ;GPD1;DGKA;AGPAT3;DGKQ;GPD1L;LPCAT1;PLD2;PLD1
prerank,positive regulation of exocytosis (GO:0045921),0.7355457232683524,0.9347522041822498,0.619,0.7933095981789965,1.0,24/37,20.65%,SDC1;PDCD6IP;RAB7A;CHMP2A;ATP6AP1;SDC4;SDCBP;HGS;VPS4B;CLASP2;SNF8;SMPD3;VPS4A;RAB5A;TSG101;RAB3D;CLASP1;CFTR;RAB27A;STXBP5;ATP13A2;RAB2B;RAB9A;RAB15
prerank,regulation of brown fat cell differentiation (GO:0090335),0.7249277184899825,0.9347477943055988,0.644,0.7929785328456274,1.0,9/18,19.77%,HNRNPU;METRNL;ZBTB7B;RREB1;PIM1;TFE3;FNDC5;FTO;NAPEPLD
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.7244171409352452,0.934733027660359,0.625,0.7926841695092512,1.0,6/20,17.17%,S100A14;LGALS9;IRAK1;OAS1;CD14;NR1H4
prerank,establishment of protein localization to organelle (GO:0072594),0.7558707738889419,0.9341802632320978,0.614,0.7943345851066637,1.0,51/76,21.35%,PTTG1IP;RAN;PHB2;RAB11A;LAMP1;KPNB1;SEC13;TSC2;AKT1;IPO5;PINK1;HK2;CD68;TPR;IPO7;APPL2;RPAIN;TNPO1;IPO9;LAMP2;CSE1L;NUP62;HK1;NEURL1B;NUTF2;HIKESHI;NUP85;RALA;NUP50;PPP1R10;NUP188;TNPO2;POM121;TSPAN17;STAT3;NUP214;FAM53B;PEX19;IPO8;APPL1;POM121C;NUP93;FAM53C;PRICKLE1;NUP133;IPO13;NUP153;EIF4ENIF1;NXT1;NUP107;SYK
prerank,RNA 3'-end processing (GO:0031123),0.7545254550644337,0.9341715523314752,0.6125,0.7940186273852723,1.0,38/69,16.94%,SRSF5;SRSF3;SRSF2;SRSF6;SRSF7;SRSF11;RNPS1;RBM8A;CPSF1;PAPOLA;PABPN1;SRSF9;SRSF1;CHTOP;DDX39A;MAGOH;SRSF4;CPSF7;CASC3;SYMPK;WDR33;POLDIP3;EIF4A3;NUDT21;SRRM1;DHX38;THOC7;PCF11;NCBP2;TENT4A;THOC2;CSTF3;TUT4;RPRD1B;TENT2;RPRD1A;U2AF2;SLU7
prerank,negative regulation of cell differentiation (GO:0045596),0.791344922495468,0.9341174307535542,0.673,0.7938685537137244,1.0,60/190,11.88%,COL5A1;COL5A2;CALR;EFNA1;ZFP36L2;PDCD4;HNRNPU;ID2;PTBP1;HPN;TRPM4;CAV1;MEIS1;ANP32B;HES1;SFRP2;SFRP1;JAG1;NOTCH1;TRIO;PPP2CA;PTEN;OSR1;FERMT2;YAP1;PTCH1;NELFB;NFKBIA;NBR1;CCDC85B;ASXL1;SNAI2;SIRT2;ADAMTS7;XDH;WWTR1;HDAC7;NR1H3;DAB2IP;GREM1;CDK6;ITGAV;TRIB2;TBX3;BMP4;LRP3;ADIPOR1;SMAD3;DLL1;CRIM1;ABCA5;PTK2B;TGFBR1;ZADH2;SRA1;SPRY2;WDR61;YTHDF2;TWIST2;MEIS2
prerank,mitochondrial translational elongation (GO:0070125),0.7581267882232645,0.9339484780880165,0.6265,0.7941331045642298,1.0,64/89,16.98%,TUFM;MRPS21;MRPL41;AURKAIP1;GADD45GIP1;MRPL51;MRPL52;MRPS26;MRPL57;MRPS34;MRPL20;MRPL12;MRPL27;MRPL23;MRPL14;MRPL33;OXA1L;MRPL43;MRPS6;CHCHD1;MRPL55;MRPL34;MRPL28;MRPS7;MRPL54;MRPL22;MRPS18A;MRPS36;MRPS16;MRPL21;MRPL11;PTCD3;MRPL24;MRPL18;MRPS5;MRPL13;MRPL37;MRPS25;MRPL4;MRPS12;MRPL17;MRPS18C;MRPL16;MRPL36;MRPS15;MRPS11;MRPL40;MRPS2;MRPS33;MRPS18B;MRPS35;MRPL15;DAP3;MRPL42;MRPL3;MRPS23;MRPL2;MRPL32;MRPL35;MRPS27;ERAL1;MRPL47;MRPL10;MRPL9
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.7662785316459818,0.9338469038831856,0.616,0.7941347856622367,1.0,50/98,14.89%,HNRNPA2B1;SRSF5;SRSF3;SRSF2;SRSF6;SRSF7;SRSF11;RNPS1;RBM8A;CPSF1;SRSF9;SEC13;SRSF1;CHTOP;DDX39A;MAGOH;SRSF4;CASC3;TPR;UPF1;MCM3AP;NXF1;YTHDC1;SYMPK;WDR33;POLDIP3;SMG1;EIF4A3;SRRM1;ALKBH5;RANBP2;DHX38;SMG5;NUP62;THOC7;EIF4E;NCBP2;SMG7;RBM15B;NUP85;AGFG1;NUP50;NUP188;THOC2;SLBP;FYTTD1;NUP160;AAAS;NUP98;POM121
prerank,steroid metabolic process (GO:0008202),0.7693614173234001,0.9335608729528726,0.6225,0.7948216503310385,1.0,21/104,10.53%,TSPO;MSMO1;SCP2;FDFT1;DHCR24;CYP3A5;DHRS9;LGMN;DHRS11;ACAA1;GBA2;UGT2B17;LIPA;SULT1A1;VDR;SULT1E1;SULT2A1;HSD17B10;CYP27A1;LSS;HSD17B4
prerank,regulation of bone mineralization (GO:0030500),0.7497995056767925,0.9335462844535894,0.602,0.7945293502090798,1.0,19/56,14.51%,PKDCC;PTN;FBN2;TRPM4;ATRAID;OSR1;NBR1;BMPR2;DDR2;GREM1;BMP4;ISG15;ANO6;PTK2B;BMPR1A;ATP2B1;SRGN;TMEM119;BMP2K
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.803871756118819,0.9335405982953814,0.714,0.7942016776409787,1.0,32/265,6.12%,FLNA;MYLK;GSN;EZR;DYNLL1;CCL21;EMP1;ITGB1;RAC1;SLC9A3R1;VCL;RAP1B;RAB1A;FSCN1;RAB11A;ARF4;PMP22;ATP6V0D1;ACTR2;EHD2;PKD1;EMP3;NRP1;EXOC7;NOTCH1;RAB17;ARF6;SDCBP;RAP1A;CYFIP1;ACTR3;DYNLL2
prerank,canonical Wnt signaling pathway (GO:0060070),0.7529056386998756,0.9334604526363758,0.6035,0.7941487052654479,1.0,28/68,16.76%,CTNNB1;PPP1CA;CAV1;CSNK1A1;SFRP2;SFRP1;CSNK1E;FZD1;PTEN;TCF7L2;DVL3;PLPP3;RAB5A;FRZB;FZD5;DVL1;FZD7;DVL2;GSK3B;AXIN1;SCYL2;TCF7L1;LRP6;LRP5;FZD2;FZD8;RYK;RARG
prerank,hippo signaling (GO:0035329),0.7243486210497665,0.9334127069722484,0.623,0.7939667126504935,1.0,15/26,18.72%,YWHAE;YWHAB;DCHS1;MOB1A;YAP1;TEAD3;WWTR1;AMOTL1;TEAD2;DVL2;TJP1;FAT4;AMOTL2;CASP3;LATS1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.7211855201328774,0.933238769880293,0.6288144072036018,0.794242199324309,1.0,11/15,23.65%,CPSF1;RTRAF;DDX1;RTCB;TSEN34;TRPT1;ZBTB8OS;TSEN54;FAM98B;CPSF4;TSEN15
prerank,synaptic vesicle endocytosis (GO:0048488),0.735352137238979,0.9331293579175403,0.6175,0.7942883396231484,1.0,12/38,14.91%,DNM2;CANX;GAK;CEL;PICALM;VAMP2;NLGN2;SNCG;KIAA1109;DNM1;PIP5K1C;ITSN1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.7238819932502296,0.9331122305359121,0.629,0.7940018360200602,1.0,14/20,20.17%,EIF6;CNOT1;MOV10;CELF1;TNRC6A;CNOT8;CNOT7;CNOT6;AGO2;TNRC6B;HELZ;AGO3;AGO1;WTIP
prerank,mitotic chromosome condensation (GO:0007076),0.7263684703761101,0.9329995750472253,0.622,0.7940489129497246,1.0,23/26,26.25%,SET;CSNK2B;AKAP8L;CHMP1A;SMC4;NUSAP1;CDK1;NCAPH2;CSNK2A1;TENT4A;CCNB1;NCAPD2;CSNK2A2;KMT5A;PLK1;RB1;PHF13;NCAPG;SMC2;CDCA5;NCAPD3;PHF8;NCAPG2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.7395814808130506,0.9329486107397278,0.607,0.7938913308545501,1.0,13/47,11.94%,CSNK2B;RBPMS;LEFTY1;SDCBP;DAB2;ENG;SMAD4;BMPR2;ACVRL1;TWSG1;BMP4;TGFBR1;BMPR1A
prerank,positive regulation of phospholipase C activity (GO:0010863),0.7395748745817949,0.9329480415636976,0.6135,0.7935472182513329,1.0,9/43,11.40%,PHB2;PDGFRB;PDGFRA;PHB;FGFR1;GNAQ;EDNRA;PLCG1;HRAS
prerank,mitotic cell cycle phase transition (GO:0044772),0.794893179937855,0.9327705588647508,0.6945,0.7938334889561856,1.0,59/207,9.88%,TUBA1A;TUBB;DYNLL1;TUBB4B;HSP90AA1;SKP1;CCND2;DNM2;PPP1CB;PPP2R1A;CDKN1A;YWHAE;CCNI;NASP;DYNC1H1;KHDRBS1;DCTN2;UBE2S;PPP1R12B;CCND1;CHMP2A;ENSA;CSNK1D;PAFAH1B1;CSNK1E;SSNA1;CDC34;CCNG2;CDK4;DCTN3;EPS8;YWHAG;ARPP19;CDC16;UBE2C;USH1C;DYNC1I2;EIF4EBP1;DCTN1;AKAP9;OPTN;ACTR1A;PCM1;SFI1;PHLDA1;GSPT1;CLASP2;CCNG1;POLE;PRKACA;CCND3;CDK6;CUL4A;CDC25B;MAPRE1;PPP1R12A;FBXL15;NES;LCMT1
prerank,positive regulation of TOR signaling (GO:0032008),0.7340217020775469,0.9327590799373386,0.613,0.7935280034319967,1.0,16/40,13.70%,LAMTOR4;LAMTOR5;LAMTOR1;GAS6;RHEB;SEC13;GOLPH3;LAMTOR2;RRAGA;PIH1D1;PIP4P1;MLST8;TELO2;HDAC3;LAMTOR3;WDR59
prerank,axonal transport (GO:0098930),0.7332397960371145,0.9325596123456515,0.6155,0.7938990878803203,1.0,21/36,20.90%,BLOC1S1;SOD1;DST;DYNC1H1;PAFAH1B1;AP3D1;DCTN1;HIF1A;AP3S1;KIF1B;NEFL;RAB21;AP3M1;BLOC1S6;KIF3B;OPA1;SNAPIN;AP3B1;BLOC1S4;FBXW11;KIF1A
prerank,sphingolipid metabolic process (GO:0006665),0.7693517468382929,0.9324936347469852,0.6295,0.7937919242169715,1.0,50/114,15.40%,CTSA;PSAP;PPP2R1A;ASAH1;TECR;VAPA;NEU1;ELOVL1;SERINC1;GBA2;PLPP1;HEXB;HEXA;PPP2CA;SMPD4;CERS2;PDXDC1;SPTSSA;ENPP7;CERK;ESYT2;FUT3;PLPP3;CSNK1G2;PLPP2;GBA;SMPD3;SMPD1;GLTP;SUMF2;GLB1;PRKD2;DEGS1;ALDH3A2;GLA;SPTLC1;ORMDL1;CERS6;HACD3;ESYT1;UGCG;ARSA;SGPL1;CPTP;PPT1;CERS4;HACD2;SPTLC2;VAPB;ORMDL3
prerank,pyroptosis (GO:0070269),0.7221142660222359,0.932468838090608,0.6335,0.7935333665490354,1.0,6/19,18.88%,GSDMD;DHX9;NLRP1;GSDMB;NAIP;APIP
prerank,maturation of 5.8S rRNA (GO:0000460),0.7239253806785088,0.9322534155558336,0.6305,0.793958493714244,1.0,13/17,21.99%,EIF6;NSA2;PRKDC;EXOSC10;MTREX;C1D;LAS1L;PES1;FTSJ3;NOL9;EXOSC4;MPHOSPH6;RPF1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.7604388262927487,0.9322022755979219,0.6145,0.793791075449694,1.0,57/89,19.71%,SKP1;PSMB1;RBX1;PSME1;PSMB4;FBXW5;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5;PSMC3;PSMD2;PSMA2;PSMB2;PSMD13;PSMD4;PSMD3;PSMC1;PSMC6;PSMC4;PSMF1;PSMA3;PSMA5;CUL4A;FBXL15;FBXO9;PSMB8;PSMD7;PSMC2;FBXW4;FBXO17;FBXL5;PSMD6;CUL1;FBXL3;PSMD1;PSMD9;FBXL12;DMAC2;FBXL7;FBXO2;FBXO31;PSME4;PSME3;PSMD14;PSMD11;FBXL6;CUL4B;PSMD12;PSMD10;SKP2
prerank,negative regulation of phosphatase activity (GO:0010923),0.7254157649393834,0.9321602490835738,0.629,0.793598189730659,1.0,16/28,21.82%,CHP1;FKBP1A;PPP1R1B;PTPA;PPP1R15A;PPP1R35;BOD1;PPP1R11;URI1;TIPRL;GSK3B;SH3RF2;BOD1L1;STYXL1;CRY2;SEMA4D
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.7411869646490126,0.9320739595487897,0.625,0.7935662420671592,1.0,22/45,19.62%,FUS;ACTR2;PPP4C;FBH1;KDM1A;SIRT6;TERF2IP;PARP1;TP53BP1;MAGEF1;SMCHD1;PPP4R2;MAD2L2;SETD2;MMS19;RIF1;WDR48;RPA2;UBQLN4;MRNIP;SPIDR;SHLD2
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.7196475219957897,0.9319628513455591,0.637,0.7936284437736552,1.0,10/20,19.02%,SOX4;MAPK3;RUVBL2;GLYR1;BRD7;PRKAA1;DIP2A;RPS6KA4;DIP2B;ARRB1
prerank,regulation of cytokinesis (GO:0032465),0.7591394366919739,0.9319521700272008,0.6285,0.7933201212464143,1.0,25/83,14.54%,CALM2;CALM1;RHOA;GIPC1;CDC42;CALM3;RAB11A;PIN1;SVIL;SH3GLB1;VPS4A;CDC25B;BECN1;GIT1;CUL3;PKN2;RAB11FIP3;PRPF40A;CENPV;SETD2;BIRC6;AURKB;MYO19;PLK2;ENTR1
prerank,mitochondrial translational termination (GO:0070126),0.757474995721344,0.9317949562366034,0.638,0.7935492209072303,1.0,64/89,16.98%,MRPS21;MRPL41;AURKAIP1;GADD45GIP1;MRPL51;MRPL52;MRPS26;MRPL57;MRPS34;MRPL20;MRPL12;MRPL27;MRPL23;MRPL14;MRPL33;OXA1L;MRPL43;MRPS6;CHCHD1;MRPL55;MRPL34;MRPL28;MRPS7;MRPL54;MRPL22;MRPS18A;MRPS36;MRPS16;MRPL21;MRPL11;PTCD3;MRPL24;MRPL18;MRPS5;MRPL13;MRPL37;MRPS25;MRPL4;MRPS12;MRPL17;MRPS18C;MRPL16;MRPL36;MRPS15;MRPS11;MRPL40;MRPS2;MRPS33;MRPS18B;MRPS35;MRPL15;DAP3;MRPL42;MRPL3;MRPS23;MRPL2;MRPL32;MRPL35;MRPS27;ERAL1;MRPL47;MRPL10;MRRF;MRPL9
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.7219075223326856,0.9317383884327062,0.642,0.7934211847385175,1.0,8/21,16.79%,FIS1;BCAP31;PRNP;PRKACA;DEFB1;ADGRL1;PTPRJ;KDR
prerank,positive regulation of vasculature development (GO:1904018),0.7649168905462361,0.931724350373664,0.63,0.7931213630655662,1.0,36/102,13.79%,HSPB1;ITGB1;GRN;JUP;RHOB;MYDGF;VEGFA;PDCD6;BTG1;EMC10;RAMP2;SFRP2;XBP1;VEGFB;CD34;CDH5;CTSH;APLNR;SEMA5A;HK2;RRAS;GATA6;HIF1A;NINJ1;PRKD2;GAB1;MTDH;PLCG1;THBS1;HSPB6;AQP1;ETS1;PTGIS;SP1;ANXA3;HIPK1
prerank,negative regulation of type I interferon production (GO:0032480),0.7367761505263052,0.9314791297207152,0.6195,0.793626161800183,1.0,14/42,13.52%,PCBP2;PIN1;YY1;NPLOC4;TAX1BP1;IRF3;UBA7;PYCARD;ISG15;OTUD5;UFD1;PPM1B;MAVS;SIRPA
prerank,lymphocyte differentiation (GO:0030098),0.7563062848993504,0.9310253619814111,0.6135,0.7949120400700856,1.0,9/84,7.45%,SLC25A5;ITGB1;KLF6;SOX4;PBX1;TPD52;TCF3;HDAC5;CEBPG
prerank,regulation of gene silencing by miRNA (GO:0060964),0.747192706493881,0.9308972756445428,0.621,0.7950329296633033,1.0,46/62,20.23%,POLR2L;ZFP36;POLR2J;POLR2H;EIF4G1;POLR2E;POLR2F;POLR2I;SEC13;DHX9;POLR2G;PUM2;POLR2A;ELAVL1;TPR;PUM1;POLR2K;FXR1;POLR2B;RANBP2;NUP62;FMR1;TNRC6A;NUP85;POLR2C;NUP50;NUP188;NUP160;AAAS;NUP98;POM121;PPARG;STAT3;RAE1;AGO2;NUP214;NUP58;IPO8;POM121C;NUP93;NUP133;NUP205;AGO1;WTIP;NUP54;NUP153
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.7340093742805665,0.9308542709196116,0.6245,0.7948403410908846,1.0,33/42,23.20%,PGAM1;EIF6;OGT;SCARB2;SEC13;TPR;HIF1A;RANBP2;NUP62;JMJD8;NUP85;NUP50;NUP188;NUP160;AAAS;NUP98;POM121;RAE1;NUP214;NUP58;PRKAG1;ZBTB7A;POM121C;NUP93;EP300;NUP133;NUP205;NUP54;NUP153;NUP107;NUP43;NDC1;PRKAG2
prerank,histone H4 acetylation (GO:0043967),0.7371769309530825,0.9307880404630208,0.614,0.7947384340569431,1.0,28/47,18.22%,MORF4L1;OGT;MORF4L2;MSL1;DMAP1;RUVBL2;NAA60;BRD8;APBB1;MCRS1;TADA3;KANSL3;EP400;ING4;PER1;KAT8;HCFC1;KMT2A;EPC1;MEAF6;ING5;TRRAP;KANSL1;WDR5;ACTL6A;ATF2;PHF20;EP300
prerank,response to light stimulus (GO:0009416),0.7419555009770341,0.9307319758614979,0.622,0.7946055207606322,1.0,23/61,20.73%,CIRBP;UBE2B;TP53I13;UBE2A;CCAR2;ERCC3;UVSSA;MAP4K3;PCLAF;CDKN2D;USP1;MSH6;MAPK10;POLD1;UBE4B;MAPK8;MEN1;COPS3;REV1;PRIMPOL;MAP2K7;CRY2;DDB2
prerank,inositol phosphate metabolic process (GO:0043647),0.7376997433950806,0.9305640641560708,0.6205,0.7948599386214518,1.0,17/48,14.19%,CALM1;IP6K2;NUDT4;INPPL1;PTEN;ITPK1;PLCD3;PLCB3;IMPA2;NUDT3;ISYNA1;INPP5A;ITPKA;PLCG1;PPIP5K2;PLCE1;INPP1
prerank,response to calcium ion (GO:0051592),0.7666944994735401,0.9305581918433884,0.626,0.7945402512117183,1.0,30/107,14.26%,CALM2;CALM1;CALM3;ADD1;CAV1;ANXA11;CLIC4;PDCD6;CPNE1;LGMN;SEC31A;D2HGDH;ITPR3;CHP2;IQGAP1;DPEP1;KCNMB1;SMPD1;AHCYL1;CAMK2D;PEF1;CPNE3;KCNMA1;THBS1;PPIF;MEF2A;PKD2;ADAM9;SLC25A24;PRKAA1
prerank,positive regulation of defense response to virus by host (GO:0002230),0.7302276149123886,0.9305119984257089,0.6285,0.7943510943680577,1.0,10/27,21.58%,HSP90AA1;PQBP1;TRIM44;MAVS;TOMM70;STAT1;SIN3A;ZC3H12A;EIF2AK4;DTX3L
prerank,mRNA export from nucleus (GO:0006406),0.7653750004920306,0.9304470649256992,0.6255,0.7942407802425134,1.0,54/105,14.89%,HNRNPA2B1;SRSF5;SRSF3;SRSF2;SRSF6;SRSF7;SRSF11;RNPS1;RBM8A;CPSF1;PABPN1;SRSF9;ENY2;SEC13;SRSF1;CHTOP;DDX39A;MAGOH;SRSF4;CASC3;TPR;UPF1;MCM3AP;NXF1;YTHDC1;SYMPK;WDR33;POLDIP3;SMG1;EIF4A3;SRRM1;ALKBH5;RANBP2;DHX38;SMG5;NUP62;THOC7;EIF4E;NCBP2;SMG7;RBM15B;NUP85;AGFG1;NUP50;NUP188;THOC2;SLBP;PCID2;FYTTD1;NUP160;AAAS;NUP98;IWS1;POM121
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.7240731085693012,0.9303523742732126,0.639,0.7942445434848296,1.0,12/30,19.65%,PCBP2;SIGIRR;C1QBP;SIRT2;TRIB1;PPM1B;TYRO3;IFI16;CARD8;RNF26;TRAFD1;MUL1
prerank,renal water homeostasis (GO:0003091),0.7280932706339709,0.9303429916968095,0.63,0.7939446254707633,1.0,14/31,19.03%,RAB11A;PRKAR1A;PRKACB;CYP4F12;ADCY6;PRKACA;MYO5B;WFS1;AQP1;PRKAR2B;PRKAR1B;PRKAR2A;ADCY5;ADCY3
prerank,nuclear membrane organization (GO:0071763),0.7229889393181006,0.9303115594267217,0.646,0.793720529766016,1.0,13/19,18.88%,AKAP8L;CHMP2A;TARDBP;DCTN1;VPS4A;NSFL1C;CHMP4B;TMEM43;EMD;CHMP7;TOR1AIP1;TOR1A;PLK1
prerank,negative regulation of lipid storage (GO:0010888),0.7229910949454826,0.9301273381924446,0.6385,0.7940307261019116,1.0,11/20,19.24%,PNPLA2;NFKBIA;NR1H3;ITGAV;CES1;NR1H2;PPARG;PPARD;OSBPL8;TTC39B;PTPN2
prerank,myotube differentiation (GO:0014902),0.7215483773338098,0.9300055783397287,0.639,0.7941266345192595,1.0,8/21,20.11%,PLD3;SORT1;CACNA1H;MEF2C;JAM2;ADAMTS5;ADAM12;SKI
prerank,positive regulation of nervous system development (GO:0051962),0.7355471369287775,0.9298058174310675,0.611,0.794519595623991,1.0,12/45,13.76%,NAP1L1;CLSTN1;TGM2;EPHB3;NUMB;DLG5;PTPRD;SERPINF1;EPHB2;NLGN2;SPEN;SNW1
prerank,long-chain fatty acid transport (GO:0015909),0.7334730408415797,0.9297998273170552,0.6315,0.7941980684284057,1.0,21/32,23.80%,APOE;FABP5;ABCD4;CPT1A;ABCD3;PPARG;ACSL3;MID1IP1;LCN12;FABP4;ACACA;CD36;CPT2;PRKAB2;MFSD2A;RPS6KB1;SLC27A4;SLC27A1;SLC27A2;PRKAG2;ACACB
prerank,mesenchyme morphogenesis (GO:0072132),0.7206230162359164,0.9297608444278547,0.6485,0.7939902420812395,1.0,7/17,11.94%,NOTCH1;ENG;ACVRL1;TBX2;MDM4;SMAD2;BMPR1A
prerank,"base-excision repair, AP site formation (GO:0006285)",0.7146578950262937,0.9297186990061831,0.6485,0.7937950484982695,1.0,14/18,23.17%,TERF2IP;MPG;NTHL1;OGG1;ACD;TERF1;SMUG1;NEIL1;MUTYH;TDG;UNG;TINF2;TERF2;MBD4
prerank,centromere complex assembly (GO:0034508),0.7302700585385071,0.9296684942480418,0.631,0.7936294275144637,1.0,8/36,7.94%,NPM1;NASP;CENPX;RBBP7;RBBP4;POGZ;SMARCA5;CENPT
prerank,regulation of cellular catabolic process (GO:0031329),0.7450654047783944,0.9294478883282866,0.619,0.7940470744578532,1.0,30/64,18.81%,HSPB1;PSAP;NUPR1;SCARB2;VPS29;ABL1;PIP4K2B;HDAC6;RRAGA;RAB8A;KEAP1;DAPK3;LONP2;KAT8;BOK;USP33;SOGA1;IFI16;ROCK1;DRAM2;MTMR3;DDIT3;RRAGC;USP10;CISD2;MTMR4;DCAF12;EP300;ATM;DEPP1
prerank,translational termination (GO:0006415),0.758027147609775,0.929329353013385,0.6465,0.7941240305611825,1.0,68/96,16.98%,TRMT112;MRPS21;MRPL41;AURKAIP1;GADD45GIP1;MRPL51;MRPL52;MRPS26;MRPL57;MRPS34;MRPL20;MRPL12;MRPL27;MRPL23;MRPL14;MRPL33;OXA1L;MRPL43;MRPS6;CHCHD1;MRPL55;MRPL34;MRPL28;APEH;MRPS7;MRPL54;GSPT1;MRPL22;MRPS18A;MRPS36;MRPS16;MRPL21;MRPL11;PTCD3;MRPL24;MRPL18;MRPS5;MRPL13;MRPL37;MRPS25;MRPL4;MRPS12;MRPL17;MRPS18C;MRPL16;MRPL36;MRPS15;MRPS11;MRPL40;MRPS2;MRPS33;MRPS18B;ETF1;MRPS35;MRPL15;DAP3;MRPL42;MRPL3;MRPS23;MRPL2;MRPL32;MRPL35;MRPS27;ERAL1;MRPL47;MRPL10;MRRF;MRPL9
prerank,chromosome condensation (GO:0030261),0.7292417100318236,0.9292489264344589,0.6285,0.7940804513706622,1.0,17/35,15.23%,SET;CSNK2B;BANF1;AKAP8L;TOP2A;CHMP1A;ERN2;SMC4;ACIN1;NUSAP1;CDK1;NCAPH2;CSNK2A1;TENT4A;CCNB1;NCAPD2;CSNK2A2
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.7193607196785139,0.9291544343209895,0.6505,0.7940664782911431,1.0,9/19,21.52%,PARK7;AGT;ABL1;POR;EDN3;RFK;GDNF;SIRT3;PDP1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.7278692731452475,0.9291335249709006,0.636,0.7938025757100573,1.0,7/33,13.92%,HES1;OCIAD1;NOTCH1;OCIAD2;F2R;PTK2B;IL10RB
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.7398803925068481,0.9290722247240337,0.629,0.7936776247907191,1.0,20/56,13.68%,RAC1;ROMO1;CDKN1A;EIF6;PDGFRB;ARF4;AGT;DCXR;PINK1;TGFBR2;ACE2;GRB2;SIRT2;XDH;CBR1;NOXA1;THBS1;MPV17;MAPK14;TP53
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.7254924762300473,0.9290577844608815,0.637,0.7933839420639505,1.0,5/34,10.40%,SCP2;FDFT1;DHRS11;LSS;PYCR1
prerank,amyloid-beta metabolic process (GO:0050435),0.715299479734585,0.9289299376721276,0.6445,0.793503978142352,1.0,9/16,16.79%,PSEN1;APH1A;NCSTN;APEH;PSENEN;DYRK1A;BACE2;ACE;BACE1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.7552776448195223,0.928655950639215,0.6205,0.7941338430536848,1.0,10/81,13.64%,VIP;GNA11;TGM2;AGT;F2R;F2RL1;GPR35;PTH1R;PLCE1;ANO1
prerank,phosphatidic acid metabolic process (GO:0046473),0.7387166522523413,0.928457862176806,0.618,0.7944802087338174,1.0,18/50,16.67%,PLA2G2A;AGPAT2;GNPAT;AGPAT1;GPAT4;LPCAT4;PLA2G10;LIPH;DGKD;DGKZ;GPD1;DGKA;AGPAT3;DGKQ;GPD1L;LPCAT1;PLD2;PLD1
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.7273887201949297,0.9281397376548013,0.628,0.7949320401327172,1.0,31/33,25.94%,RAN;SEC13;TPR;SSB;RANBP2;NUP62;NUP85;NUP50;NUP188;NUP160;AAAS;NUP98;POM121;RAE1;NUP214;NUP58;POM121C;NUP93;NUP133;NUP205;NUP54;XPOT;NUP153;NUP107;NUP43;NDC1;NOL6;NUP88;NUP210;NUP155;SEH1L
prerank,tRNA export from nucleus (GO:0006409),0.7273887201949297,0.9281397376548013,0.628,0.7949320401327172,1.0,31/33,25.94%,RAN;SEC13;TPR;SSB;RANBP2;NUP62;NUP85;NUP50;NUP188;NUP160;AAAS;NUP98;POM121;RAE1;NUP214;NUP58;POM121C;NUP93;NUP133;NUP205;NUP54;XPOT;NUP153;NUP107;NUP43;NDC1;NOL6;NUP88;NUP210;NUP155;SEH1L
prerank,ventricular septum development (GO:0003281),0.7285057968656738,0.9280002667175674,0.636,0.795100036857656,1.0,15/38,13.60%,SOX4;HES1;NOTCH1;SLIT3;APLNR;TGFBR2;SMAD4;BMPR2;HECTD1;MDM4;CITED2;ROBO1;TGFBR1;BMPR1A;TGFBR3
prerank,response to amino acid starvation (GO:1990928),0.749157256815434,0.9279298362637401,0.616,0.7950238162108249,1.0,25/74,9.76%,ATF4;LAMTOR4;ATP6V0B;CDKN1A;LAMTOR5;ATP6V1G1;MAPK3;ATP6V0D1;LAMTOR1;ATP6V0E1;ATP6V1F;RHEB;SEC13;DAP;LARP1;TCIRG1;ATP6V1E1;LAMTOR2;SH3GLB1;MAPK1;CEBPB;SESN3;GCN1;RRAGA;ATP6V1B2
prerank,response to organic cyclic compound (GO:0014070),0.7406493863757523,0.9276642609737125,0.635,0.7956411829876007,1.0,12/58,12.00%,IGFBP5;CTNNB1;ANXA1;SFRP1;ARL6IP5;CCL2;TP53I13;SPP1;FGFR4;PAQR8;STAT5B;GGT1
prerank,organelle fission (GO:0048285),0.7262655983814078,0.9275801641056151,0.636,0.7955957060562732,1.0,14/26,21.65%,DNM2;FIS1;MTFR1L;MFF;DNM1L;DNM1;ACOT8;CORO1C;PEX19;OPA1;MUL1;MIEF1;WASHC5;PEX11B
prerank,positive regulation of organelle assembly (GO:1902117),0.7353409158481441,0.9275637244663566,0.6195,0.7953139639949409,1.0,31/45,21.28%,NUMA1;FSCN1;SDC1;DYNC1H1;PDCD6IP;CNOT1;SDC4;SDCBP;G3BP2;G3BP1;CAPG;SH3GLB1;PIP4K2B;CNOT2;ARHGAP35;NUP62;HTT;RALB;CCDC88A;ENTR1;STX18;RAB3GAP1;CNOT6;CROCC;SPAG5;ASAP1;CNOT6L;RAB3GAP2;KCTD17;PIP4K2A;LCP1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.7160586798306758,0.927336353397385,0.637,0.7957717418997144,1.0,10/16,19.69%,CDC16;UBE2C;PTTG1;TPR;ANAPC7;TACC3;CDC27;ANAPC1;PLK1;CDC23
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.7186090520375285,0.9270567986082601,0.639,0.7964673612257807,1.0,7/23,17.91%,AKT1;CHRNA3;GSK3B;GSK3A;RAB3GAP1;ARRB2;MEF2C
prerank,carboxylic acid transport (GO:0046942),0.7392382333823305,0.9269256412301397,0.63,0.7965835553658617,1.0,9/56,13.12%,PSAP;LLGL2;SLC38A2;SLC3A2;SLC16A3;SLC25A29;SLC38A1;SLC16A1;SLC17A5
prerank,negative regulation of telomere maintenance (GO:0032205),0.713940909188175,0.9267216716353113,0.6565,0.7969680975773382,1.0,10/16,23.14%,ERCC1;TERF2IP;PARP1;TNKS;TERF1;ATM;TNKS2;NBN;SMG6;TERF2
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.7450166394340725,0.9265771921402793,0.6115,0.7971575480047978,1.0,35/67,17.07%,RAC1;CDC42;CAV1;CAPZB;FSCN1;ATP8B1;GAP43;RAB17;ARF6;TBC1D9B;EPHA2;P2RX4;TBC1D1;FXR1;SGSM3;RAB5A;RABGAP1;IFT20;FMR1;TBC1D2B;MYO10;PODXL;TBC1D14;TBC1D20;TWF1;TWF2;FXR2;RDX;RABEP2;TBC1D10B;ATG3;TBC1D13;TBC1D5;PLD1;TBC1D16
prerank,regulation of cellular biosynthetic process (GO:0031326),0.7265793480612066,0.9264267404321969,0.637,0.7973317473116004,1.0,9/32,13.52%,RAC1;EIF6;C3;CD47;FGFR4;ADIPOR2;ADIPOR1;CES1;SIRPA
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.7171175173072835,0.9263392233034256,0.642,0.7972914422800815,1.0,6/23,12.41%,ANK2;PRNP;CAMK2D;PTK2B;FYN;DIAPH1
prerank,neuron development (GO:0048666),0.7756994588106001,0.9262790695107568,0.6725,0.7971575234259605,1.0,41/143,11.45%,STMN1;HMGB1;LAMB1;APOE;SLC44A4;BLOC1S1;TDP2;APP;STMN2;VAPA;PRMT1;RAB11A;MAP4;BTG2;PBX1;GBA2;XBP1;MICALL2;PBX3;TBCD;UGDH;ATXN10;NPY;CDK16;RAB13;FRYL;GBA;PQBP1;EHD1;MANF;STMN3;PHOX2B;STX3;HDGFL3;SRF;WNK1;ULK1;B4GALT5;HS6ST1;ZFYVE27;L1CAM
prerank,base conversion or substitution editing (GO:0016553),0.7160358600352731,0.9261847923182115,0.6505,0.7971491662074641,1.0,6/18,23.73%,ADAR;METTL3;NUDT16;ADARB1;A1CF;APOBEC3C
prerank,polyol metabolic process (GO:0019751),0.7345539126257882,0.9259723301734502,0.635,0.7975908362542069,1.0,17/47,14.19%,CALM1;IP6K2;NUDT4;INPPL1;PTEN;ITPK1;PLCD3;PLCB3;IMPA2;NUDT3;ISYNA1;INPP5A;ITPKA;PLCG1;PPIP5K2;PLCE1;INPP1
prerank,negative regulation of GTPase activity (GO:0034260),0.7213350514980457,0.9258782211604725,0.648,0.79759057346876,1.0,10/23,15.79%,TMED2;RCC2;F11R;ARL2;GPSM1;DAB2IP;WNK1;HRAS;RDX;ARFGEF1
prerank,organelle organization (GO:0006996),0.8147191047398669,0.9256678706170324,0.821,0.7980066662290758,1.0,111/416,9.91%,DES;PPIA;CFL1;TPM1;MDK;CHGA;ATP5F1B;CHCHD2;APOE;CYCS;CHCHD10;SLC9A3R1;VMP1;PARK7;CDC42;PHB2;SEC61A1;NUMA1;TMED10;CAV1;RAB1A;CAPZB;VAPA;DST;AUP1;THY1;CSNK1A1;DPYSL2;SURF4;TMED9;LMAN2;PHB;SEC31A;MICAL1;RHOT2;PDCD6IP;PACSIN2;RAB7A;PALLD;ESRRA;CNN2;RAB34;VPS51;CHMP2A;TMED2;MAST2;GAK;CSNK1D;RAB2A;CLUH;SAR1A;OBSL1;GOLGA8A;CHMP1A;ATP8B1;PRDX3;STOML2;CCL2;TMED4;REEP6;NECTIN2;SMPD4;CHMP5;WASL;BIN1;CHMP3;SSBP1;PINK1;GOLPH3;REEP5;CXADR;HUWE1;RAB14;YME1L1;NPLOC4;GBF1;ARHGEF7;TMED3;OPTN;TTC17;TOR1AIP2;GOLGB1;VPS4B;CHMP1B;CENPT;COG4;GBA;SEC16A;CLASP2;ABCD4;HSD17B10;SORT1;LMAN1;ARL1;GOLGA2;SLC25A36;MICAL3;ARHGAP21;VPS4A;YTHDF3;FNBP1L;TMED7;LONP1;ABI2;RAB18;PARP1;DNM1L;SEMA6A;TRAPPC12;PLEKHM2;STX4
prerank,BMP signaling pathway (GO:0030509),0.7440584801146237,0.9256514549877362,0.6235,0.7977235478605129,1.0,18/65,13.67%,DDX5;PDCD4;SLC39A5;MAPK3;LEFTY1;ENG;SMAD4;BMPR2;ACVRL1;RGMB;USP9X;BMP4;SMAD2;SMAD3;BMPR1A;SMAD5;TGFBR3;ZFYVE16
prerank,regulation of autophagosome assembly (GO:2000785),0.7278250370494588,0.9254406780213792,0.632,0.7981218627486931,1.0,29/33,25.37%,NUPR1;RAB1B;PINK1;SH3GLB1;PIP4K2B;SEC22B;RAB5A;CHMP4A;CHMP4B;IFT20;RALB;TBC1D14;SCFD1;RAB3GAP1;MTMR3;FEZ2;PHF23;UBQLN2;NPRL3;TMEM39A;NPRL2;RAB3GAP2;PIKFYVE;PIP4K2A;PIP4K2C;LRSAM1;FEZ1;MTM1;IFT88
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.7208031727585862,0.9253482369237979,0.645,0.798124762982409,1.0,10/28,16.83%,MCL1;HSPA1A;FGFR1;AKT1;SNAI2;HSPA1B;UNC5B;RET;BCL2L1;MAPK7
prerank,protein-containing complex assembly (GO:0065003),0.7964617896454331,0.9252010808517287,0.742,0.7983217294915741,1.0,102/264,11.78%,FN1;SERPINA1;ELOB;APOA4;CD74;COL16A1;SKP1;CXCL12;JCHAIN;CHCHD10;SLC9A3R1;AP2M1;CTNNB1;PPP2R1A;TAPBP;VIL1;RBX1;CTSC;ST13;TMED10;LAMC1;RAB1A;CSNK2B;SPG7;CD59;CSNK1A1;PDCD6;SEC31A;HES1;GSDMD;CAPZA1;TMED2;TNFRSF1A;TFG;AREG;CSNK1D;RAB1B;HDAC1;SEC13;STOML2;DHX9;TLE2;TRAPPC2L;GPAA1;TSPAN4;SLC2A1;WASL;BAD;PICALM;PPP6R3;AFDN;FERMT2;YAP1;USH1C;TCF7L2;TLE1;NAPA;DBNL;SMARCA4;CAPG;ADAM10;TUBGCP2;CAND1;CREBBP;SEC24C;CAPZA2;SEC16A;TRAPPC1;MDM4;LMAN1;VAMP3;CNIH1;HSF1;PPP6R1;SEC22B;SEC23A;GOLGA2;COL7A1;OCLN;DNM1L;PEF1;AFG3L2;CTSZ;TEAD2;TRAPPC4;HGSNAT;ANO6;ITGB1BP1;TLE3;CD2AP;VAMP2;TRAPPC3;USO1;PDE4DIP;PTK2B;MCFD2;STX5;SAR1B;KAT5;CUL3;BOK;PPP6C
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.7152924864450811,0.9251353820160215,0.6538269134567284,0.7978832973794111,1.0,11/15,25.18%,BLOC1S1;AP3D1;AP3S1;AP3M1;BLOC1S6;SNAPIN;AP3B1;BLOC1S4;AP3M2;AP3S2;DTNBP1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.7152924864450811,0.9251353820160215,0.6538269134567284,0.7978832973794111,1.0,11/15,25.18%,BLOC1S1;AP3D1;AP3S1;AP3M1;BLOC1S6;SNAPIN;AP3B1;BLOC1S4;AP3M2;AP3S2;DTNBP1
prerank,cellular response to amino acid starvation (GO:0034198),0.7461298817597791,0.925078027891325,0.617,0.7977453126233395,1.0,24/73,9.76%,ATF4;LAMTOR4;ATP6V0B;CDKN1A;LAMTOR5;ATP6V1G1;MAPK3;ATP6V0D1;LAMTOR1;ATP6V0E1;ATP6V1F;RHEB;SEC13;DAP;TCIRG1;ATP6V1E1;LAMTOR2;SH3GLB1;MAPK1;CEBPB;SESN3;GCN1;RRAGA;ATP6V1B2
prerank,regulation of DNA metabolic process (GO:0051052),0.7302389672997575,0.9250228388166489,0.641,0.7976104024264716,1.0,24/44,19.10%,SUB1;HNRNPD;NUCKS1;XRCC5;UBE2N;UPF1;KPNA2;SIRT7;SMG1;TERF2IP;WDR18;SMG5;UBE2V2;MPV17;MYC;YLPM1;WRNIP1;USP1;CDT1;MPHOSPH8;KPNA1;PDGFA;THOC1;SMARCAD1
prerank,anion transmembrane transport (GO:0098656),0.743555627600707,0.9249280938960246,0.633,0.7975938710717759,1.0,13/67,11.24%,SLC25A5;SLC6A8;SLC44A4;SLC25A1;SLC3A2;ARL6IP5;SLC35A3;SFXN3;SLC25A11;SLC25A4;SLC35C2;SLC25A29;SLC13A2
prerank,regulation of dendrite morphogenesis (GO:0048814),0.7210485085041143,0.9247938159711264,0.646,0.7977375770095673,1.0,19/32,22.29%,YWHAH;OBSL1;NEDD4L;SDC2;CAPRIN1;CUX1;CHRNA3;NSMF;CUL7;PTPRD;GSK3B;RAP2A;GORASP1;SS18L2;CAPRIN2;RAPGEF2;SEMA4D;SS18L1;SARM1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.7292401968486283,0.9247769428549203,0.6445,0.7974549238427615,1.0,32/42,23.20%,PGAM1;EIF6;OGT;SEC13;TPR;HIF1A;RANBP2;NUP62;JMJD8;NUP85;NUP50;NUP188;NUP160;AAAS;NUP98;POM121;RAE1;NUP214;NUP58;PRKAG1;ZBTB7A;POM121C;NUP93;EP300;NUP133;NUP205;NUP54;NUP153;NUP107;NUP43;NDC1;PRKAG2
prerank,regulation of chromosome organization (GO:0033044),0.7166423149275463,0.9246987704187191,0.6625,0.7973918657978721,1.0,16/22,23.94%,HNRNPD;XRCC5;UPF1;SMG1;TERF2IP;SMG5;CENPV;MYC;YLPM1;CDT1;WAPL;RB1;PIF1;SMG6;TERF2;RMI2
prerank,neuromuscular process (GO:0050905),0.7116651356809425,0.9245111449964557,0.667,0.7977022421564323,1.0,3/19,6.78%,TPP1;PAFAH1B1;DCTN1
prerank,ganglioside metabolic process (GO:0001573),0.7158582796077226,0.9242314057678792,0.644,0.7983634525279967,1.0,3/20,5.08%,NEU1;HEXB;HEXA
prerank,"base-excision repair, gap-filling (GO:0006287)",0.7174169571630385,0.9241178021548128,0.6585,0.7984397541165802,1.0,29/34,23.54%,APEX1;PCNA;POLD4;POLD2;POLE;PARP1;RPA1;RPA3;MPG;NTHL1;POLG;OGG1;LIG1;RFC1;RPA2;RFC2;POLL;POLD1;RFC4;PNKP;SMUG1;NEIL1;MUTYH;LIG3;TDG;UNG;MBD4;XRCC1;FEN1
prerank,cellular response to BMP stimulus (GO:0071773),0.7454074303746604,0.9240529096595527,0.6265,0.7983262730758321,1.0,21/71,13.67%,DDX5;PDCD4;SLC39A5;MAPK3;SFRP1;LEFTY1;ENG;SMAD4;BMPR2;ACVRL1;RGMB;ADAMTS7;USP9X;PHOX2B;BMP4;SMAD2;SMAD3;BMPR1A;SMAD5;TGFBR3;ZFYVE16
prerank,melanosome organization (GO:0032438),0.7187676852113496,0.9239875343793174,0.6495,0.7982116247854485,1.0,15/27,21.84%,BLOC1S1;AP3D1;HPS1;AP1M1;TRAPPC6A;RAB32;AP1G1;BLOC1S6;HPS4;RAB29;SNAPIN;AP3B1;BLOC1S4;PIKFYVE;KIF13A
prerank,zinc ion transmembrane transport (GO:0071577),0.7171098462527328,0.9238785130571977,0.663,0.7982668552348201,1.0,13/22,23.58%,SLC39A5;SLC39A14;SLC39A4;SLC39A13;SLC39A7;SLC39A1;SLC30A1;SLC30A5;SLC39A8;SLC39A11;SLC39A3;SLC39A10;SLC39A6
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.7225995580717259,0.923840529988501,0.6545,0.798065054658331,1.0,16/30,20.21%,TECR;SLC25A1;ACSL5;ELOVL1;FASN;ACLY;HSD17B12;SCD;PPT1;HACD2;ACSL3;ACSF3;ELOVL5;ACACA;HSD17B8;SCD5
prerank,neural tube closure (GO:0001843),0.7202432024093114,0.9237876649495301,0.65,0.7979193396932178,1.0,21/34,22.23%,PLXNB2;VASP;TSC2;DVL3;LMO4;SCRIB;DVL1;DLC1;DVL2;BCL10;LRP6;DEAF1;SEMA4C;MTHFD1;PHACTR4;IFT122;KDM2B;PRICKLE1;SKI;COBL;MTHFR
prerank,determination of left/right symmetry (GO:0007368),0.7221285184024738,0.9237566308054767,0.644,0.797691589797317,1.0,12/39,19.99%,NOTCH1;LEFTY1;SMO;CITED2;DLL1;PKD2;KIF3B;OFD1;GALNT11;NPHP3;MEGF8;MKKS
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.7254322111885565,0.9236822895083765,0.6435,0.7976232364712411,1.0,8/38,11.32%,DYNLL1;DYNLRB1;DYNLL2;PCM1;TNPO1;IFT43;HSPB11;IFT20
prerank,mismatch repair (GO:0006298),0.7220031247666154,0.9228091043187691,0.659,0.8003337708589219,1.0,17/29,20.50%,PCNA;ABL1;POLD4;POLD2;ERCC1;RPA1;RPA3;SETD2;LIG1;MLH1;MSH6;RPA2;POLD1;XPC;MSH2;MUTYH;TDG
prerank,natural killer cell activation (GO:0030101),0.7327662992645521,0.9225788079088351,0.644,0.8008097827997596,1.0,3/42,4.03%,PRDX1;BAG6;PBX1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.7252464464822325,0.9223164389219819,0.6505,0.8013802104699886,1.0,15/35,20.16%,DUSP1;PTPRF;TNS2;DUSP6;PTPN18;PTPN12;DUSP3;PGP;PTPRJ;PTPN11;PTPN9;DUSP5;DUSP16;PTPN2;PTPRB
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.719922922721126,0.922192524656755,0.6535,0.8014928460807531,1.0,22/32,24.41%,GABARAPL2;COPE;COPZ1;COPA;NAPA;RAB6A;COPB1;COPB2;COPG1;TRAPPC3;VTI1B;COPZ2;GOSR2;COG3;COG2;NSF;COG8;GOSR1;COG1;NAPG;COG5;COG6
prerank,response to purine-containing compound (GO:0014074),0.713827556194884,0.9219064901190939,0.6598299149574788,0.8021589212857805,1.0,5/17,15.82%,P2RX4;NDUFS4;DUOX2;DGKQ;STAT1
prerank,negative regulation of execution phase of apoptosis (GO:1900118),0.7058456664202993,0.9218387749930842,0.6595,0.8020559745798551,1.0,5/15,22.67%,PAK2;BCL2L1;DFFA;RNF34;RFFL
prerank,visual system development (GO:0150063),0.7263124623693203,0.921801777953928,0.6585,0.8018557352955145,1.0,15/41,17.21%,SLC39A5;MEIS1;PBX1;C1QA;PBX3;C3;RAB18;MEIS3;MEIS2;MAB21L2;SMG9;HIPK1;SIPA1L3;CPAMD8;SH3PXD2B
prerank,connective tissue development (GO:0061448),0.7238767794529863,0.9217106520263748,0.6535,0.8018327562841367,1.0,20/38,20.18%,PKD1;SULF2;XBP1;PGRMC2;HYAL2;SULF1;NAMPT;SNORC;SLC39A13;CD44;DDRGK1;CREB3L2;LRP5;SPTLC2;COL2A1;SH3PXD2B;ARID5B;ZNF516;DYRK1B;TRIP11
prerank,positive regulation of double-strand break repair (GO:2000781),0.7245434298866249,0.921653073821762,0.657,0.8016955506399459,1.0,22/40,21.97%,FUS;ACTR2;MGMT;PRKDC;SPIRE2;PARP1;KMT5B;SMCHD1;MAD2L2;MMS19;RIF1;SLF2;WDR48;FOXM1;DDX11;MRNIP;SPIDR;PNKP;SHLD2;TIMELESS;DTX3L;ARID2
prerank,regulation of intracellular transport (GO:0032386),0.725284854684005,0.9213334231122277,0.657,0.8024680703878845,1.0,16/36,16.92%,NUMA1;DYNC1H1;LAMP1;REEP6;GAS1;RAB11B;REEP5;ATP9A;CRYAB;INPP5F;SCFD1;AAAS;CAPN10;NDEL1;NUP214;SPAG5
prerank,regulation of DNA biosynthetic process (GO:2000278),0.7199515842945143,0.9212680656663941,0.657,0.802371690760116,1.0,19/28,24.72%,CDKN1A;PDGFRB;PARP4;BMPR2;ACVRL1;FGFR4;PRKD2;SMG5;MYC;SMOC2;TNKS;ATM;PDGFA;NABP2;SMG6;TERF2;RGCC;DACH1;PDGFB
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.7136103565177244,0.9212286994551484,0.676,0.8021767536636074,1.0,16/25,22.68%,HMGN1;SUPT5H;SUPT4H1;SUPT16H;SUPT6H;TCERG1;BRD4;EAPP;CDK13;CCNT2;CCNK;SCAF8;THOC1;KAT7;CCNT1;LEO1
prerank,proteolysis (GO:0006508),0.7955286641458894,0.9212059386198892,0.76,0.8019126275358388,1.0,82/286,11.04%,CTSD;ANPEP;CTSA;MMP2;TMPRSS2;CTSB;ST14;CAPN2;NEDD8;CPE;PLAT;OGT;CTSC;PRSS3;WFDC2;HPN;CTSS;AEBP1;HTRA3;SPG7;PSMB5;CPNE1;LGMN;ADAM33;CAPN5;SPCS1;BMP1;MMP15;SPPL2B;TINAGL1;TPP1;CTSL;ECE1;CAPN1;NPEPPS;ATG4B;CNDP2;HM13;MBTPS1;PRCP;NLRP1;CTSH;SPPL2A;PSEN1;PTCH1;APH1A;CASP7;TMPRSS4;RNPEPL1;CAPN8;SPCS3;NCSTN;MMP23B;SENP6;YME1L1;ADAM10;FURIN;DPP7;HTRA1;PCSK7;APEH;FOLH1;RNPEP;CPXM1;CAPN15;SPPL3;ADAMTS7;PSMC4;THOP1;XPNPEP1;CLPP;FAM111A;LONP1;DPP4;AFG3L2;CTSZ;CUL7;METAP2;PSENEN;PGPEP1;CPD;MMP14
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.7718601045842385,0.9211458268450623,0.6835,0.8017965556298737,1.0,27/148,12.98%,CD24;HMGB1;YWHAE;FIS1;TRPM4;CAV1;BCAP31;PDGFRA;NPTN;ATP2B4;CD52;ITPR3;ABL1;SCGN;SPPL3;F2R;EDNRA;PRKACA;F2RL1;GPR35;SELENOT;SMAD3;CD55;ATP2B1;ACKR3;CIB2;PLCE1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.7213778880527787,0.9210951596961179,0.6615,0.8016336193408474,1.0,29/33,26.11%,LSM7;LSM4;LSM3;LSM2;LSM5;DDX6;LSM6;NT5C3B;WDR61;TTC37;CNOT8;LSM1;EXOSC8;CNOT7;SKIV2L;CNOT6;DCP2;EXOSC6;EDC3;EXOSC7;EXOSC4;EXOSC1;EXOSC9;DCP1A;PATL1;DIS3;HBS1L;EXOSC2;EXOSC5
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.7135593314211538,0.921066952498872,0.6668334167083542,0.8013936260254083,1.0,11/16,25.62%,ADM;AKT1;AKT2;CES1;PPARG;PPARD;LDLRAP1;IRS1;IRS2;PPM1K;PPARA
prerank,cellular response to pH (GO:0071467),0.7120588551231475,0.9210475688033964,0.6625,0.8011308933193874,1.0,2/18,6.40%,CHP1;RAB11B
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.7225174689175924,0.9209862093953013,0.6565,0.8010161750625604,1.0,31/35,26.11%,LSM7;LSM4;LSM3;POLR2G;LSM2;LSM5;DDX6;LSM6;NT5C3B;WDR61;TTC37;CNOT8;LSM1;EXOSC8;CNOT7;SKIV2L;CNOT6;DCP2;EXOSC6;EDC3;EXOSC7;EXOSC4;EXOSC1;EXOSC9;DCP1A;PATL1;DIS3;DIS3L2;HBS1L;EXOSC2;EXOSC5
prerank,NAD biosynthetic process (GO:0009435),0.7124134740328554,0.9208954095707237,0.674,0.8009930264611076,1.0,8/21,17.15%,NAPRT;QPRT;NADSYN1;NAMPT;NAXE;PTGIS;NAXD;PARP10
prerank,regulation of double-strand break repair (GO:2000779),0.72484050913376,0.9208557960379017,0.678,0.8008049377257055,1.0,24/42,21.56%,ACTR2;OTUB1;PPP4C;DEK;MGMT;TRIP12;KDM1A;SIRT7;SIRT6;TERF2IP;SPIRE2;PPP4R2;UBR5;SETD2;SLF2;RPA2;FOXM1;PML;DDX11;MRNIP;SPIDR;SHLD2;TIMELESS;RNF169
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.7139589859916022,0.9208194578420071,0.6665,0.800598059956112,1.0,11/16,26.06%,FKBP1A;CSNK2B;FSTL3;DACT1;ACVR1B;SKI;SMAD7;FST;ACVR2A;LEMD3;ACVR1
prerank,positive regulation of cell growth (GO:0030307),0.7553080227926483,0.9207989327132515,0.6495,0.8003382868158804,1.0,32/97,12.69%,EIF4G2;SLC44A4;CIB1;CDC42;DDX3X;ERBB2;HPN;EIF4G1;DNPH1;MACF1;SFRP2;NEDD4L;SFRP1;AKT1;SDCBP;RPS6KA1;DBN1;S100A8;DBNL;ADAM10;MTPN;S100A9;HDGFL2;BRAT1;USP47;MMP14;ZFYVE27;L1CAM;TGFBR1;CSNK2A1;DERL2;GOLGA4
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.712097082180548,0.9205130581211518,0.659,0.8009746806230988,1.0,8/16,23.56%,EHD2;FLOT1;EHD1;MAPK14;ADAM9;TYROBP;CAMK1;CD53
prerank,negative regulation of cell junction assembly (GO:1901889),0.7154008778366757,0.9205041808782525,0.663,0.8006692211710417,1.0,16/25,20.99%,PTEN;RCC2;ROCK2;ACVRL1;CLASP2;SRC;DLC1;ITGB1BP1;THBS1;CORO1C;ROCK1;ACE;IKBKB;PHLDB2;ROBO2;DMTN
prerank,primary neural tube formation (GO:0014020),0.7153635765424443,0.920469410967763,0.6665,0.8004592106469849,1.0,18/30,22.23%,PLXNB2;VASP;TSC2;LMO4;SCRIB;DLC1;DVL2;BCL10;LRP6;DEAF1;SEMA4C;MTHFD1;PHACTR4;IFT122;PRICKLE1;SKI;COBL;MTHFR
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.7125553057250033,0.9202834083114352,0.6715,0.8004193452946461,1.0,9/16,14.50%,PTEN;RCC2;ACVRL1;CLASP2;SRC;DLC1;ITGB1BP1;THBS1;CORO1C
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.7125553057250033,0.9202834083114352,0.6715,0.8004193452946461,1.0,9/16,14.50%,PTEN;RCC2;ACVRL1;CLASP2;SRC;DLC1;ITGB1BP1;THBS1;CORO1C
prerank,protein import (GO:0017038),0.7510759250980179,0.9201830943251454,0.6615,0.8004324442491414,1.0,61/89,21.96%,PTTG1IP;APOE;HSP90AA1;RAN;PHB2;CLU;FIS1;KPNB1;SEC13;TSC2;AKT1;IPO5;PXMP2;TPR;IPO7;APPL2;RPAIN;TOMM22;TNPO1;IPO9;LAMP2;ALDH3A2;CSE1L;NUP62;NUTF2;HIKESHI;NUP85;ABCD3;NUP50;PPP1R10;NUP188;SAMM50;HSPA4;TNPO2;POM121;PEX2;PEX26;STAT3;NUP214;FAM53B;PEX19;IPO8;APPL1;POM121C;NUP93;RAB8B;ATAD1;FAM53C;PEX16;PRICKLE1;NUP133;IPO13;PEX5;NUP153;EIF4ENIF1;NXT1;NUP107;SYK;PEX11B;SNX33;ACBD5
prerank,central nervous system development (GO:0007417),0.7894815526176157,0.9200731954685586,0.7395,0.8004795629224913,1.0,64/265,11.28%,GSN;MARCKS;GSTP1;COL4A1;UGP2;COX7B;VCAN;MARCKSL1;HSPG2;PLXNB2;ADGRA2;LSR;SOX4;NNAT;CDK5RAP3;MEIS1;BAG6;PKD1;PCDH18;NFIB;PBX1;DDIT4;GBA2;TPP1;PHGDH;C1QA;S100B;NCKAP1;SMO;PBX3;SH3GL1;PTEN;ATP6AP2;SLC2A1;UFC1;NDUFS4;DHX30;SCT;PTCH1;C3;TGFBR2;PAFAH1B3;CAPG;TUBGCP2;ADGRL2;RNF103;EIF2B5;PAFAH1B2;UFM1;ANKLE2;TMX2;RAB18;NES;IER3IP1;BPTF;TBX3;ALDH3A2;CIC;MEIS3;ADGRG1;DLL1;SMARCA1;B3GNT5;PITPNM1
prerank,"transcription, DNA-templated (GO:0006351)",0.7846371670225565,0.9199627435124402,0.726,0.8005303759921891,1.0,81/220,13.81%,PTMA;ELOB;BTF3;DDX5;TSC22D1;ATF4;POLR2L;MAF;RBMX;IVNS1ABP;RNPS1;CEBPD;POLR2J;POLR2H;POLR2E;POLR2F;TAF10;MRPL12;POLR2I;XBP1;UBTF;DEK;MLLT1;POLR2G;SSRP1;SUPT5H;NELFB;DRAP1;POLR2A;MED16;SMARCA5;SUPT4H1;NELFE;GTF3C6;NELFCD;ELOC;GTF3C1;SUPT16H;POLR2K;TAF7;PPP5C;HSF1;TCEA2;FOXO3;ZBTB7B;POLR2B;THRA;PMF1;TAF1C;GTF2A2;PARP1;TFDP1;SUPT6H;GTF3C5;BAZ2A;POLRMT;PRMT5;MBD1;GTF3A;HIPK3;AFF4;WDR61;NCBP2;SETX;GTF2F1;MEF2A;RTF1;TCEA1;POLR2C;GTF2H5;MED4;RREB1;EPC1;FUBP3;TAF11;COPS2;MMS19;TP53;CBFB;TRIM24;NFIC
prerank,ceramide metabolic process (GO:0006672),0.7320782905462352,0.9199362633269786,0.653,0.8002792723072727,1.0,23/54,17.08%,PPP2R1A;ASAH1;PLPP1;PPP2CA;SMPD4;CERS2;SPTSSA;CERK;FUT3;PLPP3;PLPP2;GBA;SMPD1;DEGS1;SPTLC1;ORMDL1;CERS6;SGPL1;CERS4;SPTLC2;ORMDL3;CERS5;ORMDL2
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.7211311414820124,0.9199165484522416,0.6645,0.8000144914754067,1.0,26/37,25.57%,HMGB2;HSPA1A;PRMT1;HIF1A;HSPA1B;FOXO3;PRKDC;STAT5B;MAPK14;ETS1;ACVR1B;PITHD1;STAT1;STAT3;BRD1;FAM210B;HOXA5;ARNT;MTURN;ANKRD54;FES;ACVR2A;SCIN;FAXDC2;ABCB10;MED1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.7185290240720901,0.9197806862779883,0.667,0.8001524411630053,1.0,20/29,22.68%,CTNNB1;HDAC1;TLE2;TCF7L2;TLE1;SMARCA4;CREBBP;TLE3;KAT5;MYC;TCF7L1;TRRAP;PYGO2;EP300;MEN1;ASH2L;BCL9L;RUVBL1;TLE4;LEO1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.7426275590837202,0.9197277615675359,0.651,0.8000150755932363,1.0,23/82,15.02%,CALM1;RGS5;YWHAB;PHB;DYNLT1;MGLL;RGS2;SLC39A14;C3;ZDHHC3;FNTA;ROCK2;ZDHHC7;RGS3;METAP2;GIT1;USP33;PLCE1;RGS12;METAP1;GIT2;DGKQ;ROCK1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.7697209358205348,0.9195911512183671,0.675,0.8001655370092756,1.0,24/147,14.21%,CD24;HMGB1;FIS1;TRPM4;CAV1;BCAP31;PDGFRA;NPTN;CD52;ITPR3;ABL1;P2RX4;SPPL3;F2R;EDNRA;F2RL1;GPR35;SELENOT;CD55;ACKR3;CIB2;PLCE1;CACNB3;S1PR3
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.7128197524159672,0.9195033862541583,0.6495,0.8001412483722078,1.0,6/15,18.08%,NT5C;ERH;UPP1;CAD;NT5C3A;TYMP
prerank,response to dsRNA (GO:0043331),0.7171592777669952,0.9193891957932712,0.664,0.8002160449693243,1.0,2/25,5.15%,SLC3A2;RIOK3
prerank,icosanoid metabolic process (GO:0006690),0.7362382943200606,0.919154302567447,0.647,0.8006877031618119,1.0,14/55,13.33%,GPX4;PON2;MGLL;HPGD;DPEP1;MAPKAPK2;CYP4F12;PLA2G10;LTA4H;GGT1;CYP2S1;FAAH;PTGR1;PTGIS
prerank,RNA destabilization (GO:0050779),0.7097328827222414,0.9190020443061455,0.6785,0.8008876457081201,1.0,16/18,28.59%,PUM1;ROCK2;CELF1;YTHDF3;METTL3;YTHDF2;YTHDF1;ROCK1;GIGYF2;FTO;RIDA;ZC3H18;DXO;METTL16;MEX3D;METTL14
prerank,regulation of defense response to virus by host (GO:0050691),0.726380727507392,0.9188457082415937,0.6565,0.8010996099879065,1.0,14/35,21.58%,HSP90AA1;DHX9;PQBP1;TRIM44;MAVS;TOMM70;STAT1;RNF216;SIN3A;MUL1;ZC3H12A;EIF2AK4;TARBP2;DTX3L
prerank,cellular lipid catabolic process (GO:0044242),0.7132251606165484,0.9188120100805612,0.6755,0.8008813122801348,1.0,16/26,22.41%,APOA2;CEL;ACOX1;MGST2;SIRT2;ABHD12;LPIN3;FAAH;ACOT8;LPIN2;PPARD;PLBD1;LPIN1;ENPP2;ACBD5;PLA2G15
prerank,dopamine metabolic process (GO:0042417),0.7107201730288079,0.918675558755042,0.6855,0.8010291233509973,1.0,2/19,5.54%,MAOA;COMT
prerank,early endosome to late endosome transport (GO:0045022),0.7060617551236124,0.9184465184327888,0.6815,0.8014998847508457,1.0,18/20,27.20%,RAB7A;HOOK2;SNF8;RAB5A;EMP2;BECN1;PTPN23;HOOK3;STX8;RILP;LMTK2;PIK3C3;WDR81;EEA1;AKTIP;ANKRD27;HOOK1;KIF16B
prerank,glial cell differentiation (GO:0010001),0.7174291978959517,0.9184079111394582,0.6605,0.8013000456234779,1.0,11/29,17.76%,SOX4;ERBB3;NFIB;GPC1;METRN;PHOX2B;EIF2B5;PICK1;STAT3;SOX11;MYRF
prerank,protein localization to chromosome (GO:0034502),0.7215855404917874,0.9182384941687229,0.6655,0.801569532335752,1.0,23/34,23.14%,XRCC5;TPP1;RAD21;TERF2IP;LEMD2;ATRX;RPA1;BOD1;CTCF;SLF2;CHMP7;RPA2;TNKS;MRNIP;IFFO1;ACD;PLK1;WAPL;MSH2;TNKS2;RB1;TINF2;TERF2
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.7035221457386753,0.9181039866819419,0.6828414207103551,0.801703628657482,1.0,15/17,26.49%,MVD;MPDU1;ALG3;ALG13;ALG12;NUS1;DHDDS;ALG2;ALG1;DPAGT1;DOLPP1;ALG8;SRD5A3;ALG14;ALG6
prerank,positive regulation of TORC1 signaling (GO:1904263),0.7025275889077764,0.9179796492086346,0.6705,0.8018114569955058,1.0,13/15,27.70%,LAMTOR5;RRAGA;PIH1D1;PIP4P1;TELO2;KLHL22;SIK3;GPR137;RRAGB;RRAGD;SEH1L;CLEC16A;FLCN
prerank,membrane lipid metabolic process (GO:0006643),0.7124302129686062,0.917957851288648,0.6735,0.8015574667452491,1.0,7/22,14.97%,TECR;SERINC1;CERK;MGST2;SPTLC1;B4GALT4;FUT2
prerank,protein localization to cell junction (GO:1902414),0.7125822337451948,0.9179519246160289,0.6665,0.801249355992927,1.0,11/22,19.80%,DSP;TJP3;FERMT2;JAK1;NLGN2;JAM3;TJP1;PAK2;MARVELD3;HEG1;CGNL1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.7112861729449322,0.9178882783547385,0.665,0.8011511170868312,1.0,7/17,11.94%,JAG1;NOTCH1;NOTCH2;RBPJ;SNAI2;BMP4;BMPR1A
prerank,cation transmembrane transport (GO:0098655),0.7275780849818989,0.917865423488872,0.6665,0.8008981233996328,1.0,13/44,17.62%,SLC44A4;ATP1B1;TRPM4;SLC3A2;SFXN3;SLC25A29;TRPM6;PKD2;SLC29A4;SFXN1;SLC38A5;CACNA1H;SLC25A38
prerank,regulation of interferon-beta production (GO:0032648),0.7288462972546073,0.9177741595979053,0.6545,0.8008747209722453,1.0,17/48,16.39%,HSP90AA1;DDX3X;RIOK3;DHX9;FLOT1;YY1;IRF3;PYCARD;ISG15;PPM1B;OAS1;MAVS;SIRPA;TOMM70;IRF1;PTPN11;RNF216
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.7103498070573818,0.9177657760948013,0.6766766766766766,0.8005762323196689,1.0,8/15,25.57%,PLPP1;BMP4;ABHD2;CALCOCO1;NR3C1;NR3C2;BMP7;MED1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.7161677667489579,0.9177327559444225,0.6815,0.8003595215073578,1.0,6/27,14.58%,THY1;APLNR;ANK2;F2R;PLCG1;PDPK1
prerank,endosome organization (GO:0007032),0.7248878775841309,0.9171855281055559,0.658,0.8018920348029865,1.0,23/41,18.86%,SQSTM1;SNX3;PLEKHJ1;LAMTOR1;TMEM9;LAPTM4B;ALS2CL;HOOK2;CLCN3;CHMP2B;DNM1;HOOK3;CORO1C;RAB22A;DNAJC13;WASHC4;RAB27A;ARFGEF2;PHETA1;RILP;USP8;VPS11;RNF26
prerank,organelle fusion (GO:0048284),0.7083084676271502,0.9170973322048227,0.664,0.8018651846000409,1.0,17/22,25.82%,FIS1;SPG7;MFF;MFN2;STX4;BAX;AFG3L2;MIGA2;CHCHD3;OPA1;MFN1;VPS11;MIEF1;EEA1;THG1L;USP30;MIGA1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.7108757994209967,0.9170647590862747,0.6675,0.8016471859536682,1.0,8/25,17.84%,PARK7;HAND2;MAD2L2;DOT1L;NSD1;SIN3A;SOX11;ZBTB7A
prerank,protein monoubiquitination (GO:0006513),0.7246458573024362,0.9170024869679284,0.6635,0.8015335236801324,1.0,24/37,21.58%,UBE2D3;RBX1;UBE2B;HUWE1;UBE2R2;WAC;RNF126;RNF40;UBE2E1;CUL3;ZNF598;NEURL1;ATXN7L3;UBE2T;FANCL;UHRF1;KLHL22;TRIM25;PAF1;KLHL12;MGRN1;CTR9;RNF20;DTX3L
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.7396371381282363,0.9167797871947895,0.6605,0.8019458570708861,1.0,12/68,11.86%,FGFR3;PPP2R1A;STAP2;VEGFA;HES1;TNFRSF1A;PPP2CA;IL6ST;SOCS3;PTK6;ARL2BP;INPP5F
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.7179205701772353,0.9163659661213033,0.6645,0.8030650506431262,1.0,7/33,7.98%,PARK7;DDX3X;TMBIM1;PEA15;TNFSF10;CFLAR;ARHGEF2
prerank,small GTPase mediated signal transduction (GO:0007264),0.7520206777767644,0.9161979350300812,0.6745,0.8033107495086116,1.0,53/106,16.94%,JUN;RAC1;PARK7;GNB1;CDKN1A;TRIM28;CHP1;ABR;RHEB;SHC1;RGL2;NUCB1;ARHGAP1;G3BP2;SHC2;G3BP1;GRB2;RRAS;DNMT1;ARFIP2;RAB18;RALGDS;HACD3;HRAS;RASSF1;KRAS;RALB;CCDC88A;CRKL;TNK2;MAPK14;PLCE1;RALA;RREB1;ARL3;MAPKAPK5;TP53;NF1;NRAS;SOS1;ARHGAP33;RALBP1;PLK2;RGL1;BCR;KSR1;NTN1;RRAGC;PLD2;PLD1;CNKSR1;NUCB2;SETDB1
prerank,protein processing (GO:0016485),0.755310638639106,0.9161370580140448,0.668,0.8031943402989402,1.0,43/106,13.56%,TMPRSS2;CPE;OGT;PRSS3;CTSS;AEBP1;SPG7;LGMN;SPCS1;SEC11A;C1R;CTSL;ECE1;STOML2;SPCS2;HM13;CTSH;PSEN1;PTCH1;APH1A;KLK1;TMPRSS4;SPCS3;NCSTN;YME1L1;ADAM10;FURIN;PCSK7;CPXM1;TMEM208;SPPL3;FAM111A;AFG3L2;SEC11C;METAP2;PSENEN;CPD;MMP14;LONP2;GGT1;VSIR;SRGN;PITRM1
prerank,tube closure (GO:0060606),0.7129313022621994,0.9160494305655891,0.681,0.8031606907157967,1.0,18/31,22.23%,PLXNB2;VASP;TSC2;LMO4;SCRIB;DLC1;DVL2;BCL10;LRP6;DEAF1;SEMA4C;MTHFD1;PHACTR4;IFT122;PRICKLE1;SKI;COBL;MTHFR
prerank,second-messenger-mediated signaling (GO:0019932),0.747460564557747,0.9158807656374054,0.6665,0.8034029807526044,1.0,20/89,13.30%,APOE;PPP2R1A;TRPM4;RCAN1;DDAH2;NUDT4;AGT;PPP2CA;P2RX4;DDAH1;INPP5A;GUCY1B1;PLCG1;DGKD;GUCY1A1;EDNRB;ACKR3;EDN3;PLCE1;CAMKK2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.725700373953889,0.9156537922232786,0.666,0.8038542219301854,1.0,17/45,19.65%,CAV1;HES1;OCIAD1;NOTCH1;OCIAD2;HGS;SOCS3;F2R;LEPROT;ADIPOR1;DOT1L;IL10RB;BCL3;NF2;PIGU;CENPJ;SH2B3
prerank,regulation of glucose transmembrane transport (GO:0010827),0.7045376668280129,0.915532378323857,0.666,0.8039527713002016,1.0,11/19,23.20%,SLC2A1;C3;OCLN;CLIP3;C1QTNF12;C2CD5;FFAR4;APPL1;INPP5K;BRAF;PRKAG2
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.7080945124885961,0.915434601127995,0.6805,0.8039656467862877,1.0,9/18,21.42%,RAP1B;RAP1A;RAB5A;PREPL;FMR1;GSK3B;RAB3GAP1;SNAPIN;RIMS3
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.7185488742085985,0.9153027857515587,0.674,0.8040832645430189,1.0,27/38,24.15%,CBX3;CBX5;UXT;RBBP7;RBBP4;RING1;PHC1;DAB2IP;PCGF2;EHMT2;TFDP1;RRM2;RYBP;MAX;EHMT1;EPC1;EZH2;TFDP2;SUZ12;PHC3;BMI1;MGA;E2F1;L3MBTL2;APAF1;RNF2;EED
prerank,myelination (GO:0042552),0.7282512673713533,0.9151638235502431,0.6665,0.8042452828552422,1.0,24/48,20.11%,MALL;MAL2;PMP22;BCAS1;MARVELD1;GPC1;SIRT2;EIF2B5;DEGS1;B4GALT5;ZNF24;NF1;LGI4;PLP1;PARD3;EIF2B4;TNFRSF21;MYRF;MBP;SBF2;EPB41L3;PLLP;CXCR4;SKI
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.7124263577176875,0.915015559474649,0.6845,0.8044375692820006,1.0,9/23,19.23%,FLOT1;APPL2;NR1H3;NINJ1;DAB2IP;F2RL1;WDFY1;APPL1;IFI35
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.7244613790736745,0.9146544128792758,0.6755,0.8053410639344203,1.0,19/50,16.57%,PARK7;MSMO1;SCP2;INSIG1;HMGCR;EBP;LBR;HSD17B10;CYP27A1;SQLE;HSD17B4;PMVK;OSBPL2;TM7SF2;ACOT8;DHCR7;OSBPL9;OSBP;SC5D
prerank,regulation of osteoblast differentiation (GO:0045667),0.7434937984409782,0.9142417212016642,0.663,0.8064631781806707,1.0,28/80,11.94%,DDX5;ATF4;FBN2;TRPM4;ATP6AP1;NOTCH1;ATRAID;FERMT2;YAP1;PTCH1;NBR1;IL6ST;SNAI2;NPNT;BMPR2;PTK2;DDR2;WWTR1;PRKACA;HDAC7;GREM1;CDK6;BMP4;LRP3;CRIM1;FGFR2;TWIST2;BMPR1A
prerank,regulation of histone acetylation (GO:0035065),0.7120314716679328,0.914201405029624,0.683,0.8062744787298625,1.0,17/33,20.41%,PARK7;SET;MAPK3;CTBP1;HDAC5;RUVBL2;TAF7;GLYR1;BRD7;NOC2L;KMT2A;IWS1;THAP7;RPS6KA4;ARRB1;MYOCD;CAMK1
prerank,response to lipid (GO:0033993),0.7546594990373601,0.9141991386142628,0.6665,0.8059547522512063,1.0,36/113,12.12%,APOA4;S100A14;CTNNB1;CPS1;HMGB2;SLPI;HNRNPA0;PCK1;ANXA1;PRDX3;LGALS9;CTSH;PCK2;SPP1;S100A8;ERBIN;ASXL1;VPS4B;GATA6;TRIB1;RXRA;MAPKAPK2;F2R;FGFR4;S100A9;PAQR8;RXRB;FOXO3;GPX3;FOXP1;IRAK1;SCD;OTUD5;STAT5B;GGT1;HSD17B2
prerank,mitochondrion localization (GO:0051646),0.7047953496604306,0.9136979938746352,0.677,0.8073497163314147,1.0,13/19,25.20%,NECTIN2;TRAK1;ALB;MFN2;BRAT1;MEF2A;TRAK2;MFN1;MARK2;MUL1;MSTO1;ZBED3;MTM1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.7171625055314447,0.913385454717046,0.671,0.808086545678624,1.0,20/32,21.95%,ROMO1;HSPD1;TOMM20;TIMM17B;DNAJC15;DNAJC19;TIMM44;TOMM40;TIMM17A;TIMM50;TOMM70;PEX2;PEX26;TIMM23;PEX6;PEX16;PEX5;GRPEL1;AIFM1;PEX10
prerank,pulmonary valve development (GO:0003177),0.708753343512581,0.9132761141599856,0.69,0.8081190476684951,1.0,7/18,11.47%,TNFRSF1A;JAG1;NOTCH1;NOTCH2;BMPR2;BMP4;ROBO1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.7184950774116559,0.9132517025544538,0.6755,0.8078775900088819,1.0,19/44,20.90%,PDCD4;GAS6;RAMP2;CCL2;CDH5;SEMA5A;ANO6;PLCG1;THBS1;NFE2L2;ECSCR;PDPK1;TNIP2;KDR;MAPK7;AKR1C3;KRIT1;PAK4;PRKCI
prerank,aspartate family amino acid catabolic process (GO:0009068),0.704832231699487,0.9131706769016039,0.685,0.8078324965859867,1.0,7/19,16.59%,PHYKPL;OGDH;DLD;GOT2;GOT1;ALDH7A1;DLST
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.7096547116700995,0.9131602353917798,0.6975,0.8075395358462436,1.0,16/28,21.54%,HMGN1;SUPT5H;SUPT4H1;SUPT16H;TCEA2;HTATSF1;CCAR2;ZMYND11;ZNF326;CCNT2;CCNK;SCAF8;THOC1;TSFM;KAT7;CCNT1
prerank,insulin receptor signaling pathway (GO:0008286),0.7392969077763738,0.9131181061370256,0.6685,0.8073579184997712,1.0,42/73,19.24%,RARRES2;ATP6V0B;ATP6V1G1;ATP6V0D1;ATP6V0E1;ATP6V1F;ATP6AP1;BCAR1;SHC1;AKT1;SLC39A14;SORBS1;TCIRG1;ATP6V1E1;AKT2;ATP6V0A1;GRB2;NAMPT;AP3S1;PDK2;IGF1R;ATP6V1B2;INSR;GAB1;RHOQ;SOGA1;PIK3R1;PHIP;GSK3B;GSK3A;SOS1;ATP6V1A;PIK3C2A;CAV2;C2CD5;ATP6V1D;APPL1;ATP6V1H;ZNF106;ATP6V1C1;IRS1;PTPN2
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.703907610844086,0.9127247683858344,0.694,0.8083832879468557,1.0,11/19,25.09%,UGDH;B3GAT3;HS6ST1;EXT1;EXT2;NDST1;GLCE;EXTL3;HS2ST1;XYLT2;XYLT1
prerank,cardiac conduction system development (GO:0003161),0.7133557910896499,0.9126586230267235,0.6835,0.808293006955013,1.0,10/25,23.50%,NOTCH2;SMAD4;GATA6;GJA1;BMP4;BMPR1A;SMAD5;MAML1;CACNA1G;GJA5
prerank,steroid hormone biosynthetic process (GO:0120178),0.7164704558845725,0.9125625581463214,0.67,0.8082914534586985,1.0,10/31,19.22%,TSPO;HSD17B11;AKR1B1;HSD17B2;FDX1;DHCR7;STARD3;HSD17B14;STARD3NL;HSD17B8
prerank,macroautophagy (GO:0016236),0.7567954483485088,0.9125091712390985,0.6735,0.8081572780958739,1.0,73/119,18.75%,DYNLL1;TOMM7;VAMP8;VPS28;SQSTM1;VCP;CSNK2B;GABARAPL2;VDAC1;TOMM20;MAP1LC3B;CHMP2A;ATG4B;UBXN6;CHMP3;DYNLL2;TCIRG1;HGS;PINK1;GABARAP;NBR1;MAP1LC3A;VPS25;EI24;VPS4B;PIP4K2B;SNF8;ULK3;TOMM22;VPS4A;LIX1L;PRKAB1;SRC;MFN2;LAMP2;VPS39;TSG101;CHMP4A;VPS37B;WIPI2;ULK1;TOMM40;UBQLN1;BECN1;CHMP4B;MVB12A;CSNK2A1;ARL8B;VPS36;CHMP2B;ATG12;VTI1B;PRKAA1;SNX14;TOMM70;VPS16;VTA1;CSNK2A2;ATG3;MTMR3;TBC1D5;CHMP6;SNAP29;ATG101;GABARAPL1;PRKAG1;MTMR14;TOMM5;VPS41;ATG13;RB1CC1;ATP13A2;MFN1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.7158047474628568,0.9122969757152077,0.6885,0.8085433536278632,1.0,17/32,20.99%,JAG1;PTEN;RCC2;ADAM15;ACVRL1;CLASP2;SRC;DLC1;MAP4K4;ITGB1BP1;THBS1;CASK;CORO1C;NF2;RASA1;PHLDB2;DMTN
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.7030113738951864,0.9122447993469522,0.6815,0.8084004721388247,1.0,4/16,15.69%,ECE1;ACE2;EDN3;ACE
prerank,carbohydrate derivative catabolic process (GO:1901136),0.7065230754033589,0.9121545504860802,0.682,0.8083887505474551,1.0,11/19,22.15%,OGA;FUCA1;STT3B;FBXO17;ADAMTS9;NAGA;FBXO2;SAMHD1;DERA;NEU4;NGLY1
prerank,cellular response to retinoic acid (GO:0071300),0.7161255123481435,0.9119460966952593,0.687,0.8087890424985422,1.0,15/42,18.93%,NDUFA13;PTK7;PTK6;FZD7;PTK2B;AQP1;SETX;SNW1;TWF2;RET;CREB1;LTK;ATM;HTRA2;FZD4
prerank,regulation of nuclear division (GO:0051783),0.7049148993387733,0.9118575766405556,0.69,0.8087524830298641,1.0,10/20,17.05%,OBSL1;PIN1;MKI67;CUL7;PRMT5;DAPK3;CCDC8;CDK13;CUL9;CAV2
prerank,cilium organization (GO:0044782),0.77593692691955,0.911053916709621,0.7345,0.8111695898870461,1.0,16/215,6.12%,FLNA;GSN;DYNLL1;SLC9A3R1;RAB1A;RAB11A;ARF4;ATP6V0D1;ACTR2;EHD2;PKD1;EXOC7;NOTCH1;RAB17;ACTR3;DYNLL2
prerank,ncRNA catabolic process (GO:0034661),0.7103448664101454,0.9109050267353443,0.6965,0.8113573621056214,1.0,22/30,26.11%,TRIR;SND1;ERN2;NUDT16L1;EXOSC10;NUDT16;DEDD2;EXOSC8;TUT4;MTREX;EXOSC6;XRN1;EXOSC7;EXOSC4;ZCCHC8;RBM7;EXOSC9;DIS3L;DIS3;DIS3L2;EXOSC2;EXOSC5
prerank,regulation of DNA replication (GO:0006275),0.7224672842360097,0.9104725337191181,0.6715,0.8125065214078444,1.0,28/52,21.36%,S100A11;PPP2R1A;NUCKS1;DHX9;PCNA;PPP2CA;ENPP7;ACVRL1;PDS5A;EHMT2;RBBP6;ZBTB38;SMC3;ANKRD17;CCDC88A;BRPF3;GMNN;EGFR;CDT1;GLI2;GLI1;TERF1;WAPL;GTPBP4;TSPYL2;FAF1;CCNA2;KAT7
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.7032683959350914,0.9104289133708515,0.7085,0.8123208195519308,1.0,15/22,26.41%,PGLS;GPI;TALDO1;HK2;TKT;PGD;HK1;H6PD;G6PC3;DERA;RPIA;PGM2L1;RPE;HKDC1;PGM2
prerank,mitotic metaphase plate congression (GO:0007080),0.7239852652555622,0.9103230307602739,0.681,0.8123469302633118,1.0,27/51,17.09%,RAB11A;DCTN2;PDCD6IP;CHMP2A;KIF22;KPNB1;CHMP1A;NUDC;CHMP5;CHMP3;EML4;VPS4B;CHMP1B;VPS4A;CHMP4A;NUP62;BOD1;BECN1;CHMP4B;CUL3;CHMP2B;CCNB1;CHMP7;RMDN1;EML3;CHMP6;CDT1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.7383255714368732,0.91023341749296,0.6825,0.8123156841437194,1.0,29/79,15.23%,EMILIN1;NBL1;UBE2D3;HTRA3;ATP2B4;PDCD6;SULF2;AGT;NOTCH1;SORL1;HGS;GPC1;SULF1;SMAD4;BMPR2;CREB3L1;LEMD2;DAB2IP;GREM1;FSTL3;CRIM1;THBS1;SPRY2;BMPR1A;SMAD5;CASK;SKIL;PPARG;EPN2
prerank,central nervous system neuron differentiation (GO:0021953),0.7135568653189794,0.9101583444637728,0.686,0.8122475329774359,1.0,5/34,9.00%,CTNNB1;SOX4;GBA2;NPY;PHOX2B
prerank,brain development (GO:0007420),0.7572325465676901,0.9101012435086594,0.6995,0.8121082284889314,1.0,55/148,15.38%,COL4A1;UGP2;HSPG2;PLXNB2;NNAT;CDK5RAP3;MEIS1;BAG6;PCDH18;NFIB;PBX1;VPS51;DDIT4;PAFAH1B1;PHGDH;PBX3;PTEN;UFC1;NDUFS4;SCT;PTCH1;TGFBR2;PAFAH1B3;TUBGCP2;ADGRL2;PAFAH1B2;UFM1;TMX2;RAB18;NES;IER3IP1;BPTF;CIC;MEIS3;ADGRG1;SMARCA1;B3GNT5;PITPNM1;MEIS2;SHANK3;ROGDI;AATK;UBE3A;SMG9;NF1;CHD8;CENPF;SCYL2;PPT1;ATXN1;NCOA6;NIPBL;CDK5RAP2;PTPN11;RAB3GAP1
prerank,cellular protein localization (GO:0034613),0.7867214218415578,0.9100388108564265,0.793,0.8119986778020918,1.0,113/314,12.85%,FLNA;CD63;CTSA;CD177;CD74;NPM1;ARF1;ID1;CTNNB1;VCL;CPE;CLTC;TM9SF3;TMED10;CTTN;RAB1A;ARF4;ERP29;TMED9;PDCD6;YWHAH;LAMTOR1;SEC31A;COPZ1;RAB5C;TM9SF2;TMED2;VPS29;RAB1B;SAR1A;SEC13;AP3D1;COPA;ARF5;RAB17;TMED4;PACS2;ARL14;ARF6;RAB5B;OXA1L;TBC1D9B;ABHD17A;FERMT2;LAPTM5;SNX17;HGS;NAPA;FBLN5;LAMTOR2;ARF3;ANK2;RAB14;VPS35;RAB6A;SNX1;TMED3;STXBP2;WLS;TBC1D1;SNX6;SGSM2;STX16;ARHGEF2;HDAC6;CORO1B;COPB2;GJA1;STX10;EHD1;ARL1;ARFRP1;ARCN1;MYO6;STX3;RRAGA;SGSM3;RAB5A;ARFIP2;TMED7;OCLN;RAB18;MFN2;ARMCX3;STX4;TM9SF4;GGA2;RABGAP1;STX7;GGA1;WIPI2;EMP2;GRTP1;USO1;HERC2;TBC1D2B;STX5;SAR1B;ESAM;VPS26A;ARL4A;NGFR;SNX9;ARFGAP3;MESD;LAMTOR3;WDR45;JAM3;VPS26B;RAB32;RAB21;STX12;AP2A1
prerank,in utero embryonic development (GO:0001701),0.7076121714757156,0.9098022154068824,0.6925,0.8124832146561346,1.0,7/25,11.79%,VEGFA;PKD1;FOXF1;MBNL1;ADAM10;TGFBR1;FGFR2
prerank,mitochondrial translation (GO:0032543),0.7438105051071903,0.9096907461537217,0.703,0.8125285387320671,1.0,72/104,18.10%,TUFM;MRPS21;MRPL41;AURKAIP1;GADD45GIP1;MRPL51;MRPL52;MRPS26;MRPL57;MRPS34;MRPL20;MRPL12;MRPL27;MRPL23;MRPL14;MRPL33;OXA1L;MRPL43;MRPS6;CHCHD1;MRPL55;MRPL34;MRPL28;MRPS7;MRPL54;MRPL22;MRPS18A;MRPS36;MRPS16;MRPL21;MRPL11;PTCD3;MRPL24;MRPL18;IARS2;MRPS5;MRPL13;MRPL37;MRPS25;MRPL4;MRPS12;NDUFA7;MRPL17;MRPS18C;MRPL16;MRPL36;MRPS15;MRPS11;MRPL40;MRPS2;MRPS33;MRPS18B;MTIF3;MRPS35;MRPL15;DAP3;MRPL42;MRPL3;MRPS23;MRPL2;MRPL32;MRPL35;MRPS27;ERAL1;RARS2;MRPL47;MRPL10;MRRF;MRPL9;MRPL48;GATC;MRPS14
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.7031710174599473,0.9096738954571438,0.695847923961981,0.8122509850521829,1.0,10/16,24.99%,MCM7;HMGA1;SSBP1;RPA1;MCM6;MCM4;MCM2;RECQL5;RECQL4;RECQL
prerank,regulation of G0 to G1 transition (GO:0070316),0.7161408100774078,0.9095607303745192,0.6875,0.8122919371974784,1.0,29/41,24.15%,CBX3;CBX5;UXT;RBBP7;RBBP4;RING1;PHC1;DAB2IP;PCGF2;EHMT2;TFDP1;RRM2;RYBP;MAX;EHMT1;EPC1;CDKN2B;EZH2;TFDP2;SUZ12;PHC3;BMI1;MGA;E2F1;L3MBTL2;RHNO1;APAF1;RNF2;EED
prerank,histone H3-K4 methylation (GO:0051568),0.7075031204320922,0.9088480630874838,0.697,0.8143977381181727,1.0,19/30,22.76%,OGT;WDR82;DPY30;KMT2B;CXXC1;WDR61;KMT2A;KMT2C;WDR5;ZNF335;MEN1;SETD1A;ASH2L;CTR9;TET2;SETD4;SETD1B;KDM6A;PAGR1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.7184650849089934,0.9082536111995615,0.694,0.8160934990881776,1.0,19/46,18.18%,CANX;MTTP;PDIA4;GOLPH3;RCN3;RAB10;TMEM167A;RAB13;SEL1L;MIA2;RAB8A;COPG1;RAB3D;ARFGAP3;PREB;SVBP;MIA3;NECAB3;RAB8B
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.7226632843856539,0.9077266702131062,0.6975,0.8175524376556076,1.0,40/60,21.55%,CSNK2B;CDK10;AKT1;TGFBR2;MAPK1;ROCK2;CAMK2D;DYRK2;PRKDC;PRKD2;WNK1;CDK1;ULK1;DYRK1A;CDC42BPA;HIPK3;TGFBR1;CAD;CSNK2A1;CDC42BPB;GSK3B;MAP3K12;HIPK1;GSK3A;ACVR1B;PRKCD;PDPK1;OXSR1;ROCK1;CSNK2A2;TNKS;MAPK8;DYRK4;PRKCA;STK39;MAP2K1;MARK2;DYRK1B;LMTK2;HIPK2
prerank,calcium ion transport into cytosol (GO:0060402),0.6988188984222177,0.9074397657908339,0.7115,0.8182050242383111,1.0,8/21,24.28%,ATP2B4;ITPR3;CACNB3;JPH2;MS4A1;CACNA1C;SLC8A1;CACNA2D1
prerank,bile acid metabolic process (GO:0008206),0.7084477489939054,0.9072795841721178,0.7105,0.8184104580729074,1.0,15/33,23.16%,SCP2;ACAA1;GBA2;HSD17B10;CYP27A1;HSD17B4;OSBPL2;ACOT8;OSBPL9;OSBP;OSBPL7;OSBPL1A;ACOX2;NPC1;SLC27A2
prerank,positive regulation of JNK cascade (GO:0046330),0.7325738133173604,0.9071469747919982,0.6955,0.8185277625682925,1.0,36/72,21.55%,CCL21;HMGB1;APP;SDCBP;PJA2;MAP3K11;LTBR;TRAF4;DAB2IP;F2RL1;PYCARD;FZD7;PTK2B;HRAS;SEMA3A;UNC5CL;TAOK1;MINK1;TRAF5;AXIN1;GADD45B;SH3RF2;TAOK2;GADD45A;TPD52L1;RASSF2;RIPK1;GADD45G;MTURN;ZNF622;MAP4K2;AGER;FLT4;SH3RF1;NCF1;HIPK2
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.7092279398237811,0.9069917965774783,0.6925,0.8187112205752906,1.0,17/33,23.30%,TECR;ELOVL1;ACAA1;ACOX1;ABCD4;CYP4F12;HACD3;ABCD3;PEX2;HACD2;ELOVL5;ACOX2;SLC27A4;ACOT2;ELOVL7;SLC27A2;HACD1
prerank,axon guidance (GO:0007411),0.7681552838673142,0.9065374868177998,0.7435,0.8199199559239251,1.0,71/202,12.61%,EZR;BSG;EFNA1;CXCL12;RAC1;SPTBN1;PLXNB2;PDLIM7;SPTAN1;EVL;PLXNB1;SEMA3B;NPTN;MAPK3;LAMA5;NCAM1;VEGFA;NOTCH3;NFIB;PALLD;NRP1;VASP;KIF5B;EFNB1;PLXND1;SHC1;GAP43;NOTCH1;SMO;NRP2;EPHA2;SLIT3;SEMA4G;CYFIP1;NOTCH2;LYPLA2;SEMA5A;ENAH;GPC1;PTPRA;EPHB4;GRB2;SEMA3C;GFRA1;MAPK1;LAMA3;DOK4;PTK2;DAG1;EPHB3;LAMA1;PLA2G10;SRC;SEMA6A;SEMA4B;ARHGAP35;GAB1;PLCG1;L1CAM;ROBO1;PLXNA1;PLXNA3;EPHB2;SHANK3;SEMA3A;USP33;FYN;IGSF9;ALCAM;EFNB2;RHOG
prerank,cartilage development (GO:0051216),0.7188312515611498,0.906465291425714,0.694,0.8198333158622646,1.0,13/51,12.53%,FGFR3;PKD1;NFIB;SULF2;SLC39A14;OSR1;HYAL2;SULF1;SNORC;BMP4;CD44;DDRGK1;CREB3L2
prerank,folic acid-containing compound metabolic process (GO:0006760),0.699187118719371,0.9062471345729912,0.714,0.8202412008834734,1.0,18/20,28.55%,GGH;SHMT2;MTHFD1;DHFR;SLC46A1;MTHFS;FTCD;FPGS;MTHFD2;MTHFR;SHMT1;ALDH1L1;MTHFD2L;MTHFD1L;MTRR;SLC19A1;SLC25A32;FOLR2
prerank,receptor signaling pathway via STAT (GO:0097696),0.6982663090466392,0.9062368980029385,0.714,0.8199482603221435,1.0,15/25,24.38%,PKD1;CCL2;STAT2;STAT6;STAT5B;PKD2;IFNAR1;STAT1;STAT3;PIAS1;SOCS6;CTR9;STAMBP;GHR;SOCS2
prerank,peripheral nervous system development (GO:0007422),0.705485827655858,0.9060999844104314,0.6965,0.8200979238348751,1.0,7/25,13.68%,ERBB3;PMP22;GPC1;GSTM3;ALDH3A2;ADGRB2;NF1
prerank,positive regulation of immune system process (GO:0002684),0.6993595565745411,0.9058893481396018,0.7015,0.8204887903777304,1.0,3/21,5.85%,VEGFA;ANXA1;LGALS9
prerank,glycoprotein catabolic process (GO:0006516),0.7007455128508138,0.9058812569639372,0.71,0.8201876948256858,1.0,13/18,28.31%,OGA;CTSL;STT3B;FBXO17;ADAMTS9;FBXO2;NEU4;NGLY1;EDEM1;EDEM2;ADAMTS12;MANBA;FBXO44
prerank,regulation of isotype switching (GO:0045191),0.6994735533362996,0.9058162265655667,0.703,0.8200921508818053,1.0,10/16,24.80%,TFRC;TP53BP1;SUPT6H;KMT5B;MAD2L2;RIF1;HMCES;SHLD2;KMT5C;SLC15A4
prerank,protein sumoylation (GO:0016925),0.720224531222523,0.9058028237791199,0.688,0.8198140582935008,1.0,44/54,26.40%,SUMO2;TRIM28;TRPM4;UBE2I;SUMO1;SUMO3;SAE1;TPR;PIAS3;UBA2;RANGAP1;RANBP2;NUP62;NUP85;ZBED1;NUP50;NUP188;NUP160;AAAS;NUP98;POM121;PIAS1;RAE1;NUP214;NUP58;ZNF451;PIAS4;POM121C;NUP93;NUP133;NUP205;NUP54;NUP153;NUP107;NUP43;NDC1;PIAS2;BCL11A;NUP88;NUP210;STX1A;NUP155;SEH1L;NSMCE2
prerank,regulation of glycolytic process (GO:0006110),0.7294404097376324,0.9057937621566551,0.698,0.8195137941490297,1.0,41/69,20.23%,PGAM1;APP;NUPR1;EIF6;OGT;SEC13;SLC4A4;PSEN1;MLXIPL;TPR;NCOR1;HIF1A;ENTPD5;INSR;RANBP2;NUP62;JMJD8;GIT1;FBP1;NUP85;NUP50;NUP188;PRKAA1;NUP160;AAAS;NUP98;POM121;RAE1;PFKFB2;NUP214;NUP58;PRKAG1;ZBTB7A;POM121C;NUP93;EP300;ARNT;NUP133;NUP205;NUP54;NUP153
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.699628711667725,0.9056395390061676,0.708,0.819702046553597,1.0,9/18,22.90%,SULT1B1;SULT1A1;SULT1E1;SULT2A1;ABHD14B;SULT1C2;TPST1;SULT1A2;TPST2
prerank,carbohydrate derivative transport (GO:1901264),0.7018305624518718,0.905234677702355,0.704352176088044,0.8207630204381408,1.0,8/18,20.30%,NPC2;SCARB1;PLA2G10;CPTP;PLTP;SLC29A1;VLDLR;MFSD2A
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.7407911643907824,0.9049976851738645,0.703,0.8212487867381784,1.0,53/98,21.55%,CCL21;HMGB1;APP;PRMT1;VEGFA;STK25;EMC10;INAVA;ARL6IP5;SDCBP;PJA2;HAND2;MAP3K11;LTBR;TRAF4;XDH;DAB2IP;F2RL1;PYCARD;FZD7;PTK2B;HRAS;SEMA3A;UNC5CL;TAOK1;MINK1;TRAF5;KLHDC10;AXIN1;PDCD10;GADD45B;EIF2AK2;SEMA4C;SH3RF2;TAOK2;SASH1;GADD45A;TPD52L1;RASSF2;RIPK1;GADD45G;BMP2;ZC3H12A;MTURN;ZNF622;MAP4K2;AGER;MID1;FLT4;SH3RF1;NCF1;MAP3K4;HIPK2
prerank,transcription by RNA polymerase III (GO:0006383),0.7041555904077789,0.9048011755005909,0.709,0.8215836454084606,1.0,20/27,26.03%,POLR2L;IVNS1ABP;GTF3C6;GTF3C1;POLR2K;GTF3C5;GTF3A;BRF1;GTF3C2;ICE1;ICE2;GTF3C3;SNAPC4;SNAPC3;POLR3GL;GTF3C4;POLR3H;SNAPC2;TBP;POLR3K
prerank,hemopoiesis (GO:0030097),0.7353699658776011,0.9045125321594808,0.691,0.8222145657520401,1.0,50/94,21.62%,ZFP36L2;ATF4;CD164;MEIS1;CEBPA;SFRP2;MKNK2;SFRP1;PRDX3;JAG1;CD34;AHSP;NOTCH2;GLRX5;TGFBR2;RRAS;SBDS;BMP4;FSTL3;PRRC2C;ARIH2;DLL1;KAT8;FGFR2;YTHDF2;PGM3;KMT2A;SNRK;TGFBR3;TP53;HIPK1;IFI16;NCOA6;CDK13;CSF1R;ZNF160;KDR;KAT6A;ARMC6;KITLG;BMI1;SH2B3;ASH2L;ZFPM1;TET2;FLT4;NOTCH4;FST;MECOM;TOX
prerank,transepithelial transport (GO:0070633),0.69316087971866,0.9044372172145175,0.705,0.8221340763574354,1.0,9/16,26.72%,SLC26A6;SLC12A2;CXADR;SLC1A1;ABCG2;SLC23A2;ABCB1;RHBG;ABCC1
prerank,regulation of sequestering of triglyceride (GO:0010889),0.6978813925604623,0.9038880113970845,0.7163581790895448,0.8236653123324992,1.0,5/15,17.17%,PNPLA2;PLIN3;PLIN2;PPARG;OSBPL8
prerank,peptidyl-threonine modification (GO:0018210),0.7239028689941347,0.9037480444419815,0.705,0.8238157067403704,1.0,44/67,21.55%,CSNK2B;CDK10;AKT1;GALNT1;TGFBR2;MAPK1;ROCK2;CAMK2D;DYRK2;PRKDC;PRKD2;WNK1;CDK1;ULK1;DYRK1A;CDC42BPA;HIPK3;TGFBR1;CAD;CSNK2A1;CDC42BPB;GALNT2;GSK3B;MAP3K12;HIPK1;GSK3A;ACVR1B;PRKCD;PDPK1;OXSR1;ROCK1;CSNK2A2;TNKS;MAPK8;GALNT11;DYRK4;PRKCA;STK39;MAP2K1;MARK2;DYRK1B;GALNT3;LMTK2;HIPK2
prerank,renal system development (GO:0072001),0.7243718677910563,0.903489148961714,0.7065,0.8243628473336424,1.0,24/57,19.64%,TCF21;VEGFA;BAG6;PKD1;SULF2;FOXF1;AGT;HYAL2;SULF1;BMP4;HSPB11;WFS1;TGFBR1;ARL3;IFT27;CENPF;ACE;STAT1;GLI2;PYGO2;LRP4;ITGA8;NPHP3;MYOCD
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.7207727753138562,0.9034817941005734,0.701,0.8240613694968821,1.0,41/56,22.83%,LSM7;ZFP36;LSM4;LSM3;CNOT1;LSM2;LSM5;DDX6;CNOT2;LSM6;NT5C3B;TNKS1BP1;WDR61;TTC37;CNOT8;SAMD4B;CNOT3;LSM1;EXOSC8;PAN3;CNOT7;CNOT9;TUT4;PAN2;SKIV2L;CNOT6;DCP2;EXOSC6;EDC3;SAMD4A;EXOSC7;RC3H2;CNOT11;CNOT6L;RC3H1;EXOSC4;EXOSC1;POLR2D;CNOT10;EXOSC9;DCP1A
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.7378317820250946,0.9031727908461848,0.709,0.8247652425192508,1.0,62/87,21.10%,SNX3;CLTC;PLEKHJ1;SURF4;TMED9;RAB7A;VPS51;VPS29;SNX5;WASHC1;DCTN1;VPS35;RAB6A;SNX1;SPAG9;GBF1;SNX6;SGSM2;STX16;RNF126;STX10;LMAN1;ARL1;VAMP3;ARFRP1;DENND5A;TRIM27;DENND2A;GGA1;PREPL;STX5;VPS26A;RHOBTB3;TMEM87A;VPS26B;VTI1B;TBC1D14;GCC2;BET1L;YKT6;GOSR2;TMEM87B;TBC1D10B;SNX2;SNX12;TBC1D5;WASHC2A;ANKFY1;VPS52;TBC1D17;TBC1D23;PHETA1;WASHC2C;RAB29;ERC1;CLN5;PIKFYVE;RAB9A;VPS54;VPS53;RBSN;TBC1D10A
prerank,polyol biosynthetic process (GO:0046173),0.698808524937207,0.9031059544349371,0.723,0.8246622395292348,1.0,8/16,19.71%,IP6K2;CYP27A1;ISYNA1;ITPKA;PPIP5K2;IP6K1;ITPKC;ITPKB
prerank,cellular response to starvation (GO:0009267),0.7598761889689465,0.902903969143488,0.731,0.8250142319690212,1.0,51/155,12.53%,HNRNPA1;HSPA8;ATF4;AOC1;LAMTOR4;HSPA5;ATP6V0B;CDKN1A;LAMTOR5;ATP6V1G1;MAPK3;GABARAPL2;ATP6V0D1;LAMTOR1;ATP6V0E1;ATP6V1F;SREBF2;MAP1LC3B;RHEB;XBP1;SEC13;SFRP1;STK24;DAP;TCIRG1;ATP6V1E1;GABARAP;MAP1LC3A;LAMTOR2;SREBF1;SH3GLB1;MAPK1;BMPR2;CEBPB;FOXO3;SESN3;GCN1;RRAGA;ALB;EHMT2;LAMP2;ATP6V1B2;WIPI2;KLF10;BECN1;MLST8;TFEB;RALB;USP33;LAMTOR3;WDR45
prerank,neural crest cell development (GO:0014032),0.7107226124188297,0.9026535695770475,0.718,0.8255333621457637,1.0,26/45,22.39%,SEMA3B;ANXA6;PDCD6;SEMA4G;SEMA5A;SEMA3C;SNAI2;SEMA6A;PEF1;SEMA4B;SEMA3A;NOLC1;CORO1C;SEMA5B;SEMA6C;SEMA4C;SEMA3F;SOX11;PHACTR4;KLHL12;GDNF;SEMA3D;TCOF1;SEMA6D;SEMA4D;TAPT1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.7016399114558277,0.9024866129288431,0.7115,0.8257696492018526,1.0,18/30,25.00%,DDX3X;TNFRSF1A;GABARAP;ZDHHC3;DELE1;SORT1;DAB2IP;BAX;DEDD2;MOAP1;DAXX;DEDD;TRADD;TNFRSF10B;BID;BCL2;BAG3;FADD
prerank,folic acid metabolic process (GO:0046655),0.6967655997363464,0.9023259636323656,0.7245,0.8259827020021586,1.0,17/19,28.55%,SHMT2;MTHFD1;DHFR;SLC46A1;MTHFS;FPGS;MTHFD2;MTHFR;PM20D2;SHMT1;ALDH1L1;MTHFD2L;MTHFD1L;MTRR;SLC19A1;SLC25A32;FOLR2
prerank,response to organonitrogen compound (GO:0010243),0.7099938210838045,0.9020753412771844,0.718,0.8264841461540239,1.0,18/38,22.79%,VCP;INAVA;UBXN6;RCN3;SEL1L;RNF5;SYVN1;ERLEC1;CCDC47;DERL1;DNAJB12;RRAGC;NR1H4;DHFR;MTOR;RNF185;KAT7;RNF139
prerank,positive regulation of kinase activity (GO:0033674),0.7461127621476651,0.9019114524937303,0.709,0.8267201708709772,1.0,33/113,12.23%,CD74;CCL21;FGFR3;CDKN1A;ERBB2;JTB;ERBB3;XRCC6;PDGFRB;PDGFRA;XRCC5;HLA-DRB1;DDR1;FGFR1;GAS6;EPHA2;RAP1A;IQGAP1;EPHB4;LMO4;TRAF4;PTK2;EPHB3;DDR2;FGFR4;IGF1R;INSR;PTK2B;MAP2K3;FGFR2;EPHB2;AXL;SNX9
prerank,cognition (GO:0050890),0.7178752584746377,0.9016184019866368,0.711,0.827364395076511,1.0,11/46,15.16%,ST3GAL4;APP;HLA-DRA;CYFIP1;DGCR2;TUSC3;NSUN5;MAGT1;CHMP2B;NF1;NIPBL
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.7232453049650044,0.9010252238636157,0.721,0.8290258928401174,1.0,35/64,18.51%,SUB1;CTNNB1;CDKN1A;TRIM28;CCND1;CDK4;PTEN;MOV10;TCF7L2;MED16;MED15;CEBPB;RELA;BAX;SRF;CDK1;TNRC6A;MED14;MED13;MED4;MED25;MED10;MED12;CCNB1;TP53;CBFB;CCNC;CSF1R;ZNF451;MED24;HNF1A;MED8;TNRC6B;MED23;ATF7IP
prerank,peptidyl-lysine dimethylation (GO:0018027),0.6942867400786372,0.9008311170783255,0.7175,0.8293490613895068,1.0,13/19,22.31%,CSKMT;EHMT2;KMT2B;KMT2A;SETD2;EHMT1;SETD3;ASH1L;SETD1A;SMYD2;EEF1AKMT2;SETD4;SETD1B
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.7007213957244847,0.9007356258958505,0.7285,0.8293413716000537,1.0,12/25,21.11%,PRKAR1A;UBE2B;CDC34;APLNR;PRKAR2B;PDE3A;PRKAR1B;PRKAR2A;FFAR4;RAPGEF2;MGRN1;GNAI1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.7655785541290305,0.9007121625748926,0.7435,0.8290903916085056,1.0,49/197,10.14%,HNRNPK;HNRNPDL;PCBP2;APOE;ZFP36L1;ARF1;ATP1B1;YBX1;CDH1;PCBP1;HNRNPD;TAPBP;APP;LDLR;HNRNPAB;SCARB2;LAMTOR1;FLOT1;CDK4;PIN1;TARDBP;HMG20B;ATRAID;ADNP;IGF2BP2;PCBP4;FUBP1;PSEN1;APLNR;POGZ;TMPRSS4;YBX3;CGGBP1;RNF187;ROCK2;SORT1;HIF1A;TRIM31;IHH;NFKBIZ;TRIM27;PHOX2B;CDK6;TRIM15;TOB1;ATXN7L3B;RFXANK;FOXP1;TRIM44
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.7057604251556618,0.9003185050727012,0.713,0.8300884854674455,1.0,20/32,24.29%,NOP53;CDKN1A;CDK5RAP3;BABAM1;CDK1;FOXN3;FZR1;TAOK1;TAOK2;MRNIP;HMGA2;ATM;PLK1;TOPBP1;NBN;BABAM2;UIMC1;MRE11;TAOK3;BRCC3
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.7029339780467855,0.899916044648534,0.727,0.831106574982018,1.0,17/27,25.03%,FLOT1;LGR4;APPL2;FLOT2;GPR108;BIRC2;TYRO3;IRF1;LRRC14;APPL1;CD36;IRF7;OTUD4;NFKBIL1;CACTIN;BIRC3;GPS2
prerank,regulation of mitotic cell cycle (GO:0007346),0.7603945470342534,0.899496360838302,0.7365,0.8321669978099882,1.0,112/178,19.23%,SKP1;HNRNPU;SLC9A3R1;CDKN1C;APP;PSMB1;USP22;PSME1;PSMB4;ANAPC11;PSME2;CDK5RAP3;PSMD8;PSMB3;PSMA7;PSMB5;LGMN;PSMB7;PSMB6;UBE2S;BTG2;BTG1;CDK10;PSMA1;PSMA4;ANAPC16;PSMC5;PSMC3;OBSL1;ANAPC5;PSMD2;DDB1;PSMA2;PIM3;PIN1;PSMB2;SDCBP;PSMD13;PSMD4;GAS1;CDC16;UBE2C;IQGAP1;PSMD3;BUB3;CKS2;EIF4EBP1;MAEA;PSMC1;PSMC6;GBF1;TMEM8B;PSMC4;HSF1;SCRIB;PSMF1;PSMA3;PSMA5;MKI67;CDC25B;RNF40;CKS1B;CDKN1B;CUL7;PRMT5;CDK1;EIF4E;DAPK3;UBE2E1;ANAPC7;SMAD3;PSMB8;ANAPC15;PSMD7;PSMC2;SRA1;PKN2;MEIS2;FZR1;TTL;DUSP3;CCDC8;PSMD6;CUL1;CCNB1;PSMD1;TTLL12;BTG3;ERCC3;PSMD9;CDC20;CDK13;CUL9;CCDC57;CDK11B;SMOC2;CDC26;TTC28;NEK7;CAV2;CDC27;PSME4;PSME3;PSMD14;PSMD11;ANAPC1;PRKCA;MDM2;PLK1;PSMD12;HECA;XPC
prerank,cellular response to nutrient levels (GO:0031669),0.7209056734131574,0.8990061938545276,0.7155,0.8334512935181208,1.0,36/64,20.56%,HSPA8;EIF4G1;SREBF2;MAP1LC3B;XBP1;SFRP1;STK24;MAP1LC3A;CD68;SREBF1;BMPR2;PDK2;RRAGA;ALB;EHMT2;LAMP2;WIPI2;ULK1;KLF10;TFEB;RALB;USP33;WDR45;WDR45B;CDKN2B;RIPOR1;PRKAA1;RRAGC;TSC1;VPS41;MTOR;AKR1C3;FNIP1;MFSD2A;FADS1;WIPI1
prerank,positive regulation of nuclear division (GO:0051785),0.6982107567833186,0.8988630612790524,0.7255,0.8336102685658392,1.0,8/27,14.74%,PDGFRB;SIRT2;INSR;NUSAP1;NUP62;EDN3;PHIP;LRP5
prerank,Golgi organization (GO:0007030),0.7478439929784982,0.8986535637153593,0.732,0.833982781591255,1.0,61/130,17.27%,YWHAZ;VMP1;CDC42;TMED10;RAB1A;CSNK1A1;SURF4;TMED9;LMAN2;STK25;VPS51;TMED2;GAK;CSNK1D;RAB2A;OBSL1;GOLGA8A;ATP8B1;TMED4;GOLPH3;HUWE1;NPLOC4;GBF1;ARHGEF7;TMED3;OPTN;GOLGB1;STX16;COG4;SEC16A;CLASP2;LMAN1;ARL1;SEC22B;GOLGA2;ARHGAP21;TMED7;TRAPPC12;PLEKHM2;NSFL1C;CUL7;PRMT5;CDK1;HTT;STX5;GORASP2;ATL3;VTI1B;TBC1D20;GCC2;CLASP1;GOSR2;PDCD10;TJAP1;ARFGEF1;LMAN2L;TMED1;TMED5;GOLGA8B;SYNE1;COG3
prerank,acute inflammatory response (GO:0002526),0.7002367848632507,0.8985441201206824,0.728,0.8340226778020492,1.0,7/27,20.32%,SIGIRR;PLSCR1;CEBPB;ANO6;CTNNBIP1;F3;AHSG
prerank,positive regulation of cell communication (GO:0010647),0.7010093694513502,0.8983451567926682,0.728,0.8343643187214026,1.0,11/28,24.61%,CLSTN1;ILK;WLS;EDN3;PTPN23;SOX11;ANK3;RIMS3;CLSTN3;EDN1;SYT1
prerank,neural crest cell differentiation (GO:0014033),0.6914412205362404,0.8983167874608162,0.7385,0.8341306066357828,1.0,14/19,29.54%,PDCD6;SNAI2;PEF1;NOLC1;LRP6;SOX11;MEF2C;KLHL12;TCOF1;TAPT1;CDH2;FAM172A;FBXL17;SOX8
prerank,regulation of rRNA processing (GO:2000232),0.6918443610656352,0.8983056402063918,0.718,0.8338404421341191,1.0,13/16,28.08%,TRMT112;SIRT7;YTHDF2;BUD23;NUDT16;USP36;WDR75;DIMT1;WDR43;HEATR1;RIOK1;RIOK2;KAT2B
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.7139468031275716,0.898085199018159,0.719,0.8342502008512093,1.0,29/45,24.39%,NUCKS1;OGT;SNX5;TSC2;TNS2;SORL1;PRKCZ;SORBS1;PIP4K2B;ZBTB7B;C1QTNF12;GSK3A;PRKCD;PTPN11;IRS1;PTPN2;AHSG;INPP5K;RPS6KB1;SLC27A4;PIP4K2A;PID1;GRB10;KANK1;GRB7;PIP4K2C;NCK1;SIK2;SIRT1
prerank,macrophage activation (GO:0042116),0.7040265716752677,0.8977264709870074,0.735,0.8351453047548008,1.0,9/36,15.28%,APP;CLU;C1QA;IFNGR1;FOXP1;CD93;CRTC3;AIF1;SBNO2
prerank,proteasomal protein catabolic process (GO:0010498),0.7650496693279764,0.8976492755340075,0.7645,0.8350791951663986,1.0,100/204,14.93%,IFI27;PCBP2;UCHL1;CTNNB1;PSMB1;UBE2D3;RBX1;PSME1;PSMB4;FBXW5;VCP;PSME2;PSMD8;PSMB3;PSMA7;PSMB5;BAG6;PSMB7;PSMB6;PSMA1;PSMA4;PSMC5;ENC1;RBCK1;PSMC3;ANKRD9;NEDD4L;UBE2B;SPSB3;UBXN1;PSMD2;DDB1;PSMA2;STUB1;CDC34;PCNP;PSMB2;UBXN6;PSMD13;PSMD4;RAD23A;PSMD3;AGAP3;MAEA;PSMC1;RCN3;HUWE1;PSMC6;ZSWIM8;MTA1;TRIM2;RAD23B;TBL1XR1;SIRT2;RNF187;PPP2R5C;PSMC4;SEL1L;RNF126;RNF5;PSMF1;SHARPIN;PSMA3;PSMA5;CUL4A;DCAF11;ZFAND2B;BIRC2;UBE2A;SYVN1;NSFL1C;GID8;ERLEC1;RMND5A;UBE2K;ZFAND2A;FEM1B;PSMB8;RNF186;PSMD7;PSMC2;KAT5;CUL3;KCTD10;NFE2L2;PSMD6;CCDC47;KCTD5;PRPF19;APPBP2;PSMD1;DERL1;GSK3A;BFAR;UBE2G1;DNAJB12;WWP2;KLHL42;PSMD9;NHLRC3
prerank,chromatin organization (GO:0006325),0.7487693505409588,0.897611852947028,0.7425,0.834876201671402,1.0,57/138,15.00%,HMGN2;NPM1;HMGN1;NUCKS1;HMGB2;HP1BP3;HMGN3;CBX3;LOXL2;PADI2;HDAC1;SAFB;RBBP4;HDAC2;FAM50A;SMARCA4;HDAC5;SMARCA5;SUPT4H1;ARID1A;KAT2A;MCM3AP;SMARCD3;RUVBL2;SMARCA2;SMARCB1;ATRX;PHF1;BPTF;SUPT6H;GATAD1;KDM5B;BAZ2A;TOP1;PIH1D1;SMARCD2;SMARCA1;SMARCC1;BAZ2B;BRWD1;HDAC3;KDM5C;SATB2;HCFC1;DR1;PBRM1;MYC;SETD2;PAK1;EHMT1;NUDT5;BAZ1B;TCF7L1;MPND;SMARCD1;EZH2;SATB1
prerank,protein complex oligomerization (GO:0051259),0.7334437833428152,0.8973155488374868,0.7325,0.8355283395075879,1.0,31/89,13.45%,FUS;RBMX;MAT2A;PRMT1;HLA-DRB1;PDCD6IP;GSDMD;CHMP2A;STOML2;OXA1L;G3BP2;UGDH;CPSF6;CPSF7;YME1L1;ELAVL1;TMEM120A;EHD1;NUDT21;NINJ1;LETM1;DNM1L;PYCARD;TP53BP1;RNF213;HGSNAT;BOK;ATL3;SHMT2;PKD2;BCL10
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.7117886397266557,0.897199460277474,0.7325,0.8355787071513966,1.0,33/49,23.20%,PGAM1;EIF6;OGT;SEC13;TPR;KHK;HIF1A;RANBP2;NUP62;JMJD8;NUP85;NUP50;NUP188;NUP160;AAAS;NUP98;POM121;RAE1;NUP214;NUP58;PRKAG1;ZBTB7A;POM121C;NUP93;EP300;NUP133;NUP205;NUP54;NUP153;NUP107;NUP43;NDC1;PRKAG2
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.6903359230118795,0.8971073679912961,0.7365,0.8355684214980849,1.0,5/18,19.25%,CCL2;PTK2B;SHANK3;NLGN2;TSHZ3
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.707422146106041,0.8968786688313145,0.721,0.8360025344113011,1.0,21/40,18.11%,MCL1;IER3;ABL1;BCLAF1;UBE2N;SIRT7;SMG1;FXR1;NSMCE4A;UBE2V2;FEM1B;FMR1;NSMCE1;MYC;FXR2;PRKCD;WRNIP1;USP1;RPA2;KMT5A;HMGA2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.695739027572327,0.8967374524754483,0.724,0.8361488141914896,1.0,20/25,28.92%,MTMR11;PTEN;PIP4P1;INPP5F;SACM1L;MTMR3;MTMR4;OCRL;INPP5K;MTMR10;MTMR2;MTMR6;MTMR12;INPP5J;MTM1;SYNJ2;MTMR9;INPP5B;PIP4P2;MTMR1
prerank,positive regulation of isotype switching (GO:0045830),0.6897506538385673,0.8965555463034055,0.736,0.8364310020127412,1.0,11/16,28.35%,TFRC;TP53BP1;KMT5B;MAD2L2;RIF1;HMCES;SHLD2;KMT5C;CLCF1;PAXIP1;TGFB1
prerank,negative regulation of double-strand break repair (GO:2000780),0.7038987835897439,0.8965403096123128,0.721,0.8361529773228368,1.0,19/31,23.94%,OTUB1;FBH1;TRIP12;HSF1;NUDT16L1;TP53BP1;MAGEF1;SMCHD1;UBR5;MAD2L2;OGG1;RIF1;UBQLN4;HMGA2;SHLD2;CYREN;RNF169;TFIP11;RMI2
prerank,DNA recombination (GO:0006310),0.7062944418808993,0.8962969176287561,0.73,0.8366293882413408,1.0,8/39,13.01%,HMGB1;RAD21;FBH1;ERCC1;RPAIN;RPA1;TSN;HMGB3
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.6900915917868063,0.8961239056888713,0.736,0.8368715915582668,1.0,13/16,29.03%,NAA10;CREBBP;NAA60;NAA50;NAA20;EP300;NAA30;NAA16;NAA40;KAT2B;NAA25;NAA35;NAA15
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.6876069574908703,0.8958620894000061,0.7377377377377378,0.8373864010047958,1.0,4/15,18.48%,ZDHHC3;ZDHHC12;NLGN2;STXBP1
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.7008464951826585,0.8955759251814827,0.737,0.8379914410599854,1.0,20/31,26.25%,TRPM4;NOTCH1;PTCH1;NBR1;HDAC7;GREM1;CDK6;CRIM1;TWIST2;LRP5;PPARG;MEN1;BAMBI;SKI;SEMA4D;SOX9;SMAD6;LIMD1;TMEM64;SUFU
prerank,dendritic cell differentiation (GO:0097028),0.6942420853749909,0.8955147500499521,0.7485,0.8378580730610162,1.0,5/24,12.04%,GAS6;LGALS9;TGFBR2;F2RL1;AXL
prerank,peptidyl-lysine trimethylation (GO:0018023),0.6975109066906767,0.895500770183482,0.7355,0.8375768105161602,1.0,17/28,23.84%,OGT;CSKMT;WDR82;KMT5B;WDR61;KMT2A;SETD2;ZNF335;SETD3;SETD1A;CTR9;TET2;SETD4;SETD1B;KMT5C;SMYD5;SETD5
prerank,regulation of glucose metabolic process (GO:0010906),0.7032242817224181,0.8953687451401307,0.7225,0.8376686586477483,1.0,16/34,19.14%,OGT;SELENOS;AKT1;AKT2;KHK;USP7;SIRT7;PDK2;ADIPOR1;ZNF692;FBP1;BCKDK;DGKQ;FOXK2;FOXK1;IRS1
prerank,regulation of adaptive immune response (GO:0002819),0.6932288424130003,0.8949388218958348,0.7263631815907954,0.8387313709409048,1.0,10/18,25.00%,IL6ST;TRIM27;PYCARD;IRF1;AHR;IRF7;EIF2AK4;RIPK3;SIRT1;FADD
prerank,protein import into peroxisome membrane (GO:0045046),0.6951860993947441,0.8945821363900172,0.728,0.8395612333374902,1.0,17/22,26.46%,FIS1;PXMP2;ALDH3A2;ABCD3;PEX2;PEX26;PEX19;RAB8B;ATAD1;PEX16;PEX5;PEX11B;ACBD5;SLC25A17;PXMP4;PEX14;PEX13
prerank,pulmonary valve morphogenesis (GO:0003184),0.6941274239798918,0.8945009042371876,0.7405,0.8394964044926164,1.0,11/17,25.81%,JAG1;NOTCH1;NOTCH2;BMP4;ROBO1;SLIT2;ROBO2;SMAD6;GJA5;HEYL;NFATC1
prerank,histone modification (GO:0016570),0.7337726718337477,0.8942549712292657,0.7375,0.839990770263328,1.0,76/113,22.89%,MORF4L1;PARK7;USP22;MORF4L2;PRMT1;PHB;PADI2;HDAC1;TAF10;ENY2;UBE2B;HDAC2;PRMT2;HUWE1;HDAC5;MTA1;RBM14;UBE2N;KAT2A;TBL1XR1;CREBBP;SIRT2;HDAC6;RUVBL2;PHC1;SIRT7;NSD3;BRD8;EHMT2;UBE2A;CARM1;BAZ2A;NAA50;SIN3B;KAT5;KAT8;RCOR3;RCOR1;EHMT1;MIER3;MAP3K12;ATXN7L3;BAZ1B;AURKB;TRRAP;PRKCD;BRMS1;EZH2;MTA3;USP3;PRMT7;NSD1;UHRF1;KAT6A;SIN3A;PHF20;RPS6KA4;USP36;PHF20L1;SUDS3;EP300;TAF6;USP16;PARP2;MIER1;KDM4A;MIER2;CCNA2;KAT6B;RUVBL1;NTMT1;MTA2;MRGBP;CDK2;TAF6L;MSL3
prerank,spermatid development (GO:0007286),0.7049166967647995,0.8942209694979715,0.728,0.8397795413671048,1.0,2/42,5.37%,CIB1;NECTIN2
prerank,protein K48-linked deubiquitination (GO:0071108),0.6899118490680748,0.8940240192833816,0.74,0.8401066577861294,1.0,19/24,30.06%,OTUB1;USP34;BAP1;OTUD5;USP33;USP5;USP8;MINDY2;OTUD4;USP20;USP25;OTUD3;ATXN3;OTUD7B;VCPIP1;TNFAIP3;MINDY1;YOD1;USP37
prerank,iron-sulfur cluster assembly (GO:0016226),0.68888428132751,0.8939071798429599,0.748,0.840174401876983,1.0,17/21,28.90%,ISCU;HSPA9;GLRX5;NUBP2;GLRX3;MMS19;CIAPIN1;ISCA1;LYRM4;ISCA2;CIAO1;NFU1;NUBP1;ABCB7;HSCB;NFS1;FXN
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.7413552610518636,0.8938867063233368,0.7385,0.8399158823396596,1.0,25/136,12.79%,MYH9;VIP;GNB1;GCG;HLA-DRB1;PRKAR1A;VIPR1;RAMP2;SELENOS;ADM;RAMP1;SCT;FURIN;DPEP1;PRKACB;GNG2;ADCY6;PRKACA;SRC;PTH1R;PLCG1;GGT1;PRKAR2B;FYN;MAPK14
prerank,regulation of cell cycle process (GO:0010564),0.7361139161560267,0.8937586873298013,0.7395,0.8400103985723472,1.0,46/105,17.61%,CALM2;CALM1;CTNNB1;CDC42;CALM3;NUMA1;RAB11A;DYNC1H1;OBSL1;SFRP1;PIN1;SND1;SH3GLB1;MKI67;CUL7;PRMT5;DAPK3;E4F1;BECN1;GIT1;RAB11FIP3;CSNK2A1;PRPF40A;YTHDF2;TTL;NUDT16;CCDC8;SETD2;BIRC6;CDKN2B;AURKB;MYO19;PLK2;ENTR1;USP19;CDK13;CSNK2A2;PRC1;RPRD1B;CUL9;KLHL9;BCL2L1;SPAG5;CAV2;CETN2;KIF20A
prerank,dicarboxylic acid transport (GO:0006835),0.6950273901814593,0.8934394499849377,0.7515,0.840725913650632,1.0,15/29,28.55%,GIPC1;ARL6IP5;SLC26A6;GJA1;PRAF2;SLC46A1;SLC1A1;SLC25A10;SLC25A13;SLC25A12;SLC19A1;SLC25A22;SLC25A32;PDPN;FOLR2
prerank,response to interleukin-1 (GO:0070555),0.7256390409863827,0.8933448721966671,0.7375,0.8407088288400465,1.0,29/84,16.94%,CCL21;APP;RBMX;ANXA1;SFRP1;CCL2;LGALS9;HYAL2;UPF1;IGBP1;ADAMTS7;MAPK13;HIF1A;CD47;SMPD1;RELA;DAB2IP;SRC;PYCARD;CCL15;IRAK1;PTGIS;SIRPA;CCL25;TAF9;GBP3;MYD88;GBP2;USP10
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.6934236465107635,0.8930552755971943,0.7405,0.8406436231076396,1.0,14/21,22.34%,ZNF207;BUB3;TPR;IK;MAD2L2;CENPF;ZWINT;CDC20;KLHL22;ATM;PLK1;APC;KNTC1;MAD2L1
prerank,spindle assembly checkpoint signaling (GO:0071173),0.6934236465107635,0.8930552755971943,0.7405,0.8406436231076396,1.0,14/21,22.34%,ZNF207;BUB3;TPR;IK;MAD2L2;CENPF;ZWINT;CDC20;KLHL22;ATM;PLK1;APC;KNTC1;MAD2L1
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.6934236465107635,0.8930552755971943,0.7405,0.8406436231076396,1.0,14/21,22.34%,ZNF207;BUB3;TPR;IK;MAD2L2;CENPF;ZWINT;CDC20;KLHL22;ATM;PLK1;APC;KNTC1;MAD2L1
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.6936862550693124,0.8927603921494521,0.7415,0.8412760690426521,1.0,13/26,22.09%,SELENOS;AKT1;SORBS1;AKT2;DYRK2;INSR;GSK3B;GSK3A;PPP1R3B;EPM2AIP1;IRS1;INPP5K;IRS2
prerank,metallo-sulfur cluster assembly (GO:0031163),0.6874145020897731,0.8927027282060949,0.75,0.8411265836720263,1.0,16/19,28.90%,ISCU;HSPA9;GLRX5;NUBP2;MMS19;CIAPIN1;ISCA1;LYRM4;ISCA2;CIAO1;NFU1;NUBP1;ABCB7;HSCB;NFS1;FXN
prerank,telomere organization (GO:0032200),0.7034095449723843,0.8926483306970351,0.733,0.8409758522122845,1.0,25/43,23.68%,PTGES3;XRCC6;XRCC5;APEX1;PCNA;POLD4;POLD2;TERF2IP;PRKDC;PARP1;RPA1;RPA3;DOT1L;RIF1;RPA2;POLD1;ACD;TERF1;ATM;SP100;NBN;TINF2;TERF2;MRE11;RECQL4
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.6849482624720719,0.8925199108216845,0.7315,0.8410635926083934,1.0,8/16,24.33%,IRAK1;COPS8;ZFP91;CARD10;MAP3K7;TNFRSF10B;MALT1;TRAF2
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.6883158987155916,0.8924317359872032,0.753,0.8410219226411264,1.0,15/21,27.47%,RAB34;SFRP1;SMO;ULK3;IHH;DLG5;TXNDC15;GLI1;TEDC1;GAS8;UCHL5;TTC23;STK36;PDCL;TEDC2
prerank,amino acid import (GO:0043090),0.6937054489170537,0.8922497101066714,0.7565,0.8412971956548663,1.0,6/22,19.09%,SLC9A3R1;SFXN3;SFXN1;SLC25A38;SLC1A1;SLC36A1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.6965887312026257,0.8920607092532541,0.729,0.841567978875016,1.0,20/28,23.86%,TSC2;TNS2;PRKCZ;PIP4K2B;APPL2;GSK3A;PRKCD;IRS1;PTPN2;AHSG;INPP5K;RPS6KB1;SLC27A4;PIP4K2A;PID1;GRB10;KANK1;GRB7;PIP4K2C;NCK1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.7852604320144582,0.8920135466140567,0.885,0.8413925019477321,1.0,96/429,11.59%,RPL6;HINT1;PFDN5;EDF1;CALR;FUS;ATF4;YBX1;ACTN4;DNM2;SFPQ;MAGED1;PPP2R1A;HNRNPD;CNBP;RALY;NONO;SOX4;HP1BP3;MLF2;CHD3;CEBPA;PHB;BTG1;ESRRA;HMGA1;SRSF10;UBE2L3;HIC1;SLC2A4RG;NOTCH1;SPIN1;ZMIZ1;PPP2CA;ABL1;MLLT6;SRRT;MLXIPL;DRAP1;POLR2A;NFIA;GPBP1L1;TCF3;GPBP1;SUPT4H1;NSD2;ENG;SNAI2;BHLHE40;CREBBP;ACVRL1;PQBP1;HIF1A;PTP4A3;SMARCA2;NSD3;AKAP17A;CEBPB;TERF2IP;RELA;WWTR1;YY1AP1;ZNF664;ZNF703;DMTF1;DVL1;ATRX;POFUT1;PHF1;APBB1;NAB2;SSBP2;TEAD2;CCAR1;CARM1;MZF1;INSR;BAZ2A;FZD7;ZBTB4;NAB1;ZNF33A;PPIE;PRMT5;DAPK3;CRABP2;DVL2;ZBTB38;FOXN3;ZNF146;JMJD1C;SP3;ZNF395;NFYC;TGFBR1;CXXC1
prerank,cellular response to alkaloid (GO:0071312),0.6876566105221598,0.8919412299215893,0.74,0.8413062978252089,1.0,7/18,24.93%,TGM2;CASP7;CASP6;CASP3;SPIDR;SLC8A1;TRPV1
prerank,fat cell differentiation (GO:0045444),0.7137313778546267,0.891933812767879,0.7445,0.841003521069826,1.0,11/58,7.25%,NR4A1;KLF4;SDF4;CEBPA;CTBP1;C1QTNF3;METRNL;TCF7L2;CTBP2;AKT2;TMEM120A
prerank,bile acid biosynthetic process (GO:0006699),0.6932046022119072,0.8918895920323799,0.7605,0.8408214821278973,1.0,12/27,23.16%,SCP2;HSD17B10;CYP27A1;HSD17B4;OSBPL2;ACOT8;OSBPL9;OSBP;OSBPL7;OSBPL1A;ACOX2;SLC27A2
prerank,heterochromatin assembly (GO:0031507),0.6926149504677783,0.8918549065304243,0.7605,0.8406190236155349,1.0,14/20,24.39%,HMGA1;HDAC1;SIRT2;BAZ2A;SMCHD1;CENPV;MBD2;HELLS;HMGA2;POLE3;EZH1;ZNFX1;BAHD1;SIRT1
prerank,protein localization to centrosome (GO:0071539),0.6860152498337302,0.8917977508317553,0.7585,0.8404812894426285,1.0,8/18,16.92%,DCTN2;CSNK1D;CCDC14;PCM1;GOLGB1;NUDCD3;HOOK3;SPAG5
prerank,kidney development (GO:0001822),0.7218753635061167,0.8916012148729161,0.739,0.8407816960473817,1.0,27/70,18.87%,TCF21;SOX4;KANK2;VEGFA;BAG6;PKD1;SULF2;AGT;OSR1;CTSH;HYAL2;SULF1;BMP4;HSPB11;WFS1;TGFBR1;ARL3;IFT27;NF1;CENPF;NIPBL;ACE;GLI2;PYGO2;LRP4;ITGA8;NPHP3
prerank,sister chromatid segregation (GO:0000819),0.6949337948067807,0.8912215284129432,0.7495,0.841672792448268,1.0,28/34,28.39%,RAN;ZNF207;TOP2A;TOP2B;SMC4;NUSAP1;SMC1A;ZWINT;TUBG1;SPAG5;KLHL22;LATS1;PLK1;WRAP73;RB1;NSL1;ESPL1;TUBG2;KIF18B;DSN1;INO80;CDCA8;NCAPG2;CENPK;NDC80;CHAMP1;MIS12;KNSTRN
prerank,dicarboxylic acid metabolic process (GO:0043648),0.7098734070707958,0.8908840713162272,0.743,0.8424363441795184,1.0,31/57,21.23%,ASS1;PCK1;MDH1;MDH2;IDH2;SDHA;D2HGDH;ALDH18A1;IDH1;ACLY;OGDH;MRPS36;GGT1;GOT2;SHMT2;GOT1;ACOT8;FH;PHYH;NIT2;MTHFD1;DLST;DHFR;SLC46A1;MTHFS;DGLUCY;FPGS;ME2;MTHFD2;ME3;GCLC
prerank,negative regulation of organelle assembly (GO:1902116),0.6996143990388272,0.890601867046919,0.749,0.8430138401957382,1.0,18/35,17.70%,NUPR1;CDK10;YAP1;PINK1;RBM14;KAT2A;SMAD4;SEC22B;CHMP4A;NBDY;TESK1;CHMP4B;LIMK2;SCFD1;CDK5RAP2;FEZ2;PHF23;TMEM39A
prerank,stem cell development (GO:0048864),0.6881997522178918,0.890506177264615,0.7525,0.8429983304741961,1.0,12/17,29.54%,PDCD6;SNAI2;PEF1;NOLC1;SOX11;KLHL12;TCOF1;TAPT1;CDH2;FAM172A;PTPRC;SOX8
prerank,negative regulation of ion transport (GO:0043271),0.691176456702624,0.8903459236391734,0.7405,0.843200265094488,1.0,4/25,11.27%,VIP;WNK2;WNK1;PTK2B
prerank,peroxisomal membrane transport (GO:0015919),0.695682530170159,0.890143490843955,0.7475,0.8435027893309908,1.0,21/27,26.46%,FIS1;PXMP2;ABCD4;ALDH3A2;ABCD3;PEX2;PEX26;PEX19;RAB8B;PEX6;ATAD1;PEX16;PEX5;PEX11B;PEX10;ACBD5;SLC25A17;PEX1;PXMP4;PEX14;PEX13
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.6856984612823882,0.8900385767732528,0.7443721860930466,0.8431754255720831,1.0,11/17,25.46%,SMARCA4;JAK1;STAT5B;BRWD1;IL2RG;STAT3;CISH;IRS1;IRS2;SOCS2;JAK3
prerank,cellular response to interleukin-7 (GO:0098761),0.6856984612823882,0.8900385767732528,0.7443721860930466,0.8431754255720831,1.0,11/17,25.46%,SMARCA4;JAK1;STAT5B;BRWD1;IL2RG;STAT3;CISH;IRS1;IRS2;SOCS2;JAK3
prerank,fatty acid biosynthetic process (GO:0006633),0.7188090465629186,0.8898184827533702,0.7355,0.8435635585741844,1.0,28/71,21.09%,GPX4;TECR;NDUFAB1;ELOVL1;EPHX2;HPGD;XBP1;ACLY;ACOT7;ABHD3;LIPH;DEGS1;DECR2;LTA4H;SCD;HACD3;ABHD2;ABCD3;HACD2;ACSF3;GSTM4;ELOVL5;CYP2C9;ACACA;HSD17B8;SCD5;FADS1;FADS3
prerank,protein maturation (GO:0051604),0.7277117570235436,0.8894227967365903,0.747,0.844517283904683,1.0,53/95,21.41%,CPE;OGT;CTSS;HSPD1;AEBP1;NNAT;NDUFAB1;CCS;ECE1;STUB1;SORL1;NAA10;PSEN1;PTCH1;APH1A;LMF2;TMPRSS4;NCSTN;ADAM10;FURIN;PCSK7;CPXM1;NAA60;AFG3L2;MAGEF1;NAA50;METAP2;PSENEN;CPD;MMP14;GLRX3;LONP2;TSPAN14;GALNT2;SRGN;PITRM1;MMS19;GCSH;ISCA1;TSPAN17;F3;BACE1;DNAJB11;CPXM2;CASP2;MMP16;CIAO1;NFU1;ADAM19;CPM;PCSK6;DDI2;TYSND1
prerank,regulation of DNA recombination (GO:0000018),0.6998996643897669,0.8892736574522677,0.761,0.8446793714847481,1.0,16/33,19.82%,PPP4C;KPNA2;KDM1A;SIRT6;TERF2IP;SUPT6H;PPP4R2;SETD2;MSH6;RPA2;KPNA1;THOC1;SMARCAD1;SPIDR;SHLD2;MSH2
prerank,positive regulation of MAPK cascade (GO:0043410),0.7675812087276364,0.8891925551910167,0.818,0.8446229458443643,1.0,85/270,16.61%,CD24;PLA2G2A;CD74;CCL21;HMGB1;APOE;FGFR3;MIF;CIB1;APP;PHB2;DDT;ERBB2;PDGFRB;PDGFRA;MAPK3;MYDGF;VEGFA;PHB;LAMTOR1;HLA-DRB1;STK25;FGFR1;INAVA;GAS6;ATP6AP1;NRP1;ARL6IP5;SHC1;CCL2;NOTCH1;PRKCZ;GLIPR2;LGALS9;RAP1A;FERMT2;HAND2;LAPTM5;IQGAP1;NOTCH2;NPNT;ROCK2;F2R;FGFR4;DAB2IP;F2RL1;IGF1R;TRAF7;PDE8A;PYCARD;CCL15;PRKD2;INSR;IRAK1;PTK2B;HRAS;ROBO1;CD44;SPRY2;FGFR2;CRKL;TAOK1;ACKR3;EDN3;JCAD;KLHDC10;MAP3K12;MST1R;CCL25;PDCD10;EZH2;ROCK1;PTPRJ;EIF2AK2;PTPN11;KSR1;CSF1R;ARRB2;RYK;PDGFC;ROR2;EGFR;SEMA4C;RET;TAOK2
prerank,sensory perception of smell (GO:0007608),0.7288369768908447,0.8891262697428991,0.7545,0.8445160376217098,1.0,5/104,25.59%,BEST2;ADCY3;UBR3;MKKS;BBS4
prerank,mesenchymal cell development (GO:0014031),0.6884635814699168,0.8891087141101488,0.7645,0.844242655627953,1.0,13/19,29.54%,PDCD6;NOTCH1;SNAI2;PEF1;NOLC1;SOX11;KLHL12;TCOF1;TAPT1;HEYL;CDH2;FAM172A;SOX8
prerank,response to retinoic acid (GO:0032526),0.7107450142241922,0.8887435337843674,0.753,0.8451091070181747,1.0,29/61,23.21%,NDUFA13;PTK7;CTSH;ASXL1;GATA6;RXRA;RXRB;PTK6;FZD7;PTK2B;AQP1;HSD17B2;SETX;SNW1;TWF2;RARA;CDKN2D;RET;CREB1;LTK;RARG;ATM;HTRA2;FZD4;TMEM161A;SOX9;ADNP2;WNT5A;AQP3
prerank,neutral amino acid transport (GO:0015804),0.6905346382519061,0.8887152185712626,0.758,0.8448721132646468,1.0,9/28,19.26%,LLGL2;SLC38A2;SLC3A2;SLC38A1;SLC1A5;SLC38A5;SLC1A1;SLC36A1;SLC7A9
prerank,calcium ion import (GO:0070509),0.6909578925106474,0.8886722559489997,0.757,0.8446905641851467,1.0,14/28,23.74%,SMDT1;ATP2A2;AFG3L2;MCUR1;SLC25A23;MICU2;MICU1;MCU;CACNA1H;CACNA1D;CACNA1G;MS4A1;CACNA1C;SLC8A1
prerank,membrane lipid biosynthetic process (GO:0046467),0.7057707920811114,0.8884719743131776,0.751,0.8450015096560552,1.0,28/57,19.63%,ST3GAL4;VAPA;ELOVL1;PLPP1;CERS2;SPTSSA;PLPP3;CSNK1G2;PLPP2;PRKD2;DEGS1;ALDH3A2;SPTLC1;CERS6;HACD3;B3GNT5;SGPL1;SCCPDH;CERS4;ST3GAL2;HACD2;SPTLC2;VAPB;CERS5;ELOVL5;DEGS2;KDSR;FA2H
prerank,protein acylation (GO:0043543),0.694390567994651,0.8880379229693931,0.7625,0.8460581593982591,1.0,26/39,23.57%,GLUL;SELENOK;NAA10;KAT2A;ZDHHC3;CREBBP;ZDHHC7;ZDHHC12;ING4;NAT9;ZDHHC5;ING5;ZDHHC8;ZDHHC6;ZDHHC9;ZDHHC20;KAT6A;ZDHHC17;EP300;ZDHHC18;GTF2B;ZDHHC14;NAT10;FOXO1;ZDHHC21;ZDHHC16
prerank,regulation of TOR signaling (GO:0032006),0.7121105413541262,0.8877738903396865,0.7595,0.846554897492843,1.0,32/68,17.39%,LAMTOR4;LAMTOR5;PDCD6;LAMTOR1;GAS6;DDIT4;RHEB;SEC13;TSC2;GOLPH3;LAMTOR2;GBA;RRAGA;TMEM127;PIH1D1;FBXO9;MLST8;TELO2;ARAF;HDAC3;LAMTOR3;AKT1S1;MAPKAPK5;WDR59;GSK3A;PRKAA1;DGKQ;UBR2;RRAGC;GNA12;TSC1;NPRL3
prerank,regulation of secretion by cell (GO:1903530),0.7080432619453295,0.887743094494196,0.753,0.8463174188761834,1.0,26/55,23.47%,VAMP8;LLGL2;ANXA1;RAB10;RAB13;VAMP3;P3H1;STX4;RAB8A;RHBDF1;VAMP2;RAB3D;FMR1;RAB21;RALA;ARFIP1;STXBP5;MEF2C;RAB8B;SCG5;NSF;RAB15;DNAJC1;SNCAIP;RAB26;KCNMB4
prerank,phospholipid translocation (GO:0045332),0.6913848120826346,0.8876362343420284,0.7605,0.8463322634920329,1.0,20/30,28.54%,ATP8B1;TMEM30A;PLSCR1;ATP9A;ANO6;ATP8A1;ATP10B;ATP11A;TMEM30B;ATP11B;PLSCR4;MFSD2A;ATP9B;ABCB1;ABCA1;ABCC1;ATP11C;ATP8B2;ATP10D;ABCA7
prerank,histone mRNA catabolic process (GO:0071044),0.682039196969245,0.887595418359842,0.757,0.846137124381478,1.0,15/15,31.83%,UPF1;SSB;EXOSC10;LSM1;TUT4;TENT2;DCP2;XRN1;ATM;EXOSC4;MTPAP;TUT7;TENT4B;TUT1;ERI1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6868354944894689,0.8874845850344516,0.7565,0.8461616285071528,1.0,11/21,26.51%,SIGIRR;TRIB1;CD55;CARD8;SASH1;PRKCA;CD36;NFKBIL1;CACTIN;TRIM5;CARD16
prerank,regulation of osteoclast differentiation (GO:0045670),0.6962326145605815,0.8873555405086053,0.762,0.8462532993892105,1.0,4/35,10.12%,FBN1;LRRC17;CEBPB;FSTL3
prerank,calcium-ion regulated exocytosis (GO:0017156),0.689404447653928,0.8871502072267736,0.7675,0.8465728593557754,1.0,13/27,27.07%,SDF4;ARHGAP17;PPP3CB;VAMP2;ARL8B;SYT11;SYT13;RIMS3;SCIN;SYT1;VAMP7;SYT7;DOC2B
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.7034688469907382,0.8868969095765653,0.746,0.8470577072464953,1.0,21/41,20.08%,FBN2;ATP6AP1;ATRAID;FERMT2;YAP1;IL6ST;NPNT;BMPR2;DDR2;WWTR1;BMP4;LRP3;BMPR1A;TMEM119;CTNNBIP1;LRP5;FFAR4;SOX11;MEF2C;SUCO;BMP2
prerank,programmed necrotic cell death (GO:0097300),0.6822568324558667,0.8868777564723096,0.7665,0.8467886533624887,1.0,11/18,27.21%,ALKBH7;ITPK1;DNM1L;PPIF;CD14;RIPK1;RIPK3;TRPM7;CYLD;TICAM1;IPMK
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.6954299613958086,0.8868344899137289,0.7595,0.8465980049147973,1.0,20/36,24.72%,ANAPC11;PDGFRB;ANAPC5;CDC16;INSR;NUSAP1;NUP62;ANAPC7;CUL3;EDN3;PHIP;LRP5;CDC27;CDC23;RB1;ANAPC4;ESPL1;RGCC;EDN1;PDGFB
prerank,zinc ion transport (GO:0006829),0.688940660793891,0.8866991361560768,0.765,0.8467031272622604,1.0,14/21,26.75%,SLC39A14;SLC39A4;SLC39A13;SLC39A7;SLC30A9;SLC39A1;SLC30A1;SLC30A5;SLC39A8;SLC39A11;SLC39A3;SLC39A6;SLC30A6;SLC30A2
prerank,synapse assembly (GO:0007416),0.7130774271981767,0.8860919035620878,0.76,0.8483173258034136,1.0,14/69,12.35%,CDH1;PLXNB2;PLXNB1;OBSL1;PLXND1;FZD1;PTEN;FARP1;DBNL;FZD5;DVL1;SLITRK6;SHANK3;NLGN2
prerank,protein O-linked mannosylation (GO:0035269),0.6831588049155166,0.8859290376041824,0.7497497497497497,0.8484896714663794,1.0,15/17,30.02%,DPM3;SDF2L1;DPM2;POMT1;B4GAT1;DPM1;TMTC2;LARGE1;TMTC3;POMGNT2;POMT2;FKRP;FKTN;TMTC4;RXYLT1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.6919042416674702,0.885674579340065,0.7745,0.8489818568531833,1.0,17/29,23.21%,ACTR2;HSF1;SIRT7;PRKDC;NUDT16L1;KMT5B;SMCHD1;MAD2L2;RIF1;MRNIP;HMGA2;PNKP;SHLD2;CYREN;DTX3L;TFIP11;KMT5C
prerank,nervous system development (GO:0007399),0.7783961078311927,0.8853166502435034,0.8935,0.8497674981682379,1.0,116/445,14.42%,MDK;FN1;GSN;MARCKS;GSTP1;ITM2B;SDCBP2;COX7B;VCAN;MARCKSL1;PTN;NBL1;CDH1;ADGRA2;ERBB3;EVL;SPG7;NDUFV2;PMP22;DPYSL2;VEGFA;ZEB2;RBFOX2;HES1;PKD1;SDHA;SREBF2;DCHS1;GBA2;TPP1;OBSL1;HMGCR;PLXND1;JAG1;S100B;NCKAP1;SMO;SH3GL1;PTEN;SLC2A1;CRMP1;IGF2BP2;DHX30;YAP1;MBNL1;NOTCH2;SEMA5A;ATXN10;PAFAH1B3;NDUFS2;DCTN1;FARP1;DBNL;CAPG;GFRA1;ZNF358;BTBD6;TRAK1;CHRNA3;BTBD2;SMPD1;RNF103;STMN3;WWTR1;PHOX2B;NINJ1;FZD5;DVL1;ANKLE2;NES;SEMA6A;SLITRK6;NAB2;TBX3;GSS;ALDH3A2;UNC119;NAB1;DYRK1A;CRIM1;B3GNT5;RAPGEFL1;CNTFR;L1CAM;ROBO1;TGFBR1;EPHB2;SHANK3;ADGRB2;NAGLU;ROGDI;AXL;EDNRB;NLGN2;PPP2R5D;MAB21L2;LRCH4;DACT1;ATN1;PKD2;NEURL1;BTBD3;DPF2;MST1R;NF1;LY6H;TYRO3;GLIS2;FGF13;ACVR1B;PPT1;PTS;LDB2;TAGLN3;GJB1;NAIP
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.6911924775766085,0.8852431843513134,0.7485,0.8496861013844794,1.0,19/27,23.86%,TSC2;TNS2;PRKCZ;PIP4K2B;GSK3A;PRKCD;IRS1;PTPN2;AHSG;INPP5K;RPS6KB1;SLC27A4;PIP4K2A;PID1;GRB10;KANK1;GRB7;PIP4K2C;NCK1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.6936343208709304,0.8847629960174395,0.7565,0.850860246827312,1.0,19/26,27.65%,APRT;DGUOK;PNP;AMPD2;PAICS;SHMT2;PRPSAP1;PRPSAP2;MTHFD1;GMPR2;GMPS;ADSL;GART;PRPS2;PRPS1;SHMT1;DCK;ADK;HPRT1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.6902901665083901,0.8845080879019068,0.773,0.851341792156811,1.0,20/32,26.21%,ID2;TYMS;PCNA;CDK16;TFDP1;RRM2;BRD4;TFDP2;CDT1;DHFR;BACH1;RB1;ZPR1;E2F1;HINFP;CDK14;CDK17;CDK18;KLF11;CDK5
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.680718559121768,0.8843554653791612,0.7681522283425137,0.8515015081065039,1.0,8/15,28.06%,OGA;NAGK;PGM3;EXTL2;LARGE1;MGAT3;CHST3;CHST2
prerank,cardiac muscle tissue development (GO:0048738),0.7048263603859607,0.8837647046000857,0.765,0.8530575779229268,1.0,22/53,21.30%,NDUFV2;NOTCH1;ACTC1;NOTCH2;SMAD4;GATA6;BMPR2;AKAP13;TBX2;GJA1;BMP4;BMPR1A;ADAMTS9;SMAD5;SGCD;CBY1;MAML1;KDM6B;MYOCD;BMP2;ZFPM1;CACNA1G
prerank,macromolecule catabolic process (GO:0009057),0.6859831388450739,0.8834777967340506,0.7795,0.8536346884839867,1.0,23/28,30.29%,LGMN;TPP1;SH3GLB1;BECN1;MVB12A;TRIM24;PPT1;CLPX;MTOR;USE1;CLN5;SIAH1;UCHL3;SMURF1;LRSAM1;PIK3R4;IDE;KIF16B;NEDD4;CLN8;TGFB1;SNX25;UVRAG
prerank,positive regulation of nervous system process (GO:0031646),0.6816548751124751,0.8831713245208523,0.76,0.854291488494843,1.0,8/17,24.89%,RNF10;DICER1;NLGN2;UNC13B;PARD3;MYRF;TENM4;TNFRSF1B
prerank,GPI anchor biosynthetic process (GO:0006506),0.6889620590818781,0.8831438438564935,0.7625,0.8540510533026442,1.0,22/31,25.50%,PIGZ;PIGT;DPM3;GPAA1;PYURF;DPM2;PIGQ;PIGS;PGAP3;MPPE1;DPM1;PIGG;PGAP2;PGAP1;PIGU;PIGC;PIGX;PIGF;PIGP;PIGL;PIGK;PIGN
prerank,signal transduction in response to DNA damage (GO:0042770),0.7035425164924618,0.882730948905929,0.7635,0.8549840032991916,1.0,14/51,13.90%,NDRG1;ABL1;GRB2;MDM4;MYO6;ATRX;TP53BP1;MAP3K20;MAD2L2;MAPK14;TIPRL;PRPF19;TP53;DOT1L
prerank,regulation of TORC1 signaling (GO:1903432),0.6879837729367619,0.8826971726389727,0.7875,0.8547646404147088,1.0,26/33,28.06%,LAMTOR5;STK11;SESN3;RRAGA;PIH1D1;PIP4P1;TELO2;DGKQ;RRAGC;KLHL22;ATM;SZT2;SIK3;ITFG2;SESN2;SESN1;GPR137;RNF152;RRAGB;RRAGD;SEH1L;CLEC16A;DEPDC5;FLCN;KPTN;SMCR8
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.7334653848053306,0.8826587047789227,0.788,0.8545610653938267,1.0,59/140,16.00%,RHOC;RHOA;RAC1;A2M;SQSTM1;CDC42;ARHGDIA;RHOB;ABR;TGM2;RHOT2;NET1;TRIO;ARHGEF17;ARHGAP1;MYO9B;ARHGEF16;ARAP1;RHOF;ARHGEF7;ARHGEF2;ARHGEF12;AKAP13;ARHGDIB;ARHGAP17;FAM13A;ARHGAP21;ITGAV;SRC;DLC1;ARHGEF1;PLEKHG2;OBSCN;TRIP10;ARHGAP35;NUP62;CD2AP;ARHGAP5;RHOQ;RHOU;VAV3;GNA13;RHOG;PLCE1;RHOJ;MCF2L;SOS1;ARHGAP33;RALBP1;ITSN1;BCR;SH3BP1;VAV2;ARHGAP4;ARHGAP26;ARHGAP45;KALRN;SYDE1;ARHGAP23
prerank,cellular macromolecule catabolic process (GO:0044265),0.7075691102682242,0.8824329342904861,0.768,0.8549460512338133,1.0,30/53,23.32%,HNRNPD;OGA;DNASE1;RNASEH2C;SND1;PABPC4;STT3B;RNASET2;ISG20;RNF5;UBE2G2;DAB2IP;FBXO17;ADAMTS9;XRN2;UBE2G1;MTREX;SIDT2;SKIV2L;FBXO2;RNASEH2B;EXOSC7;HTRA2;PPP1R8;RIPK1;NEU4;NGLY1;DENND3;SIAH2;NCBP1
prerank,sensory organ development (GO:0007423),0.7038288448364876,0.8822328841336129,0.782,0.8552428020449115,1.0,26/56,24.81%,SLC39A5;MEIS1;MYO7B;PBX1;ECE1;PBX3;RAB18;MEIS3;SMCHD1;MEIS2;MAB21L2;SMG9;HIPK1;SIPA1L3;CPAMD8;SH3PXD2B;MYO7A;ATF6;ASCL2;PBX2;AHI1;HIPK2;CHD7;ZDHHC16;RBP4;CHRDL1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.7065611710703082,0.8820908878862822,0.767,0.8553480979315629,1.0,10/58,12.77%,APP;CAPN1;AKAP9;DLGAP4;PTK2B;NEFL;DLG3;NLGN2;DLG1;MINK1
prerank,protein targeting to peroxisome (GO:0006625),0.6903681219561548,0.8818229494662323,0.769,0.8558481794322437,1.0,22/29,26.46%,FIS1;PXMP2;ZFAND6;ALDH3A2;LONP2;ABCD3;PEX2;PEX26;PEX19;RAB8B;PEX6;ATAD1;PEX16;PEX5;PEX11B;PEX10;ACBD5;SLC25A17;PEX1;PXMP4;PEX14;PEX13
prerank,regulation of dendrite development (GO:0050773),0.6937350381286976,0.8817220131044019,0.7745,0.855827677233678,1.0,8/39,9.13%,PTN;NEDD4L;SDC2;RAB17;DBN1;CHRNA3;NSMF;DAB2IP
prerank,growth hormone receptor signaling pathway (GO:0060396),0.6817096970986348,0.8814848128064116,0.772,0.8562317855609478,1.0,12/20,28.83%,PXN;STAT6;PTK2;STAT5B;PIK3R1;STAT3;GHR;SOCS2;JAK3;PRLR;PTPN1;LYN
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.6862196785161969,0.8814682474968351,0.7755,0.8559609387262787,1.0,23/32,28.45%,KANK2;CNOT1;YAP1;WBP2;UFM1;CNOT2;CARM1;DDRGK1;PAK1;AXIN1;CBFB;CNOT9;LATS1;VPS11;UBA5;STRN3;PAGR1;UFL1;UFSP2;FOXA1;KCTD6;VPS18;RUNX1
prerank,embryonic heart tube development (GO:0035050),0.6808172037585611,0.881286508833135,0.782,0.8561907262302249,1.0,9/18,27.55%,HES1;TBX2;CITED2;SOX18;IFT122;MEGF8;ACVR1;NDRG4;HAND1
prerank,regulation of response to biotic stimulus (GO:0002831),0.6872073852201944,0.8808972351969088,0.767,0.8570716930768427,1.0,19/29,26.07%,GATA6;APPL2;BIRC2;FOXP1;CD55;TKFC;IRF1;N4BP1;APPL1;ZMPSTE24;SAMHD1;ERAP1;CD36;XIAP;ELMOD2;TRAF3;BIRC3;RNF135;TRIM5
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.6835943964905262,0.8793201660375206,0.7935,0.8616523483873395,1.0,15/30,24.67%,PDGFRA;OSR1;HOXB3;TGFBR2;EIF4A3;TGFBR1;FGFR2;HOXA9;HOXA3;COL2A1;SOX11;MEGF8;HOXA4;HOXD9;HOXB4
prerank,rRNA methylation (GO:0031167),0.6792220518978473,0.8791802600822841,0.7875,0.8617457854983016,1.0,8/22,18.30%,TRMT112;FBL;NSUN5;BUD23;MTERF4;METTL5;FTSJ3;EMG1
prerank,B cell proliferation (GO:0042100),0.6913239037149037,0.8790969351604186,0.773,0.8616679179458783,1.0,7/32,24.69%,HSPD1;CD79A;MEF2C;CTPS1;MS4A1;BCL2;CR2
prerank,oligosaccharide metabolic process (GO:0009311),0.6953456615223088,0.8790919311339925,0.7765,0.861356008202385,1.0,14/49,16.52%,ST3GAL4;NEU1;MAN2C1;B4GALT1;FUT3;B3GALT5;MAN1B1;MPDU1;ABO;GLA;ST3GAL2;FUT2;ST6GAL2;NAGA
prerank,positive regulation of cell cycle process (GO:0090068),0.7221614126204605,0.8790892261604556,0.775,0.8610375136061004,1.0,32/100,14.87%,RHOA;GIPC1;CDC42;NUMA1;PDGFRB;DYNC1H1;RANBP1;RAD21;RCC2;SVIL;TPR;SIRT2;PLSCR1;CDC25B;ATRX;INSR;NSFL1C;NUSAP1;NUP62;MAP3K20;CUL3;PKN2;WIZ;NUDT16;CENPV;EDN3;PHIP;CCNB1;AURKB;PCID2;LRP5;USP19
prerank,snRNA 3'-end processing (GO:0034472),0.6835609561173835,0.878996066456505,0.8005,0.8609908772465029,1.0,19/30,30.00%,INTS1;EXOSC8;EXOSC6;INTS8;EXOSC7;EXOSC4;INTS14;EXOSC9;INTS6L;INTS6;EXOSC2;EXOSC5;USB1;INTS5;EXOSC3;INTS7;TOE1;INTS12;TUT1
prerank,determination of heart left/right asymmetry (GO:0061371),0.6919627539743336,0.8788294606441087,0.7995,0.8611747032534595,1.0,18/47,20.86%,NOTCH1;SMO;APLNR;TGFBR2;ENG;TBX2;IHH;TBX3;SRF;DLL1;PKD2;MICAL2;SOX18;MEF2C;NPHP3;MEGF8;MKKS;AHI1
prerank,protein K63-linked ubiquitination (GO:0070534),0.6995279714867169,0.8788006256587991,0.78,0.8609336715301513,1.0,34/43,27.32%,UBE2E3;UBE2S;UBE2B;STUB1;UBE2N;HECTD1;RNF126;RNF5;TRIM27;ARIH2;UBE2V2;RNF186;TRAF5;PRPF19;ZFP91;BFAR;UBE2G1;UBE2T;WWP2;RNF4;TRIM56;PELI1;RNF115;UBE2E2;RNF168;TRAF3;RNF135;TRAF2;RNF8;RNF152;UBE2O;TRIM5;TRAF3IP2;NEDD4
prerank,phosphate-containing compound metabolic process (GO:0006796),0.7467557743251252,0.8786685113902043,0.8125,0.8610087810170445,1.0,74/208,14.69%,CYP2W1;PLA2G2A;CALM1;GPX4;PFKL;AGPAT2;PGK1;PPP1CA;IP6K2;MAPK3;ALDOB;NT5C;PI4KA;EPHX2;NUDT4;PLPP1;GPI;PPA1;AKT1;GFPT1;INPPL1;PTEN;SLC20A1;PFKP;CERK;NADK;HK2;ITPK1;PLCD3;PLPP3;PLCB3;PLPP2;PIP4K2B;PANK3;ALDOA;IMPA2;PPM1A;AGPAT1;PPP3CB;NUDT3;LPCAT4;PLA2G10;ISYNA1;INPP5A;ITPKA;DUSP23;TOP1;PTPRD;TOLLIP;GDE1;PLCG1;PIP4P1;COQ8A;PFKM;EPHB2;HK1;FBP1;DUSP3;BCKDK;PPIP5K2;TNK2;TAOK1;PLCE1;PAK1;PAK2;NUDT5;LCAT;LIMK2;PPA2;ACYP1;ACP2;INPP1;NUDT14;PGP
prerank,regulation of hippo signaling (GO:0035330),0.6767333942124165,0.8785625428993766,0.792,0.8610200984525103,1.0,13/20,24.55%,VGLL4;MARK3;DLG5;MAP2K3;MAPK14;WWC3;NF2;SOX11;MOB3B;WTIP;FRMD1;LIMD1;CIT
prerank,diol biosynthetic process (GO:0034312),0.6823269101818985,0.8785605298676764,0.7883941970985493,0.860699051014447,1.0,10/17,26.67%,ASAH1;GBA;SPTLC1;SPTLC2;QDPR;DHFR;SPR;ABCA2;SPHK2;ACER3
prerank,regulation of mitochondrial translation (GO:0070129),0.6789666228292722,0.8785493709451281,0.7865,0.8604050818904889,1.0,16/21,27.49%,COA3;UQCC2;C1QBP;SHMT2;MRPS27;MALSU1;RCC1L;TSFM;RPUSD3;TRUB2;NGRN;MTG2;FASTKD2;RPUSD4;TRMT10C;RMND1
prerank,regulation of JNK cascade (GO:0046328),0.723045637488084,0.8784367429958576,0.7735,0.8604515632095988,1.0,55/104,21.55%,CCL21;HMGB1;APP;SDCBP;PJA2;MAP3K11;PINK1;LTBR;TRAF4;NCOR1;MAPK8IP3;DAB2IP;F2RL1;IGF1R;PYCARD;MAP4K4;COPS5;FZD7;PER1;PTK2B;HRAS;HDAC3;AIDA;SEMA3A;UNC5CL;DUSP3;TAOK1;MINK1;ZMYND11;DACT1;TRAF5;AXIN1;SIRPA;TGFBR3;GADD45B;EGFR;SH3RF2;TAOK2;MARVELD3;RAP2A;GADD45A;MEN1;TPD52L1;RASSF2;RIPK1;GADD45G;MTURN;ZNF622;MAP4K2;AGER;FLT4;SH3RF1;MECOM;NCF1;HIPK2
prerank,heart looping (GO:0001947),0.6899804451812624,0.8783717284363692,0.793,0.8603342857229117,1.0,17/43,20.86%,NOTCH1;SMO;APLNR;TGFBR2;ENG;TBX2;IHH;TBX3;SRF;DLL1;PKD2;MICAL2;SOX18;MEF2C;NPHP3;MKKS;AHI1
prerank,lymphocyte proliferation (GO:0046651),0.6926735309995712,0.878328399279582,0.778,0.8601380030732553,1.0,12/38,26.66%,HSPD1;MSN;PPP3CB;HELLS;CD79A;MEF2C;CTPS1;LMBR1L;MS4A1;BCL2;CR2;ELF4
prerank,embryonic heart tube morphogenesis (GO:0003143),0.6923885504284518,0.8782471250878771,0.7955,0.8600550866762146,1.0,19/47,20.86%,HES1;NOTCH1;SMO;APLNR;TGFBR2;ENG;TBX2;IHH;TBX3;SRF;DLL1;PKD2;MICAL2;SOX18;MEF2C;NPHP3;MEGF8;MKKS;AHI1
prerank,protein K63-linked deubiquitination (GO:0070536),0.6872183319529317,0.8782382327819004,0.7785,0.8597592747613745,1.0,27/32,30.48%,BABAM1;USP7;OTUD5;USP33;SHMT2;ZRANB1;PSMD14;USP8;USP16;OTUD4;BABAM2;USP20;STAMBP;STAMBPL1;USP25;UIMC1;CYLD;BRCC3;ATXN3;OTUD7B;USP13;SPATA2;OTUD1;TNFAIP3;ABRAXAS1;YOD1;ABRAXAS2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.6822467412999992,0.878198439439784,0.7715,0.8595615457611709,1.0,8/17,19.62%,FBH1;TP53BP1;MAGEF1;SMCHD1;MAD2L2;RIF1;UBQLN4;SHLD2
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.6745247963944058,0.8781080394675626,0.7778889444722361,0.8595106058117193,1.0,11/16,30.90%,OGA;NAGK;AMDHD2;EXTL2;GNPDA1;LARGE1;MGAT3;CHST3;CHST2;GNPDA2;CHST1
prerank,DNA modification (GO:0006304),0.6786399292288131,0.8780777195430919,0.798,0.8592760025189439,1.0,20/24,27.23%,TERF2IP;PARP1;MPG;NTHL1;OGG1;EXOSC6;ACD;TERF1;PARP2;SMUG1;NEIL1;MUTYH;TDG;EXOSC4;UNG;TINF2;TERF2;MBD4;EXOSC5;EXOSC3
prerank,microtubule bundle formation (GO:0001578),0.6931500879877835,0.8777187722142755,0.7955,0.8600211378476552,1.0,22/44,26.60%,CHP1;NUMA1;ZNF207;MTCL1;CLASP1;TPPP3;AAAS;CDK5RAP2;NAV1;CAPN6;KIF20A;MAP1S;PLK1;TTLL3;CLIP1;PSRC1;SPAG16;GAS8;MARK4;GAS2L1;SPAST;DCX
prerank,snRNA metabolic process (GO:0016073),0.6740211311107484,0.8775224024160551,0.7852852852852853,0.860286376039996,1.0,15/17,30.00%,INTS11;INTS1;INTS3;INTS10;MEPCE;MTREX;INTS8;ZCCHC8;RBM7;INTS4;INTS6;INTS5;INTS7;INTS12;TUT1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.7076418837728994,0.8773875240949738,0.796,0.8603720606242443,1.0,50/74,26.81%,AMN;PRSS3;CYB5R3;PDXK;GSTO1;SLC2A1;CYB5A;ABCD4;CD320;MMADHC;LMBRD1;SHMT2;SLC5A6;MMAB;MTR;MTHFD1;SLC52A2;PDZD11;CUBN;DHFR;ACP5;SLC46A1;MTHFS;TCN2;FLAD1;FPGS;SLC19A3;RFK;MCCC2;AASDHPPT;PANK2;GSTO2;MTHFD2;MCCC1;SLC2A3;MTHFR;PCCB;PC;SLC23A2;NNMT;SHMT1;PCCA;ALDH1L1;MTHFD2L;MTHFD1L;MTRR;PNPO;ABCC1;BTD;SLC19A1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.6795163224945902,0.8771974522906744,0.7885,0.8606316993718673,1.0,17/30,25.46%,PKD1;CCL2;STAT2;STAT6;PTK6;STAT5B;PKD2;IFNAR1;STAT1;STAT3;PIAS1;SOCS6;CTR9;STAMBP;GHR;SOCS2;JAK3
prerank,embryonic axis specification (GO:0000578),0.6800670877797682,0.8770990294654887,0.7925,0.8606041669320611,1.0,8/17,28.00%,PTCH1;FZD5;TBX3;SMAD2;COBL;SMAD6;HOXD8;CXXC4
prerank,positive regulation of interleukin-17 production (GO:0032740),0.6836415741201113,0.8770422516744136,0.791,0.8604523959660335,1.0,6/23,22.80%,PHB;ZBTB7B;MYD88;NR1H4;RFTN1;IL18
prerank,protein acetylation (GO:0006473),0.6816644808883233,0.8769628475632391,0.7925,0.8603723351727834,1.0,23/31,29.03%,BLOC1S1;NAA10;CREBBP;NAA60;NAA50;ING4;KAT5;NAT9;ING5;KAT6A;EP300;HAT1;GTF2B;NAT10;FOXO1;SIRT1;NAA16;CLOCK;NAA40;MAPT;KAT2B;NAA35;NAA15
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.6809716706617139,0.8764782069064898,0.786,0.861487594908552,1.0,18/22,28.85%,ZNF207;BUB3;TPR;IK;MAD2L2;CENPF;ZWINT;CDC20;KLHL22;ATM;PLK1;APC;KNTC1;MAD2L1;MAD1L1;BUB1B;FBXO5;BUB1
prerank,protein glycosylation (GO:0006486),0.7264029587735525,0.8764686642396787,0.7945,0.8611940808460358,1.0,58/129,18.36%,TMEM258;MGAT4B;ST3GAL4;ST6GALNAC1;OGT;RPN2;OGA;DAD1;GCNT3;SERP1;PLOD1;DPM3;B4GALT1;MGAT1;GFPT1;B3GNT7;GALNT1;KRTCAP2;RPN1;PLOD2;TUSC3;B3GALT5;STT3B;DDOST;PMM1;TRAK1;B3GNT3;GOLGA2;PLOD3;POFUT1;ENTPD5;POMGNT1;TMEM165;B4GALT5;B3GNT5;GALNT7;MAGT1;MOGS;GALNT2;PGM3;STT3A;POMT1;MGAT4A;MPI;ST3GAL2;ALG3;FUT2;B4GAT1;MGAT5;DPM1;MGAT2;COG3;ALG12;ALG5;B4GALT7;NUS1;B3GNT8;SLC39A8
prerank,glutamate receptor signaling pathway (GO:0007215),0.6905949028967753,0.8762220951716689,0.7895,0.8616258889280035,1.0,4/37,11.35%,APP;GNAQ;PTK2B;FMR1
prerank,lipid translocation (GO:0034204),0.6775594945420416,0.8759115747486274,0.8025,0.8622254925849364,1.0,17/23,29.92%,ATP8B1;TMEM30A;ATP9A;ATP8A1;ATP10B;ATP11A;TMEM30B;ATP11B;ATP9B;ABCB1;ABCA1;ABCC1;ATP11C;ATP8B2;ATP10D;ABCA7;RFT1
prerank,activation of adenylate cyclase activity (GO:0007190),0.6893874769334417,0.8758391562597702,0.787,0.8621222213127959,1.0,5/36,8.88%,CAP1;LGR4;RAF1;EDNRA;ADCY6
prerank,lipid biosynthetic process (GO:0008610),0.7075406433108802,0.8753148197795177,0.8015,0.8633811640268315,1.0,23/80,15.53%,ACSS2;SCP2;FDFT1;NDUFAB1;ACSL5;MVD;DHRS11;XBP1;HMGCR;ACLY;PAM;SREBF1;GNPAT;GPAT4;LSS;LIPH;SCD;ABCD3;AGPAT3;PRKAA1;LPCAT1;ACSF3;PCYT2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.6985140608124422,0.8750527881985034,0.7815,0.8638308084064189,1.0,36/59,24.84%,HMGB1;HMGB2;XRCC6;XRCC5;PAXX;SUMO1;BABAM1;NSD2;UBE2N;ERCC1;PRKDC;TP53BP1;KDM2A;UBE2V2;HERC2;KAT5;PRPF19;RIF1;SMC5;POLL;PIAS4;ZBTB7A;PSMD14;IFFO1;ATM;CYREN;LIG3;NBN;BABAM2;RNF168;MDC1;UIMC1;MRE11;BRCC3;POLM;RNF8
prerank,calcium ion import into cytosol (GO:1902656),0.6699685684188358,0.8744627791396085,0.787,0.8652702729005497,1.0,5/15,24.93%,ATP2B4;MS4A1;SLC8A1;CACNA2D1;TRPV1
prerank,modulation of chemical synaptic transmission (GO:0050804),0.7195999408771946,0.8744344515928548,0.794,0.8650296738280089,1.0,12/109,7.34%,ITGB1;CLSTN1;APP;ABR;PSMC5;EIF4EBP2;SLC12A2;CEL;PTEN;AKAP9;TPRG1L;DLGAP4
prerank,homologous chromosome segregation (GO:0045143),0.6743034011287452,0.8743093878042988,0.7855,0.8650740044751082,1.0,2/20,8.64%,PTTG1;SIRT7
prerank,regulation of interleukin-17 production (GO:0032660),0.6893268691262499,0.8739289165303645,0.795,0.8658840864372642,1.0,8/33,19.20%,PHB;PRNP;ZBTB7B;VSIR;MYD88;DDIT3;NR1H4;RFTN1
prerank,telomere maintenance (GO:0000723),0.6938923489330409,0.8735760395324851,0.7955,0.8666125597328975,1.0,30/53,23.68%,PTGES3;XRCC6;XRCC5;APEX1;PCNA;POLD4;POLD2;TERF2IP;PRKDC;PARP1;RPA1;RPA3;ZBTB48;RIF1;TPRKB;RPA2;SMC5;TEP1;POLD1;ACD;TERF1;ATM;SP100;TEN1;NBN;SMC6;TINF2;TERF2;MRE11;RECQL4
prerank,base-excision repair (GO:0006284),0.6860102452856371,0.873495993715588,0.814,0.8665259079616886,1.0,40/47,29.07%,APEX1;PCNA;POLD4;HUWE1;POLD2;POLE;PARP1;USP47;RPA1;RPA3;MPG;NTHL1;POLG;OGG1;LIG1;RFC1;RPA2;RFC2;POLL;POLD1;HMGA2;RFC4;PNKP;SMUG1;NEIL1;MUTYH;LIG3;TDG;UNG;MBD4;XRCC1;FEN1;XPA;POLB;APEX2;POLD3;RFC5;PARG;PRMT6;RFC3
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.6808045152414974,0.873482445670578,0.788,0.8662404255564322,1.0,18/22,29.51%,CDK5RAP3;VPS4A;INTS3;PRCC;WEE1;AURKB;PLK2;ZWINT;ZFYVE19;CHFR;NABP1;NABP2;PLK3;ZWILCH;BUB1B;CHMP4C;BUB1;SETMAR
prerank,melanosome transport (GO:0032402),0.6747414452396342,0.8733533177524051,0.802,0.8659794287474601,1.0,8/18,21.33%,RAB11A;RAB17;RAB11B;MLPH;BLOC1S6;RAB27A;MKKS;BBS2
prerank,pigment granule transport (GO:0051904),0.6747414452396342,0.8733533177524051,0.802,0.8659794287474601,1.0,8/18,21.33%,RAB11A;RAB17;RAB11B;MLPH;BLOC1S6;RAB27A;MKKS;BBS2
prerank,cytosolic transport (GO:0016482),0.7220987651912686,0.8732736875149604,0.809,0.8659093879338209,1.0,84/114,22.68%,CLTC;PLEKHJ1;MYO1D;LAMP1;RAB7A;VPS51;VPS29;GAK;SNX5;WASHC1;LAPTM5;DCTN1;RAB14;VPS35;RAB6A;SNX1;SPAG9;GBF1;SNX6;STX16;HOOK2;SNF8;SORT1;RNF126;STX10;ARL1;VAMP3;ARFRP1;DENND5A;TRIM27;DENND2A;RAB5A;MON2;GGA1;EMP2;PREPL;BECN1;STX5;VPS26A;RHOBTB3;TMEM87A;VPS26B;AP2A1;AP1G1;PTPN23;VTI1B;HOOK3;VPS13C;GCC2;BET1L;YKT6;CORO7;EPS15;GOSR2;TMEM87B;TBC1D10B;SNX2;STX8;TBC1D5;WASHC2A;VPS13A;ANKFY1;VPS52;TBC1D17;TBC1D23;PHETA1;RILP;WASHC2C;RAB29;ERC1;CLN5;PIKFYVE;RAB9A;VPS54;VPS53;LMTK2;RBSN;TBC1D10A;SYS1;GOSR1;STX6;AP4M1;PIK3C3;WDR81
prerank,phospholipid biosynthetic process (GO:0008654),0.6850377372336103,0.8732726803749645,0.802,0.8655896583812573,1.0,18/37,21.97%,FDPS;CPNE1;MVD;IDI1;FAR1;GNPAT;CPNE3;CRLS1;HDHD5;AGPAT3;LPCAT1;PCYT2;PIP5K1A;NUS1;DHDDS;FADS1;DPAGT1;DOLPP1
prerank,regulation of microtubule-based process (GO:0032886),0.6869984078569911,0.873212624730645,0.8035,0.8654505931958372,1.0,16/36,15.02%,ERBB2;MACF1;PHLDB1;CDK2AP2;IGBP1;HDAC6;CLASP2;CAMSAP3;DIAPH1;TAOK1;GSK3B;CLASP1;PRKAA1;KLHL42;MAP6;ROCK1
prerank,transport across blood-brain barrier (GO:0150104),0.7118007957934043,0.8727741313735319,0.8,0.8664405960553218,1.0,39/86,23.06%,ATP2A3;SLC9A3R1;FABP5;LRP1;ATP2B4;SLC38A2;TFRC;ABCC3;SLC44A1;SLC12A2;SLC2A1;SLC4A4;LRP3;INSR;SLC38A1;SLC16A1;SLCO2B1;SLC5A6;ATP8A1;SLC1A5;ABCC5;SLC29A4;SLC38A5;SLC5A1;CD36;SLC1A1;SLC29A1;SLC2A10;SLC24A3;MFSD2A;SLC7A2;AGER;SLC27A4;SLC2A3;SLC27A1;ABCG2;SLC16A2;SLC5A3;ABCA2
prerank,protein palmitoylation (GO:0018345),0.6781363913876267,0.8726895295991469,0.799,0.8663753352358555,1.0,18/31,23.57%,GLUL;SELENOK;ZDHHC3;ZDHHC7;ZDHHC12;CLIP3;ZDHHC5;GOLGA7;ZDHHC8;ZDHHC6;ZDHHC9;ZDHHC20;ZDHHC17;ZDHHC4;ZDHHC18;ZDHHC14;ZDHHC21;ZDHHC16
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.6881937485533834,0.8720263560007944,0.815,0.86798972589773,1.0,19/43,24.24%,SOX4;NNAT;BAD;SCT;TCF7L2;SELENOT;GLUD1;NLGN2;AIMP1;PSMD9;CAPN10;LRRC8A;MCU;FFAR4;AACS;IRS2;TM7SF3;GRP;RBP4
prerank,negative regulation of TOR signaling (GO:0032007),0.6839826792387127,0.8718653168373693,0.8105,0.8681562579074936,1.0,28/37,27.86%,PDCD6;DDIT4;TSC2;STK11;SESN3;TMEM127;AKT1S1;MAPKAPK5;GSK3A;PRKAA1;UBR2;TSC1;NPRL3;ATM;NPRL2;FNIP1;SZT2;ITFG2;SESN2;SESN1;SIRT1;SH3BP4;UBR1;RNF152;TNFAIP8L1;DEPDC5;FLCN;KPTN
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.6761405330317701,0.8718356864682876,0.812,0.8679241226544337,1.0,16/27,28.58%,GAS6;RAMP2;CDH5;SEMA5A;NFE2L2;PDPK1;TNIP2;KDR;MAPK7;KRIT1;PAK4;ICAM1;SCG2;TEK;FGB;TNFAIP3
prerank,regulation of innate immune response (GO:0045088),0.698350517457555,0.8717333647507111,0.802,0.8678909853648621,1.0,21/63,20.07%,HSP90AB1;HLA-E;CDC37;RIOK3;DHX9;APPL2;PLSCR1;BIRC2;TKFC;TYRO3;IFI16;IRF1;PTPN11;N4BP1;APPL1;SAMHD1;ERAP1;IFI35;TRAFD1;MUL1;ABCE1
prerank,synapse organization (GO:0050808),0.7217813766819604,0.8716984574771398,0.8145,0.8676678683523955,1.0,44/126,19.08%,CHCHD10;CDH1;CDC42;APP;PTPRF;AGRN;CAST;OBSL1;C1QA;PLXND1;PIN1;PTEN;GPC6;CYFIP1;PSEN1;DCTN1;FARP1;DBNL;F2R;FZD5;DVL1;C1QB;GPC4;SLITRK6;PDZRN3;PTPRD;L1CAM;SHANK3;NLGN2;SNCG;PPFIBP1;UNC13B;CACNB3;PPFIBP2;REST;RYK;APBB2;PPFIA1;LRP4;LRFN4;C1QC;ANK3;ACHE;RAB29
prerank,regulation of transferase activity (GO:0051338),0.672912815829955,0.8715708736217455,0.7915,0.8677267485271526,1.0,11/17,26.99%,PARP4;EMP2;JMJD8;FEM1B;LDB2;ATM;NABP2;SMG6;BAG5;FEM1A;NLRC5
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.6965023711040433,0.8715373566412733,0.807,0.8675099953184828,1.0,50/70,24.92%,POLR2L;POLR2J;INTS11;POLR2H;POLR2E;POLR2F;POLR2I;POLR2G;SRRT;INTS1;POLR2A;POLR2K;POLR2B;GTF2A2;INTS3;NCBP2;GTF2F1;POLR2C;SP1;TAF11;INTS10;TAF9;RPRD1B;CCNT2;CCNK;RPRD1A;INTS8;ICE1;TAF6;NABP1;ICE2;GTF2A1;GTF2E2;GTF2B;SNAPC4;SNAPC3;INTS14;GTF2F2;CCNT1;NABP2;POLR2D;TAF13;RPRD2;NCBP1;PHAX;INTS4;ELL2;INTS6;SNAPC2;POU2F1
prerank,snRNA transcription (GO:0009301),0.6968228797227325,0.871353171840293,0.808,0.8677242933570114,1.0,51/71,24.92%,POLR2L;POLR2J;INTS11;POLR2H;POLR2E;POLR2F;POLR2I;POLR2G;SRRT;INTS1;POLR2A;POLR2K;POLR2B;GTF2A2;INTS3;NCBP2;GTF2F1;POLR2C;SP1;TAF11;INTS10;TAF9;RPRD1B;CCNT2;CCNK;RPRD1A;INTS8;ICE1;TAF6;NABP1;ICE2;GTF2A1;GTF2E2;GTF2B;SNAPC4;SNAPC3;INTS14;GTF2F2;CCNT1;NABP2;POLR2D;TAF13;RPRD2;NCBP1;PHAX;USPL1;INTS4;ELL2;INTS6;SNAPC2;POU2F1
prerank,histone lysine methylation (GO:0034968),0.6810116946556065,0.8711875106972108,0.7975,0.8678778548316397,1.0,18/34,22.76%,TRMT112;WDR82;DPY30;EHMT2;KMT2B;CXXC1;KMT2A;DOT1L;WDR5;EZH2;SETDB1;SETD3;MEN1;ASH2L;SMYD2;SETD1B;KDM6A;PAGR1
prerank,phospholipid dephosphorylation (GO:0046839),0.6841063461185136,0.871081094686392,0.805,0.8678676559629764,1.0,28/39,28.92%,EPHX2;PLPP1;MTMR11;PTEN;PLPP3;PLPP2;PLPP5;PIP4P1;INPP5F;SACM1L;MTMR3;MTMR4;PLPPR2;OCRL;INPP5K;MTMR10;MTMR2;MTMR6;MTMR12;INPP5J;MTM1;SYNJ2;MTMR9;SGPP1;INPP5B;PIP4P2;PLPPR3;MTMR1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.6773034225591053,0.870834706069498,0.801,0.8682533375289414,1.0,9/26,19.64%,PIEZO1;GREM1;MMP14;EFNB2;MAPK14;ATP11A;MAML1;MEF2C;MYOCD
prerank,protein ADP-ribosylation (GO:0006471),0.675600610439623,0.8707160736906875,0.804,0.8682786443519425,1.0,17/29,25.85%,ARF4;PARP6;PARP4;SIRT2;SIRT6;PARP1;PARP12;TNKS;PARP10;PARP2;TNKS2;HPF1;PARP14;SIRT3;SIRT1;ZC3HAV1;SIRT5
prerank,endomembrane system organization (GO:0010256),0.7429213478715375,0.8704942754548723,0.828,0.8685939369524935,1.0,104/198,19.52%,SLC9A3R1;VMP1;SPTBN1;SQSTM1;CDC42;SEC61A1;PLEKHJ1;TMED10;RAB1A;VAPA;CSNK1A1;SYNGR2;SERP1;SURF4;TMED9;LMAN2;LAMTOR1;SEC31A;SUN1;CTDNEP1;VPS51;TMED2;GAK;CSNK1D;RAB2A;OBSL1;GOLGA8A;AP3D1;SUN2;ATP8B1;TMED4;REEP6;SMPD4;GOLPH3;REEP5;LAPTM4B;ALS2CL;HUWE1;NPLOC4;GBF1;ARHGEF7;TMED3;OPTN;TOR1AIP2;GOLGB1;HOOK2;COG4;SEC16A;CLASP2;LMAN1;ARL1;GOLGA2;ARHGAP21;VPS4A;LEMD2;TMED7;DNM1L;TRAPPC12;PLEKHM2;MYOF;NSFL1C;CUL7;REEP3;HTT;GORASP2;OSBPL2;ATL3;CHMP2B;DNM1;DMPK;SRGN;HOOK3;TBC1D20;CLASP1;RAB22A;REEP4;VAPB;TMEM170A;MIA3;DNAJC13;TJAP1;ARFGEF1;LMAN2L;TMED1;TMED5;WASHC4;GOLGA8B;SYNE1;CAV2;COG3;COG2;NUP93;GORASP1;ARFGEF2;PHETA1;TOR1A;USP8;VPS11;RNF26;ANK3;RAB29;SEC23IP;COG7;LNPK
prerank,cAMP-mediated signaling (GO:0019933),0.6754368115081046,0.8704710824560151,0.8135,0.8683418139135026,1.0,14/25,27.04%,CAP1;GAL;DEFB1;PDE3A;DGKQ;KSR1;AHR;MAPK7;RAPGEF2;SOX9;ADGRG6;PDE4D;RAPGEF3;PDE7A
prerank,gonad development (GO:0008406),0.690349261620683,0.8702107487557735,0.8115,0.8687621596182135,1.0,15/51,23.09%,CSDE1;NR2F2;MEA1;NCOA4;BASP1;GATA6;COL9A3;BIK;AKR1C3;KITLG;MSH2;MKKS;NUP107;SOX9;WNT5A
prerank,cellular modified amino acid catabolic process (GO:0042219),0.6658840680742018,0.8702028972569115,0.805,0.8684640122823705,1.0,5/17,18.80%,DPEP1;ABHD12;GGT1;GOT2;GGT5
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.7285154605825117,0.8700918037318335,0.8115,0.8684702967008314,1.0,56/139,17.49%,FGFR3;PTN;PTPRF;ERBB2;ERBB3;PDGFRB;PDGFRA;DDR1;PILRB;FGFR1;BCAR1;SHC1;TRIO;EPHA2;MPZL1;SHC2;EFS;IL6ST;EPHB4;PDZD3;BMPR2;PTK2;EPHB3;DDR2;FGFR4;PTK6;IGF1R;SRC;ABI1;RAPGEF1;LIFR;INSR;PTPRD;PTK2B;FGFR2;EPHB2;AXL;FYN;TNK2;MST1R;TYRO3;NEDD9;ACVR1B;YES1;CSF1R;GFRA2;RYK;ROR2;EGFR;RET;LTK;GUCY2C;CNKSR1;KDR;PTPRG;MTSS1
prerank,limb morphogenesis (GO:0035108),0.6753470603085487,0.8695982595198156,0.8145,0.8695948122391223,1.0,11/22,24.68%,MBNL1;PTCH1;TBX3;FBXW4;GLI3;LRP6;NIPBL;MEGF8;SKI;PCSK5;IQCE
prerank,negative regulation of interleukin-6 production (GO:0032715),0.6799428176674174,0.8695351438510435,0.8165,0.8694531235596686,1.0,9/31,22.68%,C1QTNF3;GAS6;SELENOS;GBA;SIRPA;SYT11;ARRB1;ZC3H12A;PTPN6
prerank,cellular response to DNA damage stimulus (GO:0006974),0.7577290913147097,0.8693642742509684,0.894,0.8696241104198402,1.0,77/346,11.04%,RPS3;SFN;NPM1;NOP53;CIB1;PARK7;CDKN1A;TRIM28;PRAP1;MCL1;VCP;ALKBH7;UBA1;MAPK3;CBX3;XRCC5;APEX1;BTG2;CBX5;CCND1;MCM7;TOP2A;UBE2B;HIC1;CSNK1E;DDB1;OTUB1;FAAP20;PAXX;ABL1;SUMO1;EPHA2;PSEN1;YAP1;YY1;STK11;GRB2;PARP4;WAC;CBX1;MGMT;FBH1;TRIP12;UPF1;ERCC1;MAPKAPK2;RPAIN;SIRT7;PPP1R15A;IRF3;DYRK2;PDS5A;CUL4A;FAM111A;PRKDC;UBA7;PHF1;APBB1;PARP1;BRAT1;UBE2A;NSMCE4A;FOXP1;TP53BP1;BAX;MUS81;METTL3;USP47;RPA1;ZBTB4;CDK1;SMC1A;GNL1;KMT5B;RBBP6;HERC2;INTS3
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.6884931640590146,0.8693572420882356,0.818,0.8693223110074964,1.0,25/43,24.29%,NOP53;CDKN1A;CDK5RAP3;BABAM1;CDK1;INTS3;FOXN3;FZR1;TAOK1;TAOK2;NAE1;MRNIP;CHFR;HMGA2;ATM;PLK1;NABP1;TOPBP1;NBN;BABAM2;NABP2;UIMC1;MRE11;TAOK3;BRCC3
prerank,presynaptic endocytosis (GO:0140238),0.6750453207583399,0.8692953221295382,0.806,0.869177736761021,1.0,7/27,14.52%,CANX;CEL;VAMP2;NLGN2;SNCG;KIAA1109;PIP5K1C
prerank,anterior/posterior pattern specification (GO:0009952),0.6991557256208247,0.869055270882388,0.8045,0.8695288714172014,1.0,18/63,15.95%,HES4;CDX1;HOXB5;HES1;CDX2;ATP6AP2;HOXB3;BASP1;WLS;BHLHE40;BMPR2;SMAD2;TGFBR1;HES6;HOXA9;LRP5;HOXA3;DDIT3
prerank,catecholamine metabolic process (GO:0006584),0.6710480745037485,0.8690086498948494,0.8073073073073073,0.8693457068644389,1.0,2/15,9.57%,COMT;DDC
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.6720277393719114,0.8688830443143687,0.8085,0.8693909922002743,1.0,11/25,24.53%,B3GNT7;B3GALT5;B3GNT3;EXT1;EXT2;B4GAT1;NDST1;B3GNT8;HS2ST1;B3GNT9;B3GALNT1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.6946213339491665,0.8682568849673482,0.806,0.87089573485844,1.0,33/58,24.29%,NOP53;RPS27L;CDKN1A;CDK5RAP3;CCND1;BABAM1;WAC;PRKDC;MUS81;CDK1;FOXN3;FZR1;TAOK1;TP53;RPA2;TAOK2;ATF2;FBXO31;MRNIP;HMGA2;ATM;PLK1;RAD9A;TOPBP1;NBN;BABAM2;EME2;CDK2;MDC1;UIMC1;MRE11;TAOK3;BRCC3
prerank,GPI anchor metabolic process (GO:0006505),0.6754968470186584,0.868186718659181,0.815,0.8707689356353904,1.0,20/27,29.15%,PIGZ;DPM3;PYURF;DPM2;PIGQ;PGAP3;MPPE1;DPM1;PIGG;PGAP2;PGAP1;PIGU;PIGC;PIGF;PIGP;PIGL;PIGN;PIGO;PIGH;PIGM
prerank,signal release from synapse (GO:0099643),0.6849155078141468,0.868049217866715,0.8325,0.8708333884288801,1.0,15/43,21.54%,HSPA8;STXBP2;DVL1;DNAJC5;VAMP2;NAAA;PIP5K1C;LIN7C;PDZD11;PTPRN2;STXBP1;SNAPIN;PPFIA3;STXBP3;SNAP25
prerank,inositol phosphate-mediated signaling (GO:0048016),0.6733158273003267,0.867978592267705,0.813,0.8707155593227024,1.0,13/20,28.26%,NFATC4;PPP3CB;INPP5A;ADGRB2;EDN3;PLCE1;NFAT5;PPP3CA;NFATC3;EDN1;NFATC1;PPP3CC;NFATC2
prerank,protein mannosylation (GO:0035268),0.6717938996765158,0.8677706601838943,0.809,0.8709936802319675,1.0,17/21,28.25%,DPM3;SDF2L1;DPM2;DPY19L4;POMT1;B4GAT1;DPM1;TMTC2;DPY19L3;LARGE1;TMTC3;DPY19L1;POMGNT2;POMT2;FKRP;FKTN;TMTC4
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.6846039426594958,0.8667252389423038,0.811,0.8736783370196372,1.0,34/41,29.74%,IP6K2;PI4KA;SOCS3;PIP4K2B;SMG1;PI4KB;ITPKA;PIK3R1;IP6K1;PIK3C2A;SOCS6;ITPKC;PIK3C2B;CISH;ITPKB;EFR3A;PIP4K2A;PI4K2A;PIK3CB;PIK3C3;PIP4K2C;PIK3R2;SOCS2;TMEM150A;SOCS5;PIK3CA;FAM126B;FAM126A;TTC7A;PI4K2B;TTC7B;SOCS1;SOCS4;PIK3R3
prerank,synaptic vesicle recycling (GO:0036465),0.6761131813292541,0.8666592854197984,0.814,0.8735389539439502,1.0,18/34,26.21%,CANX;CEL;RAB5A;VAMP2;NLGN2;SNCG;KIAA1109;PIP5K1C;PLD2;TBC1D24;STON1;FCHO2;SNCA;SYT1;STX1A;SYNJ2;SYT7;CDK5
prerank,purine ribonucleotide transport (GO:0015868),0.667439817278068,0.8666513990773766,0.8135,0.8732375989679432,1.0,13/17,32.87%,SLC25A4;SLC35B2;ABCC6;SLC25A24;ABCC5;LRRC8A;SLC17A9;SLC25A17;LRRC8D;SLC19A1;SLC25A42;LRRC8C;ABCC4
prerank,neurotransmitter secretion (GO:0007269),0.6842799775672708,0.8666423369520422,0.8355,0.872940700547585,1.0,15/44,21.54%,HSPA8;STXBP2;DVL1;DNAJC5;VAMP2;NAAA;PIP5K1C;LIN7C;PDZD11;PTPRN2;STXBP1;SNAPIN;PPFIA3;STXBP3;SNAP25
prerank,histone lysine demethylation (GO:0070076),0.6745367431214627,0.8663859591566319,0.8155,0.8733455815781452,1.0,19/26,28.33%,KDM1A;KDM5B;KDM2A;JMJD1C;KDM5C;KDM3A;PHF2;KDM3B;KDM4B;KDM6B;KDM2B;KDM4A;KDM5A;KDM6A;PHF8;KDM4C;RIOX2;KDM7A;KDM5D
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.6692295718721636,0.8662624670861947,0.804,0.8733686058987209,1.0,12/16,31.14%,SCARB2;PDK2;ADIPOR1;BCKDK;FOXK2;FOXK1;PDK4;SIRT1;PDK1;MLYCD;GNB3;RORA
prerank,histone acetylation (GO:0016573),0.6968098640403726,0.8662395323813292,0.8145,0.8731093197168235,1.0,45/70,22.89%,MORF4L1;MORF4L2;TAF10;DMAP1;KAT2A;CREBBP;RUVBL2;NAA60;BRD8;APBB1;TADA3;NAA50;EP400;ING4;PER1;KAT5;KAT8;BRPF3;DR1;SUPT7L;EPC1;MEAF6;ING5;TRRAP;WDR5;TAF9;ACTL6A;YEATS2;BRD1;KAT6A;ATF2;PHF20;PHF20L1;MAP3K7;EP300;TAF6;POLE3;HAT1;KAT7;KAT6B;RUVBL1;MRGBP;TAF6L;MBIP;MSL3
prerank,snRNA processing (GO:0016180),0.6708941300277065,0.866126443036863,0.812,0.8731114566097358,1.0,14/26,30.00%,INTS11;INTS1;INTS3;INTS10;INTS8;INTS14;INTS6L;INTS4;INTS6;INTS5;INTS7;TOE1;INTS12;TUT1
prerank,peroxisome organization (GO:0007031),0.6735006401055416,0.865516872637465,0.804,0.874482673378429,1.0,16/24,26.44%,FIS1;MFF;ABCD4;DNM1L;LONP2;ABCD3;ACOT8;PEX2;PEX19;PEX6;PEX16;PEX11B;PEX10;SEC16B;PEX1;PEX14
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.6683645280541083,0.8654372242180454,0.8195,0.8740681650926138,1.0,16/23,28.01%,ZDHHC3;ZDHHC7;ZDHHC12;CLIP3;GOLGA7;ZDHHC8;ZDHHC6;ZDHHC9;ZDHHC20;ZDHHC4;ZDHHC18;ZDHHC14;ZDHHC21;ZDHHC1;ZDHHC2;ZDHHC24
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.6683645280541083,0.8654372242180454,0.8195,0.8740681650926138,1.0,16/23,28.01%,ZDHHC3;ZDHHC7;ZDHHC12;CLIP3;GOLGA7;ZDHHC8;ZDHHC6;ZDHHC9;ZDHHC20;ZDHHC4;ZDHHC18;ZDHHC14;ZDHHC21;ZDHHC1;ZDHHC2;ZDHHC24
prerank,glucose transmembrane transport (GO:1904659),0.6713463924510937,0.8653646403803154,0.81,0.873957053015517,1.0,11/20,26.00%,SLC2A1;SORT1;SLC2A8;PPARD;SLC5A1;HNF1A;SLC2A10;SLC2A3;SLC2A5;SLC5A3;SLC2A2
prerank,ubiquinone metabolic process (GO:0006743),0.6638427348387673,0.8652291336415665,0.8024012006003002,0.8740179614586838,1.0,15/15,33.65%,COQ8A;COQ9;COQ8B;COQ5;COQ10B;COQ6;PDSS2;COQ2;AIFM2;COQ7;UBIAD1;PDSS1;FDXR;COQ10A;COQ3
prerank,mitotic sister chromatid segregation (GO:0000070),0.709744705915738,0.8651082546385105,0.8165,0.8740452571247831,1.0,66/101,23.18%,RAN;SET;RAB11A;CSNK2B;DCTN2;PDCD6IP;ZNF207;AKAP8L;CHMP2A;KIF22;RAD21;KPNB1;CHMP1A;NUDC;CHMP5;SMC4;CHMP3;POGZ;EML4;VPS4B;CHMP1B;REC8;VPS4A;PDS5A;CHMP4A;NAA50;NUSAP1;NUP62;BOD1;CDK1;SMC1A;BECN1;CHMP4B;NCAPH2;CUL3;CSNK2A1;CHMP2B;TENT4A;CCNB1;NCAPD2;PDS5B;ZWINT;NIPBL;CSNK2A2;PRC1;CHMP7;EML3;TUBG1;CHMP6;SPAG5;KLHL22;KMT5A;PLK1;WRAP73;CDC23;RB1;NSL1;KIF2C;PHF13;PSRC1;KIF23;ESPL1;NCAPG;TUBG2;KIF18B;SMC2
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.6671829065690968,0.864841648361909,0.8075,0.8744621827281347,1.0,15/17,32.97%,BUB3;IK;BOD1;CDK1;AURKB;CTCF;RB1;ZWILCH;CHAMP1;MIS12;SPDL1;CENPA;KNL1;ZW10;TTK
prerank,ubiquinone biosynthetic process (GO:0006744),0.6638427348387675,0.8641517128240536,0.801,0.8760960806561074,1.0,15/15,33.65%,NDUFA9;COQ8A;COQ9;COQ8B;COQ5;COQ10B;COQ6;PDSS2;COQ2;COQ7;UBIAD1;PDSS1;FDXR;COQ10A;COQ3
prerank,positive regulation of cilium assembly (GO:0045724),0.6628217708958148,0.8637891144645791,0.812,0.8768104304537124,1.0,11/17,26.28%,ARHGAP35;HTT;CCDC88A;ENTR1;CROCC;WRAP73;KCTD17;TAPT1;MARK4;BBS4;CCP110
prerank,response to ionizing radiation (GO:0010212),0.6932051766613748,0.8632157539670015,0.836,0.878080339538281,1.0,44/71,25.27%,EEF1D;CDKN1A;RHOB;NET1;ANXA1;CLK2;STK11;BABAM1;GRB2;MTA1;SMPD1;BRAT1;INTS3;TNKS1BP1;KAT5;MAPK14;MYC;TP53;PRKAA1;IFI16;COP1;MRNIP;GADD45A;TRIM13;MEN1;ATM;SWI5;TANK;SPIDR;NABP1;RAD9A;MSH2;TOPBP1;BABAM2;NABP2;RNF168;RHNO1;UIMC1;BRCC3;ECT2;SIRT1;RNF8;INO80;RAD1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.6632264790457554,0.8631754347849497,0.812,0.8778741140580524,1.0,7/15,20.93%,KHNYN;NYNRIN;DICER1;NUDT16;POP7;ZC3H12A;RPP30
prerank,chloride transmembrane transport (GO:1902476),0.6864963312740051,0.8630404869026701,0.8245,0.8779299539565015,1.0,11/50,19.07%,ANO9;SLC12A7;SLC12A2;CLCN3;ANO6;ANO1;SLC12A9;CFTR;LRRC8A;SLC5A1;SLC1A1
prerank,vascular transport (GO:0010232),0.7030039137660177,0.8630347727910382,0.836,0.8776238544413316,1.0,37/84,23.06%,ATP2A3;SLC9A3R1;LRP1;ATP2B4;SLC38A2;TFRC;ABCC3;SLC44A1;SLC12A2;SLC2A1;SLC4A4;LRP3;INSR;SLC38A1;SLC16A1;SLCO2B1;SLC5A6;ATP8A1;SLC1A5;ABCC5;SLC29A4;SLC38A5;SLC5A1;SLC1A1;SLC29A1;SLC2A10;SLC24A3;MFSD2A;SLC7A2;AGER;SLC27A4;SLC2A3;SLC27A1;ABCG2;SLC16A2;SLC5A3;ABCA2
prerank,calcium-mediated signaling (GO:0019722),0.7098267706352025,0.8626628216645519,0.8395,0.8783282902750423,1.0,29/102,17.26%,ATP1B1;FIS1;TRPM4;BCAP31;RCAN1;NUDT4;ATP2A2;P2RX4;ANK2;PRNP;PPP3CB;PRKACA;PLCG1;EDNRB;DEFB1;ACKR3;ADGRL1;PLCE1;DMPK;CAMKK2;PRKAA1;PDPK1;PTPRJ;PPP3CA;EGFR;PPP1R9B;KDR;MCU;SLC9A1
prerank,cellular response to calcium ion (GO:0071277),0.694331178495714,0.8623553188055328,0.815,0.8788627290958255,1.0,29/69,24.61%,ADD1;CLIC4;CPNE1;LGMN;CHP2;IQGAP1;DPEP1;SMPD1;CAMK2D;CPNE3;PPIF;MEF2A;PKD2;SLC25A24;PRKAA1;SYT11;CPNE2;MEF2C;AKR1C3;ITPKB;DMTN;SYT13;BRAF;WNT5A;RASGRP2;CPNE8;MCOLN1;ECT2;SYT1
prerank,establishment of melanosome localization (GO:0032401),0.6662268241611933,0.8623379910143285,0.8295,0.8785891557574379,1.0,8/19,21.33%,RAB11A;RAB17;RAB11B;MLPH;BLOC1S6;RAB27A;MKKS;BBS2
prerank,oligodendrocyte development (GO:0014003),0.664746386294365,0.8622415528940616,0.8255,0.8785342848010561,1.0,11/16,27.93%,EIF2B5;NSUN5;B4GALT5;EIF2B1;PLP1;EIF2B4;MYRF;EIF2B2;EIF2B3;SOX10;CNTNAP1
prerank,development of primary male sexual characteristics (GO:0046546),0.6782161017984522,0.8619192013594965,0.8415,0.879104405192539,1.0,13/43,24.61%,CSDE1;MEA1;NCOA4;GATA6;LHFPL2;COL9A3;BIK;AKR1C3;KITLG;MSH2;SOX9;WNT5A;WNT2B
prerank,fatty acid transmembrane transport (GO:1902001),0.6684090395004225,0.8619038784437699,0.825,0.878826296836059,1.0,12/19,23.80%,SLC2A1;ABCD4;CPT1A;ABCD3;MID1IP1;ACACA;CD36;CPT2;PRKAB2;SLC27A1;PRKAG2;ACACB
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.676283251283137,0.8618421744835568,0.835,0.8786713926353521,1.0,9/38,20.20%,HLA-DRB1;SDC4;CEBPB;DLG5;TYROBP;TNFRSF21;SOX11;ATM;RC3H1
prerank,protein localization to microtubule organizing center (GO:1905508),0.6601459326111662,0.8607554891888171,0.822911455727864,0.881337477206829,1.0,14/16,32.25%,DCTN2;CSNK1D;CCDC14;PCM1;HOOK3;SPAG5;CEP131;CEP192;BBS4;KIAA0753;C2CD3;NEDD1;PIBF1;STIL
prerank,negative regulation of cell cycle process (GO:0010948),0.6923519572526347,0.8603829886763718,0.8395,0.88201078210444,1.0,38/64,23.49%,AURKAIP1;CBX3;CBX5;CHMP2A;UXT;RBBP7;RBBP4;RING1;PHC1;VPS4A;DAB2IP;PCGF2;EHMT2;BMP4;TFDP1;RRM2;RYBP;MAX;EHMT1;TOM1L2;EPC1;PPP1R10;AURKB;EZH2;TFDP2;SUZ12;ZFYVE19;TERF1;PHC3;WAPL;BMI1;MGA;E2F1;L3MBTL2;ESPL1;APAF1;TERF2;RNF2
prerank,xenobiotic transport (GO:0042908),0.6625745697542944,0.8603396224743894,0.8214107053526764,0.8818042078215781,1.0,8/20,23.72%,ABCC3;SLC22A18;GJA1;ABCC5;SLC29A4;NR1I2;ABCG2;ABCB1
prerank,intracellular lipid transport (GO:0032365),0.6694338772118901,0.860290099232319,0.8235,0.8816132735807948,1.0,15/20,30.65%,NPC2;ABCD4;CPT1A;ABCD3;MID1IP1;ACACA;CPT2;PRKAB2;PRKAG2;ACACB;ARV1;SLC25A20;SGPP1;CPT1B;ABCD1
prerank,positive regulation of DNA replication (GO:0045740),0.6618376150230545,0.8601564715597819,0.8305,0.881670764576563,1.0,9/17,21.36%,DHX9;PCNA;BRPF3;EGFR;CDT1;GLI2;GLI1;FAF1;KAT7
prerank,protein dephosphorylation (GO:0006470),0.7172385215423632,0.8601023427615638,0.8385,0.8814929468793424,1.0,58/138,17.45%,PHPT1;DUSP1;PPP1CB;PPP2R1A;PTPRF;PPP1CA;CTDSP1;CTDSP2;PPP1CC;CTDNEP1;PPP2CB;SSU72;TNS2;PPP2CA;PTEN;DUSP6;STK11;PTPRA;PTPN18;PTPRH;PPP2R5C;PPM1A;PPP5C;PPP1R15A;PPP3CB;PPM1G;PPP1R12A;PTPN12;PPP4R1;PTPRD;SBF1;PPP6C;PPM1F;PPP4R2;SDHAF2;DUSP3;PPM1B;PPP2R5D;ILKAP;PPP2R2A;PTPRK;TIMM50;PTPRM;PGP;PTPRJ;RPRD1B;PTPN11;PPP1R15B;PPP2R5A;MTMR3;PTPN9;PPP2R2D;PPP3CA;RPRD1A;DUSP5;PTPRG;PTPRN2;MTMR4
prerank,cell cycle G1/S phase transition (GO:0044843),0.6928302276312732,0.8598722110933537,0.8255,0.881782344388091,1.0,36/63,22.90%,CDKN1A;NASP;KHDRBS1;CCND1;CDC34;CDK4;MAP3K11;EIF4EBP1;GSPT1;POLE;CDK6;CUL4A;CDKN1B;EIF4E;CUL3;PPP6C;MAX;MYC;CUL1;ACVR1B;PLK2;CDK3;CDKN2D;BCAT1;CACUL1;LATS1;CUL4B;RB1;CUL5;RPS6KB1;CCNA2;CDKN3;E2F1;CDK2;HINFP;RCC1
prerank,neurotransmitter transport (GO:0006836),0.6951388489185933,0.8587823488829165,0.8535,0.8844061088778798,1.0,24/73,21.54%,HSPA8;GLS;GLUL;SLC38A2;STXBP2;DVL1;DNAJC5;VAMP2;SLC38A1;CASK;NAAA;UNC13B;LIN7C;SLC29A4;PDZD11;PPFIA1;PTPRN2;STXBP1;SLC1A1;SNAPIN;SLC29A1;PPFIA3;STXBP3;SNAP25
prerank,regulation of neurotransmitter transport (GO:0051588),0.6594937768845347,0.857480309937866,0.8265,0.8875621921502076,1.0,6/16,25.59%,FLOT1;FMR1;MEF2C;SNCAIP;KCNMB4;MCTP2
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.7484270495711127,0.857127115537659,0.9045,0.8881599943846983,1.0,210/352,19.03%,IFI27;PCBP2;UCHL1;CTNNB1;VPS28;SQSTM1;NEDD8;PSMB1;UBE2D3;RBX1;PSME1;PSMB4;ANAPC11;FBXW5;VCP;TGFB1I1;TTC3;OS9;UBA1;PSME2;RNF7;PSMD8;PSMB3;PSMA7;PSMB5;BAG6;PSMB7;PSMB6;UBE2S;NDFIP1;PSMA1;PSMA4;UBE2I;ANAPC16;PSMC5;RBCK1;PSMC3;ANKRD9;ANAPC5;NEDD4L;XBP1;UBE2B;UBE2D2;UBE2L3;SPSB3;UBXN1;PSMD2;DDB1;PSMA2;STUB1;CDC34;PCNP;PSMB2;HERPUD1;PSMD13;PSMD4;CDC16;UBE2C;RAD23A;PSMD3;PINK1;BUB3;RNF114;ARRDC1;AGAP3;MAEA;PTTG1;PSMC1;HUWE1;NDFIP2;PSMC6;NPLOC4;ZSWIM8;MTA1;UBE2R2;UBR4;TRIP12;TRIM2;RAD23B;TBL1XR1;SIRT2;VPS4B;ELOC;ADRM1;TRPC4AP;RNF187;RNF167;RNF11;PPP2R5C;UBE2H;USP9X;PSMC4;RNF126;RNF5;PSMF1;SHARPIN;UBE2G2;PSMA3;PSMA5;VPS4A;CUL4A;DCAF11;ZFAND2B;BIRC2;FBXO7;UBE2A;UBE4A;SYVN1;TSG101;RNF40;NSFL1C;RNF213;GID8;KEAP1;RMND5A;UBE2K;VPS37B;ARIH2;TOLLIP;ZFAND2A;RBBP6;FEM1B;UBQLN1;UBE2E1;ANAPC7;PSMB8;UFD1;ANAPC15;FBXO11;MVB12A;RNF186;PSMD7;PSMC2;KAT5;FBXW4;CUL3;USP33;RNF19A;KCTD10;FZR1;NFE2L2;RNF130;PPP1R11;PSMD6;PTPN23;MIB1;BIRC6;KCTD5;APPBP2;PSMD1;GSK3A;AURKB;BFAR;UBE2G1;RNF149;WWP2;KLHL42;PSMD9;CDC20;NUB1;NHLRC3;UBE3C;ARIH1;CBLC;RNF4;ASB2;ARRB2;FBXL7;DDIT3;FBXO21;CDC26;RNF216;AMFR;PML;COP1;UHRF1;UBA6;UBAP1;ZRANB1;UBQLN4;UBL7;KLHL22;UBQLN2;RNF128;TRIM25;ATE1;RNF146;CDC27;NTAN1;PSME4;CHFR;UBE3B;PSME3;PSMD14;UBE4B;CRBN;PSMD11;HECTD3;ZNRF1;ANAPC1;ARMC8;RC3H2;RNF150;TRIM13;MDM2;PLK1;TNFAIP1;ARRB1;FEM1C;PSMD12
prerank,peptidyl-lysine modification (GO:0018205),0.7038035197718311,0.8566686045124708,0.8405,0.8890365509483616,1.0,53/104,20.23%,SUMO2;PARK7;BLOC1S1;TRIM28;TRPM4;NNAT;NDUFAB1;PLOD1;UBE2I;LOXL2;SUMO1;SUMO3;PLOD2;SAE1;SENP6;TPR;PIAS3;SIRT2;HDAC6;P3H4;SIRT7;UBA2;PLOD3;P3H3;RANGAP1;RANBP2;NUP62;KAT5;SENP7;NUP85;NUP50;NUP188;GCSH;LOXL1;NUP160;LOX;AAAS;NUP98;POM121;PIAS1;RAE1;NUP214;NUP58;ZNF451;PIAS4;POM121C;NUP93;EP300;NUP133;NUP205;SENP5;NUP54;NUP153
prerank,peptidyl-glutamic acid modification (GO:0018200),0.6666358420813698,0.8566184935469462,0.8395,0.8888446323961297,1.0,9/24,20.23%,NAA10;VKORC1;GGCX;PARP1;CFAP20;TPGS1;VKORC1L1;AGBL5;TTLL3
prerank,cellular response to mechanical stimulus (GO:0071260),0.6796199473144148,0.8565380005423282,0.863,0.888736767212221,1.0,32/49,28.71%,MAPK3;CNN2;TNFRSF1A;PIEZO1;F11R;BAD;LTBR;BNIP3;PIEZO2;AQP1;BCL10;IRF1;MYD88;BAK1;MAP3K2;SLC9A1;GADD45A;MAPK8;CASP2;MAP2K4;TNFRSF10B;MAP3K1;NFKB1;SOX9;FADD;MAP3K14;HABP4;PTGER4;CASP1;CASP8AP2;FAS;PDE2A
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.6637438517586773,0.8564414334505093,0.8335,0.8886794556812511,1.0,11/18,30.14%,NEDD4L;ANK2;KCNH2;GPD1L;PKP2;KCNQ1;SNTA1;KCNJ8;KCNE3;KCNE4;SCN3B
prerank,tRNA aminoacylation (GO:0043039),0.6603397698109511,0.8561681875810431,0.835,0.8890793836327037,1.0,18/20,32.24%,PPA1;IARS2;FARSA;PPA2;AIMP1;RARS2;FARSB;GATC;HARS2;SARS2;EEF1E1;AIMP2;LARS2;QRSL1;GATB;FARS2;WARS2;YARS2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.6849588968727915,0.8557810297309504,0.852,0.8897827413924121,1.0,21/63,20.93%,PARK7;SCP2;NDUFAB1;XBP1;ACLY;HSD17B10;CYP27A1;LIPH;HSD17B4;OSBPL2;ABCD3;ACOT8;ACSF3;OSBPL9;OSBP;GAMT;ACACA;HSD17B8;OSBPL7;OSBPL1A;ACOX2
prerank,glycolipid biosynthetic process (GO:0009247),0.674871449447789,0.855184411052912,0.845,0.8910001295080148,1.0,18/39,21.76%,ST3GAL4;PIGZ;DPM3;PYURF;B3GNT5;DPM2;PIGQ;SCCPDH;ST3GAL2;PGAP3;MPPE1;DPM1;PIGG;PGAP2;PIGU;PIGC;LARGE1;PIGF
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.7509703062851317,0.8549998691153657,0.9425,0.8911532969391532,1.0,197/460,17.14%,ELF3;PFDN5;JUN;CALR;ENO1;HSPA8;EIF4A2;PDCD4;NDUFA13;ID2;SFPQ;ID3;KLF4;ID1;YWHAQ;CTNNB1;ILF3;CDKN1C;TRIM28;SET;PHB2;NONO;HMGB2;XRCC6;SAP18;EID1;CBX3;CEBPA;PHB;KHDRBS1;XRCC5;RBFOX2;CTBP1;HES1;HNF4A;CBX5;UBE2I;HMGA1;GAS6;NR2F2;LOXL2;ZNF706;HDAC1;SFRP2;CHMP1A;SFRP1;ATP8B1;PHC2;SHC1;NOTCH1;TLE2;DAP;HDAC2;SUMO1;ERN2;BCLAF1;VGLL4;BASP1;MLXIPL;NCOR2;TCF7L2;TLE1;PRMT2;VDR;CTBP2;SMARCA4;CCDC85B;HDAC5;PHF10;DMAP1;RBPJ;RING1;SNX6;BHLHE40;PA2G4;NCOR1;SAMD1;SIRT2;SMAD4;GATA6;KDM1A;HDAC6;TBX2;LBH;TAF7;PHC1;SMARCA2;CREB3L1;RELA;ZNF703;DAB2IP;SAMD11;CREBZF;ZNF503;BAP1;THRA;TSC22D4;LIMS1;CRYAB;TBX3;PBXIP1;BMP4;FOXP1;CITED2;USP47;CIC;CDKN1B;ZBTB4;NAB1;SMAD2;KLF10;ING4;MBD1;DKK3;PER1;BRD7;ZBTB38;FOXN3;SP3;KAT5;TCEAL7;KAT8;PPM1F;TWIST2;HDAC3;KDM5C;RCOR3;RCOR1;RBM15B;COMMD7;MLX;ELK3;ZNF24;BIRC5;CCAR2;DEDD2;GATAD2A;CBFA2T2;ZMYND11;PTPRK;EHMT1;GLI3;EPC1;GMNN;MBD2;ZNF219;DPF2;COPS2;TP53;SPEN;SNW1;CNOT7;CHD8;CENPF;GLIS2;NR1H2;ZNF217;RARA;WWP2;IFI16;BRMS1;ATXN1;DEAF1;MYBBP1A;SCMH1;EZH2;PPARG;CTCF;IRF1;NIPBL;MTA3;ZEB1;SBNO2;FOXK2;ID4;FOXP2;PPARD;HEXIM1;TFDP2;REST;DDIT3;AHR;BCL3;THAP7;ZNF91;PATZ1;PSPC1;SOX18;NFIL3;CBY1;BTAF1;FOXM1;YEATS2;PML;KAT6A;SIN3A;MPHOSPH8
prerank,mRNA methylation (GO:0080009),0.6602874846055026,0.8543022209420558,0.831,0.8926676199441473,1.0,14/15,32.43%,WTAP;METTL3;ZC3H13;NSUN2;PCIF1;VIRMA;TRMT61A;CMTR1;METTL16;TRMT10C;TRMT61B;METTL14;CBLL1;METTL8
prerank,regulation of biomineral tissue development (GO:0070167),0.6659014106563792,0.8527872977146167,0.846,0.8962684747749513,1.0,12/26,22.45%,GAS6;NOTCH1;NBR1;ROCK2;DDR2;CEBPB;BMP2K;ROCK1;ANKH;ECM1;AHSG;SOX9
prerank,myeloid cell activation involved in immune response (GO:0002275),0.6590389347453963,0.8524968831334083,0.832,0.8966743809282371,1.0,7/18,21.35%,DNASE1;PYCARD;SBNO2;TYROBP;FCER1G;IFI35;SYK
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.6556892134398756,0.8515465880874565,0.8475,0.8987864704746215,1.0,12/17,29.15%,PIGZ;DPM2;PIGQ;PIGG;PIGC;PIGX;PIGF;PIGP;PIGL;PIGN;PIGH;PIGM
prerank,regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139),0.6606699716085065,0.8514667640771234,0.842,0.8986636318545183,1.0,2/19,33.50%,GADD45A;LIF
prerank,protein autoubiquitination (GO:0051865),0.6850706245122039,0.8507803940318013,0.853,0.9001073673457844,1.0,39/62,24.84%,UBE2D3;RNF181;UBE2B;UBE2D2;STUB1;RNF10;RNF187;RNF11;UBE2A;RNF213;RNF186;CUL3;RNF220;UBE3A;BFAR;UBE2T;WWP2;RNF4;UHRF2;SH3RF2;AMFR;UHRF1;RNF146;KLHL24;TRIM13;MDM2;RNF141;RNF185;RNF13;NFX1;DDB2;SH3RF1;RNF115;DTX3L;RNF19B;RNF41;LRSAM1;TRAF2;RNF8
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.7094560520917153,0.8505977697576038,0.878,0.9002318942766225,1.0,77/139,23.03%,NR4A1;POLR2L;NR2F6;MAZ;NOTCH3;POLR2J;HNF4A;POLR2H;ESRRA;POLR2E;POLR2F;HDAC1;TAF10;POLR2I;NOTCH1;POLR2G;YAP1;NCOR2;NOTCH2;POLR2A;NRBP1;VDR;TEAD3;HDAC5;RBPJ;TBL1XR1;CREBBP;NCOR1;RXRA;POLR2K;TAF7;WWTR1;RXRB;HDAC7;NR1H3;POLR2B;THRA;GTF2A2;TEAD2;NR2F1;HDAC3;GTF2F1;DR1;POLR2C;GTF2H5;TAF11;SNW1;NR1H2;TAF15;RARA;ERCC3;TAF9;PPARG;PPARD;NR2C2;MAML1;RARG;NR1H4;NR3C1;MED23;TAF6;NR2C1;GTF2A1;GTF2E2;NR5A2;GTF2B;NR1I2;NOTCH4;GTF2H1;GTF2F2;NR3C2;POLR2D;ERCC2;HNF4G;THRB;TAF13;TAF1
prerank,neurogenesis (GO:0022008),0.6726590827064091,0.8505157080443576,0.864,0.9001137278048797,1.0,27/44,29.15%,DCHS1;ANXA1;NDUFS2;BTBD6;TRAK1;BTBD2;CDK6;METTL3;ROGDI;BTBD3;THOC2;CDK5RAP2;TRAK2;RYK;FAT4;LPAR1;CXCR4;CLN5;BTBD1;SPOCK1;DAGLB;CIT;DAGLA;MAPT;ASCL1;METTL14;RITA1
prerank,glycoprotein biosynthetic process (GO:0009101),0.6900213191534577,0.8501563371150013,0.8805,0.9006978937872104,1.0,34/82,22.26%,ST3GAL4;ST6GALNAC1;DAD1;SERP1;CANT1;TNIP1;MGAT1;B3GNT7;GOLPH3;B3GALT5;DDOST;BMPR2;B3GNT3;GOLGA2;CHST13;B4GALT5;B3GNT5;GCNT1;MPI;ST3GAL2;ALG3;FUT2;B3GALT6;COG3;ALG5;B4GALT7;NUS1;B3GNT8;COG7;LARGE1;FAM20B;ALG1;NPC1;CHST12
prerank,cellular amide metabolic process (GO:0043603),0.7010993610868554,0.8498469610668639,0.868,0.9011559072724146,1.0,69/110,27.05%,ATF4;DBI;PPP2R1A;CPE;AEBP1;PLPP1;PPP2CA;ENPP7;CERK;FUT3;PLPP3;CPXM1;PLPP2;DNPEP;SMPD3;ACOT7;THOP1;SMPD1;GPAT4;ST6GAL1;ORMDL1;CPD;ACBD6;ACSF2;NIT1;ACOT13;SHMT2;SGPL1;SLC5A6;NAAA;ACOT8;ORMDL3;GNE;MTHFD1;PDZD11;ORMDL2;CYP2C9;DHFR;SLC46A1;MTHFS;CPXM2;FPGS;MCCC2;NAPEPLD;AASDHPPT;PANK2;MTHFD2;CPM;MCCC1;ACOT2;MTHFR;PLA2G15;PCCB;PC;ABCA2;ACOT11;NSMAF;NNMT;SHMT1;PCCA;ABHD4;ALDH1L1;MTHFD2L;MTHFD1L;ACOT9;MTRR;BTD;SLC19A1;SMPD2
prerank,transcription by RNA polymerase II (GO:0006366),0.7363118404322925,0.8496176059345084,0.9115,0.9013902104882631,1.0,131/319,16.14%,ELOB;BTF3;DDX5;TSC22D1;GTF2I;NR4A1;ATF4;POLR2L;MAF;RBMX;SNRPG;NR2F6;MAZ;SNRPB;SNRPE;CEBPD;NOTCH3;POLR2J;INTS11;HNF4A;CPSF1;PAPOLA;POLR2H;ESRRA;POLR2E;PABPN1;SNRPF;SNRPD3;POLR2F;HDAC1;TAF10;POLR2I;XBP1;SSU72;NOTCH1;DEK;MLLT1;POLR2G;SSRP1;SRRT;SUPT5H;YAP1;INTS1;NCOR2;NOTCH2;NELFB;DRAP1;POLR2A;NRBP1;MED16;VDR;CPSF7;TEAD3;HDAC5;SUPT4H1;NELFE;RBPJ;TBL1XR1;CREBBP;NCOR1;NELFCD;ELOC;ADRM1;SUPT16H;SYMPK;RXRA;POLR2K;TAF7;WDR33;WWTR1;RXRB;HDAC7;NUDT21;NR1H3;ZBTB7B;POLR2B;THRA;PMF1;TAF1C;GTF2A2;PARP1;TFDP1;ELP2;TEAD2;SUPT6H;NR2F1;INTS3;MBD1;PCF11;AFF4;WDR61;NCBP2;HDAC3;SETX;GTF2F1;RTF1;TCEA1;POLR2C;GTF2H5;SETD2;MED4;RREB1;SP1;TAF11;INTS10;COPS2;CBFB;TRIM24;SNW1;NFIC;SLBP;ELOF1;CSTF3;NR1H2;PCID2;TAF15;RARA;ERCC3;DEAF1;IWS1;TAF9;PPARG;CDK13;RPRD1B;CCNT2;PPARD;CCNK;NR2C2;ARRB2;KLF13;NELFA
prerank,regulation of mast cell degranulation (GO:0043304),0.6529087036259745,0.8492937789675779,0.837,0.9018637088644668,1.0,10/15,32.14%,LGALS9;STXBP2;SYK;FES;UNC13D;SPHK2;GAB2;LYN;FER;BLK
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.6573383383185307,0.8489125768559699,0.8575,0.9024958425616358,1.0,12/18,31.90%,VEGFA;PRKD2;CRTC3;CRTC1;RPS6KA4;CRTC2;CAMK1D;CD200;PRKD1;RPS6KA5;LPAR5;RELN
prerank,neuronal action potential (GO:0019228),0.6587527617972972,0.8489009005284238,0.8465,0.9022005169956718,1.0,7/22,25.92%,MYH14;CACNA1H;ANK3;SCN7A;CACNA1G;KCNMB4;SCN9A
prerank,ceramide biosynthetic process (GO:0046513),0.6674951122378372,0.8488581061274134,0.8685,0.9019811392973625,1.0,14/41,19.63%,ASAH1;SMPD4;CERS2;SPTSSA;GBA;SMPD1;DEGS1;SPTLC1;CERS6;CERS4;SPTLC2;CERS5;DEGS2;FA2H
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.6614982052908815,0.848683802616996,0.846,0.9020964744498091,1.0,10/21,26.14%,ADCY6;GUCY1B1;AMPD2;GUCY1A1;GUCY2C;ADCY5;ADCY3;NPR2;ADCY4;ADCY9
prerank,protein lipidation (GO:0006497),0.6772553828760068,0.84867336969328,0.8685,0.9017994501169418,1.0,44/60,28.43%,GLUL;PIGZ;DPM3;SELENOK;ZDHHC3;PYURF;ZDHHC7;ZDHHC12;WIPI2;UGCG;DPM2;WDR45;ATG12;PIGQ;WDR45B;ZDHHC5;ZDHHC8;ZDHHC6;PGAP3;MPPE1;ZDHHC9;DPM1;PIGG;ZDHHC20;PGAP2;ZDHHC17;PIGU;PIGC;WIPI1;ZDHHC18;ATG5;PIGF;ZDHHC14;PIK3C3;ZDHHC21;ZDHHC16;PIGP;PIGL;PIGN;ZDHHC1;PIGO;ZDHHC2;PIGH;ATG7
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.6654592696026435,0.8478897660396185,0.868,0.9034112522100287,1.0,7/33,17.91%,AKT1;CHRNA3;GSK3B;GSK3A;RAB3GAP1;ARRB2;MEF2C
prerank,regulation of neurotransmitter secretion (GO:0046928),0.6639660304505393,0.8474571377853974,0.865,0.904155439959824,1.0,15/32,25.59%,PNKD;CHRNA3;RAB5A;PREPL;FMR1;GSK3B;SLC30A1;SYT11;MEF2C;SNAPIN;RIMS3;SNCAIP;KCNMB4;DTNBP1;MCTP2
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.6525974736242431,0.8471401695237424,0.8549274637318659,0.9045828386488914,1.0,7/17,24.28%,TRPM4;ANK2;CACNA1D;CACNA1G;CACNA1C;SLC8A1;CACNA2D1
prerank,L-amino acid transport (GO:0015807),0.6615098075846777,0.8459029547988631,0.872,0.9072704044829722,1.0,17/28,30.23%,SLC38A2;SLC3A2;ARL6IP5;PRAF2;SFXN1;SLC38A5;SLC1A1;SLC36A1;SLC7A9;SLC7A2;SLC25A13;SLC25A12;SLC7A8;SLC25A22;CTNS;SLC7A1;SLC1A4
prerank,amide transport (GO:0042886),0.6574867809075049,0.8457188658035824,0.867,0.9073943785306897,1.0,16/27,28.55%,UPK3A;GLTP;SLC5A6;CPTP;TAP1;SLC38A5;PLTP;SLC46A1;SLC27A1;PLEKHA3;ABCG2;SLC19A1;SLC25A32;TAP2;PDPN;FOLR2
prerank,carboxylic acid transmembrane transport (GO:1905039),0.6650071429022013,0.8456910240548776,0.881,0.9071361848495694,1.0,20/41,26.81%,SLC7A7;SLC38A2;SLC38A10;SLC25A11;SLC13A2;SLC38A1;SLC16A1;SLC5A6;ABCC5;SLC38A5;SLC36A1;SLC7A9;SLC25A10;SLC27A1;SLC23A2;ABCB1;SLC7A6;SLC7A8;ABCC1;SLC19A1
prerank,dephosphorylation (GO:0016311),0.7074951274917198,0.8452101135480893,0.877,0.907958396129417,1.0,85/151,23.89%,PHPT1;DUSP1;PPP1CB;PPP2R1A;PTPRF;PPP1CA;CTDSP1;CTDSP2;PPP1CC;NT5C;EPHX2;CTDNEP1;PLPP1;PPP2CB;PPP2CA;PTEN;DUSP6;STK11;PTPRA;PLPP3;PTPN18;PTPRH;PLPP2;PPP2R5C;PPM1A;PPP5C;PPP3CB;PLPP5;PPM1G;PPP1R12A;PTPN12;PPP4R1;DUSP23;PTPRD;SBF1;PPP6C;PPM1F;FBP1;PPP4R2;SDHAF2;DUSP3;PPM1B;PPP2R5D;ILKAP;PPP2R2A;PTPRK;TIMM50;ACP2;PTPRM;PGP;PTPRJ;PPP2R5A;MTMR3;PTPN9;PPP3CA;DUSP5;PTPRG;PTPRN2;MTMR4;DUSP16;PLPPR2;PNKP;PPP2R5E;PPP2R3B;PTPN3;PTPRB;FBXW11;INPP5K;PPP2R5B;DUSP12;LHPP;CTTNBP2NL;FRA10AC1;PDP1;PTPN21;DUSP8;MTMR2;HDHD2;PTPN6;MTMR6;PTPN14;CTDP1;SSH2;SSH1;PTPRU
prerank,regulation of exocytosis (GO:0017157),0.6685102028058187,0.8437648924108643,0.8865,0.9110219675997382,1.0,27/48,24.94%,ATP6AP1;ANXA1;CHMP3;RAB10;RAB13;CLASP2;RAB5A;STX4;RAB8A;VAMP2;RAB3D;RAB21;RALA;CLASP1;CFTR;CHMP6;RAB27A;STXBP5;RAB8B;NSF;RAB2B;RAB9A;RAB15;RAB26;SNCA;SYT1;UNC13D
prerank,protein autophosphorylation (GO:0046777),0.7101126074074215,0.8423382408221298,0.8935,0.9140978848747786,1.0,86/159,21.21%,FGFR3;ERBB2;MAP2K2;PDGFRB;PDGFRA;MAPK3;STK25;DDR1;FGFR1;MKNK2;STK24;PIM3;AKT1;ABL1;MAP3K11;WNK2;PINK1;CLK2;STK11;EPHB4;MARK3;PTK2;EPHB3;DDR2;MAPKAPK2;ULK3;FGFR4;SMG1;CAMK2D;PTK6;IGF1R;SRC;PRKD2;HTATIP2;INSR;IRAK1;ULK1;DYRK1A;EIF2AK1;DAPK3;PTK2B;CAD;FGFR2;PEAK1;AATK;TAOK1;MINK1;PAK1;SLK;PAK2;CAMKK2;GSK3B;MAP3K12;MAPKAPK5;TYRO3;AURKB;PIM1;ACVR1B;PDPK1;OXSR1;EEF2K;MKNK1;EIF2AK2;CSF1R;EGFR;TAOK2;KDR;UHMK1;MTOR;AAK1;ATM;MAP3K13;MAPKAPK3;ATP13A2;STK39;MARK2;RIPK1;MAP3K3;CAMK4;PIKFYVE;DAPK1;ULK2;EIF2AK4;LMTK2;STK16;FLT4
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.6528327270123055,0.841940051255457,0.8725,0.9147220834712136,1.0,21/24,32.60%,PPA1;CARS2;IARS2;FARSA;PPA2;AIMP1;VARS2;RARS2;FARSB;HARS2;SARS2;EEF1E1;AIMP2;TARS2;LARS2;AARS2;FARS2;EARS2;WARS2;YARS2;NARS2
prerank,recombinational repair (GO:0000725),0.6778540462332571,0.8407510488106156,0.899,0.917135416072124,1.0,41/79,25.71%,SFPQ;MORF4L1;NUCKS1;SEM1;YY1;UBE2N;FBH1;PARP1;RPA1;RPA3;NSMCE1;ZSWIM7;AP5Z1;RPA2;SMC5;POLL;SAMHD1;PSMD14;SWI5;SPIDR;NABP1;TONSL;RNF138;LIG3;FAN1;NBN;NABP2;RECQL5;SMC6;GEN1;REV3L;RHNO1;XRCC1;FEN1;MRE11;RECQL4;ZFYVE26;RECQL;INO80;RAD51C;EXD2
prerank,peptidyl-serine phosphorylation (GO:0018105),0.7043480547875481,0.8402442623125372,0.8995,0.917960275635698,1.0,92/156,20.90%,MAP2K2;PCK1;CSNK1A1;PNCK;SGK1;PKD1;GRK2;GAS6;MAST2;CSNK1D;MKNK2;CSNK1E;AKT1;RPS6KA1;PRKCZ;PINK1;TGFBR2;CAB39;AKT2;MARK3;MAPK1;CSNK1G2;ROCK2;MAPK13;MAPKAPK2;ULK3;SMG1;PRKACA;RPS6KB2;CAMK2D;DYRK2;PRKDC;PRKD2;TOP1;WNK1;PKN1;CDK1;ULK1;DYRK1A;HIPK3;TGFBR1;PKN2;CSNK2A1;MAPK14;DMPK;MAST3;PAK2;GSK3B;MAP3K12;STK38;MAPKAPK5;HIPK1;DGKQ;PRKCD;PLK2;PDPK1;AKT3;ROCK1;MKNK1;CSNK2A2;VRK3;TLK1;TNKS;RPS6KA3;IKBKB;RPS6KA4;UHMK1;SGK2;MTOR;MAPK8;DYRK4;PRKCA;ATM;MAP3K13;MAPKAPK3;LATS1;STK39;PLK1;RPS6KA2;MARK2;RIPK1;DYRK1B;CAMK4;PIKFYVE;TLK2;ULK2;CAMK1;STK38L;MAPK9;RPS6KB1;LMTK2;PRKCI
prerank,activin receptor signaling pathway (GO:0032924),0.6494561585440035,0.8401751416524399,0.878,0.9177898685781195,1.0,8/19,31.03%,SMAD2;SMAD3;TGFBR1;ACVR1B;ACVR2A;ACVR1;GDF6;ACVR2B
prerank,cation transport (GO:0006812),0.7097070315626615,0.8398662505570613,0.8975,0.9181733968252439,1.0,28/173,14.25%,SCNN1B;ATP1B1;CHP1;TRPM4;SGK1;NDFIP1;SLC3A2;NEDD4L;SLC12A2;PIEZO1;SLC4A4;SLC22A18;NDFIP2;NDUFA9;KCNMB1;TAF7;SLC5A12;ANO6;KCNK5;SLC25A29;KCNMA1;PIEZO2;AQP1;TRPM6;SLC5A6;ANO1;FGF13;SLC39A1
prerank,phosphatidylinositol metabolic process (GO:0046488),0.6938782819230143,0.8391679368498617,0.8935,0.9194373430630893,1.0,63/111,24.56%,PLA2G2A;ARF1;PDGFRB;PI4KA;MBOAT7;MTMR11;INPPL1;PTEN;ARF3;RAB14;CDIPT;PLCB3;PIP4K2B;LPGAT1;RAB5A;PLA2G10;PI4KB;PLCG1;PIP4P1;PITPNM1;SBF1;INPP5F;RAB4A;PIK3R1;PLEKHA1;PIP5K1B;SACM1L;PIP5K1C;CSF1R;PGAP3;MTMR3;PLBD1;PIK3C2A;CDS1;MTMR4;MTMR14;PIP5K1A;PIK3C2B;INPP5E;PGAP1;PLEKHA2;RUFY1;OCRL;PIKFYVE;INPP5K;PIP4K2A;PI4K2A;SLC27A1;MTMR10;PLEKHA3;INPP4A;MTMR2;PIK3CB;PIK3C3;PLCD1;IMPA1;MTMR6;MTMR12;PIP4K2C;PIK3R2;VAC14;INPP5J;PLA2G12A
prerank,negative regulation of transposition (GO:0010529),0.650325591095823,0.8389017303694875,0.8885,0.9197209317728662,1.0,8/26,26.45%,MOV10;SIRT7;TUT4;UBR2;ZNF91;SMYD5;APOBEC3C;TUT7
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.6525975570676339,0.8384966103863614,0.879,0.9202962383836588,1.0,3/28,9.31%,F2R;F2RL1;GPR35
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.6467761949752435,0.8381654873599547,0.871,0.920709111864895,1.0,13/16,33.21%,PRKDC;KMT5B;SMCHD1;MAD2L2;RIF1;PNKP;SHLD2;DTX3L;KMT5C;PARP9;SETMAR;PARP3;WRAP53
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.6475841208534239,0.8380596678216795,0.871,0.9206055560746714,1.0,9/18,29.98%,ANK2;AKAP9;KCNH2;KCNQ1;SNTA1;GJA5;CACNA2D1;KCNE3;KCNE4
prerank,RNA biosynthetic process (GO:0032774),0.6540594772931873,0.8379864006046648,0.896,0.9204283674780496,1.0,19/32,26.91%,TAF10;POLR2A;SMARCA5;TAF7;TCEA2;PRMT5;SETX;BRF1;NCOA6;NAT14;TAF6;RSF1;GTF2B;TAF13;TAF12;POLA2;TBP;TBPL1;TAF4
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.7049868742481018,0.8379193389368863,0.9125,0.9202366411350918,1.0,91/164,23.03%,NR4A1;POLR2L;NR2F6;MAZ;MAPK3;CAVIN1;NOTCH3;POLR2J;HNF4A;POLR2H;ESRRA;POLR2E;POLR2F;HDAC1;TAF10;POLR2I;UBTF;NOTCH1;POLR2G;YAP1;NCOR2;NOTCH2;POLR2A;NRBP1;VDR;TEAD3;HDAC5;SMARCA5;RBPJ;TAF1D;TBL1XR1;CREBBP;NCOR1;GTF3C1;RXRA;POLR2K;TAF7;WWTR1;RXRB;HDAC7;NR1H3;POLR2B;THRA;TAF1C;GTF2A2;TEAD2;POLRMT;NR2F1;HDAC3;GTF2F1;POLR2C;GTF2H5;TAF11;SNW1;NR1H2;TAF15;BRF1;RARA;ERCC3;TAF9;NCOA6;PPARG;PPARD;NR2C2;MAML1;RARG;NR1H4;NAT14;NR3C1;MED23;TAF6;RSF1;NR2C1;RRN3;GTF2A1;GTF2E2;POLR1C;NR5A2;GTF2B;NR1I2;NOTCH4;GTF2H1;GTF2F2;NR3C2;POLR2D;ERCC2;HNF4G;TFAM;THRB;TAF13;TAF1
prerank,mRNA modification (GO:0016556),0.6514677910527458,0.837900887367104,0.8745,0.9199456545444225,1.0,20/22,32.54%,WTAP;METTL3;ZC3H13;NSUN2;PCIF1;VIRMA;TRMT61A;CMTR1;DKC1;PUS1;TRUB2;METTL16;TRMT10C;TRMT61B;TRUB1;METTL14;CBLL1;RPUSD2;METTL8;PUS7
prerank,aromatic amino acid family catabolic process (GO:0009074),0.643497061562687,0.8374067782326482,0.865,0.9207162254979234,1.0,6/16,27.31%,QDPR;GSTZ1;FAH;AADAT;HGD;HAAO
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.6831051700847243,0.8368862574674899,0.8905,0.9215321571007297,1.0,55/85,26.55%,CDKN1A;NASP;KHDRBS1;CCND1;CDC34;TYMS;CDK4;PCNA;EIF4EBP1;CDK16;GSPT1;POLE;CDK6;CUL4A;TFDP1;CDKN1B;RRM2;EIF4E;CUL3;PPP6C;MAX;MYC;CUL1;BRD4;ACVR1B;PLK2;CDK3;CDKN2D;TFDP2;CDT1;DHFR;BCAT1;CACUL1;LATS1;CUL4B;BACH1;RB1;CUL5;RPS6KB1;CDKN3;E2F1;CDK2;HINFP;RCC1;CDK14;CDK17;PLK3;CUL2;CDK18;CCNH;KLF11;PHF8;ACVR1;CDK5;CDKN2C
prerank,ncRNA 3'-end processing (GO:0043628),0.6495196037476877,0.8364202786132992,0.885,0.9222296422196206,1.0,14/24,35.06%,SSB;ELAC2;INTS8;INTS14;INTS6L;INTS6;INTS5;INTS7;PTCD1;TOE1;INTS12;ERI1;INTS2;TRNT1
prerank,male gonad development (GO:0008584),0.6584844195903482,0.8363519816453794,0.904,0.9220576087173239,1.0,12/43,24.61%,CSDE1;MEA1;NCOA4;GATA6;COL9A3;BIK;AKR1C3;KITLG;MSH2;SOX9;WNT5A;WNT2B
prerank,regulation of cilium assembly (GO:1902017),0.6735628288532483,0.8363493343028904,0.8945,0.9217338344757703,1.0,49/62,30.69%,CDK10;TBC1D9B;YAP1;TBC1D1;SGSM3;RABGAP1;ARHGAP35;HTT;TESK1;IFT20;TBC1D2B;CCDC88A;TBC1D14;TBC1D20;LIMK2;RABEP2;ENTR1;TBC1D10B;ATG3;TBC1D13;TBC1D5;CROCC;TBC1D16;TBC1D17;TBC1D22A;KCTD17;TBC1D15;TBC1D10A;ODF2L;SDCCAG8;ATG5;TBC1D24;TAPT1;CYLD;MARK4;DYNC2LI1;IFT140;EVI5;IFT88;BBS4;CCP110;TCHP;EVI5L;TBC1D22B;TBC1D7;CEP120;CEP97;TBC1D2;USP6NL
prerank,serine family amino acid metabolic process (GO:0009069),0.6466208159529602,0.8361777634235557,0.8622934401602403,0.9217770600816252,1.0,9/15,31.07%,SEPHS2;SHMT2;MTHFD1;GCLC;SHMT1;THNSL2;PSPH;CDO1;SEPSECS
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.653554018280147,0.8360727111096801,0.893,0.9216852622320029,1.0,19/32,28.77%,SFRP1;SBDS;BMP4;FSTL3;PRRC2C;TP53;CSF1R;ACE;KDR;ARMC6;LMBR1L;FLT4;FST;MLLT3;UFL1;HOXB4;FLT1;TGFB1;PTPRC
prerank,melanosome localization (GO:0032400),0.6457307328925241,0.836002976384056,0.885,0.92150867710216,1.0,11/21,25.98%,RAB11A;RAB17;RAB11B;MLPH;BLOC1S6;RAB27A;MKKS;BBS2;VPS33B;BBS4;VPS33A
prerank,histone H3 acetylation (GO:0043966),0.6578999188091054,0.8357716410838404,0.902,0.9216902188487163,1.0,35/42,31.83%,TAF10;KAT2A;NAA60;TADA3;ING4;PER1;BRPF3;DR1;SUPT7L;MEAF6;ING5;WDR5;PHF14;TAF9;YEATS2;BRD1;KAT6A;MAP3K7;POLE3;KAT7;KAT6B;TAF6L;MBIP;TAF12;SGF29;KAT14;JADE1;JADE2;KAT2B;BRPF1;TRIM16;LDB1;TADA1;SPI1;TAF5L
prerank,double-strand break repair via homologous recombination (GO:0000724),0.6803451247910377,0.8345846690990566,0.9045,0.9239641834637841,1.0,51/97,25.71%,SFPQ;MORF4L1;NUCKS1;SEM1;MCM7;RAD21;YY1;MCM3;UBE2N;FBH1;REC8;PARP1;MUS81;RPA1;MCM5;RPA3;NSMCE1;MCM6;MCM4;NIPBL;ZSWIM7;AP5Z1;RPA2;SMC5;MCM2;POLL;SAMHD1;PSMD14;SWI5;SPIDR;NABP1;GINS2;TONSL;RNF138;LIG3;FAN1;NBN;NABP2;RECQL5;SMC6;GEN1;REV3L;XRCC1;FEN1;MRE11;RECQL4;ZFYVE26;RECQL;INO80;RAD51C;EXD2
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.6516912968709405,0.8345543303387454,0.8925,0.92369687076032,1.0,16/27,30.81%,SLC3A2;ARL6IP5;SLC25A29;SLC38A1;PRAF2;SLC38A5;SLC25A38;SLC1A1;SLC7A2;SLC25A13;SLC25A12;SLC7A8;SLC25A22;SLC7A1;SLC1A4;SLC6A9
prerank,double-strand break repair (GO:0006302),0.6991899391545283,0.8341645783197335,0.9155,0.9242222406578101,1.0,81/161,22.60%,HMGB1;CIB1;SFPQ;MORF4L1;TDP2;NUCKS1;SEM1;HMGB2;VCP;XRCC6;XRCC5;RAD21;UBXN1;PAXX;SUMO1;YY1;BABAM1;SMARCA5;NSD2;MTA1;UBE2N;FBH1;ERCC1;KPNA2;DDX1;PPP5C;BAP1;PRKDC;APBB1;PARP1;TP53BP1;RPA1;KDM2A;UBE2V2;HERC2;TNKS1BP1;KAT5;RPA3;NSMCE1;SETX;MAD2L2;TENT4A;PRPF19;BAZ1B;RIF1;ZSWIM7;AP5Z1;KDM4B;RPA2;SMC5;POLL;PIAS4;SAMHD1;PSMD14;MAPK8;IFFO1;ATM;SWI5;SMARCAD1;SPIDR;NABP1;PARP2;KDM4A;TONSL;RNF138;CYREN;LIG3;FAN1;HPF1;APTX;NBN;BABAM2;DTX3L;NABP2;RECQL5;SMC6;EME2;GEN1;RNF168;REV3L;MDC1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.6427229066610982,0.8338060042788112,0.8674337168584292,0.9246641361739332,1.0,15/15,35.76%,MRPL12;FOXO3;POLRMT;TFAM;MTERF2;FASTKD1;EARS2;PNPT1;FASTKD5;SLC25A33;TEFM;TFB1M;TFB2M;MTERF1;TWNK
prerank,fatty acid metabolic process (GO:0006631),0.6935173294124097,0.8333162142956476,0.9015,0.9253857023480139,1.0,46/123,19.63%,GPX4;MSMO1;ALKBH7;NDUFAB1;ACSL5;PON2;ACAA1;HPGD;XBP1;CEL;FASN;ACLY;ACOX1;GNPAT;CYP4F12;ACOT7;ADIPOR2;LIPH;ADIPOR1;LPIN3;CRAT;CES1;ACSF2;GGT1;FAAH;CPT1A;SGPL1;ABCD3;NAAA;SLC27A3;ACOT8;LPIN2;PEX2;PPARG;ACSL3;ACSF3;PPARD;ACADM;ACAD9;ACACA;CD36;GGT5;LPIN1;HSD17B8;CPT2;FA2H
prerank,sphingolipid biosynthetic process (GO:0030148),0.669885962162982,0.8331501669337309,0.91,0.9254047291983747,1.0,28/72,19.63%,ASAH1;VAPA;ELOVL1;PLPP1;SMPD4;CERS2;SPTSSA;PLPP3;CSNK1G2;PLPP2;GBA;SMPD1;PRKD2;DEGS1;ALDH3A2;SPTLC1;CERS6;HACD3;SGPL1;CERS4;HACD2;SPTLC2;VAPB;CERS5;ELOVL5;DEGS2;KDSR;FA2H
prerank,DNA replication initiation (GO:0006270),0.6530809203301036,0.8323915878898343,0.905,0.9266778027338457,1.0,33/38,33.25%,MCM7;CDC34;MCM3;POLE;POLE4;RPA1;MCM5;RPA3;MCM6;GMNN;MCM4;ORC4;RPA2;CDT1;MCM2;POLE3;TOPBP1;CDK2;ORC3;POLA2;ORC6;PURA;ORC2;ORC5;LRWD1;POLA1;CDC7;DBF4;CDC45;CDC6;NOC3L;PRIM2;MCM8
prerank,positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141),0.6448461499589118,0.831566331743263,0.8845,0.9280978102248353,1.0,1/18,33.50%,LIF
prerank,peptidyl-serine modification (GO:0018209),0.6999527733390545,0.8312437131451631,0.9245,0.9284169328462298,1.0,96/167,20.90%,PCK1;CSNK1A1;PNCK;SGK1;PKD1;GRK2;GAS6;MAST2;CSNK1D;MKNK2;CSNK1E;AKT1;RPS6KA1;PRKCZ;NAA10;GALNT1;PINK1;TGFBR2;CAB39;AKT2;MARK3;MAPK1;CSNK1G2;ROCK2;MAPK13;MAPKAPK2;ULK3;SMG1;PRKACA;RPS6KB2;CAMK2D;DYRK2;PRKDC;PARP1;PRKD2;TOP1;WNK1;PKN1;CDK1;ULK1;DYRK1A;HIPK3;TGFBR1;PKN2;CSNK2A1;GALNT2;MAPK14;DMPK;MAST3;PAK2;GSK3B;MAP3K12;STK38;MAPKAPK5;HIPK1;DGKQ;PRKCD;PLK2;PDPK1;AKT3;ROCK1;MKNK1;CSNK2A2;VRK3;TLK1;TNKS;RPS6KA3;IKBKB;RPS6KA4;UHMK1;SGK2;MTOR;MAPK8;DYRK4;PRKCA;ATM;MAP3K13;MAPKAPK3;LATS1;STK39;PLK1;RPS6KA2;MARK2;PARP2;DYRK1B;GALNT3;CAMK4;TLK2;ULK2;CAMK1;STK38L;MAPK9;HPF1;RPS6KB1;LMTK2;PRKCI
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.6371208334076882,0.831133961132585,0.8815,0.9283187277406655,1.0,9/17,27.07%,RAB3D;RAB27A;CACNA1H;RAB15;CACNA1G;SCAMP5;UNC13D;STX1A;DOC2B
prerank,peptidyl-lysine methylation (GO:0018022),0.6473956233004315,0.8305119064023082,0.885,0.9292765531922563,1.0,10/25,22.25%,TRMT112;CSKMT;EHMT2;SETD2;EHMT1;SETD3;KMT5A;SMYD2;EEF1AKMT2;SETD4
prerank,necroptotic process (GO:0070266),0.6379113195316104,0.8296076761107044,0.8705,0.9307958257543892,1.0,9/16,27.21%,ITPK1;DNM1L;CD14;RIPK1;RIPK3;TRPM7;CYLD;TICAM1;IPMK
prerank,DNA strand elongation (GO:0022616),0.6409910414429469,0.8286001888558369,0.887,0.9324759641512876,1.0,12/18,31.77%,MCM7;MCM3;POLD2;MCM4;RFC4;GINS2;NBN;MRE11;POLD3;RFC3;POLA1;GINS1
prerank,synaptic vesicle exocytosis (GO:0016079),0.6503196163777103,0.8276953140695392,0.9135,0.9339699723776261,1.0,20/40,27.07%,STX3;STX4;DNAJC5;VAMP2;SNAP23;UNC13B;PIP5K1C;BLOC1S6;SNAP29;SNAPIN;STX2;RIMS3;SNAP25;SNAP47;SNCA;SYT1;STX1A;SYT7;CDK5;DOC2B
prerank,limb development (GO:0060173),0.6439647570866623,0.8276389804367423,0.9155,0.9337474915909122,1.0,15/29,28.08%,PTCH1;KAT2A;GREM1;MAP3K20;GLI3;IFT122;LRP4;MEGF8;LNPK;CHD7;KREMEN1;PCSK5;IQCE;INTU;KAT2B
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.650925612012787,0.8273045279858534,0.909,0.9340912826953284,1.0,18/36,28.83%,LGR4;GPR108;DAB2IP;F2RL1;GRAMD4;TYRO3;CD14;LRRC14;OTUD4;SARM1;NFKBIL1;CACTIN;GPS2;TICAM1;MFHAS1;SMPDL3B;TNFAIP3;LYN
prerank,hexose transmembrane transport (GO:0008645),0.6417831831701617,0.8272955342621073,0.8935,0.9337784059148488,1.0,11/23,26.00%,SLC2A1;SLC50A1;SLC2A8;PPARD;SLC5A1;SLC2A10;SLC2A3;SLC2A5;SLC5A3;SLC5A9;SLC2A2
prerank,nucleotide biosynthetic process (GO:0009165),0.6424809660947643,0.8265547565638436,0.898,0.9348840169904217,1.0,14/18,32.65%,PNP;RRM2;PRPSAP1;PRPSAP2;RRM1;MTHFD1;ADSL;GART;PRPS2;PRPS1;HPRT1;RRM2B;NMNAT1;PPAT
prerank,proteoglycan metabolic process (GO:0006029),0.6413318351450915,0.8253783287751558,0.906,0.9368110061350794,1.0,16/26,31.60%,SULF2;CANT1;SULF1;BMPR2;CHST13;B3GALT6;B4GALT7;CHST14;FAM20B;CHST12;XYLT1;ADAMTS12;CSGALNACT2;CHST10;GAL3ST4;FOXL1
prerank,cellular response to fatty acid (GO:0071398),0.6345560374374263,0.8251548019333772,0.8965,0.9369088761090105,1.0,7/17,23.68%,NR1H4;AKR1C3;IRS1;ZC3H12A;PID1;DGAT2;PDK4
prerank,amino acid transmembrane transport (GO:0003333),0.6524772424198771,0.8239172747525499,0.9245,0.938944684188692,1.0,17/45,25.59%,SLC7A7;SLC38A2;SLC38A10;SLC3A2;SFXN3;SLC38A1;SFXN1;SLC38A5;SLC36A1;SLC7A9;SLC25A13;MFSD12;SLC16A2;SLC25A12;SLC7A6;LRRC8D;SLC7A8
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.633871012355964,0.8230926989518597,0.902,0.9401703165275637,1.0,6/17,25.87%,HIF1A;MYD88;STAT3;APPL1;IL17RA;TICAM1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.6817982522896636,0.8225801635454993,0.9305,0.9407787587986549,1.0,92/124,28.03%,ARF1;IP6K2;PI4KA;PIGZ;MBOAT7;DPM3;INPPL1;PTEN;SOCS3;ARF3;RAB14;PYURF;CDIPT;PIP4K2B;SMG1;RAB5A;PI4KB;ITPKA;PITPNM1;SBF1;INPP5F;DPM2;RAB4A;PIK3R1;PIGQ;PLEKHA1;PIP5K1B;SACM1L;PIP5K1C;IP6K1;PGAP3;MTMR3;MPPE1;DPM1;PIGG;PIK3C2A;CDS1;SOCS6;PGAP2;MTMR4;ITPKC;MTMR14;PIP5K1A;PIK3C2B;INPP5E;CISH;PIGU;PLEKHA2;RUFY1;ITPKB;EFR3A;OCRL;PIKFYVE;PIGC;INPP5K;PIP4K2A;PIGF;PI4K2A;SLC27A1;PLEKHA3;INPP4A;MTMR2;PIK3CB;PIK3C3;IMPA1;MTMR6;MTMR12;PIP4K2C;PIK3R2;VAC14;SOCS2;INPP5J;TMEM150A;SOCS5;PIGP;PIK3CA;MTM1;PIGL;FAM126B;PLEKHA4;PIGN;FAM126A;SYNJ2;TTC7A;MTMR9;PIK3R4;PIGO;PI4K2B;PTPN13;INPP5D;PIGH;PLCG2
prerank,regulation of lymphocyte activation (GO:0051249),0.6354913242904111,0.8225262605972283,0.888,0.9405466275329055,1.0,2/15,7.36%,PAG1;KAT2A
prerank,cellular amino acid catabolic process (GO:0009063),0.6707249640170657,0.8224318952196099,0.938,0.9403833670413883,1.0,45/90,27.54%,GLS;GLUL;ECHS1;DDAH1;PHYKPL;OGDH;HSD17B10;DLD;BCAT2;ACAT1;GLUD1;GOT2;HMGCL;SHMT2;BCKDK;GOT1;IVD;ALDH7A1;GCSH;HNMT;BLMH;HIBCH;QDPR;DLST;BCAT1;FTCD;GSTZ1;MCCC2;HIBADH;MCCC1;BCKDHB;ABAT;FAH;ACAD8;AUH;SHMT1;AADAT;HGD;ALDH6A1;SLC25A44;DBT;MTRR;ACADSB;HAAO;ALDH5A1
prerank,oligodendrocyte differentiation (GO:0048709),0.6360628885180933,0.8223788313471299,0.907,0.9401446536454741,1.0,13/20,29.54%,EIF2B5;NSUN5;EIF2B1;EIF2B4;MYRF;SOX13;SOX9;EIF2B2;EIF2B3;SOX10;CDK5;PTPRZ1;SOX8
prerank,adrenergic receptor signaling pathway (GO:0071875),0.634320815807571,0.821418534084122,0.9045,0.9415659058768139,1.0,7/20,30.42%,AKAP13;RAPGEF2;ZDHHC21;PDE4D;ADCY9;LMBRD2;ADRA2A
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.630867957101433,0.8204518566930096,0.8983983983983984,0.942999034279382,1.0,10/15,31.46%,MUS81;ATF2;RAD9A;EME2;MDC1;MRE11;RAD17;CHEK2;FANCD2;HUS1
prerank,DNA damage checkpoint signaling (GO:0000077),0.6427709917004348,0.820138007294633,0.9235,0.943212932691828,1.0,28/31,34.99%,TP53BP1;MAP3K20;TIPRL;PRPF19;DOT1L;ATM;RAD9A;CDC5L;NBN;E2F1;RHNO1;HINFP;RAD17;RAD1;CHEK2;CLOCK;CEP63;USP28;INTS7;ATR;DONSON;ZNF830;HUS1;CHEK1;ATRIP;FBXO6;ERCC6;BRIP1
prerank,telomere capping (GO:0016233),0.6326766059817244,0.8197132066963312,0.913,0.943636315363195,1.0,13/17,31.75%,TERF2IP;PRKDC;ACD;TERF1;TEN1;NBN;TFIP11;TINF2;TERF2;MRE11;CTC1;STN1;POT1
prerank,alpha-amino acid catabolic process (GO:1901606),0.6381838574157498,0.8195534948194205,0.921,0.9435685430664924,1.0,12/30,27.31%,HSD17B10;ACAT1;GOT2;BLMH;GSTZ1;FAH;AADAT;HGD;MTRR;THNSL2;ACADSB;HAAO
prerank,proteoglycan biosynthetic process (GO:0030166),0.6395477395029482,0.8189806321263504,0.931,0.9442415123498763,1.0,19/31,30.47%,CANT1;UGDH;BMPR2;B3GAT3;CHST13;EXT1;EXT2;B3GALT6;GLCE;B4GALT7;EXTL3;FAM20B;CHST12;XYLT2;XYLT1;PXYLP1;CSGALNACT2;CHST10;GAL3ST4
prerank,anterograde trans-synaptic signaling (GO:0098916),0.6987136387271111,0.8179102281363575,0.956,0.945778080197155,1.0,38/243,16.84%,CALM1;PENK;GIPC1;SST;PMP22;PRKAR1A;PAFAH1B1;SLC12A7;SDCBP;CEL;RPS6KA1;GABARAP;NPY;AKAP9;MAPK1;KCNMB1;CNP;SYPL1;PRKACB;CHRNA3;PRKACA;UNC119;PRKAR2B;NLGN2;SNCG;DLG1;MINK1;CAMKK2;UNC13B;CACNB3;PLP1;LRP6;SPG11;EXOC4;PRKAR1B;PRKAR2A;RPS6KA3;SYNJ2BP
prerank,import into cell (GO:0098657),0.6473533841411946,0.8171769072378926,0.9315,0.9466962858529017,1.0,25/41,31.39%,GLUL;SLC12A7;SLC39A14;SLC38A1;NEURL1B;SLC5A6;SLC11A2;LRRC8A;SLC46A1;SLC36A1;SLC29A1;SNAP25;SLC27A1;SLC16A2;SLC5A3;LRSAM1;SLC12A4;LRRC8D;SLC7A8;SLC19A1;SLC7A1;SLC12A6;SLC29A2;LRRC8C;ATP1A2
prerank,tRNA methylation (GO:0030488),0.6415635758598444,0.8171318808741137,0.9285,0.9464443134549043,1.0,22/33,30.85%,TRMT112;WDR6;HSD17B10;TARBP1;TRMT1;NSUN2;DALRD3;TRMT61A;FTSJ1;GTPBP3;THUMPD2;TRMT13;THUMPD3;TRMT10C;MTO1;TYW3;METTL1;TRMT61B;THADA;TRMT5;TRMT1L;METTL2B
prerank,activation of GTPase activity (GO:0090630),0.672341628074787,0.8167120328282123,0.9395,0.9468241420733496,1.0,45/104,22.12%,CCL21;TAX1BP3;ABR;TBC1D9B;EPHA2;ARHGEF16;TBC1D1;SGSM2;SCRIB;SGSM3;RABGAP1;RANGAP1;GRTP1;TBC1D2B;SIPA1;RHOG;TBC1D14;CORO1C;SIPA1L3;SIPA1L2;TBC1D10B;BCR;RAP1GAP;ARHGAP45;TBC1D13;SYDE1;TBC1D5;RALGAPB;RABGAP1L;TSC1;TBC1D16;CXCL13;PIP5K1A;TBC1D17;DOCK7;TBC1D9;RALGAPA1;TBC1D22A;RALGAPA2;TBC1D15;NTRK3;TBC1D10A;SLC27A4;SIPA1L1;TBC1D4
prerank,tRNA metabolic process (GO:0006399),0.6286831436424417,0.8165278370381558,0.9089544772386193,0.9468118475969182,1.0,14/15,36.24%,SSB;POP5;POP7;TRPT1;RPP21;RPP30;DTD1;THG1L;FARS2;YARS2;DTD2;DARS2;ADAT1;POP1
prerank,replication fork processing (GO:0031297),0.6422495100120721,0.8162135076079761,0.9315,0.9470145846174205,1.0,23/39,30.98%,NUCKS1;CENPX;PCNA;FBH1;FAM111A;ATRX;DDX11;SAMHD1;BOD1L1;THOC1;TONSL;PRIMPOL;EME2;GEN1;MRE11;EXD2;SMARCAL1;ATR;ETAA1;ALYREF;SETMAR;CDK9;RFWD3
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.6438446972852807,0.8151557308816053,0.936,0.9484056279542061,1.0,26/43,30.98%,NUCKS1;CENPX;PCNA;FBH1;POLE;FAM111A;ATRX;DDX11;POLD1;BOD1L1;THOC1;TONSL;PRIMPOL;TIMELESS;EME2;GEN1;EXD2;SMARCAL1;ATR;ETAA1;DONSON;ALYREF;SETMAR;ZNF830;CDK9;RFWD3
prerank,mitotic recombination (GO:0006312),0.625784035430927,0.8138815218189197,0.9144572286143071,0.9501830944930154,1.0,10/15,32.36%,ERCC1;TPRKB;SMC5;TEP1;SMC6;GEN1;NSMCE2;RAD52;XRCC3;RAD51D
prerank,DNA double-strand break processing (GO:0000729),0.6281871105434798,0.8138442901890115,0.919,0.9499084740906218,1.0,18/19,36.41%,UBE2N;UBE2V2;KAT5;ATM;SMARCAD1;RNF138;NBN;MRE11;EXD2;SETMAR;BARD1;BRCA1;RAD52;RBBP8;SLX1A;SLX4;BLM;DNA2
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.6256382949672598,0.8090162166698168,0.9315,0.9570316377854877,1.0,10/20,29.78%,CCL2;IRAK1;MTDH;BCL10;CD14;IL18;TICAM1;TGFB1;LYN;CCL3
prerank,non-motile cilium assembly (GO:1905515),0.6312701978107946,0.8089947729388725,0.929,0.9567274256608915,1.0,23/30,34.59%,CSNK1D;DCTN1;PCM1;IFT122;TMEM80;IFT57;CEP89;TMEM216;CEP250;TTC8;IFT88;BBS4;CEP290;VANGL2;C2CD3;TOGARAM1;PIBF1;FUZ;TMEM107;BBS10;GORAB;DISC1;RPGRIP1L
prerank,chemical synaptic transmission (GO:0007268),0.6975015225142032,0.8084836893441602,0.9755,0.9571420519393461,1.0,52/305,16.84%,CALM1;APOE;HSPA8;PENK;GIPC1;SST;PMP22;PRKAR1A;PAFAH1B1;SLC12A7;SDCBP;CEL;RPS6KA1;PTEN;GABARAP;NAPA;NPY;AKAP9;STXBP2;MAPK1;KCNMB1;CNP;SYPL1;PRKACB;CHRNA3;PRKACA;KIF1B;DVL1;UNC119;DNAJC5;VAMP2;PRKAR2B;NLGN2;SNCG;DLG1;MINK1;CAMKK2;NSG1;PDLIM4;NAAA;UNC13B;CACNB3;PLP1;LRP6;SPG11;EXOC4;LIN7C;PRKAR1B;PRKAR2A;PDZD11;RPS6KA3;SYNJ2BP
prerank,DNA integrity checkpoint signaling (GO:0031570),0.6351340514172195,0.8075403346956235,0.958,0.958180753902519,1.0,30/38,32.88%,TP53BP1;MAP3K20;TIPRL;PRPF19;DOT1L;CDT1;ATM;RAD9A;TIMELESS;CDC5L;NBN;E2F1;RHNO1;HINFP;RAD17;RAD1;CHEK2;CLOCK;CEP63;USP28;INTS7;ATR;DONSON;SETMAR;HUS1;CHEK1;CDC45;ATRIP;CDC6;FBXO6
prerank,regulation of calcium-mediated signaling (GO:0050848),0.6285244774278625,0.8068684870166586,0.941,0.9588302125555861,1.0,12/28,29.91%,P2RX4;TMBIM4;HTT;CDH13;RGN;GBP1;MAPT;PLCG2;ITPR1;BST1;CCL3;CD22
prerank,DNA replication (GO:0006260),0.6663459861508106,0.8067676691231478,0.9565,0.9586376128333838,1.0,57/108,23.94%,PTMS;NAP1L1;SET;DUT;MCM7;POLD4;MCM3;UPF1;POLD2;RPAIN;POLE;FAM111A;RPA1;MCM5;TOP1;CDK1;RBMS1;ING4;KAT5;RPA3;POLG;MCM6;MCM4;ING5;MCMBP;TBRG1;PCLAF;WRNIP1;RFC1;CDK2AP1;ORC4;RPA2;MCM2;RFC2;POLL;POLD1;ATM;RFC4;PNKP;RAD9A;POLE3;REV1;TOPBP1;GRWD1;TIMELESS;NBN;KAT7;RECQL5;CDK2;REV3L;RHNO1;ORC3;PIF1;FEN1;MRE11;RECQL4;RMI2
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.6237854445012879,0.8058813348677695,0.924,0.959567826147794,1.0,8/18,34.68%,SUMO1;VAMP2;ANK3;RNF207;KCNE3;KCNE4;AKAP6;KCNG1
prerank,muscle cell differentiation (GO:0042692),0.6298102145216375,0.8052040513342141,0.956,0.9601600715307107,1.0,15/31,31.98%,SPEG;GATA6;KDM1A;NINJ1;SEMA4C;SYNE1;MEF2C;DMD;MYOCD;TMEM204;WNT5B;POPDC2;RORA;GLMN;CHRNB1
prerank,smoothened signaling pathway (GO:0007224),0.628583500629093,0.8041243659864603,0.9495,0.9613322810113755,1.0,12/34,18.21%,SMO;PTCH1;ULK3;IHH;DYRK2;PTCH2;GLI3;TCTN3;IFT27;HIPK1;GLI2;GLI1
prerank,neuron cell-cell adhesion (GO:0007158),0.6180348230292082,0.8040025763068007,0.924,0.9611634018817101,1.0,14/16,36.30%,CEL;NLGN2;RET;NRXN3;NRXN1;NRXN2;NLGN4X;CNTN4;ASTN2;NLGN3;NCAM2;ASTN1;CDK5R1;NLGN1
prerank,amino acid transport (GO:0006865),0.6355269661354959,0.8026787960447198,0.9645,0.9626049181529606,1.0,28/50,33.14%,SLC7A7;SLC38A2;SLC38A10;SLC3A2;SLC6A19;SLC25A29;SLC38A1;SLC1A5;SLC3A1;SLC38A5;SLC36A1;SLC7A9;SLC7A2;SLC43A2;SH3BP4;SLC7A6;SLC7A8;SLC25A44;SLC43A1;SLC7A4;PDPN;SLC7A1;SLC1A4;SLC38A7;SLC38A9;SLC38A6;SLC36A4;SLC6A6
prerank,monosaccharide transmembrane transport (GO:0015749),0.616530746916035,0.8013399754931476,0.9335,0.9640428019200692,1.0,8/17,26.00%,SLC50A1;SLC2A8;SLC5A1;SLC2A10;SLC5A3;SLC23A2;SLC5A9;SLC2A2
prerank,potassium ion transport (GO:0006813),0.6638166129525697,0.800291257371044,0.9695,0.9650578107577655,1.0,11/122,13.86%,ATP1B3;CHP1;HPN;SLC9A3;KCNMB1;KCNK5;KCNMA1;AQP1;KCNH2;PKD2;TMEM175
prerank,synaptic vesicle cycle (GO:0099504),0.6219068672323946,0.7995871638565777,0.957,0.9656082687119928,1.0,11/30,26.21%,RAB5A;DNAJC5;VAMP2;PIP5K1C;PLD2;SNAPIN;SNAP25;SNCA;STX1A;SYT7;CDK5
prerank,membrane depolarization during action potential (GO:0086010),0.6194658434443804,0.7980265289146384,0.946,0.9672027543190407,1.0,9/26,25.92%,YWHAH;KCNH2;CACNA1H;CACNA1D;SCN7A;CACNA1G;CACNA1C;SLC8A1;SCN9A
prerank,phosphorylation (GO:0016310),0.6977724910044276,0.7979408504206659,0.9875,0.9669705266119536,1.0,207/398,21.55%,YWHAZ;ILF3;IGFBP3;APP;PGK1;ERBB2;ILK;MAPK3;CSNK1A1;STK25;CTBP1;SGK1;PI4KA;FGFR1;CDK10;BRD2;GRK2;GAS6;MAST2;FASTK;CSNK1D;MKNK2;STK24;CSNK1E;CCL2;FAM20C;PIM3;AKT1;CDK4;ABL1;ERN2;PRKCZ;GLYCTK;CERK;MAP3K11;WNK2;NRBP1;PINK1;NADK;TGFBR2;CLK2;GNPTG;STK11;MARK3;CDK16;ADAM10;MAPK1;CSNK1G2;PANK3;ROCK2;BMPR2;ACVRL1;TRIB1;PRKACB;JAK1;MAPKAPK2;PRPF4B;CSK;PDK2;PPP3CB;PRKACA;TYK2;CAMK2D;DYRK2;PTK6;CDK6;CDC25B;PRKDC;PRKAB1;CLK3;TRIB2;PRKD2;MAP4K4;INSR;PPP4R1;IRAK1;TOP1;WNK1;PKN1;TOLLIP;CDK1;ULK1;DYRK1A;DAPK3;NRBP2;CDC42BPA;COQ8A;MAP3K20;PTK2B;HIPK3;TGFBR1;DGKD;PKN2;CSNK2A1;EPHB2;CDC42BPB;HK1;PEAK1;BMPR1A;AATK;COPS8;MAP4K5;FYN;BCKDK;DGKZ;TNK2;TAOK1;MAPK6;BIRC5;TKFC;MINK1;DMPK;PAK1;PAK2;CAMKK2;BIRC6;GSK3B;MAP3K12;SNRK;LIMK2;STK38;COPS2;HIPK1;GSK3A;AURKB;DGKA;PIM1;ACVR1B;PRKAA1;RARA;DGKQ;PRKCD;PLK2;BMP2K;PDPK1;PICK1;MAP4K3;AKT3;OXSR1;BCR;ROCK1;MKNK1;CDK3;CDK13;GNPTAB;EIF2AK2;GMFB;PRKAR1B;STAT3;CDK11B;RYK;GRK3;TLK1;RET;CREB1;TAOK2;NEK7;LTK;MAML1;IKBKB;RPS6KA4;MAPK10;PRKAG1;GMFG;SGK2;MTOR;MAPK8;CDK19;PRKCA;SRPK1;GRK6;AAK1;STRADB;ATM;MAP3K13;LATS1;STK39;MAP2K1;PLK1;MARK2;GK;PNKP;PRKG1;GK5;DYRK1B;CAMK4;BMP2;TLK2;DAPK1;NEK3;PAK4;SIK3;CAMK1;EIF2AK4;STK38L;MAPK9;PANK2;LMTK2;MAP4K2;PRKCI;MAP3K1;FAM20B;FNIP2;DGKH;SYK;CCNT1;HIPK2
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.6124668122806393,0.7974174674819857,0.9334667333666833,0.967259604209464,1.0,4/17,30.42%,AKAP13;RAPGEF2;ADCY9;ADRA2A
prerank,regulation of peptide hormone secretion (GO:0090276),0.6419836492659062,0.7961817614473387,0.9715,0.9683753854580693,1.0,30/74,29.23%,GCG;HADH;HNF4A;ENSA;ITPR3;SLC2A1;UQCC2;RAP1A;PPP3CB;DPP4;PICK1;PRKCA;CACNA1D;SLC8B1;EIPR1;SNAP25;CHD7;CACNA1C;GRP;STX1A;SLC2A2;PASK;SYT7;CLOCK;RAPGEF3;KCNS3;FGB;ITPR1;PER2;ITPR2
prerank,protein phosphorylation (GO:0006468),0.7030020084103805,0.7956077269775973,0.9955,0.9686899404661475,1.0,256/494,21.60%,YWHAZ;PKDCC;FGFR3;ILF3;IGFBP3;APP;ERBB2;ILK;PCK1;PDGFRB;CSNK2B;PDGFRA;MAPK3;CSNK1A1;STK25;CTBP1;PNCK;DDR1;SGK1;PKD1;FGFR1;CDK10;BRD2;GRK2;GAS6;MAST2;FASTK;CSNK1D;PRDX4;MKNK2;STK24;CSNK1E;CCL2;FAM20C;PIM3;AKT1;CDK4;RPS6KA1;ABL1;ERN2;PRKCZ;GLYCTK;MAP3K11;WNK2;NRBP1;PINK1;TGFBR2;CAB39;CLK2;STK11;EPHB4;AKT2;MARK3;CDK16;ADAM10;MAPK1;CSNK1G2;ROCK2;BMPR2;ACVRL1;PTK2;TRIB1;PRKACB;JAK1;MAPK13;EPHB3;DDR2;MAPKAPK2;PRPF4B;ULK3;FGFR4;SMG1;CSK;PDK2;PPP3CB;PRKACA;RPS6KB2;TYK2;CAMK2D;DAB2IP;DYRK2;PTK6;IGF1R;CDK6;CDC25B;PRKDC;PRKAB1;ABI2;SRC;CLK3;TRIB2;ABI1;BMP4;PRKD2;MAP4K4;HTATIP2;INSR;PPP4R1;IRAK1;TOP1;WNK1;SMAD2;PKN1;CDK1;ULK1;DYRK1A;EIF2AK1;DAPK3;NRBP2;CDC42BPA;COQ8A;MAP3K20;PTK2B;HIPK3;TGFBR1;CAD;PKN2;CSNK2A1;FGFR2;EPHB2;CDC42BPB;PEAK1;BMPR1A;AATK;COPS8;MAP4K5;FYN;BCKDK;TAOK1;MAPK6;EFEMP1;BIRC5;MINK1;MAPK14;GTF2H5;DMPK;PAK1;SLK;MAST3;PAK2;CAMKK2;BIRC6;GSK3B;MAP3K12;SNRK;LIMK2;STK38;COPS2;MAPKAPK5;TGFBR3;TYRO3;HIPK1;GSK3A;BAZ1B;AURKB;PIM1;ACVR1B;PRKAA1;RARA;DGKQ;PRKCD;PLK2;BMP2K;PDPK1;PICK1;MAP4K3;AKT3;OXSR1;BCR;ROCK1;EEF2K;MAP2K6;MKNK1;CDK3;CDK13;CSNK2A2;EIF2AK2;CSF1R;GMFB;PRKAR1B;VRK3;CDK11B;RYK;GRK3;TLK1;EGFR;TNKS;RET;CREB1;TAOK2;NEK7;LTK;MAML1;RPS6KA3;KDR;IKBKB;RPS6KA4;MAPK10;PRKAG1;GMFG;UHMK1;SGK2;MTOR;MAPK8;MAP3K7;DYRK4;CDK19;PRKCA;SRPK1;GRK6;AAK1;STRADB;ATM;MAP3K13;MAPKAPK3;ATP13A2;LATS1;STK39;MAP2K1;PLK1;RPS6KA2;MARK2;RIPK1;PRKG1;MAP3K3;DYRK1B;ERC1;CAMK4;BMP2;TLK2;DAPK1;NEK3;PAK4;SIK3;ULK2;CAMK1;EIF2AK4;STK38L;MAPK9;RPS6KB1;LMTK2;MAP4K2;PRKCI;MAP3K1;FAM20B;SMAD7;STK16;FNIP2;FLT4;CCNA2;SYK;USP15;GTF2H1;CCNT1;HIPK2;RIPK3
prerank,RNA methylation (GO:0001510),0.6361979913717127,0.7949275220090648,0.969,0.9691333351920813,1.0,41/60,30.85%,TRMT112;WDR6;FBL;WTAP;NSUN5;METTL3;TARBP1;BUD23;RBM15B;MTERF4;MEPCE;ZC3H13;NSUN2;METTL5;PCIF1;FTSJ3;VIRMA;TRMT61A;FTSJ1;CMTR1;MRM2;GTPBP3;DIMT1;THUMPD2;TRMT13;THUMPD3;METTL16;TRMT10C;MTO1;TYW3;METTL1;TRMT61B;METTL14;THADA;TGS1;RBM15;NOP2;TRMT5;NSUN4;CBLL1;METTL2B
prerank,B cell activation involved in immune response (GO:0002312),0.6150036043725313,0.7936513770785112,0.924,0.9702302090381184,1.0,9/15,35.80%,MSH6;EXOSC6;MSH2;RNF168;RNF8;EXOSC3;LIG4;GPR183;CD19
prerank,neuromuscular synaptic transmission (GO:0007274),0.6126986764083223,0.7933273309164841,0.947,0.970243324396477,1.0,10/20,34.90%,CHRNA3;KIF1B;ERC1;TBC1D24;FCHSD2;TSPOAP1;FCHSD1;CHRNB1;RIMBP2;DTNA
prerank,protein localization to cilium (GO:0061512),0.6191346913744826,0.7910394611789014,0.967,0.9723542380888831,1.0,21/34,32.48%,CSNK1D;EHD1;IFT20;ARL3;RABEP1;ATP6V1D;IFT122;RAB29;TUB;WDR19;TCTN1;IFT140;TULP3;BBS4;ZNF423;TTC21B;FAM149B1;WDR35;TMEM107;NPHP4;TCTN2
prerank,regulation of regulated secretory pathway (GO:1903305),0.6159233808982848,0.7883726512900853,0.965,0.9746895674620544,1.0,15/34,27.88%,RAB5A;PREPL;RAB3D;GSK3B;SYT11;RAB27A;SNAPIN;RAB15;SYT13;RIMS3;SYT1;UNC13D;DTNBP1;SYT7;VPS18
prerank,DNA replication checkpoint signaling (GO:0000076),0.6060190411621552,0.7880614725389944,0.9555,0.9746534117570418,1.0,14/17,38.55%,NAE1;CDT1;RAD9A;TOPBP1;TIMELESS;RAD17;ZNF830;HUS1;CDC45;CDC6;TICRR;DNA2;ORC1;TIPIN
prerank,heterocycle biosynthetic process (GO:0018130),0.6018185585267348,0.7842178799456072,0.9495,0.9778787904866824,1.0,11/15,38.36%,PYCR1;PYCR2;MOCS2;LIAS;NFS1;GPHN;GCH1;PYCR3;MOCS3;MOCS1;ALOX5
prerank,regulation of transposition (GO:0010528),0.6033952188409706,0.7815486951703472,0.9555,0.9798597103410377,1.0,4/21,23.73%,SIRT7;UBR2;SMYD5;APOBEC3C
prerank,amino acid import across plasma membrane (GO:0089718),0.605652340734346,0.7754149650180255,0.9655,0.9842045472335065,1.0,10/24,30.81%,SLC3A2;SLC1A5;SLC1A1;SLC36A1;SLC7A2;SLC16A2;SLC7A8;SLC7A1;SLC1A4;SLC6A9
prerank,ganglioside biosynthetic process (GO:0001574),0.5970739745144469,0.7751450199756813,0.9525,0.9840474290632525,1.0,11/15,37.25%,B4GALT5;ST3GAL2;ST6GALNAC4;ST6GALNAC3;B3GALT4;ST3GAL5;ST3GAL1;B4GALT6;ST8SIA2;ST8SIA4;ST6GALNAC5
prerank,male meiosis I (GO:0007141),0.5971354383793872,0.7750365142879715,0.958,0.9837821441391323,1.0,6/16,36.83%,FOXJ3;FOXJ2;ING2;ZSCAN21;MYBL1;MOV10L1
prerank,tRNA processing (GO:0008033),0.622843309344093,0.7749884800278873,0.9865,0.9834718719707413,1.0,54/59,36.67%,CPSF1;RTRAF;SSB;QTRT1;DDX1;RTCB;URM1;TSEN34;POP5;TRMT1;ELAC2;POP7;TRPT1;ZBTB8OS;ELP5;NSUN2;TSEN54;THUMPD1;DTWD1;TRMT61A;FTSJ1;RPP21;RPP30;FAM98B;CPSF4;TSEN15;THG1L;ADAT2;TRMT10C;PTCD1;METTL1;TRUB1;TRIT1;CTU1;CDKAL1;AARS2;FARS2;TSEN2;CTU2;TRMT10B;QTRT2;TYW5;CSTF2;NSUN6;WDR4;ANKRD16;TRNT1;ADAT1;TRMT6;CLP1;PUS3;POP1;TRMT9B;LCMT2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.6111948032039747,0.7724285710933176,0.9865,0.9848869493317625,1.0,18/46,33.39%,CCL2;TPRG1L;PTK2B;SHANK3;NLGN2;DGKZ;MEF2C;ATAD1;TSHZ3;SYT1;CDK5;CDH2;MAPK8IP2;NRXN1;ATP1A2;RELN;GRIK3;NLGN3
prerank,RNA modification (GO:0009451),0.6194476796817018,0.7714568952431334,0.9885,0.9851615970897492,1.0,46/56,35.42%,NOP10;ADAR;SSB;QTRT1;NSUN5;METTL3;TSR3;URM1;RBM15B;TRMT1;MEPCE;ELP5;NSUN2;FTSJ3;THUMPD1;JMJD6;ADARB1;DTWD1;TRMT61A;FTSJ1;MRM2;NAT10;THG1L;ADAT2;METTL1;TRUB1;TRIT1;PARN;CTU1;PUS7L;CDKAL1;RBM15;NOP2;AARS2;NSUN4;PUS7;CTU2;QTRT2;TYW5;TFB1M;ALKBH1;NSUN6;WDR4;ANKRD16;HENMT1;TRMT6
prerank,tRNA modification (GO:0006400),0.6163459303557635,0.7658596104236409,0.991,0.988139715168503,1.0,57/63,37.33%,TRMT112;WDR6;SSB;QTRT1;TARBP1;URM1;OSGEP;TRMT1;TPRKB;ELP5;NSUN2;THUMPD1;DTWD1;TRMT61A;FTSJ1;PUS1;GTPBP3;THUMPD2;THG1L;PUSL1;TRMT13;ADAT2;THUMPD3;MTO1;TYW3;METTL1;TRMT61B;TRUB1;TRIT1;THADA;CTU1;CDKAL1;TRMT5;AARS2;DUS2;METTL2B;TYW1;PUS7;CTU2;QTRT2;TYW5;TRMT44;ALKBH1;NSUN6;WDR4;ANKRD16;METTL2A;TRMT6;TRMO;MOCS3;PUS10;PUS3;TRMT9B;LCMT2;METTL6;TRMT12;BCDIN3D
prerank,positive regulation of dendrite extension (GO:1903861),0.5869444014472351,0.7598692798099643,0.9685,0.9907963587780673,1.0,7/17,32.39%,NEDD4L;ITSN2;SMURF1;SYT1;RNF157;PLAA;CPNE5
prerank,regulation of dendrite extension (GO:1903859),0.5865288816708314,0.7589605461447642,0.9745,0.9908751149296858,1.0,7/18,32.39%,NEDD4L;ITSN2;SMURF1;SYT1;RNF157;PLAA;CPNE5
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.5930909478701486,0.7585271482903144,0.986,0.9907268676277181,1.0,13/31,27.07%,SYT11;RAB3GAP1;REST;CACNA1H;STXBP1;STXBP3;CACNA1G;SYT13;SCAMP5;SYT1;STX1A;SYT7;DOC2B
prerank,B cell receptor signaling pathway (GO:0050853),0.5927668107595317,0.7549171115968838,0.9915,0.9918990411744123,1.0,14/34,28.77%,BCAR1;BAX;VAV3;PLEKHA1;CD79A;CD79B;MEF2C;RFTN1;SYK;MS4A1;BCL2;PLCG2;NFATC2;PTPRC
prerank,meiosis I (GO:0007127),0.5805098165159991,0.7487700955745873,0.9855,0.9937864667133499,1.0,9/25,36.83%,PTTG1;FOXJ3;BCL2L11;FOXJ2;ING2;SGO2;ZSCAN21;MYBL1;MOV10L1
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.5757197213593404,0.7469608911747585,0.9715,0.9940078294368492,1.0,11/16,37.37%,LARGE1;ST6GALNAC4;ST6GALNAC3;B3GALT4;ST3GAL5;B4GALT6;ST8SIA2;ST8SIA4;A4GALT;ST6GALNAC5;ST8SIA1
prerank,regulation of AMPA receptor activity (GO:2000311),0.5790489518462667,0.7430577783005711,0.987,0.9948211618494771,1.0,14/25,40.24%,SHANK3;NLGN2;MINK1;MEF2C;MAPK8IP2;ARC;CNIH2;RELN;NLGN3;PRRT1;NLGN1;CACNG4;SHISA9;CNIH3
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.5711203436839287,0.7425365720473717,0.9759879939969985,0.9946276702278518,1.0,6/15,38.93%,HOMER3;DAGLB;DAGLA;GRIK3;HOMER1;HOMER2
prerank,regulation of dopamine secretion (GO:0014059),0.574454644811383,0.7408518286628679,0.9925,0.9947296500747242,1.0,7/25,26.18%,SYT11;GDNF;SYT13;SNCA;SYT1;DTNBP1;SYT7
prerank,cilium-dependent cell motility (GO:0060285),0.5703379582796431,0.7373290500239958,0.9915,0.9952300490712517,1.0,6/22,31.24%,GAS8;EFHC1;DNAH1;DNAAF2;RFX3;CFAP44
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.5626465160480397,0.7285756788622242,0.9895,0.9966212065886377,1.0,10/18,39.37%,NAPA;UNC13B;NAPB;GRIK5;SLC1A4;GRIK3;GRIA2;GRIK1;GRIK2;GRID1
prerank,axoneme assembly (GO:0035082),0.5387969620123987,0.6933803146519023,1.0,0.9997608473773177,1.0,12/31,40.40%,TTLL3;SPAG16;GAS8;DCX;DNAAF2;SPAG1;TOGARAM1;TTC12;RSPH9;TTC26;CCDC40;RSPH1
prerank,cilium movement (GO:0003341),0.5396035270247046,0.6848414864056962,1.0,0.9997916279573366,1.0,7/43,30.68%,CAMSAP3;DNAAF5;GAS8;DNAH1;DNAAF2;DNHD1;SPEF2
prerank,piRNA metabolic process (GO:0034587),0.5251592331484127,0.6790673034052175,0.998,0.9996617609285818,1.0,8/19,43.21%,GPAT2;PIWIL4;HENMT1;MYBL1;MOV10L1;PLD6;PIWIL2;TDRKH
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5204376399546881,0.6755810424306661,0.995,0.9994292528515759,1.0,7/16,43.35%,IL18;IL17D;DDX58;IL1B;CARD9;ISL1;CD84
prerank,axonemal dynein complex assembly (GO:0070286),0.5113417993336167,0.6614518929295956,1.0,0.9994086821205563,1.0,8/25,39.67%,DNAAF5;DNAH1;DNAAF2;SPAG1;DNAL1;LRRC49;TTC12;CCDC40
